2018 Synapse Publications Report...online before print articles . Retrospective content dating back...

1 OF 288

MSK LIBRARY | 2018 SYNAPSE PUBLICATIONS REPORT

LIBRARYMEMORIAL SLOAN KETTERING CANCER CENTER

M A K E T H E CO N N E C T I O N

2018 Synapse Publications Report

2 OF 288


Contents

Director’s Welcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4About Synapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

ORCID@MSK: The Value of Having an ORCID Record . . . . . . 5

People . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6Top Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

New Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15Journal Subject Coverage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

Journal Articles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

Meeting Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Top Five Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Top Journals by Subject Category . . . . . . . . . . . . . . . . . . . . . . 17

Works . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18Highly-Cited Papers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18

Top-Scoring Papers via Altmetric . . . . . . . . . . . . . . . . . . . . . . . 19

Research Collaborations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20

Research Collaborations: International . . . . . . . . . . . . . . . . . . . 21

Research Collaborations: United States . . . . . . . . . . . . . . . . . . 22

Bibliography of Works . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23Journal Articles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Conference Papers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193

Meeting Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196

Book Sections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .280

Whole Books . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .286

Contact Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288

3 OF 288


Director’s Welcome

Synapse is the authoritative database of MSK publications developed and maintained by the Library . Through the written word, this publicly accessible resource showcases the research of our scientists, physicians/clinicians, nurses, and other healthcare professionals . We presently have almost 70,000 entries [references] dating back to 1994, representing both current and former employees . For this reporting period (as of 05/31/19), there were 4,602 works vetted in 2018 .

All references found in this report were pulled from five commercial bibliographic databases . These citations were then reviewed in detail, assessed, and uploaded into Synapse by a team of information professionals led by Jeanine McSweeney, Associate Librarian, Scholarly Communications .

I am delighted to share the 2018 Synapse Publications Report . This online documentation is a testament to the dedication of our authors in conducting innovative and collaborative research . I hope that readers will enjoy reviewing the research and clinical activities associated with Memorial Sloan Kettering Cancer Center, as well as appreciate the commitment required to maintain this indispensable resource .

Donna Gibson Director of Library Services

Christopher Boire, Janet Burka, Marina Rosenfield, Jeanine McSweeney (Not pictured: Eric Muzzy)

4 OF 288


Introduction

About Synapse Synapse is a collection of author profiles providing access to publications that are the result of research conducted at Memorial Sloan Kettering . The MSK Library developed Synapse in order to increase the visibility of and promote the work and collaboration of MSK researchers, clinicians, nurses, and healthcare professionals, ensuring that their publications are discoverable .

To populate Synapse, the following commercial databases are searched for publications with an affiliation of “Memorial Sloan Kettering Cancer Center” and other name variations:

• Scopus – science, technology, medicine, social science, and arts & humanities

• Web of Science – biochemistry, biology, biotechnology, chemistry, medicine, neuroscience, oncology, pediatrics, pharmacology, psychiatry, & surgery

• BIOSIS Citation Index – biochemistry, bioengineering, biology, biotechnology, life sciences, sciences, medicine, psychology, & life science

• CINAHL – nursing and allied health

• PsycINFO – psychology & related disciplines

Librarians then manually vet each record to eliminate duplicates, verify citation details, add identifiers (DOI, PMID, PMCID), standardize metadata, and identify the appropriate MSK authors . New content is added monthly, excluding in-press, epub, and online before print articles . Retrospective content dating back

to 1884 is scheduled for inclusion . As of May 15, 2019, Synapse contains content dating back to 1994 .

2018 Works: 4,602

3,018 Journal Articles

1,459 Meeting Abstracts

85 Book Sections

36 Conference Papers

4 Whole Books

1,666 (55%) Of 2018’s journal articles

are NIH funded*

*In Synapse, a “journal article” may refer to a research article,

review/survey, editorial, letter or chapter in a monographic series .

Only peer-reviewed articles are required to cite NIH funding .

5 OF 288


Introduction

ORCID@MSK: The Value of Having an ORCID RecordThere are many MSK authors who now have a unique ORCID identifier that helps to distinguish and ensure their research outputs are correctly attributed to them . The information found in their ORCID record is and has always been under their control . Researchers can set the level of privacy on what can or cannot be viewed and they determine what is publicly available, private, or shared with trusted third parties (e .g . MSK Library) .

In addition, an author can add his/her biography, employment history, education and qualifications, funding, and publications (works) . Links to variant name formats, relevant websites, or other IDs can be included . The researcher’s name, published name, biography, and email addresses need to be added manually, but all other fields can be populated by connecting the ORCID iD with other information systems .

ORCID@MSK works with Synapse (MSK Publication Database), to populate the Author’s ORCID record . There are also other databases available that save the researcher’s time in updating their record . CrossRef, ResearcherID (Web of Science), and Scopus, are just three resources that can be leveraged to populate their ORCID record . And believe it or not, the maximum number of works an author can add to their ORCID record is 10,000!

Publishers are beginning to require that authors include their ORCID iD during the manuscript submission process which presents an opportunity for researchers to take full advantage of setting up their ORCID record to include more than just their unique identifier . An ORCID record travels with them wherever they go . The best part of having an ORCID iD and record is that the content is tied to the individual and not the institution .

More About ORCID@MSK

Informational page: https://library .mskcc .org/services/orcid-at-msk

FAQs: https://library .mskcc .org/help/faq/orcid

Registration homepage: https://synapse .mskcc .org/orcid

As of May 2019, 1,109 (25% of) authors currently employed at MSK have registered their ORCID iDs with our service .

https://library.mskcc.org/services/orcid-at-msk

6 OF 288


Top AuthorsAs new works are added to Synapse, the Synapse team consults the original published documents to find out which authors list MSK as an affiliation . We then use resources provided by Human Resources and Public Affairs to identify which employees match each of the named authors . When a match is confirmed, we “verify” the author on the work so that it becomes linked to the author’s profile page .

New authors may be discovered at this point, and if so, profile pages are created and the author is notified by email .

The top 10 most prolific authors* of 2018, include:

People

Sergio A . Giralt, MD 87 Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple Myeloma

Marc Ladanyi, MD 65 Chief, Molecular Diagnostics Service; William J . Ruane Chair in Molecular Oncology

Martin S . Tallman, MD 61 Chief, Leukemia Service

Nancy Y . Lee, MD, FASTRO 59 Vice Chair, Department of Radiation Oncology; Service Chief, Head & Neck Radiation Oncology; Director, Proton TherapyS

Jedd D . Wolchok, MD, PhD 56 Lloyd J . Old/Virginia and Daniel K . Ludwig Chair in Clinical Investigation; Chief, Melanoma & Immunotherapeutics Service; Director, Parker Institute for Cancer Immunotherapy at MSK; Associate Director, Ludwig Center for Cancer Immunotherapy

Matthew D . Hellmann, MD 55 Medical Oncologist

Sean M . Devlin, PhD 55 Assistant Attending Biostatician

Joseph O . Deasy, PhD 52 Chair, Department of Medical Physics; Enid A . Haupt Chair in Medical Physics

Miguel-Angel Perales, MD 53 Deputy Chief, Adult Bone Marrow Transplant Service; Director, Adult Bone Marrow Transplantation Fellowship Program

Maria E . Arcila, MD 54 Director, Diagnostic Molecular Pathology Laboratory

Robert J . Motzer, MD 52 Jack and Dorothy Byrne Chair in Clinical Oncology

Ross L . Levine, MD 52 Laurence Joseph Dineen Chair in Leukemia Research; Director, MSK Center for Hematologic Malignancies

*Note: five authors tied for number of works published

7 OF 288


New Authors

Afuye, Aishat Olaide Medicine

Aghalar, Jahan Medicine

Ahern, Jennifer Marie Neurology

Aleynick, Nathaniel Collaborative Research Centers - PIC Directed

Allgood, Natasha B Medical Physics

Almassi, Nima Graduate Staff

Andrejko, Marci Advanced Practice Providers

Anopa, Jenny Research and Technology Management

Arango Ossa, Juan Esteban Collaborative Research Centers - PIC Directed

Aslam, Anoshe A Medicine

Atiq, Mohammad SKI Medicine

Aypar, Umut Pathology

Azizi, Elham Computational and Systems Biology Program

Bahgat, Alexandra Medicine

Baik, Jee Yeon Pathology

Bailey, Kayleen Amelia Graduate Staff

Bal, Susan Graduate Staff

Bala, Neeta SKI Medicine

Bale, Tejus Pathology

Ball, Brian John Graduate Staff

Bandlamudi, Chaitanya Collaborative Research Centers - PIC Directed

Banerjee, Ankan Molecular Biology

Baptiste, Renise Research Facilities

Barrow, Brooke Biostat/Epidemiology

Batalha, Jason Louis Silva Advanced Practice Providers

Bates, David Dawson Bartlett Radiology

Batista, Jeanette Nursing

Baytshtok, Vladimir Structural Biology

Behr, Gerald Gideon Radiology

Bendheim, Gemma A Medicine

Benhamida, Jamal Khalil Pathology

Beras, Amanda Marie Pathology

Bernal, Camila Medicine

Bernie, Helen Levey Graduate Staff

Binyamin, Anna Immunology

Blouin, Amanda Germaine Laboratory Medicine

Blouin, William Research Service Centers

Blum, Kyle SKI Surgery

Boelens, Jaap Jan Pediatrics

Boerner, Thomas SKI Surgery

Bolton, Kelly Leigh Medicine

Boltyanskiy, Rostislav G SKI Radiology

Bourne, Sam Lloyd General & Administrative

Bourque, Caitlin Collaborative Research Centers - PIC Directed

Bowden, Jill Marie Psychosocial Support

Bowers, Jennifer Marie SKI Psychiatry/Counseling

Bowman, Anita S Pathology

Bracken, Deirdre Anne Ld - Advanced Practice Providers

Brown, David Norman SKI Pathology

Buckley, Michael Thomas Research and Technology Management

Burdziak, Cassandra Graduate Studies

Bustillo, Maria E Graduate Studies

Cabriolu, Annalisa Immunology

Cadet, Kechna SKI Psychiatry/Counseling

Cadete Portelinha, Ana SKI Medicine

Cai, Weixing Westchester

Cai, Yanyan SKI Pathology

Campanella, Gabriele Graduate Studies

Cannon, Maureen Elizabeth Ld - Advanced Practice Providers

Canny, Megan L Health Informatics

Cao, Fang Qiong Pathology

Capaci, Catherine Medicine

In 2018, Synapse profiles were created for the following 584 MSK employees:

Author Profiles in Synapse (14,588)

4,470 Current employees*

10,118 Former employees

*as of May 3, 2019

8 OF 288


New Authors

Carbone, Emily Ann Medicine

Carollo, Gabriella SKI Radiology

Caso Jr, Raul SKI Surgery

Chan, Angela Advanced Practice Providers

Chan, Hei Ton Main Campus Outpatient Services

Chan, Jason Earl Graduate Staff

Chang, Cara A Pharmacy

Chansakul, Aisara Medicine

Chapman-Lim, Jessica R Pathology

Chatila, Walid Khaled Graduate School Administration

Chaudhari, Jagrutiben Research Facilities

Chavan, Shweta S Collaborative Research Centers - PIC Directed

Cheleuitte-Nieves, Christopher Research Facilities

Chen, Hsuan An Graduate School Administration

Chen, Jian Laboratory Medicine

Chen, Patricia Anne Medicine

Chen, Xi Graduate Studies

Cheng, James W Development

Chervin, Jordan Medicine

Chilov, Marina Information Systems

Chin, Joanne Radiology

Chinapen, Stephanie Amalie Noelle Medicine

Chiu, Yeneat O Strategy and Innovation

Cho, Nicholas Radiology

Chong, Curtis Medicine

Chou, Chun Immunology

Chu, Karen Graduate Studies

Clurman, Annelie G Medicine

Cobovic, Armend SKI Surgery

Coffman, Kelley Medicine

Colletti, Michelle L Ld - Advanced Practice Providers

Corbett, Virginia Graduate Staff

Cordner, Keith Bryan Human Oncology and Pathogenesis Program

Coriddi, Michelle Renee Surgery

Corsale, Lorraine Pathology

Cortes, Melissa Advanced Practice Providers

Cost, Zachary H Radiation Oncology

Cruz, Elizabeth Maria MSK At 53 Street

Cue, Jessica Fay Antonio MSK At 53 Street

Cuomo, Stacey Jennifer MSK 60th Street

Dacek, Megan Graduate Studies

Damron, Dorothy J Research and Technology Management

Dason, Shawn Graduate Staff

Davis, Erin K 64th Street

Davis, Margaret 64th Street

Dawson, Melissa Christina Radiation Oncology

De Frank, Stephanie Medicine

De La Cruz, Michael Jason V Research Facilities

Dean, Lucas Wyatt Graduate Staff

Dearie, Helen Farrell Ld - Advanced Practice Providers

Debonis, Dylan Radiation Oncology

Deng, Zihou Immunology

DeOcampo, Rommel V Radiology

DePaola, Nadia Emerick-Kralovic Ld - Advanced Practice Providers

DeRito, Janice L Integrative Medicine

Deslauriers, Andre SKI Epidemiology/Biostatistics

Dhawan, Vikram Anesthesiology

Diab, Victoria Nursing

Diaz Salazar Albelda, Carlos Graduate Studies

Dick-Godfrey, Rosalind Celeste Radiation Oncology

Dicostanzo, Joanna N Medicine

Dinatale, Renzo Giuseppe SKI Surgery

Diosdado Rodriguez, Monica Sofia Pathology

Donoghue, Timothy Joseph Anesthesiology

Dorsey, Colleen Nursing

Dorso, Madeline Anne Graduate Studies

Dsouza, Crisbane Pathology

Dubard Gault, Marianne Emmanuelle Graduate Staff

Duran, Mercedes A Human Oncology and Pathogenesis Program

Durani, Vidushi Human Oncology and Pathogenesis Program

Durney, Christina M Pediatrics

Duzgol, Cihan Graduate Staff

Echeverry, German Anesthesiology

Egorova, Anastasiya SKI Medicine

Ejaz, Anam Graduate Studies

El Jalby, Mahmoud Graduate Staff

Elezovic, Daniela Pathology

9 OF 288


New Authors

Elguindi, Sharif Medical Physics

Elko, Theresa Ann Ld - Advanced Practice Providers

Emoto, Katsura SKI Surgery

England, Christine Marie Hospital Administration

English, Crystal L Health Informatics

Erazo Andrade, Ingrid Tatiana SKI Medicine

Eskreis-Winkler, Sarah Graduate Staff

Evans, Nancy A MSK at 53 Street

Fan, Dan SKI Radiation Oncology

Fansler, Mervin M Graduate School Administration

Faruque, Promie Ruhini Corporate

Featherstone, Ashley BAIC

Feit, Noah Z Graduate Staff

Fenelus, Maly Laboratory Medicine

Feng, Elvin Research Facilities

Fernandez, Jimmy Quality of Care Initiative

Ferrari, Christine Commack

Filippova, Olga Timurovna Graduate Staff

Fiordaliso, Christine M MSK at 53 Street

Fischer, Gregory Walter Anesthesiology

Fitzgerald, Kelly Jean Graduate Staff

Fitzpatrick, Cristy B Ld - Advanced Practice Providers

Flynn, Jessica Biostat/Epidemiology

Freeman, Rachel Tooley Ld - Advanced Practice Providers

Fridman, Yuliya Research and Technology Management

Fromme, Rachel SKI Surgery

Fujisawa, Yumi SKI Pathology

Fung, Maggie Radiology

Furuta, Yasuhide Research Facilities

Gatarny, Redwane SKI Psychiatry/Counseling

Gaviria, Ervin Human Resources

Gearty, Sofia Elena Vaccarino Graduate School Administration

Ged, Yasser Mohamed Ali Graduate Staff

Gedvilaite, Erika SKI Pathology

George, Login S SKI Psychiatry/Counseling

Gharzeddine, Karem Graduate Staff

Ghione, Paola SKI Medicine

Gillespie, Erin Faye Radiation Oncology

Gjonbalaj, Mergim Immunology

Glodzik, Dominik Collaborative Research Centers - PIC Directed

Goel, Reema Graduate Staff

Goh, Alvin Chun chin Surgery

Gonzales, Junior SKI Radiology

Gonzalez, Carlene Research Facilities

Goodman, Tawni Clark Medicine

Goos, Jeroen Adrianus Cornelis Maria SKI Radiology

Gorelick, Alexander Graduate Studies

Gorenshteyn, Dmitriy Strategy and Innovation

Gottesdiener, Lee Graduate Staff

Gourkanti, Saroj R Molecular Pharmacology Program

Graham, Maya Srikanth Graduate Staff

Greally, Megan Graduate Staff

Green, Angela Kellen Medicine

Guo, Yan Wei Nursing

Gupta, Sounak Graduate Staff

Gutgarts, Victoria Graduate Staff

Guzman, Sean Research Facilities

Hailemariam, Mimi Ld - Advanced Practice Providers

Hall, Malloury W Research and Technology Management

Hammel, Jennifer Nursing

Hampton, Oliver Alexander Collaborative Research Centers

Hamrokulova, Aziza Research Facilities

Hancock, Helen Nursing

Hanna, Matthew George Pathology

Hannum, Margaret L Biostat/Epidemiology

Harrington, Kate Anne Radiology

Harrison, Mabel Lou Ann Outpatient Rehab Facility

Harschnitz, Oliver Developmental Biology

Hasan, Maysun M Collaborative Research Centers - PIC Directed

Haviland, Ingrid Christina Integrative Medicine

Haywood, Samuel Graduate Staff

Hedal-Siegel, Jane Patient Support Svcs

Henchcliffe, Claire Neurology

Herman, Koby Graduate Staff

Hernandez, Karen Bergen

Hickey, Christine Communications Public Affairs

Hiestand, Brian MSK 60th Street

Hite, Richard Kevin Structural Biology

10 OF 288


New Authors

Ho, Alan Neurology

Ho, Yu-jui Cancer Biology and Genetics

Hoidra, Carol Research and Technology Management

Hou, Shengqi Human Oncology and Pathogenesis Program

Houck-Loomis, Brian Robert Collaborative Research Centers - PIC Directed

Houghton, Sean Health Informatics

Hsieh, Wilson Human Oncology and Pathogenesis Program

Hu, Yu Pathology

Huang, Melody Ou Neurology

Huang, Sheng Graduate Staff

Huang, Xiaojing Graduate Staff

Huicochea Castellanos, Sandra Radiology

Hussain, Ibrahim Graduate Staff

Hussain, Suleman S SKI Radiation Oncology

Isik, Mehtap Graduate Studies

Italiano, Deborah A MSK at 53 Street

Jackson, Ashley Medical Physics

Jain, Tania Graduate Staff

James, Monique C Psychiatry Service

Jannetti, Stephen A SKI Radiology

Jean-Charles, Dominique S Case Management

Jia, Liwei Graduate Staff

Johnson, Ian Collaborative Research Centers - PIC Directed

Jones, Gregory SKI Surgery

Jones, Heather Frances Graduate Studies

Jutagir, Devika RuthSKI Psychiatry/Counseling

Kabel, Charlene Claire Pharmacey

Kane, Peter T Medicine

Kapinos, Yvonne Lau Anesthesiology

Kasbekar, Priyanka Pratod Medicine

Katzman, Braden Michael Harris Developmental Biology

Kaufmann, Erica Susan Advanced Practice Providers

Kelly, Brian Christopher Psychosocial Support

Kelly, Virginia Bowen Medicine

Kenan, Shachar Graduate Staff

Kenney, Jessica Marie Biostat/Epidemiology

Kennington, Jessica Strategic Partnerships

Kiesgen, Stefan Thomas SKI Surgery

Kiguchi, Hiroto Pediatrics

Kilkenny, Dawn Psychosocial Support

Kim, Joseph Kiho SKI Radiation Oncology

Kim, Rachel K Medicine

Kim, Taewan Developmental Biology

Kim, Young Suk Collaborative Research Centers - PIC Directed

Kiseliovas, Vaidotas Computational and Systems Biology Program

Kit, Yulia Ld - Advanced Practice Providers

Kivovich, Violetta Pediatrics

Klages, Peter Edward SKI Medical Physics

Klatt, Martin Gunther Molecular Pharmacology Program

Kleber, Julie Diane Nursing

Knezevic, Andrea Biostat/Epidemiology

Koch, Matthew James Research and Technology Management

Kothari, Prachi Dilip Pediatrics

Kracun, Mihaela Pathology

Krasnopolsky, Isaac M Molecular Pharmacology Program

Kumar, Priyadarshini Graduate Staff

Kuo, Hsiang-Chi Medical Physics

Lafontaine, Daniel Medical Physics

Lagdamen, Liza Lee Ld - Advanced Practice Providers

Laks, Dan R Cancer Biology and Genetics

Laraque, Leana Medicine

Latham Schwark, Alicia Jil Medicine

Latte-Naor, Shelly Integrative Medicine

Lavallee, Vincent Philippe Computational and Systems Biology Program

Lee Chuy, Katherine Graduate Staff

Lee, Anna Graduate Staff

Lee, Chan Graduate Studies

Lee, Christopher Adam Development

Leibold, Josef Cancer Biology and Genetics

Lengfellner, Joseph Michael Research and Technology Management

Lertpiriyapong, Kvin Research Facilities

Levine, Kathleen Ann MSK at 53 Street

Levine, Max Collaborative Research Centers - PIC Directed

Levy, Olivier Immunology

Lewis, Clare Molecular Biology

Lezcano Lopez, Maria Cecilia Pathology

Li, Bing Human Oncology and Pathogenesis Program

11 OF 288


New Authors

Li, Christy Y Graduate Studies

Li, Jia Medicine

LI, QING Human Oncology Pathogenesis Program

Li, Shibai Molecular Biology

Li, Shun Immunology

Li, Zhuoning Research Facilities

Lichtenwalner, Phillip Glenn Basking Ridge

Lin, Emily Y Research Facilities

Lin, Yi-Chih Pediatrics

Liu, Ying Graduate Staff

Lochansingh, Savanah Research Service Centers

Lopez Rodrigo, Estibaliz Pediatrics

Lopez, Katherine Pathology

Low, Vi Vien Research Facilities

Loyher, Pierre-Louis Marcel Immunology

Luckett, Kathleen A Human Oncology and Pathogenesis Program

Lui, Jo Weng Allan Graduate Staff

Lukaszewicz, Agnieszka Developmental Biology

Luo, Hanzhi Molecular Pharmacology Program

Lynch, Kathleen A SKI Psychiatry/Counseling

Maaaag, Jesper Lars Viktor Collaborative Research Centers - PIC Directed

Maciag, Lidia Pathology

Mack, Kyle Neurology

Maeda, Masatomo Molecular Pharmacology Program

Makkar, Priyanka Sham Graduate Staff

Mamoor, Maha Biostat/Epidemiology

Manne, Malbora Westchester

Mao, David Graduate Staff

Maples, Kathryn T Pharmacy

Marcelli, Annarita Medicine

Marciscano, Ariel Elan Radiation Oncology

Marco, Michael SKI Surgery

Markey, Kate Ann Medicine

Masilionis, Ignas Computational and Systems Biology Program

Mason, Emilia Structural Biology

Massler, Jessica R Surgery

Masson, Geema Shetty Anesthesiology

Mastrogiacomo, Brooke Medicine

Mathews, James C SKI Medical Physics

Mato, Anthony R Medicine

Matthews, Leslie Victoria Ld - Advanced Practice Providers

Mayers, Dave L Nursing

Mazutis, Linas Computational and Systems Biology Program

Mcalpine, Jessica L Developmental Biology

McCaskey, Sarah Woods Ld - Advanced Practice Providers

McCormack, Maura Anne Pathology

McCormick, Patrick J Anesthesiology

McGovern, Erin M Collaborative Research Centers - PIC Directed

Mcgriskin, Rory Nora Molecular Pharmacology Program

McHugh, Deaglan Joseph Medicine

Mcintyre, Caitlin Anne SKI Surgery

McKeown, Andrew Thomas Research and Technology Management

Mcknight, Dominique Radiation Oncology

McPherson, Victor Allon Graduate Staff

Mehta, Vishisht Graduate Staff

Melcer, Myra Beth Medicine

Mendoza, Alejandra Immunology

Menzer, Christian SKI Medicine

Merlinsky, Tiffany Human Oncology and Pathogenesis Program

Messinger, John Conrad SKI Surgery

Midya, Abhishek SKI Surgery

Milli, Lisania I Ld - Advanced Practice Providers

Mimica, Ximena Sofia SKI Surgery

Misale, Sandra Molecular Pharmacology Program

Modi, Lauren Elizabeth Bailey Neurology

Modlin, Leslie Ann Graduate Staff

Mondaca Contreras, Sebastian Patricio Graduate Staff

Moore, Gillian F Medicine

Muller, Stephanie Graduate Staff

Mun, Sung Soo Molecular Pharmacology Program

Murphy, Kristie Anne Nursing

Myers, Mackenzie Medicine

Na, Na Molecular Pharmacology Program

Nadeem, Saad SKI Medical Physics

Nakajima, Reiko SKI Radiology

Namakydoust, Azadeh Medicine

Narang, Bharat Psychiatry Service

Nautiyal, Astha Immunology

12 OF 288


New Authors

Navarrete, Cristian Patricio SKI Medicine

Navid-Azarbaijani, Pedram Graduate Staff

Nawaly, Karla Pediatrics

Nicholas, Kevin Joseph Strategy and Innovation

Nicoletti, Eileen Marie Pediatrics

Nie, Xingyu SKI Medical Physics

Nikolovski, Ines Radiology

Nobel, Tamar B SKI Surgery

Noch, Evan K Graduate Staff

Nurili, Fuad Radiology

Obadi, Obadi A Medicine

O'Donnell, Devon B Medicine

Oh, Patrick Graduate Staff

Okpako, Molly MSK at 53 Street

Osborn, Alice SKI Pediatrics

Otazo Torres, Jose Ricardo Medical Physics

Ottey, Hector Human Resources

Otto, Christian A Physician in Chief

Ozaki, Kanako Cell Biology

Pacheco, Hector Oscar Research and Technology Management

Palmaira, Randze Lerie Dela Cruz Surgery

Palumbo, Dayna Ann Advanced Practice Providers

Pandya, Rutu Medical Physics

Park, Jane Collaborative Research Centers - PIC Directed

Park, Wungki Medicine

Paroder, Viktoriya Radiology

Patel, Amish J Human Oncology and Pathogenesis Program

Patel, Juber Ahamad Abdul Bari Collaborative Research Centers - PIC Directed

Patel, Mira Graduate Staff

Patterson, Pamela Case Management

Perchick, Wendy Executive VP

Perez Johnston, Rocio Radiology

Perica, Karlo Graduate Staff

Phillips, Andrea Lynne Monmouth

Phillips, Gregory Scott Graduate Staff

Pineda, John Nursing

Pirovano, Giacomo Maria SKI Radiology

Piulson, Lauren Medicine

Polcino, Tracy Marie Ld - Advanced Practice Providers

Polvorosa, Cynthia S Westchester

Poty, Sophie SKI Radiology

Pouryahya, Maryam SKI Medical Physics

Prabhakaran, Sandhya Computational and Systems Biology Program

Prather, Anne M MSK at 53rd Street

Pratt, Edwin C Graduate Studies

Puklin, Sarah Hannah 64th Street

Puno, Marc Rhyan Jimenez Structural Biology

Qeriqi, Besnik Research Facilities

Ragupathi, Ashwin SKI Radiology

Rahman, Hafsa Medicine

Rajanna, Arjun Raj SKI Pathology

Rajshekar, Srivarsha Graduate Studies

Ramanathapuram, Lalitha V Collaborative Research Centers - PIC Directed

Rana, Satshil Pathology

Rao, Sahana Dinesh Graduate Studies

Rawlins-Peters, Gayle Case Management

Ray-Kirton, Jordana A Pathology

Razzell, William Developmental Biology

Redmond, David Connor SKI Medicine

Regan, Jaclyn Physician in Chief

Rehal, Sonia SKI Surgery

Ribeiro Pereira, Patricia Manuela SKI Radiology

Rickert, Robert W Developmental Biology

Riffle, Meredith Ld - Advanced Practice Providers

Rishpon, Ayelet SKI Medicine

Rizvi, Syeda Research Facilities

Roberts, Sheryl SKI Radiology

Rocco, Gaetano Surgery

Rodriguez, Natasia Tina Nursing

Roeker, Lindsey Elizabeth Graduate Staff

Rogado, Aimee T Nursing

Rondon Clavo, Carlos Mauricio SKI Medicine

Rosado, Andrea Pathology

Rowed, Kylie A Medicine

Ruh, Peter Alfred Research Facilities

Ruscetti, Marcus Andrew Cancer Biology and Genetics

Russo, Tara Ld - Advanced Practice Providers

Rustad, Even Holth SKI Medicine

Sadeghi, Keimya Dana Biostat/Epidemiology

13 OF 288


New Authors

Sadinski, Meredith SKI Radiology

Saini, Jasmeen Kaur SKI Surgery

Salcedo, Meghan E Nursing

Salgado, Nelson R SKI Surgery

Saliu, Abiola Neurology

Samboy, Jennifer Pathology

Sams, Allison Jean Ld - Advanced Practice Providers

Samuels, Andrea Medicine

Sanchez, Alejandro Graduate Staff

Sanchez, Elisa Elena Graduate Studies

Sanchez-Escamilla, Miriam SKI Medicine

Sanchez-Rivera, Francisco Cancer Biology and Genetics

Sanford, Rachel Ann Medicine

Sanghrajka, Reeti Mayur Graduate Studies

Satty, Alexandra Melissa Graduate Staff

Schad, Sara Graduate Studies

Schmidt, Elizabeth Irene Ld - Advanced Practice Providers

Schoenfeld, Adam Jacob Graduate Staff

Schurer, Alexandra Molecular Pharmacology Program

Search, Benjamin Glenn Research and Technology Management

Segna, Alexa N BAIC

Shah, Sohrab Prakash Biostat/Epidemiology

Shah, Urvi A Medicine

Shapnik, Natalie Medicine

Sharma, Roshan Computational and Systems Biology Program

Sheppard, Sam Immunology

Shifman, Sophie SKI Pathology

Shih, Hao-Hsin Radiology

Shipman, William Graduate Staff

Shobana Ganesh, Kripa Shobana Graduate School Administration

Shrestha Bhattarai, Tripti Human Oncology and Pathogenesis Program

Siegel, Samantha Ld - Advanced Practice Providers

Sigler, Allison Marie SKI Pathology

Sikkema, Lisa Computational and Systems Biology Program

Simicich, Mira Nursing

Simon, Brett Andrew Josie Robertson Surgery Center

Simon, Claire Samantha Developmental Biology

Simon, Jennifer Ann Nursing

Sirenko, Maria Graduate School Administration

Skakodub, Anna Neurology

Smith, Alison Elizabeth Graduate Studies

Smith, Evan Scott Graduate Staff

Smith, Ryan Christopher Graduate School Administration

Sokolowski, Stefania Sophia Strategy and Innovation

Soldan, Krysten Nicole Nursing

Solomon, James Patrick Graduate Staff

Spanheimer, Philip Merle Graduate Staff

Sridharan, Ramya Graduate Studies

Staley, Jessica M Physician in Chief

Stasenko, Marina Graduate Staff

Stein, Daniel Mark Health Informatics

Stein, Seth Graduate Staff

Steinberger, Ashley 64th Street

Stewart, Caitlin Marie SKI Pathology

Stone-Molloy, Zoe Sophia Medicine

Stopsack, Konrad Hermann SKI Medicine

Strah, Tamara M Nursing

Sulis, Maria Luisa Pediatrics

Sullivan-Hendry, Anne M Outpatient Rehab Facility

Suri, Beth Pediatrics

Syed, Umar Ali Medicine

Synborski, Elisa Ld - Advanced Practice Providers

Szeglin, Bryan Charles Graduate Staff

Tadros, Audree Blythe Surgery

Takao, Sumiko Molecular Pharmacology Program

Takemoto, Naofumi Human Oncology and Pathogenesis Program

Tammela, Tuomas Cancer Biology and Genetics

Tamura, Ryo Molecular Pharmacology Program

Tao, Jessica Jing Graduate Staff

Tavitian, Elizabet Rafi Medicine

Taylor, Bradford P Computational and Systems Biology Program

Temares, Danielle Strongwater Radiation Oncology

Thompson, Erika Johanna Main Campus Outpatient Services

Thompson, Melissa Quality of Care Initiative

Tigershtrom, Ashley R SKI Psychiatry/Counseling

Tixier, Florent SKI Medical Physics

Topf, Jill Anne Radiation Oncology

14 OF 288


Trapani, Michael D Patient Financial Services

Tully, Kathryn Margaret Graduate Studies

Turner, Ryan Pediatrics

Tutino, Rebecca C SKI Psychiatry/Counseling

Uhlitskykh, Khrystyna Medicine

Um, Hyemin SKI Medical Physics

Uprety, Rajendra Molecular Pharmacology Program

Uraoka, Naohiro SKI Pathology

Urbano, Starr BAIC

Vanderbilt, Chad Michael Pathology

Varghese, Melissa Shaji Radiation Oncology

Vasani, Naresh B Human Oncology and Pathogenesis Program

Vassallo, Carla M MSK at 53rd Street

Vemuri, Shreya Research Service Centers

Vincenzino, Adrienne Medicine

Vojnic, Morana SKI Pathology

Von Keudell, Gottfried Medicine

Von Morgen, Patrick Joel Molecular Biology

Vorkas, Charles Immunology

Vyas, Monika Graduate Staff

Wang, Chongyuan Structural Biology

Wang, Yi SKI Medicine

Webb, Andrew R SKI Psychiatry/Counseling

Wei, Iris Hsin - chu Surgery

Wei, Karen Elizabeth Human Oncology and Pathogenesis Program

Weick, Eva-Maria Structural Biology

Wiedemann, Gabriela Maria Immunology

Wilkins, Olivia F SKI Pediatrics

Wills, Analisa A Medicine

Wind, Tyler Rose SKI Surgery

Wong, Jeffrey L Graduate Staff

Wong, Serena T Medicine

Wu, Chao SKI Surgery

Xu, Guotai SKI Pathology

Xu, Yichi Developmental Biology

Yagi, Yukako Pathology

Yan, Bernice Graduate Staff

Yellapantula, Venkata D Collaborative Research Centers - PIC Directed

Yim, Christina Yeaeun Molecular Pharmacology Program

Yin, Vivian Tsui-Wen Surgery

Yoshikawa, Yuki SKI Medicine

Yu, Yao Radiation Oncology

Zamechek, Leah Brooke Cancer Biology and Genetics

Zarski, Andrew Research and Technology Management

Zavolas, Stephanie Neurology

Zeng, Chuan Commack

Zeng, Jennifer Graduate Staff

Zhang, Kai Human Oncology and Pathogenesis Program

Zhang, Lance SKI Pathology

Zhang, Miao Bergen

Zhang, Minggang Immunology

Zhang, Peng Monmouth

Zhi, Wanqing Iris Medicine

Zhou, Yangyu Collaborative Research Centers - PIC Directed

Ziolkowska, Martha C Radiology

Zorina, Yana Research Facilities

New Authors

15 OF 288


Publications

Journal Subject Coverage In 2018, MSK authors published in 864 different journal titles covering topics such as:

• Cancer Genetics & Genomics

• Cancer Immunotherapy & Vaccines

• Cancer Metabolism

• Cell Signaling & Regulation

• Cell-Based Therapy

• Chemical Biology • Computational

Oncology • Developmental

Biology • Epidemiology• Exercise

Oncology • Genome Integrity • Hematologic

Malignancies • Imaging

• Immunology• Metastasis & Drug

Resistance• Microbiome &

Inflammation• Molecular

Pathology & Diagnostics

• Nanotechnology• Neuroscience &

Neuro-Oncology• Nursing • Solid Tumor

Oncogenesis• Stem Cells • Structural Biology• Systems Biology• Targeted Therapy• Tumor

Microenvironment

Journal ArticlesThe following chart shows the top 10 journal titles for this reporting period (as of 5/3/2019) that MSK authors published articles in . In Synapse, a “journal article” may refer to a research article, review/survey, editorial, letter, or chapter in a monographic series .

*Impact factors were retrieved on 6/20/2019 from Journal Citation Reports, a product of Clarivate Analytics. ** denotes open access journal

Journal of Clinical Oncology

Journal of the National Comprehensive Cancer Network

JAMA Oncology

Annals of Surgical Oncology

Cancer

Clinical Cancer Research

American Journal of Surgical Pathology

Nature Communications**

International Journal of Radiation Oncology, Biology, Physics

New England Journal of Medicine

Impact FactorNumber of Synapse works for the year

28 .245

7 .570

22 .416

3 .681

6 .102

8 .911

6 .155

11 .878

6 .203

70 .670

14 .196

89

37

42

33

32

51

36

39

32

31

Annals of Oncology 31

16 OF 288


Publications

Meeting Abstracts The following chart shows the top 10 journal titles for this reporting period (as of 5/3/2019) that MSK authors published meeting abstracts in .

Top Five MeetingsIn 2018, these meetings generated the most abstracts:

1 . 60th Annual Meeting of the American Society of Hematology (ASH)

2 . 107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP 2018)

3 . 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO)

4 . 43rd ESMO Congress (ESMO 2018)

5 . IASLC 19th World Conference on Lung Cancer

Blood

International Journal of Radiation Oncology, Biology, Physics

Modern Pathology

Medical Physics

Neuro-Oncology

Journal of Clinical Oncology

Journal of Thoracic Oncology

Annals of Oncology

Cancer Research

Number of Synapse works for the year

220

105

114

63

62

56

117

65

108

62

Biology of Blood and Marrow Transplantation

17 OF 288


Publications

Top Journals by Subject Category Impact Factors are a benchmark of a journal's reputation and reflect how frequently peer-reviewed journals are cited by other researchers in a specific year . A journal’s impact factor helps to evaluate the journal’s relative importance or prestige, especially when compared with others in the same field .

Revised annually by Journal Citation Reports (JCR), the impact factor calculation is largely based on the average number of times the journal’s articles have been cited in other publications over the previous two years, while correcting for inter-journal variability (for example, number of articles per issue and frequency of publication) .

JCR can also be used to see how a journal is categorized within a specific research field and the ranking of the journal within its subject category/categories, providing additional insights to the journal’s value .

This illustration represents the number of 2018 Synapse works published in top journals within their respective JCR subject category .

OncologyCA: A Cancer Journal for Clinicians,

Nature Reviews Cancer, Lancet Oncology,Nature Reviews Clinical Oncology, JCO

130

Cell BiologyNature Reviews MolecularCell Biology, Cell, Nature

Medicine, Cancer Cell,Cell Metabolism

61

General &Internal MedicineNEJM, Lancet, JAMA,

Nature Reviews DiseasePrimers, The British

Medical Journal

48

MultidisciplinarySciences

Nature, Science, National ScienceReview, Science Advances,

Nature Communications

74

18 OF 288


Works

Highly-Cited Papers The following represent the most highly-cited papers of 2018 with an MSK affiliation according to data retrieved from Scopus on 05/10/2019 .

MSK-affiliated Article . . . . . . . . . . . . . . . . . . . . . . . . . Citation Count

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors . [Hira Abbas Rizvi, Matthew David Hellmann] Science . 359(6371): 91-97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 377

Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden . [Matthew David Hellmann] New England Journal of Medicine . 378(22): 2093-2104 . . . . . . . . 310

Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma . [Robert Motzer] New England Journal of Medicine . 378(14): 1277-1290 . . . . . . . . .269

Detection and localization of surgically resectable cancers with a multi-analyte blood test . [Peter Allen] Science . 359(6378): 926-930 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .246

Immune-related adverse events associated with immune checkpoint blockade . [Michael Andrew Postow, Robert Sidlow, Matthew David Hellmann] New England Journal of Medicine . 378(2): 158-168 . . . . . . . . . . . . 223

Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia . [Jae Hong Park, Isabelle C . Riviere, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin Joseph Curran, Craig Steven Sauter, Yongzeng Wang, Bianca D . Santomasso, Elena Mead, Mikhail Roshal, Peter Maslak, Marco Luis Davila, Renier J . Brentjens, Michel W .J . Sadelain] New England Journal of Medicine . 378(5): 449-459 . . . . . . . . . . 177

MSK-affiliated Article . . . . . . . . . . . . . . . . . . . . . . . . . Citation Count

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells . [Jonathan Eric Rosenberg] Nature . 554(7693): 544-548 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169

Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline . [Bianca D . Santomasso, Jedd D . Wolchok] Journal of Clinical Oncology . 36(17): 1714-1768 . . . . . . . . . . . . . . . 164

Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children . [Alexander Edward Drilon, Jaclyn Frances Hechtman, Rym Benayed, Marc Ladanyi, David Hyman] New England Journal of Medicine . 378(8): 731-739 . . . . . . . . . . . . 145

Neoadjuvant PD-1 blockade in resectable lung cancer . [Jamie Erin Chaft, Matthew David Hellmann, David Randolph Jones, Moises Velez, Natasha Rekhtman, Zachary T . Olah, Valerie W . Rusch, Jedd D . Wolchok, Taha Merghoub] New England Journal of Medicine . 378(21): 1976-1986 . . . . . . . . . 124

19 OF 288


Works

Top-Scoring Papers via Altmetric The Altmetric Attention Score is derived from an automated algorithm and represents a weighted count of the amount of attention a research output receives on the Internet . It gives a guide to the overall attention at that moment in time . The colors of the donut also have significance . Each color represents the source in which mentions of the paper were found (e .g . red for news outlets, blue for Twitter, yellow for blogs, etc .)

LEGEND • News • Blogs • Twitter • Facebook • Sina Weibo • Syllabi • Policy Documents • Post-Publication Peer-Reviews

• Wikipedia • LinkedIn • Reddit • Google+ • YouTube • Pinterest • Patents • Q&A (Stack Overflow) • Research Highlight platform

*Altmetric attention scores occur in real time and can fluctuate based on new mentions or new sources added to the calculation. The scores shown are current as of 5/13/2019

Detection and Localization of Surgically Resectable Cancers with a Multi-Analyte Blood Test Science Peter Allen

Nut Consumption and Survival in Patients with Stage III Colon Cancer: Results from CALGB 89803 (Alliance) Journal of Clinical Oncology Leonard B . Saltz

Forecasting Life Expectancy, Years of Life Lost, and All-Cause and Cause-Specific Mortality for 250 Causes of Death: Reference and Alternative Scenarios for 2016–40 for 195 Countries and Territories The Lancet Victor Reuter

Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster JAMA Oncology Carl Ola Landgren, Kazunori Murata, Katie Lynn Thoren, Lakshmi Vulimiri Ramanathan, Malin Lisa Hultcrantz, Ahmet Dogan, Shani N . Irby

Man Against Machine: Diagnostic Performance of a Deep Learning Convolutional Neural Network for Dermoscopic Melanoma Recognition in Comparison to 58 Dermatologists Annals of Oncology Aadi Kalloo

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma New England Journal of Medicine Lara Dunn

Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children New England Journal of Medicine Alexander Edward Drilon, Jaclyn Frances Hechtman, Rym Benayed, Marc Ladanyi, David Hyman

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer New England Journal of Medicine Jamie Erin Chaft, Matthew David Hellmann, David Randolph Jones, Moises Velez, Natasha Rekhtman, Zachary T . Olah, Valerie W . Rusch, Jedd D . Wolchok, Taha Merghoub

Gut Microbiome Influences Efficacy of PD-1–Based Immunotherapy Against Epithelial Tumors Science Matthew David Hellmann and Hira Abbas Rizvi

Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Journal of Clinical Oncology Bianca D . Santomasso and Jedd D . Wolchok

20 OF 288


Works

Research CollaborationsThe Synapse team analyzed the author affiliation data from (2,078) research articles authored by MSK researchers in 2018 . For each paper, we recorded the number of authors and unique geographic locations listed (i .e . if a paper had 5 author affiliations in NY, New York, we recorded NY, New York only once) . The results show the international scope of MSK research collaboration through journals, which span over 1,000 cities and 72 countries worldwide . The illustrations below represent three key outcomes: (1) the percentage of papers that include international affiliations; (2) the number of papers that showcase collaborative work done outside the Center; and (3) the frequency of authors per paper .

1% of all MSK research articles were single-authored papers

Research Papers (2,078)

Authors per Paper

Research Collaborations

US-only1,143(55%)

International935

(45%)

Internal243

(12%)

External1,835(88%)

Average18

Median10

Mode7

21 OF 288


Works

Research Collaborations: International

0 1–50 51–100 101–150

AUTHORS' AFFILIATION COUNTS

151–250 251+

*If an affiliation appeared more then once on the paper, it was only recorded one time in final analysis.

Top 15 CountriesAuthors' Affiliations*

United Kingdom 403Canada 335Germany 322Italy 307France 269Spain 202Australia 194Netherlands 149Japan 118China 115Sweden 105Switzerland 98Israel 87South Korea 68Belgium 54

Top Collaborating Institutions

# of Papers

University of Toronto (Toronto, Canada)

76

Ontario Cancer Institute (Toronto, Canada)

45

University of Oxford (Oxford, UK)

41

University of Cambridge (Cambridge, UK)

41

INSERM (Villejuif, France) 40German Cancer Research Center (Heidelberg, Germany)

38

Mediziniscche Universitat Wein (Vienna, Austria)

36

University Health Network (Toronto, Canada)

35

Peter Maccallum Cancer Centre (Melbourne, Australia)

35

Karolinska Institutet (Solna, Sweden)

34

22 OF 288


Works

Research Collaborations: United States

*If an affiliation appeared more then once on the paper, it was only recorded one time in final analysis.0 101–2001–100 201–300

AUTHORS' AFFILIATION COUNTS

301-600 601+

Top 15 StatesAuthors' Affiliations*

New York 1084California 682Massachusetts 534Texas 359Pennsylvania 299Maryland 297North Carolina 214Florida 202Ohio 198Washington 183Illinois 177Michigan 171Minnesota 164New Jersey 150Tennessee 137

Top Collaborating Institutions

# of papers

Weill Cornell Medical College (New York, NY)

398

University of Texas MD Anderson Cancer Center (Houston, TX)

238

Dana-Farber Cancer Institute (Boston, MA)

191

Harvard Medical School (Cambridge, MA)

163

Mayo Clinic (Rochester, MN) 119Brigham and Women's Hospital (Boston, MA)

115

Massachusetts General Hospital (Boston, MA)

113

Icahn School of Medicine at Mount Sinai (New York, NY)

111

University of California, San Francisco (San Francisco, CA)

105

Univeristy of Pennsylvania (Philadelphia, PA)

94

23 OF 288


Bibliography of Works

The following bibliography consists of 2018 works that were ingested into Synapse as of 5/3/2019 . Based on the submission schedules of different publishers and commercial databases, there may be delays in 2018 content being added to Synapse .

The bibliography is divided into five sections:

Journal Articles

Works published in a serial publication including, (but not limited to):

• Research articles

• Reviews/surveys

• Editorials

• Letters

• Chapters from a monographic series

Conference Papers

Original articles published for or presented at a conference, symposium, or other professional gathering .

Meeting Abstracts

Published abstracts of presentations held at a conference, symposium, or other professional gathering including, (but not limited to):

• Poster presentations

• Oral presentations

• Panel discussions

Book Sections

Chapters or sections of a monograph or book . Occasionally, these will be represented in Synapse as journal articles (if they are part of a monographic series) or conference papers/meeting abstracts (if they are part of a proceedings booklet) .

Whole Books

Whole monographs or entire books .

24 OF 288

Journal Articles (3,018)

mailto:[email protected]

25 OF 288


Journal Articles

Aşkan G, Bağcı P, Hameed M, Baştürk O . Dedifferentiated liposarcoma of the gastroesophageal junction . Turk Patoloji Dergisi . 2018;34(1):104-107 .

Abdel-Wahab O, Gebauer F . Editorial overview: Cancer genomics: RNA metabolism and translation in cancer pathogenesis and therapy . Current Opinion in Genetics and Development . 2018;48:iv-vi .

Abelson S, Collord G, Ng SWK, Weissbrod O, Mendelson Cohen N, Niemeyer E, Barda N, Zuzarte PC, Heisler L, Sundaravadanam Y, Luben R, Hayat S, Wang TT, Zhao Z, Cirlan I, Pugh TJ, Soave D, Ng K, Latimer C, Hardy C, Raine K, Jones D, Hoult D, Britten A, McPherson JD, Johansson M, Mbabaali F, Eagles J, Miller JK, Pasternack D, Timms L, Krzyzanowski P, Awadalla P, Costa R, Segal E, Bratman S V, Beer P, Behjati S, Martincorena I, Wang JCY, Bowles KM, Quiros JR, Karakatsani A, La Vecchia C, Trichopoulou A, Salamanca-Fernandez E, Huerta JM, Barricarte A, Travis RC, Tumino R, Masala G, Boeing H, Panico S, Kaaks R, Kramer A, Sieri S, Riboli E, Vineis P, Foll M, McKay J, Polidoro S, Sala N, Khaw KT, Vermeulen R, Campbell PJ, Papaemmanuil E, Minden MD, Tanay A, Balicer RD, Wareham NJ, Gerstung M, Dick JE, Brennan P, Vassiliou GS, Shlush L I . Prediction of acute myeloid leukaemia risk in healthy individuals . Nature . 2018;559(7714):400-404 .

Abida W, Sawyers CL . Targeting DNA repair in prostate cancer . Journal of Clinical Oncology . 2018;36(10):1017-1019 .

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL . Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease . Blood . 2018;131(26):2877-2890 . PMCID: PMC6024636

Abou-Alfa GK, Qin S, Ryoo BY, Lu SN, Yen CJ, Feng YH, Lim HY, Izzo F, Colombo M, Sarker D, Bolondi L, Vaccaro G, Harris WP, Chen Z, Hubner RA, Meyer T, Sun W, Harding JJ, Hollywood EM, Ma J, Wan PJ, Ly M, Bomalaski J, Johnston A, Lin CC, Chao Y, Chen LT . Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma . Annals of Oncology . 2018;29(6):1402-1408 .

Abou-Alfa GK, Borgman-Hagey AE, Kelley RK . Cabozantinib in hepatocellular carcinoma - The author’s reply . New England Journal of Medicine . 2018;379(14):1384-1385 .

Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, Blanc JF, Bolondi L, Klümpen HJ, Chan SL, Zagonel V, Pressiani T, Ryu MH, Venook AP, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK . Cabozantinib in patients with advanced and progressing hepatocellular carcinoma . New England Journal of Medicine . 2018;379(1):54-63 .

Abraham A, Ahn R, Woodbridge A, Madden E, Keyhani S, Korenstein D . What constitutes an independent statistical analysis? . Journal of General Internal Medicine . 2018;33(6):786-788 . PMCID: PMC5975170

Abraham A, Zhang AJ, Ahn R, Woodbridge A, Korenstein D, Keyhani S . Media content analysis of marijuana’s health effects in news coverage . Journal of General Internal Medicine . 2018;33(9):1438-1440 . PMCID: PMC6108999

Abraham J, Caldera H, Coleman R, Elias A, Goetz MP, Kittaneh M, Lower E, Mahtani R, Mamounas ET, Pegram M, Rugo H, Schwartzberg L, Traina T, Vogel C . Endocrine therapy and related issues in hormone receptor-positive early breast cancer: A roundtable discussion by the breast cancer therapy expert group

(BCTEG) . Breast Cancer Research and Treatment . 2018;169(1):1-7 . PMCID: PMC5882621

Abramson DH, Folberg R, Francis JH . Clinicopathological correlation of choroidal invasion in retinoblastoma . JAMA Ophthalmology . 2018;136(6):e180940- .

Abramson DH . Re: Skalet et al .: Screening children at risk for retinoblastoma: Consensus report from the American Association of Ophthalmic Oncologists and Pathologists (Ophthalmology . 2018;125:453-458) . Ophthalmology . 2018;125(9):e63-e64 .

Abramson DH, Folberg R, Francis JH . Clinicopathologic correlation of choroidal invasion in retinoblastoma . Ophthalmology . 2018;125(4):568- .

Abramson DH, Catalanotti F, Brodie SE, Kellick MG, Francis JH . Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma . Ophthalmic Genetics . 2018;39(3):353-356 .

Abreu CM, Prakash R, Romanienko PJ, Roig I, Keeney S, Jasin M . Shu complex SWS1-SWSAP1 promotes early steps in mouse meiotic recombination . Nature Communications . 2018;9:3961- . PMCID: PMC6180034

Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, Zlotta AR, Shariat SF . The role of surgery in metastatic bladder cancer: A systematic review . European Urology . 2018;73(4):543-557 .

Acquisto S, Iyer R, Rosati LM, Pinheirn N, Driskill K, Musto K, Lowitzer H, Bradley E, Drapek L . Cholangiocarcinoma: Treatment, outcomes, and nutrition overview for oncology nurses . Clinical Journal of Oncology Nursing . 2018;22(4):E97-E102 .

Adams NM, Lau CM, Fan X, Rapp M, Geary CD, Weizman OE, Diaz-Salazar C, Sun JC . Transcription factor IRF8 orchestrates the adaptive natural killer cell response . Immunity . 2018;48(6):1172-1182 .e6 .

Adams NM, Sun JC . Spatial and temporal coordination of antiviral responses by group 1 ILCs .

26 OF 288


Journal Articles

Immunological Reviews . 2018;286(1):23-36 . PMCID: PMC6178831

Adams SC, Iyengar NM, Scott JM, Jones LW . Exercise implementation in oncology: One size does not fit all . Journal of Clinical Oncology . 2018;36(9):925-926 .

Adumeau P, Vivier D, Sharma SK, Wang J, Zhang T, Chen A, Agnew BJ, Zeglis BM . Site-specifically labeled antibody-drug conjugate for simultaneous therapy and immunoPET . Molecular Pharmaceutics . 2018;15(3):892-898 .

Adumeau P, Davydova M, Zeglis BM . Thiol-reactive bifunctional chelators for the creation of site-selectively modified radioimmunoconjugates with improved stability . Bioconjugate Chemistry . 2018;29(4):1364-1372 .

Aebersold R, Agar JN, Amster IJ, Baker MS, Bertozzi CR, Boja ES, Costello CE, Cravatt BF, Fenselau C, Garcia BA, Ge Y, Gunawardena J, Hendrickson RC, Hergenrother PJ, Huber CG, Ivanov AR, Jensen ON, Jewett MC, Kelleher NL, Kiessling LL, Krogan NJ, Larsen MR, Loo JA, Ogorzalek Loo RR, Lundberg E, MacCoss MJ, Mallick P, Mootha VK, Mrksich M, Muir TW, Patrie SM, Pesavento JJ, Pitteri SJ, Rodriguez H, Saghatelian A, Sandoval W, Schlüter H, Sechi S, Slavoff SA, Smith LM, Snyder MP, Thomas PM, Uhlén M, Van Eyk JE, Vidal M, Walt DR, White FM, Williams ER, Wohlschlager T, Wysocki VH, Yates NA, Young NL, Zhang B . How many human proteoforms are there? . Nature Chemical Biology . 2018;14(3):206-214 . PMCID: PMC5837046

Agaram NP, Zhang L, Cotzia P, Antonescu CR . Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions . American Journal of Surgical Pathology . 2018;42(12):1653-1661 .

Agarwal R, Epstein AS . Advance care planning and end-of-life decision making for patients with cancer . Seminars in Oncology Nursing . 2018;34(3):316-326 . PMCID: PMC6156999

Agbu SO, Liang Y, Liu A, Anderson K V . The small GTPase RSG1 controls a final step in primary cilia initiation . Journal of Cell Biology . 2018;217(1):413-427 . PMCID: PMC5748968

Aghajanian C, Filiaci V, Dizon DS, Carlson JW, Powell MA, Secord AA, Tewari KS, Bender DP, O’Malley DM, Stuckey A, Gao J, Dao F, Soslow RA, Lankes HA, Moore K, Levine DA . A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer . Gynecologic Oncology . 2018;150(2):274-281 .

Aghajanian C, Bell-McGuinn KM, Burris HA 3rd, Siu LL, Stayner LA, Wheler JJ, Hong DS, Kurkjian C, Pant S, Santiago-Walker A, Gauvin JL, Antal JM, Opalinska JB, Morris SR, Infante JR . A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors . Investigational New Drugs . 2018;36(6):1016-1025 . PMCID: PMC6170741

Aghazadeh MA, Goh AC . Robotic left-sided level II caval thrombectomy and nephrectomy using a novel supine, single-dock approach: Primary description . Urology . 2018;112:205-208 .

Agostini A, Mahmood U, Erdi Y, Borgheresi A, Ragucci M, Sawan P, Ryan D, Laino ME, Corrias G, Mannelli L . Quantification of iodine concentration using single-source dual-energy computed tomography in a calf liver . Journal of Computer Assisted Tomography . 2018;42(2):222-229 . PMCID: PMC5847415

Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, Do RK . Intrahepatic cholangiocarcinoma: Can imaging phenotypes predict survival and tumor genetics? . Abdominal Radiology . 2018;43(10):2665-2672 . PMCID: PMC6113129

Aherne EA, Plodkowski AJ, Montecalvo J, Hayan S, Zheng J, Capanu M, Adusumilli PS, Travis WD, Ginsberg MS . What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology? . Lung Cancer . 2018;118:83-89 . PMCID: PMC5912171

Ahles TA, Hurria A . New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions . Psycho-Oncology . 2018;27(1):3-9 .

Ahles TA, Root JC . Cognitive effects of cancer and cancer treatments . Annual Review of Clinical Psychology . 2018;14:425-451 .

Ahlgrimm-Siess V, Laimer M, Rabinovitz HS, Oliviero M, Hofmann-Wellenhof R, Marghoob AA, Scope A . Confocal microscopy in skin cancer . Current Dermatology Reports . 2018;7(2):105-118 . PMCID: PMC5956038

Ahmad AS, Parameshwaran V, Beltran L, Fisher G, North B V, Greenberg D, Soosay G, Møller H, Scardino P, Cuzick J, Berney DM, on behalf of the Transatlantic Prostate Group . Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? Correlation with outcome in biopsy cases treated conservatively . Oncotarget . 2018;9(29):20555-20562 . PMCID: PMC5945501

Ahmed A, Deng W, Tew W, Bender D, Mannel RS, Littell RD, DeNittis AS, Edelson M, Morgan M, Carlson J, Darus CJ, Fleury AC, Modesitt S, Olawaiye A, Evans A, Fleming GF . Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG Oncology Group/Gynecologic Oncology Group study . Gynecologic Oncology . 2018;150(2):300-305 .

Ahmed M, Lopez-Albaitero A, Pankov D, Santich BH, Liu H, Yan S, Xiang J, Wang P, Hasan AN, Selvakumar A, O’Reilly RJ, Liu C, Cheung NK V . TCR-mimic

27 OF 288


Journal Articles

bispecific antibodies targeting LMP2A show potent activity against EBV malignancies . JCI Insight . 2018;3(4):e97805- .

Aisner DL, Sholl LM, Berry LD, Rossi MR, Chen H, Fujimoto J, Moreira AL, Ramalingam SS, Villaruz LC, Otterson GA, Haura E, Politi K, Glisson B, Cetnar J, Garon EB, Schiller J, Waqar SN, Sequist L V, Brahmer J, Shyr Y, Kugler K, Wistuba I I, Johnson BE, Minna JD, Kris MG, Bunn PA, Kwiatkowski DJ, for the LCMC2 investigators . The impact of smoking and TP53 mutations in lung adenocarcinoma patients with targetable mutations - The Lung Cancer Mutation Consortium (LCMC2) . Clinical Cancer Research . 2018;24(5):1038-1047 .

Aiyer R, Mehta N, Gungor S, Gulati A . A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice . Clinical Journal of Pain . 2018;34(5):450-467 .

Aiyer R, Gulati A, Gungor S, Bhatia A, Mehta N . Treatment of chronic pain with various buprenorphine formulations: A systematic review of clinical studies . Anesthesia and Analgesia . 2018;127(2):529-538 .

Akaike K, Suehara Y, Kohsaka S, Hayashi T, Tanabe Y, Kazuno S, Mukaihara K, Toda-Ishii M, Kurihara T, Kim Y, Okubo T, Hayashi Y, Takamochi K, Takahashi F, Kaneko K, Ladanyi M, Saito T . PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma . Oncotarget . 2018;9(38):25206-25215 . PMCID: PMC5982774

Akella SS, Francis JH, Knezevic A, Ostrovnaya I, Gobin YP, Friedman D, Guarini E, Eibeler L, Catalanotti F, Abramson DH . Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery . PLoS ONE . 2018;13(5):e0197052- . PMCID: PMC5937785

Al-Ahmadie H, Iyer G . Updates on the genetics and molecular subtypes of urothelial carcinoma

and select variants . Surgical Pathology Clinics . 2018;11(4):713-723 .

Al Efishat M, Allen PJ . ASO author reflections: Progression after resection of noninvasive or microinvasive intraductal papillary mucinous neoplasms . Annals of Surgical Oncology . 2018;25(Suppl . 3):S822-S823 .

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D’Angelica M I, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ . Progression patterns in the remnant pancreas after resection of non-invasive or micro-invasive intraductal papillary mucinous neoplasms (IPMN) . Annals of Surgical Oncology . 2018;25(6):1752-1759 .

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CFD, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D’Angelica M I, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ . Multi-institutional validation study of pancreatic cyst fluid protein analysis for prediction of high-risk intraductal papillary mucinous neoplasms of the pancreas . Annals of Surgery . 2018;268(2):340-347 . PMCID: PMC5764837

Alam M, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, Eisen DB, Iyengar V, Lober C, Margolis DJ, Messina J, Miller A, Miller S, Mostow E, Mowad C, Nehal K, Schmitt-Burr K, Sekulic A, Storrs P, Teng J, Yu S, Huang C, Boyer K, Begolka WS, Bichakjian C . Guidelines of care for the management of cutaneous squamous cell carcinoma . Journal of the American Academy of Dermatology . 2018;78(3):560-578 .

Alatise O I, Ayandipo OO, Adeyeye A, Seier K, Komolafe AO, Bojuwoye MO, Afuwape OO, Zauber A, Omisore A, Olatoke S, Akere A, Famurewa O, Gonen M, Irabor DO, Kingham TP . A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of

patients at high risk for colorectal cancer . Cancer . 2018;124(13):2766-2773 . PMCID: PMC6005740

Albanese SK, Parton DL, Isik M, Rodríguez-Laureano L, Hanson SM, Behr JM, Gradia S, Jeans C, Levinson NM, Seeliger MA, Chodera JD . An open library of human kinase domain constructs for automated bacterial expression . Biochemistry . 2018;57(31):4675-4689 . PMCID: PMC6081246

Albany C, Einhorn L, Garbo L, Boyd T, Josephson N, Feldman DR . Treatment of CD30-expressing germ cell tumors and sex cord stromal tumors with brentuximab vedotin: Identification and report of seven cases . The Oncologist . 2018;23(3):316-323 .

Aldeghi M, Ross GA, Bodkin MJ, Essex JW, Knapp S, Biggin PC . Large-scale analysis of water stability in bromodomain binding pockets with grand canonical Monte Carlo . Communications Chemistry . 2018;1:19- .PMCID: PMC5978690

Algazi AP, Esteve-Puig R, Nosrati A, Hinds B, Hobbs-Muthukumar A, Nandoskar P, Ortiz-Urda S, Chapman PB, Daud A . Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma . Pigment Cell & Melanoma Research . 2018;31(1):110-114 .

Alholle A, Karanian M, Brini AT, Morris MR, Kannappan V, Niada S, Niblett A, Ranchère-Vince D, Pissaloux D, Delfour C, Maran-Gonzalez A, Antonescu CR, Sumathi V, Tirode F, Latif F . Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent CRTC1-SS18 gene fusion . Journal of Pathology . 2018;245(2):186-196 .

Alig S, Jurinovic V, Pastore A, Bararia D, Habe S, Hellmuth JC, Kridel R, Gascoyne R, Schmidt C, Zöllner AK, Buske C, Dreyling M, Unterhalt M, Hiddemann W, Hoster E, Weigert O . Impact of age on genetics and treatment efficacy in follicular lymphoma . Haematologica . 2018;103(8):e364-e367 . PMCID: PMC6068024

28 OF 288


Journal Articles

Allen PJ, D’Angelica M I, Kingham TP, Balachandran VK, Jarnagin WR . Levels of evidence in medical research: “Bigger is not always better” - Reply . Annals of Surgery . 2018;267(5):e96-e97 .

Almassi N, Pietzak E . The patient’s perspective on blue light flexible cystoscopy: Insight from a prospective clinical study . Translational Andrology and Urology . 2018;7(Suppl . 6):S727-S728 . PMCID: PMC6323283

Aloisi A, Casanova JM, Tseng JH, Seader KA, Nguyen NT, Alektiar KM, Makker V, Chiang S, Soslow RA, Leitao MM Jr, Abu-Rustum NR . Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment . Gynecologic Oncology . 2018;151(3):395-400 . PMCID: PMC6281769

Aloisi A, Sonoda Y, Gardner GJ, Park KJ, Elliott SL, Zhou QC, Iasonos A, Abu-Rustum NR . Prospective comparative study of laparoscopic narrow band imaging (NBI) versus standard imaging in gynecologic oncology . Annals of Surgical Oncology . 2018;25(4):984-990 .

Aloisi A, Abu-Rustum NR . ASO author reflections: Narrow-band imaging: A novel imaging method in minimally invasive surgery . Annals of Surgical Oncology . 2018;25(Suppl . 3):S880-S881 .

Alpert JS, Boland P, Hameed M, Panicek DM . Undifferentiated pleomorphic sarcoma: Indolent, tail-like recurrence of a high-grade tumor . Skeletal Radiology . 2018;47(1):141-144 .

Altman JK, Foran JM, Pratz KW, Trone D, Cortes JE, Tallman MS . Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia . American Journal of Hematology . 2018;93(2):213-221 .

Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS,

Kamel M, Pass H I, Mitchell JD, Stinchcombe T, Vokes E, Kohman LJ . Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: Post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503) . The Lancet Respiratory Medicine . 2018;6(12):915-924 .

Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova E V, Hagan EA, Bodei L, Clemons PA, Dela Cruz FS, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel U, Li Z, Lee J, Li H, Livolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A . A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors . Nature Genetics . 2018;50(7):979-989 .

Amar D, Pedoto A, Desiderio DP . In response .Anesthesia and Analgesia . 2018;126(1):367- .

Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini B I, Heng DYC, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ . Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: The CheckMate 016 study . Journal for ImmunoTherapy of Cancer . 2018;6:109- . PMCID: PMC6196426

Amin S, Cook B, Zhou T, Ghazizadeh Z, Lis R, Zhang T, Khalaj M, Crespo M, Perera M, Xiang JZ, Zhu Z, Tomishima M, Liu C, Naji A, Evans T, Huangfu D, Chen S . Discovery of a drug candidate for GLIS3-associated diabetes . Nature Communications . 2018;9:2681- . PMCID: PMC6041295

Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS, on behalf of the Blood Marrow Transplant Clinical Trials Network . The microbiome and hematopoietic cell transplantation: Past, present, and future . Biology of Blood and Marrow Transplantation . 2018;24(7):1322-1340 . PMCID: PMC6045977

Anderson DC, Jackson AA, Halpern NA . Informatics for the modern intensive care unit . Critical Care Nursing Quarterly . 2018;41(1):60-67 .

Andolina JR, Reinish AL, Akhtar R, Noronha S, Shand JC, Girvin A, Korones DN, Bruckner LB, Mullen CA, Curran KJ, Boulad F . Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children . Pediatric Blood and Cancer . 2018;65(8):e27218- .

Angelos P, Hartl DM, Shah JP, Nixon IJ, Owen RP, Rinaldo A, Rodrigo JP, Shaha AR, Silver CE, Suarez C, Ferlito A . Ethical issues in non-intervention trials for thyroid cancer . European Journal of Surgical Oncology . 2018;44(3):316-320 .

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ . A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts . European Urology . 2018;74(2):197-203 .

Antonescu CR, Agaram NP, Sung YS, Zhang L, Swanson D, Dickson BC . A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: Expanding the spectrum of pathologic

29 OF 288


Journal Articles

entities with ACTB/MALAT1/PTCH1-GLI1 fusions . American Journal of Surgical Pathology . 2018;42(4):553-560 . PMCID: PMC5844813

Applebaum AJ, Buda K, Kryza-Lacombe M, Buthorn JJ, Walker R, Shaffer KM, D’Agostino TA, Diamond EL . Prognostic awareness and communication preferences among caregivers of patients with malignant glioma . Psycho-Oncology . 2018;27(3):817-823 . PMCID: PMC5873587

Applebaum AJ, Buda KL, Schofield E, Farberov M, Teitelbaum ND, Evans K, Cowens-Alvarado R, Cannady RS . Exploring the cancer caregiver’s journey through web-based Meaning-Centered Psychotherapy . Psycho-Oncology . 2018;27(3):847-856 .

Apte AP, Iyer A, Crispin-Ortuzar M, Pandya R, van Dijk L V, Spezi E, Thor M, Um H, Veeraraghavan H, Oh JH, Shukla-Dave A, Deasy JO . Technical Note: Extension of CERR for computational radiomics: A comprehensive MATLAB platform for reproducible radiomics research . Medical Physics . 2018;45(8):3713-3720 .

Aras O, Pearce G, Watkins AJ, Nurili F, Medine E I, Guldu OK, Tekin V, Wong J, Ma X, Ting R, Unak P, Akin O . An in-vivo pilot study into the effects of FDG-mNP in cancer in mice . PLoS ONE . 2018;13(8):e0202482- . PMCID: PMC6101388

Arbour KC, Kris MG, Riely GJ, Ni A, Beal K, Daras M, Hayes SA, Young RJ, Rodriguez CR, Ahn L, Pao W, Yu HA . Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases . Cancer . 2018;124(1):105-109 . PMCID: PMC5735028

Arbour KC, Jordan E, Kim HR, Dienstag J, Yu HA, Sanchez-Vega F, Lito P, Berger M, Solit DB, Hellmann M, Kris MG, Rudin CM, Ni A, Arcila M, Ladanyi M, Riely GJ . Effects of co-occurring genomic alterations on outcomes in patients with KRAS-

mutant non-small cell lung cancer . Clinical Cancer Research . 2018;24(2):334-340 . PMCID: PMC5771996

Arbour KC, Riely GJ . Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer . Cancer . 2018;124(11):2272-2275 .

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai W V, Hendriks LEL, Sabari JK, Caramella C, Plodkowski

AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD . Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer . Journal of Clinical Oncology . 2018;36(28):2872-2878 .

Argani P, Pawel B, Szabo S, Reyes-Mugica M, Timmons C, Antonescu CR . Diffuse strong BCOR immunoreactivity is a sensitive and specific marker for clear cell sarcoma of the kidney (CCSK) in pediatric renal neoplasia . American Journal of Surgical Pathology . 2018;42(8):1128-1131 . PMCID: PMC6041176

Argani P, Reuter VE, Kapur P, Brown JE, Sung YS, Zhang L, Williamson R, Francis G, Sommerville S, Swanson D, Dickson BC, Antonescu CR . Novel MEIS1-NCOA2 gene fusions define a distinct primitive spindle cell sarcoma of the kidney . American Journal of Surgical Pathology . 2018;42(11):1562-1570 .

Argolo DF, Hudis CA, Iyengar NM . The impact of obesity on breast cancer . Current Oncology Reports . 2018;20(6):47- .

Argyropoulos K V, Lia M . First-generation and second-generation Bruton tyrosine kinase inhibitors in Waldenström macroglobulinemia . Hematology/Oncology Clinics of North America . 2018;32(5):853-864 .

Ariyan CE, Brady MS, Siegelbaum RH, Hu J, Bello DM, Rand J, Fisher C, Lefkowitz RA, Panageas KS, Pulitzer M, Vignali M, Emerson R, Tipton C, Robins H,

Merghoub T, Yuan J, Jungbluth A, Blando J, Sharma P, Rudensky AY, Wolchok JD, Allison JP . Robust antitumor responses result from local chemotherapy and CTLA-4 blockade . Cancer Immunology Research . 2018;6(2):189-200 .

Arlow RL, Paddock LE, Niu X, Kirstein L, Haffty BG, Goyal S, Kearney T, Toppmeyer D, Stroup AM, Khan AJ . Breast-conservation therapy after neoadjuvant chemotherapy does not compromise 10-year breast cancer-specific mortality . American Journal of Clinical Oncology: Cancer Clinical Trials . 2018;41(12):1246-1251 .

Armand P, Engert A, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman JM, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Shipp MA, Kato K, Sumbul A, Farsaci B, Ansell SM . Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: Extended follow-up of the multicohort single-arm phase II CheckMate 205 trial . Journal of Clinical Oncology . 2018;36(14):1428-1439 .

Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, Chatila WK, Chakravarty D, Han GC, Coleman I, Montgomery B, Pritchard C, Morrissey C, Barbieri CE, Beltran H, Sboner A, Zafeiriou Z, Miranda S, Bielski CM, Penson A V, Tolonen C, Huang FW, Robinson D, Wu YM, Lonigro R, Garraway LA, Demichelis F, Kantoff PW, Taplin ME, Abida W, Taylor BS, Scher H I, Nelson PS, de Bono JS, Rubin MA, Sawyers CL, Chinnaiyan AM, PCF/SU2C International Prostate Cancer Dream Team, Schultz N, Van Allen EM . The long tail of oncogenic drivers in prostate cancer . Nature Genetics . 2018;50(5):645-651 .

Armstrong AJ, Anand A, Edenbrandt L, Bondesson E, Bjartell A, Widmark A, Sternberg CN, Pili R, Tuvesson H, Nordle O, Carducci MA, Morris MJ . Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate

30 OF 288


Journal Articles

cancer: A secondary analysis of a randomized clinical trial . JAMA Oncology . 2018;4(7):944-951 .

Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher H I . Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet . Annals of Oncology . 2018;29(1):23-25 . PMCID: PMC6248721

Arrieta-Bolaños E, Crivello P, Shaw BE, Ahn KW, Wang HL, Verneris MR, Hsu KC, Pidala J, Lee SJ, Fleischhauer K, Spellman SR . In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance . Blood Advances . 2018;2(14):1773-1783 . PMCID: PMC6058232

Arvold ND, Armstrong TS, Warren KE, Chang SM, Deangelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY . Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group . Neuro-Oncology . 2018;20(7):897-906 . PMCID: PMC6007454

Asada S, Goyama S, Inoue D, Shikata S, Takeda R, Fukushima T, Yonezawa T, Fujino T, Hayashi Y, Kawabata KC, Fukuyama T, Tanaka Y, Yokoyama A, Yamazaki S, Kozuka-Hata H, Oyama M, Kojima S, Kawazu M, Mano H, Kitamura T . Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis . Nature Communications . 2018;9:2733- . PMCID: PMC6048047

Asarkar A, Shaha M, Shaha A, Nathan CAO . Does mutational analysis influence the management of differentiated thyroid cancers? . Laryngoscope . 2018;128(1):1-2

Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caraco C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M . Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy) . Journal of Translational Medicine . 2018;16:207- . PMCID: PMC6054754

Ascierto PA, Brugarolas J, Buonaguro L, Butterfield LH, Carbone D, Daniele B, Ferris R, Fox BA, Galon J, Gridelli C, Kaufman HL, Klebanoff CA, Melero I, Nathan P, Paulos CM, Ruella M, Sullivan R, Zarour H, Puzanov I . Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy) . Journal for ImmunoTherapy of Cancer . 2018;6:69- . PMCID: PMC6042369

Ashtekar A, Huk D, Magner A, La Perle KMD, Boucai L, Kirschner LS . Alterations in SOD2-induced oxidative stress affect endocrine cancer progression . Journal of Clinical Endocrinology and Metabolism . 2018;103(11):4135-4145 . PMCID: PMC6194813

Assali A, Akhavan O, Adeli M, Razzazan S, Dinarvand R, Zanganeh S, Soleimani M, Dinarvand M, Atyabi F . Multifunctional core-shell nanoplatforms (gold@graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery . Nanomedicine-Nanotechnology Biology and Medicine . 2018;14(6):1891-1903 .

Assel M, Dahlin A, Ulmert D, Bergh A, Stattin P, Lilja H, Vickers AJ . Association between lead time and prostate cancer grade: Evidence of grade progression from long-term follow-up of large population-based cohorts not subject to prostate-specific antigen screening . European Urology . 2018;73(6):961-967 . PMCID: PMC5911245

Assel M, Vickers AJ . Statistical code for clinical research papers in a high-impact specialist medical

journal . Annals of Internal Medicine . 2018;168(11):832-833 .

Assel MJ, Li F, Wang Y, Allen AS, Baggerly KA, Vickers AJ . Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration: Independent statistical evaluations of data from the Age-Related Eye Disease Study . Ophthalmology . 2018;125(3):391-397 .PMCID: PMC5820191

Assel MJ, Gerdtsson A, Thorek DLJ, Carlsson S V, Malm J, Scardino PT, Vickers A, Lilja H, Ulmert D . Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: Data from the Malmö Preventive Project . Oncotarget . 2018;9(5):5778-5785 . PMCID: PMC5814173

Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE . Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia . BMC Cancer . 2018;18:359- . PMCID: PMC5879565

Atiq S, Mobley JM, Atiq OO, Atiq MO, Meena N . A unique case of severe anemia secondary to copper deficiency in an adult patient . Cureus . 2018;10(11):e3636- . PMCID: PMC6351007

Atiq SO, Atiq OO, Atiq MO, Phillips KC, Jacks BB, Moreno M, Maraboyina S, Atiq OT . The role of immunotherapy and radiation therapy in tumor chemosensitivity in advanced head and neck cancer . The American Journal of Case Reports . 2018;19:1241-1244 . PMCID: PMC6202879

Atkins KM, Chen MH, Wu J, Renshaw AA, Loffredo M, Kantoff PW, Small EJ, D’Amico A V . Low testosterone at first prostate-specific antigen failure and

31 OF 288


Journal Articles

assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials . Cancer . 2018;124(7):1383-1390 .

Atkinson TM, Gounder MM . Reply to E . Younger et al . Journal of Clinical Oncology . 2018;36(16):1643-1644 .

Atkinson TM, Hay JL, Dueck AC, Mitchell SA, Mendoza TR, Rogak LJ, Minasian LM, Basch E . What do “none,” “mild,” “moderate,” “severe,” and “very severe” mean to patients with cancer? Content validity of PRO-CTCAE™ response scales . Journal of Pain and Symptom Management . 2018;55(3):e3-e6 . PMCID: PMC6317851

Attiyeh MA, Fernandez-del Castillo C, Al Efishat M, Eaton AA, Gönen M, Batts R, Pergolini I, Rezaee N, Lillemoe KD, Ferrone CR, Mino-Kenudson M, Weiss MJ, Cameron JL, Hruban RH, D’Angelica M I, DeMatteo RP, Kingham TP, Jarnagin WR, Wolfgang CL, Allen PJ . Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: A report from the Pancreatic Surgery Consortium . Annals of Surgery . 2018;267(1):157-163 . PMCID: PMC5565720

Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran VP, D’Angelica M I, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK . Survival prediction in pancreatic ductal adenocarcinoma by quantitative computed tomography image analysis . Annals of Surgical Oncology . 2018;25(4):1034-1042 .

Audenet F, Vertosick EA, Fine SW, Sjoberg DD, Vickers AJ, Reuter VE, Eastham JA, Scardino PT, Touijer KA . Biopsy core features are poor predictors of adverse pathology in men with Grade Group 1 prostate cancer . Journal of Urology . 2018;199(4):961-968 . PMCID: PMC5893437

Aufhauser DD Jr, Sadot E, Murken DR, Eddinger K, Hoteit M, Abt PL, Goldberg DS, DeMatteo RP, Levine MH . Incidence of occult intrahepatic metastasis in

hepatocellular carcinoma treated with transplantation corresponds to early recurrence rates after partial hepatectomy . Annals of Surgery . 2018;267(5):922-928 .PMCID: PMC5507755

Austin CA, Choudhury S, Lincoln T, Chang LH, Cox CE, Weaver MA, Hanson LC, Nelson JE, Carson SS . Rapid response events in hospitalized patients: Patient symptoms and clinician communication . Journal of Pain and Symptom Management . 2018;55(3):946-952 . PMCID: PMC5856233

Austin-Tse CA, Mandelker DL, Oza AM, Mason-Suares H, Rehm HL, Amr SS . Analysis of intragenic USH2A copy number variation unveils broad spectrum of unique and recurrent variants . European Journal of Medical Genetics . 2018;61(10):621-626 .

Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Milowsky M I, Posadas EM, Ryan CJ, Graf RP, Dittamore R, Schreiber NA, Summa JM, Youssoufian H, Morris MJ, Scher H I . Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: A phase 2 clinical trial . JAMA Oncology . 2018;4(10):1344-1351 .

Avanzi MP, Yeku O, Li X, Wijewarnasuriya DP, van Leeuwen DG, Cheung K, Park H, Purdon TJ, Daniyan AF, Spitzer MH, Brentjens RJ . Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system . Cell Reports . 2018;23(7):2130-2141 .

Aviki EM, Schleicher SM, Mullangi S, Matsoukas K, Korenstein D . Alternative payment and care-delivery models in oncology: A systematic review . Cancer . 2018;124(16):3293-3306 . PMCID: PMC6110102

Avila AM, Giralt S . Autoimmune disorders and multiple myeloma: Two illustrative case reports and a literature review . Revista Colombiana De Cancerologia . 2018;22(2):76-83 .

Ayash C, Costas-Muñiz R, Badreddine D, Ramirez J, Gany F . An investigation of unmet socio-economic needs among Arab American breast cancer patients compared with other immigrant and migrant patients . Journal of Community Health . 2018;43(1):89-95 .

Azizi E, Carr AJ, Plitas G, Cornish AE, Konopacki C, Prabhakaran S, Nainys J, Wu K, Kiseliovas V, Setty M, Choi K, Fromme RM, Dao P, McKenney PT, Wasti RC, Kadaveru K, Mazutis L, Rudensky AY, Pe’er D . Single-cell map of diverse immune phenotypes in the breast tumor microenvironment . Cell . 2018;174(5):1293-1308 .e36 .

Babady NE, England MR, Jurcic Smith KL, He T, Wijetunge DS, Tang YW, Chamberland RR, Menegus M, Swierkosz EM, Jerris RC, Greene W . Multicenter evaluation of the ePlex Respiratory Pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs . Journal of Clinical Microbiology . 2018;56(2):e01353-17- . PMCID: PMC5786739

Babady NE . Importance of accuracy of multiplex PCR systems for rapid diagnosis of respiratory virus infection . Clinical Microbiology and Infection . 2018;24(10):1033-1034 .

Bach PB, Brawley OW, Silvestri GA . Low-dose CT for lung cancer screening . Lancet Oncology . 2018;19(3):e133-e134 .

Bach PB . National coverage analysis of CAR-T therapies - Policy, evidence, and payment . New England Journal of Medicine . 2018;379(15):1396-1398 .

Bach PB, Sachs RE . Expansion of the Medicare 340B payment program: Hospital participation, prescribing patterns and reimbursement, and legal challenges . JAMA - Journal of the American Medical Association . 2018;320(22):2311-2312 .

Bacusmo JM, Orsini SS, Hu J, DeMott M, Thiaville PC, Elfarash A, Paulines MJ, Rojas-Benítez D, Meineke B, Deutsch C, Iwata-Reuyl D, Limbach PA, Dedon

32 OF 288


Journal Articles

PC, Rice KC, Shuman S, Crécy-Lagard VD . The t(6)A modification acts as a positive determinant for the anticodon nuclease PrrC, and is distinctively nonessential in Streptococcus mutans . RNA Biology . 2018;15(4-5):508-517 . PMCID: PMC6103680

Badieyan ZS, Hoseini SS . Adverse effects associated with clinical applications of CAR engineered T cells . Archivum Immunologiae et Therapiae Experimentalis . 2018;66(4):283-288 .

Bae MS, Shin SU, Song SE, Ryu HS, Han W, Moon WK . Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1–T2N0 breast cancer . Acta Radiologica . 2018;59(4):402-408 .

Bae MS, Chang JM, Cho N, Han W, Ryu HS, Moon WK . Association of preoperative breast MRI features with locoregional recurrence after breast conservation therapy . Acta Radiologica . 2018;59(4):409-417 .

Bagrodia A, Kaffenberger S, Winer A, Murray K, Vacchio M, Zheng J, Ostrovnaya I, Bochner BH, Dalbagni G, Cha EK, Coleman JA . Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma . World Journal of Urology . 2018;36(4):645-653 .

Bagrodia A, Sukhu R, Winer AG, Levy E, Vacchio M, Lee B, Pietzak EJ, Donahue TF, Cha E, Iyer G, Sjoberg DD, Vickers AJ, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH . Incidence and effect of thromboembolic events in radical cystectomy patients undergoing preoperative chemotherapy for muscle-invasive bladder cancer . Clinical Genitourinary Cancer . 2018;16(1):e113-e120 . PMCID: PMC6053335

Bailey K, Roth M, Weiser D, Gill J . High-dose chemotherapy with stem cell rescue in desmoplastic small round cell tumor: A single-institution experience and review of the literature . Sarcoma . 2018;2018:1948093- . PMCID: PMC5960572

Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PKS, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, The MC3 Working Group, The Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L . Comprehensive characterization of cancer driver genes and mutations . Cell . 2018;173(2):371-385 .e18 .

Bair SM, Mato A, Svoboda J . Immunotherapy for the treatment of Hodgkin lymphoma: An evolving paradigm . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(6):380-391 .

Bakhoum SF, Cantley LC . The multifaceted role of chromosomal instability in cancer and its microenvironment . Cell . 2018;174(6):1347-1360 . PMCID: PMC6136429

Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, Duran M, Pauli C, Shaw C, Chadalavada K, Rajasekhar VK, Genovese G, Venkatesan S, Birkbak NJ, McGranahan N, Lundquist M, LaPlant Q, Healey JH, Elemento O, Chung CH, Lee NY, Imielenski M, Nanjangud G, Pe’er D, Cleveland DW, Powell SN, Lammerding J, Swanton C, Cantley LC . Chromosomal instability drives metastasis through a cytosolic DNA response . Nature . 2018;553(7689):467-472 . PMCID: PMC5785464

Bakst RL, Dabaja BS, Specht LK, Yahalom J . Use of radiation in extramedullary leukemia/chloroma: Guidelines from the International Lymphoma Radiation Oncology Group . International Journal of Radiation Oncology, Biology, Physics . 2018;102(2):314-319 .

Balakrishnan M, Baylies MK . Myonuclear positioning and aneurysms are LINC’d by Ariande . Developmental Cell . 2018;45(2):149-150 .

Ball B, Komrokji RS, Adès L, Sekeres MA, DeZern AE, Pleyer L, Vey N, Almeida A, Germing U, Cluzeau T, Platzbecker U, Gore SD, Fenaux P, Prebet T . Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia . Blood Advances . 2018;2(16):2063-2071 . PMCID: PMC6113613

Ball B, Abdel-Wahab O . Activating p53 and inhibiting superenhancers to cure leukemia . Trends in Pharmacological Sciences . 2018;39(12):1002-1004 .

Ballangrud A, Kuo LC, Happersett L, Lim SB, Beal K, Yamada Y, Hunt M, Mechalakos J . Institutional experience with SRS VMAT planning for multiple cranial metastases . Journal of Applied Clinical Medical Physics . 2018;19(2):176-183 . PMCID: PMC5849827

Baltzer PAT, Bickel H, Spick C, Wengert G, Woitek R, Kapetas P, Clauser P, Helbich TH, Pinker K . Potential of noncontrast magnetic resonance imaging with diffusion-weighted imaging in characterization of breast lesions: Intraindividual comparison with dynamic contrast-enhanced magnetic resonance imaging . Investigative Radiology . 2018;53(4):229-235 .

Bamias A, Tzannis K, Harshman LC, Crabb SJ, Wong YN, Kumar Pal S, De Giorgi U, Ladoire S, Agarwal N, Yu EY, Niegisch G, Necchi A, Sternberg CN, Srinivas S, Alva A, Vaishampayan U, Cerbone L, Liontos M, Rosenberg J, Powles T, Bellmunt J, Galsky MD, RISC Investigators . Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: A Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) . Annals of Oncology . 2018;29(2):361-369 .

Banerjee SC, D’Agostino TA, Gordon ML, Hay JL . “It’s not JUST skin cancer”: Understanding their cancer

33 OF 288


Journal Articles

experience from melanoma survivor narratives shared online . Health Communication . 2018;33(2):188-201 .PMCID: PMC5474216

Banerjee SC, Walters CB, Staley JM, Alexander K, Parker PA . Knowledge, beliefs, and communication behavior of oncology health-care providers (HCPs) regarding lesbian, gay, bisexual, and transgender (LGBT) patient health care . Journal of Health Communication . 2018;23(4):329-339 .

Bange E, Timlin C, Kabel C, Svoboda J, Roeker L, Mato AR . Evidence for and against green tea and turmeric in the management of chronic lymphocytic leukemia . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(10):e421-e426 .

Banito A, Li X, Laporte AN, Roe JS, Sanchez-Vega F, Huang CH, Dancsok AR, Hatzi K, Chen CC, Tschaharganeh DF, Chandwani R, Tasdemir N, Jones KB, Capecchi MR, Vakoc CR, Schultz N, Ladanyi M, Nielsen TO, Lowe SW . The SS18-SSX oncoprotein hijacks KDM2B-PRC1 .1 to drive synovial sarcoma . Cancer Cell . 2018;33(3):527-541 .e8 . PMCID: PMC5881394

Bao T, Li SQ, Dearing JL, Piulson LA, Seluzicki CM, Sidlow R, Mao JJ . Acupuncture versus medication for pain management: A cross-sectional study of breast cancer survivors . Acupuncture in Medicine . 2018;36(2):80-87 .

Bao T, Li Q, DeRito JL, Seluzicki C, Im EO, Mao J . Barriers to acupuncture use among breast cancer survivors: A cross-sectional analysis . Integrative Cancer Therapies . 2018;17(3):854-859 .

Bao T, Peppone LJ, Robinson P . Addressing the unintentional consequences of cancer therapy with novel integrative therapeutics . American Society of Clinical Oncology Educational Book . 2018;38:822-828 .

Bao T, Seidman A, Li Q, Seluzicki C, Blinder V, Meghani SH, Farrar JT, Mao JJ . Living with chronic

pain: Perceptions of breast cancer survivors . Breast Cancer Research and Treatment . 2018;169(1):133-140 .

Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, Blinder VS, Zhi W I, Li Q, Vahdat LT, Dickler MN, Robson ME, Mao JJ . A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients . European Journal of Cancer . 2018;101:12-19 .

Bao T, Zhi W I, Vertosick EA, Li QS, DeRito J, Vickers A, Cassileth BR, Mao JJ, Van Zee KJ . Acupuncture for breast cancer-related lymphedema: A randomized controlled trial . Breast Cancer Research and Treatment . 2018;170(1):77-87 .

Baradaran R, Wang C, Siliciano AF, Long SB . Cryo-EM structures of fungal and metazoan mitochondrial calcium uniporters . Nature . 2018;559(7715):580-584 .

Barba P, Martino R, Zhou Q, Cho C, Castro-Malaspina H, Devlin S, Esquirol A, Giralt S, Jakubowski AA, Caballero D, Maloy M, Papadopoulos EB, Piñana JL, Fox ML, Marquez-Malaver FJ, Valcarcel D, Solano C, Lopez-Corral L, Sierra J, Perales MA . CD34(+) cell selection versus reduced-intensity conditioning and unmodified grafts for allogeneic hematopoietic cell transplantation in patients age >50 years with acute myelogenous leukemia and myelodysplastic syndrome . Biology of Blood and Marrow Transplantation . 2018;24(5):964-972 .

Barbetta A, Faraz S, Shah P, Gerdes H, Hsu M, Tan KS, Nobel T, Bains MS, Bott M, Isbell JM, Sewell DB, Jones DR, Molena D . Quality of endoscopy reports for esophageal cancer patients: Where do we stand? . Journal of Gastrointestinal Surgery . 2018;22(5):778-784 . PMCID: PMC5988358

Barbetta A, Schlottmann F, Nobel T, Sewell DB, Hsu M, Tan KS, Gerdes H, Shah P, Bains MS, Bott M, Isbell JM, Jones DR, Molena D . Predictors of nodal metastases for clinical T2N0 esophageal

adenocarcinoma . Annals of Thoracic Surgery . 2018;106(1):172-177 .

Barbetta A, Hsu M, Tan KS, Stefanova D, Herman K, Adusumilli PS, Bains MS, Bott MJ, Isbell JM, Janjigian YY, Ku GY, Park BJ, Wu AJ, Jones DR, Molena D . Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma . Journal of Thoracic and Cardiovascular Surgery . 2018;155(6):2710-2721 .e3 . PMCID: PMC5960990

Barbetta A, Nobel TB, Sihag S, Hsu M, Tan KS, Bains MS, Isbell JM, Janjigian YY, Wu AJ, Bott MJ, Jones DR, Molena D . Neutrophil to lymphocyte ratio as predictor of treatment response in esophageal squamous cell cancer . Annals of Thoracic Surgery . 2018;106(3):864-871 . PMCID: PMC6117834

Bardia A, Parton M, Kümmel S, Estévez LG, Huang CS, Cortés J, Ruiz-Borrego M, Telli ML, Martin-Martorell P, Lopez R, Beck JT, Ismail-Khan R, Chen SC, Hurvitz SA, Mayer IA, Carreon D, Cameron S, Liao S, Baselga J, Kim SB . Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial . Journal of Clinical Oncology . 2018;36(31):3126-3133 .

Bardia A, Gucalp A, DaCosta N, Gabrail N, Danso M, Ali H, Blackwell KL, Carey LA, Eisner JR, Baskin-Bey ES, Traina TA . Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer . Breast Cancer Research and Treatment . 2018;171(1):111-120 .

Barker CA, Salama AK . New NCCN Guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma . Journal of the National Comprehensive Cancer Network . 2018;16(5 Suppl .):646-650 .

34 OF 288


Journal Articles

Barker CA . Adjuvant pembrolizumab in resected stage III melanoma . New England Journal of Medicine . 2018;379(6):593- .

Barker CA, Kim SK, Budhu S, Matsoukas K, Daniyan AF, D’Angelo SP . Cytokine release syndrome after radiation therapy: Case report and review of the literature . Journal for ImmunoTherapy of Cancer . 2018;6:1- .PMCID: PMC5795275

Barnett M . Heartthrobs: A history of women and desire . Journal of Women & Aging . 2018;30(1):85-86 .

Baron R, Drucker K, Lagdamen L, Cannon M, Mancini C, Fischer-Cartlidge E . Breast cancer screening: A review of current guidelines . American Journal of Nursing . 2018;118(7):34-41 .

Barrett AJ, Prockop S, Bollard CM . Virus-specific T cells: Broadening applicability . Biology of Blood and Marrow Transplantation . 2018;24(1):13-18 . PMCID: PMC5743764

Barrett-Campbell O, Petkovska I, Slovin SF . Malignant priapism in metastatic prostate cancer: A late event occurring early . Urology Case Reports . 2018;19:1-3 . PMCID: PMC5991306

Bartenstein DW, Coe TM, Gordon SC, Friedmann AM, Senna MM, Kelleher CM, Antonescu CR, Nazarian RM, Hawryluk EB . Lipofibromatosis-like neural tumor: Case report of a unique infantile presentation . JAAD Case Reports . 2018;4(2):185-188 . PMCID: PMC5993549

Barzilai O, Fisher CG, Bilsky MH . State of the art treatment of spinal metastatic disease . Neurosurgery . 2018;82(6):757-769 .

Barzilai O . Current role of uninstrumented lumbar fusion . World Neurosurgery . 2018;115:509-511 .

Barzilai O, McLaughlin L, Amato MK, Reiner AS, Ogilvie SQ, Lis E, Yamada Y, Bilsky MH, Laufer I . Minimal access surgery for spinal metastases: Prospective evaluation of a treatment algorithm using

patient-reported outcomes . World Neurosurgery . 2018;120:e889-e901 .

Barzilai O, DiStefano N, Lis E, Yamada Y, Lovelock DM, Fontanella AN, Bilsky MH, Laufer I . Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: A clinical and dosimetric analysis . Journal of Neurosurgery-Spine . 2018;28(1):72-78 .

Barzilai O, Amato MK, McLaughlin L, Reiner AS, Ogilvie SQ, Lis E, Yamada Y, Bilsky MH, Laufer I . Hybrid surgery-radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes . Neuro-Oncology Practice . 2018;5(2):104-113 . PMCID: PMC5946922

Barzilai O, McLaughlin L, Amato MK, Reiner AS, Ogilvie SQ, Lis E, Yamada Y, Bilsky MH, Laufer I . Predictors of quality of life improvement after surgery for metastatic tumors of the spine: Prospective cohort study . Spine Journal . 2018;18(7):1109-1115 . PMCID: PMC5936646

Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N,

Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, Weiser MR, Kolevska T, Reeve BB, Bruner DW, Schrag D . Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter trial: NCCTG N1048 . Journal of Clinical Oncology . 2018;36(31):3120-3125 .PMCID: PMC6209091

Baskin KM, Durack JC, Abu-Elmagd K, Doellman D, Drews BB, Journeycake JM, Kocoshis SA, McLennan G, Rupp SM, Towbin RB, Wasse H, Mermel LA, Toomay SM, Camillus JC, Ahrar K, White SB . Chronic central venous access: From research consensus panel to national multistakeholder initiative . Journal of Vascular and Interventional Radiology . 2018;29(4):461-469 .

Basu D, Salgado CM, Bauer B, Khakoo Y, Patel JR, Hoehl RM, Bertolini DM, Zabec J, Brzozowski MR, Reyes-Mugica M . The dual PI3K/mToR inhibitor omipalisib/GSK2126458 inhibits clonogenic growth in oncogenically-transformed cells from neurocutaneous melanocytosis . Cancer Genomics and Proteomics . 2018;15(4):239-248 .

Bates DDB, Fernandez MB, Ponchiardi C, von Plato M, Teich JP, Narsule C, Anderson SW, Gupta A, LeBedis CA . Surgical management in acute diverticulitis and its association with multi-detector CT, modified Hinchey classification, and clinical parameters . Abdominal Radiology . 2018;43(8):2060-2065 .

Batlevi CL, Younes A . Surrogate end points in lymphoma . Annals of Oncology . 2018;29(8):1622-1623 .

Bauman JR, Schleicher SM, Nipp R, El-Jawahri A, Pirl WF, Greer JA, Temel JS . Enhancing communication between oncology care providers and patient caregivers during hospice . Journal of Community and Supportive Oncology . 2018;16(2):e72-e80 .

Baumann BC, Verginadis I I, Zeng C, Bell B, Koduri S, Vachani C, MacArthur KM, Solberg TD, Koumenis C, Metz JM . Assessing the validity of clinician advice that patients avoid use of topical agents before daily radiotherapy treatments . JAMA Oncology . 2018;4(12):1742-1748 . PMCID: PMC6440719

Baumann MH, Pasternak GW . Novel synthetic opioids and overdose deaths: Tip of the iceberg? . Neuropsychopharmacology . 2018;43(1):216-217 .PMCID: PMC5719114

Baumann MH, Majumdar S, Le Rouzic V, Hunkele A, Uprety R, Huang XP, Xu J, Roth BL, Pan YX, Pasternak GW . Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace . Neuropharmacology . 2018;134(Pt . A):101-107 . PMCID: PMC5809328

Baxi S, Yang A, Gennarelli RL, Khan N, Wang Z, Boyce L, Korenstein D . Immune-related adverse

35 OF 288


Journal Articles

events for anti-PD-1 and anti-PD-L1 drugs: Systematic review and meta-analysis . BMJ: British Medical Journal (International Edition) . 2018;360:k793- . PMCID: PMC5851471

Baxi SS, Cullen G, Xiao H, Atoria CL, Sherman EJ, Ho A, Lee NY, Elkin EB, Pfister DG . Long-term quality of life in older patients with HPV-related oropharyngeal cancer . Head & Neck . 2018;40(11):2321-2328 .

Bayers S, Nehal KS, Nijhawan R I . Tacking sutures to shrink surgical defects near free margins . Journal of the American Academy of Dermatology . 2018;79(3):e39-e41 .

Bayin NS, Wojcinski A, Mourton A, Saito H, Suzuki N, Joyner AL . Age-dependent dormant residentprogenitors are stimulated by injury to regenerate Purkinje neurons . eLife . 2018;7:e39879- . PMCID: PMC6115187

Beasley W, Thor M, McWilliam A, Green A, Mackay R, Slevin N, Olsson C, Pettersson N, Finizia C, Estilo C, Riaz N, Lee NY, Deasy JO, van Herk M . Image-based data mining to probe dosimetric correlates of radiation-induced trismus . International Journal of Radiation Oncology, Biology, Physics . 2018;102(4):1330-1338 .

Becattini S, Pamer EG . Multifaceted defense against Listeria monocytogenes in the gastro-intestinal lumen . Pathogens . 2018;7(1):1- .

Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, Socci N, Carlo M I, Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, Hsieh JJ . Comparative genomic profiling of matched primary and metastatic tumors in renal cell carcinoma . European Urology Focus . 2018;4(6):986-994 . PMCID: PMC5910293

Beck DM, Dossey B, Rosa W . Florence Nightingale and the U .N .’s 17 Sustainable Development Goals: Her keen relevance for our times . Beginnings . 2018;38(2):18-23 .

Beckham TH, Romesser PB, Groen AH, Sabol C, Shaha AR, Sabra M, Brinkman T, Spielsinger D, McBride S, Tsai CJ, Riaz N, Tuttle RM, Fagin JA, Sherman EJ, Wong RJ, Lee NY . Intensity-modulated radiation therapy with or without concurrent chemotherapy in nonanaplastic thyroid cancer with unresectable or gross residual disease . Thyroid . 2018;28(9):1180-1189 .

Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, Hoeffel C, Kim SH, Laghi A, Maier A, Rafaelsen SR, Stoker J, Taylor SA, Torkzad MR, Blomqvist L . Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting . European Radiology . 2018;28(4):1465-1475 . PMCID: PMC5834554

Begg CB, Ellenberg SS . Expedited approval programs at the Food and Drug Administration . Clinical Trials . 2018;15(3):217-218 .

Begg CB, Seshan VE, Zabor EC . Re: “A multinomial regression approach to model outcome heterogeneity” . American Journal of Epidemiology . 2018;187(5):1129-1130 .

Begg CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, Ng CKY, Sakr RA, Bernstein JL, Burke KA, King TA, Piscuoglio S, Mauguen A, Orlow I, Weigelt B, Seshan VE, Morrow M, Reis-Filho JS . Contralateral breast cancers: Independent cancers or metastases? . International Journal of Cancer . 2018;142(2):347-356 . PMCID: PMC5749409

Begnis M, Apte MS, Masuda H, Jain D, Wheeler DL, Cooper JP . RNAi drives nonreciprocal translocations at eroding chromosome ends to establish telomere-

free linear chromosomes . Genes and Development . 2018;32(7-8):537-554 . PMCID: PMC5959237

Behr G, Mema E, Costa K, Garg A . Proportion and clinical relevance of intraspinal air in patients with pneumomediastinum . American Journal of Roentgenology . 2018;211(2):321-326 .

Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks D I, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Gale RP, Lazarus HM, Ustun C, Copelan E, Hamilton BK, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ . Pretransplant consolidation is not beneficial for adults with ALL undergoing myeloablative allogeneic transplantation . Biology of Blood and Marrow Transplantation . 2018;24(5):945-955 . PMCID: PMC5953798

Bekaii-Saab T, Yu K, Lima CMSR, Wolin EM . Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: Focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma . Clinical Advances in Hematology & Oncology . 2018;16(9 Suppl . 17):1-16 .

Bekaroğlu MG, Nurili F, Işci S . Montmorillonite as imaging and drug delivery agent for cancer therapy . Applied Clay Science . 2018;162:469-477 .

Bekelman JE, Rumble RB, Chen RC, Pisansky TM, Finelli A, Feifer A, Nguyen PL, Loblaw DA, Tagawa ST, Gillessen S, Morgan TM, Liu G, Vapiwala N, Haluschak JJ, Stephenson A, Touijer K, Kungel T, Freedland SJ . Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology/ Society of Urologic Oncology Guideline . Journal of Clinical Oncology . 2018;36(32):3251-3258 .

Bellat V, Ting R, Southard TL, Vahdat L, Molina H, Fernandez J, Aras O, Stokol T, Law B . Functional

36 OF 288


Journal Articles

peptide nanofibers with unique tumor targeting and enzyme-induced local retention properties . Advanced Functional Materials . 2018;28(44):1803969- . PMCID: PMC6261308

Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A, Advani RH, Pesce EA, Ko YH, Martinez V, Montoto S, Chiattone C, Moskowitz A, Spina M, Biasoli I, Manni M, Federico M, on behalf of the International T-Cell Project Network . The outcome of peripheral T-cell lymphoma patients failing first-line therapy: A report from the prospective, International T-Cell Project . Haematologica . 2018;103(7):1191-1197 . PMCID: PMC6029527

Bellelli R, Vitagliano D, Federico G, Marotta P, Tamburrino A, Salerno P, Paciello O, Papparella S, Knauf JA, Fagin JA, Refetoff S, Troncone G, Santoro M . Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia . Molecular and Cellular Endocrinology . 2018;460:24-35 . PMCID: PMC5741508

Bellmunt J, Lalani AKA, Jacobus S, Wankowicz SA, Polacek L, Takeda DY, Harshman LC, Wagle N, Moreno I, Lundgren K, Bossé D, Van Allen EM, Choueiri TK, Rosenberg JE . Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma . British Journal of Cancer . 2018;119(6):707-712 .

Bello DM, Ariyan CE . Adjuvant therapy in the treatment of melanoma . Annals of Surgical Oncology . 2018;25(7):1807-1813 .

Bello DM, Russell C, McCullough D, Tierno M, Morrow M . Lymph node status in breast cancer does not predict tumor biology . Annals of Surgical Oncology . 2018;25(10):2884-2889 . PMCID: PMC6123264

Bendell J, Andre V, Ho A, Kudchadkar R, Migden M, Infante J, Tiu R V, Pitou C, Tucker T, Brail L, Von Hoff D . Phase I study of LY2940680, a Smo antagonist, in patients with advanced cancer including treatment-

naïve and previously treated basal cell carcinoma . Clinical Cancer Research . 2018;24(9):2082-2091 .

Bendell JC, Varghese AM, Hyman DM, Bauer TM, Pant S, Callies S, Lin J, Martinez R, Wickremsinhe E, Fink A, Wacheck V, Moore KN . A first-in-human phase 1 study of LY3023414, an oral PI3K/mTOR dual inhibitor, in patients with advanced cancer . Clinical Cancer Research . 2018;24(14):3253-3262 .

Benedict C, Thom B, Friedman DN, Pottenger E, Raghunathan N, Kelvin JF . Fertility information needs and concerns post-treatment contribute to lowered quality of life among young adult female cancer survivors . Supportive Care in Cancer . 2018;26(7):2209-2215 .

Benedict C, DuHamel K, Nelson CJ . Reduction in social activities mediates the relationship between diarrhea and distress in rectal/anal cancer survivors . Psycho-Oncology . 2018;27(2):691-694 . PMCID: PMC5748015

Benedict C, McLeggon JA, Thom B, Kelvin JF, Landwehr M, Watson S, Ford JS . “Creating a family after battling cancer is exhausting and maddening”: Exploring real-world experiences of young adult cancer survivors seeking financial assistance for family building after treatment . Psycho-Oncology . 2018;27(12):2829-2839 .

Bengsch B, Ohtani T, Khan O, Setty M, Manne S, O’Brien S, Gherardini PF, Herati RS, Huang AC, Chang KM, Newell EW, Bovenschen N, Pe’er D, Albelda SM, Wherry EJ . Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells . Immunity . 2018;48(5):1029-1045 .e5 .

Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, Zhang L, Morales-Oyarvide V, Kiyokawa T, Zannoni GF, Carlson J, Slavik T, Tornos C, Antonescu CR, Oliva E . Uterine PEComas: A morphologic, immunohistochemical, and molecular analysis of 32 tumors . American Journal of

Surgical Pathology . 2018;42(10):1370-1383 . PMCID: PMC6133752

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA . Anal carcinoma, version 2 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(7):852-871 .

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA . Rectal cancer, version 2 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(7):874-901 .

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA . NCCN Guidelines® Insights: Colon cancer, version 2 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(4):359-369 .

37 OF 288


Journal Articles

Berger MF, Mardis ER . The emerging clinical relevance of genomics in cancer medicine . Nature Reviews Clinical Oncology . 2018;15(6):353-365 .

Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN . Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) centers . Gynecologic Oncology . 2018;148(3):480-484 .

Berhe S, Danzer E, Meyers PA, Behr G, LaQuaglia MP, Price AP . Unusual abdominal metastases in osteosarcoma . Journal of Pediatric Surgery Case Reports . 2018;28:13-16 . PMCID: PMC5659360

Berlin NL, Hamill JB, Qi J, Kim HM, Pusic AL, Wilkins EG . Nonresponse bias in survey research: Lessons from a prospective study of breast reconstruction . Journal of Surgical Research . 2018;224:112-120 . PMCID: PMC5844368

Berman E, Druker BJ, Burwick R . Chronic myelogenous leukemia: Pregnancy in the era of stopping tyrosine kinase inhibitor therapy . Journal of Clinical Oncology . 2018;36(12):1250-1256 .

Berman E . Pregnancy in patients with chronic myeloid leukemia . Journal of the National Comprehensive Cancer Network . 2018;16(5 Suppl .):660-662 .

Berman E, Druker BJ, Burwick R . Reply to D .M . Ross et al and V . Florou et al . Journal of Clinical Oncology . 2018;36(25):2660-2661 .

Bernie HL, Goldstein M . Varicocele repair versus testosterone therapy for older hypogonadal men with clinical naricocele and low testosterone . European Urology Focus . 2018;4(3):314-316 .

Bernstein J, Woloschak GE . NCRP Program Area Committee 1: Basic criteria, epidemiology,

radiobiology, and risk . Health Physics . 2018;114(2):243-245 .

Berntsson SG, Merrell RT, Amirian ES, Armstrong GN, Lachance D, Smits A, Zhou R, Jacobs D I, Wrensch MR, Olson SH, Il’yasova D, Claus EB, Barnholtz-Sloan JS, Schildkraut J, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Bernstein JL, Lai R, Shete S, Amos C I, Bondy ML, Melin BS . Glioma-related seizures in relation to histopathological subtypes: A report from the Glioma International Case–Control study . Journal of Neurology . 2018;265(6):1432-1442 . PMCID: PMC5990563

Berry SL, Tierney KP, Elguindi S, Mechalakos JG . Five years’ experience with a customized electronic checklist for radiation therapy planning quality assurance in a multicampus institution . Practical Radiation Oncology . 2018;8(4):279-286 . PMCID: PMC6015771

Bertolaccini L, Rocco G . The forest of methodology and the writing of evidence-based medicine papers . European Journal of Cardio-Thoracic Surgery . 2018;54(4):615-621 .

Bestvina CM, Wroblewski KE, Daly B, Beach B, Chow S, Hantel A, Malec M, Huber MT, Polite BN . A rules-based algorithm to prioritize poor prognosis cancer patients in need of advance care planning . Journal of Palliative Medicine . 2018;21(6):846-849 .

Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, Garber JE, Gray R, Greenberg CC, Greenup R, Hansen NM, Harris RE, Heerdt AS, Helsten T, Hodgkiss L, Hoyt TL, Huff JG, Jacobs L, Lehman CD, Monsees B, Niell BL, Parker CC, Pearlman M, Philpotts L, Shepardson LB, Smith ML, Stein M, Tumyan L, Williams C, Bergman MA, Kumar R . Breast Cancer Screening and Diagnosis, version 3 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(11):1362-1389 .

Bevilacqua LA, Dulak D, Schofield E, Starr TD, Nelson CJ, Roth AJ, Holland JC, Alici Y . Prevalence and predictors of depression, pain, and fatigue in older- versus younger-adult cancer survivors . Psycho-Oncology . 2018;27(3):900-907 .

Bhat S, Gupta D, Akel O, Polos PG, DeBari VA, Akhtar S, McIntyre A, Ming SX, Upadhyay H, Chokroverty S . The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea . Sleep Medicine . 2018;49:81-89 .

Bhatia A, Ulaner G, Rampal R, Hyman DM, Abdel-Wahab O, Durham BH, Dogan A, Ozkaya N, Lacouture ME, Hajdenberg J, Ganzel C, Diamond EL . Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis . Haematologica . 2018;103(4):e177-e180 . PMCID: PMC5865413

Bhatt V . Current market and regulatory landscape of biosimilars . American Journal of Managed Care . 2018;24(21):S451-S456 .

Bi G, Wu L, Huang P, Islam S, Heruth DP, Zhang LQ, Li DY, Sampath V, Huang W, Simon BA, Easley RB, Ye SQ . Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown . FASEB Journal . 2018;32(7):3583-3596 . PMCID: PMC5998971

Bialer PA, McIntosh CA . A new generation speaks out . Journal of Gay and Lesbian Mental Health . 2018;22(3):203- .

Bialer PA, McIntosh CA . Our struggle continues . Journal of Gay and Lesbian Mental Health . 2018;22(4):309- .

Bichakjian C, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, Eisen DB, Iyengar V, Lober C, Margolis DJ, Messina J, Miller A, Miller S, Mostow E, Mowad C, Nehal K, Schmitt-Burr K, Sekulic A, Storrs P, Teng J, Yu S, Huang C, Boyer K, Begolka WS, Alam

38 OF 288


Journal Articles

M . Guidelines of care for the management of basal cell carcinoma . Journal of the American Academy of Dermatology . 2018;78(3):540-559 .

Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Blitzblau R, Bowen GM, Contreras CM, Daniels GA, Decker R, Farma JM, Fisher K, Gastman B, Ghosh K, Grekin RC, Grossman K, Ho AL, Lewis KD, Loss M, Lydiatt DD, Messina J, Nehal KS, Nghiem P, Puzanov I, Schmults CD, Shaha AR, Thomas V, Xu YG, Zic JA, Hoffmann KG, Engh AM . Merkel cell carcinoma, version 1 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(6):742-774 .

Biechonski S, Olender L, Zipin-Roitman A, Yassin M, Aqaqe N, Marcu-Malina V, Rall-Scharpf M, Trottier M, Meyn MS, Wiesmüller L, Beider K, Raz Y, Grisaru D, Nagler A, Milyavsky M . Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation . Scientific Reports . 2018;8:6071- . PMCID: PMC5904119

Bielski CM, Donoghue MTA, Gadiya M, Hanrahan AJ, Won HH, Chang MT, Jonsson P, Penson A V, Gorelick A, Harris C, Schram AM, Syed A, Zehir A, Chapman PB, Hyman DM, Solit DB, Shannon K, Chandarlapaty S, Berger MF, Taylor BS . Widespread selection for oncogenic mutant allele imbalance in cancer . Cancer Cell . 2018;34(5):852-862 .e4 . PMCID: PMC6234065

Bielski CM, Zehir A, Penson A V, Donoghue MTA, Chatila W, Armenia J, Chang MT, Schram AM, Jonsson P, Bandlamudi C, Razavi P, Iyer G, Robson ME, Stadler ZK, Schultz N, Baselga J, Solit DB, Hyman DM, Berger MF, Taylor BS . Genome doubling shapes the evolution and prognosis of advanced cancers . Nature Genetics . 2018;50(8):1189-1195 . PMCID: PMC6072608

Bierings M, Bonfim C, Peffault De Latour R, Aljurf M, Mehta PA, Knol C, Boulad F, Tbakhi A, Esquirol A, McQuaker G, Sucak GA, Othman TB, Halkes CJM,

Carpenter B, Niederwieser D, Zecca M, Kröger N, Michallet M, Risitano AM, Ehninger G, Porcher R, Dufour C, On behalf of the EBMT SAA WP . Transplant results in adults with Fanconi anaemia . British Journal of Haematology . 2018;180(1):100-109 .

Birn CS . Mastocytosis . Gastroenterology Nursing . 2018;41(5):380-387 .

Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL . Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group study . American Journal of Obstetrics and Gynecology . 2018;218(1):109 .e1-109 .e11 . PMCID: PMC5756682

Bitar M, Danish SF, Rosenblum MK . A newly diagnosed case of polymorphous low-grade neuroepithelial tumor of the young . Clinical Neuropathology . 2018;37(4):178-181 .

Bjornard KL, Leventaki V, Nichols KE, Sandlund JT, Prockop S, Ehrhardt MJ . Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis . Pediatric Blood and Cancer . 2018;65(12):e27415- .

Blaeschke F, Stenger D, Kaeuferle T, Willier S, Lotfi R, Kaiser AD, Assenmacher M, Döring M, Feucht J, Feuchtinger T . Induction of a central memory and stem cell memory phenotype in functionally active CD4(+) and CD8(+) CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19(+) acute lymphoblastic leukemia . Cancer Immunology, Immunotherapy . 2018;67(7):1053-1066 .

Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ . Proton therapy for head and neck cancers . Seminars in Radiation Oncology . 2018;28(1):53-63 .

Blee AM, He Y, Yang Y, Ye Z, Yan Y, Pan Y, Ma T, Dugdale J, Kuehn E, Kohli M, Jimenez R, Chen Y, Xu W, Wang L, Huang H . TMPRSS2-ERG controls luminal epithelial lineage and antiandrogen sensitivity in PTEN and TP53-mutated prostate cancer . Clinical Cancer Research . 2018;24(18):4551-4565 . PMCID: PMC6139075

Blenman KRM, He TF, Frankel PH, Ruel NH, Schwartz EJ, Krag DN, Tan LK, Yim JH, Mortimer JE, Yuan Y, Lee PP . Sentinel lymph node B cells can predict disease-free survival in breast cancer patients . npj Breast Cancer . 2018;4:28- . PMCID: PMC6107630

Bloomfield CD, Estey E, Pleyer L, Schuh AC, Stein EM, Tallman MS, Wei A . Time to repeal and replace response criteria for acute myeloid leukemia? . Blood Reviews . 2018;32(5):416-425 .

Blumenthal GM, Bunn PA Jr, Chaft JE, McCoach CE, Perez EA, Scagliotti G V, Carbone DP, Aerts HJWL, Aisner DL, Bergh J, Berry DA, Jarkowski A, Botwood N, Cross DAE, Diehn M, Drezner NL, Doebele RC, Blakely CM, Eberhardt WEE, Felip E, Gianni L, Keller SP, Leavey PJ, Malik S, Pignatti F, Prowell TM, Redman MW, Rizvi NA, Rosell R, Rusch V, de Ruysscher D, Schwartz LH, Sridhara R, Stahel RA, Swisher S, Taube JM, Travis WD, Keegan P, Wiens JR, Wistuba I I, Wynes MW, Hirsch FR, Kris MG . Current status and future perspectives on neoadjuvant therapy in lung cancer . Journal of Thoracic Oncology . 2018;13(12):1818-1831 .

Bochner BH . Postchemotherapy surgery for advanced urothelial cancer: Another tool to improve outcome . European Urology . 2018;73(4):558-559 .

Bochner BH, Dalbagni G, Marzouk KH, Sjoberg DD, Lee J, Donat SM, Coleman JA, Vickers A, Herr HW, Laudone VP . Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: Oncologic outcomes . European Urology . 2018;74(4):465-471 .

39 OF 288


Journal Articles

Bodei L, Weber WA . Somatostatin receptor imaging of neuroendocrine tumors: From agonists to antagonists . Journal of Nuclear Medicine . 2018;59(6):907-908 .

Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, Drozdov IA, Cwikla J, Baum RP, Kwekkeboom DJ, Paganelli G, Krenning EP, Modlin IM . PRRT genomic signature in blood for prediction of (177)Lu-octreotate efficacy . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(7):1155-1169 .

Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J . Evaluation of the Vitek MS v3 .0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species . Journal of Clinical Microbiology . 2018;56(6):e00237-18- . PMCID: PMC5971548

Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH . Choroidal infarction following ophthalmic artery chemotherapy . International Journal of Retina and Vitreous . 2018;4:16- . PMCID: PMC5925835

Boilève A, Carlo M I, Barthélémy P, Oudard S, Borchiellini D, Voss MH, George S, Chevreau C, Landman-Parker J, Tabone MD, Chism DD, Amin A, Bilen MA, Bosse D, Coulomb-L’Hermine A, Su X, Choueiri TK, Tannir NM, Malouf GG . Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders . Journal for ImmunoTherapy of Cancer . 2018;6:159- . PMCID: PMC6307255

Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, Lim CK, Krementsov DN, Hernandez N, Ma CS, Zhang Q, Markle J, Martinez-Barricarte R, Payne K, Fisch R, Deswarte C, Halpern J, Bouaziz M, Mulwa J, Sivanesan D, Lazarov T, Naves R, Garcia P,

Itan Y, Boisson B, Checchi A, Jabot-Hanin F, Cobat A, Guennoun A, Jackson CC, Pekcan S, Caliskaner Z, Inostroza J, Costa-Carvalho BT, de Albuquerque JAT, Garcia-Ortiz H, Orozco L, Ozcelik T, Abid A, Rhorfi IA, Souhi H, Amrani HN, Zegmout A, Geissmann F, Michnick SW, Muller-Fleckenstein I, Fleckenstein B, Puel A, Ciancanelli MJ, Marr N, Abolhassani H, Balcells ME, Condino-Neto A, Strickler A, Abarca K, Teuscher C, Ochs HD, Reisli I, Sayar EH, El-Baghdadi J, Bustamante J, Hammarström L, Tangye SG, Pellegrini S, Quintana-Murci L, Abel L, Casanova JL . Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant . Science Immunology . 2018;3(30):eaau8714- . PMCID: PMC6341984

Bolli N, Biancon G, Moarii M, Gimondi S, Li Y, de Philippis C, Maura F, Sathiaseelan V, Tai YT, Mudie L, O’Meara S, Raine K, Teague JW, Butler AP, Carniti C, Gerstung M, Bagratuni T, Kastritis E, Dimopoulos M, Corradini P, Anderson KC, Moreau P, Minvielle S, Campbell PJ, Papaemmanuil E, Avet-Loiseau H, Munshi NC . Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups . Leukemia . 2018;32(12):2604-2616 . PMCID: PMC6286326

Bombard Y, Clausen M, Mighton C, Carlsson L, Casalino S, Glogowski E, Schrader K, Evans M, Scheer A, Baxter N, Hamilton JG, Lerner-Ellis J, Offit K, Robson M, Laupacis A . The Genomics ADvISER: Development and usability testing of a decision aid for the selection of incidental sequencing results . European Journal of Human Genetics . 2018;26(7):984-995 . PMCID: PMC6018661

Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ . Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure . Clinicoeconomics and Outcomes Research . 2018;10:629-641 . PMCID: PMC6198880

Bonazzoli E, Predolini F, Cocco E, Bellone S, Altwerger G, Menderes G, Zammataro L, Bianchi A, Pettinella F, Riccio F, Han C, Yadav G, Lopez S, Manzano A, Manara P, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Schlessinger J, Santin AD . Inhibition of BET bromodomain proteins with GS-5829 and GS-626510 in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer . Clinical Cancer Research . 2018;24(19):4845-4853 . PMCID: PMC6168417

Boone BA, Perkins S, Bandi R, Santos E, McCluskey K, Bartlett DL, Pingpank JF . Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma . Journal of Surgical Oncology . 2018;117(5):940-946 .

Booth CAG, Barkas N, Neo WH, Boukarabila H, Soilleux EJ, Giotopoulos G, Farnoud N, Giustacchini A, Ashley N, Carrelha J, Jamieson L, Atkinson D, Bouriez-Jones T, Prinjha RK, Milne TA, Teachey DT, Papaemmanuil E, Huntly BJP, Jacobsen SEW, Mead AJ . Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors . Cancer Cell . 2018;33(2):274-291 .e8 .

Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman G I, Erinjeri JP, Covey A, Yarmohammadi H, Ziv E, Sofocleous CT, Boas FE . Does enhancement or perfusion on preprocedure CT predict outcomes after embolization of hepatocellular carcinoma? . Academic Radiology . 2018;25(12):1588-1594 . PMCID: PMC6160360

Boseki B, Finaldi L, Siegel S . Introduction to immunotherapy: What nurses need to know about emerging therapies . American Nurse Today . 2018;13(7):6-11 .

Bosse T, Nout RA, McAlpine JN, McConechy MK, Britton H, Hussein YR, Gonzalez C, Ganesan R, Steele JC, Harrison BT, Oliva E, Vidal A, Matias-Guiu X, Abu-Rustum NR, Levine DA, Gilks CB, Soslow RA .

40 OF 288


Journal Articles

Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups . American Journal of Surgical Pathology . 2018;42(5):561-568 . PMCID: PMC5893364

Bott MJ . Predicting outcomes in esophageal cancer: No such thing as a crystal ball . Journal of Thoracic and Cardiovascular Surgery . 2018;156(2):845-846 .

Bott MJ . Prolonged air leak: Another instance where time is money . Journal of Thoracic and Cardiovascular Surgery . 2018;156(3):1222-1223 .

Bott MJ, Cools-Lartigue J, Tan KS, Dycoco J, Bains MS, Downey RJ, Huang J, Isbell JM, Molena D, Park BJ, Rusch VW, Sihag S, Jones DR, Adusumilli PS . Safety and feasibility of lung resection After immunotherapy for metastatic or unresectable tumors . Annals of Thoracic Surgery . 2018;106(1):178-183 .

Boucai L, Falcone J, Ukena J, Coombs CC, Zehir A, Ptashkin R, Berger MF, Levine RL, Fagin JA . Radioactive iodine-related clonal hematopoiesis in thyroid cancer is common and associated with decreased survival . Journal of Clinical Endocrinology and Metabolism . 2018;103(11):4216-4223 . PMCID: PMC6194804

Boudreau JE, Hsu KC . Natural killer cell education in human health and disease . Current Opinion in Immunology . 2018;50:102-111 .

Boudreau JE, Hsu KC . Natural killer cell education and the response to infection and cancer therapy: Stay tuned . Trends in Immunology . 2018;39(3):222-239 .

Boulad F, Mansilla-Soto J, Cabriolu A, Rivière I, Sadelain M . Gene therapy and genome editing . Hematology/Oncology Clinics of North America . 2018;32(2):329-342 .

Boulad F, Shore T, van Besien K, Minniti C, Barbu-Stevanovic M, Wiener Fedus S, Perna F, Greenberg J, Guarneri D, Nandi V, Mauguen A, Yazdanbakhsh K, Sadelain M, Shi PA . Safety and efficacy of plerixafor

dose escalation for the mobilization of CD34(+) hematopoietic progenitor cells in patients with sickle cell disease: Interim results . Haematologica . 2018;103(5):770-777 . PMCID: PMC5927989

Boustani J, Bertaut A, Galsky MD, Rosenberg JE, Bellmunt J, Powles T, Recine F, Harshman LC, Chowdhury S, Niegisch G, Yu EY, Pal SK, De Giorgi U, Crabb SJ, Caubet M, Balssa L, Milowsky M I, Ladoire S, Créhange G, Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators . Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators . Acta Oncologica . 2018;57(4):491-497 .

Bowie E, Norris R, Anderson K V, Goetz SC . Spinocerebellar ataxia type 11-associated alleles of Ttbk2 dominantly interfere with ciliogenesis and cilium stability . PLoS Genetics . 2018;14(12):e1007844- . PMCID: PMC6307817

Bowman RL, Busque L, Levine RL . Clonal hematopoiesis and evolution to hematopoietic malignancies . Cell Stem Cell . 2018;22(2):157-170 . PMCID: PMC5804896

Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A . Somatostatinrezeptor-PET/CT . Nuklearmedizin . 2018;57(1):4-17 .

Boyiadzis MM, Dhodapkar M V, Brentjens RJ, Kochenderfer JN, Neelapu SS, Maus M V, Porter DL, Maloney DG, Grupp SA, Mackall CL, June CH, Bishop MR . Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: Clinical perspective and significance . Journal for ImmunoTherapy of Cancer . 2018;6:137- . PMCID: PMC6278156

Bozal-Basterra L, Martín-Ruíz I, Pirone L, Liang Y, Sigurdsson JO, Gonzalez-Santamarta M, Giordano I,

Gabicagogeascoa E, de Luca A, Rodríguez JA, Wilkie AOM, Kohlhase J, Eastwood D, Yale C, Olsen J V, Rauchman M, Anderson K V, Sutherland JD, Barrio R . Truncated SALL1 impedes primary cilia function in Townes-Brocks syndrome . American Journal of Human Genetics . 2018;102(2):249-265 .

Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Chakrabarty JH, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA, in collaboration with the National Comprehensive Cancer Network . Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline . Journal of Clinical Oncology . 2018;36(17):1714-1768 .

Brahmer JR, Govindan R, Anders RA, Antonia SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L, Garon EB, Hellmann MD, Hirsch FR, Malik S, Neal JW, Papadimitrakopoulou VA, Rimm DL, Schwartz LH, Sepesi B, Yeap BY, Rizvi NA, Herbst RS . The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC) . Journal for ImmunoTherapy of Cancer . 2018;6:75- . PMCID: PMC6048854

Brailsford JA, Stockdill JL, Axelrod AJ, Peterson MT, Vadola PA, Johnston E V, Danishefsky SJ . Total chemical synthesis of human thyroid-stimulating hormone (hTSH) β-subunit: Application of arginine-tagged acetamidomethyl (Acm(R)) protecting groups . Tetrahedron . 2018;74(15):1951-1956 .

Brand C, Sadique A, Houghton JL, Gangangari K, Ponte JF, Lewis JS, Pillarsetty NVK, Konner JA, Reiner T . Leveraging PET to image folate receptor

41 OF 288


Journal Articles

α therapy of an antibody-drug conjugate . EJNMMI Research . 2018;8:87- . PMCID: PMC6113196

Brandt WS, Bouabdallah I, Tan KS, Park BJ, Adusumilli PS, Molena D, Bains MS, Huang J, Isbell JM, Bott MJ, Jones DR . Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma . Journal of Thoracic and Cardiovascular Surgery . 2018;155(3):1212-1224 .e3 . PMCID: PMC5816702

Brandt WS, Yan W, Leeman JE, Tan KS, Park BJ, Adusumilli PS, Bott MJ, Molena D, Isbell J, Chaft J, Rimner A, Jones DR . Postoperative radiotherapy for surgically resected ypN2 non-small cell lung cancer . Annals of Thoracic Surgery . 2018;106(3):848-855 .

Braunstein LZ, Cahlon O . Potential morbidity reduction with proton radiation therapy for breast cancer . Seminars in Radiation Oncology . 2018;28(2):138-149 .

Braza MS, van Leent MMT, Lameijer M, Sanchez-Gaytan BL, Arts RJW, Pérez-Medina C, Conde P, Garcia MR, Gonzalez-Perez M, Brahmachary M, Fay F, Kluza E, Kossatz S, Dress RJ, Salem F, Rialdi A, Reiner T, Boros P, Strijkers GJ, Calcagno CC, Ginhoux F, Marazzi I, Lutgens E, Nicolaes GAF, Weber C, Swirski FK, Nahrendorf M, Fisher EA, Duivenvoorden R, Fayad ZA, Netea MG, Mulder WJM, Ochando J . Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance . Immunity . 2018;49(5):819-828 .e6 .PMCID: PMC6251711

Brazier J, Briggs A, Bryan S . EQ-5D-5L: Smaller steps but a major step change? . Health Economics . 2018;27(1):4-6 .

Breitbart W . Jimmie C . Holland, M .D . . Psychosomatics . 2018;59(2):123-124 . PMCID: PMC5857250

Breitbart W . In memoriam: Jimmie C . Holland, MD, 1928-2017 . Palliative and Supportive Care . 2018;16(2):124-126 . PMCID: PMC5924696

Breitbart W . Forgiveness . Palliative and Supportive Care . 2018;16(3):244-245 . PMCID: PMC6020015

Breitbart W, Pessin H, Rosenfeld B, Applebaum AJ, Lichtenthal WG, Li Y, Saracino RM, Marziliano AM, Masterson M, Tobias K, Fenn N . Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer . Cancer . 2018;124(15):3231-3239 . PMCID: PMC6097940

Breitbart W . Dignity and meaning in supportive care . Palliative and Supportive Care . 2018;16(6):641-642 .PMCID: PMC6416782

Breitbart W . Learning to live, learning to die . Palliative and Supportive Care . 2018;16(5):501-502 . PMCID: PMC6294117

Breneman JC, Donaldson SS, Constine L, Merchant T, Marcus K, Paulino AC, Followill D, Mahajan A, Laack N, Esiashvili N, Haas-Kogan D, Laurie F, Olch A, Ulin K, Hodgson D, Yock T I, Terezakis S, Krasin M, Panoff J, Chuba P, Hua CH, Hess CB, Houghton PJ, Wolden S, Buchsbaum J, Fitzgerald TJ, Kalapurakal JA . The Children’s Oncology Group radiation oncology discipline: 15 years of contributions to the treatment of childhood cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):860-874 .

Brennan SB, D’Alessio D, Kaplan J, Edelweiss M, Heerdt AS, Morris EA . Positive predictive value of biopsy of palpable masses following mastectomy . Breast Journal . 2018;24(5):789-797 .

Brentjens R, Davila ML . CAR T cells, immunologic and cellular therapies in hematologic malignancies . Best Practice and Research: Clinical Haematology . 2018;31(2):115-116 .

Brier MJ, Chambless DL, Chen J, Mao JJ . Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors . European

Journal of Cancer . 2018;91:145-152 . PMCID: PMC5803454

Brite J, McMillen T, Robilotti E, Sun J, Chow HY, Stell F, Seo SK, McKenna D, Eagan J, Montecalvo M, Chen D, Sepkowitz K, Kamboj M . Effectiveness of ultraviolet disinfection in reducing hospital-acquired Clostridium difficile and vancomycin-resistant Enterococcus on a bone marrow transplant unit . Infection Control and Hospital Epidemiology . 2018;39(11):1301-1306 .

Brito JP, Moon JH, Zeuren R, Kong SH, Kim YG, Iñiguez-Ariza NM, Choi JY, Lee KE, Kim JH, Hargraves I, Bernet V, Montori VM, Park YJ, Tuttle RM . Thyroid cancer treatment choice: A pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options . Thyroid . 2018;28(10):1325-1331 .

Brogden KA, Parashar D, Hallier AR, Braun T, Qian F, Rizvi NA, Bossler AD, Milhem MM, Chan TA, Abbasi T, Vali S . Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy . BMC Cancer . 2018;18:225- .

Brooks JD, Sung JS, Pike MC, Orlow I, Stanczyk FZ, Bernstein JL, Morris EA . MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women . International Journal of Cancer . 2018;143(4):823-830 . PMCID: PMC6041161

Brooks JD, Comen EA, Reiner AS, Orlow I, Leong SF, Liang X, Mellemkjær L, Knight JA, Lynch CF, John EM, Bernstein L, Woods M, Doody DR, WECARE Study Collaborative Group, Malone KE, Bernstein JL . CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study . Breast Cancer Research . 2018;20:149- . PMCID: PMC6288916

Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M,

42 OF 288


Journal Articles

Seshan V, Bhola P, O’Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivtsov A V, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G,

Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A . MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia . Cancer Discovery . 2018;8(4):478-497 . PMCID: PMC5882571

Browne JP, Jeevan R, Pusic AL, Klassen AF, Gulliver-Clarke C, Pereira J, Caddy CM, Cano SJ . Measuring the patient perspective on latissimus dorsi donor site outcomes following breast reconstruction . Journal of Plastic Reconstructive and Aesthetic Surgery . 2018;71(3):336-343 .

Bruce Macdonald HE, Cave-Ayland C, Ross GA, Essex JW . Ligand binding free energies with adaptive water networks: Two-dimensional grand canonical alchemical perturbations . Journal of Chemical Theory and Computation . 2018;14(12):6586-6597 . PMCID: PMC6293443

Brufsky AM, Dickler MN . Estrogen receptor-positive breast cancer: Exploiting signaling pathways implicated in endocrine resistance . The Oncologist . 2018;23(5):528-539 . PMCID: PMC5947450

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF . Understanding the role of advanced practice providers in oncology in the United States . Journal of Oncology Practice . 2018;14(9):e518-e532 .

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF . Understanding the role of advanced practice providers in oncology in the United States . Journal of the American Academy of Physician Assistants . 2018;31(12):1-12 .

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF . Understanding the role of advanced practice providers in oncology in the United States . Journal of the Advanced Practitioner in Oncology . 2018;9(6):585-599 .

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF . Understanding the role of advanced practice providers in oncology in the United States . Oncology Nursing Forum . 2018;45(6):786-800 .

Brunelle CL, Barrio A V, Shaitelman SF, Singhal D, Sayegh HE, Taghian AG . On “Diagnosis of upper quadrant lymphedema secondary to cancer: Clinical practice guideline from the Oncology Section of the American Physical Therapy Association .” Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L . Phys Ther . 2017;97:729-745 . Physical Therapy . 2018;98(4):277-281 .

Brunet E, Jasin M . Induction of chromosomal translocations with CRISPR-Cas9 and other nucleases: Understanding the repair mechanisms that give rise to translocations . Advances in Experimental Medicine and Biology . 2018;1044:15-25 .

Brunner TH, DiFortuna K, LeTang M, Murphy J, Stemplewicz K, Kovacs M, DeRosa AP, Gibson DS, Ginex PK . Feasibility of an iPad to facilitate communication in postoperative patients with head and neck cancer . Journal of PeriAnesthesia Nursing . 2018;33(4):399-406 .

Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, Gouw A, Kagen A, Klimstra D, Komuta M, Kondo F, Miksad R, Nakano M, Nakanuma Y, Ng I, Paradis V, Nyun Park Y, Quaglia A, Roncalli M, Roskams T, Sakamoto M, Saxena R, Sempoux C, Sirlin C, Stueck A, Thung S, Tsui WMS, Wang XW, Wee A, Yano H, Yeh M, Zen Y, Zucman-Rossi J, Thiese N .

cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation . Hepatology . 2018;68(1):113-126 .

Bryant AR, Perales MA, Tamari R, Peled JU, Giralt S . Severe pembrolizumab-associated neutropenia after CD34(+) selected allogeneic hematopoietic-cell transplantation for multiple myeloma . Bone Marrow Transplantation . 2018;53(8):1065-1068 .

Bryce Y, Santos E . Balloon pulmonary angioplasty in a patient with prostate cancer and chronic thromboembolic pulmonary hypertension . Clinical Imaging . 2018;50:185-187 .

Bryce Y, Kim W, Katzen B, Benenati J, Samuels S . Outcomes over time in patients with hostile neck anatomy undergoing endovascular repair of abdominal aortic aneurysm . Journal of Vascular and Interventional Radiology . 2018;29(7):1011-1016 .

Bryce Y, Schiro B, Cooper K, Ganguli S, Khayat M, Lam CK, Oklu R, Vatakencherry G, Gandhi RT . Type II endoleaks: Diagnosis and treatment algorithm . Cardiovascular Diagnosis and Therapy . 2018;8(Suppl . 1):S131-S137 . PMCID: PMC5949582

Bryce Y, Lam C, Ganguli S, Schiro BJ, Cooper K, Cline M, Oklu R, Vatakencherry G, Peña CS, Gandhi RT . Step-by-step approach to management of type II endoleaks . Techniques in Vascular and Interventional Radiology . 2018;21(3):188-195 .

Bucciarelli PR, Tan KS, Chudgar NP, Brandt W, Montecalvo J, Eguchi T, Liu Y, Aly R, Travis WD, Adusumilli PS, Jones DR . BRMS1 expression in surgically resected lung adenocarcinoma predicts future metastases and is associated with a poor prognosis . Journal of Thoracic Oncology . 2018;13(1):73-84 . PMCID: PMC5738269

Buckley BJ, Aboelela A, Minaei E, Jiang LX, Xu Z, Ali U, Fildes K, Cheung CY, Cook SM, Johnson DC, Bachovchin DA, Cook GM, Apte M, Huang M, Ranson M, Kelso MJ . 6-substituted hexamethylene amiloride

43 OF 288


Journal Articles

(HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer . Journal of Medicinal Chemistry . 2018;61(18):8299-8320 .

Bulik-Sullivan B, Busby J, Palmer CD, Davis MJ, Murphy T, Clark A, Busby M, Duke F, Yang A, Young L, Ojo NC, Caldwell K, Abhyankar J, Boucher T, Hart MG, Makarov V, De Montpreville VT, Mercier O, Chan TA, Scagliotti G, Bironzo P, Novello S, Karachaliou N, Rosell R, Anderson I, Gabrail N, Hrom J, Limvarapuss C, Choquette K, Spira A, Rousseau R, Voong C, Rizvi NA, Fadel E, Frattini M, Jooss K, Skoberne M, Francis J, Yelensky R . Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification . Nature Biotechnology . 2018;37(1):55-63 .

Burger RA, Deng W, Makker V, Collins Y, Gray H, Debernardo R, Martin LP, Aghajanian C . Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study . Gynecologic Oncology . 2018;150(3):466-470 .

Burke PW, Aldoss I, Lunning MA, Devlin SM, Tallman MS, Pullarkat V, Mohrbacher AM, Douer D . Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses . Leukemia Research . 2018;66:49-56 .

Burkhalter JE, Atkinson TM, Berry-Lawhorn J, Goldstone S, Einstein MH, Wilkin TJ, Lee J, Cella D, Palefsky JM, ANCHOR HRQOL Implementation Group . Initial development and content validation of a health-related symptom index for persons either treated or monitored fortreated or monitored for anal high-grade squamous intraepithelial lesions . Value in Health . 2018;21(8):984-992 . PMCID: PMC6093301

Burkhalter JE, Aboulafia DM, Botello-Harbaum M, Lee JY . Participant characteristics and clinical

trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006) . HIV Clinical Trials . 2018;19(6):235-241 . PMCID: PMC6428211

Burn SF, Washkowitz AJ, Gavrilov S, Papaioannou VE . Postimplantation Mga expression and embryonic lethality of two gene-trap alleles . Gene Expression Patterns . 2018;27:31-35 . PMCID: PMC5835168

Burris HA, Saltz LB, Yu PP . Assessing the value of next-generation sequencing tests in a dynamic environment . American Society of Clinical Oncology Educational Book . 2018;38:139-146 .

Burton TM, Ye X, Parker ED, Bancroft T, Healey J . Burden of illness associated with tenosynovial giant cell tumors . Clinical Therapeutics . 2018;40(4):593-602 .e1 .

Busque L, Buscarlet M, Mollica L, Levine RL . Concise review: Age-related clonal hematopoiesis: Stem cells tempting the devil . Stem Cells . 2018;36(9):1287-1294 . PMCID: PMC6125185

Buturovic L, Shelton J, Spellman SR, Wang T, Friedman L, Loftus D, Hesterberg L, Woodring T, Fleischhauer K, Hsu KC, Verneris MR, Haagenson M, Lee SJ . Evaluation of a machine learning-based prognostic model for unrelated hematopoietic cell transplantation donor selection . Biology of Blood and Marrow Transplantation . 2018;24(6):1299-1306 . PMCID: PMC5993610

Bylund CL, Banerjee SC, Bialer PA, Manna R, Levin TT, Parker PA, Schofield E, Li Y, Bartell A, Chou A, Hichenberg SA, Dickler M, Kissane DW . A rigorous evaluation of an institutionally-based communication skills program for post-graduate oncology trainees . Patient Education and Counseling . 2018;101(11):1924-1933 .

Byrd JC, Ruppert AS, Heerema NA, Halvorson AE, Hoke E, Smith MR, Godwin JE, Couban S, Fehniger TA, Thirman MJ, Tallman MS, Appelbaum FR, Stone

RM, Robinson S, Chang JE, Mandrekar SJ, Larson RA . Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance) . Blood Advances . 2018;2(14):1705-1718 . PMCID: PMC6058242

Byrd S, Morris LGT . Neck dissection for salivary gland malignancies . Operative Techniques in Otolaryngology - Head and Neck Surgery . 2018;29(3):157-161 .

Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD . Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma . Clinical Cancer Research . 2018;24(2):295-305 .

Cadoo KA, Kaufman PA, Seidman AD, Chang C, Xing D, Traina TA . Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer . Clinical Breast Cancer . 2018;18(6):433-440 .e1 . PMCID: PMC6174098

Caffery LJ, Clunie D, Curiel-Lewandrowski C, Malvehy J, Soyer HP, Halpern AC . Transforming dermatologic imaging for the digital era: Metadata and standards . Journal of Digital Imaging . 2018;31(4):568-577 . PMCID: PMC6113154

Callahan MK, Kluger H, Postow MA, Segal NH, Lesokhin A, Atkins MB, Kirkwood JM, Krishnan S, Bhore R, Horak C, Wolchok JD, Sznol M . Nivolumab plus ipilimumab in patients with advanced melanoma: Updated survival, response, and safety data in a phase I dose-escalation study . Journal of Clinical Oncology . 2018;36(4):391-398 .

44 OF 288


Journal Articles

Callahan SJ, Tepan S, Zhang YM, Lindsay H, Burger A, Campbell NR, Kim IS, Hollmann TJ, Studer L, Mosimann C, White RM . Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ) . Disease Models & Mechanisms . 2018;11(9):dmm034561- . PMCID: PMC6177007

Callaway M V, Foley KM . The International Palliative Care Initiative . Journal of Pain and Symptom Management . 2018;55(2 Suppl .):S1-S5 .

Callaway M V, Connor SR, Foley KM . World Health Organization public health model: A roadmap for palliative care development . Journal of Pain and Symptom Management . 2018;55(2 Suppl .):S6-S13 .

Campanella G, Rajanna AR, Corsale L, Schüffler PJ, Yagi Y, Fuchs TJ . Towards machine learned quality control: A benchmark for sharpness quantification in digital pathology . Computerized Medical Imaging and Graphics . 2018;65:142-151 .

Campbell C, Dikiy S, Bhattarai SK, Chinen T, Matheis F, Calafiore M, Hoyos B, Hanash A, Mucida D, Bucci V, Rudensky AY . Extrathymically generated regulatory T cells establish a niche for intestinal border-dwelling bacteria and affect physiologic metabolite balance . Immunity . 2018;48(6):1245-1257 .e9 .

Campbell JD, Belozeroff V, Whittington MD, Rubin RJ, Raggi P, Briggs AH . Prices for common cardiovascular drugs in the US are not consistently aligned with value . Health Affairs . 2018;37(8):1298-1305 .

Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina A I, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou

JH, Rustgi AK, Drill E, Shen R, Wong CK, The Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Pickering CR, Zhang J, Chen Z, Van Waes C . Genomic, pathway network, and immunologic features distinguishing squamous carcinomas . Cell Reports . 2018;23(1):194-212 .e6 .

Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Le Mouhaer S, Sankaran B, Bourdeau L, El-Hashimy M, Sellami D, Baselga J . Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 . European Journal of Cancer . 2018;103:147-154 .

Cao C, Huang J, Rimner A, Wang D, Chung C, Jones DR . Stereotactic body radiation therapy: Focusing on the short game . Journal of Clinical Oncology . 2018;36(23):2455-2456 .

Cao C, Tian DH, Fu B, Huang J, Ranganath NK, Gossot D . The problem with sublobar resections . Journal of Thoracic Disease . 2018;10(Suppl . 26):S3224-S3226 . PMCID: PMC6186600

Cao C, Jones DR . Stereotactic body radiotherapy for early-stage non-small cell lung cancer: A surgical perspective on the American Society for Radiation Oncology Guidelines . Video-Assisted Thoracic Surgery . 2018;3:11- .

Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E, Chierigo F, Oreggia D, Moretti D, Briganti A, Vickers AJ, Montorsi F, Salonia A . Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia . Urology . 2018;122:152-157 .

Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell’Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, Capitanio U . Risk based

surveillance after surgical treatment of renal cell carcinoma . Journal of Urology . 2018;200(1):61-67 .

Cappadocia L, Lima CD . Ubiquitin-like protein conjugation: Structures, chemistry, and mechanism . Chemical Reviews . 2018;118(3):889-918 . PMCID: PMC5815371

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hanggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Hernaiz Driever P, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM . DNA methylation-based classification of central nervous system tumours . Nature . 2018;555(7697):469-474 .

45 OF 288


Journal Articles

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH . Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program . Annals of Oncology . 2018;29(2):405-417 . PMCID: PMC5834077

Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Dié Ras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen B V, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP . 4th ESO-ESMO International Consensus guidelines for advanced breast cancer (ABC 4) . Annals of Oncology . 2018;29(8):1634-1657 .

Carella AM, Saglio G, Mahon XF, Mauro MJ . Present results and future perspectives in optimizing chronic myeloid leukemia therapy . Haematologica . 2018;103(6):928-930 .

Carlo M I, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, Knezevic A, Patil S, Ceyhan-Birsoy O, Huang KC, Redzematovic A, Coskey DT, Stewart C, Pradhan N, Arnold AG, Hakimi AA, Chen YB, Coleman JA, Hyman DM, Ladanyi M, Cadoo KA, Walsh MF, Stadler ZK, Lee CH, Feldman DR, Voss MH, Robson M, Motzer RJ, Offit K . Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma . JAMA Oncology . 2018;4(9):1228-1235 .

Carlos G, Saulan M . Robotic emergencies: Are you prepared for a disaster? . AORN Journal . 2018;108(5):493-501 .

Carlsson S . Editorial comment . Journal of Urology . 2018;200(1):87- .

Carlsson S, Ehdaie B . Editorial comment . Journal of Urology . 2018;200(4):765- .

Carlsson S . Novel method in the diagnostic arsenal for prostate cancer . Urology Times . 2018;46(10):4- .

Carney B, Kossatz S, Lok BH, Schneeberger V, Gangangari KK, Pillarsetty NVK, Weber WA, Rudin CM, Poirier JT, Reiner T . Target engagement imaging of PARP inhibitors in small-cell lung cancer . Nature Communications . 2018;9:176- . PMCID: PMC5766608

Carrasquillo JA, O’Donoghue JA, Beylergil V, Ruan S, Pandit-Taskar N, Larson SM, Smith-Jones PM, Lyashchenko SK, Ohishi N, Ohtomo T, Abou-Alfa GK . I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma . EJNMMI Research . 2018;8:20- . PMCID: PMC5838028

Carrera C, Scope A, Dusza SW, Argenziano G, Nazzaro G, Phan A, Tromme I, Rubegni P, Malvehy J, Puig S, Marghoob AA . Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases . Journal of the American Academy of Dermatology . 2018;78(2):278-288 .

Carrera PM, Kantarjian HM, Blinder VS . The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment . CA - A Cancer Journal for Clinicians . 2018;68(2):153-165 .

Carrow JK, Cross LM, Reese RW, Jaiswal MK, Gregory CA, Kaunas R, Singh I, Gaharwar AK . Widespread changes in transcriptome profile of human mesenchymal stem cells induced by two-dimensional nanosilicates . Proceedings of the National Academy

of Sciences of the United States of America . 2018;115(17):E3905-E3913 .PMCID: PMC5924886

Carter J, Lacchetti C, Rowland JH . Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline adaptation summary . Journal of Oncology Practice . 2018;14(3):173-179 .

Carter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, Diefenbach MA, DuHamel K, Florendo J, Ganz PA, Goldfarb S, Hallmeyer S, Kushner DM, Rowland JH . Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care Ontario guideline . Journal of Clinical Oncology . 2018;36(5):492-511 .

Carter LM, Poty S, Sharma SK, Lewis JS . Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy - Model, vector, and radionuclide selection . Journal of Labelled Compounds and Radiopharmaceuticals . 2018;61(9):611-635 . PMCID: PMC6081268

Carvajal RD, Piperno-Neumann S, Kapiteijn E, Chapman PB, Frank S, Joshua AM, Piulats JM, Wolter P, Cocquyt V, Chmielowski B, Evans TRJ, Gastaud L, Linette G, Berking C, Schachter J, Rodrigues MJ, Shoushtari AN, Clemett D, Ghiorghiu D, Mariani G, Spratt S, Lovick S, Barker P, Kilgour E, Lai Z, Schwartz GK, Nathan P . Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A phase III, multicenter, randomized trial (SUMIT) . Journal of Clinical Oncology . 2018;36(12):1232-1239 .

Casanova J, Sicam RVG, Moreira-Barros J, Huang KG . Late retroperitoneal hematoma with abscess formation following laparoscopic staging of endometrial cancer . Gynecology and Minimally Invasive Therapy . 2018;7(1):31-32 . PMCID: PMC6135148

46 OF 288


Journal Articles

Casey DL, Kushner BH, Cheung NK V, Modak S, LaQuaglia MP, Wolden SL . Dose-escalation is needed for gross disease in high-risk neuroblastoma . Pediatric Blood and Cancer . 2018;65(7):e27009- .

Casey DL, Wolden SL . Rhabdomyosarcoma of the head and neck: A multimodal approach . Journal of Neurological Surgery . Part B: Skull Base . 2018;79(1):58-64 . PMCID: PMC5796820

Casey DL, Pitter KL, Kushner BH, Cheung NK V, Modak S, LaQuaglia MP, Wolden SL . Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: Can long-term control be achieved? . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1204-1209 . PMCID: PMC5934297

Casey E, Bournazos S, Mo G, Mondello P, Tan KS, Ravetch J V, Scheinberg DA . A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies . Leukemia . 2018;32(2):547-549 . PMCID: PMC5803448

Caso R, Jones GD, Jones DR . Sentinel lymph node mapping in lung cancer: A step forward? . Journal of Thoracic Disease . 2018;10(Suppl . 26):S3254-S3256 . PMCID: PMC6186604

Cassidy MR, Zabor EC, Stempel M, Mehrara B, Gemignani ML . Does response to neo-adjuvant chemotherapy impact breast reconstruction? . Breast Journal . 2018;24(4):567-573 . PMCID: PMC6035888

Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP . Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia . Haematologica . 2018;103(10):e466-e468 . PMCID: PMC6165799

Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzman M, Rodríguez O, Grueso J, Bonache S, Moles-Fernandez A, Villacampa

G, Viaplana C, Gomez P, Vidal M, Peg V, Serres-Créixams X, Dellaire G, Simard J, Nuciforo P, Rubio IT, Dientsmann R, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Déas O, Jonkers J, Masson JY, Cairo S, Judde JG, O’Connor MJ, Díez O, Balmaña J, Serra V . A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation . EMBO Molecular Medicine . 2018;10(12):e9172- . PMCID: PMC6284440

Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen A I, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M . Autologous transplantation in follicular lymphoma with early therapy failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research analysis . Biology of Blood and Marrow Transplantation . 2018;24(6):1163-1171 . PMCID: PMC5993598

Caudell JJ, Ward MC, Riaz N, Zakem SJ, Awan MJ, Dunlap NE, Isrow D, Hassanzadeh C, Vargo JA, Heron DE, Marcrom S, Boggs DH, Reddy CA, Dault J, Bonner JA, Higgins KA, Beitler JJ, Koyfman SA, Machtay M, Yao M, Trotti AM, Siddiqui F, Lee NY, on behalf of the Multi-Institution Reirradiation (MIRI) Collaborative . Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: A multi-institution analysis . International Journal of Radiation Oncology, Biology, Physics . 2018;100(3):606-617 .

Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen MLC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan

JA, Klekner A, Chambless LB, Hwang E I, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti C, Tirapelli DPC, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V . Heterogeneity within the PF-EPN-B ependymoma subgroup . Acta Neuropathologica . 2018;136(2):227-237 .

Cella D, Motzer RJ, Rini B I, Cappelleri JC, Ramaswamy K, Hariharan S, Arondekar B, Bushmakin AG . Important group differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms in patients with metastatic renal cell carcinoma . Value in Health . 2018;21(12):1413-1418 .

Cella D, Escudier B, Tannir NM, Powles T, Donskov F, Peltola K, Schmidinger M, Heng DYC, Mainwaring PN, Hammers HJ, Lee JL, Roth BJ, Marteau F, Williams P, Baer J, Mangeshkar M, Scheffold C, Hutson TE, Pal S, Motzer RJ, Choueiri TK . Quality of life outcomes for cabozantinib versus everolimus in patients with metastatic renal cell carcinoma: METEOR phase III randomized trial . Journal of Clinical Oncology . 2018;36(8):757-764 .

Centeno C, Sitte T, de Lima L, Alsirafy S, Bruera E, Callaway M, Foley K, Luyirika E, Mosoiu D, Pettus K, Puchalski C, Rajagopal MR, Yong J, Garralda E, Rhee JY, Comoretto N . White paper for global palliative care advocacy: Recommendations from a PAL-LIFE Expert Advisory Group of the Pontifical Academy for Life, Vatican City . Journal of Palliative Medicine . 2018;21(10):1389-1397 . PMCID: PMC6201784

Centeno C, Sitte T, De Lima L, Alsirafy S, Bruera E, Callaway M, Foley K, Luyirika E, Mosoiu D, Pettus K, Puchalski C, Rajagopal MR, Yong J, Garralda E, Rhee JY, Comoretto N . Documento de Posicion Oficial sobre la Promocion Global de Cuidados Paliativos: Recomendaciones del Grupo Internacional Asesor PAL-LIFE de la Academia Pontificia de la Vida,

47 OF 288


Journal Articles

Ciudad del Vaticano . Journal of Palliative Medicine . 2018;21(10):1398-1407 .PMCID: PMC6201785

Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K, Gonen M, Segal NH, Reidy DL, Varghese A, Shia J, Vakiani E, Wu AJ, Crane CH, Gollub MJ, Garcia-Aguilar J, Saltz LB, Weiser MR . Adoption of total neoadjuvant therapy for locally advanced rectal cancer . JAMA Oncology . 2018;4(6):e180071- . PMCID: PMC5885165

Cerfolio RJ, Ghanim AF, Dylewski M, Veronesi G, Spaggiari L, Park BJ . The long-term survival of robotic lobectomy for non–small cell lung cancer: A multi-institutional study . Journal of Thoracic and Cardiovascular Surgery . 2018;155(2):778-786 .

Ceyhan-Birsoy O, Miatkowski MM, Hynes E, Funke BH, Mason-Suares H . NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genes . Human Mutation . 2018;39(7):954-958 .

Cha EK, Sfakianos JP, Sukhu R, Yee AM, Sjoberg DD, Bochner BH . Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy . BJU International . 2018;122(4):627-632 .

Chaft JE, Dagogo-Jack I, Santini FC, Eng J, Yeap BY, Izar B, Chin E, Jones DR, Kris MG, Shaw AT, Gainor JF . Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer . Lung Cancer . 2018;122:67-71 . PMCID: PMC6062851

Chakrabarti R, Celia-Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, Hwang J, Peng J, Nixon B, Grady JJ, DeCoste C, Gao J, van Es JH, Li MO, Aifantis I, Clevers H, Kang Y . Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche . Science . 2018;360(6396):eaan4153- .

Chakraborty D, Basu S, Ulaner GA, Alavi A, Kumar R . Diagnostic role of fluorodeoxyglucose PET in breast

cancer: A history to current application . PET Clinics . 2018;13(3):355-361 .

Chakraborty J, Midya A, Rabidas R . Computer-aided detection and diagnosis of mammographic masses using multi-resolution analysis of oriented tissue patterns . Expert Systems with Applications . 2018;99:168-179 .

Chakraborty J, Midya A, Gazit L, Attiyeh M, Langdon-Embry L, Allen PJ, Do RKG, Simpson AL . CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas . Medical Physics . 2018;45(11):5019-5029 .

Chan AS, Muller RJ, Mancuso CE . Description of a tall-man lettering program for look-alike and sound-alike antineoplastic agents . American Journal of Health-System Pharmacy . 2018;75(8):512-513 .

Chan CS, Laddha S V, Lewis PW, Koletsky MS, Robzyk K, Da Silva E, Torres PJ, Untch BR, Li J, Bose P, Chan TA, Klimstra DS, Allis CD, Tang LH . ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup . Nature Communications . 2018;9:4158- . PMCID: PMC6185985

Chang AJ, McBride S, Keyes M, Chung HT, Davis BJ, Cox BW, Crook J, Demanes DJ, Hsu IC, Kamrava M, Krauss DJ, Morton G, Orio PF 3rd, Roach M 3rd, Venkat PS, Vigneault E, Zelefsky MJ . The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee endorse the American Society of Clinical Oncology/Cancer Care Ontario guidelines . Journal of Clinical Oncology . 2018;36(33):3342-3344 .

Chang CJ, Kotini AG, Olszewska M, Georgomanoli M, Teruya-Feldstein J, Sperber H, Sanchez R, DeVita R, Martins TJ, Abdel-Wahab O, Bradley RK, Papapetrou EP . Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs . Stem Cell Reports . 2018;10(5):1610-1624 .

Chang D, Lim M, Goos JACM, Qiao R, Ng YY, Mansfeld FM, Jackson M, Davis TP, Kavallaris M . Biologically targeted magnetic hyperthermia: Potential and limitations . Frontiers in Pharmacology . 2018;9:831- . PMCID: PMC6083434

Chang JC, Montecalvo J, Borsu L, Lu S, Larsen BT, Wallace WD, Sae-Ow W, Mackinnon AC, Kim HR, Bowman A, Sauter JL, Arcila ME, Ladanyi M, Travis WD, Rekhtman N . Bronchiolar adenoma: Expansion of the concept of ciliated muconodular papillary tumors with proposal for revised terminology based on morphologic, immunophenotypic, and genomic analysis of 25 cases . American Journal of Surgical Pathology . 2018;42(8):1010-1026 .

Chang KK, Yoon C, Yi BC, Tap WD, Simon MC, Yoon SS . Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas . Oncogenesis . 2018;7(6):47- . PMCID: PMC6006341

Chang MT, Shrestha Bhattarai T, Schram AM, Bielski CM, Donoghue MTA, Jonsson P, Chakravarty D, Phillips S, Kandoth C, Penson A, Gorelick A, Shamu T, Patel S, Harris C, Gao J, Sumer SO, Kundra R, Razavi P, Li BT, Reales DN, Socci ND, Jayakumaran G, Zehir A, Benayed R, Arcila ME, Chandarlapaty S, Ladanyi M, Schultz N, Baselga J, Berger MF, Rosen N, Solit DB, Hyman DM, Taylor BS . Accelerating discovery of functional mutant alleles in cancer . Cancer Discovery . 2018;8(2):174-183 . PMCID: PMC5809279

Chang MT, Penson A, Desai NB, Socci ND, Shen R, Seshan VE, Kundra R, Abeshouse A, Viale A, Cha EK, Hao X, Reuter VE, Rudin CM, Bochner BH, Rosenberg JE, Bajorin DF, Schultz N, Berger MF, Iyer G, Solit DB, Al-Ahmadie HA, Taylor BS . Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis . Clinical Cancer Research . 2018;24(8):1965-1973 .

48 OF 288


Journal Articles

Chapman PB . Changing the standard of care for treating melanoma brain metastases . Lancet Oncology . 2018;19(5):589-591 .

Charak G, Kuritzkes BA, Al-Mazrou A, Suradkar K, Valizadeh N, Lee-Kong SA, Feingold DL, Pappou EP . Use of an ACE inhibitor or angiotensin receptor blocker is a major risk factor for dehydration requiring readmission in the setting of a new ileostomy . International Journal of Colorectal Disease . 2018;33(3):311-316 .

Charalel RA, Durack JC, Mao J, Ross JS, Meltzer AJ, Sedrakyan A . Statewide inferior vena cava filter placement, complications, and retrievals: Epidemiology and recent trends . Medical Care . 2018;56(3):260-265 .

Charas T, McBride S . 2nd generation anti-androgens and radiotherapy for localized prostate cancer . Translational Cancer Research . 2018;7(Suppl . 6):S690-S694 .

Chatterjee A, Gass J, Burke MB, Kopkash K, El-Tamer MB, Holmes DR, Clark P, Reiland J . Results from the American Society of Breast Surgeons Oncoplastic Surgery Committee 2017 survey: Current practice and future directions . Annals of Surgical Oncology . 2018;25(10):2790-2794 .

Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll F I, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL . Structure of the nanobody-stabilized active state of the kappa opioid receptor . Cell . 2018;172(1-2):55-67 .e9 . PMCID: PMC5802374

Cheal SM, Xu H, Guo HF, Patel M, Punzalan B, Fung EK, Lee SG, Bell M, Singh M, Jungbluth AA, Zanzonico PB, Piersigilli A, Larson SM, Cheung NK V . Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of

HER2-positive breast carcinoma . Theranostics . 2018;8(18):5106-5125 . PMCID: PMC6217068

Cheal SM, Ruan S, Veach DR, Longo VA, Punzalan BJ, Wu J, Fung EK, Kelly MP, Kirshner JR, Giurleo JT, Ehrlich G, Han AQ, Thurston G, Olson WC, Zanzonico PB, Larson SM, Carrasquillo JA . ImmunoPET imaging of endogenous and transfected prolactin receptor tumor xenografts . Molecular Pharmaceutics . 2018;15(6):2133-2141 .

Cheang E, Ha R, Thornton CM, Mango VL . Innovations in image-guided preoperative breast lesion localization . British Journal of Radiology . 2018;91(1085):20170740- .

Chehab MA, Thakor AS, Tulin-Silver S, Connolly BL, Cahill AM, Ward TJ, Padia SA, Kohi MP, Midia M, Chaudry G, Gemmete JJ, Mitchell JW, Brody L, Crowley JJ, Heran MKS, Weinstein JL, Nikolic B, Dariushnia SR, Tam AL, Venkatesan AM . Adult and pediatric antibiotic prophylaxis during vascular and IR procedures: A Society of Interventional Radiology practice parameter update endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology . Journal of Vascular and Interventional Radiology . 2018;29(11):1483-1501 .e2 .

Cheleuitte-Nieves C, Gulvik CA, Humrighouse BW, Bell ME, Villarma A, Westblade LF, Lipman NS, Fischetti VA, McQuiston JR . Draft reference genome sequence of Corynebacterium mastitidis 16-1433, isolated from a mouse . Genome Announcements . 2018;6(7):e00050-18- . PMCID: PMC5814488

Cheleuitte-Nieves C, Gulvik CA, McQuiston JR, Humrighouse BW, Bell ME, Villarma A, Fischetti VA, Westblade LF, Lipman NS . Genotypic differences between strains of the opportunistic pathogen Corynebacterium bovis isolated from humans, cows, and rodents . PLoS ONE . 2018;13(12):e0209231- . PMCID: PMC6306256

Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, Klosky JL, Barnes N, Clark KL, Farr JB, Fernandez-Pineda I, Bishop MW, Metzger M, Pui CH, Kaste SC, Ness KK, Srivastava DK, Robison LL, Hudson MM, Yasui Y, Sklar CA . Premature ovarian insufficiency in childhood cancer survivors: A report from the St . Jude Lifetime Cohort . Obstetrical and Gynecological Survey . 2018;73(3):155-156 .

Chemaitilly W, Cohen LE, Mostoufi-Moab S, Patterson BC, Simmons JH, Meacham LR, van Santen HM, Sklar CA . Endocrine late effects in childhood cancer survivors . Journal of Clinical Oncology . 2018;36(21):2153-2159 .

Chen BT, Sethi SK, Jin T, Patel SK, Ye N, Sun CL, Rockne RC, Haacke EM, Root JC, Saykin AJ, Ahles TA, Holodny A I, Prakash N, Mortimer J, Waisman J, Yuan Y, Somlo G, Li D, Yang R, Tan H, Katheria V, Morrison R, Hurria A . Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: A brain magnetic resonance imaging pilot study . Breast Cancer Research . 2018;20:38- . PMCID: PMC5932862

Chen BT, Jin T, Patel SK, Ye N, Sun CL, Ma H, Rockne RC, Root JC, Saykin AJ, Ahles TA, Holodny A I, Prakash N, Mortimer J, Waisman J, Yuan Y, Li D, Somlo G, Vazquez J, Levi A, Tan H, Yang R, Katheria V, Hurria A . Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer . Breast Cancer Research and Treatment . 2018;172(2):363-370 .

Chen BT, Ghassaban K, Jin T, Patel SK, Ye N, Sun CL, Kim H, Rockne RC, Mark Haacke E, Root JC, Saykin AJ, Ahles TA, Holodny A I, Prakash N, Mortimer J, Waisman J, Yuan Y, Somlo G, Li D, Yang R, Tan H, Katheria V, Morrison R, Hurria A . Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study . Magnetic Resonance Imaging . 2018;54:218-224 .

49 OF 288


Journal Articles

Chen CC, Feng W, Lim PX, Kass EM, Jasin M . Homology-directed repair and the role of BRCA1, BRCA2, and related proteins in genome integrity and cancer . Annual Review of Cancer Biology . 2018;2:313-336 . PMCID: PMC6193498

Chen F . Size-, shape- and charge-dependent pharmacokinetics of radiolabeled nanoparticles . Biological and Medical Physics, Biomedical Engineering . 2018;:313-329 .

Chen F, Zhang X, Ma K, Madajewski B, Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F, Penate-Medina O, Overholtzer M, Pauliah M, Gonen M, Zanzonico P, Wiesner U, Bradbury MS, Quinn TP . Melanocortin-1 receptor-targeting ultrasmall silica nanoparticles for dual-modality human melanoma imaging . ACS Applied Materials & Interfaces . 2018;10(5):4379-4393 . PMCID: PMC5803308

Chen F, Ma K, Madajewski B, Zhuang L, Zhang L, Rickert K, Marelli M, Yoo B, Turker MZ, Overholtzer M, Quinn TP, Gonen M, Zanzonico P, Tuesca A, Bowen MA, Norton L, Subramony JA, Wiesner U, Bradbury MS . Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer . Nature Communications . 2018;9:4141- . PMCID: PMC6175906

Chen J, Biller E, Losos M, Li J, Hamad D, Blower L, Grevenow M, Oakley J . Irradiation and prolonged storage of red cells are associated with increased adverse events . Vox Sanguinis . 2018;113(5):468-475 .

Chen KF, Tang YY, Wang R, Fang D, Chen JH, Zeng Y, Li B, Wen TF, Wang WT, Wu H, Xu MQ, Yang JY, Wei YG, Huang JW, Li JX, Zhang HZ, Feng X, Yan LN, Chen ZY . The choose of different surgical therapies of hepatic alveolar echinococcosis: A single-center retrospective case-control study . Medicine . 2018;97(8):e0033- . PMCID: PMC5841995

Chen KL, Cho YT, Yang CW, Sheen YS, Liang CW, Lacouture ME, Chu CY . Olmutinib-induced palmoplantar keratoderma . British Journal of

Dermatology . 2018;178(2):e129-e131 . PMCID: PMC5812798

Chen L, Malek T . Point-of-care ultrasonography in emergency and critical care medicine . Critical Care Nursing Quarterly . 2018;41(2):94-101 .

Chen L, Chen JY, Huang YJ, Gu Y, Qiu J, Qian H, Shao C, Zhang X, Hu J, Li H, He S, Zhou Y, Abdel-Wahab O, Zhang DE, Fu XD . The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations . Molecular Cell . 2018;69(3):412-425 .e6 .

Chen LL, Finan M, Mead E, Halpern NA . A lung cancer patient with respiratory insufficiency and hemodynamic instability . Chest . 2018;153(3):e49-e52 .

Chen LL, Lim F . Routine supplemental oxygen for AMI: Modern-day myth . Nursing . 2018;48(11):19- .

Chen LL, Mead E, Dhawan V, Halpern NA . A patient in respiratory distress after esophagectomy . Chest . 2018;154(6):e157-e160 .

Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon A V, Webster KA, Ng C, Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J, Signoretti S, Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP . An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer . Nature Genetics . 2018;50(2):206-218 .

Chen N, Li X, Chintala NK, Tano ZE, Adusumilli PS . Driving CARs on the uneven road of antigen heterogeneity in solid tumors . Current Opinion in Immunology . 2018;51:103-110 .

Chen Q, Kirk K, Shurubor Y I, Zhao D, Arreguin AJ, Shahi I, Valsecchi F, Primiano G, Calder EL, Carelli V, Denton TT, Beal MF, Gross SS, Manfredi G, D’Aurelio M . Rewiring of glutamine metabolism Is a bioenergetic adaptation of human cells with mitochondrial DNA mutations . Cell Metabolism . 2018;27(5):1007-1025 .e5 . PMCID: PMC5932217

Chen R, Overholtzer M . When BAX doesn’t kill . Cell Cycle . 2018;17(4):412-413 . PMCID: PMC5927683

Chen T, Zhang M, Jabbour S, Wang H, Barbee D, Das IJ, Yue N . Principal component analysis-based imaging angle determination for 3D motion monitoring using single-slice on-board imaging . Medical Physics . 2018;45(6):2377-2387 .

Chen X, Hay JL, Waters EA, Kiviniemi MT, Biddle C, Schofield E, Li Y, Kaphingst K, Orom H . Health literacy and use and trust in health information . Journal of Health Communication . 2018;23(8):724-734 .

Chen Y, Chi P . Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers . Journal of Hematology & Oncology . 2018;11:78- . PMCID: PMC5992878

Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, Looijenga LHJ . Testicular cancer . Nature Reviews Disease Primers . 2018;4:29- .

Cheng ML, Iyer G . Novel biomarkers in bladder cancer . Urologic Oncology: Seminars and Original Investigations . 2018;36(3):115-119 .

Cheng ML, Solit DB . Opportunities and challenges in genomic sequencing for precision cancer care . Annals of Internal Medicine . 2018;168(3):221-222 .

Cheng ML, Berger MF, Hyman DM, Solit DB . Clinical tumour sequencing for precision oncology: Time for a universal strategy . Nature Reviews Cancer . 2018;18(9):527-528 .

Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, Kono Y, Do RK, Mitchell DG, Singal AG, Tang A, Sirlin CB . Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients . Radiology . 2018;289(3):816-830 .

50 OF 288


Journal Articles

Cheung F, Sandhu JS . Voiding dysfunction after non-urologic pelvic surgery . Current Urology Reports . 2018;19(9):75- .

Cheung NK, Hsu KC . Genotyping natural killer immune checkpoints to discover biomarkers of response . Clinical Cancer Research . 2018;24(1):3-5 . PMCID: PMC5754255

Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR . NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma . American Journal of Surgical Pathology . 2018;42(6):791-798 .

Chim CS, Kumar SK, Orlowski RZ, Cook G, Richardson PG, Gertz MA, Giralt S, Mateos M V, Leleu X, Anderson KC . Management of relapsed and refractory multiple myeloma: Novel agents, antibodies, immunotherapies and beyond . Leukemia . 2018;32(2):252-262 . PMCID: PMC5808071

Chisholm JC, Suvada J, Dunkel IJ, Casanova M, Zhang W, Ritchie N, Choi Y, Park J, Das Thakur M, Simko S, Tam NWR, Ferrari A . BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma . Pediatric Blood and Cancer . 2018;65(5):e26947- . PMCID: PMC5867229

Chmielewski JP, Bowlby SC, Wheeler FB, Shi L, Sui G, Davis AL, Howard TD, D’Agostino RB Jr, Miller LD, Sirintrapun SJ, Cramer SD, Kridel SJ . CD38 inhibits prostate cancer metabolism and proliferation by reducing cellular NAD(+) pools . Molecular Cancer Research . 2018;16(11):1687-1700 . PMCID: PMC6214722

Cho A, Eskandari R, Miloushev VZ, Keshari KR . A non-synthetic approach to extending the lifetime of hyperpolarized molecules using D(2)O solvation . Journal of Magnetic Resonance . 2018;295:57-62 .

Cho NS, Jenabi M, Arevalo-Perez J, Brennan N, Young RJ, Karimi S, Holodny A I, Peck KK . Diffusion tensor imaging shows corpus callosum differences between high-grade gliomas and metastases . Journal of Neuroimaging . 2018;28(2):199-205 .

Cho NS, Peck KK, Zhang Z, Holodny A I . Paradoxical activation in the cerebellum during language fMRI in patients with brain tumors: Possible explanations based on neurovascular uncoupling and functional reorganization . Cerebellum . 2018;17(3):286-293 .

Cho S, Lee HM, Yu IS, Choi YS, Huang HY, Hashemifar SS, Lin LL, Chen MC, Afanasiev ND, Khan AA, Lin SW, Rudensky AY, Crotty S, Lu LF . Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b . Nature Communications . 2018;9:2757- . PMCID: PMC6048122

Cho SJ, Yoon C, Lee JH, Chang KK, Lin JX, Kim YH, Kook MC, Aksoy BA, Park DJ, Ashktorab H, Smoot DT, Schultz N, Yoon SS . KMT2C mutations in diffuse-type gastric adenocarcinoma promote epithelial-to-mesenchymal transition . Clinical Cancer Research . 2018;24(24):6556-6569 . PMCID: PMC6295255

Chohan MO, Kahn S, Cederquist G, Reiner AS, Schwab J, Laufer I, Bilsky M . Surgical decompression of high-grade spinal cord compression from hormone refractory metastatic prostate cancer . Neurosurgery . 2018;82(5):670-677 .

Chohan MO, Ryan CT, Singh R, Lanning RM, Reiner AS, Rosenblum MK, Tabar V, Gutin PH . Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology . Neurosurgery . 2018;82(6):824-832 . PMCID: PMC6257020

Choi KW, Shaffer KM, Zale EL, Funes CJ, Koenen KC, Tehan T, Rosand J, Vranceanu AM . Early risk and resiliency factors predict chronic posttraumatic stress disorder in caregivers of patients admitted to a neuroscience ICU . Critical Care Medicine . 2018;46(5):713-719 . PMCID: PMC5899036

Choi W, Oh JH, Riyahi S, Liu CJ, Jiang F, Chen W, White C, Rimner A, Mechalakos JG, Deasy JO, Lu W . Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer . Medical Physics . 2018;45(4):1537-1549 . PMCID: PMC5903960

Chong IY, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, Pettitt S, Wilkerson P, Lambros MB, Reis-Filho JS, Ramessur A, Davidson M, Chau I, Cunningham D, Ashworth A, Lord CJ . Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer . Gut . 2018;67(10):1780-1792 . PMCID: PMC6145286

Chopra N, Gervasio KA, Kalosza B, Wu AY . Gun trauma and ophthalmic outcomes . Eye . 2018;32(4):687-692 . PMCID: PMC5898850

Chou C, Li MO . Re(de)fining innate lymphocyte lineages in the face of cancer . Cancer Immunology Research . 2018;6(4):372-377 .

Chou C, Li MO . Tissue-resident lymphocytes across innate and adaptive lineages . Frontiers in Immunology . 2018;9:2104- . PMCID: PMC6160555

Chou TC . The combination index (CI < 1) as the definition of synergism and of synergy claims . Synergy . 2018;7:49-50 .

Choudhury AD, Gray KP, Supko JG, Harshman LC, Taplin ME, Pace AF, Farina M, Zukotynski KA, Bernard B, Kantoff PW, Pomerantz M, Sweeney C . A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer . Prostate . 2018;78(14):1053-1062 .

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ . Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free

51 OF 288


Journal Articles

survival by independent review and overall survival update . European Journal of Cancer . 2018;94:115-125 .

Chow EJ, Antal Z, Constine LS, Gardner RW, Wallace H, Weil BR, Yeh JM, Fox E . New agents, emerging late effects, and the development of precision survivorship . Journal of Clinical Oncology . 2018;36(21):2231-2240 .

Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Border WL, Green DM, Meacham LR, Mulrooney DA, Ness KK, Oeffinger KC, Ronckers CM, Sklar CA, Stovall M, van der Pal HJ, van Dijk IWEM, van Leeuwen FE, Weathers RE, Robison LL, Armstrong GT, Yasui Y . Prediction of ischemic heart disease and stroke in survivors of childhood cancer . Journal of Clinical Oncology . 2018;36(1):44-52 . PMCID: PMC5756324

Chow K . Lessons from an immersion experience in southern India . Journal of Hospice & Palliative Nursing . 2018;20(5):500-505 .

Chow K, Dahlin C . Integration of palliative care and oncology nursing . Seminars in Oncology Nursing . 2018;34(3):192-201 .

Chowell D, Morris LGT, Grigg CM, Weber JK, Samstein RM, Makarov V, Kuo F, Kendall SM, Requena D, Riaz N, Greenbaum B, Carroll J, Garon E, Hyman DM, Zehir A, Solit D, Berger M, Zhou R, Rizvi NA, Chan TA . Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy . Science . 2018;359(6375):582-587 .

Choy E, Ballman K, Chen J, Dickson MA, Chugh R, George S, Okuno S, Pollock R, Patel RM, Hoering A, Patel S . SARC018_SPORE02: Phase II study of mocetinostat administered with gemcitabine for patients with metastatic leiomyosarcoma with progression or relapse following prior treatment with gemcitabine-containing therapy . Sarcoma . 2018;2018:2068517- . PMCID: PMC6220374

Chu CY, Choi J, Eaby-Sandy B, Langer CJ, Lacouture ME . Osimertinib: A novel dermatologic adverse event profile in patients with lung cancer . The Oncologist . 2018;23(8):891-899 . PMCID: PMC6156184

Chu SH, Song EJ, Chabon JR, Minehart J, Matovina CN, Makofske JL, Frank ES, Ross K, Koche RP, Feng Z, Xu H, Krivtsov A, Nussenzweig A, Armstrong SA . Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras . Blood Advances . 2018;2(19):2478-2490 . PMCID: PMC6177652

Chun K, Wenger GD, Chaubey A, Dash DP, Kanagal-Shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM . Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia . Cancer Genetics . 2018;228-229:236-250 .

Chung DJ, Carvajal RD, Postow MA, Sharma S, Pronschinske KB, Shyer JA, Singh-Kandah S, Dickson MA, D’Angelo SP, Wolchok JD, Young JW . Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial . OncoImmunology . 2018;7(1):e1372081- . PMCID: PMC5739582

Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, Dela Cruz FS, Tannenbaum-Dvir S, Glade-Bender JL, Kung AL, DuBois SG, Kozakewich HP, Janeway KA, Perez-Atayde AR, Harris MH . Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy . Modern Pathology . 2018;31(3):463-473 .

Cibula D, Abu-Rustum NR, Fischerova D, Pather S, Lavigne K, Slama J, Alektiar K, Ming-Yin L, Kocian R, Germanova A, Frühauf F, Dostalek L, Dusek L,

Narayan K . Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy - A retrospective cohort study and review of the literature . Gynecologic Oncology . 2018;151(3):438-443 .

Cicconi L, Fenaux P, Kantarjian H, Tallman M, Sanz MA, Lo-Coco F . Molecular remission as a therapeutic objective in acute promyelocytic leukemia . Leukemia . 2018;32(8):1671-1678 .

Cifani P, Dhabaria A, Chen Z, Yoshimi A, Kawaler E, Abdel-Wahab O, Poirier JT, Kentsis A . ProteomeGenerator: A framework for comprehensive proteomics based on de novo transcriptome assembly and high-accuracy peptide mass spectral matching . Journal of Proteome Research . 2018;17(11):3681-3692 .

Cimino PJ, Kim Y, Wu HJ, Alexander J, Wirsching HG, Szulzewsky F, Pitter K, Ozawa T, Wang J, Vazquez J, Arora S, Rabadan R, Levine R, Michor F, Holland EC . Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma . Genes and Development . 2018;32(7-8):512-523 .PMCID: PMC5959235

Cinotti E, Labeille B, Debarbieux S, Carrera C, Lacarrubba F, Witkowski AM, Moscarella E, Arzberger E, Kittler H, Bahadoran P, Gonzalez S, Guitera P, Agozzino M, Farnetani F, Hofmann-Wellenhof R, Ardigo M, Rubegni P, Tognetti L, Łudzik J, Zalaudek I, Argenziano G, Longo C, Ribero S, Malvehy J, Pellacani G, Cambazard F, Perrot JL . Dermoscopy vs . reflectance confocal microscopy for the diagnosis of lentigo maligna . Journal of the European Academy of Dermatology and Venereology . 2018;32(8):1284-1291 .

Clapp JD, Luta G, Small BJ, Ahles TA, Root JC, Graham D, Hurria A, Jacobsen PB, Jim H, McDonald BC, Stern RA, Saykin AJ, Mandelblatt JS, for the Thinking and Living with Cancer (TLC) Study . The impact of using different reference populations on measurement of breast cancer-related

52 OF 288


Journal Articles

cognitive impairment rates . Archives of Clinical Neuropsychology . 2018;33(8):956-963 . PMCID: PMC6246339

Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, Nieveen van Dijkum EJM, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM . Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium . Cancer Treatment Reviews . 2018;63:28-39 .

Clements JB, Baird CT, de Boer SF, Fairobent LA, Fisher T, Goodwin JH, Gress DA, Johnson JL, Kolsky KL, Mageras GS, Marsh RM, Martin MC, Parker B, Pavord DC, Schell MC, Seibert JA, Stevens DM, Tarver RB, Waite-Jones CG, Wingreen N . AAPM medical physics practice guideline 10 .a .: Scope of practice for clinical medical physics . Journal of Applied Clinical Medical Physics . 2018;19(6):11-25 . PMCID: PMC6236822

Click ZR, Seddon AN, Bae YR, Fisher JD, Ogunniyi A . New Food and Drug Administration-approved and emerging novel treatment options for acute myeloid leukemia . Pharmacotherapy . 2018;38(11):1143-1154 .

Clifford K, Copeland A, Knutzen G, Samuelson E, Grove L, Schiavo K . Brentuximab vedotin: A nursing perspective on best practices and management of associated adverse events . Clinical Journal of Oncology Nursing . 2018;22(4):e103-e114 .

Cline M, Cooper KJ, Khaja MS, Gandhi R, Bryce YC, Williams DM . Endovascular management of acute

traumatic aortic injury . Techniques in Vascular and Interventional Radiology . 2018;21(3):131-136 .

Cline MS, Liao RG, Parsons MT, Paten B, Alquaddoomi F, Antoniou A, Baxter S, Brody L, Cook-Deegan R, Coffin A, Couch FJ, Craft B, Currie R, Dlott CC, Dolman L, den Dunnen JT, Dyke SOM, Domchek SM, Easton D, Fischmann Z, Foulkes WD, Garber J, Goldgar D, Goldman MJ, Goodhand P, Harrison S, Haussler D, Kato K, Knoppers B, Markello C, Nussbaum R, Offit K, Plon SE, Rashbass J, Rehm HL, Robson M, Rubinstein WS, Stoppa-Lyonnet D, Tavtigian S, Thorogood A, Zhang C, Zimmermann M, BRCA Challenge Authors, Burn J, Chanock S, Ratsch G, Spurdle AB . BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 . PLoS Genetics . 2018;14(12):e1007752- . PMCID: PMC6324924

Cobo I, Martinelli P, Flandez M, Bakiri L, Zhang M, Carrillo-De-Santa-Pau E, Jia J, Lobo VJSA, Megías D, Felipe I, del Pozo N, Millan I, Thommesen L, Bruland T, Olson SH, Smith J, Schoonjans K, Bamlet WR, Petersen GM, Malats N, Amundadottir LT, Wagner EF, Real FX . Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas . Nature . 2018;554(7693):533-537 .

Cocco E, Scaltriti M, Drilon A . NTRK fusion-positive cancers and TRK inhibitor therapy . Nature Reviews Clinical Oncology . 2018;15(12):731-747 . PMCID: PMC6419506

Cocco E, Carmona FJ, Razavi P, Won HH, Cai Y, Rossi V, Chan C, Cownie J, Soong J, Toska E, Shifman SG, Sarotto I, Savas P, Wick MJ, Papadopoulos KP, Moriarty A, Cutler RE Jr, Avogadri-Connors F, Lalani AS, Bryce RP, Chandarlapaty S, Hyman DM, Solit DB, Boni V, Loi S, Baselga J, Berger MF, Montemurro F, Scaltriti M . Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2) . Science Signaling . 2018;11(551):eaat9773- .PMCID: PMC6498841

Cocks Eschler D, Javanmard P, Cox K, Geer EB . Prolactinoma through the female life cycle . Endocrine . 2018;59(1):16-29 .

Codella NCF, Celebi ME, Dana K, Halpern A . ISIC 2018 preface . Lecture Notes in Computer Science . 2018;11041:XIV- .

Coffey K, Mango V, Keating DM, Morris EA, D’Alessio D . The impact of patient-initiated subspecialty review on patient care . Journal of the American College of Radiology . 2018;15(8):1109-1115 .

Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA Jr, Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N . Detection and localization of surgically resectable cancers with a multi-analyte blood test . Science . 2018;359(6378):926-930 .

Cohen NA, Strong VE, Janjigian YY . Checkpoint blockade in esophagogastric cancer . Journal of Surgical Oncology . 2018;118(1):77-85 .

Coit D, Ariyan C . MelMART trial: It’s now or never . Annals of Surgical Oncology . 2018;25(9):2493-2495 .

Coit DG, Hernandez J, Schoder H, Goldman D . Response to the letter to the editor by CM den Bakker and DL van Der Peet . Annals of Surgery . 2018;268(6):e79-e80 .

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad R I, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns

53 OF 288


Journal Articles

JL, Darlow SD . NCCN Guidelines® Insights: Head and neck cancers, version 1 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(5):479-490 .

Colon-Franco JM, Bossuyt PMM, Algeciras-Schimnich A, Bird C, Engstrom-Melnyk J, Fleisher M, Kattan M, Lambert-Messerlian G . Current and emerging multianalyte assays with algorithmic analyses - Are laboratories ready for clinical adoption? . Clinical Chemistry . 2018;64(6):885-891 .

Colombo M, Lopez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomaki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadel A, Benitez J, Boeckx B, Bogdanova N V, Bojesen SE, Bonanni B, Brauch H, Brenner H, Burwinkel B, Chang-Claude J, Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dörk T, Eriksson M, Fasching PA, Figueroa J, Fletcher O, Flyger H, Gabrielson M, García-Closas M, Giles GG, Gonzalez-Neira A, Guénel P, Haiman CA, Hall P, Hamann U, Hartman M, Hauke J, Hollestelle A, Hopper JL, Jakubowska A, Jung A, Kosma VM, Lambrechts D, Le Marchand L, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Miao H, Milne RL, Neuhausen SL, Nevanlinna H, Olson JE, Peterlongo P, Peto J, Pylkas K, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, See MH, Southey MC, Swerdlow A, Teo SH, Toland AE, Tomlinson I, Truong T, van Asperen CJ, van den Ouweland AMW, van der Kolk LE, Winqvist R, Yannoukakos D, Zheng W, kConFab/AOCS Investigators, Dunning AM, Easton DF, Henderson A, Hogervorst FBL, Izatt L, Offitt K, Side LE, van Rensburg EJ, Study EMBRACE, Study HEBON, McGuffog L, Antoniou AC, Chenevix-Trench G, Spurdle AB, Goldgar DE, de la Hoya M, Radice P . The BRCA2 c .68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity . Human Mutation . 2018;39(5):729-741 .

Combes G, Barysz H, Garand C, Braga LG, Alharbi I, Thebault P, Murakami L, Bryne DP, Stankovic S, Eyers PA, Bolanos-Garcia VM, Earnshaw WC, Maciejowski J, Jallepalli P V, Elowe S . Mps1 phosphorylates its N-terminal extension to relieve autoinhibition and activate the spindle assembly checkpoint . Current Biology . 2018;28(6):872-883 .e5 . PMCID: PMC5863767

Comen EA, Bowman RL, Kleppe M . Underlying causes and therapeutic targeting of the inflammatory tumor microenvironment . Frontiers in Cell and Developmental Biology . 2018;6:56- . PMCID: PMC6005853

Concors SJ, Kirkland ML, Schuricht AL, Dempsey DT, Morris JB, Vollmer CM, Drebin JA, Lee MK . Resection of gallbladder remnants after subtotal cholecystectomy: Presentation and management . HPB . 2018;20(11):1062-1066 .

Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J, for the ECHELON-1 Study Group . Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphoma . New England Journal of Medicine . 2018;378(4):331-344 . PMCID: PMC5819601

Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT . The role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1100-1118 .

Cook BE, Membreno R, Zeglis BM . Dendrimer scaffold for the amplification of in vivo pretargeting

ligations . Bioconjugate Chemistry . 2018;29(8):2734-2740 . PMCID: PMC6432625

Cook ED, Yeager KA, Cecchini RS, Boparai J, Brown CL, Duncan M, Cronin WM, Paskett ED . Recruitment practices for U .S . minority and underserved populations in NRG oncology: Results of an online survey . Contemporary Clinical Trials Communications . 2018;10:100-104 . PMCID: PMC6046466

Coombs CC, Gillis NK, Tan X, Berg JS, Ball M, Balasis ME, Montgomery ND, Bolton KL, Parker JS, Mesa TE, Yoder SJ, Hayward MC, Patel NM, Richards KL, Walko CM, Knepper TC, Soper JT, Weiss J, Grilley-Olson JE, Kim WY, Earp HS 3rd, Levine RL, Papaemmanuil E, Zehir A, Hayes DN, Padron E . Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays . Clinical Cancer Research . 2018;24(23):5918-5924 .

Cooper JP, Ginhoux F, Jessberger S, Overholtzer M . Life Science Alliance, from the academic editors . Life Science Alliance . 2018;1(1):e201800044- . PMCID: PMC6246889

Copur MS, Gnewuch C, Schriner M, Tharnish M, Gonen M, McDonald M, Kezeor J, Ramaekers RC, Gauchan D, Clark D, Greenwalt L, Mickey M, Norvell M . Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center . Journal of Oncology Pharmacy Practice . 2018;24(2):116-120 .

Corbett V, Epstein AS, McCabe MS . Characteristics and outcomes of ethics consultations on a comprehensive cancer center’s gastrointestinal medical oncology service . HEC Forum . 2018;30(4):379-387 .PMCID: PMC6263815

Corcoran RB, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G, Muro K, Gordon MS, Tabernero J, Yaeger R, O’Dwyer PJ, Humblet Y, De Vos F, Jung AS, Brase JC, Jaeger S, Bettinger S, Mookerjee B, Rangwala F, Van Cutsem E . Combined BRAF, EGFR,

54 OF 288


Journal Articles

and MEK inhibition in patients with BRAF(V600E)-mutant colorectal cancer . Cancer Discovery . 2018;8(4):428-443 . PMCID: PMC5882509

Cordeiro PG, Henderson PW, Matros E . A 20-year experience with 202 segmental mandibulectomy defects: A defect classification system, algorithm for flap selection, and surgical outcomes . Plastic and Reconstructive Surgery . 2018;141(4):571e-581e . PMCID: PMC5880317

Coriddi M, Kenworthy E, Weinstein A, Mehrara BJ, Dayan JH . The importance of indocyanine green near-infrared fluorescence angiography in perfusion assessment in vascularized omentum lymphatic transplant . Journal of Surgical Oncology . 2018;118(1):109-112 . PMCID: PMC6168345

Corines MJ, Nougaret S, Weiser MR, Khan M, Gollub MJ . Gadolinium-based contrast agent during pelvic MRI: Contribution to patient management in rectal cancer . Diseases of the Colon and Rectum . 2018;61(2):193-201 . PMCID: PMC5772900

Cornelis FH, Borgheresi A, Petre EN, Santos E, Solomon SB, Brown K . Hepatic arterial embolization using cone beam CT with tumor feeding vessel detection software: Impact on hepatocellular carcinoma response . CardioVascular and Interventional Radiology . 2018;41(1):104-111 .

Cornelis FH, Solomon SB . Treatment of primary liver tumors and liver metastases, part 2: Non–nuclear medicine techniques . Journal of Nuclear Medicine . 2018;59(12):1801-1808 . PMCID: PMC6278901

Cornelis FH, Durack JC, Pandit-Taskar N, Ulaner GA, Lewis JS, Morris MJ, Solomon SB . Long-half-life (89)Z-labeled radiotracers can guide percutaneous biopsy within the PET/CT suite without reinjection of radiotracer . Journal of Nuclear Medicine . 2018;59(3):399-402 . PMCID: PMC5868497

Cornelis FH, Petre EN, Vakiani E, Klimstra D, Durack JC, Gonen M, Osborne J, Solomon SB, Sofocleous

CT . Immediate postablation (18)F-FDG injection and corresponding SUV are surrogate biomarkers of local tumor progression after thermal ablation of colorectal carcinoma liver metastases . Journal of Nuclear Medicine . 2018;59(9):1360-1365 . PMCID: PMC6126442

Cornetta K, Duffy L, Feldman SA, Mackall CL, Davila ML, Curran KJ, Junghans RP, Tang JY, Kochenderfer JN, O’Cearbhaill R, Archer G, Kiem HP, Shah NN, Delbrook C, Kaplan R, Brentjens RJ, Rivière I, Sadelain M, Rosenberg SA . Screening clinical cell products for replication competent retrovirus: The National Gene Vector Biorepository experience . Molecular Therapy - Methods & Clinical Development . 2018;10:371-378 . PMCID: PMC6134358

Correa DD, Kryza-Lacombe M, Zhou X, Baser RE, Beattie BJ, Beiene Z, Humm J, DeAngelis LM, Orlow I, Weber W, Osborne J . A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas . Journal of Neuro-Oncology . 2018;136(3):613-622 . PMCID: PMC5807139

Corrias G, Monti S, Horvat N, Tang L, Basturk O, Saba L, Mannelli L . Imaging features of malignant abdominal neuroendocrine tumors with rare presentation . Clinical Imaging . 2018;51:59-64 .

Corrias G, Monti S, Mannelli L . Right upper quadrant pain in a 47-year-old woman . Gastroenterology . 2018;154(6):e11-e12 . PMCID: PMC5825236

Corrias G, Krebs S, Eskreis-Winkler S, Ryan D, Zheng J, Capanu M, Saba L, Monti S, Fung M, Reeder S, Mannelli L . MRI liver fat quantification in an oncologic population: The added value of complex chemical shift-encoded MRI . Clinical Imaging . 2018;52:193-199 .

Corrias G, Huicochea Castellanos S, Merkow R, Langan R, Balachandran V, Ragucci M, Carollo G, Mancini M, Saba L, Mannelli L . Does second reader opinion affect patient management in pancreatic ductal adenocarcinoma? . Academic Radiology . 2018;25(7):825-832 . PMCID: PMC5995638

Cortes JE, Tallman MS, Schiller GJ, Trone D, Gammon G, Goldberg SL, Perl AE, Marie JP, Martinelli G, Kantarjian HM, Levis MJ . Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD - mutated, relapsed or refractory AML . Blood . 2018;132(6):598-607 . PMCID: PMC6085992

Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH . Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial . Journal of Clinical Oncology . 2018;36(3):231-237 . PMCID: PMC5966023

Costa LJ, Landau HJ, Chhabra S, Hari P, Innis-Shelton R, Godby KN, Hamadani M, Tamari R, Anderton K, Dixon P, Giralt SA . Phase 1/2 trial of carfilzomib plus high-dose melphalan preparative regimen for salvage autologous hematopoietic cell transplantation followed by maintenance carfilzomib in patients with relapsed/refractory multiple myeloma . Biology of Blood and Marrow Transplantation . 2018;24(7):1379-1385 .

Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, Rekhtman N, Anders RA, Cuda JD, Illei PB, Gabrielson E, Askin FB, Niknafs N, Smith KN, Velez MJ, Sauter JL, Isbell JM, Jones DR, Battafarano RJ, Yang SC, Danilova L, Wolchok JD, Topalian SL, Velculescu VE, Pardoll DM, Brahmer JR, Hellmann MD, Chaft JE, Cimino-Mathews A, Taube JM . Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: A proposal for quantitative immune-related pathologic response criteria (irPRC) . Annals of Oncology . 2018;29(8):1853-1860 . PMCID: PMC6096736

Covey AM . Hepatocellular carcinoma: Updates to screening and diagnosis . Journal of the National Comprehensive Cancer Network . 2018;16(5 Suppl .):663-665 .

55 OF 288


Journal Articles

Cowan RA, Tseng J, Ali N, Dearie H, Murthy V, Gennarelli RL, Iasonos A, Abu-Rustum NR, Chi DS, Long Roche KC, Brown CL . Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center . Gynecologic Oncology . 2018;149(1):43-48 .

Cracchiolo JR, Wong RJ . Management of the lateral neck in well differentiated thyroid cancer . European Journal of Surgical Oncology . 2018;44(3):332-337 .

Cracchiolo JR, Patel K, Migliacci JC, Morris LT, Ganly I, Roman BR, McBride SM, Tabar VS, Cohen MA . Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma . Journal of Surgical Oncology . 2018;117(4):756-764 . PMCID: PMC5878715

Cracchiolo JR, Xu B, Migliacci JC, Katabi N, Pfister DG, Lee NY, Patel SG, Ghossein RA, Wong RJ . Patterns of recurrence in oral tongue cancer with perineural invasion . Head & Neck . 2018;40(6):1287-1295 . PMCID: PMC5980694

Creasy JM, D’Angelica M I . ASO author reflections: Primary tumor location and long-term survival after hepatic resection for metastatic colon cancer . Annals of Surgical Oncology . 2018;25(Suppl . 3):S747-S748 .

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Saltz LB, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Jarnagin WR, D’Angelica M I . The impact of primary tumor location on long-term survival in patients undergoing hepatic resection for metastatic colon cancer . Annals of Surgical Oncology . 2018;25(2):431-438 .

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Blumgart LH, Jarnagin WR, D’Angelica M I . Actual 10-year survival after hepatic resection of colorectal liver metastases: What factors preclude cure? . Surgery . 2018;163(6):1238-1244 .

Cremonesi M, Ferrari ME, Bodei L, Chiesa C, Sarnelli A, Garibaldi C, Pacilio M, Strigari L, Summers PE, Orecchia R, Grana CM, Botta F . Correlation of dose with toxicity and tumour response to (90)Y- and (177)Lu-PRRT provides the basis for optimization through individualized treatment planning . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(13):2426-2441 .

Cressman ENK, Newton I, Larson AC, Woodrum DA, Srimathveeravalli G, Borrelli MJ, Hunt S, Johnson T, Kim CY, White S, Pereira PL, Katsanos K, Gaba RC . State of the research enterprise in IR and recommendations for the future: Proceedings from the Society of Interventional Radiology Foundation Investigator Development Task Force . Journal of Vascular and Interventional Radiology . 2018;29(6):751-757 .

Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M, Curtis JR, Holloway RG . Neuropalliative care: Priorities to move the field forward . Neurology . 2018;91(5):217-226 . PMCID: PMC6093769

Crispin-Ortuzar M, Apte A, Grkovski M, Oh JH, Lee NY, Schöder H, Humm JL, Deasy JO . Predicting hypoxia status using a combination of contrast-enhanced computed tomography and (18)F-fluorodeoxyglucose positron emission tomography radiomics features . Radiotherapy and Oncology . 2018;127(1):36-42 . PMCID: PMC5924729

Cromwell RL, Scott JM, Downs M, Yarbough PO, Zanello SB, Ploutz-Snyder L . Overview of the NASA 70-day Bed Rest Study . Medicine and Science in Sports and Exercise . 2018;50(9):1909-1919 .

Cronin PA, Romanoff A, Zabor EC, Stempel M, Eaton A, Smyth LM, Ho AY, Morrow M, El-Tamer M, Gemignani ML . Influence of age on the clinical outcome of breast cancer for men and the development of second primary cancers . Annals of

Surgical Oncology . 2018;25(13):3858-3866 . PMCID: PMC6234073

Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN, Kristel P, de Bustos L, Guzman M, Rodríguez O, Grueso J, Montalban G, Caratu G, Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O, O’Connor MJ, Balmaña J, Serra V . RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer . Annals of Oncology . 2018;29(5):1203-1210 . PMCID: PMC5961353

Cruz-Correa M, Hylind LM, Hernandez Marrero J, Zahurak ML, Murray-Stewart T, Casero RA Jr, Montgomery EA, Iacobuzio-Donahue C, Brosens LA, Offerhaus GJ, Umar A, Rodriguez LM, Giardiello FM . Efficacy and safety of curcumin in treatment of intestinal adenomas in patients with familial adenomatous polyposis . Gastroenterology . 2018;155(3):668-673 . PMCID: PMC6120769

Cui T, Miller GW, Mugler JP 3rd, Cates GD Jr, Mata JF, de Lange EE, Huang Q, Altes TA, Yin FF, Cai J . An initial investigation of hyperpolarized gas tagging magnetic resonance imaging in evaluating deformable image registration-based lung ventilation . Medical Physics . 2018;45(12):5535-5542 . PMCID: PMC6289841

Cunanan KM, Koopmeiners JS . Efficacy/toxicity dose-finding using hierarchical modeling for multiple populations . Contemporary Clinical Trials . 2018;71:162-172 .

Cunanan KM, Koopmeiners JS . Hierarchical models for sharing information across populations in phase I dose-escalation studies . Statistical Methods in Medical Research . 2018;27(11):3447-3459 .

56 OF 288


Journal Articles

Cunniff C, Djavid AR, Carrubba S, Cohen B, Ellis NA, Fein Levy C, Jeong S, Lederman HM, Vogiatzi M, Walsh MF, Zauber AG . Health supervision for people with Bloom syndrome . American Journal of Medical Genetics Part A . 2018;176(9):1872-1881 .

Cuomo S, Abate M, Springer C, Kessel D, Bracken D, Fischer-Cartlidge E . Nurse practitioner–driven optimization of presurgical testing . Journal of PeriAnesthesia Nursing . 2018;33(6):887-894 .

Currie BM, Getrajdman G I, Covey AM, Alago W Jr, Erinjeri JP, Maybody M, Boas FE . Push versus pull gastrostomy in cancer patients: A single center retrospective analysis of complications and technical success rates . Diagnostic and Interventional Imaging . 2018;99(9):547-553 .

Cusan M, Cai SF, Mohammad HP, Krivtsov A, Chramiec A, Loizou E, Witkin MD, Smitheman KN, Tenen DG, Ye M, Will B, Steidl U, Kruger RG, Levine RL, Rienhoff HY Jr, Koche RP, Armstrong SA . LSD1 inhibition exerts its antileukemic effect by recommissioning PU .1- and C/EBPα-dependent enhancers in AML . Blood . 2018;131(15):1730-1742 . PMCID: PMC5897868

Cushing K, Undvall E, Ceder Y, Lilja H, Laurell T . Reducing WBC background in cancer cell separation products by negative acoustic contrast particle immuno-acoustophoresis . Analytica Chimica Acta . 2018;1000:256-264 .

Cutrone JN, Segna AN, Baron RH . Male patients with breast cancer: Addressing needs using an educational task force . Clinical Journal of Oncology Nursing . 2018;22(4):415-420 .

Cutrone JN, Baron RH . Response to “Male patients with breast cancer: Addressing needs using an educational task force” - The authors respond . Clinical Journal of Oncology Nursing . 2018;22(6):610- .

Cybulska P, Stewart JM, Sayad A, Virtanen C, Shaw PA, Clarke B, Stickle N, Bernardini MQ, Neel

BG . A genomically characterized collection of high-grade serous ovarian cancer xenografts for preclinical testing . American Journal of Pathology . 2018;188(5):1120-1131 .

Cybulska P, Stasenko M, Alter R, Makker V, Cadoo KA, Sonoda Y, Abu-Rustum NR, Mueller JJ, Leitao MM Jr . Brain metastases in patients with low-grade endometrial carcinoma . Gynecologic Oncology Reports . 2018;26:87-90 . PMCID: PMC6223185

D’Agostino TA, Shuk E, Maloney EK, Zeuren R, Tuttle RM, Bylund CL . Treatment decision making in early-stage papillary thyroid cancer . Psycho-Oncology . 2018;27(1):61-68 . PMCID: PMC5529258

D’Angelo SP, Hamid OA, Tarhini A, Schadendorf D, Chmielowski B, Collichio FA, Pavlick AC, Lewis KD, Weil SC, Heyburn J, Schweizer C, O’Shannessy DJ, Carvajal RD . A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma . Investigational New Drugs . 2018;36(1):103-113 .

D’Angelo SP, Mahoney MR, Van Tine BA, Atkins J, Milhem MM, Jahagirdar BN, Antonescu CR, Horvath E, Tap WD, Schwartz GK, Streicher H . Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials . Lancet Oncology . 2018;19(3):416-426 .

D’Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL . Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1(c259)T cells in synovial sarcoma . Cancer Discovery . 2018;8(8):944-957 .

D’Angelo SP, Russell J, Lebbé C, Chmielowski B, Gambichler T, Grob JJ, Kiecker F, Rabinowits G, Terheyden P, Zwiener I, Bajars M, Hennessy

M, Kaufman HL . Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: A preplanned interim analysis of a clinical trial . JAMA Oncology . 2018;4(9):e180077- . PMCID: PMC5885245

D’Cruz AK, Vaish R, Vaidya A, Nixon IJ, Williams MD, Vander Poorten V, Lopez F, Angelos P, Shaha AR, Khafif A, Skalova A, Rinaldo A, Hunt JL, Ferlito A . Molecular markers in well-differentiated thyroid cancer . European Archives of Oto-Rhino-Laryngology . 2018;275(6):1375-1384 .

Dabaja BS, Specht L, Yahalom J . Lymphoblastic lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3):508-514 .

Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J . Proton therapy for adults with mediastinal lymphomas: The International Lymphoma Radiation Oncology Group guidelines . Blood . 2018;132(16):1635-1646 .

Dai H, Tilley DM, Mercedes G, Doherty C, Gulati A, Mehta N, Khalil A, Holzhaus K, Reynolds FM . Opiate-free pain therapy using carbamazepine-loaded microparticles provides up to 2 weeks of pain relief in a neuropathic pain model . Pain Practice . 2018;18(8):1024-1035 .

Daly B, Zon RT, Page RD, Edge SB, Lyman GH, Green SR, Wollins DS, Bosserman LD . Oncology clinical pathways: Charting the landscape of pathway providers . Journal of Oncology Practice . 2018;14(3):193-197 .

Daly B, Bach PB, Page RD . Financial conflicts of interest among oncology clinical pathway vendors . JAMA Oncology . 2018;4(2):255-257 . PMCID: PMC5838596

57 OF 288


Journal Articles

Daly B, Nicholas K, Gorenshteyn D, Sokolowski S, Gazit L, Adams L, Matays J, Katzen LL, Chiu YO, Xiao H, Salvaggio R, Baldwin-Medsker A, Chow K, Nelson J, Ross M, Ng KK, Zervoudakis A, Perchick W, Reidy DL, Simon BA, Wagner I . Misery loves company: Presenting symptom clusters to urgent care by patients receiving antineoplastic therapy . Journal of Oncology Practice . 2018;14(8):e484-e495 .

Damaskos P, Amaya B, Gordon R, Walters CB . Intersectionality and the LGBT cancer patient . Seminars in Oncology Nursing . 2018;34(1):30-36 .

Dang CT, Blaes A, Lynce F, Swain SM, Dent S . Left ventricular ejection fraction monitoring adherence rates: Why so low? . JACC: Cardiovascular Imaging . 2018;11(8):1094-1097 .

Dang CT, Yu AF, Liu J, Steingart R . Risk-imaging mismatch: Why is there a disconnect? . Journal of Clinical Oncology . 2018;36(30):2975-2977 .

Dang CT, Singh JC, Steingart RM, Yu AF . In reply . The Oncologist . 2018;23(12):e165-e166 .

Dang NH, Ogura M, Castaigne S, Fayad LE, Jerkeman M, Radford J, Pezzutto A, Bondarenko I, Stewart DA, Shnaidman M, Sullivan S, Vandendries E, Tobinai K, Ramchandren R, Hamlin PA, Giné E, Ando K . Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma . British Journal of Haematology . 2018;182(4):583-586 . PMCID: PMC6200343

Danhof S, Hudecek M, Smith EL . CARs and other T cell therapies for MM: The clinical experience . Best Practice and Research: Clinical Haematology . 2018;31(2):147-157 .

Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang F, Creighton CJ, Deneen B, Miller CR, Picketts DJ, Kannan K, Huse JT . Atrx inactivation drives disease-defining

phenotypes in glioma cells of origin through global epigenomic remodeling . Nature Communications . 2018;9:1057- . PMCID: PMC5849741

Danzig MR, Mallin K, McKiernan JM, Stadler WM, Sridhar SS, Morgan TM, Bochner BH, Lee CT . Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis . Cancer . 2018;124(12):2507-2514 .

Das S, Haedicke K, Grimm J . Cerenkov-activated sticky tag for in vivo fluorescence imaging . Journal of Nuclear Medicine . 2018;59(1):58-65 . PMCID: PMC5750525

Das S, Dunbar S, Tang YW . Laboratory diagnosis of respiratory tract infections in children - The state of the art . Frontiers in Microbiology . 2018;9:2478- .

Dashevsky BZ, Oh JH, Apte AP, Bernard-Davila B, Morris EA, Deasy JO, Sutton EJ . MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation . Scientific Reports . 2018;8:315- . PMCID: PMC5762896

Dason S, Goh AC . Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions . Current Opinion in Urology . 2018;28(2):115-122 .

Dason S, Goh AC . Updates on robotic intracorporeal urinary diversions . Current Urology Reports . 2018;19(5):28- .

Dauer LT . Seeing through a glass darkly and taking the next right steps . European Journal of Epidemiology . 2018;33(12):1135-1137 .

Davare MA, Henderson JJ, Agarwal A, Wagner JP, Iyer SR, Shah N, Woltjer R, Somwar R, Gilheeney SW, DeCarvalo A, Mikkelson T, Van Meir EG, Ladanyi M, Druker BJ . Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma . Clinical

Cancer Research . 2018;24(24):6471-6482 . PMCID: PMC6295214

David CJ, Massagué J . Contextual determinants of TGFβ action in development, immunity and cancer . Nature Reviews Molecular Cell Biology . 2018;19(7):419-435 .

Davids MS, Hallek M, Wierda W, Roberts AW, Stilgenbauer S, Jones JA, Gerecitano JF, Kim SY, Potluri J, Busman T, Best A, Verdugo ME, Cerri E, Desai M, Hillmen P, Seymour JF . Comprehensive safety analysis of venetoclax monotherapy for patients with relapsed/refractory chronic lymphocytic leukemia . Clinical Cancer Research . 2018;24(18):4371-4379 .

Davis E, Devlin S, Cooper C, Nhaissi M, Paulson J, Wells D, Scaradavou A, Giralt S, Papadopoulos E, Kernan NA, Byam C, Barker JN . Validation of an algorithm to predict the likelihood of an 8/8 HLA-matched unrelated donor at search initiation . Biology of Blood and Marrow Transplantation . 2018;24(5):1057-1062 .PMCID: PMC5953787

Davis ME, Bossert D, Manne M . Toward precision medicine: Promising areas of research in glioma . Seminars in Oncology Nursing . 2018;34(5):569-572 .

Davis ME . Epidemiology and overview of gliomas . Seminars in Oncology Nursing . 2018;34(5):420-429 .

Davis ME, Fugett S . Financial toxicity: Limitations and challenges when caring for older adult patients with cancer . Clinical Journal of Oncology Nursing . 2018;22(6 Suppl .):43-48 .

Davis MP, Pasternak G, Behm B . Treating chronic pain: An overview of clinical studies centered on the buprenorphine option . Drugs . 2018;78(12):1211-1228 .

Dayan JH, Ly CL, Kataru RP, Mehrara BJ . Lymphedema: Pathogenesis and novel therapies . Annual Review of Medicine . 2018;69:263-276 .

58 OF 288


Journal Articles

Dayan JH, Voineskos S, Verma R, Mehrara BJ . Managing venous hypertension in vascularized omentum lymphatic transplant: Restoring bidirectional venous drainage . Plastic and Reconstructive Surgery . 2018;141(2):326e-327e . PMCID: PMC5796759

De B, Khakoo Y, Souweidane MM, Dunkel IJ, Patel SH, Gilheeney SW, De Braganca KC, Karajannis MA, Wolden SL . Patterns of relapse for children with localized intracranial ependymoma . Journal of Neuro-Oncology . 2018;138(2):435-445 .

De B, Kinnaman MD, Wexler LH, Kramer K, Wolden SL . Central nervous system relapse of rhabdomyosarcoma . Pediatric Blood and Cancer . 2018;65(1):e26710- .

De B, Cahlon O, Sine K, Mah D, Hug EB, Wolden SL . Early axial growth outcomes of pediatric patients receiving proton craniospinal irradiation . Journal of Pediatric Hematology/Oncology . 2018;40(8):574-579 .PMCID: PMC6197896

De B, Beal K, De Braganca KC, Souweidane MM, Dunkel IJ, Khakoo Y, Gilheeney SW, DeAngelis LM, Menzel P, Patel SH, Wolden SL . Long-term outcomes of adult medulloblastoma patients treated with radiotherapy . Journal of Neuro-Oncology . 2018;136(1):95-104 . PMCID: PMC5918279

de Bree R, Senft A, Coca-Pelaz A, Kowalski L, Lopez F, Mendenhall W, Quer M, Rinaldo A, Shaha AR, Strojan P, Takes RP, Silver CE, Leemans CR, Ferlito A . Detection of distant metastases in head and neck cancer: Changing landscape . Advances in Therapy . 2018;35(2):161-172 .

De Carolis S, Pellegrini A, Santini D, Ceccarelli C, De Leo A, Alessandrini F, Arienti C, Pignatta S, Tesei A, Mantovani V, Zamagni C, Taffurelli M, Sansone P, Bonafé M, Cricca M . Liquid biopsy in the diagnosis of HPV DNA in breast lesions . Future Microbiology . 2018;13(2):187-194 .

de Lima M, Oran B, Champlin RE, Papadopoulos EB, Giralt SA, Scott BL, William BM, Hetzer J, Laille E, Hubbell B, Skikne BS, Craddock C . CC-486 maintenance after stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndromes . Biology of Blood and Marrow Transplantation . 2018;24(10):2017-2024 .

de Marinis F, Ciardiello F, Baas P, Crino L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz-Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C . 30 immunotherapy in advanced NSCLC - from the ‘tsunami’ of therapeutic knowledge to a clinical practice algorithm: Results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT) . ESMO Open . 2018;3(4):e000298- . PMCID: PMC6012561

De Mattos-Arruda L, Ng CKY, Piscuoglio S, Gonzalez-Cao M, Lim RS, De Filippo MR, Fusco N, Schultheis AM, Ortiz C, Viteri S, Arias A, Macedo GS, Oliveira M, Gomez P, Teixido C, Nuciforo P, Peg V, Saura C, Cajal SR, Casas FT, Weigelt B, Cortes J, Seoane J, Reis-Filho JS . Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases . Oncotarget . 2018;9(29):20617-20630 .PMCID: PMC5945519

De Moraes CG, Muhammad H, Kaur K, Wang D, Ritch R, Hood DC . Interindividual variations in foveal anatomy and artifacts seen on inner retinal probability maps from spectral domain OCT scans of the macula . Translational Vision Science and Technology . 2018;7(2):4- . PMCID: PMC5846440

de Velasco G, Wankowicz SA, Madison R, Ali SM, Norton C, Duquette A, Ross JS, Bossé D, Lalani AKA, Miller VA, Stephens PJ, Young L, Hakimi AA, Signoretti S, Pal SK, Choueiri TK . Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma . British Journal of Cancer . 2018;118(9):1238-1242 .

Deal SB, D’Angelica M I, Hawkins WG, Pucci M, Ujiki M, Brunt LM, Wexner S, Alseidi AA . Synoptic operative reporting for laparoscopic cholecystectomy and pancreaticoduodenectomy: A multi institutional pilot study evaluating completeness and surgeon perceptions . American Journal of Surgery . 2018;216(5):935-940 .

Dean J, Wong K, Gay H, Welsh L, Jones AB, Schick U, Oh JH, Apte A, Newbold K, Bhide S, Harrington K, Deasy J, Nutting C, Gulliford S . Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy . Clinical and Translational Radiation Oncology . 2018;8:27-39 . PMCID: PMC5796681

DeAngelis LM . The trials of neuro-oncology clinical research . Neuro-Oncology . 2018;20(8):1007-1008 .

Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, Li N, Liu Y, Yang YS, Eiseman M, Shim JH, Hameed M, Healey JH, Bostrom MP, Landau DA, Greenblatt MB . Discovery of a periosteal stem cell mediating intramembranous bone formation . Nature . 2018;562(7725):133-139 . PMCID: PMC6193396

Deborde S, Yu Y, Marcadis A, Chen CH, Fan N, Bakst RL, Wong RJ . An in vivo murine sciatic nerve model of perineural invasion . Journal of Visualized Experiments . 2018;2018(134):e56857- . PMCID: PMC5965264

Deeg HJ, Stevens EA, Salit RB, Ermoian RP, Fang M, Gyurkocza B, Sorror ML, Fatobene G, Baumgart J, Burroughs LM, Delaney C, Doney K, Egan DN, Flowers MED, Milano F, Radich JP, Scott BL, Sickle EJ, Wood BL, Yeung C, Storer BE . Transplant conditioning with treosulfan/fludarabine with or without total body irradiation: A randomized phase II trial in patients with myelodysplastic syndrome and acute myeloid leukemia . Biology of Blood and Marrow Transplantation . 2018;24(5):956-963 .

59 OF 288


Journal Articles

DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, Del Rio C, Valles B, Kempner ME, Smith M, Brown J, Dey BR, El-Jawahri A, McAfee SL, Spitzer TR, Ballen KK, Sung AD, Dalton TE, Messina JA, Dettmer K, Liebisch G, Oefner P, Taur Y, Pamer EG, Holler E, Mansour MK, van den Brink MRM, Hohmann E, Jenq RR, Chen YB . Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity . Blood Advances . 2018;2(7):745-753 . PMCID: PMC5894265

Deipolyi AR, Czaplicki CD, Oklu R . Inflammatory and infectious aortic diseases . Cardiovascular Diagnosis and Therapy . 2018;8(Suppl . 1):S61-S70 . PMCID: PMC5949581

Deipolyi AR, Bromberg JF, Erinjeri JP, Solomon SB, Brody LA, Riedl CC . Abscopal effect after radioembolization for metastatic breast cancer in the setting of immunotherapy . Journal of Vascular and Interventional Radiology . 2018;29(3):432-433 .

Deipolyi AR, Riedl CC, Bromberg J, Chandarlapaty S, Klebanoff CA, Sofocleous CT, Yarmohammadi H, Brody LA, Boas FE, Ziv E . Association of PI3K pathway mutations with early positron-emission tomography/CT imaging response after radioembolization for breast cancer liver metastases: Results of a single-center retrospective pilot study . Journal of Vascular and Interventional Radiology . 2018;29(9):1226-1235 .

Del Ferraro G, Moreno A, Min B, Morone F, Pérez-Ramírez U, Pérez-Cervera L, Parra LC, Holodny A, Canals S, Makse HA . Finding influential nodes for integration in brain networks using optimal percolation theory . Nature Communications . 2018;9:2274- . PMCID: PMC5995874

Delporte G, Henon F, Ploussard G, Briganti A, Rizk J, Rozet F, Touijer K, Ouzzane A . Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature . Prostatectomie totale pour cancer de prostate a haut risque et

localement avancé: Revue de littérature . Progrès en Urologie . 2018;28(16):875-889 .

Deng G, Bao T, Mao JJ . Understanding the benefits of acupuncture treatment for cancer pain management . Oncology (Norwalk) . 2018;32(6):310-316 .

Deng G, Giralt S, Chung DJ, Landau H, Siman J, Search B, Coleton M, Vertosick E, Shapiro N, Chien C, Wang XS, Cassileth B, Mao JJ . Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: A randomized sham-controlled trial . Supportive Care in Cancer . 2018;26(2):657-665 . PMCID: PMC6159943

Deng P, Zhou Y, Jiang J, Li H, Tian W, Cao Y, Qin Y, Kim J, Roeder RG, Patel DJ, Wang Z . Transcriptional elongation factor Paf1 core complex adopts a spirally wrapped solenoidal topology . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(40):9998-10003 . PMCID: PMC6176576

Deng Z, Paknejad N, Maksaev G, Sala-Rabanal M, Nichols CG, Hite RK, Yuan P . Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms . Nature Structural and Molecular Biology . 2018;25(3):252-260 .

Derenzini E, Mondello P, Erazo T, Portelinha A, Liu Y, Scallion M, Asgari Z, Philip J, Hilden P, Valli D, Rossi A, Djaballah H, Ouerfelli O, de Stanchina E, Seshan VE, Hendrickson RC, Younes A . BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors . Cell Reports . 2018;24(8):2155-2166 .

Derosa L, Hellmann MD, Spaziano M, Halpenny D, Fidelle M, Rizvi H, Long N, Plodkowski AJ, Arbour KC, Chaft JE, Rouche JA, Zitvogel L, Zalcman G, Albiges L, Escudier B, Routy B . Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced

renal cell and non-small-cell lung cancer . Annals of Oncology . 2018;29(6):1437-1444 .

Desai A V, Klimek VM, Chow K, Epstein AS, Bernal C, Anderson K, Okpako M, Rawlins-Duell R, Kramer D, Romano D, Goldberg J I, Nelson JE . 1-2-3 Project: A quality improvement initiative to normalize and systematize palliative care for all patients with cancer in the outpatient clinic setting . Journal of Oncology Practice . 2018;14(12):e775-e785 .

Desai A V, Epstein AS, Colbert LE, Saltz LB . Author’s response . Journal of Pain and Symptom Management . 2018;55(1):e2-e3 .

DeSelm C, Palomba ML, Yahalom J, Hamieh M, Eyquem J, Rajasekhar VK, Sadelain M . Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape . Molecular Therapy . 2018;26(11):2542-2552 .PMCID: PMC6225039

DeSimone RA, Berlin DA, Avecilla ST, Goss CA . Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah’s Witness with hemorrhagic shock . Transfusion . 2018;58(10):2297-2300 .

Desrichard A, Kuo F, Chowell D, Lee KW, Riaz N, Wong RJ, Chan TA, Morris LGT . Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas . JNCI: Journal of the National Cancer Institute . 2018;110(12):1386-1392 . PMCID: PMC6292793

Devine KA, Mertens AC, Whitton JA, Wilson CL, Ness KK, Marchak JG, Leisenring W, Oeffinger KC, Robison LL, Armstrong GT, Krull KR . Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) . Psycho-Oncology . 2018;27(2):613-619 . PMCID: PMC5807155

Di Cosimo S, Campbell C, Azim HA Jr, Galli G, Bregni G, Curigliano G, Criscitiello C, Izquierdo M, de la Pena L, Fumagalli D, Fein L, Vinholes J, Ng WMJ, Colleoni M, Ferro A, Naume BJ, Patel A, Huober

60 OF 288


Journal Articles

J, Piccart-Gebhart MJ, Baselga J, de Azambuja E . The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO . European Journal of Cancer . 2018;89:42-48 . PMCID: PMC5777154

Di Mascio M, Srinivasula S, Kim I, Duralde G, St Claire A, DeGrange P, St Claire M, Reimann KA, Gabriel EE, Carrasquillo J, Reba RC, Paik C, Lane HC . Total body CD4(+) T cell dynamics in treated and untreated SIV infection revealed by in vivo imaging . JCI Insight . 2018;3(13):e97880- . PMCID: PMC6124531

Diamond E, Lahoud OB, Landau H . Managing multiple myeloma in elderly patients . Leukemia and Lymphoma . 2018;59(6):1300-1311 .

Diamond EL, Subbiah V, Lockhart AC, Blay JY, Puzanov I, Chau I, Raje NS, Wolf J, Erinjeri JP, Torrisi J, Lacouture M, Elez E, Martínez-Valle F, Durham B, Arcila ME, Ulaner G, Abdel-Wahab O, Pitcher B, Makrutzki M, Riehl T, Baselga J, Hyman DM . Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study . JAMA Oncology . 2018;4(3):384-388 . PMCID: PMC5844839

Dickler MN, Saura C, Richards DA, Krop IE, Cervantes A, Bedard PL, Patel MR, Pusztai L, Oliveira M, Cardenas AK, Cui N, Wilson TR, Stout TJ, Wei MC, Hsu JY, Baselga J . Phase II study of taselisib (GDC-0032) in combination with fulvestrant in patients with HER2-negative, hormone receptor-positive advanced breast cancer . Clinical Cancer Research . 2018;24(18):4380-4387 . PMCID: PMC6139036

Dickson BC, Sung YS, Rosenblum MK, Reuter VE, Harb M, Wunder JS, Swanson D, Antonescu CR . NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors . American Journal of Surgical Pathology . 2018;42(5):636-645 . PMCID: PMC5893407

Dickson BC, Hornick JL, Fletcher CDM, Demicco EG, Howarth DJ, Swanson D, Zhang L, Sung YS, Antonescu CR . Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast . Genes Chromosomes and Cancer . 2018;57(9):437-445 .

Dickson BC, Antonescu CR, Argyris PP, Bilodeau EA, Bullock MJ, Freedman PD, Gnepp DR, Jordan RC, Koutlas IG, Lee CH, Leong I, Merzianu M, Purgina BM, Thompson LDR, Wehrli B, Wright JM, Swanson D, Zhang L, Bishop JA . Ectomesenchymal chondromyxoid tumor: A neoplasm characterized by recurrent RREB1-MKL2 fusions . American Journal of Surgical Pathology . 2018;42(10):1297-1305 . PMCID: PMC6133728

DiGiuseppe JA, Cardinali JL, Rezuke WN, Pe’er D . PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data . Cytometry Part B—Clinical Cytometry . 2018;94(5):588-601 . PMCID: PMC5834343

Dimopoulos MA, Tedeschi A, Trotman J, García-Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous J V, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C, for the iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia . Phase 3 trial of Ibrutinib plus rituximab in Waldenström’s macroglobulinemia . New England Journal of Medicine . 2018;378(25):2399-2410 .

DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Swords R, Collins RH, Mannis GN, Pollyea DA, Donnellan W, Fathi AT, Pigneux A, Erba HP, Prince GT, Stein AS, Uy GL, Foran JM, Traer E, Stuart RK, Arellano ML, Slack JL, Sekeres MA, Willekens C, Choe S, Wang H, Zhang V, Yen KE, Kapsalis SM, Yang H, Dai D, Fan B, Goldwasser M, Liu H, Agresta S, Wu B, Attar EC, Tallman MS, Stone RM, Kantarjian HM . Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML . New

England Journal of Medicine . 2018;378(25):2386-2398 .

DiNardo CD, Stein EM . SOHO State of the Art Update and Next Questions: IDH therapeutic targeting in AML . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(12):769-772 .

Diolaiti D, Dela Cruz FS, Gundem G, Bouvier N, Boulad M, Zhang Y, Chou AJ, Dunkel IJ, Sanghvi R, Shah M, Geiger H, Rahman S, Felice V, Wrzeszczynski KO, Darnell RB, Antonescu CR, French CA, Papaemmanuil E, Kung AL, Shukla N . A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma . Cold Spring Harbor Molecular Case Studies . 2018;4(6):a003194- . PMCID: PMC6318763

Dionne-Odom JN, Applebaum AJ, Ornstein KA, Azuero A, Warren PP, Taylor RA, Rocque GB, Kvale EA, Demark-Wahnefried W, Pisu M, Partridge EE, Martin MY, Bakitas MA . Participation and interest in support services among family caregivers of older adults with cancer . Psycho-Oncology . 2018;27(3):969-976 . PMCID: PMC5840039

Disa JJ . Discussion: Motiva Ergonomix round SilkSurface silicone breast implants: Outcome analysis of 100 primary breast augmentations over 3 years and technical considerations . Plastic and Reconstructive Surgery . 2018;141(6):843e-844e .

Disney-Hogg L, Cornish AJ, Sud A, Law PJ, Kinnersley B, Jacobs D I, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS . Impact of atopy on risk of glioma: A Mendelian randomisation study . BMC Medicine . 2018;16:42- . PMCID: PMC5853158

Disney-Hogg L, Sud A, Law PJ, Cornish AJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE,

61 OF 288


Journal Articles

Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Swerdlow AJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS . Influence of obesity-related risk factors in the aetiology of glioma . British Journal of Cancer . 2018;118(7):1020-1027 .

Diver MM, Pedi L, Koide A, Koide S, Long SB . Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT . Nature . 2018;553(7689):526-529 . PMCID: PMC5785467

Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Australian Ovarian Cancer Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Jung AY, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, du Bois A, Harter P, Schwaab I, Karlan BY, Lester J, Orsulic S, Rimel BJ, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera E V, Olson SH, Salvesen HB, Thomsen LC V, Kopperud RK, Bjorge L, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubiński J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-

Mieszkowska A, Budzilowska A, Rzepecka IK, Webb PM, on behalf of the Ovarian Cancer Association Consortium . Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study . British Journal of Cancer . 2018;118(8):1123-1129 .

Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, Roehrl MHA, Barrera-Saldaña HA . The dawn of the liquid biopsy in the fight against cancer . Oncotarget . 2018;9(2):2912-2922 . PMCID: PMC5788692

Dominguez PM, Ghamlouch H, Rosikiewicz W, Kumar P, Béguelin W, Fontan L, Rivas MA, Pawlikowska P, Armand M, Mouly E, Torres-Martin M, Doane AS, Calvo Fernandez MT, Durant M, Della-Valle V, Teater M, Cimmino L, Droin N, Tadros S, Motanagh S, Shih AH, Rubin MA, Tam W, Aifantis I, Levine RL, Elemento O, Inghirami G, Green MR, Figueroa ME, Bernard OA, Aoufouchi S, Li S, Shaknovich R, Melnick AM . TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis . Cancer Discovery . 2018;8(12):1632-1653 . PMCID: PMC6279514

Donabedian PL, Kossatz S, Engelbach JA, Jannetti SA, Carney B, Young RJ, Weber WA, Garbow JR, Reiner T . Discriminating radiation injury from recurrent tumor with [(18)F]PARPi and amino acid PET in mouse models . EJNMMI Research . 2018;8:59- . PMCID: PMC6031550

Dong J, Ren Y, Zhang T, Wang Z, Ling CC, Li GC, He F, Wang C, Wen B . Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair . Oncology Reports . 2018;39(3):912-920 . PMCID: PMC5802037

Donoghue JF, Kerr LT, Alexander NW, Greenall SA, Longano AB, Gottardo NG, Wang R, Tabar V, Adams TE, Mischel PS, Johns TG . Activation of ERBB4 in glioblastoma can contribute to increased tumorigenicity and influence therapeutic response . Cancers . 2018;10(8):243- . PMCID: PMC6116191

Donoghue TJ . Herbal medications and anesthesia case management . AANA Journal . 2018;86(3):242-248 .

Dosani T, Mailankody S, Korde N, Manasanch E, Bhutani M, Tageja N, Roschewski M, Kwok M, Kazandjian D, Costello R, Burton D, Zhang Y, Liewehr D, Steinberg SM, Maric I, Landgren O . Host-related immunodeficiency in the development of multiple myeloma . Leukemia and Lymphoma . 2018;59(5):1127-1132 .

Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson JR, Mehta SJ, Becerra TA, Zhao WK, Schottinger J, Doria-Rose VP, Levin TR, Weiss NS, Fletcher RH . Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: A large community-based study . Gut . 2018;67(2):291-298 . PMCID: PMC5868294

Dowling CM, Assel M, Musser JE, Meeks JJ, Sjoberg DD, Bosl G, Motzer R, Bajorin D, Feldman D, Carver BS, Sheinfeld J . Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen . Urology . 2018;114:133-138 .

Downey RJ . Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found? . Journal of Thoracic and Cardiovascular Surgery . 2018;155(3):1252-1253 .

Dozier J, Chintala N, Adusumilli P . Immunotherapy for thoracic malignancies . Indian Journal of Thoracic and Cardiovascular Surgery . 2018;34(Suppl . 1):S54-S64 .

Drazin D, Grunert P, Hartl R, Polly D, Meyer B, Catchpole K, Laufer I, Sethi R, Perry T, Simon D, Wang M, Fisher C, Scribner M, White G, Tubbs RS, Oskouian RJ, Kim T, Johnson JP . Highlights from the First Annual Spinal Navigation, Emerging Technologies and Systems Integration meeting .

62 OF 288


Journal Articles

Annals of Translational Medicine . 2018;6(6):110- . PMCID: PMC5900067

Drew A, Bittner N, Florin W, Koch A . Prosthetically driven therapy for a patient with systemic lupus erythematosus and common variable immunodeficiency: A case report . Journal of Oral Implantology . 2018;44(6):447-455 .

Drilon A, Hu Z I, Lai GGY, Tan DSW . Targeting RET-driven cancers: Lessons from evolving preclinical and clinical landscapes . Nature Reviews Clinical Oncology . 2018;15(3):151-167 .

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM . Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children . New England Journal of Medicine . 2018;378(8):731-739 . PMCID: PMC5857389

Drilon A, Lin JJ, Filleron T, Ni A, Milia J, Bergagnini I, Hatzoglou V, Velcheti V, Offin M, Li B, Carbone DP, Besse B, Mok T, Awad MM, Wolf J, Owen D, Camidge DR, Riely GJ, Peled N, Kris MG, Mazieres J, Gainor JF, Gautschi O . Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET–rearranged lung cancers . Journal of Thoracic Oncology . 2018;13(10):1595-1601 .

Drilon A, Ou SH I, Cho BC, Kim DW, Lee J, Lin JJ, Zhu VW, Ahn MJ, Camidge DR, Nguyen J, Zhai D, Deng W, Huang Z, Rogers E, Liu J, Whitten J, Lim JK, Stopatschinskaja S, Hyman DM, Doebele RC, Cui JJ, Shaw AT . Repotrectinib (TPX-0005) is a next-generation ROS1/TRK/ALK inhibitor that potently inhibits ROS1/TRK/ALK solvent-front mutations . Cancer Discovery . 2018;8(10):1227-1236 .

Drilon A, Somwar R, Mangatt BP, Edgren H, Desmeules P, Ruusulehto A, Smith RS, Delasos L, Vojnic M, Plodkowski AJ, Sabari J, Ng K, Montecalvo J, Chang J, Tai H, Lockwood WW, Martinez V, Riely GJ, Rudin CM, Kris MG, Arcila ME, Matheny C, Benayed R, Rekhtman N, Ladanyi M, Ganji G . Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers . Cancer Discovery . 2018;8(6):686-695 . PMCID: PMC5984717

Drudge-Coates L, Oh WK, Tombal B, Delacruz A, Tomlinson B, Ripley A V, Mastris K, O’Sullivan JM, Shore ND . Recognizing symptom burden in advanced prostate cancer: A global patient and caregiver survey . Clinical Genitourinary Cancer . 2018;16(2):e411-e419 .

Du Q, Zhang C, Zhu X, Liang X, Zhang C, Verma V, Follet K, Wang S, Fan Q, Ma R, Zhou S, Zheng D . Application of statistical and computational methodology to predict brainstem dosimetry for trigeminal neuralgia stereotactic radiosurgery . Medical Physics . 2018;45(5):1822-1831 .

Duan H, de Navas LF, Hu F, Sun K, Mavromatakis YE, Viets K, Zhou C, Kavaler J, Johnston RJ, Tomlinson A, Lai EC . The mir-279/996 cluster represses receptor tyrosine kinase signaling to determine cell fates in the Drosophila eye . Development . 2018;145(7):dev159053- .

Dubard Gault M, Mandelker D, Delair D, Stewart CR, Kemel Y, Sheehan MR, Siegel B, Kennedy J, Marcell V, Arnold A, Al-Ahmadie H, Modak S, Robson M, Shukla N, Roberts S, Vijai J, Topka S, Kentsis A, Cadoo K, Carlo M, Latham Schwark A, Reznik E, Dinatale R, Hechtman J, Borras Flores E, Jairam S, Yang C, Li Y, Bayraktar EC, Ceyhan-Birsoy O, Zhang L, Kohlman W, Schiffman J, Stadler Z, Birsoy K, Kung A, Offit K, Walsh MF . Germline SDHA mutations in children and adults with cancer . Cold Spring Harbor Molecular Case Studies . 2018;4(4):a002584- . PMCID: PMC6071569

Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017 . Reply to ‘The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: The point of view of an international panel of experts in radiation oncology’ by Kirova et al . . Annals of Oncology . 2018;29(1):281-282 . PMCID: PMC6246427

Duchmann M, Yalniz FF, Sanna A, Sallman D, Coombs CC, Renneville A, Kosmider O, Braun T, Platzbecker U, Willems L, Adès L, Fontenay M, Rampal R, Padron E, Droin N, Preudhomme C, Santini V, Patnaik MM, Fenaux P, Solary E, Itzykson R . Prognostic role of gene mutations in chronic myelomonocytic leukemia patients treated with hypomethylating agents . EBioMedicine . 2018;31:174-181 .

Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Liu F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram MA, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW, Melanoma GWAS Consortium, Kayser M, Hunter DJ, Newton Bishop JA, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martin NG . Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways . Nature Communications . 2018;9:4774- . PMCID: PMC6235897

Duggan EG, Fernandez J, Saulan MM, Mayers DL, Nikolaj M, Strah TM, Swift LM, Temple L . 1,300 days and counting: A risk model approach to preventing retained foreign objects (RFOs) . Joint Commission Journal on Quality and Patient Safety . 2018;44(5):260-269 .

63 OF 288


Journal Articles

Dumane VA, Saksornchai K, Zhou Y, Hong L, Powell S, Ho AY . Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation . Radiation Oncology . 2018;13:187- . PMCID: PMC6154906

Dums J, Murphree C, Vasani N, Young D, Sederoff H . Metabolic and transcriptional profiles of Dunaliella viridis supplemented with ammonium derived from glutamine . Frontiers in Marine Science . 2018;5:311- .

Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M . Gene therapy comes of age . Science . 2018;359(6372):eaan4672- .

Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH . Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: A prospective, multicentre, single-arm phase 2 study . The Lancet Haematology . 2018;5(12):e609-e617 .

Dunn LA, Fury MG, Sherman EJ, Ho AA, Katabi N, Haque SS, Pfister DG . Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer . Head & Neck . 2018;40(2):233-241 .

Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, Weber W, Lyashchenko SK, Kung HF, Lewis JS . In vivo PET assay of tumor glutamine flux and metabolism: In-human trial of (18)F-(2S,4R)-4-fluoroglutamine .

Radiology . 2018;287(2):667-675 . PMCID: PMC5929369

Dupnik KM, Bean JM, Lee MH, Jean Juste MA, Skrabanek L, Rivera V, Vorkas CK, Pape JW, Fitzgerald DW, Glickman M . Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum . International Journal of Tuberculosis and Lung Disease . 2018;22(8):950-958 .

Durack JC, Brown KT, Avignon G, Brody LA, Sofocleous CT, Erinjeri JP, Solomon SB . Assessment of automated cone-beam CT vessel identification software during transarterial hepatic embolisation: Radiation dose, contrast medium volume, processing time, and operator perspectives compared to digital subtraction angiography . Clinical Radiology . 2018;73(12):1057 .e1-1057 .e6 . PMCID: PMC6239952

Dy BM, Shaha AR . Philosophy on neck dissection in thyroid cancer: Current controversies and consensus . Indian Journal of Surgical Oncology . 2018;9(1):2-5 . PMCID: PMC5856702

Dy BM, Katabi N, Boucai L, Shaha A . Follicular carcinoma masquerading as a hot nodule in a pediatric patient . American Surgeon . 2018;84(6):1117-1119 .

Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera E V, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hildebrandt MAT, Hillemanns P, Hogdall CK, Høgdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Jung AY, Karlan BY, Kellar M, Kiemeney LA, Lim BK, Kjaer SK, Krakstad C, Kupryjanczyk J, Lambrechts

D, Lambrechts S, Le ND, Lele S, Lester J, Levine DA, Li Z, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LFAG, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic S, Paul J, Pejovic T, Pelttari LM, Permuth JB, Pike MC, Poole EM, Rosen B, Rossing MA, Rothstein JH, Runnebaum IB, Rzepecka IK, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston-Campbell L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tworoger SS, van Altena AM, Vergote I, Vestrheim Thomsen LC, Vierkant RA, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu AH, Wu X, Xiang YB, Yang H, Zheng W, Ziogas A, Lee AW, Pearce CL, Berchuck A, Schildkraut JM, Ramus SJ, Monteiro ANA, Narod SA, Sellers TA, Gayther SA, Kelemen LE, Chenevix-Trench G, Risch HA, Pharoah PDP, Goode EL, Phelan CM . Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility . PLoS ONE . 2018;13(7):e0197561- . PMCID: PMC6034790

Ebhardt HA, Root A, Liu Y, Gauthier NP, Sander C, Aebersold R . Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer . npj Systems Biology and Applications . 2018;4:26- . PMCID: PMC6026592

Eccles LJ, Bell AC, Powell SN . Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks . DNA Repair . 2018;64:1-9 .

Echeverry G, Dalton A . Hematologic Disorders . Anesthesiology Clinics . 2018;36(4):553-565 .

Edwards RL, Andan C, Lalla R V, Lacouture ME, O’Brien D, Sequist L V . Afatinib therapy: Practical management of adverse events with an oral agent for non-small cell lung cancer treatment . Clinical Journal of Oncology Nursing . 2018;22(5):542-548 .

64 OF 288


Journal Articles

Efuni E, Schofield E, DuHamel KN, Villagra C, Cohen N, Reid F, Jandorf L . Optimism, worry, and colorectal cancer screening among low-income Latinos . Health Behavior and Policy Review . 2018;5(2):23-32 .

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M . Utility of Pathology Imagebase for standardisation of prostate cancer grading . Histopathology . 2018;73(1):8-18 .

Egli D, Zuccaro M V, Kosicki M, Church GM, Bradley A, Jasin M . Inter-homologue repair in fertilized human eggs? . Nature . 2018;560(7717):E5-E7 .

Ehdaie B, Carlsson S . Reply to ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’ . Prostate Cancer and Prostatic Diseases . 2018;21(3):446-447 .

Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP . Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM classification for the interpretation of PSMA-ligand PET/CT . Journal of Nuclear Medicine . 2018;59(3):469-478 .

Eisenstein A, Panova IP, Chung HJ, Goldberg LJ, Zhang Q, Lazova R, Bhawan J, Busam KJ, Symanowski JT, Alani RM, Ryu B . Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions . Melanoma Research . 2018;28(1):71-75 . PMCID: PMC5805139

Ejaz A, Shuman S . Characterization of Lhr-Core DNA helicase and manganese-dependent DNA nuclease components of a bacterial gene cluster encoding nucleic acid repair enzymes . Journal of Biological

Chemistry . 2018;293(45):17491-17504 . PMCID: PMC6231139

Ejaz A, Ordonez H, Jacewicz A, Ferrao R, Shuman S . Structure of mycobacterial 3’-to-5’ RNA: DNA helicase Lhr bound to a ssDNA tracking strand highlights distinctive features of a novel family of bacterial helicases . Nucleic Acids Research . 2018;46(1):442-455 . PMCID: PMC5758891

El Dika I, Ilson DH . Current and future therapies for targeting HER2 mutations in gastrointestinal cancer . Expert Review of Anticancer Therapy . 2018;18(11):1085-1092 .

El Naqa I, Ruan D, Valdes G, Dekker A, McNutt T, Ge Y, Wu QJ, Oh JH, Thor M, Smith W, Rao A, Fuller C, Xiao Y, Manion F, Schipper M, Mayo C, Moran JM, Ten Haken R . Machine learning and modeling: Data, validation, communication challenges . Medical Physics . 2018;45(10):e834-e840 . PMCID: PMC6181755

Elarre PS, Yu KH . Neoadjuvant therapy should not be used as part of standard clinical practice . Oncology (Norwalk) . 2018;32(1):39, 42-44 .

Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CWD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ . Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma . Cancer Medicine . 2018;7(10):4880-4892 .PMCID: PMC6198206

Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD, on behalf of MICCAI/MD Anderson Cancer

Center Head and Neck Quantitative Imaging Working Group . Machine learning applications in head and neck radiation oncology: Lessons from open-source radiomics challenges . Frontiers in Oncology . 2018;8:294- . PMCID: PMC6107800

Eliasen AM, Chin MR, Axelrod AJ, Abagyan R, Siegel D . Cascade reactions leading to the mechanism of action of vinaxanthone and xanthofulvin, natural products that drive nerve repair . Tetrahedron . 2018;74(26):3238-3245 .

Elizalde S, Laughney AM, Bakhoum SF . A Markov chain for numerical chromosomal instability in clonally expanding populations . PLoS Computational Biology . 2018;14(9):e1006447- . PMCID: PMC6150543

Elkabets M, Brook S . Methods to study the role of progranulin in the tumor microenvironment . Methods in Molecular Biology . 2018;1806:155-176 .

Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF . Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma . Neuro-Oncology . 2018;20(9):1240-1250 . PMCID: PMC6071654

Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, Sofia HJ, Hutter C, Getz G, Wheeler D, Ding L, MC3 Working Group, Cancer Genome Atlas Research Network . Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines . Cell Systems . 2018;6(3):271-281 .e7 .

Elmer DeWitt M, Greene DJ, Gill B, Nyame Y, Haywood S, Sabanegh E Jr . Isolated right varicocele

65 OF 288


Journal Articles

and incidence of associated cancer . Urology . 2018;117:82-85 .

Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A, Bashir MR, Hecht EM, Kamaya A, Jambhekar K, Kamath A, Arora S, Bijan B, Ash R, Kassam Z, Chaudhry H, McGahan JP, Yacoub JH, McInnes M, Fung AW, Shanbhogue K, Lee J, Deshmukh S, Horvat N, Mitchell DG, Do RKG, Surabhi VR, Szklaruk J, Sirlin CB . White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI . Abdominal Radiology . 2018;43(10):2625-2642 .

Elster N, Toomey S, Fan Y, Cremona M, Morgan C, Gorzel KW, Bhreathnach U, Milewska M, Murphy M, Madden S, Naidoo J, Fay J, Kay E, Carr A, Kennedy S, Furney S, Mezynski J, Breathhnach O, Morris P, Grogan L, Hill A, Kennedy S, Crown J, Gallagher W, Hennessy B, Eustace A . Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer . Therapeutic Advances in Medical Oncology . 2018;10 PMCID: PMC6047239

Elterman DS, Chughtai B, Vertosick E, Thomas D, Eastham J, Sandhu J . Trends and clinical practice patterns of sacral neuromodulation for overactive bladder . Female Pelvic Medicine and Reconstructive Surgery . 2018;24(4):264-266 .

Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR . Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation . Science . 1989 . 246: 1617-1620 . Journal of Immunology . 2018;201(11):3149-3152 .

Emoto K, Vaghjiani RG, Adusumilli PS . Tracing the origin, tracking the evolution, and the treatment of the future . Journal of Thoracic and Cardiovascular Surgery . 2018;155(3):1203-1204 .

Engels EA, Jennings LW, Everly MJ, Landgren O, Murata K, Yanik EL, Pfeiffer RM, Onaca N, Klintmalm

GB . Donor-specific antibodies, immunoglobulin-free light chains, and BAFF levels in relation to risk of late-onset PTLD in liver recipients . Transplantation Direct . 2018;4(6):e353- . PMCID: PMC6089512

England RW, Geer EB, Deipolyi AR . Role of venous sampling in the diagnosis of endocrine disorders . Journal of Clinical Medicine . 2018;7(5):114- . PMCID: PMC5977153

Engstrom TA, Zhang T, Lawton AK, Joyner AL, Schwarz JM . Buckling without bending: A new paradigm in morphogenesis . Physical Review X . 2018;8(4):041053- .

Ensslin CJ, Hibler BP, Lee EH, Nehal KS, Busam KJ, Rossi AM . Atypical melanocytic proliferations: A review of the literature . Dermatologic Surgery . 2018;44(2):159-174 .

Epstein AS . The night of 1000 Stevies . Journal of Palliative Medicine . 2018;21(7):1043-1044 . PMCID: PMC6034392

Epstein AS, O’Reilly EM, Shuk E, Romano D, Li Y, Breitbart W, Volandes AE . A randomized trial of acceptability and effects of values-based advance care planning in outpatient oncology: Person-Centered Oncologic Care and Choices . Journal of Pain and Symptom Management . 2018;56(2):169-177 .e1 . PMCID: PMC6050128

Epstein DJ, Seo SK, Brown JM, Papanicolaou GA . Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies . Journal of Antimicrobial Chemotherapy . 2018;73(Suppl . 1):i60-i72 .

Epstein DJ, Seo SK, Huang YT, Park JH, Klimek VM, Berman E, Tallman MS, Frattini MG, Papanicolaou GA . Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study . Journal of Infection . 2018;77(3):227-234 .

Epstein-Peterson ZD, Devlin SM, Stein EM, Estey E, Tallman MS . Widespread use of measurable residual disease in acute myeloid leukemia practice . Leukemia Research . 2018;67:92-98 .

Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J . Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization . Nature Cell Biology . 2018;20(8):966-978 .

Erdmann-Sager J, Wilkins EG, Pusic AL, Qi J, Hamill JB, Kim HM, Guldbrandsen GE, Chun YS . Complications and patient-reported outcomes after abdominally based breast reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study . Plastic and Reconstructive Surgery . 2018;141(2):271-281 .PMCID: PMC5785552

Eriksen WT, Singerman L, Romero SAD, Bussell J, Barg FK, Mao JJ . Understanding the use of acupuncture for insomnia among cancer survivors: A qualitative study . Journal of Alternative and Complementary Medicine . 2018;24(9-10):962-967 . PMCID: PMC6157314

Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, Liniker E, Kong B, Munhoz R, Rapisuwon S, Gherardini PF, Chmielowski B, Wang X, Shintaku IP, Wei C, Sosman JA, Joseph RW, Postow MA, Carlino MS, Hwu WJ, Scolyer RA, Messina J, Cochran AJ, Long G V, Ribas A . High response rate to PD-1 blockade in desmoplastic melanomas . Nature . 2018;553(7688):347-350 . PMCID: PMC5773412

Eryaman Y, Zhang P, Utecht L, Kose K, Lagore RL, DelaBarre L, Kulesa J, Eberly LE, Adriany G, Iles TL, Iaizzo PA, Vaughan JT, Ugurbil K . Investigating the physiological effects of 10 .5 Tesla static field exposure on anesthetized swine . Magnetic Resonance in Medicine . 2018;79(1):511-514 . PMCID: PMC5612859

Escalon JG, Harrington KA, Plodkowski AJ, Zheng J, Capanu M, Zauderer MG, Rusch VW, Ginsberg MS .

66 OF 288


Journal Articles

Malignant pleural mesothelioma: Are there imaging characteristics associated with different histologic subtypes on computed tomography? . Journal of Computer Assisted Tomography . 2018;42(4):601-606 . PMCID: PMC6053321

Escobar Hoyos L, Abdel-Wahab O . Cancer-specific splicing changes and the potential for splicing-derived neoantigens . Cancer Cell . 2018;34(2):181-183 .

Escorcia FE, Steckler JM, Abdel-Atti D, Price EW, Carlin SD, Scholz WW, Lewis JS, Houghton JL . Tumor-specific Zr-89 immuno-PET imaging in a human bladder cancer model . Molecular Imaging and Biology . 2018;20(5):808-815 . PMCID: PMC6153671

Escudier B, Porta C, Eisen T, Belsey J, Gibson D, Morgan J, Motzer R . The role of tivozanib in advanced renal cell carcinoma therapy . Expert Review of Anticancer Therapy . 2018;18(11):1113-1124 .

Escudier B, Powles T, Motzer RJ, Olencki T, Frontera OA, Oudard S, Rolland F, Tomczak P, Castellano D, Appleman LJ, Drabkin H, Vaena D, Milwee S, Youkstetter J, Lougheed JC, Bracarda S, Choueiri TK . Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial . Journal of Clinical Oncology . 2018;36(8):765-772 .

Eskreis-Winkler S, Corrias G, Monti S, Zheng J, Capanu M, Krebs S, Fung M, Reeder S, Mannelli L . IDEAL-IQ in an oncologic population: Meeting the challenge of concomitant liver fat and liver iron . Cancer Imaging . 2018;18:51- . PMCID: PMC6292167

Espinal-Ahern J, Winters C . The role of therapeutic Pilates in occupational therapy practice within oncology . OT Practice . 2018;23(19):31-33 .

Esquenazi Y, Moussazadeh N, Link TW, Hovinga KE, Reiner AS, DiStefano NM, Brennan C, Gutin P, Tabar V . Thalamic glioblastoma: Clinical presentation, management strategies, and outcomes . Neurosurgery . 2018;83(1):76-85 .

Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M . NCCN Guidelines® Insights: Non–small cell lung cancer, version 5 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(7):807-821 .

European Study Group on Cystic Tumours of the Pancreas . European evidence-based guidelines on pancreatic cystic neoplasms . Gut . 2018;67(5):789-804 . PMCID: PMC5890653

Evans A, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PA, Bick U, Camps Herrero J, Clauser P, Colin C, Cornford E, Fallenberg EM, Fuchsjaeger MH, Gilbert FJ, Helbich TH, Kinkel K, Heywang-Köbrunner SH, Kuhl CK, Mann RM, Martincich L, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Zackrisson S, Forrai G, Sardanelli F, for the European Society of Breast Imaging with language review by Europa Donna-The European Breast Cancer Coalition . Breast ultrasound: Recommendations for information to women and referring physicians by the European Society of Breast Imaging . Insights into Imaging . 2018;9(4):449-461 . PMCID: PMC6108964

Evens AM, Advani RH, Helenowski IB, Fanale M, Smith SM, Jovanovic BD, Bociek GR, Klein AK, Winter JN, Gordon L I, Hamlin PA . Multicenter phase II study of sequential brentuximab vedotin and doxorubicin, vinblastine, and dacarbazine chemotherapy for older patients with untreated classical hodgkin lymphoma . Journal of Clinical Oncology . 2018;36(30):3015-3022 .

Expert Panel on Breast Imaging . ACR Appropriateness Criteria® evaluation of the symptomatic male breast . Journal of the American College of Radiology . 2018;15(11 Suppl .):S313-S320 .

Expert Panel on Women’s Imaging . ACR Appropriateness Criteria® postmenopausal subacute or chronic pelvic pain . Journal of the American College of Radiology . 2018;15(11 Suppl .):S365-S372 .

Fadelu T, Zhang S, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson AB, Atienza DM, Messino M, Kindler HL, Venook A, Ogino S, Ng K, Wu K, Willett W, Giovannucci E, Meyerhardt J, Bao Y, Fuchs CS . Nut consumption and survival in patients with stage III colon cancer: Results from CALGB 89803 (Alliance) . Journal of Clinical Oncology . 2018;36(11):1112-1120 . PMCID: PMC5891130

Fahimnia S, Mirhedayati Roudsari H, Doucette J, Shahrokni A . Falls in older patients with cancer undergoing surgery: Prevalence and association with geriatric syndromes and levels of disability assessed in preoperative evaluation . Current Gerontology and Geriatrics Research . 2018;2018:5713285- . PMCID: PMC5977004

Fairweather M, Cavnar MJ, Li GZ, Bertagnolli MM, DeMatteo RP, Raut CP . Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy . British Journal of Surgery . 2018;105(6):743-750 .

Fairweather M, Balachandran VP, Li GZ, Bertagnolli MM, Antonescu C, Tap W, Singer S, DeMatteo RP, Raut CP . Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with tyrosine kinase inhibitors: A 2-institutional analysis . Annals of Surgery . 2018;268(2):296-302 . PMCID: PMC6203295

Fais S, Overholtzer M . Cell-in-cell phenomena, cannibalism, and autophagy: Is there a relationship? . Cell Death & Disease . 2018;9:95- . PMCID: PMC5833709

Fais S, Overholtzer M . Cell-in-cell phenomena in cancer . Nature Reviews Cancer . 2018;18(12):758-766 .

67 OF 288


Journal Articles

Faletti L, Peintner L, Neumann S, Sandler S, Grabinger T, Mac Nelly S, Merfort I, Huang CH, Tschaharganeh D, Kang TW, Heinzmann F, D’Artista L, Maurer U, Brunner T, Lowe S, Zender L, Borner C . TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation . Cell Death & Disease . 2018;9(9):909- . PMCID: PMC6125596

Fallahzadeh R, Ghasemzadeh H, Shahrokni A . Electronic assessment of physical decline in geriatric cancer patients . Current Oncology Reports . 2018;20(3):26- .

Faltas BM, Gennarelli RL, Elkin E, Nguyen DP, Hu J, Tagawa ST . Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes . Urologic Oncology: Seminars and Original Investigations . 2018;36(1):9 .e11-9 .e17 . PMCID: PMC5793883

Fan PD, Narzisi G, Jayaprakash AD, Venturini E, Robine N, Smibert P, Germer S, Yu HA, Jordan EJ, Paik PK, Janjigian YY, Chaft JE, Wang L, Jungbluth AA, Middha S, Spraggon L, Qiao H, Lovly CM, Kris MG, Riely GJ, Politi K, Varmus H, Ladanyi M . YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(26):E6030-E6038 . PMCID: PMC6042104

Fan PD, Yu HA . ERBBal remedies: Combination therapy for EGFR-mutant lung cancers . Clinical Cancer Research . 2018;24(22):5499-5501 .

Fan X, Moltedo B, Mendoza A, Davydov AN, Faire MB, Mazutis L, Sharma R, Pe’er D, Chudakov DM, Rudensky AY . CD49b defines functionally mature Treg cells that survey skin and vascular tissues . Journal of Experimental Medicine . 2018;215(11):2796-2814 . PMCID: PMC6219731

Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T,

Uttarwar M, Lee SY, Ren H, Kennedy DA, Shustov AR . Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas . Blood . 2018;131(19):2120-2124 .

Fang J, Muto T, Kleppe M, Bolanos LC, Hueneman KM, Walker CS, Sampson L, Wellendorf AM, Chetal K, Choi K, Salomonis N, Choi Y, Zheng Y, Cancelas JA, Levine RL, Starczynowski DT . TRAF6 mediates basal activation of NF-κB necessary for hematopoietic stem cell homeostasis . Cell Reports . 2018;22(5):1250-1262 .

Fankhauser CD, Schüffler PJ, Gillessen S, Omlin A, Rupp NJ, Rueschoff JH, Hermanns T, Poyet C, Sulser T, Moch H, Wild PJ . Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer . Oncotarget . 2018;9(12):10284-10293 . PMCID: PMC5828186

Fanning SW, Jeselsohn R, Dharmarajan V, Mayne CG, Karimi M, Buchwalter G, Houtman R, Toy W, Fowler CE, Han R, Lainé M, Carlson KE, Martin TA, Nowak J, Nwachukwu JC, Hosfield DJ, Chandarlapaty S, Tajkhorshid E, Nettles KW, Griffin PR, Shen Y, Katzenellenbogen JA, Brown M, Greene GL . The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells . eLife . 2018;7:e37161- .PMCID: PMC6335054

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O’Sullivan JM, Padhani AR, Schalken JA, Scher H I, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG . Consensus on molecular imaging and theranostics in prostate cancer . Lancet Oncology . 2018;19(12):e696-e708 .

Farago AF, Taylor MS, Doebele RC, Zhu VW, Kummar S, Spira A I, Boyle TA, Haura EB, Arcila ME, Benayed

R, Aisner DL, Horick NK, Lennerz JK, Le LP, Iafrate AJ, Ou SH I, Shaw AT, Mino-Kenudson M, Drilon A . Clinicopathologic features of non-small-cell lung cancer harboring an NTRK gene fusion . JCO Precision Oncology . 2018;2 PMCID: PMC6132056

Faraz S, Salem SB, Schattner M, Mendelsohn R, Markowitz A, Ludwig E, Zheng J, Gerdes H, Shah PM . Predictors of clinical outcome of colonic stents in patients with malignant large-bowel obstruction because of extracolonic malignancy . Gastrointestinal Endoscopy . 2018;87(5):1310-1317 .

Farber BA, Lalazar G, Simon EP, Hammond WJ, Requena D, Bhanot UK, La Quaglia MP, Simon SM . Non coding RNA analysis in fibrolamellar hepatocellular carcinoma . Oncotarget . 2018;9(12):10211-10227 . PMCID: PMC5828204

Farber G, Hurtado R, Loh S, Monette S, Mtui J, Kopan R, Quaggin S, Meyer-Schwesinger C, Herzlinger D, Scott RP, Blobel CP . Glomerular endothelial cell maturation depends on ADAM10, a key regulator of Notch signaling . Angiogenesis . 2018;21(2):335-347 . PMCID: PMC5878725

Farouk Sait S, Danzer E, Ramirez D, LaQuaglia MP, Paul M . Spontaneous regression in a patient with infantile fibrosarcoma . Journal of Pediatric Hematology/Oncology . 2018;40(4):e253-e255 . PMCID: PMC5916333

Farvadi F, Ghahremani MH, Hashemi F, Hormozi-Nezhad MR, Raoufi M, Zanganeh S, Atyabi F, Dinarvand R, Mahmoudi M . Cell shape affects nanoparticle uptake and toxicity: An overlooked factor at the nanobio interfaces . Journal of Colloid and Interface Science . 2018;531:245-252 .

Fass J, Sivak DA, Crooks GE, Beauchamp KA, Leimkuhler B, Chodera JD . Quantifying configuration-sampling error in Langevin simulations of complex molecular systems . Entropy . 2018;20(5):318- . PMCID: PMC6208357

68 OF 288


Journal Articles

Fathi AT, DiNardo CD, Kline I, Kenvin L, Gupta I, Attar EC, Stein EM, de Botton S, for the AG221-C-001 Study Investigators . Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2 analysis of a phase 1/2 study . JAMA Oncology . 2018;4(8):1106-1110 .

Fathi AT, Erba HP, Lancet JE, Stein EM, Ravandi F, Faderl S, Walter RB, Advani AS, DeAngelo DJ, Kovacsovics TJ, Jillella A, Bixby D, Levy MY, O’Meara MM, Ho PA, Voellinger J, Stein AS . A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML . Blood . 2018;132(11):1125-1133 .

Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton J V, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA . Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: Consensus recommendations from the North American Menopause Society and the International Society for the Study of Women’s Sexual Health . Menopause . 2018;25(6):596-608 .

Fay JS, Milch HS, Gutman D, Law AS, Mardakhaev E, Saraiya MS, Lipton ML . MR . Implant: Rapid evidence-based determination of implant safety status . Journal of the American College of Radiology . 2018;15(7):993-997 .

Fazlollahi L, Hsiao SJ, Mansukhani MM, Glade Bender JL, Kung AL, Yamashiro DJ, Remotti HE . INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor . Human Pathology: Case Reports . 2018;12:42-47 .

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH, on behalf of the T

cell Project Network . Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS) . A new prognostic model developed by the International T cell Project Network . British Journal of Haematology . 2018;181(6):760-769 .

Fei DL, Zhen T, Durham B, Ferrarone J, Zhang T, Garrett L, Yoshimi A, Abdel-Wahab O, Bradley RK, Liu P, Varmus H . Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1 . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(44):E10437-E10446 . PMCID: PMC6217397

Felder S I, Ramanathan R, Russo AE, Jimenez-Rodriguez RM, Hogg ME, Zureikat AH, Strong VE, Zeh HJ, Weiser MR . Robotic gastrointestinal surgery . Current Problems in Surgery . 2018;55(6):198-246 . PMCID: PMC6377083

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD, for the Platinum Study Group . Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: Application of the Framingham Risk Score . Clinical Genitourinary Cancer . 2018;16(4):e761-e769 . PMCID: PMC6063791

Feldman DR . State-of-the-art management of germ cell tumors . American Society of Clinical Oncology Educational Book . 2018;38:319-323 .

Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C I, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA . Receipt of adjuvant endometrial cancer treatment according to race: An NRG Oncology/Gynecologic Oncology Group 210 Study . American Journal of Obstetrics and Gynecology . 2018;219(5):459 .e1-459 .e11 . PMCID: PMC6239903

Fellows K . Balanced versus unbalanced crystalloids in initial sepsis fluid resuscitation . Journal of Emergency Nursing . 2018;44(2):184-185 .

Fenelus M, Peerschke EIB . HITTING the diagnosis: Testing for heparin-induced thrombocytopenia in cancer patients . American Journal of Clinical Pathology . 2018;150(2):116-120 . PMCID: PMC6049042

Fennell M, Simpson KJ . Society of Biomolecular Imaging and Informatics special issue . Assay and Drug Development Technologies . 2018;16(6):289-290 .

Fera D, Lee MS, Wiehe K, Meyerhoff RR, Piai A, Bonsignori M, Aussedat B, Walkowicz WE, Ton T, Zhou JO, Danishefsky S, Haynes BF, Harrison SC . HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope . Nature Communications . 2018;9:1111- . PMCID: PMC5856820

Fernandez-Pineda I, Davidoff AM, Lu L, Rao BN, Wilson CL, Srivastava DK, Klosky JL, Metzger ML, Krasin MJ, Ness KK, Pui CH, Robison LL, Hudson MM, Sklar CA, Green DM, Chemaitilly W . Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St . Jude Lifetime Cohort Study . Pediatric Blood and Cancer . 2018;65(9):e27232- . PMCID: PMC6105417

Ferris FD, Moore SY, Callaway M V, Foley KM . Leadership Development Initiative: Growing global leaders… advancing palliative care . Journal of Pain and Symptom Management . 2018;55(2 Suppl .):S146-S156 .

Ferris RL, Nikiforov Y, Terris D, Seethala RR, Ridge JA, Angelos P, Duh QY, Wong R, Sabra MM, Fagin JA, McIver B, Bernet VJ, Harrell RM, Busaidy N, Cibas ES, Faquin WC, Sadow P, Baloch Z, Shindo M, Orloff L, Davies L, Randolph GW . AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State-of-the-art thyroid surgical recommendations in the era of noninvasive follicular

69 OF 288


Journal Articles

thyroid neoplasm with papillary-like nuclear features . Head & Neck . 2018;40(9):1881-1888 .

Ferro A, Morais S, Rota M, Pelucchi C, Bertuccio P, Bonzi R, Galeone C, Zhang ZF, Matsuo K, Ito H, Hu J, Johnson KC, Yuo GP, Palli D, Ferraroni M, Muscat J, Malekzadeh R, Ye W, Song H, Zaridze D, Maximovitch D, Aragonés N, Castaño-Vinyals G, Vioque J, Navarrete-Muñoz EM, Pakseresht M, Pourfarzi F, Wolk A, Orsini N, Bellavia A, Håkansson N, Mu L, Pastorino R, Kurtz RC, Derakhshan MH, Lagiou A, Lagioul P, Boffetta P, Boccia S, Negri E, La Vecchia C, Peleteiro B, Lunet N . Tobacco smoking and gastric cancer: Meta-analyses of published data versus pooled analyses of individual participant data (StoP Project) . European Journal of Cancer Prevention . 2018;27(3):197-204 .

Ferro A, Morais S, Rota M, Pelucchi C, Bertuccio P, Bonzi R, Galeone C, Zhang ZF, Matsuo K, Ito H, Hu J, Johnson KC, Yu GP, Palli D, Ferraroni M, Muscat J, Malekzadeh R, Ye W, Song H, Zaridze D, Maximovitch D, Fernandez de Larrea N, Kogevinas M, Vioque J, Navarrete-Muñoz EM, Pakseresht M, Pourfarzi F, Wolk A, Orsini N, Bellavia A, Håkansson N, Mu L, Pastorino R, Kurtz RC, Derakhshan MH, Lagiou A, Lagiou P, Boffetta P, Boccia S, Negri E, La Vecchia C, Peleteiro B, Lunet N . Alcohol intake and gastric cancer: Meta-analyses of published data versus individual participant data pooled analyses (StoP Project) . Cancer Epidemiology . 2018;54:125-132 .

Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC 3rd, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, Tardio JC, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN . Clinicopathologic features and prognostic impact of lymph node involvement in

patients with breast implant-associated anaplastic large cell lymphoma . American Journal of Surgical Pathology . 2018;42(3):293-305 .

Fessele KL, Wright F . Primer in genetics and genomics, article 6: Basics of epigenetic control . Biological Research for Nursing . 2018;20(1):103-110 .

Fessele KL . The rise of big data in oncology . Seminars in Oncology Nursing . 2018;34(2):168-176 .

Filippova OT, Chi DS . The unyielding fight against the premature death of patients with advanced-stage ovarian cancer . Obstetrics and Gynecology . 2018;132(3):541-544 .

Filosso PL, Kidd M, Roffinella M, Lewczuk A, Chung KM, Kolasinska-Cwikla A, Cwikla J, Lowczak A, Doboszynska A, Malczewska A, Catalano M, Zunino V, Boita M, Arvat E, Cristofori R, Guerrera F, Oliaro A, Tesselaar M, Buikhuisen W, Kos-Kudla B, Papotti M, Bodei L, Drozdov I, Modlin I . The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression . European Journal of Cardio-Thoracic Surgery . 2018;53(3):631-639 .

Filosso PL, Falcoz PE, Solidoro P, Pellicano D, Passani S, Guerrera F, Ruffini E, ESTS Lung Neuroendocrine Working-Group Participating Centers . The European Society of Thoracic Surgeons (ESTS) lung neuroendocrine tumors (NETs) database . Journal of Thoracic Disease . 2018;10(Suppl . 29):S3528-S3532 .PMCID: PMC6230831

Fine SW . Neuroendocrine tumors of the prostate . Modern Pathology . 2018;31(Suppl . 1):S122-S132 .

Fine SW . Evolution in prostate cancer staging: Pathology updates from AJCC 8th edition and opportunities that remain . Advances in Anatomic Pathology . 2018;25(5):327-332 .

Fine SW, Al-Ahmadie HA, Chen YB, Gopalan A, Tickoo SK, Reuter VE . Comedonecrosis revisited:

Strong association with intraductal carcinoma of the prostate . American Journal of Surgical Pathology . 2018;42(8):1036-1041 . PMCID: PMC6041141

Finkelstein-Fox L, Park CL, Riley KE . Mindfulness and emotion regulation: Promoting well-being during the transition to college . Anxiety Stress and Coping . 2018;31(6):639-653 .

Finley LWS, Vardhana SA, Carey BW, Alonso-Curbelo D, Koche R, Chen Y, Wen D, King B, Radler MR, Rafii S, Lowe SW, Allis CD, Thompson CB . Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity . Nature Cell Biology . 2018;20(5):565-574 . PMCID: PMC5937285

Fischer-Cartlidge E, Ross M, Hernandez K, Featherstone A, Haase C . Scalp cooling: Implementation of a program at a multisite organization . Clinical Journal of Oncology Nursing . 2018;22(5):534-541 .

Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lazaro C, Le LQ, Li W, Listernick R, Martin S, Morrison H, Pasmant E, Ratner N, Schorry E, Ullrich NJ, Viskochil D, Weiss B, Widemann BC, Zhu Y, Bakker A, Serra E . 2016 Children’s Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis . American Journal of Medical Genetics Part A . 2018;176(5):1258-1269 . PMCID: PMC5918269

Fittall MW, Mifsud W, Pillay N, Ye H, Strobl AC, Verfaillie A, Demeulemeester J, Zhang L, Berisha F, Tarabichi M, Young MD, Miranda E, Tarpey PS, Tirabosco R, Amary F, Grigoriadis AE, Stratton MR, Van Loo P, Antonescu CR, Campbell PJ, Flanagan AM, Behjati S . Recurrent rearrangements of FOS and FOSB define osteoblastoma . Nature Communications . 2018;9:2150- . PMCID: PMC5984627

Fitzgerald MJ, Ullrich S, Singh K, Misholy O, Kingham P, Brady MS . Parastomal hernia repair using the “top

70 OF 288


Journal Articles

hat” technique - An initial experience in 30 patients at Memorial Sloan Kettering Cancer Center . American Journal of Surgery . 2018;216(3):465-470 .

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA . NCCN Guidelines® Insights: Bladder cancer, version 5 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(9):1041-1053 .

Fleischhauer K, Hsu KC, Shaw BE . Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection . Bone Marrow Transplantation . 2018;53(12):1498-1507 .

Fleshner K, Carlsson S V . The USPSTF screening recommendation: A swinging pendulum . Nature Reviews Urology . 2018;15(9):532-534 .

Fleshner K, Tin A, Benfante N, Carlsson S, Vickers AJ . Comparison of physician-documented versus patient-reported collection of comorbidities among patients with prostate cancer upon first visit to the urology clinic . JCO Clinical Cancer Informatics . 2018;2:1-10 .

Flinn IW, Patel M, Oki Y, Horwitz S, Foss FF, Allen K, Douglas M, Stern H, Sweeney J, Kharidia J, Kelly P, Kelly VM, Kahl B . Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study . American Journal of Hematology . 2018;93(11):1311-1317 .

Flinn IW, O’Brien S, Kahl B, Patel M, Oki Y, Foss FF, Porcu P, Jones J, Burger JA, Jain N, Kelly VM, Allen K, Douglas M, Sweeney J, Kelly P, Horwitz S . Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies . Blood . 2018;131(8):877-887 .

Flombaum CD, Liu D, Yan SQ, Chan A, Mathew S, Meyers PA, Glezerman IG, Muthukumar T . Management of patients with acute methotrexate mephrotoxicity with high-dose leucovorin . Pharmacotherapy . 2018;38(7):714-724 .

Florey O, Overholtzer M . Macropinocytosis and autophagy crosstalk in nutrient scavenging . Philosophical Transactions of the Royal Society B: Biological Sciences . 2018;374(1765):20180154- .

Floros K V, Lochmann TL, Hu B, Monterrubio C, Hughes MT, Wells JD, Morales CB, Ghotra MS, Costa C, Souers AJ, Boikos SA, Leverson JD, Tan M, Serra V, Koblinski JE, Arribas J, Prat A, Paré L, Miller TW, Dozmorov MG, Harada H, Windle BE, Scaltriti M, Faber AC . Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(11):E2594-E2603 . PMCID: PMC5856537

Fong CS, Ozaki K, Tsou MFB . PPP1R35 ensures centriole homeostasis by promoting centriole-to-centrosome conversion . Molecular Biology of the Cell . 2018;29(23):2801-2808 . PMCID: PMC6249868

Forastiere AA, Ismaila N, Lewin JS, Nathan CA, Adelstein DJ, Eisbruch A, Fass G, Fisher SG, Laurie SA, Le QT, O’Malley B, Mendenhall WM, Patel S, Pfister DG, Provenzano AF, Weber R, Weinstein GS, Wolf GT . Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline update . Journal of Clinical Oncology . 2018;36(11):1143-1169 .

Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G . White paper on microbial anti-cancer therapy and prevention . Journal for ImmunoTherapy of Cancer . 2018;6:78- . PMCID: PMC6091193

Forde PM, Chaft JE, Pardoll DM . Neoadjuvant PD-1 blockade in resectable lung cancer - The authors reply . New England Journal of Medicine . 2018;379(9):e14(2)- .

Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, Marrone KA, Verde F, Guo H, Zhang J, Caushi JX, Chan HY, Sidhom JW, Scharpf RB, White J, Gabrielson E, Wang H, Rosner GL, Rusch V, Wolchok JD, Merghoub T, Taube JM, Velculescu VE, Topalian SL, Brahmer JR, Pardoll DM . Neoadjuvant PD-1 blockade in resectable lung cancer . New England Journal of Medicine . 2018;378(21):1976-1986 .

Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories . Lancet . 2018;392(10159):2052-2090 .PMCID: PMC6227505

Forlenza CJ, Zhang Y, Yao J, Benayed R, Steinherz P, Ramaswamy K, Kessel R, Roshal M, Shukla N . A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia . Cold Spring Harbor Molecular Case Studies . 2018;4(6):a003426- . PMCID: PMC6318764

Fosko SW, Navarrete-Dechent CP, Nehal KS . Lentigo maligna - Challenges, observations, imiquimod, confocal microscopy, and personalized treatment . JAMA Dermatology . 2018;154(8):879-881 .

71 OF 288


Journal Articles

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gonen M, Beattie B, Vargas HA, Schoder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher H I, Morris MJ, Larson SM . Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer . JAMA Oncology . 2018;4(2):217-224 . PMCID: PMC6231549

Frånlund M, Arnsrud Godtman R, Carlsson S V, Lilja H, Månsson M, Stranne J, Hugosson J . Prostate cancer risk assessment in men with an initial P .S .A . below 3 ng/mL: Results from the Göteborg randomized population-based prostate cancer screening trial . Scandinavian Journal of Urology . 2018;52(4):256-262 .PMCID: PMC6298808

Fraggetta F, Yagi Y, Garcia-Rojo M, Evans AJ, Tuthill JM, Baidoshvili A, Hartman DJ, Fukuoka J, Pantanowitz L . The importance of eSlide macro images for primary diagnosis with whole slide imaging . Journal of Pathology Informatics . 2018;9(1):46- . PMCID: PMC6319037

Francini E, Yip S, Ahmed S, Li H, Ardolino L, Evan CP, Kaymakcalan M, Shaw GK, Kantoff PW, Taplin ME, Alimohamed NS, Joshua AM, Heng DYC, Sweeney CJ . Clinical outcomes of first-line abiraterone acetate or enzalutamide for metastatic castration-resistant prostate cancer after androgen deprivation therapy + docetaxel or ADT alone for metastatic hormone-sensitive prostate cancer . Clinical Genitourinary Cancer . 2018;16(2):130-134 .

Francini E, Gray KP, Xie W, Shaw GK, Valenca L, Bernard B, Albiges L, Harshman LC, Kantoff PW, Taplin ME, Sweeney CJ . Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC) . Prostate . 2018;78(12):889-895 .

Francis JH, Grossniklaus HE, Habib LA, Marr B, Abramson DH, Busam KJ . BRAF, NRAS, and GNAQ mutations in conjunctival melanocytic nevi . Investigative Ophthalmology & Visual Science (IOVS) . 2018;59(1):117-121 .

Francis JH, Habib LA, Abramson DH . Peripheral leptochoroid: Clinical and anatomical findings . British Journal of Ophthalmology . 2018;102(1):120-125 .

Francis JH, Abramson DH, Habib L, Yannuzzi LA, Catalanotti F . Re: Francis et al .: Clinical and morphologic characteristics of MEK inhibitor-associated retinopathy: Differences from central serous chorioretinopathy (Ophthalmology . 2017;124:1788-1798) Reply . Ophthalmology . 2018;125(4):e31- .

Francis JH, Levin AM, Zabor EC, Gobin YP, Abramson DH . Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival . PLoS ONE . 2018;13(5):e0197081- . PMCID: PMC5965845

Francis JH, Roosipu N, Levin AM, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH . Current treatment of bilateral retinoblastoma: The impact of intraarterial and intravitreous chemotherapy . NeoPlasia . 2018;20(8):757-763 . PMCID: PMC6020084

Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP . Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab . American Journal of Ophthalmology Case Reports . 2018;11:49-51 . PMCID: PMC6026768

Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal D I, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL . Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: The journey from clinical trial concept to activation . Seminars

in Radiation Oncology . 2018;28(2):108-113 . PMCID: PMC5942581

Freeman EE, Semeere A, Osman H, Peterson G, Rajadhyaksha M, Gonzalez S, Martin JN, Rox Anderson R, Tearney GJ, Kang D . Smartphone confocal microscopy for imaging cellular structures in human skin in vivo . Biomedical Optics Express . 2018;9(4):1906-1915 . PMCID: PMC5905933

Freites-Martinez A, Shapiro J, Chan D, Fornier M, Modi S, Gajria D, Dusza S, Goldfarb S, Lacouture ME . Endocrine therapy-induced alopecia in patients with breast cancer . JAMA Dermatology . 2018;154(6):670-675 .

Fridman E, Na’ara S, Agarwal J, Amit M, Bachar G, Villaret AB, Brandao J, Cernea CR, Chaturvedi P, Clark J, Ebrahimi A, Fliss DM, Jonnalagadda S, Kohler HF, Kowalski LP, Kreppel M, Liao CT, Patel SG, Patel RS, Robbins KT, Shah JP, Shpitzer T, Yen TC, Zöller JE, Gil Z, for the International Consortium for Outcome Research in Head and Neck Cancer . The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study . Cancer . 2018;124(14):2948-2955 .

Fridman I, Glare PA, Stabler SM, Epstein AS, Wiesenthal A, Leblanc TW, Higgins ET . Information framing reduces initial negative attitudes in cancer patients’ decisions about hospice care . Journal of Pain and Symptom Management . 2018;55(6):1540-1545 .

Friedlander MA, Pineault LS, Roberson J, Spiczka AW . Perspectives on expanded scope of practice in cytotechnology . Laboratory Medicine . 2018;49(3):e52-e61 .

Friedlander MA, Pineault LS, Donnelly A, Giroux S, Naik K . Voices from the field: Supporting the educational needs of cytotechnologists . Laboratory Medicine . 2018;49(3):e41-e51 .

72 OF 288


Journal Articles

Friedlander MA, Pineault LS, Roberson J, Wendel Spiczka A . Perspectives on expanded scope of practice in cytotechnology . Journal of the American Society of Cytopathology . 2018;7(5):240-249 .

Friedlander MA, Pineault LS, Donnelly A, Giroux S, Naik K . Voices from the field: Supporting the educational needs of cytotechnologists . Journal of the American Society of Cytopathology . 2018;7(5):250-260 .

Friedman CF, Hensley ML . Options for adjuvant therapy for uterine leiomyosarcoma . Current Treatment Options in Oncology . 2018;19(2):7- .

Friedman DN, Hilden P, Moskowitz CS, Wolden SL, Tonorezos ES, Antal Z, Carlow D, Modak S, Cheung NK, Oeffinger KC, Sklar CA . Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study . Pediatric Blood and Cancer . 2018;65(11):e27304- . PMCID: PMC6150783

Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS . Vision-targeted health-related quality of life in adult survivors of retinoblastoma . JAMA Ophthalmology . 2018;136(6):637-641 . PMCID: PMC5933456

Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR . Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): A randomised, phase 3, multicentre, non-inferiority trial . Lancet Oncology . 2018;19(10):1394-1403 .

Frumovitz M, Abu-Rustum NR . Tailoring adjuvant treatment in patients with uterine cancer – Authors’ reply . Lancet Oncology . 2018;19(12):e656- .

Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun WJ, Jalal S I, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci

D V, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang JD, Rosales M, Dalal RP, Yoon HH . Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial . JAMA Oncology . 2018;4(5):e180013- . PMCID: PMC5885175

Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, Nuñez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P . Microbial metabolite sensor GPR43 controls severity of experimental GVHD . Nature Communications . 2018;9:3674- . PMCID: PMC6131147

Funato K, Hayashi T, Echizen K, Negishi L, Shimizu N, Koyama-Nasu R, Nasu-Nishimura Y, Morishita Y, Tabar V, Todo T, Ino Y, Mukasa A, Saito N, Akiyama T . SIRT2-mediated inactivation of p73 is required for glioblastoma tumorigenicity . EMBO Reports . 2018;19(11):e45587- . PMCID: PMC6216266

Funato K, Tabar V . Histone mutations in cancer . Annual Review of Cancer Biology . 2018;2:337-351 .

Fundakowski CE, Hales NW, Agrawal N, Barczyński M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo M, Randolph GW . Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society consensus statement . Head & Neck . 2018;40(4):663-675 .

Funkhouser WK Jr, Hayes DN, Moore DT, Funkhouser WK 3rd, Fine JP, Jo H, Nikolaishvilli-Feinberg N, Eeva M, Grilley-Olson JE, Banks PM, Graziano P, Boswell EL, Elmberger G, Raparia K, Hart CF, Sholl LM, Nolan NJ, Fritchie KJ, Pouagare E, Allen TC, Volmar KE, Biddinger PW, Kleven DT, Papez MJ, Spencer D V, Rekhtman N, Mino-Kenudson M, Hariri L, Driver B,

Cagle PT . Interpathologist diagnostic agreement for non–small cell lung carcinomas using current and recent classifications . Archives of Pathology & Laboratory Medicine . 2018;142(12):1537-1548 .

Furuta Y, Kiyonari H . Animal transgenesis on the fast track in the era of evolving genome editing technologies: Report for TT2017 the 14th Transgenic Technology Meeting in Snowbird, Utah . Transgenic Research . 2018;27(1):123-129 . PMCID: PMC5847142

Gadalla SM, Wang T, Loftus D, Friedman L, Dagnall C, Haagenson M, Spellman SR, Buturovic L, Blauwkamp M, Shelton J, Fleischhauer K, Hsu KC, Verneris MR, Krstajic D, Hicks B, Jones K, Lee SJ, Savage SA . No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia . Bone Marrow Transplantation . 2018;53(4):383-391 . PMCID: PMC5898974

Gadiya M, Chakraborty G . Signaling by discoidin domain receptor 1 in cancer metastasis . Cell Adhesion & Migration . 2018;12(4):315-323 .

Gafoor K, Patel S, Girvin F, Gupta N, Naidich D, Machnicki S, Brown KK, Mehta A, Husta B, Ryu JH, Sarosi GA, Franquet T, Verschakelen J, Johkoh T, Travis W, Raoof S . Cavitary lung diseases: A clinical-radiologic algorithmic approach . Chest . 2018;153(6):1443-1465 .

Gagliano-Juca T, Travison TG, Kantoff PW, Nguyen PL, Taplin ME, Kibel AS, Huang G, Bearup R, Schram H, Manley R, Beleva YM, Edwards RR, Basaria S . Androgen deprivation therapy is associated with prolongation of QTc interval in men with prostate cancer . Journal of the Endocrine Society . 2018;2(5):485-496 . PMCID: PMC5941157

Gagliano-Juca T, Travison TG, Nguyen PL, Kantoff PW, Taplin ME, Kibel AS, Manley R, Hally K, Bearup R, Beleva YM, Huang G, Edwards RR, Basaria S . Effects of androgen deprivation therapy on pain perception, quality of life, and depression in men with prostate

73 OF 288


Journal Articles

cancer . Journal of Pain and Symptom Management . 2018;55(2):307-317 .e1 . PMCID: PMC5794536

Gagliano-Juca T, Pencina KM, Ganz T, Travison TG, Kantoff PW, Nguyen PL, Taplin ME, Kibel AS, Li Z, Huang G, Edwards RR, Nemeth E, Basaria S . Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer . American Journal of Physiology - Endocrinology and Metabolism . 2018;315(6):E1185-E1193 . PMCID: PMC6336960

Gagnière J, Poston GJ, Boerner T, Le Roy B, Dupré A . Unresectable colorectal liver metastases: When definitions matter to appropriately assess extreme liver resection techniques . Annals of Surgery . 2018;268(6):e82-e83 .

Gala K, Li Q, Sinha A, Razavi P, Dorso M, Sanchez-Vega F, Chung YR, Hendrickson R, Hsieh JJ, Berger M, Schultz N, Pastore A, Abdel-Wahab O, Chandarlapaty S . KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function . Oncogene . 2018;37(34):4692-4710 . PMCID: PMC6107480

Galassi T V, Jena P V, Shah J, Ao G, Molitor E, Bram Y, Frankel A, Park J, Jessurun J, Ory DS, Haimovitz-Friedman A, Roxbury D, Mittal J, Zheng M, Schwartz RE, Heller DA . An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo . Science Translational Medicine . 2018;10(461):eaar2680- .

Galateau Salle F, Le Stang N, Nicholson AG, Pissaloux D, Churg A, Klebe S, Roggli VL, Tazelaar HD, Vignaud JM, Attanoos R, Beasley MB, Begueret H, Capron F, Chirieac L, Copin MC, Dacic S, Danel C, Foulet-Roge A, Gibbs A, Giusiano-Courcambeck S, Hiroshima K, Hofman V, Husain AN, Kerr K, Marchevsky A, Nabeshima K, Picquenot JM, Rouquette I, Sagan C, Sauter JL, Thivolet F, Travis WD, Tsao MS, Weynand B, Damiola F, Scherpereel A, Pairon JC, Lantuejoul

S, Rusch V, Girard N . New insights on diagnostic reproducibility of biphasic mesotheliomas: A multi-institutional evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center . Journal of Thoracic Oncology . 2018;13(8):1189-1203 .

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov A V, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny M V, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FKM, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D’Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jaattela M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander

Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G . Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018 . Cell Death and Differentiation . 2018;25(3):486-541 .

Galluzzi L, Chan TA, Kroemer G, Wolchok JD, Lopez-Soto A . The hallmarks of successful anticancer immunotherapy . Science Translational Medicine . 2018;10(459):eaat7807- .

Galluzzi L, Vanpouille-Box C, Bakhoum SF, Demaria S . SnapShot: CGAS-STING Signaling . Cell . 2018;173(1):276-276 .e1 .

Ganesh K, Massagué J . TGF-β inhibition and immunotherapy: Checkmate . Immunity . 2018;48(4):626-628 .

Gangangari KK, Humm JL, Larson SM, Pillarsetty NVK . TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F] fluoro-β-D-arabinofuranosylcytosine ([(18)F] FAC) . PLoS ONE . 2018;13(5):e0196784- . PMCID: PMC5929562

Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Blecua Carrillo Albornoz P, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA . Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes . Cancer Cell . 2018;34(2):256-270 .e5 .

Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, Paietta EM, Ketterling R, O’Connell MJ, Wiernik PH, Bennett JM, Litzow MR, Luger SM, Lazarus HM, Tallman MS . Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience . American Journal of Hematology . 2018;93(8):1074-1081 .

74 OF 288


Journal Articles

Gao M, Jiang X . To eat or not to eat - the metabolic flavor of ferroptosis . Current Opinion in Cell Biology . 2018;51:58-64 . PMCID: PMC5949249

Gao Q, Yellapantula V, Fenelus M, Pichardo J, Wang L, Landgren O, Dogan A, Roshal M . Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms . Modern Pathology . 2018;31(6):881-889 . PMCID: PMC5998376

Gao S, Stein S, Petre EN, Shady W, Durack JC, Ridge C, Adusumilli P, Rekhtman N, Solomon SB, Ziv E . Micropapillary and/or solid histologic subtype based on pre-treatment biopsy predicts local recurrence after thermal ablation of lung adenocarcinoma . CardioVascular and Interventional Radiology . 2018;41(2):253-259 . PMCID: PMC5760368

Gao Y, Quinn B, Pandit-Taskar N, Behr G, Mahmood U, Long D, Xu XG, St . Germain J, Dauer LT . Patient-specific organ and effective dose estimates in pediatric oncology computed tomography . Physica Medica . 2018;45:146-155 . PMCID: PMC5828028

Gao Y, Chang MT, McKay D, Na N, Zhou B, Yaeger R, Torres NM, Muniz K, Drosten M, Barbacid M, Caponigro G, Stuart D, Moebitz H, Solit DB, Abdel-Wahab O, Taylor BS, Yao Z, Rosen N . Allele-specific mechanisms of activation of mek1 mutants determine their properties . Cancer Discovery . 2018;8(5):648-661 .

García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Canovas MS, Conesa MA V, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L . Trial watch: Immunostimulation with recombinant cytokines for cancer therapy . OncoImmunology . 2018;7(6):e1433982- . PMCID: PMC5980390

García Nores GD, Ly CL, Savetsky IL, Kataru RP, Ghanta S, Hespe GE, Rockson SG, Mehrara BJ . Regulatory T cells mediate local immunosuppression

in lymphedema . Journal of Investigative Dermatology . 2018;138(2):325-335 . PMCID: PMC5794510

García Nores GD, Ly CL, Cuzzone DA, Kataru RP, Hespe GE, Torrisi JS, Huang JJ, Gardenier JC, Savetsky IL, Nitti MD, Yu JZ, Rehal S, Mehrara BJ . CD4(+) T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema . Nature Communications . 2018;9:1970- . PMCID: PMC5958132

Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Nunes-Silva I, Linares-Espinos E, Rozet F, Galiano M, Cathelineau X . Comparative analysis of partial gland ablation and radical prostatectomy to treat low and intermediate risk prostate cancer: Oncologic and functional outcomes . Journal of Urology . 2018;199(1):140-146 .

Garg A, Sanchez AM, Shuman S, Schwer B . A long noncoding (lnc)RNA governs expression of the phosphate transporter Pho84 in fission yeast and has cascading effects on the flanking prt lncRNA and pho1 genes . Journal of Biological Chemistry . 2018;293(12):4456-4467 . PMCID: PMC5868275

Garg A, Goldgur Y, Schwer B, Shuman S . Distinctive structural basis for DNA recognition by the fission yeast Zn(2)Cys(6) transcription factor Pho7 and its role in phosphate homeostasis . Nucleic Acids Research . 2018;46(21):11262-11273 . PMCID: PMC6265462

Garland SN, Eriksen W, Song S, Dearing J, Barg FK, Gehrman P, Mao JJ . Factors that shape preference for acupuncture or cognitive behavioral therapy for the treatment of insomnia in cancer patients . Supportive Care in Cancer . 2018;26(7):2407-2415 .

Gaspersz MP, Buettner S, Roos E, van Vugt JLA, Coelen RJS, Vugts J, Wiggers JK, Allen PJ, Besselink MG, Busch ORC, Belt EJ, D’Angelica M I, DeMatteo RP, de Jonge J, Kingham TP, Polak WG, Willemssen FEJA, van Gulik TM, Jarnagin WR, Ijzermans JNM, Groot Koerkamp B . A preoperative prognostic model to predict surgical success in patients with perihilar

cholangiocarcinoma . Journal of Surgical Oncology . 2018;118(3):469-476 .

Gaudiuso R, Ewusi-Annan E, Melikechi N, Sun X, Liu B, Campesato LF, Merghoub T . Using LIBS to diagnose melanoma in biomedical fluids deposited on solid substrates: Limits of direct spectral analysis and capability of machine learning . Spectrochimica Acta - Part B Atomic Spectroscopy . 2018;146:106-114 .

Gay HA, Oh JH, Apte AP, Daly MD, Adkins DR, Rich J, Oppelt PJ, Dyk PT, Mullen DF, Eschen L, Chin R I, Nussenbaum B, Haughey BH, Thorstad WL, Deasy JO . Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer . Clinical and Translational Radiation Oncology . 2018;13:1-6 . PMCID: PMC6134163

Geary CD, Krishna C, Lau CM, Adams NM, Gearty S V, Pritykin Y, Thomsen AR, Leslie CS, Sun JC . Non-redundant ISGF3 components promote NK cell survival in an auto-regulatory manner during viral infection . Cell Reports . 2018;24(8):1949-1957 .e6 .

Geer EB . Pituitary surgery is becoming more common: Does this reflect a change in tumor incidence, detection, or treatment pattern? . Endocrine . 2018;61(3):355-356 .

Gehring K, Kloek CJJ, Aaronson NK, Janssen KW, Jones LW, Sitskoorn MM, Stuiver MM . Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: A pilot randomized controlled trial . Clinical Rehabilitation . 2018;32(3):352-366 .

Gejman RS, Chang AY, Jones HF, DiKun K, Hakimi AA, Schietinger A, Scheinberg DA . Rejection of immunogenic tumor clones is limited by clonal fraction . eLife . 2018;7:e41090- . PMCID: PMC6269121

Geller AC, Jablonski NG, Pagoto SL, Hay JL, Hillhouse J, Buller DB, Kenney WL, Robinson JK, Weller RB, Moreno MA, Gilchrest BA, Sinclair C, Arndt J, Taber JM, Morris KL, Dwyer LA, Perna FM, Klein WMP,

75 OF 288


Journal Articles

Suls J . Interdisciplinary perspectives on sun safety . JAMA Dermatology . 2018;154(1):88-92 . PMCID: PMC5839662

Geller S, Marghoob AA, Scope A, Braun RP, Myskowski PL . Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma . Journal of the European Academy of Dermatology and Venereology . 2018;32(1):53-56 . PMCID: PMC5773353

Geller S, Myskowski PL, Kim YH, Moskowitz A, Horwitz S . The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet? . British Journal of Dermatology . 2018;178(2):571- .

Geller S, Canavan TN, Pulitzer M, Moskowitz AJ, Myskowski PL . ALK-positive primary cutaneous anaplastic large cell lymphoma: A case report and review of the literature . International Journal of Dermatology . 2018;57(5):515-520 . PMCID: PMC5893427

Geller S, Xu H, Lebwohl M, Nardone B, Lacouture ME, Kheterpal M . Malignancy risk and recurrence with psoriasis and its treatments: A concise update . American Journal of Clinical Dermatology . 2018;19(3):363-375 .PMCID: PMC5948118

Geller S, Pulitzer M, Myskowski PL . Solitary orange papule on the back of a middle-aged man . Dermatology Practical & Conceptual . 2018;8(1):51-53 . PMCID: PMC5808373

Geller S, Myskowski PL, Pulitzer M . NK/T-cell lymphoma, nasal type, γδ T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma - Clinical and histopathologic features, differential diagnosis, and treatment . Seminars in Cutaneous Medicine and Surgery . 2018;37(1):30-38 .

Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL . Treatment of vulvar mycosis fungoides tumors with localized radiotherapy .

Clinical Lymphoma, Myeloma and Leukemia . 2018;18(7):e279-e281 . PMCID: PMC6026479

Geller S, Pulitzer M, Myskowski PL . Diffuse eruptive ulcerated plaques . International Journal of Dermatology . 2018;57(9):1055-1057 . PMCID: PMC6105444

Geller S, Dickson MA, Busam KJ, Myskowski PL . Kaposi’s sarcoma after autologous stem-cell transplantation and rituximab treatment . Journal of Oncology Practice . 2018;14(9):565-568 . PMCID: PMC6136896

Geller S, Pulitzer M, Myskowski PL . Acneiform follicular mucinosis: An indolent follicular mucinosis variant unrelated to mycosis fungoides? . Clinical and Experimental Dermatology . 2018;43(8):921-924 . PMCID: PMC6214779

Geller S, Pulitzer M, Myskowski PL, Kheterpal M . Low-grade cutaneous B-cell lymphoma in African American patients . Journal of Drugs in Dermatology . 2018;17(12):1334-1337 .

Georg P, Andrzejewski P, Baltzer P, Daniel M, Wadsak W, Mitterhauser M, Sturdza A, Majercakova K, Karanikas G, Pötter R, Hacker M, Helbich T, Georg D, Pinker K . Changes in tumor biology during chemoradiation of cervix cancer assessed by multiparametric MRI and hypoxia PET . Molecular Imaging and Biology . 2018;20(1):160-169 . PMCID: PMC5775363

George DJ, Martini JF, Staehler M, Motzer RJ, Magheli A, Escudier B, Gerletti P, Li S, Casey M, Laguerre B, Pandha HS, Pantuck AJ, Patel A, Lechuga MJ, Ravaud A . Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: From randomized phase III S-TRAC study . Clinical Cancer Research . 2018;24(7):1554-1561 .

George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme

TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soloway MG, Wilkerson MD, Cun Y, McKay JD, Moro-Sibilot D, Brambilla CG, Lantuejoul S, Lemaitre N, Soltermann A, Weder W, Tischler V, Brustugun OT, Lund-Iversen M, Helland Å, Solberg S, Ansén S, Wright G, Solomon B, Roz L, Pastorino U, Petersen I, Clement JH, Sanger J, Wolf J, Vingron M, Zander T, Perner S, Travis WD, Haas SA, Olivier M, Foll M, Büttner R, Hayes DN, Brambilla E, Fernandez-Cuesta L, Thomas RK . Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors . Nature Communications . 2018;9:1048- . PMCID: PMC5849599

George S, Serrano C, Hensley ML, Ray-Coquard I . Soft tissue and uterine leiomyosarcoma . Journal of Clinical Oncology . 2018;36(2):144-150 . PMCID: PMC5759317

Getta BM, Devlin S, Park JH, Tallman MS, Berman E . Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia . Leukemia Research . 2018;65:80-85 .

Gettinger S, Horn L, Jackman D, Spigel D, Antonia S, Hellmann M, Powderly J, Heist R, Sequist L V, Smith DC, Leming P, Geese WJ, Yoon D, Li A, Brahmer J . Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: Results from the CA209-003 study . Journal of Clinical Oncology . 2018;36(17):1675-1684 .

Gettinger S, Hellmann MD, Chow LQM, Borghaei H, Antonia S, Brahmer JR, Goldman JW, Gerber DE, Juergens RA, Shepherd FA, Laurie SA, Young TC, Li X, Geese WJ, Rizvi N . Nivolumab plus erlotinib in patients with EGFR-mutant advanced NSCLC . Journal of Thoracic Oncology . 2018;13(9):1363-1372 .

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R,

76 OF 288


Journal Articles

Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada JR, Blecua P, Muenst S, Jungbluth AA, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha EA, Chandarlapaty S, Weigelt B, Reis-Filho JS . Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas . Nature Communications . 2018;9:1816- . PMCID: PMC5940840

Geyer MB, Tallman MS . Digging deeper in relapsed acute lymphoblastic leukemia: Impact of MRD status on outcome in second remission . Leukemia and Lymphoma . 2018;59(2):269-271 .

Geyer MB, Manjunath SH, Evans AG, Park JH, Davila ML, Cutler CS, Wang X, Wang Y, Senechal B, Rivière I, Sadelain M, Liesveld JL, Brentjens RJ . Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells . Leukemia and Lymphoma . 2018;59(7):1717-1721 . PMCID: PMC6037308

Geyer MB, Rivière I, Sénéchal B, Wang X, Wang Y, Purdon TJ, Hsu M, Devlin SM, Halton E, Lamanna N, Rademaker J, Sadelain M, Brentjens RJ, Park JH . Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy . Molecular Therapy . 2018;26(8):1896-1905 . PMCID: PMC6094824

Ghai NR, Jensen CD, Corley DA, Doubeni CA, Schottinger JE, Zauber AG, Lee AT, Contreras R, Levin TR, Lee JK, Quinn VP . Colorectal cancer screening participation among Asian Americans overall and subgroups in an integrated health care setting with organized screening . Clinical and Translational Gastroenterology . 2018;9(9):186- . PMCID: PMC6155113

Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Donahue TF, Dalbagni G, Herr HW, Bochner BH, Vickers AJ, Donat SM . Comparison of postradical cystectomy ileus rates

using GIA-80 versus GIA-60 intestinal stapler device . Urology . 2018;122:121-126 .

Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, Austin PC, Keyhani S . Marijuana use, respiratory symptoms, and pulmonary function: A systematic review and meta-analysis . Annals of Internal Medicine . 2018;169(2):106-115 .

Ghaznavi SA, Ganly I, Shaha AR, English C, Wills J, Tuttle RM . Using the American Thyroid Association risk-stratification system to refine and individualize the American Joint Committee on Cancer eighth edition disease-specific survival estimates in differentiated thyroid cancer . Thyroid . 2018;28(10):1293-1300 .

Ghebrehiwet B, Kandov E, Kishore U, Peerschke EIB . Is the A-chain the engine that drives the diversity of C1q functions? Revisiting its unique structure . Frontiers in Immunology . 2018;9:162- . PMCID: PMC5807628

Ghesquières H, Larrabee BR, Casasnovas O, Maurer MJ, McKay JD, Ansell SM, Montgomery D, Asmann YW, Farrell K, Verney A, Slager SL, Allmer C, Perrot A, Delarue R, Habermann TM, Dupuis J, Link BK, Canioni D, Dogan A, Cozen W, Jarrett RF, Cerhan JR, Salles G . A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts . British Journal of Haematology . 2018;180(2):286-290 . PMCID: PMC5344766

Ghione P, Moskowitz AJ, De Paola NEK, Horwitz SM, Ruella M . Novel immunotherapies for T cell lymphoma and leukemia . Current Hematologic Malignancy Reports . 2018;13(6):494-506 . PMCID: PMC6295363

Gholami S, Brennan MF . Preoperative stenting for benign and malignant periampullary diseases: Unnecessary if not harmful . Surgical Clinics of North America . 2018;98(1):37-47 .

Ghose P, Rashid A, Insley P, Trivedi M, Shah P, Singhal A, Lu Y, Bao Z, Shaham S . EFF-1 fusogen promotes phagosome sealing during cell process clearance in Caenorhabditis elegans . Nature Cell Biology . 2018;20(4):393-399 . PMCID: PMC5876135

Ghosh A, Mailankody S, Giralt SA, Landgren CO, Smith EL, Brentjens RJ . CAR T cell therapy for multiple myeloma: Where are we now and where are we headed? . Leukemia and Lymphoma . 2018;59(9):2056-2067 .PMCID: PMC5936668

Giancipoli RG, Khattar P, Bodei L . Two abdominal masses detected with (68)Ga-DOTATATE PET/CT in a patient with necrolytic migratory erythema . Gastroenterology . 2018;155(4):e11-e13 .

Giancipoli RG, Monti S, Basturk O, Klimstra D, Keohan ML, Schillaci O, Corrias G, Sawan P, Mannelli L . Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with (18)F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report . Medicine . 2018;97(42):e12795- . PMCID: PMC6211838

Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M . CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade . Nature Medicine . 2018;24(6):731-738 .

Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC . Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: A report from the Childhood Cancer Survivor Study cohort . Lancet Oncology . 2018;19(12):1590-1601 .

Gigoux M, Wolchok J . Refusing to TAP out: 16 new human TEIPPs identified . Journal of Experimental

77 OF 288


Journal Articles

Medicine . 2018;215(9):2233-2234 . PMCID: PMC6122966

Gill IS, Azzouzi AR, Emberton M, Coleman JA, Coeytaux E, Scherz A, Scardino PT, for the PCM301 Study Group . Randomized trial of partial gland ablation with vascular targeted phototherapy versus active surveillance for low risk prostate cancer: Extended followup and analyses of effectiveness . Journal of Urology . 2018;200(4):786-793 .

Gill SC, Lim NM, Grinaway PB, Rustenburg AS, Fass J, Ross GA, Chodera JD, Mobley DL . Binding modes of ligands using enhanced sampling (BLUES): Rapid decorrelation of ligand binding modes via nonequilibrium candidate Monte Carlo . Journal of Physical Chemistry B . 2018;122(21):5579-5598 . PMCID: PMC5980761

Gilleland Marchak J, Seidel KD, Mertens AC, Ritenour CWM, Wasilewski-Masker K, Leisenring WM, Sklar CA, Ford JS, Krull KR, Stovall M, Robison LL, Armstrong GT, Meacham LR . Perceptions of risk of infertility among male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study . Cancer . 2018;124(11):2447-2455 . PMCID: PMC5992044

Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, dos Reis RB, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A . Management of patients with advanced prostate cancer: The report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 . European Urology . 2018;73(2):178-211 .

Ginex P, Montefusco M, Zecco G, Trocchia Mattessich N, Burns J, Hedal-Siegel J, Kopelman J, Tan KS . Animal-facilitated therapy program: Outcomes from Caring Canines, a program for patients and staff on an inpatient surgical oncology unit . Clinical Journal of Oncology Nursing . 2018;22(2):193-198 .

Gini A, Zauber AG, Cenin DR, Omidvari AH, Hempstead SE, Fink AK, Lowenfels AB, Lansdorp-Vogelaar I . Cost effectiveness of screening individuals with cystic fibrosis for colorectal cancer . Gastroenterology . 2018;154(3):556-567 .e18 . PMCID: PMC5823285

Ginsburg KB, Auffenberg GB, Qi J, Powell IJ, Linsell SM, Montie JE, Miller DC, Cher ML . Risk of becoming lost to follow-up during active surveillance for prostate cancer . European Urology . 2018;74(6):704-707 .

Giordano SH, Temin S, Chandarlapaty S, Crews JR, Esteva FJ, Kirshner JJ, Krop IE, Levinson J, Lin NU, Modi S, Patt DA, Perlmutter J, Ramakrishna N, Winer EP, Davidson NE . Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO clinical practice guideline update . Journal of Clinical Oncology . 2018;36(26):2736-2740 .

Giralt S, Seifter E . Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients . Hematology-American Society of Hematology Education Program . 2018;2018(1):103-109 .PMCID: PMC6245961

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh L I, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen

SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj G V, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG . Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017 . Journal of Clinical Oncology . 2018;36(4):414-424 .

Giroux DJ, Van Schil P, Asamura H, Rami-Porta R, Chansky K, Crowley JJ, Rusch VW, Kernstine K, on behalf of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee . The IASLC Lung Cancer Staging Project: A renewed call to participation . Journal of Thoracic Oncology . 2018;13(6):801-809 .

Giuliante MM, Greenberg SA, McDonald M V, Squires A, Moore R, Cortes TA . Geriatric Interdisciplinary Team Training 2 .0: A collaborative team-based approach to delivering care . Journal of Interprofessional Care . 2018;32(5):629-633 .

Giulino-Roth L, O’Donohue T, Chen Z, Trippett TM, Klein E, Kernan NA, Kobos R, Prockop SE, Scaradavou A, Shukla N, Steinherz PG, Moskowitz AJ, Moskowitz CH, Boulad F . Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: The Memorial Sloan Kettering Cancer Center experience . Leukemia and Lymphoma . 2018;59(8):1861-1870 .

Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O’Reilly EM, Yu KH . Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience . BMC Cancer . 2018;18:693- . PMCID: PMC6020418

Glickman MS . Challenges for the MD physician-scientist upon entering the lab: From the grand

78 OF 288


Journal Articles

to the practical . Journal of Infectious Diseases . 2018;218(Suppl . 1):S25-S27 . PMCID: PMC6093401

Glincher R, Price AP, Laquaglia MP, Kushner BH, Modak S . Bevacizumab-associated bowel microperforation in a patient with neuroblastoma . Journal of Pediatric Hematology/Oncology . 2018;40(6):e394-e396 . PMCID: PMC5812839

Goh AC . Editorial comment . Journal of Urology . 2018;200(4):902- .

Golan R, Bernstein A, Sedrakyan A, Daskivich TJ, Du DT, Ehdaie B, Fisher B, Gorin MA, Grunberger I, Hunt B, Jiang HH, Kim HL, Marinac-Dabic D, Marks LS, McClure TD, Montgomery JS, Parekh DJ, Punnen S, Scionti S, Viviano CJ, Wei JT, Wenske S, Wysock JS, Rewcastle J, Carol M, Oczachowski M, Hu JC . Development of a nationally representative coordinated registry network for prostate ablation technologies . Journal of Urology . 2018;199(6):1488-1493 .

Goldberg J I, Burhenn PS, Ginex PK . Nursing education: Review of assessment, clinical care, and implications for practice regarding older adult patients with cancer . Clinical Journal of Oncology Nursing . 2018;22(6 Suppl .):19-25 .

Goldberg SL, Savona M, Mauro MJ . Considerations for successful treatment-free remission in chronic myeloid leukemia . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(2):98-105 .

Goldenberg D, Ferris RL, Shindo ML, Shaha A, Stack B, Tufano RP . Thyroidectomy in patients who have undergone gastric bypass surgery . Head & Neck . 2018;40(6):1237-1244 .

Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS . The relationship between repeat resection and overall survival in patients with glioblastoma: A time-dependent analysis . Journal of Neurosurgery . 2018;129(5):1231-1239 .

Goldsby RE, Stratton KL, Raber S, Ablin A, Strong LC, Oeffinger K, Sklar CA, Armstrong GT, Robison LL, Bhatia S, Leisenring WM . Long-term sequelae in survivors of childhood leukemia with Down syndrome: A Childhood Cancer Survivor Study report . Cancer . 2018;124(3):617-625 . PMCID: PMC5780223

Goldstein RD, Lederman R I, Lichtenthal WG, Morris SE, Human M, Elliott AJ, Tobacco D, Angal J, Odendaal H, Kinney HC, Prigerson HG, for the PASS Network . The grief of mothers after the sudden unexpected death of their infants . Pediatrics . 2018;141(5):e20173651- .

Golfmann K, Meder L, Koker M, Volz C, Borchmann S, Tharun L, Dietlein F, Malchers F, Florin A, Büttner R, Rosen N, Rodrik-Outmezguine V, Hallek M, Ullrich RT . Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer . Oncogene . 2018;37(42):5682-5693 .

Gollub MJ, Hotker AM, Woo KM, Mazaheri Y, Gonen M . Quantitating whole lesion tumor biology in rectal cancer MRI: Taking a lesson from FDG-PET tumor metrics . Abdominal Radiology . 2018;43(7):1575-1582 .PMCID: PMC5960599

Gollub MJ, Arya S, Beets-Tan RG, dePrisco G, Gonen M, Jhaveri K, Kassam Z, Kaur H, Kim D, Knezevic A, Korngold E, Lall C, Lalwani N, Blair Macdonald D, Moreno C, Nougaret S, Pickhardt P, Sheedy S, Harisinghani M . Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017 . Abdominal Radiology . 2018;43(11):2893-2902 .

Gombos RB, Gonzalez A, Manrique M, Chand D, Savitsky D, Morin B, Breous-Nystrom E, Dupont C, Ward RA, Mundt C, Duckless B, Tang H, Findeis MA, Schuster A, Waight JD, Underwood D, Clarke C, Ritter G, Merghoub T, Schaer D, Wolchok JD, van Dijk M, Buell JS, Cuillerot JM, Stein R, Drouin EE, Wilson

NS . Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody . PLoS ONE . 2018;13(4):e0191926- . PMCID: PMC5884502

Goncalves Filho J, Zafereo ME, Ahmad F I, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP . Decision making for the central compartment in differentiated thyroid cancer . European Journal of Surgical Oncology . 2018;44(11):1671-1678 .

Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M, Jones LW, Downey RJ . Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer . Clinical Radiology . 2018;73(5):505 .e1-505 .e8 .

Gonzalez-Vallinas M, Rodríguez-Paredes M, Albrecht M, Sticht C, Stichel D, Gutekunst J, Pitea A, Sass S, Sanchez-Rivera FJ, Lorenzo-Bermejo J, Schmitt J, De La Torre C, Warth A, Theis FJ, Müller NS, Gretz N, Muley T, Meister M, Tschaharganeh DF, Schirmacher P, Matthaus F, Breuhahn K . Epigenetically regulated chromosome 14q32 miRNA cluster induces metastasis and predicts poor prognosis in lung adenocarcinoma patients . Molecular Cancer Research . 2018;16(3):390-402 .

Gonzales J, Kossatz S, Roberts S, Pirovano G, Brand C, Pérez-Medina C, Donabedian P, De La Cruz MJ, Mulder WJM, Reiner T . Nanoemulsion-based delivery of fluorescent PARP inhibitors in mouse models of small cell lung cancer . Bioconjugate Chemistry . 2018;29(11):3776-3782 .

Gonzalez-Aguirre A, Covey AM, Brown KT, Brody LA, Boas FE, Sofocleous CT, Maybody M, Getrajdman G I, Erinjeri JP . Comparison of biliary brush biopsy and fine needle biopsy in the diagnosis of biliary

79 OF 288


Journal Articles

strictures . Minimally Invasive Therapy and Allied Technologies . 2018;27(5):278-283 .

Gonzalez-Aguirre AJ, Petre EN, Hsu M, Moskowitz CS, Solomon SB, Durack JC . Arms down cone beam CT hepatic angiography performance assessment: Vascular imaging quality and imaging artifacts . CardioVascular and Interventional Radiology . 2018;41(6):898-904 .

Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, Louis DN, Yong WH, Lopes MB, Rosenblum MK, Butowski N, Tihan T, Bollen AW, Phillips JJ, Wiita AP, Yeh I, Jacobson MP, Bastian BC, Perry A, Solomon DA . A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle . Nature Communications . 2018;9:810- . PMCID: PMC5824822

Goodwin CR, Ahmed AK, Boone C, Abu-Bonsrah N, Xu R, Germscheid N, Fourney DR, Clarke M, Laufer I, Fisher CG, Bettegowda C, Sciubba DM . The challenges of renal cell carcinoma metastatic to the spine: A systematic review of survival and treatment . Global Spine Journal . 2018;8(5):517-526 . PMCID: PMC6149047

Gorlov I, Orlow I, Ringelberg C, Hernando E, Ernstoff MS, Cheng C, Her S, Parker JS, Thompson CL, Gerstenblith MR, Berwick M, Amos C . Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics . Melanoma Research . 2018;28(5):380-389 .

Gorman AW, Deh KM, Schwiedrzik CM, White JR, Groman E V, Fisher CA, Gillen KM, Spincemaille P, Rasmussen S, Prince MR, Voss HU, Freiwald WA, Wang Y . Brain iron distribution after multiple doses of ultra-small superparamagnetic iron oxide particles in rats . Comparative Medicine . 2018;68(2):139-147 . PMCID: PMC5897970

Gorman JR, Julian AK, Roberts SA, Romero SAD, Ehren JL, Krychman ML, Boles SG, Mao J, Su H I . Developing a post-treatment survivorship care plan to help breast cancer survivors understand their fertility . Supportive Care in Cancer . 2018;26(2):589-595 .

Gotlib J, Gerds AT, Bose P, Castells MC, Deininger MW, Gojo I, Gundabolu K, Hobbs G, Jamieson C, McMahon B, Mohan SR, Oehler V, Oh S, Padron E, Pancari P, Papadantonakis N, Pardanani A, Podoltsev N, Rampal R, Ranheim E, Rein L, Snyder DS, Stein BL, Talpaz M, Thota S, Wadleigh M, Walsh K, Bergman MA, Sundar H . Systemic mastocytosis, version 2 .2019: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(12):1500-1537 .

Gottesdiener LS, O’Connor S, Busam KJ, Won H, Solit DB, Hyman DM, Shoushtari AN . Rates of ERBB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ERBB2-amplified acral melanoma . Clinical Cancer Research . 2018;24(23):5815-5819 .

Gould DJ, Mehrara BJ, Neligan P, Cheng MH, Patel KM . Lymph node transplantation for the treatment of lymphedema . Journal of Surgical Oncology . 2018;118(5):736-742 .

Gounder MM, Thomas DM, Tap WD . Locally aggressive connective tissue tumors . Journal of Clinical Oncology . 2018;36(2):202-209 .

Gounder MM, Solit DB, Tap WD . Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation - To the editor . New England Journal of Medicine . 2018;378(20):1945-1947 .

Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK . Sorafenib for advanced

and refractory desmoid tumors . New England Journal of Medicine . 2018;379(25):2417-2428 . PMCID: PMC6447029

Goyal NG, Levine BJ, Van Zee KJ, Naftalis E, Avis NE . Trajectories of quality of life following breast cancer diagnosis . Breast Cancer Research and Treatment . 2018;169(1):163-173 .

Gracia-Cazaña T, Salazar N, Vera-Álvarez J, Aguilera J, Lopez-Navarro N, Herrera-Ceballos E, Gonzalez S, Juarranz Á, Gilaberte Y . Clinical, histological and immunohistochemical markers of resistance to methyl aminolaevulinate photodynamic therapy in Bowen disease . British Journal of Dermatology . 2018;178(2):e138-e140 .

Gracia-Cazaña T, Mascaraque M, Salazar N, Vera-Álvarez J, Pilar Frías M, Gonzalez S, Juarranz Á, Gilaberte Y . Photodynamic therapy: Influence of clinical and procedure variables on treatment response in basal cell carcinoma and Bowen disease . Acta Dermato-Venereologica . 2018;98(1):116-118 .

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O’Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli ML, Ward JH, Kumar R, Shead DA . Breast cancer, version 4 .2017: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(3):310-320 .

Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM . Dietary acrylamide intake and risk of renal cell carcinoma in two large prospective cohorts . Cancer Epidemiology Biomarkers and Prevention . 2018;27(8):979-982 . PMCID: PMC6072568

Graham L, Banda K, Torres A, Carver BS, Chen Y, Pisano K, Shelkey G, Curley T, Scher H I, Lotan TL, Hsieh AC, Rathkopf DE . A phase II study of the dual

80 OF 288


Journal Articles

mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer . Investigational New Drugs . 2018;36(3):458-467 .

Graham MS, DeAngelis LM . Improving outcomes in primary CNS lymphoma . Best Practice and Research: Clinical Haematology . 2018;31(3):262-269 .

Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG . Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;101(5):1222-1225 . PMCID: PMC6050125

Gray HJ, Bell-McGuinn K, Fleming GF, Cristea M, Xiong H, Sullivan D, Luo Y, McKee MD, Munasinghe W, Martin LP . Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies . Gynecologic Oncology . 2018;148(3):507-514 .

Greally M, Kelly CM, Cercek A . HER2: An emerging target in colorectal cancer . Current Problems in Cancer . 2018;42(6):560-571 .

Greally M, Ilson DH . Neoadjuvant therapy for esophageal cancer: Who, when, and what? . Cancer . 2018;124(22):4276-4278 .

Greally M, Ku GY . Immune checkpoint inhibitors in esophagogastric adenocarcinoma: Do the results justify the hype? . Journal of Thoracic Disease . 2018;10(12):6407-6411 .

Green AK, Aviki EM, Matsoukas K, Patil S, Korenstein D, Blinder V . Racial disparities in chemotherapy administration for early-stage breast cancer: A systematic review and meta-analysis . Breast Cancer Research and Treatment . 2018;172(2):247-263 .

Green AK, Bach P . Model-based eligibility for lung cancer screening: Where theory meets practice . Annals of Internal Medicine . 2018;168(3):223-224 .

Green AK, Saltz LB . Can we afford that CAR? Confronting the effect of novel immunotherapies on future health care costs . Journal of Clinical Oncology . 2018;36(13):1381-1382 .

Greenblatt SM, Man N, Hamard PJ, Asai T, Karl D, Martinez C, Bilbao D, Stathais V, McGrew-Jermacowicz A, Duffort S, Tadi M, Blumenthal E, Newman S, Vu L, Xu Y, Liu F, Schurer SC, McCabe MT, Kruger RG, Xu M, Yang FC, Tenen D, Watts J, Vega F, Nimer SD . CARM1 is essential for myeloid leukemogenesis but dispensable for normal hematopoiesis . Cancer Cell . 2018;33(6):1111-1127 .e5 .

Grenen E, Kent EE, Hennessy E, Hamilton JG, Ferrer RA . Association between nutrition resource stress and dietary consumption: Results from a U .S . nationally representative survey . Health Education and Behavior . 2018;45(4):524-531 . PMCID: PMC5930116

Griewank KG, Wiesner T, Murali R, Pischler C, Müller H, Koelsche C, Möller I, Franklin C, Cosgarea I, Sucker A, Schadendorf D, Schaller J, Horn S, Brenn T, Mentzel T . Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles . Modern Pathology . 2018;31(3):418-428 .

Griewank KG, Koelsche C, van de Nes JAP, Schrimpf D, Gessi M, Möller I, Sucker A, Scolyer RA, Buckland ME, Murali R, Pietsch T, von Deimling A, Schadendorf D . Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profiling . Clinical Cancer Research . 2018;24(18):4494-4504 .

Grimm J . High-resolution Cherenkov tomography in vivo . Nature Biomedical Engineering . 2018;2(4):205-206 .

Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, Godfrey AL, Papaemmanuil E, Gundem G, MacLean C, Cook J, O’Neil L, O’Meara S, Teague JW, Butler AP, Massie CE, Williams N, Nice FL, Andersen CL, Hasselbalch HC, Guglielmelli P, McMullin MF, Vannucchi AM, Harrison CN, Gerstung M, Green AR, Campbell PJ . Classification and personalized prognosis in myeloproliferative neoplasms . New England Journal of Medicine . 2018;379(15):1416-1430 .

Grisham RN, Iyer G . Low-grade serous ovarian cancer: Current treatment paradigms and future directions . Current Treatment Options in Oncology . 2018;19(11):54- .

Grisham RN, Moore KN, Gordon MS, Harb W, Cody G, Halpenny DF, Makker V, Aghajanian CA . Phase Ib study of binimetinib with paclitaxel in patients with platinum-resistant ovarian cancer: Final results, potential biomarkers, and extreme responders . Clinical Cancer Research . 2018;24(22):5525-5533 .

Grkovski M, Fanchon L, Pillarsetty NVK, Russell J, Humm JL . (18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model . EJNMMI Research . 2018;8:53- . PMCID: PMC6005997

Grkovski M, Gharzeddine K, Sawan P, Schöder H, Michaud L, Weber WA, Humm JL . (11)C-choline pharmacokinetics in recurrent prostate cancer . Journal of Nuclear Medicine . 2018;59(11):1672-1678 . PMCID: PMC6225540

Gronchi A, Crago A, Raut CP . Minimally invasive surgery for retroperitoneal sarcoma: Just because we can does not mean we should . Annals of Surgical Oncology . 2018;25(8):2129-2131 .

Groot Koerkamp B, Jarnagin WR . Surgery for perihilar cholangiocarcinoma . British Journal of Surgery . 2018;105(7):771-772 .

Grothey A, Strosberg JR, Renfro LA, Hurwitz H I, Marshall JL, Safran H, Guarino MJ, Kim GP, Hecht

81 OF 288


Journal Articles

JR, Weil SC, Heyburn J, Wang W, Schweizer C, O’Shannessy DJ, Diaz LA Jr . A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of monotherapy ontuxizumab (MORAb-004) plus best supportive care in patients with chemorefractory metastatic colorectal cancer . Clinical Cancer Research . 2018;24(2):316-325 .

Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, Dicaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH . The use of central pathology review with digital slide scanning in advanced-stage mycosis fungoides and Sézary syndrome: A multi-institutional and international pathology study . American Journal of Surgical Pathology . 2018;42(6):726-734 .

Grüner F, Blumendorf F, Schmutzler O, Staufer T, Bradbury M, Wiesner U, Rosentreter T, Loers G, Lutz D, Richter B, Fischer M, Schulz F, Steiner S, Warmer M, Burkhardt A, Meents A, Kupinski M, Hoeschen C . Localising functionalised gold-nanoparticles in murine spinal cords by X-ray fluorescence imaging and background-reduction through spatial filtering for human-sized objects . Scientific Reports . 2018;8:16561- . PMCID: PMC6224495

Guérin A, Kerner G, Marr N, Markle JG, Fenollar F, Wong N, Boughorbel S, Avery DT, Ma CS, Bougarn S, Bouaziz M, Béziat V, Della Mina E, Oleaga-Quintas C, Lazarov T, Worley L, Nguyen T, Patin E, Deswarte C, Martinez-Barricarte R, Boucherit S, Ayral X, Edouard S, Boisson-Dupuis S, Rattina V, Bigio B, Vogt G, Geissmann F, Quintana-Murci L, Chaussabel D, Tangye SG, Raoult D, Abel L, Bustamante J, Casanova JL . IRF4 haploinsufficiency in a family with Whipple’s disease . eLife . 2018;7:e32340- . PMCID: PMC5915175

Gu Y, Srimathveeravalli G, Cai L, Ueshima E, Maybody M, Yarmohammadi H, Zhu YS, Durack JC, Solomon SB, Coleman JA, Erinjeri JP . Pirfenidone inhibits cryoablation induced local macrophage

infiltration along with its associated TGFb1 expression and serum cytokine level in a mouse model . Cryobiology . 2018;82:106-111 .

Guan Q, Xiao C, Zhang M . Immune regulatory cells in inflammation, infection, tumor, metabolism, and other diseases . Mediators of Inflammation . 2018;2018:4170780- . PMCID: PMC6020649

Gucalp A, Zhou XK, Cook ED, Garber JE, Crew KD, Nangia JR, Bhardwaj P, Giri DD, Elemento O, Verma A, Wang H, Lee JJ, Vornik LA, Mays C, Weber D, Sepeda V, O’Kane H, Krasne M, Williams S, Morris PG, Heckman-Stoddard BM, Dunn BK, Hudis CA, Brown PH, Dannenberg AJ . A randomized multicenter phase II study of docosahexaenoic acid in patients with a history of breast cancer, premalignant lesions, or benign breast disease . Cancer Prevention Research . 2018;11(4):203-213 .

Guercio BJ, Zhang S, Niedzwiecki D, Li Y, Babic A, Morales-Oyarvide V, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Zoltick ES, Stampfer M, Ng K, Wu K, Willett WC, Giovannucci EL, Meyerhardt JA, Fuchs CS . Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) . PLoS ONE . 2018;13(7):e0199244- . PMCID: PMC6053135

Gulati N, Béguelin W, Giulino-Roth L . Enhancer of zeste homolog 2 (EZH2) inhibitors . Leukemia and Lymphoma . 2018;59(7):1574-1585 .

Guney T, Wenderski TA, Boudreau MW, Tan DS . Synthesis of benzannulated medium-ring lactams via a tandem oxidative dearomatization-ring expansion reaction . Chemistry - A European Journal . 2018;24(50):13150-13157 .

Guney T, Wenderski TA, Boudreau MW, Tan DS . Front cover: Synthesis of benzannulated medium-ring lactams via a tandem oxidative dearomatization-ring

expansion reaction . Chemistry - A European Journal . 2018;24(50):13063- .

Gunnala V, Pereira N, Irani M, Lilienthal D, Pirog EC, Soslow R, Caputo TA, Elias R, Kligman I, Rosenwaks Z . Novel fumarate hydratase mutation in siblings with early onset uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer syndrome . International Journal of Gynecological Pathology . 2018;37(3):256-261 . PMCID: PMC5908258

Gunther JR, Jimenez RB, Yechieli RL, Parekh A, Berman AT, Braunstein SE, Hirsch AE, Gillespie EF, Vapiwala N, Thomas CR Jr, Fields EC, Golden DW . Introductory radiation oncology curriculum: Report of a national needs assessment and multi-institutional pilot implementation . International Journal of Radiation Oncology, Biology, Physics . 2018;101(5):1029-1038 .

Guntinas-Lichius O, Silver CE, Thielker J, Bernal-Sprekelsen M, Bradford CR, De Bree R, Kowalski LP, Olsen KD, Quer M, Rinaldo A, Rodrigo JR, Sanabria A, Shaha AR, Takes RP, Vander Poorten V, Zbaren P, Ferlito A . Management of the facial nerve in parotid cancer: Preservation or resection and reconstruction . European Archives of Oto-Rhino-Laryngology . 2018;275(11):2615-2626 .

Guo J, Jin J, Oya M, Uemura H, Takahashi S, Tatsugami K, Rha SY, Lee JL, Chung J, Lim HY, Wu HC, Chang YH, Azad A, Davis ID, Carrasco-Alfonso MJ, Nanua B, Han J, Ahmad Q, Motzer R . Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial . Journal of Hematology & Oncology . 2018;11:69- . PMCID: PMC5964681

Gupta D, Tang F, Masoudi FA, Jones PG, Chan PS, Daugherty SL . Practitioner gender and quality of care in ambulatory cardiology practices: A report from the National Cardiovascular Data Practice Innovation and Clinical Excellence (PINNACLE) Registry . Journal of

82 OF 288


Journal Articles

Cardiovascular Nursing . 2018;33(3):255-260 . PMCID: PMC5812833

Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM . Cardiovascular and metabolic effects of androgen-deprivation therapy for prostate cancer . Journal of Oncology Practice . 2018;14(10):580-587 .

Gupta P, Migliacci JC, Hay A, Rosenthal M, Mimica X, Lee N, Wong RJ, Shah J, Patel S, Ganly I . Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution . Oral Oncology . 2018;83:140-146 . PMCID: PMC6092037

Gupta P, Migliacci JC, Montero PH, Zanoni DK, Shah JP, Patel SG, Ganly I . Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers? . Oral Oncology . 2018;78:64-71 . PMCID: PMC5836801

Gustafson AM, Goldfrank DJ, Dunson WA, Mulkerin DL, Caires RL, Eaton KD . Pregnancy screening in patients with cancer . Journal of the National Comprehensive Cancer Network . 2018;16(1):99-103 .

Gutierrez A, Kentsis A . Acute myeloid/T-lymphoblastic leukaemia (AMTL): A distinct category of acute leukaemias with common pathogenesis in need of improved therapy . British Journal of Haematology . 2018;180(6):919-924 . PMCID: PMC5837942

Gutierrez C, McEvoy C, Mead E, Stephens RS, Munshi L, Detsky ME, Pastores SM, Nates JL . Management of the critically ill adult chimeric antigen receptor-t cell therapy patient: A critical care perspective . Critical Care Medicine . 2018;46(9):1402-1410 .

Guzik J, Patel G, Kothari P, Sharp M, Ostrowsky B, and the UHF Outpatient ASP Collaborative Team . Antibiotic prescribing for acute respiratory infections

in New York City: A model for collaboration . Infection Control and Hospital Epidemiology . 2018;39(11):1360-1366 .

Gyedu A, Gaskill CE, Agbedinu K, Salazar DR, Kingham TP . Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes . Journal of Surgical Oncology . 2018;118(3):581-587 . PMCID: PMC6160332

Ha R, Friedlander LC, Hibshoosh H, Hendon C, Feldman S, Ahn S, Schmidt H, Akens MK, Fitzmaurice M, Wilson BC, Mango VL . Optical coherence tomography: A novel imaging method for post-lumpectomy breast margin assessment - A multi-reader study . Academic Radiology . 2018;25(3):279-287 .

Ha R, Mango V, Al-Khalili R, Mema E, Friedlander L, Desperito E, Wynn RT . Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype . Clinical Imaging . 2018;51:307-310 .

Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, van den Brink MR, Geyer A I, Cross JR, Pamer EG, Taur Y . Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT . Blood . 2018;131(26):2978-2986 . PMCID: PMC6024637

Habib LA, Francis JH, Fabius AWM, Gobin PY, Dunkel IJ, Abramson DH . Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: The first 10 years . British Journal of Ophthalmology . 2018;102(2):272-275 .

Habous M, Tealab A, Farag M, Soliman T, Williamson B, Mahmoud S, Elserafy A, Mekawi Z, Remeah A, Nassar M, Laban O, Abdelwahab O, Binsaleh S, Giona S, Ralph D, Mulhall J . Malleable penile implant is an effective therapeutic option in men with Peyronie’s disease and erectile dysfunction . Sexual Medicine . 2018;6(1):24-29 .PMCID: PMC5815935

Habous M, Tal R, Tealab A, Soliman T, Nassar M, Mekawi Z, Mahmoud S, Abdelwahab O, Elkhouly M, Kamr H, Remeah A, Binsaleh S, Ralph D, Mulhall J . Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection . BJU International . 2018;121(2):293-300 .

Habous M, Muir G, Soliman T, Farag M, Williamson B, Binsaleh S, Elhadek W, Mahmoud S, Ibrahim H, Abdelwahab O, Abdelrahman Z, Abdelkader M, Jenkins LC, Mulhall JP . Outcomes of variation in technique and variation in accuracy of measurement in penile length measurement . International Journal of Impotence Research . 2018;30(1):21-26 .

Habous M, Tal R, Tealab A, Aziz M, Sherif H, Mahmoud S, Abdelwahab O, Nassar M, Kamil U, Abdelrahman Z, Binsaleh S, Giona S, Ralph D, Bettocchi C, Mulhall JP . Predictors of satisfaction in men after penile implant surgery . Journal of Sexual Medicine . 2018;15(8):1180-1186 .

Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Davila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O’Reilly RJ, Notarangelo LD . SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery . Blood . 2018;132(17):1737-1749 . PMCID: PMC6202916

Haddad R I, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner

83 OF 288


Journal Articles

W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA . NCCN Guidelines® Insights: Thyroid carcinoma, version 2 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(12):1429-1440 .

Hadjiliadis D, Khoruts A, Zauber AG, Hempstead SE, Maisonneuve P, Lowenfels AB, on behalf of the Cystic Fibrosis Colorectal Cancer Screening Task Force . Cystic fibrosis colorectal cancer screening consensus recommendations . Gastroenterology . 2018;154(3):736-745 .e14 .

Hadjiliadis D, Khoruts A, Zauber AG, Hempstead SE, Maisonneuve P, Lowenfels AB . Reply . Gastroenterology . 2018;154(8):2283-2284 .

Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, Kalloo A, Ben Hadj Hassen A, Thomas L, Enk A, Uhlmann L . Man against machine: Diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists . Annals of Oncology . 2018;29(8):1836-1842 .

Haidar M, Baassiri A, Maroun G, Barakat A, Nassar L, Abusamra M, Gharzeddine K, Berjawi G . New era of PET/CT in breast cancer: High-resolution PET/dfCT . Nuclear Medicine Communications . 2018;39(11):1039-1044 .

Hakimi AA, Voss MH . Genomic classifiers in renal cell carcinoma . European Urology . 2018;73(5):770-771 .

Halpenny DF, Goncalves M, Schwitzer E, Golia Pernicka J, Jackson J, Gandelman S, Moskowitz CS, Postow M, Mourtzakis M, Caan B, Jones LW, Plodkowski AJ . Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume

in cancer patients . British Journal of Radiology . 2018;91(1092):20180451- .

Halpern JA, Oromendia C, Shoag JE, Mittal S, Cosiano MF, Ballman K V, Vickers AJ, Hu JC . Use of digital rectal examination as an adjunct to prostate specific antigen in the detection of clinically significant prostate cancer . Journal of Urology . 2018;199(4):947-953 .

Halpern NA . Early warning systems for hospitalized pediatric patients . JAMA - Journal of the American Medical Association . 2018;319(10):981-982 .

Hamada N, Shore RE, Dauer LT . Outline of NCRP commentary no . 27: Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection . Japanese Journal of Health Physics . 2018;53(2):47-64 .

Hamann HA, Ver Hoeve ES, Carter-Harris L, Studts JL, Ostroff JS . Multilevel opportunities to address lung cancer stigma across the cancer control continuum . Journal of Thoracic Oncology . 2018;13(8):1062-1075 .

Hameed M, Mandelker D . Tumor syndromes predisposing to osteosarcoma . Advances in Anatomic Pathology . 2018;25(4):217-222 .

Hamidian S, Vachha B, Jenabi M, Karimi S, Young RJ, Holodny A I, Peck KK . Resting-state functional magnetic resonance imaging and probabilistic diffusion tensor imaging demonstrate that the greatest functional and structural connectivity in the hand motor homunculus occurs in the area of the thumb . Brain Connectivity . 2018;8(6):371-379 . PMCID: PMC6103248

Hamieh M, Sadelain M . Insights into chimeric antigen receptor therapy for chronic lymphoblastic leukemia . Trends in Molecular Medicine . 2018;24(9):729-731 .

Hamilton EP, Patel MR, Armstrong AC, Baird RD, Jhaveri K, Hoch M, Klinowska T, Lindemann JPO, Morgan SR, Schiavon G, Weir HM, Im SA . A first-in-human study of the new oral selective estrogen

receptor degrader AZD9496 for ER(+)/HER2(-) advanced breast cancer . Clinical Cancer Research . 2018;24(15):3510-3518 .

Hamilton JG, Waters EA . How are multifactorial beliefs about the role of genetics and behavior in cancer causation associated with cancer risk cognitions and emotions in the US population? . Psycho-Oncology . 2018;27(2):640-647 . PMCID: PMC5863733

Hamilton JG, Peshkin BN, Mays D, DeMarco TA, Patenaude AF, Tercyak KP . Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives . Psycho-Oncology . 2018;27(7):1825-1832 .

Hammill JT, Scott DC, Min J, Connelly MC, Holbrook G, Zhu F, Matheny A, Yang L, Singh B, Schulman BA, Guy RK . Piperidinyl ureas chemically control defective in cullin neddylation 1 (DCN1)-mediated cullin neddylation . Journal of Medicinal Chemistry . 2018;61(7):2680-2693 . PMCID: PMC5898815

Hammill JT, Bhasin D, Scott DC, Min J, Chen Y, Lu Y, Yang L, Kim HS, Connelly MC, Hammill C, Holbrook G, Jeffries C, Singh B, Schulman BA, Guy RK . Discovery of an orally bioavailable inhibitor of defective in cullin neddylation 1 (DCN1)-mediated cullin neddylation . Journal of Medicinal Chemistry . 2018;61(7):2694-2706 .PMCID: PMC5914176

Hammond WJ, Lalazar G, Saltsman JA, Farber BA, Danzer E, Sherpa TC, Banda CD, Andolina JR, Karimi S, Brennan CW, Torbenson MS, La Quaglia MP, Simon SM . Intracranial metastasis in fibrolamellar hepatocellular carcinoma . Pediatric Blood and Cancer . 2018;65(4):e26919- .

Han S, Stoyanova R, Lee H, Carlin SD, Koutcher JA, Cho H, Ackerstaff E . Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular

84 OF 288


Journal Articles

heterogeneity . Magnetic Resonance in Medicine . 2018;79(3):1736-1744 . PMCID: PMC5775918

Handkiewicz-Junak D, Poeppel TD, Bodei L, Aktolun C, Ezziddin S, Giammarile F, Delgado-Bolton RC, Gabriel M . EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(5):846-859 .

Harding JJ, Lowery MA, Shih AH, Schvartzman JM, Hou S, Famulare C, Patel M, Roshal M, Do RK, Zehir A, You D, Selcuklu SD, Viale A, Tallman MS, Hyman DM, Reznik E, Finley LWS, Papaemmanuil E, Tosolini A, Frattini MG, MacBeth KJ, Liu G, Fan B, Choe S, Wu B, Janjigian YY, Mellinghoff IK, Diaz LA, Levine RL, Abou-Alfa GK, Stein EM, Intlekofer AM . Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition . Cancer Discovery . 2018;8(12):1540-1547 .

Harding JJ, Do RK, El Dika I, Hollywood E, Uhlitskykh K, Valentino E, Wan P, Hamilton C, Feng X, Johnston A, Bomalaski J, Li CF, O’Reilly EM, Abou-Alfa GK . A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies . Cancer Chemotherapy and Pharmacology . 2018;82(3):429-440 .

Harding JJ . Immune checkpoint blockade in advanced hepatocellular carcinoma: An update and critical review of ongoing clinical trials . Future Oncology . 2018;14(22):2293-2302 .

Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, Capanu M, Do R, Kemeny NE, O’Reilly EM, Saltz LB, Abou-Alfa GK . Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma . Journal of the National Comprehensive Cancer Network . 2018;16(1):50-58 .

Harrington KA, Kennedy DS, Tang B, HicKie C, Phelan E, Torreggiani W, Halpenny D . Computed tomographic evaluation of the thymus-does obesity

affect thymic fatty involution in a healthy young adult population? . British Journal of Radiology . 2018;91(1089):20170609- .

Harris WP, Wong KM, Saha S, El Dika I, Abou-Alfa GK . Biomarker-driven and molecular targeted therapies for hepatobiliary cancers . Seminars in Oncology . 2018;45(3):116-123 .

Harshman LC, Tripathi A, Kaag M, Efstathiou JA, Apolo AB, Hoffman-Censits JH, Stadler WM, Yu EY, Bochner BH, Skinner EC, Downs T, Kiltie AE, Bajorin DF, Guru K, Shipley WU, Steinberg GD, Hahn NM, Sridhar SS . Contemporary patterns of multidisciplinary care in patients with muscle-invasive bladder cancer . Clinical Genitourinary Cancer . 2018;16(3):213-218 .

Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P . Nanotechnology strategies to advance outcomes in clinical cancer care . ACS Nano . 2018;12(1):24-43 .

Harvey JD, Zerze GH, Tully KM, Mittal J, Heller DA . Electrostatic screening modulates analyte binding and emission of carbon nanotubes . Journal of Physical Chemistry C . 2018;122(19):10592-10599 .

Hashmi SK, Lee SJ, Savani BN, Burns L, Wingard JR, Perales MA, Palmer J, Chow E, Meyer E, Marks D, Mohty M, Inamoto Y, Rodriguez C, Nagler A, Sauter C, Komanduri K V, Pidala J, Hamadani M, Johnston L, Shah N, Shaughnessy P, Hamilton BK, Majhail N, Kharfan-Dabaja MA, Schriber J, DeFilipp Z, Tarlock KG, Fanning S, Curtin P, Rizzo JD, Carpenter PA . ASBMT Practice Guidelines Committee survey on long-term follow-up clinics for hematopoietic cell transplant survivors . Biology of Blood and Marrow Transplantation . 2018;24(6):1119-1124 .

Hatswell AJ, Bullement A, Briggs A, Paulden M, Stevenson MD . Probabilistic sensitivity analysis in cost-effectiveness models: Determining model convergence in cohort models . PharmacoEconomics . 2018;36(12):1421-1426 .

Hatt M, Laurent B, Ouahabi A, Fayad H, Tan S, Li L, Lu W, Jaouen V, Tauber C, Czakon J, Drapejkowski F, Dyrka W, Camarasu-Pop S, Cervenansky F, Girard P, Glatard T, Kain M, Yao Y, Barillot C, Kirov A, Visvikis D . The first MICCAI challenge on PET tumor segmentation . Medical Image Analysis . 2018;44:177-195 .

Hatzoglou V, Oh JH, Buck O, Lin X, Lee M, Shukla-Dave A, Young RJ, Peck KK, Vachha B, Holodny A I, Grommes C . Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma . Journal of Neuro-Oncology . 2018;140(2):351-358 .

Hauser K, Negron C, Albanese SK, Ray S, Steinbrecher T, Abel R, Chodera JD, Wang L . Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations . Communications Biology . 2018;1:70- . PMCID: PMC6110136

Hawk MA, Gorsuch CL, Fagan P, Lee C, Kim SE, Hamann JC, Mason JA, Weigel KJ, Tsegaye MA, Shen L, Shuff S, Zuo J, Hu S, Jiang L, Chapman S, Leevy WM, Deberardinis RJ, Overholtzer M, Schafer ZT . RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells . Nature Cell Biology . 2018;20(3):272-284 .

Hawkins DS, Chi YY, Anderson JR, Tian J, Arndt CAS, Bomgaars L, Donaldson SS, Hayes-Jordan A, Mascarenhas L, McCarville MB, McCune JS, McCowage G, Million L, Morris CD, Parham DM, Rodeberg DA, Rudzinski ER, Shnorhavorian M, Spunt SL, Skapek SX, Teot LA, Wolden S, Yock T I, Meyer WH . Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: A report from the Children’s Oncology Group . Journal of Clinical Oncology . 2018;36(27):2770-2777 . PMCID: PMC6145831

85 OF 288


Journal Articles

Hawley ST, Li Y, An LC, Resnicow K, Janz NK, Sabel MS, Ward KC, Fagerlin A, Morrow M, Jagsi R, Hofer TP, Katz SJ . Improving breast cancer surgical treatment decision making: The iCanDecide randomized clinical trial . Journal of Clinical Oncology . 2018;36(7):659-666 .

Haxaire C, Hakobyan N, Pannellini T, Carballo C, McIlwain D, Mak TW, Rodeo S, Acharya S, Li D, Szymonifka J, Song X, Monette S, Srivastava A, Salmon JE, Blobel CP . Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway . Blood . 2018;132(10):1064-1074 .PMCID: PMC6128089

Hay A, Nixon IJ . Recent advances in the understanding and management of oropharyngeal cancer . F1000Research . 2018;7:1362- . PMCID: PMC6117847

Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ, Patel SG, Ganly I . Haemorrhage following transoral robotic surgery . Clinical Otolaryngology . 2018;43(2):638-644 . PMCID: PMC5851834

Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I . Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands . Head & Neck . 2018;40(5):1008-1015 . PMCID: PMC5912956

Hay CM, Donovan HS, Hartnett EG, Carter J, Roberge MC, Campbell GB, Zuchelkowski BE, Taylor SE . Sexual health as part of gynecologic cancer care: What do patients want? . International Journal of Gynecological Cancer . 2018;28(9):1737-1742 .

Hay JL, Baser RE, Westerman JS, Ford JS . Prevalence and correlates of worry about medical imaging radiation among United States cancer survivors . International Journal of Behavioral Medicine . 2018;25(5):569-578 .

Hay JL, Zielaskowski K, Meyer White K, Kaphingst K, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Rodríguez VM, Li Y, Schofield E, Bigney J, Hunley K, Buller D, Berwick M . Interest and uptake of MC1R testing for melanoma risk in a diverse primary care population: A randomized clinical trial . JAMA Dermatology . 2018;154(6):684-693 . PMCID: PMC5999534

Hayashi T, Desmeules P, Smith RS, Drilon A, Somwar R, Ladanyi M . RASA1 and NF1 are preferentially co-mutated and define a distinct genetic subset of smoking-associated non–small cell lung carcinomas sensitive to MEK inhibition . Clinical Cancer Research . 2018;24(6):1436-1447 . PMCID: PMC6440215

Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, Agalliu I, Burk RD, Ganly I, Purdue MP, Freedman ND, Gapstur SM, Pei Z . Association of oral microbiome with risk for incident head and neck squamous cell cancer . JAMA Oncology . 2018;4(3):358-365 . PMCID: PMC5885828

Hayes SA, Huang J, Golia Pernicka J, Cunningham J, Zheng J, Moskowitz CS, Ginsberg MS . Radiographic predictors of resectability in thymic carcinoma . Annals of Thoracic Surgery . 2018;106(1):242-248 .

He T, Kaplan SE, Gomez LA, Lu X, Ramanathan L V, Kamboj M, Tang YW . Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection . European Journal of Clinical Microbiology and Infectious Diseases . 2018;37(12):2341-2346 . PMCID: PMC6230305

Healey JH . CORR Insights®: Does an algorithmic approach to using brachytherapy and external beam radiation result in good function, local control rates, and low morbidity in patients with extremity soft tissue sarcoma? . Clinical Orthopaedics and Related Research . 2018;476(3):645-647 .

Healey JH . CORR Insights®: Can machine-learning techniques be used for 5-year survival prediction of patients with chondrosarcoma? . Clinical Orthopaedics

and Related Research . 2018;476(10):2049-2051 . PMCID: PMC6259854

Healey JH . Editorial comment: Selected proceedings of ISOLS 2017 . Clinical Orthopaedics and Related Research . 2018;476(9):1717-1718 . PMCID: PMC6259793

Hearn JWD, Xie W, Nakabayashi M, Almassi N, Reichard CA, Pomerantz M, Kantoff PW, Sharifi N . Association of HSD3B1 genotype with response to androgen-deprivation therapy for biochemical recurrence after radiotherapy for localized prostate cancer . JAMA Oncology . 2018;4(4):558-562 . PMCID: PMC5933377

Heavner JJ, Akgün KM, Heavner MS, Eng CC, Drew M, Jackson P, Pritchard D 9th, Honiden S . Implementation of an ICU-specific alcohol withdrawal syndrome management protocol reduces the need for mechanical ventilation . Pharmacotherapy . 2018;38(7):701-713 .

Heavner MS, Rouse GE, Lemieux SM, Owusu KA, Pritchard D 9th, Yazdi M, Lee LA . Experience with integrating pharmacist documenters on cardiac arrest teams to improve quality . Journal of the American Pharmacists Association . 2018;58(3):311-317 .

Hegedüs L, Sherman S I, Tuttle RM, von Scholten BJ, Rasmussen S, Karsbøl JD, Daniels GH, for the LEADER Publication Committee on behalf of the LEADER Trial Investigators . No evidence of increase in calcitonin concentrations or development of C-cellmalignancy in response to liraglutide for up to 5 years in the LEADER trial . Diabetes Care . 2018;41(3):620-622 .

Heiselman JS, Clements LW, Collins JA, Weis JA, Simpson AL, Geevarghese SK, Kingham TP, Jarnagin WR, Miga M I . Characterization and correction of intraoperative soft tissue deformation in image-guided laparoscopic liver surgery . Journal of Medical Imaging . 2018;5(2):021203- . PMCID: PMC5729961

86 OF 288


Journal Articles

Heller BJ, Deshpande P, Heller JA, McCormick P, Lin HM, Huang R, Fischer G, Weiner MM . Tissue oximetry during cardiac surgery and in the cardiac intensive care unit: A prospective observational trial . Annals of Cardiac Anaesthesia . 2018;21(4):371-375 . PMCID: PMC6206809

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon A, Fizazi K, Fleisher M, de Bono JS, Scher H I . Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: A comparison with prostate-specific antigen across five randomized phase III clinical trials . Journal of Clinical Oncology . 2018;36(6):572-580 .PMCID: PMC5815402

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon-Carrera A, Fizazi K, Fleisher M, de Bono JS, Scher H I . Reply to C . Ren et al . Journal of Clinical Oncology . 2018;36(22):2354-2356 .

Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ . Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer . Cancer Cell . 2018;33(5):853-861 .e4 .

Hellmann MD, Ciuleanu TE, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P, Borghaei H, Ramalingam SS, Brahmer J, Reck M, O’Byrne KJ, Geese WJ, Green G, Chang H, Szustakowski J, Bhagavatheeswaran P, Healey D, Fu Y, Nathan F, Paz-Ares L . Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden . New England Journal of Medicine . 2018;378(22):2093-2104 .

Hellmann MD, Paz‐Ares L . The authors reply . New England Journal of Medicine . 2018;379(11):1094- .

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD . Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer . Cancer Cell . 2018;33(5):843-852 .e4 .PMCID: PMC5953836

Hellmuth JC, Louissaint A Jr, Szczepanowski M, Haebe S, Pastore A, Alig S, Staiger AM, Hartmann S, Kridel R, Ducar MD, Koch P, Dreyling M, Hansmann ML, Ott G, Rosenwald A, Gascoyne RD, Weinstock DM, Hiddemann W, Klapper W, Weigert O . Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles . Blood . 2018;132(16):1695-1702 .

Helman E, Nguyen M, Karlovich CA, Despain D, Choquette AK, Spira A I, Yu HA, Camidge DR, Harding TC, Lanman RB, Simmons AD . Cell-free DNA next-generation sequencing prediction of response and resistance to third-generation EGFR inhibitor . Clinical Lung Cancer . 2018;19(6):518-530 .e7 .

Henning AN, Klebanoff CA, Restifo NP . Silencing stemness in T cell differentiation: Epigenetic repression is required for the generation of CD8(+) effector T cells . Science . 2018;359(6372):163-164 .

Henry KE, Dilling TR, Abdel-Atti D, Edwards KJ, Evans MJ, Lewis JS . Noninvasive (89)Zr-transferrin PET shows improved tumor targeting compared with (18)F-FDG PET in MYC-overexpressing human triple-negative breast cancer . Journal of Nuclear Medicine . 2018;59(1):51-57 . PMCID: PMC5750524

Henry KE, Ulaner GA, Lewis JS . Clinical potential of human epidermal growth factor receptor 2 and human epidermal growth factor receptor 3 imaging

in breast cancer . PET Clinics . 2018;13(3):423-435 . PMCID: PMC6092024

Hensley ML, Enserro D, Hatcher H, Ottevanger PB, Krarup-Hansen A, Blay JY, Fisher C, Moxley KM, Lele SB, Lea JS, Tewari KS, Thaker PH, Zivanovic O, O’Malley DM, Robison K, Miller DS . Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG Oncology/Gynecologic Oncology Group study . Journal of Clinical Oncology . 2018;36(33):3324-3330 . PMCID: PMC6241678

Henssen AG, Kentsis A . Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development . JCI Insight . 2018;3(20):e123172- . PMCID: PMC6237467

Herbert G, Karakousis GC, Bartlett EK, Zaheer S, Graham D, Czerniecki BJ, Fraker DL, Ariyan C, Coit DG, Brady MS . Transected thin melanoma: Implications for sentinel lymph node staging . Journal of Surgical Oncology . 2018;117(4):567-571 . PMCID: PMC5878707

Herbert KJ, Ashton TM, Prevo R, Pirovano G, Higgins GS . T-LAK cell-originated protein kinase (TOPK): An emerging target for cancer-specific therapeutics . Cell Death & Disease . 2018;9(11):1089- . PMCID: PMC6200809

Herman JM, Jabbour SK, Lin SH, Deek MP, Hsu CC, Fishman EK, Kim S, Cameron JL, Chekmareva M, Laheru DA, Narang AK, Pawlik TM, Hruban RH, Wolfgang CL, Iacobuzio-Donahue CA . SMAD4 loss correlates with higher rates of local and distant failure in pancreatic adenocarcinoma patients receiving adjuvant chemoradiation . Pancreas . 2018;47(2):208-212 . PMCID: PMC5800523

Hernandez JM, Beylergil V, Goldman DA, van Beek E, Gonen M, Tang L, Downey R, Rizk N, Shah M, Strong V, Janjigian Y, Schöder H, Coit DG . Post-treatment/pre-operative PET response is not an

87 OF 288


Journal Articles

independent predictor of outcomes for patients with gastric and GEJ adenocarcinoma . Annals of Surgery . 2018;267(5):898-904 . PMCID: PMC5794647

Herr H . Editorial commentary . Urology Practice .2018;5(1):13-14 .

Herrera AF, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Ansell SM, Moskowitz CH, Fenton K, Ogden CA, Taft D, Zhang Q, Kato K, Campbell M, Advani RH . Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma . Blood . 2018;131(11):1183-1194 . PMCID: PMC5855021

Hess CB, Indelicato DJ, Paulino AC, Hartsell WF, Hill-Kayser CE, Perkins SM, Mahajan A, Laack NN, Ermoian RP, Chang AL, Wolden SL, Mangona VS, Kwok Y, Breneman JC, Perentesis JP, Gallotto SL, Weyman EA, Bajaj B V, Lawell MP, Yeap BY, Yock T I . An update from the Pediatric Proton Consortium Registry . Frontiers in Oncology . 2018;8:165- . PMCID: PMC5976731

Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran R, Dale W, DeMichele A, Magid Diefenbach CS, Dreicer R, Epstein AS, Gillison ML, Graham DL, Jones J, Ko AH, Lopez AM, Maki RG, Rodriguez-Galindo C, Schilsky RL, Sznol M, Westin SN, Burstein H . Clinical Cancer Advances 2018: Annual report on progress against cancer from the American Society of Clinical Oncology . Journal of Clinical Oncology .2018;36(10):1020-1044 .

Hibler BP, Yan BY, Marchetti MA, Momtahen S, Busam KJ, Rossi AM . Facial swelling and foreign body granulomatous reaction to hyaluronic acid filler in the setting of tyrosine kinase inhibitor therapy . Journal of the European Academy of Dermatology and Venereology . 2018;32(6):e225-e227 .

Hicks AM, DeRosa A, Raj M, Do R, Yu KH, Lowery MA, Varghese A, O’Reilly EM . Visceral thromboses in

pancreas adenocarcinoma: Systematic review . Clinical Colorectal Cancer . 2018;17(2):e207-e216 .

Hieronymus H, Murali R, Tin A, Yadav K, Abida W, Moller H, Berney D, Scher H, Carver B, Scardino P, Schultz N, Taylor B, Vickers A, Cuzick J, Sawyers CL . Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death . eLife . 2018;7:e37294- . PMCID: PMC6145837

Hill BT, Ahn KW, Hu ZH, Aljurf M, Beitinjaneh A, Cahn JY, Cerny J, Kharfan-Dabaja MA, Ganguly S, Ghosh N, Grunwald MR, Inamoto Y, Kindwall-Keller T, Nishihori T, Olsson RF, Saad A, Seftel M, Seo S, Szer J, Tallman M, Ustun C, Wiernik PH, Maziarz RT, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W . Assessment of impact of HLA type on outcomes of allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia . Biology of Blood and Marrow Transplantation . 2018;24(3):581-586 .

Hissong E, Ramrattan G, Zhang P, Zhou XK, Young G, Klimstra DS, Shia J, Fernandes H, Yantiss RK . Gastric carcinomas with lymphoid stroma: An evaluation of the histopathologic and molecular features . American Journal of Surgical Pathology . 2018;42(4):453-462 .

Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman D, Tarpey P, Danilova L, Drill E, Gibb EA, Bowlby R, Kanchi R, Osmanbeyoglu HU, Sekido Y, Takeshita J, Newton Y, Graim K, Gupta M, Gay CM, Diao L, Gibbs DL, Thorsson V, Iype L, Kantheti H, Severson DT, Ravegnini G, Desmeules P, Jungbluth AA, Travis WD, Dacic S, Chirieac LR, Galateau-Sallé F, Fujimoto J, Husain AN, Silveira HC, Rusch VW, Rintoul RC, Pass H, Kindler H, Zauderer MG, Kwiatkowski DJ, Bueno R, Tsao AS, Creaney J, Lichtenberg T, Leraas K, Bowen J, TCGA Research Network, Felau I, Zenklusen JC, Akbani R, Cherniack AD, Byers LA, Noble MS, Fletcher JA, Robertson AG, Shen R, Aburatani H, Robinson BW, Campbell P, Ladanyi M . Integrative molecular characterization of malignant pleural mesothelioma . Cancer Discovery . 2018;8(12):1549-1565 . PMCID: PMC6310008

Ho AL . Developing androgen receptor targeting for salivary gland cancers . Annals of Oncology . 2018;29(4):792-794 . PMCID: PMC5913640

Ho AL, Pfister DG . Challenges and opportunities for developing new therapeutics for salivary gland cancers . Journal of Oncology Practice . 2018;14(2):109-110 .

Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, Arnold BB, Porinchak M, Lacouture M, McCormick B, Powell SN, Gelblum DY, Cahlon O . A randomized trial of mometasone furoate 0 .1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation . International Journal of Radiation Oncology, Biology, Physics . 2018;101(2):325-333 .

Ho C, Arcila ME . Minimal residual disease detection of myeloma using sequencing of immunoglobulin heavy chain gene VDJ regions . Seminars in Hematology . 2018;55(1):13-18 .

Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, The Cancer Genome Atlas Network, Stuart JM, Benz CC, Laird PW . Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer . Cell . 2018;173(2):291-304 .e6 .

Hoang L, Chiang S, Lee CH . Endometrial stromal sarcomas and related neoplasms: New developments and diagnostic considerations . Pathology . 2018;50(2):162-177 .

Hobbs GS, Hanasoge Somasundara A V, Kleppe M, Litvin R, Arcila M, Ahn J, McKenney AS, Knapp K, Ptashkin R, Weinstein H, Heinemann MH, Francis J, Chanel S, Berman E, Mauro M, Tallman MS, Heaney ML, Levine RL, Rampal RK . Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative

88 OF 288


Journal Articles

neoplasms . Haematologica . 2018;103(1):e5-e9 . PMCID: PMC5777196

Hodgson A, Slodkowska E, Jungbluth A, Liu SK, Vesprini D, Enepekides D, Higgins K, Katabi N, Xu B, Downes MR . PD-L1 immunohistochemistry assay concordance in urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma . American Journal of Surgical Pathology . 2018;42(8):1059-1066 .

Hodi FS, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Cowey CL, Lao CD, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hill A, Hogg D, Marquez-Rodas I, Jiang J, Rizzo J, Larkin J, Wolchok JD . Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial . Lancet Oncology . 2018;19(11):1480-1492 .

Hodi FS, Ballinger M, Lyons B, Soria JC, Nishino M, Tabernero J, Powles T, Smith D, Hoos A, McKenna C, Beyer U, Rhee I, Fine G, Winslow N, Chen DS, Wolchok JD . Immune-modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy . Journal of Clinical Oncology . 2018;36(9):850-858 .

Hofer IS, Levin MA, Simpao AF, McCormick PJ, Rothman BS . Anesthesia informatics grows up . Anesthesia and Analgesia . 2018;127(1):18-20 .

Hoffman AF, Nolan J, Gebhard DF, Nickischer D, Omta W, Cooper S, Presnell S, Wardwell-Swanson J, Fennell M . Society of Biomolecular Imaging and Informatics high-content screening/high-content analysis emerging technologies in biological models, when and why? . Assay and Drug Development Technologies . 2018;16(1):1-6 .

Hofstatter EW, Horvath S, Dalela D, Gupta P, Chagpar AB, Wali VB, Bossuyt V, Storniolo AM, Hatzis C, Patwardhan G, Von Wahlde MK, Butler M, Epstein

L, Stavris K, Sturrock T, Au A, Kwei S, Pusztai L . Increased epigenetic age in normal breast tissue from luminal breast cancer patients . Clinical Epigenetics . 2018;10:112- .PMCID: PMC6114717

Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, Lim KPH, Lin H, Man TK, Remark R, Baxter S, Kana V, Jordan S, Karoulia Z, Kwan WH, Leboeuf M, Brandt E, Salmon H, McClain K, Poulikakos P, Chipuk J, Mulder WJM, Allen CE, Merad M . RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions . Journal of Experimental Medicine . 2018;215(1):319-336 . PMCID: PMC5748846

Holland JC . Psycho-oncology: Overview, obstacles and opportunities . Psycho-Oncology . 2018;27(5):1364-1376 .

Holm IA, Agrawal PB, Ceyhan-Birsoy O, Christensen KD, Fayer S, Frankel LA, Genetti CA, Krier JB, LaMay RC, Levy HL, McGuire AL, Parad RB, Park PJ, Pereira S, Rehm HL, Schwartz TS, Waisbren SE, Yu TW, The BabySeq Project Team, Green RC, Beggs AH . The BabySeq project: Implementing genomic sequencing in newborns . BMC Pediatrics . 2018;18:225- . PMCID: PMC6038274

Holodny A I . Right brain language function and academic honesty . Brain Connectivity . 2018;8(6):319-320 .

Hong J, Brandt N, Abdul-Rahman F, Yang A, Hughes T, Gresham D . An incoherent feedforward loop facilitates adaptive tuning of gene expression . eLife . 2018;7:e32323- . PMCID: PMC5903863

Hong L, Ballangrud A, McCormick B, Mechalakos J . Electron postmastectomy chest wall plus comprehensive nodal irradiation technique using Electron Monte Carlo dose algorithm . Medical Dosimetry . 2018;43(3):230-236 .

Hong TS, Grassberger C, Yeap BY, Jiang W, Wo JY, Goyal L, Clark JW, Crane CH, Koay EJ, Dima S, Eyler CE, Popescu I, DeLaney TF, Zhu AX, Duda DG . Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy . npj Precision Oncology . 2018;2:22- . PMCID: PMC6194077

Hope S, Rosa W . Holistic care of the spirit: The use of entheogens in patients with advanced serious illness . Beginnings . 2018;38(4):18-21 .

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon L I, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N . NCCN guidelines insights: Hodgkin lymphoma, version 1 .2018: Featured updates to the NCCN guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(3):245-254 .

Horvat J V, D’Alessio DD, Bernard-Davila B, Martinez DF, Morris EA . Second opinion interpretation of breast ultrasound images-Is it worth another look? . Clinical Imaging . 2018;52:79-87 .

Horvat J V, Durando M, Milans S, Patil S, Massler J, Gibbons G, Giri D, Pinker K, Morris EA, Thakur SB . Apparent diffusion coefficient mapping using diffusion-weighted MRI: Impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis . European Radiology . 2018;28(6):2516-2524 .

Horvat N, Raj A, Ward JM, Smith JJ, Markowitz AJ, Gollub MJ . Clinical value of CT colonography versus preoperative colonoscopy in the surgical management of occlusive colorectal cancer . American Journal of Roentgenology . 2018;210(2):333-340 .

89 OF 288


Journal Articles

Horvat N, Ragucci M, Mannelli L . Hepatic mass in a patient with bladder cancer history . Gastroenterology . 2018;154(3):493-494 .

Horvat N, Petkovska I, Gollub MJ . MR imaging of rectal cancer . Radiologic Clinics of North America . 2018;56(5):751-774 .

Horvat N, Monti S, Oliveira BC, Rocha CCT, Giancipoli RG, Mannelli L . State of the art in magnetic resonance imaging of hepatocellular carcinoma . Radiology and Oncology . 2018;52(4):353-364 . PMCID: PMC6287184

Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, Sala E, Garcia-Aguilar J, Gollub MJ, Petkovska I . MR imaging of rectal cancer: Radiomics analysis to assess treatment response after neoadjuvant therapy . Radiology . 2018;287(3):833-843 . PMCID: PMC5978457

Horvat N, Nikolovski I, Long N, Gerst S, Zheng J, Pak LM, Simpson A, Zheng J, Capanu M, Jarnagin WR, Mannelli L, Do RKG . Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014 . Abdominal Radiology . 2018;43(1):169-178 .

Horvat TZ, Seddon AN, Ogunniyi A, King AC, Buie LW, Daley RJ . The ABCs of immunotherapy for adult patients with B-cell acute lymphoblastic leukemia . Annals of Pharmacotherapy . 2018;52(3):268-276 .

Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Bradley MH, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H . T-cell lymphomas, version 2 .2018: Featured updates to the NCCN Guidelines . Journal

of the National Comprehensive Cancer Network . 2018;16(2):123-135 .

Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster JC, Weaver D, Foss FM, Weinstock DM . Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma . Blood . 2018;131(8):888-898 . PMCID: PMC5824337

Hoseini SS, Guo H, Wu Z, Nakajima Hatano M, Cheung NK V . A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia . Blood Advances . 2018;2(11):1250-1258 . PMCID: PMC5998923

Hoshii T, Cifani P, Feng Z, Huang CH, Koche R, Chen CW, Delaney CD, Lowe SW, Kentsis A, Armstrong SA . A non-catalytic function of SETD1A regulates cyclin K and the DNA damage response . Cell . 2018;172(5):1007-1021 .e17 .

Hou X, Burstein SR, Long SB . Structures reveal opening of the store-operated calcium channel Orai . eLife . 2018;7:e36758- . PMCID: PMC6170153

Houston TP, Ostroff JS . Cardiovascular risk factors and breast cancer . Journal of Clinical Oncology . 2018;36(27):2810- .

Hricak H . 2016 New Horizons lecture: Beyond imaging - Radiology of tomorrow . Radiology . 2018;286(3):764-775 .

Hrit J, Goodrich L, Li C, Wang BA, Nie J, Cui X, Martin EA, Simental E, Fernandez J, Liu MY, Nery JR, Castanon R, Kohli RM, Tretyakova N, He C, Ecker JR, Goll M, Panning B . OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development . eLife . 2018;7:e34870- . PMCID: PMC6214653

Hsieh JJ, Le V, Cao D, Cheng EH, Creighton CJ . Genomic classifications of renal cell carcinoma:

A critical step towards the future application of personalized kidney cancer care with pan-omics precision . Journal of Pathology . 2018;244(5):525-537 .

Hsieh JJ, Le VH, Oyama T, Ricketts CJ, Ho TH, Cheng EH . Chromosome 3p loss–orchestrated VHL, HIF, and epigenetic deregulation in clear cell renal cell carcinoma . Journal of Clinical Oncology . 2018;36(36):3533-3539 .PMCID: PMC6299341

Hsin JP, Lu Y, Loeb GB, Leslie CS, Rudensky AY . The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types . Nature Immunology . 2018;19(10):1137-1145 . PMCID: PMC6158091

Hu Z I, Hellmann MD, Wolchok JD, Vyas M, Shia J, Stadler ZK, Diaz LA Jr, O’Reilly EM . Acquired resistance to immunotherapy in MMR-D pancreatic cancer . Journal for ImmunoTherapy of Cancer . 2018;6:127- . PMCID: PMC6247688

Hu Z I, Shia J, Stadler ZK, Varghese AM, Capanu M, Salo-Mullen E, Lowery MA, Diaz LA Jr, Mandelker D, Yu KH, Zervoudakis A, Kelsen DP, Iacobuzio-Donahue CA, Klimstra DS, Saltz LB, Sahin IH, O’Reilly EM . Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: Challenges and recommendations . Clinical Cancer Research . 2018;24(6):1326-1336 . PMCID: PMC5856632

Huang B, He Y, Ma X, Cai R, Zeng J, Lu Y, Zhang W, Lan K, E S, Tang YW, Kreiswirth BN, Chen C, Chen L . Promoter variation and gene expression of mcr-1-harboring plasmids in clinical isolates of Escherichia coli and Klebsiella pneumoniae from a Chinese hospital . Antimicrobial Agents and Chemotherapy . 2018;62(5):e00018-18- . PMCID: PMC5923141

Huang C, Niethammer P . Tissue damage signaling is a prerequisite for protective neutrophil recruitment to microbial infection in zebrafish . Immunity . 2018;48(5):1006-1013 .e6 .

90 OF 288


Journal Articles

Huang HC, Qin LX . Empirical evaluation of data normalization methods for molecular classification . PeerJ . 2018;6:e4584- . PMCID: PMC5899419

Huang IC, Jones CM, Brinkman TM, Hudson MM, Srivastava DK, Li Y, Robison LL, Krull KR . Development of the functional social network index for adolescent and young adult cancer survivors . Cancer . 2018;124(10):2220-2227 . PMCID: PMC5935560

Huang Q, Jabbour SK, Xiao Z, Yue N, Wang X, Cao H, Kuang Y, Zhang Y, Nie K . Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer . Radiation Oncology . 2018;13:78- . PMCID: PMC5918906

Huang S, Kang M, Souris K, Ainsley C, Solberg TD, McDonough JE, Simone CB 2nd, Lin L . Validation and clinical implementation of an accurate Monte Carlo code for pencil beam scanning proton therapy . Journal of Applied Clinical Medical Physics . 2018;19(5):558-572 . PMCID: PMC6123159

Huang S, Souris K, Li S, Kang M, Barragan Montero AM, Janssens G, Lin A, Garver E, Ainsley C, Taylor P, Xiao Y, Lin L . Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy . Medical Physics . 2018;45(12):5631-5642 .

Huang Y, Zhuo W, Gao Y, Liu H . Monte Carlo simulation of eye lens dose reduction from CT scan using organ based tube current modulation . Physica Medica . 2018;48:72-75 .

Hugosson J, Godtman RA, Carlsson S V, Aus G, Grenabo Bergdahl A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H . Eighteen-year follow-up of the Göteborg randomized population-based prostate cancer screening trial: Effect of sociodemographic variables on participation, prostate cancer incidence

and mortality . Scandinavian Journal of Urology . 2018;52(1):27-37 .

Hui D, Mori M, Meng YC, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E . Automatic referral to standardize palliative care access: An international Delphi survey . Supportive Care in Cancer . 2018;26(1):175-180 . PMCID: PMC5705294

Hultcrantz M, Björkholm M, Landgren O, Kristinsson SY, Andersson TML . Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms - In response . Annals of Internal Medicine . 2018;169(4):268- .

Hultcrantz M, Björkholm M, Dickman PW, Landgren O, Derolf ÅR, Kristinsson SY, Andersson TML . Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: A population-based cohort study . Annals of Internal Medicine . 2018;168(5):317-325 .

Hultcrantz M, Morgan GJ, Landgren O . Epidemiology and pathophysiology of multiple myeloma . Hematologic Malignancies . 2018;:1-15 .

Hung PJ, Johnson B, Chen BR, Byrum AK, Bredemeyer AL, Yewdell WT, Johnson TE, Lee BJ, Deivasigamani S, Hindi I, Amatya P, Gross ML, Paull TT, Pisapia DJ, Chaudhuri J, Petrini JJH, Mosammaparast N, Amarasinghe GK, Zha S, Tyler JK, Sleckman BP . MRI is a DNA damage response adaptor during classical non-homologous end joining . Molecular Cell . 2018;71(2):332-342 .e8 .

Hunter CW, Stovall B, Chen G, Carlson J, Levy R . Anatomy, pathophysiology and interventional therapies for chronic pelvic pain: A review . Pain Physician . 2018;21(2):147-167 .

Huntington SF, von Keudell G, Davidoff AJ, Gross CP, Prasad SA . Cost-effectiveness analysis of brentuximab vedotin with chemotherapy in newly diagnosed stage III and IV Hodgkin lymphoma .

Journal of Clinical Oncology . 2018;36(33):3307-3314 . PMCID: PMC6241679

Huntsman DG, Ladanyi M . The molecular pathology of cancer: from pan-genomics to post-genomics . Journal of Pathology . 2018;244(5):509-511 .

Hurst C, Rosenberg J, Knowles M . SnapShot: Bladder cancer . Cancer Cell . 2018;34(2):350-350 .e1 .

Hurvitz SA, Quek RGW, Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke E, Mina LA, Balmaña J, Fasching PA, Bhattacharyya H, Hannah AL, Robson ME, Wardley AM . Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: Patient-reported outcomes from the ABRAZO phase 2 trial . European Journal of Cancer . 2018;104:160-168 .

Hurwitz H, Van Cutsem E, Bendell J, Hidalgo M, Li CP, Salvo MG, Macarulla T, Sahai V, Sama A, Greeno E, Yu KH, Verslype C, Dawkins F, Walker C, Clark J, O’Reilly EM . Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies . Investigational New Drugs . 2018;36(4):683-695 .

Husain AN, Colby T V, Ordoñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR . Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group . Archives of Pathology & Laboratory Medicine . 2018;142(1):89-108 .

Hussain I, Barzilai O, Reiner AS, DiStefano N, McLaughlin L, Ogilvie S, Bilsky M, Laufer I . Patient-reported outcomes after surgical stabilization of spinal tumors: Symptom-based validation of the

91 OF 288


Journal Articles

Spinal Instability Neoplastic Score (SINS) and surgery . Spine Journal . 2018;18(2):261-267 .

Hussain SS, Huang SB, Bedolla RG, Rivas P, Basler JW, Swanson GP, Hui-Ming Huang T, Narayanasamy G, Papanikolaou N, Miyamoto H, Yeh IT, Reddick RL, Pollock BH, Ghosh R, Kumar AP . Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation . Cancer Letters . 2018;433:232-241 .

Hussein AA, Sexton KJ, May PR, Meng M V, Hosseini A, Eun DD, Daneshmand S, Bochner BH, Peabody JO, Abaza R, Skinner EC, Hautmann RE, Guru KA . Development and validation of surgical training tool: Cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men . Surgical Endoscopy . 2018;32(11):4458-4464 .

Hussein YR, Soslow RA . Molecular insights into the classification of high-grade endometrial carcinoma . Pathology . 2018;50(2):151-161 .

Hyman DM, Rizvi N, Natale R, Armstrong DK, Birrer M, Recht L, Dotan E, Makker V, Kaley T, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar M . Phase I study of MEDI3617, a selective angiopoietin-2 inhibitor alone and combined with carboplatin/paclitaxel, paclitaxel, or bevacizumab for advanced solid tumors . Clinical Cancer Research . 2018;24(12):2749-2757 .

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro G I, Juric D, Quinn D I, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB . HER kinase inhibition in patients with HER2-and HER3-mutant cancers . Nature . 2018;554(7691):189-194 . PMCID: PMC5808581

Işık M, Levorse D, Rustenburg AS, Ndukwe IE, Wang H, Wang X, Reibarkh M, Martin GE, Makarov AA, Mobley DL, Rhodes T, Chodera JD . pK(a)measurements for the SAMPL6 prediction challenge for a set of kinase inhibitor-like fragments . Journal of Computer-Aided Molecular Design . 2018;32(10):1117-1138 . PMCID: PMC6367941

Ibañez G, Calder PA, Radu C, Bhinder B, Shum D, Antczak C, Djaballah H . Evaluation of compound optical interference in high-content screening . SLAS Discovery . 2018;23(4):321-329 .

Ibañez N, Abrisqueta J, Lujan J, Sanchez P, Soriano MT, Arevalo-Pérez J, Parrilla P . Reintervencion tras complicaciones en cirugía laparoscopica colorrectal . ¿Aporta ventajas el abordaje laparoscopico? . Cirugía Española . 2018;96(2):110-117 .

Ibanez K, Espiritu N, Souverain RL, Stimler L, Ward L, Riedel ER, Lehrman R, Boulad F, Stubblefield MD . Safety and feasibility of rehabilitation interventions in children undergoing hematopoietic stem cell transplant with thrombocytopenia . Archives of Physical Medicine and Rehabilitation . 2018;99(2):226-233 . PMCID: PMC6342002

Ignatz-Hoover JJ, Wang V, Mackowski NM, Roe AJ, Ghansah IK, Ueda M, Lazarus HM, de Lima M, Paietta E, Fernandez H, Cripe L, Tallman M, Wald DN . Aberrant GSK3β nuclear localization promotes AML growth and drug resistance . Blood Advances . 2018;2(21):2890-2903 . PMCID: PMC6234355

Illan IA, Ramirez J, Gorriz JM, Marino MA, Avendano D, Helbich T, Baltzer P, Pinker K, Meyer-Baese A . Automated detection and segmentation of nonmass-enhancing breast tumors with dynamic contrast-enhanced magnetic resonance imaging . Contrast Media and Molecular Imaging . 2018;2018:5308517- . PMCID: PMC6311739

Ilonen IK, Molena D . Gambling with esophageal cancer: May the odds be in your favor! . Journal

of Thoracic and Cardiovascular Surgery . 2018;156(1):404-405 .

Ilson D . Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer? . Lancet Oncology . 2018;19(10):1285-1286 .

Ilson DH, van Hillegersberg R . Management of patients with adenocarcinoma or squamous cancer of the esophagus . Gastroenterology . 2018;154(2):437-451 .

Ilson DH . Adjuvant therapy in colon cancer: Less is more . Lancet Oncology . 2018;19(4):442-443 .

Ilson DH . Is there a future for EGFR targeted agents in esophageal cancer? . Annals of Oncology . 2018;29(6):1343-1344 .

Ilson DH . Advances in the treatment of gastric cancer . Current Opinion in Gastroenterology . 2018;34(6):465-468 .

Imamura M, Moon JS, Chung KP, Nakahira K, Muthukumar T, Shingarev R, Ryter SW, Choi AMK, Choi ME . RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase . JCI Insight . 2018;3(3):e94979- . PMCID: PMC5821177

Imielinski M, Ladanyi M . Fusion oncogenes—genetic musical chairs . Science . 2018;361(6405):848-849 .

In H, Ravetch E, Langdon-Embry M, Palis B, Ajani JA, Hofstetter WL, Kelsen DP, Sano T . The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging . Gastric Cancer . 2018;21(1):1-9 .

Inoue D, Fujino T, Kitamura T . ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells . Oncotarget . 2018;9(81):35203-35204 . PMCID: PMC6219660

Inskip PD, Veiga LHS, Brenner A V, Sigurdson AJ, Ostroumova E, Chow EJ, Stovall M, Smith SA, Weathers RE, Leisenring W, Robison LL, Armstrong

92 OF 288


Journal Articles

GT, Sklar CA, Lubin JH . Hypothyroidism after radiation therapy for childhood cancer: A report from the Childhood Cancer Survivor Study . Radiation Research . 2018;190(2):117-132 .

Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N, Durani V, Liu H, Taylor J, Farnoud N, Papaemmanuil E, Cross JR, Tallman MS, Arcila ME, Roshal M, Petsko GA, Wu B, Choe S, Konteatis ZD, Biller SA, Chodera JD, Thompson CB, Levine RL, Stein EM . Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations . Nature . 2018;559(7712):125-129 .

Intlekofer AM, Joffe E, Batlevi CL, Hilden P, He J, Seshan VE, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Straus DJ, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, van den Brink MR, Knapp KM, Pichardo JD, Nahas MK, Trabucco SE, Mughal T, Copeland AR, Papaemmanuil E, Moarii M, Levine RL, Dogan A, Miller VA, Younes A . Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay . Blood Cancer Journal . 2018;8(6):60- .PMCID: PMC5997645

Isa F, Collins S, Lee MH, Decome D, Dorvil N, Joseph P, Smith L, Salerno S, Wells MT, Fischer S, Bean JM, Pape JW, Johnson WD, Fitzgerald DW, Rhee KY . Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis . EBioMedicine . 2018;31:157-165 .

Isbell JM, Jones DR, Li BT . Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non–small cell lung cancer . Journal of Thoracic and Cardiovascular Surgery . 2018;155(6):2628-2631 .

Isenberg-Grzeda E, MacGregor M, Bergel A, Eagle S, Espi Forcen F, Mehta R, Matsoukas K, Wills J, Reidy-Lagunes D, Alici Y . Antidepressants appear safe in patients with carcinoid tumor: Results of a

retrospective review . European Journal of Surgical Oncology . 2018;44(6):744-749 . PMCID: PMC5970966

Isharwal S, Huang H, Nanjangud G, Audenet F, Chen YB, Gopalan A, Fine SW, Tickoo SK, Lee BH, Iyer G, Chadalavada K, Rosenberg JE, Bajorin DF, Herr HW, Donat SM, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA . Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma . Human Pathology . 2018;77:63-69 . PMCID: PMC6019182

Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, Kantoff PW, Farokhzad OC, Zetter BR, Shi J . Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA . Nature Biomedical Engineering . 2018;2(11):850-864 .

Italiano D . Hepatic arterial infusion pump: Complications and nursing management regarding use in patients with colorectal cancer . Clinical Journal of Oncology Nursing . 2018;22(3):340-346 .

Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Scudder C, Boyd KA, Briggs A, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan HS, Paul J . 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): An international, randomised, phase 3, non-inferiority trial . Lancet Oncology . 2018;19(4):562-578 . PMCID: PMC5883334

Iyengar NM, Chen IC, Zhou XK, Giri DD, Falcone DJ, Winston LA, Wang H, Williams S, Lu YS, Hsueh TH, Cheng AL, Hudis CA, Lin CH, Dannenberg AJ . Adiposity, inflammation, and breast cancer

pathogenesis in Asian Women . Cancer Prevention Research . 2018;11(4):227-236 . PMCID: PMC5882588

Iyer G, Rosenberg JE . Novel therapies in urothelial carcinoma: A biomarker-driven approach . Annals of Oncology . 2018;29(12):2302-2312 .

Iyer G, Balar A V, Milowsky M I, Bochner BH, Dalbagni G, Donat SM, Herr HW, Huang WC, Taneja SS, Woods M, Ostrovnaya I, Al-Ahmadie H, Arcila ME, Riches JC, Meier A, Bourque C, Shady M, Won H, Rose TL, Kim WY, Kania BE, Boyd ME, Cipolla CK, Regazzi AM, Delbeau D, McCoy AS, Vargas HA, Berger MF, Solit DB, Rosenberg JE, Bajorin DF . Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer . Journal of Clinical Oncology . 2018;36(19):1949-1956 .

Izraelson M, Nakonechnaya TO, Moltedo B, Egorov ES, Kasatskaya SA, Putintseva E V, Mamedov IZ, Staroverov DB, Shemiakina I I, Zakharova MY, Davydov AN, Bolotin DA, Shugay M, Chudakov DM, Rudensky AY, Britanova O V . Comparative analysis of murine T-cell receptor repertoires . Immunology . 2018;153(2):133-144 . PMCID: PMC5765371

Jacobsen PB, DeRosa AP, Henderson TO, Mayer DK, Moskowitz CS, Paskett ED, Rowland JH . Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery . Journal of Clinical Oncology . 2018;36(20):2088-2100 . PMCID: PMC6036622

Jacquelin S, Straube J, Cooper L, Vu T, Song A, Bywater M, Baxter E, Heidecker M, Wackrow B, Porter A, Ling V, Green J, Austin R, Kazakoff S, Waddell N, Hesson LB, Pimanda JE, Stegelmann F, Bullinger L, Döhner K, Rampal RK, Heckl D, Hill GR, Lane SW . Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation . Blood . 2018;132(26):2707-2721 .

Jadeja PH, Mango V, Patel S, Friedlander L, Desperito E, Ayala-Bustamante E, Wynn R, Chen-Seetoo M,

93 OF 288


Journal Articles

Taback B, Feldman S, Ha R . Utilization of multiple SAVI SCOUT Surgical Guidance System reflectors in the same breast: A single-institution feasibility study . Breast Journal . 2018;24(4):531-534 .

Jagsi R, Momoh AO, Qi J, Hamill JB, Billig J, Kim HM, Pusic AL, Wilkins EG . Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction . JNCI: Journal of the National Cancer Institute .2018;110(2):djx148- . PMCID: PMC6059091

Jain D, Puno MR, Meydan C, Lailler N, Mason CE, Lima CD, Anderson K V, Keeney S . ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2 . eLife . 2018;7:e30919- . PMCID: PMC5832417

Jain D, Allen TC, Aisner DL, Beasley MB, Cagle PT, Capelozzi VL, Hariri LP, Lantuejoul S, Miller R, Mino-Kenudson M, Monaco SE, Moreira A, Raparia K, Rekhtman N, Roden AC, Roy-Chowdhuri S, da Cunha Santos G, Thunnissen E, Troncone G, Vivero M . Rapid on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspirations for the diagnosis of lung cancer: A perspective from members of the Pulmonary Pathology Society . Archives of Pathology & Laboratory Medicine . 2018;142(2):253-262 .

Jain M, Robinson BD, Wu B, Khani F, Mukherjee S . Exploring multiphoton microscopy as a novel tool to differentiate chromophobe renal cell carcinoma from oncocytoma in fixed tissue sections . Archives of Pathology & Laboratory Medicine . 2018;142(3):383-390 .

Jain M, Pulijal S V, Rajadhyaksha M, Halpern AC, Gonzalez S . Evaluation of bedside diagnostic accuracy, learning curve, and challenges for a novice reflectance confocal microscopy reader for skin cancer detection in vivo . JAMA Dermatology . 2018;154(8):962-965 .

Jain N, Thompson P, Ferrajoli A, Nabhan C, Mato AR, O’Brien S . Approaches to chronic lymphocytic leukemia therapy in the era of new agents: The conundrum of many options . American Society of Clinical Oncology Educational Book . 2018;38:580-591 .

Jain T, Litzow MR . No free rides: Management of toxicities of novel immunotherapies in ALL, including financial . Hematology-American Society of Hematology Education Program . 2018;2018(1):25-34 . PMCID: PMC6246022

Jain T, Litzow MR . No free rides: Management of toxicities of novel immunotherapies in ALL, including financial . Blood Advances . 2018;2(22):3393-3403 . PMCID: PMC6258912

Jakchairoongruang K, Khakoo Y, Beckwith M, Barkovich AJ . New insights into neurocutaneous melanosis . Pediatric Radiology . 2018;48(12):1786-1796 .

Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk J V, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S . Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: A multi-institutional study . JAMA Surgery . 2018;153(2):123-129 . PMCID: PMC5838709

Jamaspishvili T, Berman DM, Ross AE, Scher H I, De Marzo AM, Squire JA, Lotan TL . Clinical implications of PTEN loss in prostate cancer . Nature Reviews Urology . 2018;15(4):222-234 .

James M, Peterson A, Mangurian C . A women’s health clinic for a safety-net inpatient psychiatry unit: Project PETIT . Psychiatric Services . 2018;69(8):943- .

Janelsins MC, Heckler CE, Peppone LJ, Ahles TA, Mohile SG, Mustian KM, Palesh O, O’Mara AM, Minasian LM, Williams AM, Magnuson A, Geer J, Dakhil SR, Hopkins JO, Morrow GR . Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study .

Journal of Clinical Oncology . 2018;36(32):3231-3239 . PMCID: PMC6225503

Jang TL, Patel N, Faiena I, Radadia KD, Moore DF, Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y, Kim IY, Lu-Yao GL . Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer . Cancer . 2018;124(20):4010-4022 . PMCID: PMC6234085

Janjigian YY, Bissig M, Curigliano G, Coppola J, Latymer M . Talking to patients about biosimilars . Future Oncology . 2018;14(23):2403-2414 .

Janjigian YY, Bendell J, Calvo E, Kim JW, Ascierto PA, Sharma P, Ott PA, Peltola K, Jaeger D, Evans J, de Braud F, Chau I, Harbison CT, Dorange C, Tschaika M, Le DT . CheckMate-032 Study: Efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer . Journal of Clinical Oncology . 2018;36(28):2836-2844 .

Janjigian YY, Sanchez-Vega F, Jonsson P, Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R, Bouvier N, Vakiani E, Gao J, Heins ZJ, Gross BE, Kelsen DP, Zhang L, Strong VE, Schattner M, Gerdes H, Coit DG, Bains M, Stadler ZK, Rusch VW, Jones DR, Molena D, Shia J, Robson ME, Capanu M, Middha S, Zehir A, Hyman DM, Scaltriti M, Ladanyi M, Rosen N, Ilson DH, Berger MF, Tang L, Taylor BS, Solit DB, Schultz N . Genetic predictors of response to systemic therapy in esophagogastric cancer . Cancer Discovery . 2018;8(1):49-58 . PMCID: PMC5813492

Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL, Cunanan KM, Gönen M, Ponomarev V, Zeglis BM, Souweidane MM, Lewis JS, Weber WA, Humm JL, Reiner T . PARP-1-targeted radiotherapy in mouse models of glioblastoma . Journal of Nuclear Medicine . 2018;59(8):1225-1233 . PMCID: PMC6071508

94 OF 288


Journal Articles

Jasin M . Under the influence: Cas9 ends and DNA repair outcomes . Crispr Journal . 2018;1(2):132-134 .

Javanmard P, Duan D, Geer EB . Mortality in patients with endogenous Cushing’s syndrome . Endocrinology and Metabolism Clinics of North America . 2018;47(2):313-333 .

Javle M, Lowery M, Shroff RT, Weiss KH, Springfeld C, Borad MJ, Ramanathan RK, Goyal L, Sadeghi S, Macarulla T, El-Khoueiry A, Kelley RK, Borbath I, Choo SP, Oh DY, Philip PA, Chen LT, Reungwetwattana T, Van Cutsem E, Yeh KH, Ciombor K, Finn RS, Patel A, Sen S, Porter D, Isaacs R, Zhu AX, Abou-Alfa GK, Bekaii-Saab T . Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma . Journal of Clinical Oncology . 2018;36(3):276-282 .

Jee D, Yang JS, Park SM, Farmer DT, Wen J, Chou T, Chow A, McManus MT, Kharas MG, Lai EC . Dual strategies for Argonaute2-mediated biogenesis of erythroid miRNAs underlie conserved requirements for slicing in mammals . Molecular Cell . 2018;69(2):265-278 .e6 . PMCID: PMC5824974

Jelinic P, Ricca J, Van Oudenhove E, Olvera N, Merghoub T, Levine DA, Zamarin D . Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: Rationale for immune checkpoint blockade . JNCI: Journal of the National Cancer Institute . 2018;110(7):787-790 . PMCID: PMC6037122

Jeng PS, Inoue-Yamauchi A, Hsieh JJ, Cheng EH . BH3-dependent and independent activation of BAX and BAK in mitochondrial apoptosis . Current Opinion in Physiology . 2018;3:71-81 . PMCID: PMC6186458

Jeon CY, Li D, Cleary S, Stolzenberg-Solomon R, Bosetti C, La Vecchia C, Porta M, Toriola AT, Hung RJ, Kurtz RC, Olson SH . The association of recently diagnosed diabetes and long-term diabetes with survival in pancreatic cancer patients: A pooled analysis . Pancreas . 2018;47(3):314-320 . PMCID: PMC5807116

Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt S I, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu C, Bien SA, Zubair N, Macinnis RJ, Buchanan DD, Hopper JL, Cao Y, Nishihara R, Rennert G, Slattery ML, Thomas DC, Woods MO, Prentice RL, Gruber SB, Zheng Y, Brenner H, Hayes RB, White E, Peters U, Hsu L, on behalf of the Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium . Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors . Gastroenterology . 2018;154(8):2152-2164 .e19 . PMCID: PMC5985207

Jewell EL, Aghajanian C, Montovano M, Lewin SN, Baser RE, Carter J . Association of ß-hCG surveillance with emotional, reproductive, and sexual health in women treated for gestational trophoblastic neoplasia . Journal of Women’s Health . 2018;27(3):387-393 . PMCID: PMC5865249

Jewett P I, Gangnon RE, Elkin E, Hampton JM, Jacobs EA, Malecki K, LaGro J, Newcomb PA, Trentham-Dietz A . Geographic access to mammography facilities and frequency of mammography screening . Annals of Epidemiology . 2018;28(2):65-71 .e2 . PMCID: PMC5819606

Ji Y, Jin JY, Hyman DM, Kim G, Suri A . Challenges and opportunities in dose finding in oncology and immuno-oncology . CTS-Clinical and Translational Science . 2018;11(4):345-351 . PMCID: PMC6039198

Jiang J, Pavlova NN, Zhang J . Asparagine, a critical limiting metabolite during glutamine starvation . Molecular and Cellular Oncology . 2018;5(3):e1441633- . PMCID: PMC6149945

Jiang W, Ulmert D, Simons BW, Abou DS, Thorek DLJ . The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates . Nuclear Medicine and Biology . 2018;62-63:1-8 .

Jimenez-Rodriguez RM, Weiser MR . In brief . Current Problems in Surgery . 2018;55(6):194-195 .

Jimenez-Rodriguez RM, Araujo-Miguez A, Sobrino-Rodriguez S, Heller F, Díaz-Pavon JM, Bozada Garcia JM, De la Portilla F . A new perspective on vacuum-assisted closure for the treatment of anastomotic leak following low anterior resection for rectal cancer, is it worthy? . Surgical Innovation . 2018;25(4):350-356 .

Johncilla M, Jessurun J, Brown I, Hornick JL, Bellizzi AM, Shia J, Yantiss RK . Are enterocolic mucosal mast cell aggregates clinically relevant in patients without suspected or established systemic mastocytosis? . American Journal of Surgical Pathology . 2018;42(10):1390-1395 .

Johnson CB, Win SY . Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials . OncoImmunology . 2018;7(4):e1408744- . PMCID: PMC5889289

Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A, Bachovchin DA . DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia . Nature Medicine . 2018;24(8):1151-1156 . PMCID: PMC6082709

Johnson DR, Omuro AMP, Ravelo A, Sommer N, Guerin A, Ionescu-Ittu R, Shi S, Macalalad A, Uhm JH . Overall survival in patients with glioblastoma before and after bevacizumab approval . Current Medical Research and Opinion . 2018;34(5):813-820 .

Jones CW, Misemer BS, Platts-Mills TF, Ahn R, Woodbridge A, Abraham A, Saba S, Korenstein D, Madden E, Keyhani S . Primary outcome switching among drug trials with and without principal investigator financial ties to industry: A cross-sectional study . BMJ Open . 2018;8(2):e019831- . PMCID: PMC5829948

95 OF 288


Journal Articles

Jones DR . Bending the curve: The importance of expertise . Annals of Thoracic Surgery . 2018;105(5):1287-1293 .

Jones RL, Demetri GD, Schuetze SM, Milhem M, Elias A, Van Tine BA, Hamm J, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Patel S, Von Mehren M . Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma . Annals of Oncology . 2018;29(9):1995-2002 .

Jonsson P, Taylor BS . Transforming biomarker development with exceptional responders . Trends in Cancer . 2018;4(1):3-6 . PMCID: PMC5806204

Jordan EJ, Lowery MA, Basturk O, Allen PJ, Yu KH, Tabar V, Beal K, Reidy DL, Yamada Y, Janjigian Y, Abou-Alfa GK, O’Reilly EM . Brain metastases in pancreatic ductal adenocarcinoma: Assessment of molecular genotype - Phenotype features - An entity with an increasing incidence? . Clinical Colorectal Cancer . 2018;17(2):e315-e321 .

Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM . Lung cancer screening and smoking cessation clinical trials . SCALE (Smoking Cessation within the Context of Lung Cancer Screening) collaboration . American Journal of Respiratory and Critical Care Medicine . 2018;197(2):172-182 . PMCID: PMC5768904

Joseph B, Kondo S, Lai EC . Short cryptic exons mediate recursive splicing in Drosophila . Nature Structural and Molecular Biology . 2018;25(5):365-371 .

Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM, Ribas A, Hodi FS, Hamid O, Robert C, Daud A, Dronca R, Hersey P, Weber JS, Patnaik A, de Alwis DP, Perrone A, Zhang J, Kang SP, Ebbinghaus S, Anderson KM, Gangadhar TC . Baseline

tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab . Clinical Cancer Research . 2018;24(20):4960-4967 .

Joshi S, Wang T, Araujo TLS, Sharma S, Brodsky JL, Chiosis G . Adapting to stress — chaperome networks in cancer . Nature Reviews Cancer . 2018;18(9):562-575 . PMCID: PMC6108944

Juluru K, Elnajjar P, Shih HH, Hiestand B, Durack JC . An informatics approach to facilitate clinical management of patients with retrievable inferior vena cava filters . American Journal of Roentgenology . 2018;211(3):W178-W184 . PMCID: PMC6139028

June CH, Sadelain M . Chimeric antigen receptor therapy . New England Journal of Medicine . 2018;379(1):64-73 .

Juric D, Rodon J, Tabernero J, Janku F, Burris HA, Schellens JHM, Middleton MR, Berlin J, Schuler M, Gil-Martin M, Rugo HS, Seggewiss-Bernhardt R, Huang A, Bootle D, Demanse D, Blumenstein L, Coughlin C, Quadt C, Baselga J . Phosphatidylinositol 3-kinase α-selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors: Results from the first-in-human study . Journal of Clinical Oncology . 2018;36(13):1291-1299 . PMCID: PMC5920739

Köbel M, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Stewart CJR, Lee CH . Undifferentiated endometrial carcinomas show frequent loss of core switch/sucrose nonfermentable complex proteins . American Journal of Surgical Pathology . 2018;42(1):76-83 .

Kahles A, Lehmann K V, Toussaint NC, Hüser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, The Cancer Genome Atlas Research Network, Ratsch G . Comprehensive analysis of alternative splicing across tumors from 8,705 patients . Cancer Cell . 2018;34(2):211-224 .e6 .

Kaittanis C, Andreou C, Hieronymus H, Mao N, Foss CA, Eiber M, Weirich G, Panchal P, Gopalan A, Zurita J, Achilefu S, Chiosis G, Ponomarev V, Schwaiger M, Carver BS, Pomper MG, Grimm J . Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors . Journal of Experimental Medicine . 2018;215(1):159-175 . PMCID: PMC5748857

Kale MS, Korenstein D . Overdiagnosis in primary care: Framing the problem and finding solutions . BMJ: British Medical Journal (International Edition) . 2018;362:k2820- .

Kalemkerian GP, Loo BW Jr, Akerley W, Attia A, Bassetti M, Boumber Y, Decker R, Dobelbower MC, Dowlati A, Downey RJ, Florsheim C, Ganti AKP, Grecula JC, Gubens MA, Hann CL, Hayman JA, Heist RS, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran CA, Morgensztern D, Pokharel S, Portnoy DC, Rhodes D, Rusthoven C, Santana-Davila R, Williams CC Jr, Hoffmann KG, Hughes M . NCCN Guidelines® Insights: Small cell lung cancer, version 2 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(10):1171-1182 .

Kaley T, Touat M, Subbiah V, Hollebecque A, Rodon J, Lockhart AC, Keedy V, Bielle F, Hofheinz RD, Joly F, Blay JY, Chau I, Puzanov I, Raje NS, Wolf J, DeAngelis LM, Makrutzki M, Riehl T, Pitcher B, Baselga J, Hyman DM . BRAF inhibition in BRAF(V600)-mutant gliomas: Results from the VE-BASKET study . Journal of Clinical Oncology . 2018;36(35):3477-3484 . PMCID: PMC6286161

Kalinsky K, Sparano JA, Zhong X, Andreopoulou E, Taback B, Wiechmann L, Feldman SM, Ananthakrishnan P, Ahmad A, Cremers S, Sireci AN, Cross JR, Marks DK, Mundi P, Connolly E, Crew KD, Maurer MA, Hibshoosh H, Lee S, Hershman DL . Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: A New York Cancer Consortium trial . Clinical &

96 OF 288


Journal Articles

Translational Oncology . 2018;20(11):1474-1483 . PMCID: PMC6222014

Kalkhoran S, Kruse GR, Rigotti NA, Rabin J, Ostroff JS, Park ER . Electronic cigarette use patterns and reasons for use among smokers recently diagnosed with cancer . Cancer Medicine . 2018;7(7):3484-3491 . PMCID: PMC6051164

Kallio HML, Hieta R, Latonen L, Brofeldt A, Annala M, Kivinummi K, Tammela TL, Nykter M, Isaacs WB, Lilja HG, Bova GS, Visakorpi T . Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases . British Journal of Cancer . 2018;119(3):347-356 .

Kaltenboeck A, Bach PB . Defining value-based pricing of drugs - Reply . JAMA - Journal of the American Medical Association . 2018;320(16):1710-1711 .

Kaltenboeck A, Bach PB . Value-based pricing for drugs: Theme and variations . JAMA - Journal of the American Medical Association . 2018;319(21):2165-2166 .

Kambadakone AR, Zaheer A, Le O, Bhosale P, Meier J, Guimaraes AR, Shah Z, Hough DM, Mannelli L, Soloff E, Friedman A, Tamm E . Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma . Abdominal Radiology . 2018;43(2):245-252 .

Kamboj M, Brite J, McMillen T, Robilotti E, Herrera A, Sepkowitz K, Babady NE . Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C . difficile infection (CDI) in patients with cancer . Journal of Infection . 2018;76(4):369-375 . PMCID: PMC5889955

Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, Duncan K, Fedderson J, Glasgow R, Hall B, Hirsch M, Hutter M, Kimbro L, Kuvshinoff B 2nd, Makary M, Morris M, Nehring S,

Ramamoorthy S, Scott R, Sovel M, Strong V, Webster A, Wick E, Aguilar JG, Carlson R, Sepkowitz K . Risk of surgical site infection (SSI) following colorectal resection is higher in patients with disseminated cancer: An NCCN member cohort study . Infection Control and Hospital Epidemiology . 2018;39(5):555-562 .

Kamboj M, Brite J, Aslam A, Kennington J, Babady NE, Calfee D, Furuya Y, Chen D, Augenbraun M, Ostrowsky B, Patel G, Mircescu M, Kak V, Tuma R, Karre TA, Fry DA, Duhaney YP, Moyer A, Mitchell D, Cantu S, Hsieh C, Warren N, Martin S, Willson J, Dickman J, Knight J, Delahanty K, Flood A, Harrington J, Korenstein D, Eagan J, Sepkowitz K . Artificial differences in Clostridium difficile infection rates associated with disparity in testing . Emerging Infectious Diseases . 2018;24(3):584-587 . PMCID: PMC5823336

Kameda K, Eguchi T, Lu S, Qu Y, Tan KS, Kadota K, Adusumilli PS, Travis WD . Implications of the eighth edition of the TNM proposal: Invasive versus total tumor size for the T descriptor in pathologic stage I-IIA lung adenocarcinoma . Journal of Thoracic Oncology . 2018;13(12):1919-1929 . PMCID: PMC6309787

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M . Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: A CIBMTR analysis . British Journal of Haematology . 2018;182(6):916-920 . PMCID: PMC5796874

Kanaujiya J, Bastow E, Luxmi R, Hao Z, Zattas D, Hochstrasser M, Reichenberger EJ, Chen IP . Rapid degradation of progressive ankylosis protein (ANKH)

in craniometaphyseal dysplasia . Scientific Reports . 2018;8:15710- .PMCID: PMC6200807

Kandov E, Kaur A, Kishore U, Ji P, Williams J, Peerschke EIB, Ghebrehiwet B . C1q and C1q receptors (gC1qR and cC1qR) as potential novel targets for therapy against breast cancer . Current Trends in Immunology . 2018;19:59-76 .

Kanesvaran R, Le Saux O, Motzer R, Choueiri TK, Scotté F, Bellmunt J, Launay-Vacher V . Elderly patients with metastatic renal cell carcinoma: Position paper from the International Society of Geriatric Oncology . Lancet Oncology . 2018;19(6):e317-e326 .

Kanetsky PA, Hay JL . Marshaling the translational potential of MC1R for precision risk assessment of melanoma . Cancer Prevention Research . 2018;11(3):121-124 . PMCID: PMC5839988

Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS . Machine learning and radiogenomics: Lessons learned and future directions . Frontiers in Oncology . 2018;8:228- . PMCID: PMC6021505

Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande P V, Salazar GM, Shipp TD, Simpson L, Small W Jr, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P . ACR Appropriateness Criteria® staging and follow-up of ovarian cancer . Journal of the American College of Radiology . 2018;15(5 Suppl .):S198-S207 .

Kantor ED, Newton CC, Giovannucci EL, McCullough ML, Campbell PT, Jacobs EJ . Glucosamine use and risk of colorectal cancer: Results from the Cancer Prevention Study II Nutrition Cohort . Cancer Causes & Control . 2018;29(3):389-397 . PMCID: PMC5870876

Kao YC, Fletcher CDM, Alaggio R, Wexler L, Zhang L, Sung YS, Orhan D, Chang WC, Swanson D, Dickson BC, Antonescu CR . Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: Expanding

97 OF 288


Journal Articles

the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma . American Journal of Surgical Pathology . 2018;42(1):28-38 . PMCID: PMC5730460

Kao YC, Flucke U, Eijkelenboom A, Zhang L, Sung YS, Suurmeijer AJH, Antonescu CR . Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms . American Journal of Surgical Pathology . 2018;42(4):522-528 . PMCID: PMC5844807

Kao YC, Owosho AA, Sung YS, Zhang L, Fujisawa Y, Lee JC, Wexler L, Argani P, Swanson D, Dickson BC, Fletcher CDM, Antonescu CR . BCOR - CCNB3 fusion positive sarcomas: A clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas . American Journal of Surgical Pathology . 2018;42(5):604-615 . PMCID: PMC5893395

Kapetanakos M, Wisniewski S, Golden M, Randazzo J . Restoration of facial form and lip competence in a patient with a midfacial defect . Journal of Prosthodontics - Implant Esthetic and Reconstructive Dentistry . 2018;27(6):496-500 .

Kapetas P, Clauser P, Woitek R, Pinker K, Bernathova M, Helbich TH, Baltzer PA . Virtual Touch IQ elastography reduces unnecessary breast biopsies by applying quantitative “rule-in” and “rule-out” threshold values . Scientific Reports . 2018;8:3583- . PMCID: PMC5827686

Kapetas P, Woitek R, Clauser P, Bernathova M, Pinker K, Helbich TH, Baltzer PA . A simple ultrasound based classification algorithm allows differentiation of benign from malignant breast lesions by using only quantitative parameters . Molecular Imaging and Biology . 2018;20(6):1053-1060 . PMCID: PMC6244531

Karimi S . Reply . American Journal of Neuroradiology . 2018;39(10):E108- .

Karimov RR, Tan DS, Gin DY . Synthesis of the hexacyclic triterpene core of the jujuboside saponins

via tandem Wolff rearrangement–intramolecular ketene hetero-Diels–Alder reaction . Tetrahedron . 2018;74(26):3370-3383 .

Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra MF, Manley BJ, Casuscelli J, Chiok M, Coleman JA, Russo P, Tickoo SK, Akin O, Hakimi AA . Cystic renal cell carcinoma: A report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging . Journal of Urology . 2018;200(2):275-282 . PMCID: PMC6050111

Katabi N, Xu B . Salivary gland neoplasms: Diagnostic approach with focus on patterns of recognition and useful ancillary tools . Diagnostic Histopathology . 2018;24(5):180-188 .

Katabi N . Neuroendocrine neoplasms of the ear . Head and Neck Pathology . 2018;12(3):362-366 . PMCID: PMC6081292

Katabi N, Xu B, Jungbluth AA, Zhang L, Shao SY, Lane J, Ghossein R, Antonescu CR . PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: A comparative study with PLAG1 genetic abnormalities . Histopathology . 2018;72(2):285-293 . PMCID: PMC5730461

Katona BW, Yurgelun MB, Garber JE, Offit K, Domchek SM, Robson ME, Stadler ZK . A counseling framework for moderate-penetrance colorectal cancer susceptibility genes . Genetics in Medicine . 2018;20(11):1324-1327 .

Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N . Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery . Laryngoscope . 2018;128(11):2539-2545 . PMCID: PMC6179950

Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP . Surgeon influence on variation in receipt of contralateral prophylactic mastectomy

for women with breast cancer . JAMA Surgery . 2018;153(1):29-36 . PMCID: PMC5833615

Katz SJ, Jagsi R, Morrow M . Reducing overtreatment of cancer with precision medicine: Just what the doctor ordered . JAMA - Journal of the American Medical Association . 2018;319(11):1091-1092 .

Katz SJ, Ward KC, Hamilton AS, McLeod MC, Wallner LP, Morrow M, Jagsi R, Hawley ST, Kurian AW . Gaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancer . Journal of Clinical Oncology . 2018;36(12):1218-1224 . PMCID: PMC5908222

Katz SJ, Bondarenko I, Ward KC, Hamilton AS, Morrow M, Kurian AW, Hofer TP . Association of attending surgeon with variation in the receipt of genetic testing after diagnosis of breast cancer . JAMA Surgery . 2018;153(10):909-916 .

Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S . Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance . Nature Reviews Cancer . 2018;18(6):377-388 .

Katzman B, Tang D, Santella A, Bao Z . AceTree: A major update and case study in the long term maintenance of open-source scientific software . BMC Bioinformatics . 2018;19:121- . PMCID: PMC5885296

Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D’Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P . Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial . Journal for ImmunoTherapy of Cancer . 2018;6:7- . PMCID: PMC5774167

Kavaler J, Duan H, Aradhya R, de Navas LF, Joseph B, Shklyar B, Lai EC . miRNA suppression of a Notch repressor directs nonneuronal fate in Drosophila

98 OF 288


Journal Articles

mechanosensory organs . Journal of Cell Biology . 2018;217(2):571-583 . PMCID: PMC5800810

Kawabata KC, Hayashi Y, Inoue D, Meguro H, Sakurai H, Fukuyama T, Tanaka Y, Asada S, Fukushima T, Nagase R, Takeda R, Harada Y, Kitaura J, Goyama S, Harada H, Aburatani H, Kitamura T . High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis . Leukemia . 2018;32(2):419-428 .

Kayano PP, Carneiro A, Castilho TML, Sivaraman A, Claros OR, Baroni RH, Garcia RG, Mariotti GC, Smaletz O, Filippi RZ, Lemos GC . Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer . International Brazilian Journal of Urology . 2018;44(6):1106-1113 . PMCID: PMC6442175

Kazandjian D, Korde N, Mailankody S, Hill E, Figg WD, Roschewski M, Landgren O . Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial . JAMA Oncology . 2018;4(12):1781-1783 . PMCID: PMC6440717

Keall PJ, Nguyen DT, O’Brien R, Zhang P, Happersett L, Bertholet J, Poulsen PR . Review of real-time 3-dimensional image guided radiation therapy on standard-equipped cancer radiation therapy systems: Are we at the tipping point for the era of real-time radiation therapy? . International Journal of Radiation Oncology, Biology, Physics . 2018;102(4):922-931 .

Keaney TC, Anolik R, Braz A, Eidelman M, Eviatar JA, Green JB, Jones DH, Narurkar VA, Rossi AM, Gallagher CJ . The male aesthetic patient: Facial anatomy, concepts of attractiveness, and treatment patterns . Journal of Drugs in Dermatology . 2018;17(1):19-28 .

Kearney SE, Zahoranszky-Kohalmi G, Brimacombe KR, Henderson MJ, Lynch C, Zhao T, Wan KK, Itkin Z,

Dillon C, Shen M, Cheff DM, Lee TD, Bougie D, Cheng K, Coussens NP, Dorjsuren D, Eastman RT, Huang R, Iannotti MJ, Karavadhi S, Klumpp-Thomas C, Roth JS, Sakamuru S, Sun W, Titus SA, Yasgar A, Zhang YQ, Zhao J, Andrade RB, Brown MK, Burns NZ, Cha JK, Mevers EE, Clardy J, Clement JA, Crooks PA, Cuny GD, Ganor J, Moreno J, Morrill LA, Picazo E, Susick RB, Garg NK, Goess BC, Grossman RB, Hughes CC, Johnston JN, Joullie MM, Kinghorn AD, Kingston DG I, Krische MJ, Kwon O, Maimone TJ, Majumdar S, Maloney KN, Mohamed E, Murphy BT, Nagorny P, Olson DE, Overman LE, Brown LE, Snyder JK, Porco JA, Rivas F, Ross SA, Sarpong R, Sharma I, Shaw JT, Xu Z, Shen B, Shi W, Stephenson CRJ, Verano AL, Tan DS, Tang Y, Taylor RE, Thomson RJ, Vosburg DA, Wu J, Wuest WM, Zakarian A, Zhang Y, Ren T, Zuo Z, Inglese J, Michael S, Simeonov A, Zheng W, Shinn P, Jadhav A, Boxer MB, Hall MD, Xia M, Guha R, Rohde JM . Canvass: A crowd-sourced, natural-product screening library for exploring biological space . ACS Central Science . 2018;4(12):1727-1741 . PMCID: PMC6311695

Kebriaei P, Cutler C, de Lima M, Giralt S, Lee SJ, Marks D, Merchant A, Stock W, van Besien K, Stelljes M . Management of important adverse events associated with inotuzumab ozogamicin: Expert panel review . Bone Marrow Transplantation . 2018;53(4):449-456 .

Keedy VL, Lenz HJ, Saltz L, Whisenant JG, Berlin JD, Camacho LH . First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors . Investigational New Drugs . 2018;36(5):860-868 .

Keefe JR, Guo W, Li QS, Amsterdam JD, Mao JJ . An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder . Journal of Psychiatric Research . 2018;96:189-195 . PMCID: PMC5710842

Keene KS, King T, Hwang ES, Peng B, McGuire KP, Tapia C, Zhang H, Bae S, Nakhlis F, Klauber-Demore

N, Meszoely I, Sabel MS, Willey SC, Eterovic AK, Hudis C, Wolff AC, De Los Santos J, Thompson A, Mills GB, Meric-Bernstam F . Molecular determinants of post-mastectomy breast cancer recurrence . npj Breast Cancer . 2018;4:34- . PMCID: PMC6185974

Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, on behalf of the Australian Ovarian Cancer Study Group, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, Chang-Claude J, Behrens S, Moysich KB, Cannioto R, Lele S, Odunsi K, Goodman MT, Shvetsov YB, Thompson PJ, Wilkens LR, Dörk T, Antonenkova N, Bogdanova N, Hillemanns P, Runnebaum IB, du Bois A, Harter P, Heitz F, Schwaab I, Butzow R, Pelttari LM, Nevanlinna H, Modugno F, Edwards RP, Kelley JL, Ness RB, Karlan BY, Lester J, Orsulic S, Walsh C, Kjaer SK, Jensen A, Cunningham JM, Vierkant RA, Giles GG, Bruinsma F, Southey MC, Hildebrandt MAT, Liang D, Lu K, Wu X, Sellers TA, Levine DA, Schildkraut JM, Iversen ES, Terry KL, Cramer DW, Tworoger SS, Poole EM, Bandera E V, Olson SH, Orlow I, Thomsen LC V, Bjorge L, Krakstad C, Tangen IL, Kiemeney LA, Aben KKH, Massuger LFAG, van Altena AM, Pejovic T, Bean Y, Kellar M, Cook LS, Le ND, Brooks-Wilson A, Gronwald J, Cybulski C, Jakubowska A, Lubiński J, Wentzensen N, Brinton LA, Lissowska J, Hogdall E, Engelholm SA, Hogdall C, Lundvall L, Nedergaard L, Pharoah PDP, Dicks E, Song H, Tyrer JP, McNeish I, Siddiqui N, Carty K, Glasspool R, Paul J, Campbell IG, Eccles D, Whittemore AS, McGuire V, Rothstein JH, Sieh W, Narod SA, Phelan CM, McLaughlin JR, Risch HA, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Gentry-Maharaj A, Ramus SJ, Wu AH, Pearce CL, Lee AW, Pike MC, Kupryjanczyk J, Podgorska A, Plisiecka-Halasa J, Sawicki W, Goode EL, Berchuck A, Ovarian Cancer Association Consortium . rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology . International Journal of Molecular Sciences . 2018;19(9):2473- .

99 OF 288


Journal Articles

Kellner JN, Delemarre EM, Yvon E, Nierkens S, Boelens JJ, McNiece I, Olson A, Nieto Y, Ciurea S, Popat U, Ahmed S, Champlin R, Ramos J, Nishimoto M, Ma H, Ke Z, Thall P, Khoury JD, Negrin R, Andersson B, Parmar S . Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: Feasibility, safety and immune reconstitution . Oncotarget . 2018;9(86):35611-35622 . PMCID: PMC6235025

Kenan S, Kahn L, Edelman M, Redner A, Kenan S . Epiphyseal primary diffuse large B-cell lymphoma of bone . Case Reports in Pathology . 2018;2018:4160925- . PMCID: PMC6287168

Kenoth R, Zou X, Simanshu DK, Pike HM, Malinina L, Patel DJ, Brown RE, Kamlekar RK . Functional evaluation of tryptophans in glycolipid binding and membrane interaction by HET-C2, a fungal glycolipid transfer protein . Biochimica et Biophysica Acta (BBA) - Biomembranes . 2018;1860(5):1069-1076 .

Kenworthy EO, Nelson JA, Verma R, Mbabuike J, Mehrara BJ, Dayan JH . Double vascularized omentum lymphatic transplant (VOLT) for the treatment of lymphedema . Journal of Surgical Oncology . 2018;117(7):1413-1419 .

Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, Lehmann L, Shore T, Ho VT, Bunin N, Iacobelli M, Liang W, Hume R, Tappe W, Soiffer R, Richardson P . Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome . British Journal of Haematology . 2018;181(6):816-827 .

Kernan NA, Richardson PG, Smith AR, Triplett BM, Antin JH, Lehmann L, Messinger Y, Liang W, Hume R, Tappe W, Soiffer RJ, Grupp SA . Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-

access program . Pediatric Blood and Cancer . 2018;65(10):e27269- .

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid M I, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, for the Platinum Study Group . Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: A multi-institutional study . Journal of Clinical Oncology . 2018;36(15):1505-1512 .

Kesner A, Laforest R, Otazo R, Jennifer K, Pan T . Medical imaging data in the digital innovation age . Medical Physics . 2018;45(4):e40-e52 .

Kesner A, Pan T, Zaidi H . Data-driven motion correction will replace motion-tracking devices in molecular imaging-guided radiation therapy treatment planning . Medical Physics . 2018;45(8):3477-3480 .

Kesner AL, Meier JG, Burckhardt DD, Schwartz J, Lynch DA . Data-driven optimal binning for respiratory motion management in PET . Medical Physics . 2018;45(1):277-286 .

Kesner AL, Bodei L . Modern radiopharmaceutical dosimetry should include robust biodistribution reporting . Journal of Nuclear Medicine . 2018;59(10):1507-1509 .

Khalil DN, O’Reilly EM . Classification of pancreatic cancer: Ready for practical application? . Clinical Cancer Research . 2018;24(18):4355-4356 . PMCID: PMC6139048

Khan A, Budnick A, Barnea D, Feldman DR, Oeffinger KC, Tonorezos ES . Hearing loss in adult survivors of childhood cancer treated with radiotherapy . Children . 2018;5(5):59- . PMCID: PMC5977041

Khan AJ, Misenko SM, Thandoni A, Schiff D, Jhawar SR, Bunting SF, Haffty BG . VX-984 is a selective

inhibitor of non-homologous end joining, with possible preferential activity in transformed cells . Oncotarget . 2018;9(40):25833-25841 . PMCID: PMC5995231

Khan N, Ozkaya N, Moskowitz A, Dogan A, Horwitz S . Peripheral T-cell lymphoma – Are we making progress? . Best Practice and Research: Clinical Haematology . 2018;31(3):306-314 .

Khan S, Beard RE, Kingham PT, Fong Y, Boerner T, Martinie JB, Vrochides D, Buell JF, Berber E, Kahramangil B, Troisi R I, Vanlander A, Molinari M, Tsung A . Long-term oncologic outcomes following robotic liver resections for primary hepatobiliary malignancies: A multicenter study . Annals of Surgical Oncology . 2018;25(9):2652-2660 .

Khattar P, Xiao W . Lymphohistiocytic nodules caused by luetic infection . Human Pathology: Case Reports . 2018;13:9-10 .

Khattar P, Bedi P, Gonzalez M, Zhong M, Yin C, Huang W, Islam HK, Fallon JT . Genomic analysis reveals distinct subtypes in two rare cases of primary ovarian lymphoma . Pathology Research and Practice . 2018;214(4):593-598 .

Khayat M, Cooper KJ, Khaja MS, Gandhi R, Bryce YC, Williams DM . Endovascular management of acute aortic dissection . Cardiovascular Diagnosis and Therapy . 2018;8(Suppl . 1):S97-S107 . PMCID: PMC5949590

Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O’Connell C, Carrier M . Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: Guidance from the SSC of the ISTH . Journal of Thrombosis and Haemostasis . 2018;16(9):1891-1894 .

Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR . Validation of immunohistochemical assays for integral biomarkers

100 OF 288


Journal Articles

in the NCI-MATCH EAY131 clinical trial . Clinical Cancer Research . 2018;24(3):521-531 . PMCID: PMC5796858

Kidd M, Modlin IM, Drozdov I, Aslanian H, Bodei L, Matar S, Chung KM . A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis . Oncotarget . 2018;9(6):7182-7196 . PMCID: PMC5805546

Kidwell KM, Postow MA, Panageas KS . Sequential, multiple assignment, randomized trial designs in immuno-oncology research . Clinical Cancer Research . 2018;24(4):730-736 . PMCID: PMC5963278

Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, Kim C, Chernyak V, Yokoo T, Meyer J, Newton I, Do RK . Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm . Abdominal Radiology . 2018;43(1):218-230 . PMCID: PMC5771991

Kielar AZ, Chernyak V, Bashir MR, Do RK, Fowler KJ, Mitchell DG, Cerny M, Elsayes KM, Santillan C, Kamaya A, Kono Y, Sirlin CB, Tang A . LI-RADS 2017: An update . Journal of Magnetic Resonance Imaging . 2018;47(6):1459-1474 .

Kiesgen S, Chicaybam L, Chintala NK, Adusumilli PS . Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies . Journal of Thoracic Oncology . 2018;13(1):16-26 . PMCID: PMC5738277

Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC, for the Pigmented Lesion Subcommittee Melanoma Prevention Working Group . Risk of subsequent cutaneous melanoma in moderately dysplastic nevi excisionally biopsied but with positive histologic margins . JAMA Dermatology . 2018;154(12):1401-1408 .

Kim FJ, Pasternak GW . σ(1) Receptor ligand binding: An open-and-shut case . Nature Structural and Molecular Biology . 2018;25(11):992-993 .

Kim H, Yoo S, Zhou R, Xu A, Bernitz JM, Yuan Y, Gomes AM, Daniel MG, Su J, Demicco EG, Zhu J, Moore KA, Lee DF, Lemischka IR, Schaniel C . Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(47):E11128-E11137 . PMCID: PMC6255152

Kim J, Geyer FC, Martelotto LG, Ng CKY, Lim RS, Selenica P, Li A, Pareja F, Fusco N, Edelweiss M, Kumar R, Gularte-Merida R, Forbes AN, Khurana E, Mariani O, Badve S, Vincent-Salomon A, Norton L, Reis-Filho JS, Weigelt B . MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene . Journal of Pathology . 2018;244(2):143-150 . PMCID: PMC5839480

Kim JK, Leeman JE, Riaz N, McBride S, Tsai CJ, Lee NY . Proton therapy for head and neck cancer . Current Treatment Options in Oncology . 2018;19(6):28- .

Kim K, Watson PA, Lebdai S, Jebiwott S, Somma AJ, La Rosa S, Mehta D, Murray KS, Lilja H, Ulmert D, Monette S, Scherz A, Coleman JA . Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts . Clinical Cancer Research . 2018;24(10):2408-2416 .PMCID: PMC5955858

Kim SJ, Huang YT, Foldi J, Lee YJ, Maloy M, Giralt SA, Jakubowski AA, Papanicolaou GA . Cytomegalovirus resistance in CD34(+)-selected hematopoietic cell transplant recipients . Transplant Infectious Disease . 2018;20(3):e12881- . PMCID: PMC5988949

Kim SJ, Vickers AJ, Hu JC . Challenges in adopting level 1 evidence for multiparametric magnetic

resonance imaging as a biomarker for prostate cancer screening . JAMA Oncology . 2018;4(12):1663-1664 .

Kim SK, Barker CA . Outcomes of radiation therapy for advanced T3/T4 nonmelanoma cutaneous squamous cell and basal cell carcinoma . British Journal of Dermatology . 2018;178(1):e30-e32 . PMCID: PMC5732100

Kim SYH, Flory J, Relton C . Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design . Clinical Trials . 2018;15(1):9-16 .

Kim SYH, Flory J, Relton C . Rejoinder . Clinical Trials . 2018;15(1):27-28 .

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M, for the MAVORIC Investigators . Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): An international, open-label, randomised, controlled phase 3 trial . Lancet Oncology . 2018;19(9):1192-1204 .

Kincaid RE Jr, Hertanto AE, Hu YC, Wu AJ, Goodman KA, Pham HD, Yorke ED, Zhang Q, Chen Q, Mageras GS . Evaluation of respiratory motion-corrected cone-beam CT at end expiration in abdominal radiotherapy sites: A prospective study . Acta Oncologica . 2018;57(8):1017-1024 . PMCID: PMC6053337

Kindler HL, Ismaila N, Armato SG 3rd, Bueno R, Hesdorffer M, Jahan T, Jones CM, Miettinen M, Pass H, Rimner A, Rusch V, Sterman D, Thomas A, Hassan R . Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline . Journal of Clinical Oncology . 2018;36(13):1343-1373 .

101 OF 288


Journal Articles

Kindler HL, Rusch V, Bueno R, Ismaila N, Pass H, Sterman D, Hassan R . Reply to D . de Fonseka et al . Journal of Clinical Oncology . 2018;36(26):2746-2747 .

Kingham TP, Pak LM, Simpson AL, Leung U, Doussot A, D’Angelica M I, DeMatteo RP, Allen PJ, Jarnagin WR . 3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: Results from a prospective trial . HPB . 2018;20(3):260-267 .

Kinsella N, Helleman J, Bruinsma S, Carlsson S, Cahill D, Brown C, Van Hemelrijck M . Active surveillance for prostate cancer: A systematic review of contemporary worldwide practices . Translational Andrology and Urology . 2018;7(1):83-97 . PMCID: PMC5861285

Kinsella N, Stattin P, Cahill D, Brown C, Bill-Axelson A, Bratt O, Carlsson S, Van Hemelrijck M . Factors influencing men’s choice of and adherence to active surveillance for low-risk prostate cancer: A mixed-method systematic review . European Urology . 2018;74(3):261-280 .

Kinsley K, Pritchett W . Liposomal irinotecan: Nursing considerations in an outpatient cancer center . Clinical Journal of Oncology Nursing . 2018;22(2):221-224 .

Kirichenko A, Koay EJ, Hasan S, Crane C . Stereotactic body radiotherapy with functional treatment planning in hepatocellular carcinoma . Medical Radiology-Radiation Oncology . 2018;:203-210 .

Kirkman LA, Zhan W, Visone J, Dziedziech A, Singh PK, Fan H, Tong X, Bruzual I, Hara R, Kawasaki M, Imaeda T, Okamoto R, Sato K, Michino M, Fernandez Alvaro E, Guiang LF, Sanz L, Mota DJ, Govindasamy K, Wang R, Ling Y, Tumwebaze PK, Sukenick G, Shi L, Vendome J, Bhanot P, Rosenthal PJ, Aso K, Foley MA, Cooper RA, Kafsack B, Stone Doggett J, Nathan CF, Lin G . Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance . Proceedings of the National Academy of Sciences of the United States

of America . 2018;115(29):E6863-E6870 . PMCID: PMC6055138

Kirov AS, Fanchon LM, Seiter D, Czmielewski C, Russell J, Dogan S, Carlin S, Pinker-Domenig K, Yorke E, Schmidtlein CR, Boyko V, Fujisawa S, Manova-Todorova K, Zanzonico P, Dauer L, Deasy JO, Humm JL, Solomon S . Technical note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity (18)F-FDG injection . Medical Physics . 2018;45(5):2179-2185 . PMCID: PMC5948146

Kishinevsky S, Wang T, Rodina A, Chung SY, Xu C, Philip J, Taldone T, Joshi S, Alpaugh ML, Bolaender A, Gutbier S, Sandhu D, Fattahi F, Zimmer B, Shah SK, Chang E, Inda C, Koren J 3rd, Saurat NG, Leist M, Gross SS, Seshan VE, Klein C, Tomishima MJ, Erdjument-Bromage H, Neubert TA, Henrickson RC, Chiosis G, Studer L . HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons . Nature Communications . 2018;9:4345- . PMCID: PMC6195591

Kissane DW . Jimmie C . Holland, MD: In memoriam (1928-2017) . Cancer Research . 2018;78(9):2147-2148 .

Kissane DW . Dr Jimmie C . Holland, MD (1928-2017): A remarkable woman in medicine and cancer care . Psycho-Oncology . 2018;27(5):1377-1378 .

Kiviniemi MT, Orom H, Waters EA, McKillip M, Hay JL . Education-based disparities in knowledge of novel health risks: The case of knowledge gaps in HIV risk perceptions . British Journal of Health Psychology . 2018;23(2):420-435 . PMCID: PMC5882541

Klassen AF, Riff KWYW, Longmire NM, Albert A, Allen GC, Aydin MA, Baker SB, Cano SJ, Chan AJ, Courtemanche DJ, Dreise MM, Goldstein JA, Goodacre TEE, Harman KE, Munill M, Mahony AO, Palomares Aguilera M, Peterson P, Pusic AL, Slator

R, Stiernman M, Tsangaris E, Tholpady SS, Vargas F, Forrest CR . Psychometric findings and normative values for the CLEFT-Q based on 2434 children and young adult patients with cleft lip and/or palate from 12 countries . Canadian Medical Association Journal . 2018;190(15):E455-E462 . PMCID: PMC5903887

Klassen AF, Kaur M, Poulsen L, Fielding C, Geerards D, van de Grift TC, Hoogbergen M, Juhl CB, Lorenzen MM, McEvenue G, McLean H, Moliver C, Mullender MG, Panchapakesan V, Repo JP, Rose M, Sorensen JA, Stoving RK, Pusic AL . Development of the BODY-Q chest module evaluating outcomes following chest contouring surgery . Plastic and Reconstructive Surgery . 2018;142(6):1600-1608 .

Klassen AF, Kaur M, Breitkopf T, Thoma A, Cano S, Pusic A . Using the BODY-Q to understand impact of weight loss, excess skin, and the need for body contouring following bariatric surgery . Plastic and Reconstructive Surgery . 2018;142(1):77-86 .

Klebanoff CA, Wolchok JD . Shared cancer neoantigens: Making private matters public . Journal of Experimental Medicine . 2018;215(1):5-7 . PMCID: PMC5748868

Kleber J . Environmental stewardship: The nurse’s role in sustainability . Clinical Journal of Oncology Nursing . 2018;22(3):354-356 .

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt S I, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-De-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, Gaziano JMM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I,

102 OF 288


Journal Articles

Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníkova-Duchoňova B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel A V, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT . Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer . Nature Communications . 2018;9:556- . PMCID: PMC5805680

Klein ME, Kovatcheva M, Davis LE, Tap WD, Koff A . CDK4/6 inhibitors: The mechanism of action may not be as simple as once thought . Cancer Cell . 2018;34(1):9-20 . PMCID: PMC6039233

Klein ME, Dickson MA, Antonescu C, Qin LX, Dooley SJ, Barlas A, Manova K, Schwartz GK, Crago AM, Singer S, Koff A, Tap WD . PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence . Oncogene . 2018;37(37):5066-5078 . PMCID: PMC6137027

Kleppe M, Koche R, Zou L, van Galen P, Hill CE, Dong L, De Groote S, Papalexi E, Hanasoge Somasundara A V, Cordner K, Keller M, Farnoud N, Medina J, McGovern E, Reyes J, Roberts J, Witkin M, Rapaport F, Teruya-Feldstein J, Qi J, Rampal R, Bernstein BE, Bradner JE, Levine RL . Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms . Cancer Cell . 2018;33(1):29-43 .e7 . PMCID: PMC5760343

Knauf JA, Luckett KA, Chen KY, Voza F, Socci ND, Ghossein R, Fagin JA . Hgf/Met activation mediates

resistance to BRAF inhibition in murine anaplastic thyroid cancers . Journal of Clinical Investigation . 2018;128(9):4086-4097 . PMCID: PMC6118575

Knickelbein K, Tong J, Chen D, Wang YJ, Misale S, Bardelli A, Yu J, Zhang L . Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer . Oncogene . 2018;37(33):4599-4610 .

Knight JA, Blackmore KM, Fan J, Malone KE, John EM, Lynch CF, Vachon CM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M, WECARE Study Collaborative Group, Bernstein JL . The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study . Breast Cancer Research . 2018;20:23- . PMCID: PMC5863854

Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD . Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP) . Gynecologic Oncology . 2018;149(2):232-240 .

Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, San Lucas FA, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez M V, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB . A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma . Clinical Cancer Research . 2018;24(23):5883-5894 . PMCID: PMC6279613

Kobi M, Flusberg M, Paroder V, Chernyak V . Practical guide to dynamic pelvic floor MRI . Journal of Magnetic Resonance Imaging . 2018;47(5):1155-1170 .

Kodama H, Vroomen LG, Ueshima E, Reilly J, Brandt W, Paluch LR, Monette S, Jones D, Solomon SB, Srimathveeravalli G . Catheter-based endobronchial electroporation is feasible for the focal treatment of peribronchial tumors . Journal of Thoracic and Cardiovascular Surgery . 2018;155(5):2150-2159 .e3 . PMCID: PMC5899684

Kodama H, Ueshima E, Gao S, Monette S, Paluch LR, Howk K, Erinjeri JP, Solomon SB, Srimathveeravalli G . High power microwave ablation of normal swine lung: Impact of duration of energy delivery on adverse event and heat sink effects . InternationalJournal of Hyperthermia . 2018;34(8):1186-1193 .PMCID: PMC6136968

Koelsche C, Hartmann W, Schrimpf D, Stichel D, Jabar S, Ranft A, Reuss DE, Sahm F, Jones DTW, Bewerunge-Hudler M, Trautmann M, Klingebiel T, Vokuhl C, Gessler M, Wardelmann E, Petersen I, Baumhoer D, Flucke U, Antonescu C, Esteller M, Fröhling S, Kool M, Pfister SM, Mechtersheimer G, Dirksen U, von Deimling A . Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information . Modern Pathology . 2018;31(8):1246-1256 .

Koenig JL, Tsai CJ, Sborov K, Horst KC, Pollom EL . Impact of insurance coverage on outcomes in primary breast sarcoma . Sarcoma . 2018;2018:4626174- . PMCID: PMC5875066

Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL . Uterine neoplasms, version 1 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(2):170-199 .

103 OF 288


Journal Articles

Kohestani K, Chilov M, Carlsson S V . Prostate cancer screening-when to start and how to screen? . Translational Andrology and Urology . 2018;7(1):34-45 . PMCID: PMC5861291

Kolva E, Rosenfeld B, Saracino R . Assessing the decision-making capacity of terminally ill patients with cancer . American Journal of Geriatric Psychiatry . 2018;26(5):523-531 .

Komforti MK, Sokolovskaya E, D’Agostino CA, Benayed R, Thomas RM . Extra-osseous Ewing sarcoma of the pancreas: Case report with radiologic, pathologic, and molecular correlation, and brief review of the literature . Virchows Archiv . 2018;473(3):361-369 .

Kommidi H, Guo H, Nurili F, Vedvyas Y, Jin MM, McClure TD, Ehdaie B, Sayman HB, Akin O, Aras O, Ting R . (18)F-positron emitting/trimethine cyanine-fluorescent contrast for image-guided prostate cancer management . Journal of Medicinal Chemistry . 2018;61(9):4256-4262 .

Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW . Current treatment strategies for advanced prostate cancer . International Journal of Urology . 2018;25(3):220-231 . PMCID: PMC6053280

Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GSM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW . ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D . Journal of Clinical Investigation . 2018;128(7):2979-2995 . PMCID: PMC6025984

Kong XF, Martinez-Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick EK, Ma CS, Breton G, Lucero KB, Langlais D, Bousfiha A, Aytekin C, Markle J, Trouillet C, Jabot-Hanin F, Arlehamn CSL, Rao G, Picard C, Lasseau T, Latorre D, Hambleton S, Deswarte C, Itan Y, Abarca K, Moraes-Vasconcelos D, Ailal F,

Ikinciogullari A, Dogu F, Benhsaien I, Sette A, Abel L, Boisson-Dupuis S, Schröder B, Nussenzweig MC, Liu K, Geissmann F, Tangye SG, Gros P, Sallusto F, Bustamante J, Casanova JL . Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency . Nature Immunology . 2018;19(9):973-985 . PMCID: PMC6130844

Konishi T, Shimada Y, Lee LH, Cavalcanti MS, Hsu M, Smith JJ, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Vakiani E, Gonen M, Shia J, Weiser MR . Poorly differentiated clusters predict colon cancer recurrence: An in-depth comparative analysis of invasive-front prognostic markers . American Journal of Surgical Pathology . 2018;42(6):705-714 . PMCID: PMC5943141

Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A, Yaeger R, Saltz L, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Gonen M, Weiser MR . Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome . JAMA Oncology . 2018;4(3):309-315 . PMCID: PMC5885834

Koppelmans V, Scott JM, Downs ME, Cassady KE, Yuan P, Pasternak O, Wood SJ, De Dios YE, Gadd NE, Kofman I, Riascos R, Reuter-Lorenz PA, Bloomberg JJ, Mulavara AP, Ploutz-Snyder LL, Seidler RD . Exercise effects on bed rest-induced brain changes . PLoS ONE . 2018;13(10):e0205515- . PMCID: PMC6181401

Korc-Grodzicki B . Geriatric oncology education for the oncologist is overdue . Journal of the National Comprehensive Cancer Network . 2018;16(3):336-338 .

Korenstein D . Wise guidance and its challenges: The new Canadian recommendations on breast cancer screening . Canadian Medical Association Journal . 2018;190(49):E1432-E1433 . PMCID: PMC6279442

Korenstein D, Husain S, Gennarelli RL, White C, Masciale JN, Roman BR . Impact of clinical specialty

on attitudes regarding overuse of inpatient laboratory testing . Journal of Hospital Medicine . 2018;13(12):844-847 .PMCID: PMC6265055

Korenstein D, Chimonas S, Barrow B, Keyhani S, Troy A, Lipitz-Snyderman A . Development of a conceptual map of negative consequences for patients of overuse of medical tests and treatments . JAMA Internal Medicine . 2018;178(10):1401-1407 .

Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z, Hansel D, de Velasco G, Pennathur A, Andersen JB, O’Rourke CJ, Ohshiro K, Jogunoori W, Nguyen BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W, Zhang J, Tong P, Cherniack AD, Deng C, Resar L, The Cancer Genome Atlas Research Network, Weinstein JN, Mishra L, Akbani R . A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily . Cell Systems . 2018;7(4):422-437 .e7 . PMCID: PMC6370347

Korshunov A, Chavez L, Sharma T, Ryzhova M, Schrimpf D, Stichel D, Capper D, Sturm D, Kool M, Habel A, Kleinschmidt-DeMasters BK, Rosenblum M, Absalyamova O, Golanov A, Lichter P, Pfister SM, Jones DTW, Perry A, von Deimling A . Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis . Brain Pathology . 2018;28(5):656-662 .

Kossatz S, Carney B, Farley C, Weber WA, Drain CM, Reiner T . Direct imaging of drug distribution and target engagement of the PARP inhibitor rucaparib . Journal of Nuclear Medicine . 2018;59(8):1316-1320 . PMCID: PMC6071506

Kotrotsou A, Elakkad A, Sun J, Thomas GA, Yang D, Abrol S, Wei W, Weinberg JS, Bakhtiari AS, Kircher MF, Luedi MM, de Groot JF, Sawaya R, Kumar AJ, Zinn PO, Colen RR . Multi-center study finds postoperative

104 OF 288


Journal Articles

residual non-enhancing component of glioblastoma as a new determinant of patient outcome . Journal of Neuro-Oncology . 2018;139(1):125-133 .

Kourtis N, Lazaris C, Hockemeyer K, Balandran JC, Jimenez AR, Mullenders J, Gong Y, Trimarchi T, Bhatt K, Hu H, Shrestha L, Ambesi-Impiombato A, Kelliher M, Paietta E, Chiosis G, Guzman ML, Ferrando AA, Tsirigos A, Aifantis I . Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia . Nature Medicine . 2018;24(8):1157-1166 . PMCID: PMC6082694

Kovac E, Vertosick EA, Sjoberg DD, Vickers AJ, Stephenson AJ . Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer . BJU International . 2018;122(6):1003-1009 .

Kovatcheva M, Klein ME, Tap WD, Koff A . Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors . Molecular & Cellular Oncology . 2018;5(1):e1384882- . PMCID: PMC5791849

Kowanetz M, Zou W, Gettinger SN, Koeppen H, Kockx M, Schmid P, Kadel EE 3rd, Wistuba I, Chaft J, Rizvi NA, Spigel DR, Spira A, Hirsch FR, Cohen V, Smith D, Boyd Z, Miley N, Flynn S, Leveque V, Shames DS, Ballinger M, Mocci S, Shankar G, Funke R, Hampton G, Sandler A, Amler L, Mellman I, Chen DS, Hegde PS . Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1) . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(43):E10119-E10126 . PMCID: PMC6205493

Kraetzig T, McLaughlin L, Bilsky MH, Laufer I . Metastases of spinal myxopapillary ependymoma: Unique characteristics and clinical management . Journal of Neurosurgery-Spine . 2018;28(2):201-208 .

Kramer K, Pandit-Taskar N, Humm JL, Zanzonico PB, Haque S, Dunkel IJ, Wolden SL, Donzelli M,

Goldman DA, Lewis JS, Lyashchenko SK, Khakoo Y, Carrasquillo JA, Souweidane MM, Greenfield JP, Lyden D, De Braganca KD, Gilheeney SW, Larson SM, Cheung NK V . A phase II study of radioimmunotherapy with intraventricular (131)I-3F8 for medulloblastoma . Pediatric Blood and Cancer . 2018;65(1):e26754- .

Krantz BA, O’Reilly EM . Biomarker-based therapy in pancreatic ductal adenocarcinoma: An emerging reality? . Clinical Cancer Research . 2018;24(10):2241-2250 . PMCID: PMC5955785

Krebs S, Ahad A, Carter LM, Eyquem J, Brand C, Bell M, Ponomarev V, Reiner T, Meares CF, Gottschalk S, Sadelain M, Larson SM, Weber WA . Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes . Journal of Nuclear Medicine . 2018;59(12):1894-1900 . PMCID: PMC6278895

Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, FitzGerald DJ, Santiago L, Gao G, Lanasa MC, Pastan I . Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: Phase 1 results and long-term follow-up . Blood . 2018;131(21):2331-2334 . PMCID: PMC5969375

Krishnaswami S, Stephens CQ, Yang GP, Nwomeh BC, Swaroop M, Nadler EP, Holterman AX, Simeone DM, Kingham TP, Merchant N, Orloff SL . An academic career in global surgery: A position paper from the Society of University Surgeons Committee on Academic Global Surgery . Surgery . 2018;163(4):954-960 .

Krishnaswamy S, Zivanovic N, Sharma R, Pe’er D, Bodenmiller B . Learning time-varying information flow from single-cell epithelial to mesenchymal transition data . PLoS ONE . 2018;13(10):e0203389- . PMCID: PMC6205587

Kroger N, Bishop M, Giralt S, Wayne A . Third International Workshop on the Biology, Prevention, and Treatment of Relapse after Stem Cell

Transplantation . Bone Marrow Transplantation . 2018;53(1):1-2 .

Ku A, Lim HC, Evander M, Lilja H, Laurell T, Scheding S, Ceder Y . Acoustic enrichment of extracellular vesicles from biological fluids . Analytical Chemistry . 2018;90(13):8011-8019 .

Kulikov O V, Siriwardane DA, Budhathoki-Uprety J, McCandless GT, Mahmood SF, Novak BM . The secondary structures of PEG-functionalized random copolymers derived from (R)- and (S)- families of alkyne polycarbodiimides . Polymer Chemistry . 2018;9(20):2759-2768 .

Kumar A, Katz LS, Schulz AM, Kim M, Honig LB, Li L, Davenport B, Homann D, Garcia-Ocaña A, Herman MA, Haynes CM, Chipuk JE, Scott DK . Activation of Nrf2 is required for normal and ChREBPα-augmented glucose-stimulated β-cell proliferation . Diabetes . 2018;67(8):1561-1575 . PMCID: PMC6054434

Kumar A, Vardhana S, Moskowitz AJ, Porcu P, Dogan A, Dubovsky JA, Matasar MJ, Zhang Z, Younes

A, Horwitz SM . Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma . Blood Advances . 2018;2(8):871-876 . PMCID: PMC5915998

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Castillo J, Chandler JC, Costello C, Faiman M, Fung HC, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kang Y, Kassim A, Liedtke M, Malek E, Martin T, Neppalli VT, Omel J, Raje N, Singhal S, Somlo G, Stockerl-Goldstein K, Weber D, Yahalom J, Kumar R, Shead DA . NCCN Guidelines® Insights: Multiple myeloma, version 3 .2018: Featured updates to the NCCN guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(1):11-20 .

Kunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, Maher R, Pronier E, Meyer SC, Garrett-Bakelman FE, Tallman M, Melnick A, Levine RL, Shih AH . Cooperative epigenetic remodeling

105 OF 288


Journal Articles

by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity . Cancer Cell . 2018;33(1):44-59 .e8 .PMCID: PMC5760367

Kunitake JAMR, Choi S, Nguyen KX, Lee MM, He F, Sudilovsky D, Morris PG, Jochelson MS, Hudis CA, Muller DA, Fratzl P, Fischbach C, Masic A, Estroff LA . Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas . Journal of Structural Biology . 2018;202(1):25-34 . PMCID: PMC5835408

Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ . Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer . JAMA Oncology . 2018;4(8):1066-1072 .

Kurilova I, Beets-Tan RGH, Ulaner GA, Boas FE, Petre EN, Yarmohammadi H, Ziv E, Deipolyi AR, Brody LA, Gonen M, Sofocleous CT . (90)Y resin microspheres radioembolization for colon cancer liver metastases using full-strength contrast material . CardioVascular and Interventional Radiology . 2018;41(9):1419-1427 .

Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, Erinjeri J, Petre EN, Gonen M, Bains M, Kemeny NE, Solomon SB, Sofocleous CT . Microwave ablation in the management of colorectal cancer pulmonary metastases . CardioVascular and Interventional Radiology . 2018;41(10):1530-1544 .

Kurita K, Reid MC, Siegler EL, Diamond EL, Prigerson HG . Associations between mild cognitive dysfunction and end-of-life outcomes in patients with advanced cancer . Journal of Palliative Medicine . 2018;21(4):536-540 .PMCID: PMC5867505

Kuritzkes BA, Pappou EP, Kiran RP, Baser O, Fan L, Guo X, Zhao B, Bentley-Hibbert S . Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer . International Journal of Colorectal Disease . 2018;33(8):1019-1028 .

Kushner BH . Enigmatic entities: Opsoclonus myoclonus ataxia syndrome linked to neuroblastoma . The Lancet Child & Adolescent Health . 2018;2(1):3-5 .

Kushner BH, Cheung IY, Modak S, Basu EM, Roberts SS, Cheung NK . Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial . JAMA Oncology . 2018;4(12):1729-1735 . PMCID: PMC6440722

Kuzu I, Dogan A . Immunohistochemical biomarkers in diagnosis of hematolymphoid neoplasms of endocrine organs . Endocrine Pathology . 2018;29(2):176-188 .

Kwa M, Li X, Novik Y, Oratz R, Jhaveri K, Wu J, Gu P, Meyers M, Muggia F, Speyer J, Iwano A, Bonakdar M, Kozhaya L, Tavukcuoglu E, Budan B, Raad R, Goldberg JD, Unutmaz D, Adams S . Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer . Breast Cancer Research and Treatment . 2018;168(1):57-67 .

Kwan SW, Charalel RA, Stover AM, Baumhauer JF, Cella D, Darien G, Durack JC, Gerson J, Opelka F, Patrick DL, Salem R, Spies JB, Wu AW, White SB . Development of national research and clinical agendas for patient-reported outcomes in IR: Proceedings from a multidisciplinary consensus panel . Journal of Vascular and Interventional Radiology . 2018;29(1):1-8 .

Lacouture ME . Taking it in the chin: Vitamin K1 for the prevention of acneiform rash . Annals of Oncology . 2018;29(4):796-798 . PMCID: PMC5913626

Lacouture ME, Anadkat M, Jatoi A, Garawin T, Bohac C, Mitchell E . Dermatologic toxicity occurring during anti-EGFR monoclonal inhibitor therapy in patients with metastatic colorectal cancer: A systematic review . Clinical Colorectal Cancer . 2018;17(2):85-96 .

Lacouture ME, Kopsky DJ, Lilker R, Damstra F, van der Linden MHM, Freites-Martinez A, Nagel MPM . Podiatric adverse events and foot care in cancer patients and survivors: Awareness, education, and literature review . Journal of the American Podiatric Medical Association . 2018;108(6):508-516 .

Lahoud OB, Moskowitz AJ, Horwitz SM, Giralt SA, Dahi PB . Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma . Bone Marrow Transplantation . 2018;53(5):654-656 .

Lai H, Huang C, Cai J, Ye J, She J, Zheng Y, Wang L, Wei Y, Fang W, Wang X, Tang YW, Luo Y, Jin D . Simultaneous detection and characterization of toxigenic Clostridium difficile directly from clinical stool specimens . Frontiers of Medicine . 2018;12(2):196-205 .

Laino ME, Ragucci M, Klimstra DS, Mannelli L . Hepatobiliary and pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy . Journal of Gastroenterology and Hepatology . 2018;33(5):977- . PMCID: PMC5905723

Laird J, Lok B, Siu C, Cahlon O, Khan AJ, McCormick B, Powell SN, Cody H, Wen HY, Ho A, Braunstein LZ . Impact of an in situ component on outcome after in-breast tumor recurrence in patients treated with breast-conserving therapy . Annals of Surgical Oncology . 2018;25(1):154-163 . PMCID: PMC5827945

Laird J, Braunstein LZ . Reply to “Questions about in-breast tumor recurrence in patients treated with breast-conserving therapy” . Annals of Surgical Oncology . 2018;25(12):3779- .

Laird J, Braunstein LZ . ASO author reflections: Breast cancer local recurrence versus new primary: Clinical predictors and prognostic implications . Annals of Surgical Oncology . 2018;25(Suppl . 3):S648-S649 .

Laird J, Ma J, Chau K, Chelius M, Shi W, Zhang Z, Lok BH, Yahalom J . Outcome after radiation therapy for

106 OF 288


Journal Articles

Langerhans cell histiocytosis is dependent on site of involvement . International Journal of Radiation Oncology, Biology, Physics . 2018;100(3):670-678 . PMCID: PMC5806138

Laird JH, Lok BH, Ma J, Bell A, de Stanchina E, Poirier JT, Rudin CM . Talazoparib is a potent radiosensitizer in small cell lung cancer cell lines and xenografts . Clinical Cancer Research . 2018;24(20):5143-5152 .

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Ficher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R . Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates . Nature Biomedical Engineering . 2018;2(5):279-292 .

Landgren O . MRD testing in multiple myeloma: From a surrogate marker of clinical outcomes to an every-day clinical tool . Seminars in Hematology . 2018;55(1):1-3 .

Landgren O, Lu SX, Hultcrantz M . MRD testing in multiple myeloma: The main future driver for modern tailored treatment . Seminars in Hematology . 2018;55(1):44-50 .

Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K, Ramanathan L, Hultcrantz M, Dogan A, Nwankwo G, Steidl U, Pradhan K, Hall CB, Cohen HW, Jaber N, Schwartz T, Crowley L, Crane M, Irby S, Webber MP, Verma A, Prezant DJ . Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster . JAMA Oncology . 2018;4(6):821-827 .

Landtblom AR, Bower H, Andersson TML, Dickman PW, Samuelsson J, Björkholm M, Kristinsson SY, Hultcrantz M . Second malignancies in patients

with myeloproliferative neoplasms: A population-based cohort study of 9379 patients . Leukemia . 2018;32(10):2203-2210 .

Langballe R, John EM, Malone KE, Bernstein L, Knight JA, Lynch CF, Howell RM, Shore R, Woods M, Concannon P, the WECARE Study Collaborative Group, Bernstein JL, Mellemkjær L . Agreement between self-reported and register-based cardiovascular events among Danish breast cancer survivors . Journal of Cancer Survivorship . 2018;12(1):95-100 . PMCID: PMC5790612

Lange KR, Fischer C, Rajappa P, Connors S, Pisapia D, Greenfield JP, Beltran H, Rubin M, Mosquera JM, Khakoo Y . Rapid autopsy of a patient with recurrent anaplastic ependymoma . Palliative and Supportive Care . 2018;16(2):238-242 . PMCID: PMC5977387

Lapen K, Benusis L, Pearson S, Search B, Coleton M, Li QS, Sjoberg D, Konner J, Mao JJ, Deng G . A feasibility study of restorative yoga versus vigorous yoga intervention for sedentary breast and ovarian cancer survivors . International Journal of Yoga Therapy . 2018;28(1):79-85 .

Larkin J, Minor D, D’Angelo S, Neyns B, Smylie M, Miller WH Jr, Gutzmer R, Linette G, Chmielowski B, Lao CD, Lorigan P, Grossmann K, Hassel JC, Sznol M, Daud A, Sosman J, Khushalani N, Schadendorf D, Hoeller C, Walker D, Kong G, Horak C, Weber J . Overall survival in patients with advanced melanoma who received nivolumab versus investigator’s choice chemotherapy in CheckMate 037: A randomized, controlled, open-label phase III trial . Journal of Clinical Oncology . 2018;36(4):383-390 .

Latcha S, Jaimes EA, Gutgarts V, Seshan S . Case of proteinuria, worsening hypertension, and glomerular endotheliosis with erlotinib and gefitinib . Kidney International Reports . 2018;3(6):1477-1481 . PMCID: PMC6224627

Latham Schwark A, Walsh MF . Duty to Warn in the Era of Next Generation Sequencing . American Journal of Bioethics . 2018;18(7):79-80 .

Lattanzi M, Deng FM, Chiriboga LA, Femia AN, Meehan SA, Iyer G, Voss MH, Sundatova Y, Huang WC, Balar A V . Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: A report on the successful treatment of a rare malignancy . Journal for ImmunoTherapy of Cancer . 2018;6:97- . PMCID: PMC6167873

Latte-Naor S, Sidlow R, Sun L, Li QS, Mao JJ . Influence of family on expected benefits of complementary and alternative medicine (CAM) in cancer patients . Supportive Care in Cancer . 2018;26(6):2063-2069 .

Lau CM, Adams NM, Geary CD, Weizman OE, Rapp M, Pritykin Y, Leslie CS, Sun JC . Epigenetic control of innate and adaptive immune memory . Nature Immunology . 2018;19(9):963-972 .

Lau CM, Sun JC . The widening spectrum of immunological memory . Current Opinion in Immunology . 2018;54:42-49 .

Lau YTK, Baytshtok V, Howard TA, Fiala BM, Johnson JM, Carter LP, Baker D, Lima CD, Bahl CD . Discovery and engineering of enhanced sumo protease enzymes . Journal of Biological Chemistry . 2018;293(34):13224-13233 .PMCID: PMC6109922

Laudati C, Clark C, Knezevic A, Zhang Z, Barton-Burke M . Hypersensitivity reactions: Priming practice change to reduce incidence in first-dose rituximab treatment . Clinical Journal of Oncology Nursing . 2018;22(4):407-414 .

Laufer I, Lo SS, Chang EL, Sheehan J, Guckenberger M, Sohn MJ, Ryu S, Foote M, Muacevic A, Soltys SG, Chao S, Myrehaug S, Gerszten PC, Lis E, Maralani P, Bilsky M, Fisher C, Rhines L, Verlaan JJ, Schiff D, Fehlings MG, Ma LJ, Chang S, Parulekar WR, Vogelbaum MA, Sahgal A . Population description and

107 OF 288


Journal Articles

clinical response assessment for spinal metastases: Part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report . Neuro-Oncology . 2018;20(9):1215-1224 . PMCID: PMC6071663

LaVigne K, Hyman DM, Zhou QC, Iasonos A, Tew WP, Aghajanian C, Makker V, Hensley ML, Konner J, Grisham RN, Cangemi N, Soldan K, Spriggs DR, Sabbatini PJ, O’Cearbhaill RE . A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer . International Journal of Gynecological Cancer . 2018;28(6):1176-1182 . PMCID: PMC6033627

Lawrence YR, Moughan J, Magliocco AM, Klimowicz AC, Regine WF, Mowat RB, DiPetrillo TA, Small W Jr, Simko JP, Golan T, Winter KA, Guha C, Crane CH, Dicker AP . Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704 . Cancer . 2018;124(3):491-498 . PMCID: PMC5780226

Lazarev S, Kushner BH, Wolden SL . Short hypofractionated radiation therapy in palliation of pediatric malignancies: Outcomes and toxicities . International Journal of Radiation Oncology, Biology, Physics . 2018;102(5):1457-1464 .

Lazarus J, Maj T, Smith JJ, Perusina Lanfranca M, Rao A, D’Angelica M I, Delrosario L, Girgis A, Schukow C, Shia J, Kryczek I, Shi J, Wasserman I, Crawford H, Nathan H, Pasca Di Magliano M, Zou W, Frankel TL . Spatial and phenotypic immune profiling of metastatic colon cancer . JCI Insight . 2018;3(22):e121932- . PMCID: PMC6302940

Lazenby M, Ercolano E, Knies A, Pasacreta N, Grant M, Holland JC, Jacobsen PB, Badger T, Jutagir DR, McCorkle R . Psychosocial distress screening: An educational program’s impact on participants’ goals for screening implementation in routine cancer care . Clinical Journal of Oncology Nursing . 2018;22(3):E85-E91 . PMCID: PMC5984040

Le Luduec JB, Kudva A, Boudreau JE, Hsu KC . Novel multiplex PCR-SSP method for centromeric KIR allele discrimination . Scientific Reports . 2018;8:14853- . PMCID: PMC6173694

Lebron-Zapata L, Jochelson MS . Overview of breast cancer screening and diagnosis . PET Clinics . 2018;13(3):301-323 .

Leddy LS . Management of lower urinary tract symptoms after pelvic radiation in females . Current Urology Reports . 2018;19(12):106- .

Ledergor G, Weiner A, Zada M, Wang SY, Cohen YC, Gatt ME, Snir N, Magen H, Koren-Michowitz M, Herzog-Tzarfati K, Keren-Shaul H, Bornstein C, Rotkopf R, Yofe I, David E, Yellapantula V, Kay S, Salai M, Ben Yehuda D, Nagler A, Shvidel L, Orr-Urtreger A, Halpern KB, Itzkovitz S, Landgren O, San-Miguel J, Paiva B, Keats JJ, Papaemmanuil E, Avivi I, Barbash G I, Tanay A, Amit I . Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma . Nature Medicine . 2018;24(12):1867-1876 .

Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O’Sullivan B, Ozyar E, Peters LJ, Rosenthal D I, Soong YL, Tao Y, Yom SS, Wee JT . International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma . Radiotherapy and Oncology . 2018;126(1):25-36 .

Lee BH, Feifer A, Feuerstein MA, Benfante NE, Kou L, Yu C, Kattan MW, Russo P . Validation of a postoperative nomogram predicting recurrence in patients with conventional clear cell renal cell carcinoma . European Urology Focus . 2018;4(1):100-105 .

Lee BH, Zabor EC, Tennenbaum D, Furberg H, Benfante N, Coleman JA, Jaimes EA, Russo P . Renal function recovery after radical nephroureterectomy

for upper tract urothelial carcinoma . World Journal of Urology . 2018;36(2):257-263 .

Lee C, Haneuse S, Wang HL, Rose S, Spellman SR, Verneris M, Hsu KC, Fleischhauer K, Lee SJ, Abdi R . Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation . PLoS ONE . 2018;13:e0190610- . PMCID: PMC5773230

Lee CH, Yelensky R, Jooss K, Chan TA . Update on tumor neoantigens and their utility: Why it is good to be different . Trends in Immunology . 2018;39(7):536-548 .

Lee CH, Motzer R . Combination VEGFR/immune checkpoint inhibitor therapy: A promising new treatment for renal cell carcinoma . British Journal of Cancer . 2018;119(8):911-912 .

Lee EH, Klassen AF, Cano SJ, Nehal KS, Pusic AL . FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery . British Journal of Dermatology . 2018;179(1):88-94 .

Lee EH, Rossi AM, Nehal KS . Age and treatment of nonmelanoma skin cancer . JAMA Sugery . 2018;153(9):865-866 .

Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS . Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma . Annals of Surgery . 2018;267(1):105-113 . PMCID: PMC5515689

Lee JK, Sjoberg DD, Imnadze Miller M, Vickers AJ, Mulhall JP, Ehdaie B . Improved recovery of erectile function in younger men after radical prostatectomy: Does it justify immediate surgery in low-risk patients? . European Urology . 2018;73(1):33-37 . PMCID: PMC5732855

Lee JR, Appelmann I, Miething C, Shultz TO, Ruderman D, Kim D, Mallick P, Lowe SW, Wang SX . Longitudinal multiplexed measurement of quantitative proteomic signatures in mouse

108 OF 288


Journal Articles

lymphoma models using magneto-nanosensors . Theranostics . 2018;8(5):1389-1398 . PMCID: PMC5835944

Lee JT, Moroz MA, Ponomarev V . Imaging T cell dynamics and function using PET and human nuclear reporter genes . Methods in Molecular Biology . 2018;1790:165-180 .

Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, Dixon K, Figueiredo J, Ghosh R, Huntsman D, Kaurah P, Kesserwan C, Landrith T, Li S, Mensenkamp AR, Oliveira C, Pardo C, Pesaran T, Richardson M, Slavin TP, Spurdle AB, Trapp M, Witkowski L, Yi CS, Zhang L, Plon SE, Schrader KA, Karam R . Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants . Human Mutation . 2018;39(11):1553-1568 . PMCID: PMC6188664

Lee MC, Aly RG, Adusumilli PS . New staging system for pulmonary neuroendocrine tumors: A clinical and pathologic necessity . Journal of Thoracic and Cardiovascular Surgery . 2018;155(1):367-368 .

Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH . Machine learning on a genome-wide association study to predict late genitourinary toxicity after prostate radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;101(1):128-135 . PMCID: PMC5886789

Lee SCW, North K, Kim E, Jang E, Obeng E, Lu SX, Liu B, Inoue D, Yoshimi A, Ki M, Yeo M, Zhang XJ, Kim MK, Cho H, Chung YR, Taylor J, Durham BH, Kim YJ, Pastore A, Monette S, Palacino J, Seiler M, Buonamici S, Smith PG, Ebert BL, Bradley RK, Abdel-Wahab O . Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations . Cancer Cell . 2018;34(2):225-241 .e8 .

Lee SH, Rimner A, Gelb E, Deasy JO, Hunt MA, Humm JL, Tyagi N . Correlation between tumor metabolism and semiquantitative perfusion magnetic resonance imaging metrics in non-small cell lung

cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(4):718-726 . PMCID: PMC6119645

Lee SH, Singh I, Tisdale S, Abdel-Wahab O, Leslie CS, Mayr C . Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia . Nature . 2018;561(7721):127-131 .

Lee SH, Hu W, Matulay JT, Silva M V, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM . Tumor evolution and drug response in patient-derived organoid models of bladder cancer . Cell . 2018;173(2):515-528 .e17 . PMCID: PMC5890941

Lee YJ, Bacchus M, Schmidt E, Chawla M, Barker JN, Papanicolaou GA . Paradoxical immune reconstitution inflammatory syndrome associated with disseminated tuberculosis infection in an unrelated donor cord blood transplant recipient . Transplant Infectious Disease . 2018;20(3):e12889- .

Lee YJ, Neofytos D, Kim SJ, Cheteyan L, Huang YT, Papadopoulos EB, Jakubowski AA, Papanicolaou GA . Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients . Transplant Infectious Disease . 2018;20(6):e12977- . PMCID: PMC6310478

Lee YJ, Huang YT, Kim SJ, Kerpelev M, Gonzalez V, Kaltsas A, Papanicolaou G . Trends in invasive pneumococcal disease in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine: A 20-year longitudinal study at a major urban cancer center . Clinical Infectious Diseases . 2018;66(2):244-253 .PMCID: PMC5850633

Leeman JE, McBride SM, Spielsinger D, Sherman EJ, Wong R, Riaz N, Lee NY, Tsai CJ . Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks .

International Journal of Cancer . 2018;142(12):2485-2490 . PMCID: PMC5908749

Leftin A, Koutcher JA . Quantification of nanoparticle enhancement in polarized breast tumor macrophage deposits by spatial analysis of MRI and histological iron contrast using computer vision . Contrast Media and Molecular Imaging . 2018;2018:3526438- . PMCID: PMC6232789

Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Rodrigues Peres RM, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai W V, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ . Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer . Cell Reports . 2018;24(6):1434-1444 .e7 .

Leiserson MDM, Syrgkanis V, Gilson A, Dudik M, Gillett S, Chayes J, Borgs C, Bajorin DF, Rosenberg JE, Funt S, Snyder A, Mackey L . A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor . PLoS ONE . 2018;13(12):e0208422- . PMCID: PMC6312275

Leitao MM Jr . The LACC trial: Has minimally invasive surgery for early-stage cervical cancer been dealt a knockout punch? . International Journal of Gynecological Cancer . 2018;28(7):1248-1250 .

Leitao MM Jr . Management of epithelial ovarian cancer . Clinical Advances in Hematology & Oncology . 2018;16(10):656-659 .

Leiter A, Bickell NA, LeRoith D, Nayak A, Feldman SM, Friedman NB, Estabrook A, King TA, Fei K, Franco R, Gallagher EJ . Statin use and breast cancer prognosis in black and white women . Hormones and Cancer . 2018;9(1):55-61 . PMCID: PMC5873288

109 OF 288


Journal Articles

Leithner D, Wengert GJ, Helbich TH, Thakur S, Ochoa-Albiztegui RE, Morris EA, Pinker K . Clinical role of breast MRI now and going forward . Clinical Radiology . 2018;73(8):700-714 .

Leithner D, Gruber-Rouh T, Beeres M, Wichmann JL, Mahmoudi S, Martin SS, Lenga L, Albrecht MH, Booz C, Vogl TJ, Scholtz JE . 90-kVp low-tube-voltage CT pulmonary angiography in combination with advanced modeled iterative reconstruction algorithm: Effects on radiation dose, image quality and diagnostic accuracy for the detection of pulmonary embolism . British Journal of Radiology . 2018;91(1088):20180269- .

Leithner D, Horvat J V, Ochoa-Albiztegui RE, Thakur S, Wengert G, Morris EA, Helbich TH, Pinker K . Imaging and the completion of the omics paradigm in breast cancer . Radiologe . 2018;58(Suppl . 1):7-13 .PMCID: PMC6244523

Lencz T, Yu J, Palmer C, Carmi S, Ben-Avraham D, Barzilai N, Bressman S, Darvasi A, Cho JH, Clark LN, Gümüş ZH, Joseph V, Klein R, Lipkin S, Offit K, Ostrer H, Ozelius LJ, Peter I, Atzmon G, Pe’er I . High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation . Human Genetics . 2018;137(4):343-355 .

Lendvai N, Tsakos I, Devlin SM, Schaffer WL, Hassoun H, Lesokhin AM, Landau H, Korde N, Mailankody S, Smith E, Chung DJ, Koehne G, Shah GL, Alexander A, Patel M, Ballagi A, Grundberg I, Giralt SA, Landgren O . Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity . Leukemia and Lymphoma . 2018;59(8):1981-1985 .

Leng J, Lui F, Chen A, Huang X, Breitbart W, Gany F . Adapting meaning-centered psychotherapy in advanced cancer for the Chinese immigrant population . Journal of Immigrant and Minority Health . 2018;20(3):680-686 .PMCID: PMC5660672

Lenga L, Czwikla R, Wichmann JL, Leithner D, Albrecht MH, Booz C, Arendt CT, Yel I, D’Angelo T, Vogl TJ, Martin SS . Dual-energy CT in patients with colorectal cancer: Improved assessment of hypoattenuating liver metastases using noise-optimized virtual monoenergetic imaging . European Journal of Radiology . 2018;106:184-191 .

Leonard CE, Han X, Brensinger CM, Bilker WB, Cardillo S, Flory JH, Hennessy S . Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study . Pharmacoepidemiology and Drug Safety . 2018;27(1):9-18 . PMCID: PMC5770147

Leonard CE, Brensinger CM, Aquilante CL, Bilker WB, Boudreau DM, Deo R, Flory JH, Gagne JJ, Mangaali MJ, Hennessy S . Comparative safety of sulfonylureas and the risk of sudden cardiac arrest and ventricular arrhythmia . Diabetes Care . 2018;41(4):713-722 . PMCID: PMC5860838

Leonardi GC, Gainor JF, Altan M, Kravets S, Dahlberg SE, Gedmintas L, Azimi R, Rizvi H, Riess JW, Hellmann MD, Awad MM . Safety of programmed death-1 pathway inhibitors among patients with non-small-cell lung cancer and preexisting autoimmune disorders . Journal of Clinical Oncology . 2018;36(19):1905-1912 .

Leung S, Gregg SR, Coopersmith CM, Layon AJ, Oropello J, Brown DR, Pastores SM, Kvetan V, for the Academic Leaders in Critical Care Medicine Task Force of the Society of the Critical Care Medicine . Critical care organizations: Business of critical care and value/performance building . Critical Care Medicine . 2018;46(1):1-11 .

Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, Lee AT, Quesenberry CP, Fireman BH, Doubeni CA . Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population .

Gastroenterology . 2018;155(5):1383-1391 .e5 .PMCID: PMC6240353

Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall M, Robison LL, Armstrong GT, Sklar CA . Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study . Cancer . 2018;124(5):1044-1052 . PMCID: PMC5869021

Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, Blennow K, Strapagiel D, Paciotti S, Vogelgsang J, Roehrl MH, Mendoza S, Kornhuber J, Teunissen C . Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer’s disease . Alzheimer’s Research and Therapy . 2018;10:87- . PMCID: PMC6114189

Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S . ZC3H7B-BCOR high-grade endometrial stromal sarcomas: A report of 17 cases of a newly defined entity . Modern Pathology . 2018;31(4):674-684 .

Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ . PRAME expression in melanocytic tumors . American Journal of Surgical Pathology . 2018;42(11):1456-1465 .

Lezcano C, Shoushtari AN, Ariyan C, Hollmann TJ, Busam KJ . Primary and metastatic melanoma with NTRK fusions . American Journal of Surgical Pathology . 2018;42(8):1052-1058 . PMCID: PMC6041134

Li AG, Murphy EC, Culhane AC, Powell E, Wang H, Bronson RT, Von T, Giobbie-Hurder A, Gelman RS, Briggs KJ, Piwnica-Worms H, Zhao JJ, Kung AL, Kaelin WG Jr, Livingston DM . BRCA1-IRIS

110 OF 288


Journal Articles

promotes human tumor progression through PTEN blockade and HIF-1α activation . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(41):E9600-E9609 . PMCID: PMC6187201

Li B, Mascarenhas JO, Rampal RK . Leukemic transformation of myeloproliferative neoplasms: Therapeutic and genomic considerations . Current Hematologic Malignancy Reports . 2018;13(6):588-595 .

Li BT, Shen RL, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, Brzostowski EB, Riely GJ, Solit DB, Hyman DM, Drilon A, Rudin CM, Berger MF, Baselga J, Scaltriti M, Arcila ME, Kris MG . Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial . Journal of Clinical Oncology . 2018;36(24):2532-2537 .

Li D, McCall LM, Hahn OM, Hudis CA, Cohen HJ, Muss HB, Jatoi A, Lafky JM, Ballman K V, Winer EP, Tripathy D, Schneider B, Barry W, Dickler MN, Hurria A . Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study . Breast Cancer Research and Treatment . 2018;171(2):325-334 . PMCID: PMC6076849

Li G, Sun A, Nie X, Moody J, Huang K, Zhang S, Sharma S, Deasy J . Introduction of a pseudo demons force to enhance deformation range for robust reconstruction of super-resolution time-resolved 4DMRI . Medical Physics . 2018;45(11):5197-5207 . PMCID: PMC6278596

Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, Gordon N, Norgard RJ, Yuan S, Yu S, Chao T, Ye S, Eisinger-Mathason TSK, Faryabi RB, Tobias JW, Lowe SW, CoussensLM,

Wherry EJ, Vonderheide RH, Stanger BZ . Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to imunotherapy . Immunity . 2018;49(1):178-193 .e7 .

Li JWY, Hua X, Reidy-Lagunes D, Untch BR . MENIN loss as a tissue-specific driver of tumorigenesis . Molecular and Cellular Endocrinology . 2018;469:98-106 .

Li JZ, Tu HY V, Avram R, Pinthus J, Bordeleau L, Hodgson N . Cancer prevention and screening in a BRCA2-positive male to female transgender patient . Breast Journal . 2018;24(6):1112-1113 .

Li K, Vorkas CK, Chaudhry A, Bell DL, Willis RA, Rudensky A, Altman JD, Glickman MS, Aubé J . Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU) . PLoS ONE . 2018;13(2):e0191837- . PMCID: PMC5798775

Li L, Nelson JE, Hanson LC, Cox CE, Carson SS, Chai EJ, Keller KL, Tulsky JA, Danis M . How surrogate decision-makers for patients with chronic critical illness perceive and carry out their role . Critical Care Medicine . 2018;46(5):699-704 .

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman N I, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN . Authors’ reply . Journal of Molecular Diagnostics . 2018;20(1):125-126 . PMCID: PMC5818630

Li P, Huang CM, Zheng CH, Russo A, Kasbekar P, Brennan MF, Coit DG, Strong VE . Comparison of gastric cancer survival after R0 resection in the US and China . Journal of Surgical Oncology . 2018;118(6):975-982 .PMCID: PMC6319936

Li R, Xiao D, Yang J, Sun S, Kaplan S, Li Z, Niu Y, Qiang C, Zhai Y, Wang X, Zhao X, Zhao B, Welker M, Pincus DH, Jin D, Kamboj M, Zheng G, Zhang G, Zhang J, Tang YW, Zhao J . Identification and characterization of Clostridium difficile sequence

type 37 genotype by matrix-assisted laser desorption ionization-time of flight mass spectrometry . Journal of Clinical Microbiology . 2018;56(5):e01990-17- . PMCID: PMC5925732

Li W, Han Y, Wang C, Guo X, Shen B, Liu F, Jiang C, Li Y, Yang Y, Lang R, Fan Y, Gu F, Niu Y, Zhang X, Zhang L, Wen HY, Fu L . Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: A 12-year prospective clinical study . Modern Pathology . 2018;31(6):956-964 .

Li W, Middha M, Bicak M, Sjoberg DD, Vertosick E, Dahlin A, Haggström C, Hallmans G, Rönn AC, Stattin P, Melander O, Ulmert D, Lilja H, Klein RJ . Genome-wide scan identifies role for AOX1 in prostate cancer survival . European Urology . 2018;74(6):710-719 . PMCID: PMC6287611

Li X, Li T, Yorke E, Mageras G, Tang X, Chan M, Xiong W, Reyngold M, Gewanter R, Wu A, Cuaron J, Hunt M . Effects of irregular respiratory motion on the positioning accuracy of moving target with free breathing cone-beam computerized tomography . International Journal of Medical Physics, Clinical Engineering and Radiation Oncology . 2018;7(2):173-183 . PMCID: PMC6016851

Li Y, Lord-Bessen J, Shiyko M, Loeb R . Bayesian latent class analysis tutorial . Multivariate Behavioral Research . 2018;53(3):430-451 .

Li Y, Reuter VE, Matoso A, Netto GJ, Epstein J I, Argani P . Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients . Histopathology . 2018;72(4):588-600 .

Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, Hsieh W, Sanchez-Vega F, Brown DN, Da Cruz Paula AF, Morris L, Selenica P, Eichenberger E, Shen R, Schultz N, Rosen N, Scaltriti M, Brogi E, Baselga J, Reis-Filho JS, Chandarlapaty S . Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors

111 OF 288


Journal Articles

via the Hippo pathway . Cancer Cell . 2018;34(6):893-905 .e8 . PMCID: PMC6294301

Lichtenthal WG, Maciejewski PK, Craig Demirjian C, Roberts KE, First MB, Kissane DW, Neimeyer RA, Breitbart W, Slivjak E, Jankauskaite G, Napolitano S, Maercker A, Prigerson HG . Evidence of the clinical utility of a prolonged grief disorder diagnosis . World Psychiatry . 2018;17(3):364-365 . PMCID: PMC6127759

Lichtenthal WG . Supporting the bereaved in greatest need: We can do better . Palliative and Supportive Care . 2018;16(4):371-374 .

Lidsky ME, Jarnagin WR . Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center . Annals of Gastroenterological Surgery . 2018;2(4):304-312 . PMCID: PMC6036362

Lienemann M, Deutzmann JS, Milton RD, Sahin M, Spormann AM . Mediator-free enzymatic electrosynthesis of formate by the Methanococcus maripaludis heterodisulfide reductase supercomplex . Bioresource Technology . 2018;254:278-283 .

Lilley EJ, Scott JW, Goldberg JE, Cauley CE, Temel JS, Epstein AS, Lipsitz SR, Smalls BL, Haider AH, Bader AM, Weissman JS, Cooper Z . Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: Comparative study of surgery, venting gastrostomy, or medical management . Annals of Surgery . 2018;267(4):692-699 .

Lin AL, Jonsson P, Tabar V, Yang TJ, Cuaron J, Beal K, Cohen M, Postow M, Rosenblum M, Shia J, Deangelis LM, Taylor BS, Young RJ, Geer EB . Marked response of a hypermutated acth-secreting pituitary carcinoma to ipilimumab and nivolumab . Journal of Clinical Endocrinology and Metabolism . 2018;103(10):3925-3930 .

Lin CJ, Hu F, Dubruille R, Vedanayagam J, Wen J, Smibert P, Loppin B, Lai EC . The hpRNA/RNAi pathway is essential to resolve intragenomic conflict

in the Drosophila male germline . Developmental Cell . 2018;46(3):316-326 .e5 . PMCID: PMC6114144

Lin DW, Crawford ED, Keane T, Evans B, Reid J, Rajamani S, Brown K, Gutin A, Tward J, Scardino P, Brawer M, Stone S, Cuzick J . Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance . Urologic Oncology: Seminars and Original Investigations . 2018;36(6):310 .e7-310 .e13 .

Lin H, Liu T, Shi C, Petillion S, Kindts I, Weltens C, Depuydt T, Song Y, Saleh Z, Xu XG, Tang X . Feasibility study of individualized optimal positioning selection for left-sided whole breast radiotherapy: DIBH or prone . Journal of Applied Clinical Medical Physics . 2018;19(2):218-229 . PMCID: PMC5849849

Lin JJ, Zhu VW, Schoenfeld AJ, Yeap BY, Saxena A, Ferris LA, Dagogo-Jack I, Farago AF, Taber A, Traynor A, Menon S, Gainor JF, Lennerz JK, Plodkowski AJ, Digumarthy SR, Ou SH I, Shaw AT, Riely GJ . Brigatinib in patients With alectinib-refractory ALK-positive NSCLC . Journal of Thoracic Oncology . 2018;13(10):1530-1538 .

Lin JX, Yi BC, Yoon C, Li P, Zheng CH, Huang CM, Yoon SS . Comparison of outcomes for elderly gastric cancer patients at least 80 years of age following gastrectomy in the United States and China . Annals of Surgical Oncology . 2018;25(12):3629-3638 . PMCID: PMC6292729

Lin KF, Stewart CR, Steig PE, Brennan CW, Gutin PH, Selesnick SH . Incidence of prolonged systemic steroid treatment after surgery for acoustic neuroma and its implications . Journal of Neurological Surgery . Part B: Skull Base . 2018;79(6):559-568 . PMCID: PMC6239872

Lin MY, Dobrotwir A, McNally O, Abu-Rustum NR, Narayan K . Role of imaging in the routine management of endometrial cancer . International Journal of Gynecology and Obstetrics . 2018;143(Suppl . 2):109-117 .

Lin O . Telecytology for rapid on-site evaluation: Current status . Journal of the American Society of Cytopathology . 2018;7(1):1-6 . PMCID: PMC5846691

Lin R, Xia S, Shan C, Chen D, Liu Y, Gao X, Wang M, Kang HB, Pan Y, Liu S, Chung YR, Abdel-Wahab O, Merghoub T, Rossi M, Kudchadkar RR, Lawson DH, Khuri FR, Lonial S, Chen J . The dietary supplement chondroitin-4-sulfate exhibits oncogene-specific pro-tumor effects on BRAF V600E melanoma cells . Molecular Cell . 2018;69(6):923-937 .e8 . PMCID: PMC5858191

Lin RJ, Green DL, Shah GL . Therapeutic anticoagulation in patients with primary brain tumors or secondary brain metastasis . The Oncologist . 2018;23(4):468-473 . PMCID: PMC5896701

Lin RJ, Ma H, Guo R, Troxel AB, Diefenbach CS . Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities . British Journal of Haematology . 2018;180(2):267-270 .

Lin RJ, Shahrokni A, Dahi PB, Jakubowski AA, Devlin SM, Maloy MA, Robinson KS, Perales MA, Shah GL, Korc-Grodzicki B, Giralt SA . Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: A single center experience . Bone Marrow Transplantation . 2018;53(9):1184-1187 .

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ . Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer . Endocrine-Related Cancer . 2018;25(10):853-864 .

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ . Activity of roniciclib in medullary thyroid cancer . Oncotarget . 2018;9(46):28030-28041 . PMCID: PMC6021325

Lin YH, Hong LX, Hunt MA, Berry SL . Use of a constrained hierarchical optimization dataset enhances knowledge-based planning as a quality assurance tool for prostate bed irradiation . Medical Physics . 2018;45(10):4364-4369 .

112 OF 288


Journal Articles

Lindeman N I, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y . Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase Inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology . Archives of Pathology & Laboratory Medicine . 2018;142(3):321-346 .

Lindeman N I, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y . Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology . Journal of Molecular Diagnostics . 2018;20(2):129-159 .

Lindeman N I, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y . Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology . Journal of Thoracic Oncology . 2018;13(3):323-358 .

Ling L, Kaplan SE, Lopez JC, Stiles J, Lu X, Tang YW . Parallel validation of three molecular devices for simultaneous detection and identification of influenza

A and B and respiratory syncytial viruses . Journal of Clinical Microbiology . 2018;56(3):e01691-17- . PMCID: PMC5824037

Lipitz-Snyderman A . Accountability for underuse and overuse of cancer screening . JAMA Internal Medicine . 2018;178(5):655-656 .

Lischalk JW, Sura K, Repka MC, Leeman JE, Osborn V, Engel S, Barry P . First Annual Report of the Resident Committee of the American College of Radiation Oncology . Journal of Radiation Oncology . 2018;7(1):1-5 .

Liu D, Offin M, Harnicar S, Li BT, Drilon A . Entrectinib: An orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors . Therapeutics and Clinical Risk Management . 2018;14:1247-1252 . PMCID: PMC6055893

Liu HY, Tuckett AZ, Fennell M, Garippa R, Zakrzewski JL . Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation . Investigational New Drugs . 2018;36(4):590-600 .

Liu J, Banchs J, Mousavi N, Plana JC, Scherrer-Crosbie M, Thavendiranathan P, Barac A . Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy . JACC: Cardiovascular Imaging . 2018;11(8):1122-1131 .

Liu M, Li S, Li MO . TGF-β control of adaptive immune tolerance: A break from Treg cells . BioEssays . 2018;40(11):1800063- .

Liu N, Molena D, Stem M, Blackford AL, Sewell DB, Lidor AO . Underutilization of treatment for regional gastric cancer among the elderly in the USA . Journal of Gastrointestinal Surgery . 2018;22(6):955-963 . PMCID: PMC5983904

Liu WA, Chen S, Li Z, Lee CH, Mirzaa G, Dobyns WB, Ross ME, Zhang J, Shi SH . PARD3 dysfunction in

conjunction with dynamic HIPPO signaling drives cortical enlargement with massive heterotopia . Genes and Development . 2018;32(11-12):763-780 .

Liu X, Zhang Y, Tang LL, Le QT, Chua MLK, Wee JTS, Lee NY, O’Sullivan B, Lee AWM, Sun Y, Ma J . Characteristics of radiotherapy trials compared with other oncological clinical trials in the past 10 years . JAMA Oncology . 2018;4(8):1073-1079 .

Liu Y, Kaljunen H, Pavić A, Saarenpaa T, Himanen JP, Nikolov DB, Goldman A . Binding of EphrinA5 to RET receptor tyrosine kinase: An in vitro study . PLoS ONE . 2018;13(6):e0198291- . PMCID: PMC5995387

Liu Y, Esyunina D, Olovnikov I, Teplova M, Kulbachinskiy A, Aravin AA, Patel DJ . Accommodation of helical imperfections in rhodobacter sphaeroides argonaute ternary complexes with guide RNA and target DNA . Cell Reports . 2018;24(2):453-462 .

Liu Y, Gaisa MM, Wang X, Swartz TH, Arens Y, Dresser KA, Sigel C, Sigel K . Differences in the immune microenvironment of anal cancer precursors by HIV status and association with ablation outcomes . Journal of Infectious Diseases . 2018;217(5):703-709 . PMCID: PMC5853940

Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina A I, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, The Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW . Comparative molecular analysis of gastrointestinal adenocarcinomas . Cancer Cell . 2018;33(4):721-735 .e8 .

Liu Y, Mondello P, Erazo T, Tannan NB, Asgari Z, de Stanchina E, Nanjangud G, Seshan VE, Wang S, Wendel HG, Younes A . NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death . Proceedings of the National Academy of Sciences of the United

113 OF 288


Journal Articles

States of America . 2018;115(47):12034-12039 . PMCID: PMC6255185

Liu YL, Connolly EP, Kalinsky K . Obesity’s impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer . Breast Cancer Research and Treatment . 2018;168(1):285- .

Liu YL, Chin C, Catanese B, Lee SM, Zhan S, Kalinsky K, Connolly EP . Concurrent use of capecitabine with radiation therapy and survival in breast cancer (BC) after neoadjuvant chemotherapy . Clinical & Translational Oncology . 2018;20(10):1280-1288 .

Liu YL, Zamarin D . Combination immune checkpoint blockade strategies to maximize immune response in gynecological cancers . Current Oncology Reports . 2018;20(12):94- . PMCID: PMC6244932

Livshits G, Alonso-Curbelo D, Morris JP 4th, Koche R, Saborowski M, Wilkinson JE, Lowe SW . Arid1a restrains Kras-dependent changes in acinar cell identity . eLife . 2018;7:e35216- . PMCID: PMC6050044

Liyanage UE, Law MH, Ong JS, Cust AE, Mann GJ, Ward S V, Melanoma Meta-Analysis Consortium, Gharahkhani P, Iles MM, MacGregor S . Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis . International Journal of Cancer . 2018;143(3):508-514 .

Lloyd R V, Asa SL, LiVolsi VA, Sadow PM, Tischler AS, Ghossein RA, Tuttle RM, Nikiforov YE . The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) . Human Pathology . 2018;74:1-4 .

Lopez-Lopez V, Robles-Campos R, Brusadin R, Lopez-Conesa A, Navarro Á, Arevalo-Perez J, Gil PJ, Parrilla P . Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma . Oncotarget . 2018;9(46):28267-28280 . PMCID: PMC6021344

Lockau H, Neuschmelting V, Ogirala A, Vilaseca A, Grimm J . Dynamic (18)F-FDG PET lymphography for in vivo identification of lymph node metastases in murine melanoma . Journal of Nuclear Medicine . 2018;59(2):210-215 . PMCID: PMC5807531

Lockney DT, Jia AY, Lis E, Lockney NA, Liu C, Hopkins B, Higginson DS, Yamada Y, Laufer I, Bilsky M, Schmitt AM . Myositis following spine radiosurgery for metastatic disease: A case series . Journal of Neurosurgery-Spine . 2018;28(4):416-421 .

Lockney NA, Wang DG, Pei X, Goldman DA, Zhang Z, Lin A, Chan TA, Yamada Y, Beal K, Yang TJ . Phosphatidylinositol-3-kinase mutations are associated with increased local failure in brain metastases treated with radiation . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):833-844 .

Logan SL, Thomas J, Yan J, Baker RP, Shields DS, Xavier JB, Hammer BK, Parthasarathy R . The Vibrio cholerae type VI secretion system can modulate host intestinal mechanics to displace gut bacterial symbionts . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(16):E3779-E3787 .PMCID: PMC5910850

Logothetis C, Morris MJ, Den R, Coleman RE . Current perspectives on bone metastases in castrate-resistant prostate cancer . Cancer and Metastasis Reviews . 2018;37(1):189-196 . PMCID: PMC5801387

Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Baldini C, Rodrigues M, Lichtman SM, Wildiers H . What every oncologist should know about geriatric assessment for older patients with cancer: Young International Society of Geriatric Oncology position paper . Journal of Oncology Practice . 2018;14(2):85-94 .PMCID: PMC5812308

Loh PR, Genovese G, Handsaker RE, Finucane HK, Reshef YA, Palamara PF, Birmann BM, Talkowski ME, Bakhoum SF, McCarroll SA, Price AL . Insights into clonal haematopoiesis from

8,342 mosaic chromosomal alterations . Nature . 2018;559(7714):350-355 . PMCID: PMC6054542

Longacre ML, Applebaum AJ, Buzaglo JS, Miller MF, Golant M, Rowland JH, Given B, Dockham B, Northouse L . Reducing informal caregiver burden in cancer: Evidence-based programs in practice . Translational Behavioral Medicine . 2018;8(2):145-155 . PMCID: PMC6257028

Lorente D, Olmos D, Mateo J, Dolling D, Bianchini D, Seed G, Flohr P, Crespo M, Figueiredo I, Miranda S, Scher H I, Terstappen LWMM, de Bono JS . Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts . Annals of Oncology . 2018;29(7):1554-1560 .

Loupakis F, Hurwitz H I, Saltz L, Arnold D, Grothey A, Nguyen QL, Osborne S, Talbot J, Srock S, Lenz HJ . Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer . British Journal of Cancer . 2018;119(12):1451-1455 .

Lowery-Allison AE, Passik SD, Cribbet MR, Reinsel RA, O’Sullivan B, Norton L, Kirsh KL, Kavey NB . Sleep problems in breast cancer survivors 1-10 years posttreatment . Palliative and Supportive Care . 2018;16(3):325-334 .

Lowery MA, Kelsen DP, Capanu M, Smith SC, Lee JW, Stadler ZK, Moore MJ, Kindler HL, Golan T, Segal A, Maynard H, Hollywood E, Moynahan M, Salo-Mullen EE, Do RKG, Chen AP, Yu KH, Tang LH, O’Reilly EM . Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma . European Journal of Cancer . 2018;89:19-26 .

Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M, Kemeny NE, O’Reilly EM, El-Dika I, Jarnagin WR, Harding JJ, D’Angelica M I, Cercek A, Hechtman JF, Solit DB, Schultz N, Hyman DM, Klimstra DS, Saltz LB, Abou-Alfa GK .

114 OF 288


Journal Articles

Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention . Clinical Cancer Research . 2018;24(17):4154-4161 .

Lowry KP, Braunstein LZ, Economopoulos KP, Salama L, Lehman CD, Gazelle GS, Halpern EF, Giess CS, Taghian AG, Lee JM . Predictors of surveillance mammography outcomes in women with a personal history of breast cancer . Breast Cancer Research and Treatment . 2018;171(1):209-215 .

Loyher PL, Hamon P, Laviron M, Meghraoui-Kheddar A, Goncalves E, Deng Z, Torstensson S, Bercovici N, de Chanville CB, Combadière B, Geissmann F, Savina A, Combadière C, Boissonnas A . Macrophages of distinct origins contribute to tumor development in the lung . Journal of Experimental Medicine . 2018;215(9):2536-2553 . PMCID: PMC6170177

Lozada JR, Basili T, Pareja F, Alemar B, Da Cruz Paula A, Gularte-Merida R, Giri DD, Querzoli P, Cserni G, Rakha EA, Foschini MP, Reis-Filho JS, Brogi E, Weigelt B, Geyer FC . Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: A validation cohort . Histopathology . 2018;73(2):339-344 .

Lu C, Alex D, Benayed R, Rosenblum M, Hameed M . Solitary fibrous tumor with neuroendocrine and squamous dedifferentiation: A potential diagnostic pitfall . Human Pathology . 2018;77:175-180 . PMCID: PMC6019107

Lu M, Sanderson SM, Zessin A, Ashcraft KA, Jones LW, Dewhirst MW, Locasale JW, Hsu DS . Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer . Cancer & Metabolism . 2018;6:14- . PMCID: PMC6237036

Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK,

Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, Bandera E V, Barkardottir RB, Barnes DR, Benitez J, Bjorge L, Brenton J, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Claes KBM, Couch FJ, Cramer DW, Daly MB, deFazio A, Dennis J, Diez O, Domchek SM, Dörk T, Easton DF, Eccles DM, Fasching PA, Fortner RT, Fountzilas G, Friedman E, Ganz PA, Garber J, Giles GG, Godwin AK, Goldgar DE, Goodman MT, Greene MH, Gronwald J, Hamann U, Heitz F, Hildebrandt MAT, Høgdall CK, Hollestelle A, Hulick PJ, Huntsman DG, Imyanitov EN, Isaacs C, Jakubowska A, James P, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Kwong A, Le ND, Leslie G, Lesueur F, Levine DA, Mattiello A, May T, McGuffog L, McNeish IA, Merritt MA, Modugno F, Montagna M, Neuhausen SL, Nevanlinna H, Nielsen FC, Nikitina-Zake L, Nussbaum RL, Offit K, Olah E, Olopade O I, Olson SH, Olsson HK, Osorio A, Park SK, Parsons MT, Peeters PHM, Pejovic T, Peterlongo P, Phelan CM, Pujana MA, Ramus SJ, Rennert G, Risch H, Rodriguez GC, Rodríguez-Antona C, Romieu I, Rookus MA, Rossing MA, Rzepecka IK, Sandler DP, Schmutzler RK, Setiawan VW, Sharma P, Sieh W, Simard J, Singer CF, Song H, Southey MC, Spurdle AB, Sutphen R, Swerdlow AJ, Teixeira MR, Teo SH, Thomassen M, Tischkowitz M, Toland AE, Trichopoulou A, Tung N, Tworoger SS, van Rensburg EJ, Vanderstichele A, Vega A, Velez Edwards D, Webb PM, Weitzel JN, Wentzensen N, White E, Wolk A, Wu AH, Yannoukakos D, Zorn KK, Gayther SA, Antoniou AC, Berchuck A, Goode EL, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J . A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk . Cancer Research . 2018;78(18):5419-5430 . PMCID: PMC6139053

Lu Z, Xu J, Xu M, Rossi GC, Majumdar S, Pasternak GW, Pan YX . Truncated μ-opioid receptors with 6 transmembrane domains are essential for opioid analgesia . Anesthesia and Analgesia . 2018;126(3):1050-1057 .PMCID: PMC5820199

Lubetkin E I, Guidry JA, Webb A, Ocampo A, Burkhalter JE . Examining transdiagnostic vulnerabilities among HIV positive smokers seen at three inner city community based organizations . AIDS Care . 2018;30(2):140-145 .PMCID: PMC6075673

Lucas AS, Lacouture M, Thompson J, Schneider SM . Radiation dermatitis: A prevention protocol for patients with breast cancer . Clinical Journal of Oncology Nursing . 2018;22(4):429-437 .

Luckenbaugh AN, Auffenberg GB . Leveraging the clinical collaborative model to drive value improvement . Current Opinion in Urology . 2018;28(4):348-353 .

Lukaszewicz A, Lange J, Keeney S, Jasin M . Control of meiotic double-strand-break formation by ATM: Local and global views . Cell Cycle . 2018;17(10):1155-1172 . PMCID: PMC6110601

Luo CT, Li MO . Foxo transcription factors in T cell biology and tumor immunity . Seminars in Cancer Biology . 2018;50:13-20 . PMCID: PMC5986613

Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj G V . Role of androgen receptor variants in prostate cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting . European Urology . 2018;73(5):715-723 . PMCID: PMC5929166

Luo M . Chemical and biochemical perspectives of protein lysine methylation . Chemical Reviews . 2018;118(14):6656-6705 .

Luo W, Xu C, Ayello J, Dela Cruz F, Rosenblum JM, Lessnick SL, Cairo MS . Protein phosphatase 1 regulatory subunit 1A in Ewing sarcoma tumorigenesis and metastasis . Oncogene . 2018;37(6):798-809 .

115 OF 288


Journal Articles

Álvarez-Fernandez M, Sanz-Flores M, Sanz-Castillo B, Salazar-Roa M, Partida D, Zapatero-Solana E, Ali HR, Manchado E, Lowe S, VanArsdale T, Shields D, Caldas C, Quintela-Fandino M, Malumbres M . Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer . Cell Death and Differentiation . 2018;25(5):828-840 .

Lydiatt W, O’Sullivan B, Patel S . Major changes in head and neck staging for 2018 . American Society of Clinical Oncology Educational Book . 2018;38:505-514 .

Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L . Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline . Journal of Clinical Oncology . 2018;36(25):2647-2655 .

Lynch DA, Sverzellati N, Travis WD, Colby T V, Inoue Y, Nicholson AG, Raoof S, Richeldi L, Ryerson CJ, Ryu JH . Diagnostic criteria for idiopathic pulmonary fibrosis – Authors’ reply . The Lancet Respiratory Medicine . 2018;6(2):e7- .

Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby T V, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU . Diagnostic criteria for idiopathic pulmonary fibrosis: A Fleischner Society white paper . The Lancet Respiratory Medicine . 2018;6(2):138-153 .

Lyons TG, Dickler MN, Comen EE . Checkpoint inhibitors in the treatment of breast cancer . Current Oncology Reports . 2018;20(7):51- .

Lyons TG, Robson ME . Resurrection of PARP inhibitors in breast cancer . Journal of the National Comprehensive Cancer Network . 2018;16(9):1150-1156 .

Ma J, Setton J, Lee NY, Riaz N, Powell SN . The therapeutic significance of mutational signatures

from DNA repair deficiency in cancer . Nature Communications . 2018;9:3292- . PMCID: PMC6098043

Ma J, Shen Z, Yu YC, Shi SH . Neural lineage tracing in the mammalian brain . Current Opinion in Neurobiology . 2018;50:7-16 . PMCID: PMC5938148

Ma W, Mayr C . A membraneless organelle associated with the endoplasmic reticulum enables 3’UTR-mediated protein-protein interactions . Cell . 2018;175(6):1492-1506 .

Maag JL V . gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2 . F1000Research . 2018;7:1576- . PMCID: PMC6208569

Machida H, Mandelbaum RS, Mikami M, Enomoto T, Sonoda Y, Grubbs BH, Paulson RJ, Roman LD, Wright JD, Matsuo K . Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: Trachelectomy vs hysterectomy . American Journal of Obstetrics and Gynecology . 2018;219(5):461 .e1-461 .e18 .

Madera S, Geary CD, Lau CM, Pikovskaya O, Reiner SL, Sun JC . Cutting edge: Divergent requirement of T-box transcription factors in effector and memory NK cells . Journal of Immunology . 2018;200(6):1977-1981 . PMCID: PMC5840019

Magbanua MJM, Rugo HS, Wolf DM, Hauranieh L, Roy R, Pendyala P, Sosa E V, Scott JH, Lee JS, Pitcher B, Hyslop T, Barry WT, Isakoff SJ, Dickler M, van’t Veer L, Park JW . Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time (CALGB 40502 and CALGB 40503, Alliance) . Clinical Cancer Research . 2018;24(6):1486-1499 . PMCID: PMC5856614

Mahajan S, Shaha A, Grewal RK . Incidental detection of medullary thyroid carcinoma by (68)Ga-DOTATATE PET/CT in a patient with neuroendocrine tumor liver

metastases . Clinical Nuclear Medicine . 2018;43(2):136-138 . PMCID: PMC5752440

Mahajan S, Goel R, Riedl C, Ulaner GA . Mazabraud’s syndrome mimicking metastases on FDG PET/CT in a patient with colon cancer . Clinical Nuclear Medicine . 2018;43(8):625-626 .

Mahajan S, Dunphy MP, Haque S, Pandit-Taskar N . Solitary orbital metastasis in carcinoma esophagus: Findings on serial (18)F-FDG PET/CT scans . Clinical Nuclear Medicine . 2018;43(1):19-22 .

Mahajan S, Schoder H . Ectopic undescended parathyroid adenoma - SPECT/CT avoids false-negative interpretation on (99m)Tc-MIBI dual-phase scintigraphy . Clinical Nuclear Medicine . 2018;43(3):199-200 .

Mahal BA, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D’Amico A V . Early versus delayed initiation of salvage androgen deprivation therapy and risk of prostate cancer-specific mortality . Journal of the National Comprehensive Cancer Network . 2018;16(6):727-734 .

Mahmood SS, Fradley MG, Cohen J V, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD, Neilan TG . Myocarditis in patients treated with immune checkpoint inhibitors . Journal of the American College of Cardiology . 2018;71(16):1755-1764 .

Mahmood SS, Chen CL, Shapnik N, Krishnan U, Singh HS, Makker V . Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report . Gynecologic Oncology Reports . 2018;25:74-77 . PMCID: PMC6005798

Mahmood U, Horvat N, Horvat J V, Ryan D, Gao Y, Carollo G, DeOcampo R, Do RK, Katz S, Gerst S, Schmidtlein CR, Dauer L, Erdi Y, Mannelli L . Rapid

116 OF 288


Journal Articles

switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams . European Journal of Radiology . 2018;102:102-108 . PMCID: PMC5918634

Mai TT, Lito P . A treatment strategy for KRAS-driven tumors . Nature Medicine . 2018;24(7):902-904 .

Maiga AW, Deppen SA, Mercaldo SF, Blume JD, Montgomery C, Vaszar LT, Williamson C, Isbell JM, Rickman OB, Pinkerman R, Lambright ES, Nesbitt JC, Grogan EL . Assessment of fluorodeoxyglucose F18-labeled positron emission tomography for diagnosis of high-risk lung nodules . JAMA Surgery . 2018;153(4):329-334 . PMCID: PMC5910279

Mailankody S, Prasad V . Overall survival vs disease-specific survival - In reply . JAMA Oncology . 2018;4(4):586-587 .

Mailankody S, Bach PB . Money-back guarantees for expensive drugs: Wolf’s clothing but a sheep underneath . Annals of Internal Medicine . 2018;168(12):888-889 .

Majumdar S, Devi LA . Strategy for making safer opioids bolstered . Nature . 2018;553(7688):286-288 .

Makkar P, Mehta V, Vander Els N . A case of steroid-induced diffuse alveolar hemorrhage . Lung India . 2018;35(6):532-533 . PMCID: PMC6219135

Makohon-Moore AP, Matsukuma K, Zhang M, Reiter JG, Gerold JM, Jiao Y, Sikkema L, Attiyeh MA, Yachida S, Sandone C, Hruban RH, Klimstra DS, Papadopoulos N, Nowak MA, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA . Precancerous neoplastic cells can move through the pancreatic ductal system . Nature . 2018;561(7722):201-205 .

Malard F, Labopin M, Cho C, Blaise D, Papadopoulos EB, Passweg J, O’Reilly R, Forcade E, Maloy M, Volin L, Castro-Malaspina H, Hicheri Y, Jakubowski AA, Orvain C, Giralt S, Mohty M, Nagler A, Perales MA . Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid

leukemia in first complete remission resulted in similar overall survival: On behalf of the ALWP of the EBMT and the MSKCC . Journal of Hematology & Oncology . 2018;11:127- . PMCID: PMC6195954

Mally AD, Tin AL, Lee JK, Satasivam P, Cha EK, Donat SM, Herr HW, Bochner BH, Sjoberg DD, Dalbagni G . Clinical outcomes of patients with T1 nested variant of urothelial carcinoma compared to pure urothelial carcinoma of the bladder . Clinical Genitourinary Cancer . 2018;16(1):e23-e27 . PMCID: PMC5767538

Malyarenko D, Fedorov A, Bell L, Prah M, Hectors S, Arlinghaus L, Muzi M, Solaiyappan M, Jacobs M, Fung M, Shukla-Dave A, McManus K, Boss M, Taouli B, Yankeelov TE, Quarles CC, Schmainda K, Chenevert TL, Newitt DC . Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies . Journal of Medical Imaging . 2018;5(1):011006- .PMCID: PMC5658654

Mancini J, Briggs A, Elkin EB, Regan J, Hickey C, Targett C, Ager R, Masuda S, Bach PB, Sabbatini PJ . The impact of patient education on consideration of enrollment in clinical trials . Journal of Community and Supportive Oncology . 2018;16(2):e81-e88 .

Mandel JE, Morel-Ovalle L, Boas FE, Ziv E, Yarmohammadi H, Deipolyi A, Mohabir HR, Erinjeri JP . Optimizing travel time to outpatient interventional radiology procedures in a multi-site hospital system using a Google Maps application . Journal of Digital Imaging . 2018;31(5):591-595 . PMCID: PMC6148822

Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, Graham D, Zhou X, Clapp J, Zhai W, Breen E, Carroll JE, Denduluri N, Dilawari A, Extermann M, Isaacs C, Jacobsen PB, Kobayashi LC, Holohan Nudelman K, Root J, Stern RA, Tometich D, Turner R, VanMeter JW, Saykin AJ, Ahles T . Cancer-related cognitive outcomes among older

breast cancer survivors in the Thinking and Living with Cancer study . Journal of Clinical Oncology . 2018;36(32):3211-3222 .

Mandelker D, Zhang L . The emerging significance of secondary germline testing in cancer genomics . Journal of Pathology . 2018;244(5):610-615 .

Mango V, Bryce Y, Morris EA, Gianotti E, Pinker K . Commentary ACOG Practice Bulletin July 2017: Breast cancer risk assessment and screening in average-risk women . British Journal of Radiology . 2018;91(1090):20170907- .

Mango VL, Goodman S, Clarkin K, Wynn RT, Friedlander L, Hibshoosh H, Ha R . The unusual suspects: A review of unusual benign and malignant male breast imaging cases . Clinical Imaging . 2018;50:78-85 .

Mangurian C, Packman W, Riano NS, Kearney J . The need to support caregivers during pediatric bone marrow transplantation (BMT): A case report . Palliative and Supportive Care . 2018;16(3):367-370 .

Manhart A, Windner S, Baylies M, Mogilner A . Mechanical positioning of multiple nuclei in muscle cells . PLoS Computational Biology . 2018;14(6):e1006208- . PMCID: PMC6013246

Manley PE, Trippett T, Smith AA, Macy ME, Leary SES, Boklan J, Cohen KJ, Goldman S, Kilburn LB, Dhall G, Devin J, Herzog CE, Partap S, Fauchet F, Badreddine E, Bernard JP, Chi SN . A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system . Pediatric Blood and Cancer . 2018;65(9):e27217- .

Manne S, Kashy DA, Zaider T, Lee D, Kim IY, Heckman C, Penedo F, Kissane D, Virtue SM . Interpersonal processes and intimacy among men with localized prostate cancer and their partners . Journal of Family Psychology . 2018;32(5):664-675 . PMCID: PMC6072581

117 OF 288


Journal Articles

Manne SL, Kashy DA, Virtue S, Criswell KR, Kissane DW, Ozga M, Heckman CJ, Stapleton J, Rodriguez L . Acceptance, social support, benefit-finding, and depression in women with gynecological cancer . Quality of Life Research . 2018;27(11):2991-3002 . PMCID: PMC6196117

Manning EP, Moskowitz CS . Is repeating direct-fluorescent antibody testing for influenza beneficial? . Connecticut Medicine . 2018;82(8):487-488 .

Mano R, Zilber S, Di Natale RG, Kedar D, Lifshitz DA, Yossepowitch O, Baniel J, Margel D . Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy . Urologic Oncology: Seminars and Original Investigations . 2018;36(12):531 .e9-531 .e17 . PMCID: PMC6289697

Mantha S, Tallman MS, Devlin SM, Soff GA . Predictive factors of fatal bleeding in acute promyelocytic leukemia . Thrombosis Research . 2018;164(Suppl . 1):S98-S102 .

Manzanares A, Restrepo-Perdomo CA, Botteri G, Castillo-Ecija H, Pascual-Pasto G, Cano F, Garcia-Alvarez L, Monterrubio C, Ruiz B, Vazquez-Carrera M, Suñol M, Mora J, Tornero JA, Sosnik A, Carcaboso AM . Tissue compatibility of SN-38-loaded anticancer nanofiber matrices . Advanced Healthcare Materials . 2018;7(15):1800255- .

Mao H, Bao T, Shen X, Li Q, Seluzicki C, Im EO, Mao JJ . Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors . European Journal of Cancer . 2018;101:47-54 .

Mao JJ, Farrar JT . Acupuncture for aromatase inhibitor-related joint pain among breast cancer patients - To the editor . JAMA - Journal of the American Medical Association . 2018;320(21):2269-2270 .

Marcellino BK, Hoffman R, Tripodi J, Lu M, Kosiorek H, Mascarenhas J, Rampal RK, Dueck

A, Najfeld V . Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53 . Blood Advances . 2018;2(24):3581-3589 . PMCID: PMC6306879

Marchetti MA, Marino ML, Virmani P, Dusza SW, Marghoob AA, Nazzaro G, Lallas A, Landi C, Cabo H, Quiñones R, Gomez E, Puig S, Carrera C . Dermoscopic features and patterns of poromas: A multicentre observational case–control study conducted by the International Dermoscopy Society . Journal of the European Academy of Dermatology and Venereology . 2018;32(8):1263-1271 . PMCID: PMC5984114

Marchetti MA, Codella NCF, Dusza SW, Gutman DA, Helba B, Kalloo A, Mishra N, Carrera C, Celebi ME, DeFazio JL, Jaimes N, Marghoob AA, Quigley E, Scope A, Yélamos O, Halpern AC, for the International Skin Imaging Collaboration . Results of the 2016 International Skin Imaging Collaboration International Symposium on Biomedical Imaging challenge: Comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images . Journal of the American Academy of Dermatology . 2018;78(2):270-277 .e1 . PMCID: PMC5768444

Marchio C, Dell’Orto P, Annaratone L, Geyer FC, Venesio T, Berrino E, di Cantogno L V, Garofoli A, Rangel N, Casorzo L, dell’Aglio C, Gugliotta P, Trisolini E, Beano A, Pietribiasi F, Orlassino R, Cassoni P, Pich A, Montemurro F, Mottolese M, Vincent-Salomon A, Penault-Llorca F, Medico E, Ng CKY, Viale G, Sapino A . The dilemma of HER2 double-equivocal breast carcinomas: Genomic profiling and implications for treatment . American Journal of Surgical Pathology . 2018;42(9):1190-1200 . PMCID: PMC6110371

Marciscano AE, Thorek DLJ . Role of noninvasive molecular imaging in determining response . Advances in Radiation Oncology . 2018;3(4):534-547 . PMCID: PMC6200886

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG . Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy . Clinical Cancer Research . 2018;24(20):5058-5071 .

Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J, for the Timing of Rectal Cancer Response to Chemoradiation Consortium . Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: Final results of a multicenter phase II trial . Diseases of the Colon and Rectum . 2018;61(10):1146-1155 . PMCID: PMC6130918

Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A . External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma . World Journal of Urology . 2018;36(12):1973-1980 .

Marghoob AA, Marchetti M, Halpern AC, Busam KJ . Comment on: Screening for malignant melanoma - A critical assessment in historical perspective . Dermatology Practical & Conceptual . 2018;8(2):73-74 . PMCID: PMC5955071

Marghoob AA, Marchetti MA, Dusza SW . Performance of dermatology physician assistants . JAMA Dermatology . 2018;154(10):1229- .

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D’Angelica M I, Weiss MJ . Genetic

118 OF 288


Journal Articles

And Morphological Evaluation (GAME) score for patients with colorectal liver metastases . British Journal of Surgery . 2018;105(9):1210-1220 .

Marians KJ . Lesion bypass and the reactivation of stalled replication forks . Annual Review of Biochemistry . 2018;87:217-238 .

Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE 3rd, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, Şenbabaoǧlu Y, Santoro S, Sheinson D, Hung J, Giltnane JM, Pierce AA, Mesh K, Lianoglou S, Riegler J, Carano RAD, Eriksson P, Höglund M, Somarriba L, Halligan DL, van der Heijden MS, Loriot Y, Rosenberg JE, Fong L, Mellman I, Chen DS, Green M, Derleth C, Fine GD, Hegde PS, Bourgon R, Powles T . TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells . Nature . 2018;554(7693):544-548 .

Marino MA, Riedl CC, Bernathova M, Bernhart C, Baltzer PAT, Helbich TH, Pinker K . Imaging phenotypes in women at high risk for breast cancer on mammography, ultrasound, and magnetic resonance imaging using the fifth edition of the Breast Imaging Reporting and Data System . European Journal of Radiology . 2018;106:150-159 .

Marino MA, Helbich T, Baltzer P, Pinker-Domenig K . Multiparametric MRI of the breast: A review . Journal of Magnetic Resonance Imaging . 2018;47(2):301-315 .

Markovsky E, de Stanchina E, Itzkowitz A, Haimovitz-Friedman A, Rotenberg SA . Phosphorylation state of Ser(165) in α-tubulin is a toggle switch that controls proliferating human breast tumors . Cellular Signalling . 2018;52:74-82 .

Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM . Pericardial effusion in Hodgkin lymphoma: A report from the Children’s Oncology Group AHOD0031 protocol . Blood . 2018;132(11):1208-1211 .PMCID: PMC6137557

Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL . Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children’s Oncology Group . Pediatric Blood and Cancer . 2018;65(12):e27375- . PMCID: PMC6192844

Marlow LA, Rohl SD, Miller JL, Knauf JA, Fagin JA, Ryder M, Milosevic D, Netzel BC, Grebe SK, Reddi H V, Smallridge RC, Copland JA . Methodology, criteria, and characterization of patient-matched thyroid cell lines and patient-derived tumor xenografts . Journal of Clinical Endocrinology and Metabolism . 2018;103(9):3169-3182 . PMCID: PMC6126888

Marsh RA, Hebert KM, Keesler D, Boelens JJ, Dvorak CC, Eckrich MJ, Kapoor N, Parikh S, Eapen M . Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies . Journal of Allergy and Clinical Immunology . 2018;142(6):2004-2007 .

Marsolier-Kergoat MC, Khan M, Schott J, Zhu X, Llorente B . Mechanistic view and genetic control of DNA recombination during meiosis . Molecular Cell . 2018;70(1):9-20 .e6 .

Marti JL, Morris LGT, Ho AS . Selective use of radioactive iodine (RAI) in thyroid cancer: No longer “one size fits all” . European Journal of Surgical Oncology . 2018;44(3):348-356 .

Martínez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramírez-Alejo N, Mele F, Latorre D, Mahdaviani SA, Aytekin C, Mansouri D, Bryant VL, Jabot-Hanin F, Deswarte C, Nieto-Patlan A, Surace L, Kerner G, Itan Y, Jovic S, Avery DT, Wong N, Rao G, Patin E, Okada S, Bigio B, Boisson B, Rapaport F, Seeleuthner Y, Schmidt M, Ikinciogullari A, Dogu F, Tanir G, Tabarsi P, Bloursaz MR, Joseph JK, Heer A, Kong XF, Migaud M, Lazarov T, Geissmann F, Fleckenstein B, Arlehamn CL, Sette A, Puel A, Emile JF, van de Vosse E, Quintana-Murci L, Di Santo JP, Abel L, Boisson-Dupuis S, Bustamante J, Tangye SG,

Sallusto F, Casanova JL . Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23 . Science Immunology . 2018;3(30):eaau6759- . PMCID: PMC6380365

Martin LW, Sarosiek BM, Harrison MA, Hedrick T, Isbell JM, Krupnick AS, Lau CL, Mehaffey JH, Thiele RH, Walters DM, Blank RS . Implementing a thoracic enhanced recovery program: Lessons learned in the first year . Annals of Thoracic Surgery . 2018;105(6):1597-1604 .

Martin M, Sabari JK, Turashvili G, Halpenny DF, Rizvi H, Shapnik N, Makker V . Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors . Gynecologic Oncology Reports . 2018;24:94-98 . PMCID: PMC6003430

Martin ML, Zeng Z, Adileh M, Jacobo A, Li C, Vakiani E, Hua G, Zhang L, Haimovitz-Friedman A, Fuks Z, Kolesnick R, Paty PB . Logarithmic expansion of LGR5(+) cells in human colorectal cancer . Cellular Signalling . 2018;42:97-105 . PMCID: PMC5766032

Martins CO, Lezcano C, Yi S, Landau HJ, Chapman JR, Dogan A . Novel iatrogenic amyloidosis caused by peptide drug liraglutide: A clinical mimic of AL amyloidosis . Haematologica . 2018;103(12):E610-E612 . PMCID: PMC6269298

Marturano-Kruik A, Villasante A, Yaeger K, Ambati SR, Chramiec A, Raimondi MT, Vunjak-Novakovic G . Biomechanical regulation of drug sensitivity in an engineered model of human tumor . Biomaterials . 2018;150:150-161 . PMCID: PMC5660643

Maryanovich M, Zahalka AH, Pierce H, Pinho S, Nakahara F, Asada N, Wei Q, Wang X, Ciero P, Xu J, Leftin A, Frenette PS . Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche . Nature Medicine . 2018;24(6):782-791 .

Marziliano A, Pessin H, Rosenfeld B, Breitbart W . Measuring cohesion and self-disclosure in

119 OF 288


Journal Articles

psychotherapy groups for patients with advanced cancer: An analysis of the psychometric properties of the Group Therapy Experience Scale . International Journal of Group Psychotherapy . 2018;68(3):407-427 .

Marzouk K, Tin A, Liu N, Sjoberg D, Hakimi AA, Russo P, Coleman J . The natural history of large renal masses followed on observation . Urologic Oncology: Seminars and Original Investigations . 2018;36(8):362 .e17-362 .e21 .

Marzouk K, Ehdaie B . New imaging techniques in prostate cancer . Cancer Treatment and Research . 2018;175:1-13 .

Marzouk K, Assel M, Ehdaie B, Vickers A . Long-term cancer specific anxiety in men undergoing active surveillance of prostate cancer: Findings from a large prospective cohort . Journal of Urology . 2018;200(6):1250-1254; discussion 1254-1255 .

Mashour GA, Ben Abdallah A, Pryor KO, El-Gabalawy R, Vlisides PE, Jacobsohn E, Lenze E, Maybrier HR, Veselis RA, Avidan MS, on behalf of the PODCAST Research Group . Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: An international, multicentre, double-blind, randomised clinical trial . British Journal of Anaesthesia . 2018;121(5):1075-1083 . PMCID: PMC6208292

Maslak PG, Dao T, Bernal Y, Chanel SM, Zhang R, Frattini M, Rosenblat T, Jurcic JG, Brentjens RJ, Arcila ME, Rampal R, Park JH, Douer D, Katz L, Sarlis N, Tallman MS, Scheinberg DA . Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia . Blood Advances . 2018;2(3):224-234 . PMCID: PMC5812332

Masterson MP, Applebaum AJ, Buda K, Reisch S, Rosenfeld B . Don’t shoot the messenger: Experiences of delivering prognostic information in the context of advanced cancer . American Journal of Hospice & Palliative Medicine . 2018;35(12):1526-1531 .

Masterson MP, Slivjak E, Jankauskaite G, Breitbart W, Pessin H, Schofield E, Holland J, Lichtenthal WG . Beyond the bucket list: Unfinished and business among advanced cancer patients . Psycho-Oncology . 2018;27(11):2573-2580 . PMCID: PMC6219918

Mateo J, Chakravarty D, Dienstmann R, Jezdic S, Gonzalez-Perez A, Lopez-Bigas N, Ng CKY, Bedard PL, Tortora G, Douillard JY, Van Allen EM, Schultz N, Swanton C, André F, Pusztai L . A framework to rank genomic alterations as targets for cancer precision medicine: The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) . Annals of Oncology . 2018;29(9):1895-1902 . PMCID: PMC6158764

Matin SF, Coleman JA . Misclassification of upper tract urothelial carcinoma in patients with Lynch syndrome . JAMA Oncology . 2018;4(7):1010- .

Mato A, Jahnke J, Li P, Mehra M, Ladage VP, Mahler M, Huntington S, Doshi JA . Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era . Haematologica . 2018;103(10):e462-e465 . PMCID: PMC6165790

Mato AR, Samp JC, Gauthier G, Terasawa E, Brander DM . Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies . Cancer Biology and Therapy . 2018;19(7):636-643 . PMCID: PMC5989798

Mato AR, Roeker LE, Allan JN, Pagel JM, Brander DM, Hill BT, Cheson BD, Furman RR, Lamanna N, Tam CS, Handunnetti S, Jacobs R, Lansigan F, Bhavsar E, Barr PM, Shadman M, Skarbnik AP, Goy A, Beach DF, Svoboda J, Pu JJ, Sehgal AR, Zent CS, Tuncer HH, Schuster SJ, Pickens P V, Shah NN, Rhodes J, Ujjani CS, Nabhan C . Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial . American Journal of Hematology . 2018;93(11):1394-1401 .

Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs

R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens P V, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C . Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States . Haematologica . 2018;103(9):1511-1517 . PMCID: PMC6119152

Matros E, Disa JJ . Discussion: The cost of contralateral prophylactic mastectomy in women with unilateral breast cancer . Plastic and Reconstructive Surgery . 2018;141(5):1103-1104 .

Mattar M, McCarthy CR, Kulick AR, Qeriqi B, Guzman S, de Stanchina E . Establishing and maintaining an extensive library of patient-derived xenograft models . Frontiers in Oncology . 2018;8:19- . PMCID: PMC5825907

Matuszak MM, Fuller CD, Yock T I, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M . Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology . Medical Physics . 2018;45(10):e811-e819 .

Mauguen A, Seshan VE, Ostrovnaya I, Begg CB . Estimating the probability of clonal relatedness of pairs of tumors in cancer patients . Biometrics . 2018;74(1):321-330 . PMCID: PMC5677588

Mayo CS, Phillips M, McNutt TR, Palta J, Dekker A, Miller RC, Xiao Y, Moran JM, Matuszak MM, Gabriel P, Ayan AS, Prisciandaro J, Thor M, Dixit N, Popple R, Killoran J, Kaleba E, Kantor M, Ruan D, Kapoor R, Kessler ML, Lawrence TS . Treatment data and technical process challenges for practical big data

120 OF 288


Journal Articles

efforts in radiation oncology . Medical Physics . 2018;45(10):e793-e810 .

Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Wu QRJ, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St . James ST, Ulin K, Yom SS, Yock T I . American Association of Physicists in Medicine Task Group 263: Standardizing nomenclatures in radiation oncology . International Journal of Radiation Oncology, Biology, Physics . 2018;100(4):1057-1066 .

Mayr C . Proteins assemble as they are being made . Nature . 2018;561(7722):186-187 .

Mazaheri Y, Hötker AM, Shukla-Dave A, Akin O, Hricak H . Model selection for high b-value diffusion-weighted MRI of the prostate . Magnetic Resonance Imaging . 2018;46:21-27 .

Mazaheri Y, Hötker AM, Shukla-Dave A, Akin O, Hricak H . Effect of intravascular contrast agent on diffusion and perfusion fraction coefficients in the peripheral zone and prostate cancer . Magnetic Resonance Imaging . 2018;51:120-127 .

Mazza P, Moran GW, Li G, Robins DJ, Matulay JT, Herr HW, Decastro GJ, McKiernan JM, Anderson CB . Conservative management following complete clinical response to neoadjuvant chemotherapy of muscle invasive bladder cancer: Contemporary outcomes of a multi-institutional cohort study . Journal of Urology . 2018;200(5):1005-1013 .

McCarthy CM, Horwitz SM . Association of breast implants with anaplastic large-cell lymphoma . JAMA Oncology . 2018;4(3):341-342 .

McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L . Data set for the reporting of carcinomas of the cervix: Recommendations from the International Collaboration on Cancer Reporting (ICCR) . International Journal of Gynecological Pathology . 2018;37(3):205-228 .

McCormick B . It is time to personalize local treatment options for women with “good risk” DCIS . Breast Journal . 2018;24(3):231-232 .

McCormick PJ, Lin HM, Deiner SG, Levin MA . Validation of the All Patient Refined Diagnosis Related Group (APR-DRG) risk of mortality and severity of illness modifiers as a measure of perioperative risk . Journal of Medical Systems . 2018;42(5):81- .

McCormick PJ . Cancer tsunami: Emerging trends, economic burden, and perioperative implications . Current Anesthesiology Reports . 2018;8(4):348-354 .

McCubrey JA, Abrams SL, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Lombardi P, Montalto G, Cervello M, Gizak A, Rakus D, Steelman LS . Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals . Advances in Biological Regulation . 2018;67:190-211 .

McCurdy SR, Zhang MJ, St . Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M . Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide . Blood Advances . 2018;2(3):299-307 . PMCID: PMC5812334

McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini B I, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK,

Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suarez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T . Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma . Nature Medicine . 2018;24(6):749-757 .

McDevitt MR, Sgouros G, Sofou S . Targeted and nontargeted α-particle therapies . Annual Review of Biomedical Engineering . 2018;20:73-93 . PMCID: PMC5988956

McDevitt MR, Thorek DLJ, Hashimoto T, Gondo T, Veach DR, Sharma SK, Kalidindi TM, Abou DS, Watson PA, Beattie BJ, Timmermand O V, Strand SE, Lewis JS, Scardino PT, Scher H I, Lilja H, Larson SM, Ulmert D . Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer . Nature Communications . 2018;9:1629- . PMCID: PMC5915579

McDonald ES, Ulaner GA . Uses and opportunities for molecular imaging in patients with breast cancer . PET Clinics . 2018;13(3):xi-xii .

McDonald SR, Heflin MT, Whitson HE, Dalton TO, Lidsky ME, Liu P, Poer CM, Sloane R, Thacker JK, White HK, Yanamadala M, Lagoo-Deenadayalan SA . Association of integrated care coordination with postsurgical outcomes in high-risk older adults: The Perioperative Optimization of Senior Health (POSH) initiative . JAMA Surgery . 2018;153(5):454-462 . PMCID: PMC5875304

McDonnell GA, Pope AW, Schuler TA, Ford JS . The relationship between cancer-related worry and posttraumatic growth in adolescent and young adult cancer survivors . Psycho-Oncology . 2018;27(9):2155-2164 . PMCID: PMC6156934

McDuff SGR, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D’Amico A V . Impact of time to testosterone rebound and comorbidity on the risk of

121 OF 288


Journal Articles

cause-specific mortality in men with unfavorable-risk prostate cancer . Cancer . 2018;124(7):1391-1399 .

McEvoy SH, Raeside MC, Chaim J, Ehdaie B, Akin O . Preoperative prostate MRI: A road map for surgery . American Journal of Roentgenology . 2018;211(2):383-391 .

McFarland D . Biologic Psychiatry of Cancer and Cancer Treatment - Book review . Psycho-Oncology . 2018;27(8):2060- .

McFarland DC . A tribute to Jimmie C . Holland, MD . Oncology (Norwalk) . 2018;32(2):56, 68- .

McFarland DC, Shaffer KM, Tiersten A, Holland J . Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer . Psycho-Oncology . 2018;27(5):1394-1403 .PMCID: PMC5948165

McFarland DC, Shaffer KM, Tiersten A, Holland J . Physical symptom burden and its association with distress, anxiety, and depression in breast cancer . Psychosomatics . 2018;59(5):464-471 . PMCID: PMC6067989

McFarland DC, Shaffer KM, Polizzi H, Mascarenhas J, Kremyanskaya M, Holland J, Hoffman R . Associations of physical and psychologic symptom burden in patients with Philadelphia chromosome-negative myeloproliferative neoplasms . Psychosomatics . 2018;59(5):472-480 . PMCID: PMC6067992

McHugh DJ, Feldman DR . Conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors . Advances in Urology . 2018;2018:7272541- . PMCID: PMC5874975

McHugh DJ, Root JC, Nelson CJ, Morris MJ . Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire? . Cancer . 2018;124(7):1326-1334 . PMCID: PMC5885282

McIntosh CA, Bialer PA . The stories we tell . Journal of Gay and Lesbian Mental Health . 2018;22(2):89- .

McIntosh CA, Bialer PA . I will survive: Resilience in the LGBTQ+ community . Journal of Gay and Lesbian Mental Health . 2018;22(1):1-2 .

McIntyre CA, Allen PJ . How long should patients with cystic lesions of the pancreas be followed? . Advances in Surgery . 2018;52(1):223-233 .

McIver B, Freeman J, Shah JP, Shaha AR, Haugen B, Cohen E, Witterick IJ, Randolph GW . Summary of the Third World Congress on Thyroid Cancer . Thyroid . 2018;28(11):1401-1405 .

McKay RR, Bosse D, Xie W, Wankowicz SAM, Flaifel A, Brandao R, Lalani AKA, Martini DJ, Wei XX, Braun DA, Van Allen E, Castellano D, De Velasco G, Wells JC, Heng DY, Fay AP, Schutz FA, Hsu J, Pal SK, Lee JL, Hsieh JJ, Harshman LC, Signoretti S, Motzer RJ, Feldman D, Choueiri TK . The clinical activity of PD-1/PD-L1 inhibitors in metastatic non–clear cell renal cell carcinoma . Cancer Immunology Research . 2018;6(7):758-765 .

McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh QD, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin ME . Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade . Prostate Cancer and Prostatic Diseases . 2018;21(3):364-372 . PMCID: PMC6013399

McKenney AS, Lau AN, Hanasoge Somasundara A V, Spitzer B, Intlekofer AM, Ahn J, Shank K, Rapaport FT, Patel MA, Papalexi E, Shih AH, Chiu A, Freinkman E, Akbay EA, Steadman M, Nagaraja R, Yen K, Teruya-Feldstein J, Wong KK, Rampal R, Vander Heiden MG, Thompson CB, Levine RL . JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition . Journal of Clinical Investigation . 2018;128(2):789-804 . PMCID: PMC5785272

McKnight BN, Kuda-Wedagedara ANW, Sevak KK, Abdel-Atti D, Wiesend WN, Ku A, Selvakumar D, Carlin SD, Lewis JS, Viola-Villegas NT . Imaging EGFR and HER3 through (89)Zr-labeled MEHD7945A (Duligotuzumab) . Scientific Reports . 2018;8:9043- . PMCID: PMC5998059

McMaster ML, Berndt S I, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Monnereau A, Link BK, Vermeulen RCH, Ansell SM, Maria A, Diver WR, Melbye M, Ojesina A I, Kraft P, Boffetta P, Clavel J, Giovannucci E, Besson CM, Canzian F, Travis RC, Vineis P, Weiderpass E, Montalvan R, Wang Z, Yeager M, Becker N, Benavente Y, Brennan P, Foretova L, Maynadie M, Nieters A, de Sanjose S, Staines A, Conde L, Riby J, Glimelius B, Hjalgrim H, Pradhan N, Feldman AL, Novak AJ, Lawrence C, Bassig BA, Lan Q, Zheng T, North KE, Tinker LF, Cozen W, Severson RK, Hofmann JN, Zhang Y, Jackson RD, Morton LM, Purdue MP, Chatterjee N, Offit K, Cerhan JR, Chanock SJ, Rothman N, Vijai J, Goldin LR, Skibola CF, Caporaso NE . Two high-risk susceptibility loci at 6p25 .3 and 14q32 .13 for Waldenström macroglobulinemia . Nature Communications . 2018;9:4182- . PMCID: PMC6180091

McMillen T, Usiak SC, Chen LH, Gomez L, Ntiamoah P, Hameed MR, Budvytiene I, Banaei N, Kamboj M, Babady NE . Evaluation of the Xpert MTB/RIF performance on tissues: Potential impact on airborne infection isolation at a tertiary cancer care center . Infection Control and Hospital Epidemiology . 2018;39(4):462-466 .

McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu

122 OF 288


Journal Articles

P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long G V, Johnson DB, Menzies AM, Davies MA . Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: A retrospective, multicohort analysis . Lancet Oncology . 2018;19(3):310-322 . PMCID: PMC5840029

Means AL, Freeman TJ, Zhu J, Woodbury LG, Marincola-Smith P, Wu C, Meyer AR, Weaver CJ, Padmanabhan C, An H, Zi J, Wessinger BC, Chaturvedi R, Brown TD, Deane NG, Coffey RJ, Wilson KT, Smith JJ, Sawyers CL, Goldenring JR, Novitskiy S V, Washington MK, Shi C, Beauchamp RD . Epithelial SMAD4 deletion up-regulates inflammation and promotes inflammation-associated cancer . Cellular and Molecular Gastroenterology and Hepatology . 2018;6(3):257-276 . PMCID: PMC6083016

Medica ACO, Stark SS, Hadnott TN, Dietz AC, Romero SAD, Natarajan L, Martinez E, Whitcomb BW, Su H I . Use of emergency contraception among female young adult cancer survivors . Fertility and Sterility . 2018;109(6):1114-1120 .e1 . PMCID: PMC6020163

Meduri GU, Rochwerg B, Annane D, Pastores SM, and on behalf of the Corticosteroid Guideline Task Force of SCCM and ESICM . Prolonged corticosteroid treatment in acute respiratory distress syndrome: Impact on mortality and ventilator-free days . Critical Care . 2018;22:135- . PMCID: PMC5968582

Meester RGS, Peterse EFP, Knudsen AB, de Weerdt AC, Chen JC, Lietz AP, Dwyer A, Ahnen DJ, Siegel RL, Smith RA, Zauber AG, Lansdorp-Vogelaar I . Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline . Cancer . 2018;124(14):2974-2985 . PMCID: PMC6055229

Mehta AC, Hood KL, Schwarz Y, Solomon SB . The evolutional history of electromagnetic navigation bronchoscopy: State of the art . Chest . 2018;154(4):935-947 .

Mehta B, Kasturi S, Teruya-Feldstein J, Horwitz S, Bass AR, Erkan D . Adult-onset Still’s disease and macrophage-activating syndrome progressing to lymphoma: A Clinical Pathology Conference held by the Division of Rheumatology at Hospital for Special Surgery . HSS Journal . 2018;14(2):214-221 . PMCID: PMC6031528

Mehta-Shah N, Clemens MW, Horwitz SM . How I treat breast implant-associated anaplastic large cell lymphoma . Blood . 2018;132(18):1889-1898 .

Melero I, Sznol M, Tessmer MS, Whiteside TL, Wolchok JD . Introducing a new series: Immunotherapy facts and hopes . Clinical Cancer Research . 2018;24(8):1773-1774 .

Mema E, Mango VL, Guo X, Karcich J, Yeh R, Wynn RT, Zhao B, Ha RS . Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis . Journal of Magnetic Resonance Imaging . 2018;47(3):753-759 .

Membreno R, Cook BE, Fung K, Lewis JS, Zeglis BM . Click-mediated pretargeted radioimmunotherapy of colorectal carcinoma . Molecular Pharmaceutics . 2018;15(4):1729-1734 .

Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C . The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades . Neuro-Oncology . 2018;20(5):687-694 . PMCID: PMC5892148

Mendez JS, DeAngelis LM . Metastatic complications of cancer involving the central and peripheral nervous systems . Neurologic Clinics . 2018;36(3):579-598 . PMCID: PMC6082424

Mendez JS, Grommes C . Treatment of primary central nervous system lymphoma: From chemotherapy to small molecules . American Society of Clinical Oncology Educational Book . 2018;38:604-615 .

Mendonca SJ, Sanchez A, Blum KA, Ghanaat M, Kashan MY, Benfante N, Russo P, Coleman JA, Crago AM, Hakimi AA . The association of renal cell carcinoma with gastrointestinal stromal tumors . Journal of Surgical Oncology . 2018;117(8):1716-1720 . PMCID: PMC6135662

Mendzelevski B, Ferber G, Janku F, Li BT, Sullivan RJ, Welsch D, Chi W, Jackson J, Weng O, Sager PT . Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies . Cancer Chemotherapy and Pharmacology . 2018;81(6):1129-1141 . PMCID: PMC5973962

Menghrajani K, Tallman MS . New therapeutic strategies for high-risk acute myeloid leukemia . Current opinion in Hematology . 2018;25(2):90-94 .

Menghrajani KN, Tallman MS . Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: A continued, complicated conversation . Blood Advances . 2018;2(2):164- . PMCID: PMC5787872

Menzer C, Beedgen B, Rom J, Duffert CM, Volckmar AL, Sedlaczek O, Richtig E, Enk A, Jager D, Hassel JC . Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy . European Journal of Cancer . 2018;104:239-242 .

Mermelstein J, Mermelstein AC, Chait MM . Proton pump inhibitor-refractory gastroesophageal reflux disease: Challenges and solutions . Clinical and Experimental Gastroenterology . 2018;11:119-134 . PMCID: PMC5868737

Merzianu M, Groman A, Hutson A, Cotta C, Brynes RK, Orazi A, Reddy V, Teruya-Feldstein J, Amre R, Balasubramanian M, Brandao G, Cherian S, Courville

123 OF 288


Journal Articles

E, Czuchlewski D, Fan G, Grier D, Hoehn D, Inamdar K V, Juskevicius R, Kaur P, Lazarchick J, Lewis MR, Miles RR, Myers JB, Nasr MR, Qureishi HN, Olteanu H, Robu VG, Salaru G, Vajpayee N, Vos J, Zhang L, Zhang S, Aye L, Brega E, Coad JE, Grantham J, Ivelja S, McKenna R, Sultan K, Wilding G, Hutchison R, Peterson L, Cheney RT . Trends in bone marrow sampling and core biopsy specimen adequacy in the United States and Canada: A multicenter study . American Journal of Clinical Pathology . 2018;150(5):393-405 . PMCID: PMC6166687

Mester JL, Ghosh R, Pesaran T, Huether R, Karam R, Hruska KS, Costa HA, Lachlan K, Ngeow J, Barnholtz-Sloan J, Sesock K, Hernandez F, Zhang L, Milko L, Plon SE, Hegde M, Eng C . Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel . Human Mutation . 2018;39(11):1581-1592 .PMCID: PMC6329583

Meyer JP, Tully KM, Jackson J, Dilling TR, Reiner T, Lewis JS . Bioorthogonal masking of circulating antibody-TCO groups using tetrazine-functionalized dextran polymers . Bioconjugate Chemistry . 2018;29(2):538-545 .

Mi X, Griffin G, Lee W, Patel S, Ohgami R, Ok CY, Wang S, Geyer JT, Xiao W, Roshal M, Garcia JS, Silverman LB, Sallan SE, Aster JC, Harris MH, Weinberg OK . Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations . American Journal of Hematology . 2018;93(11):1358-1367 .

Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, Norton C, Bossé D, Wankowicz SM, Cullen D, Horak C, Wind-Rotolo M, Tracy A, Giannakis M, Hodi FS, Drake CG, Ball MW, Allaf ME, Snyder A, Hellmann MD, Ho T, Motzer RJ, Signoretti S, Kaelin WG Jr, Choueiri TK, Van Allen EM . Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma . Science . 2018;359(6377):801-806 .

Midya A, Rabidas R, Sadhu A, Chakraborty J . Edge weighted local texture features for the categorization of mammographic masses . Journal of Medical and Biological Engineering . 2018;38(3):457-468 .

Midya A, Chakraborty J, Gönen M, Do RKG, Simpson AL . Influence of CT acquisition and reconstruction parameters on radiomic feature reproducibility . Journal of Medical Imaging . 2018;5(1):011020- . PMCID: PMC5812985

Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, O’Reilly EM . Incidence, management, and implications of visceral thrombosis in pancreatic ductal adenocarcinoma . Clinical Colorectal Cancer . 2018;17(2):121-128 .

Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani N I, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG . PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma . New England Journal of Medicine . 2018;379(4):341-351 .

Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Davila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O’Reilly RJ, Notarangelo LD, Pai SY . B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation . Blood . 2018;131(26):2967-2977 . PMCID: PMC6024640

Mikropoulos C, Hutten Selkirk CG, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van

Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadalo L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MGEM, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden ATJM, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra A V, Moynihan C, Rennert G, Suri M, Tricker K, IMPACT study collaborators, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA . Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition . British Journal of Cancer . 2018;118(2):266-276 . PMCID: PMC5785754

Milanovic M, Fan DNY, Belenki D, Dabritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, Dörken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, Schmitt CA . Senescence-associated reprogramming promotes cancer stemness . Nature . 2018;553(7686):96-100 .

Miller DG, Kim SYH, Li X, Dickert NW, Flory J, Runge CP, Relton C . Ethical acceptability of postrandomization consent in pragmatic clinical

124 OF 288


Journal Articles

trials . Jama Network Open . 2018;1(8):e186149- . PMCID: PMC6324565

Miller E, Cantrell C, Beard M, Derylak A, Babady NE, McMillen T, Miranda E, Body B, Tang YW, Vasireddy R, Vasireddy S, Smith T, Iakhiaeva E, Wallace RJ Jr, Brown-Elliott BA, Moreno E, Totty H, Deol P . Performance of Vitek MS v3 .0 for identification of mycobacterium species from patient samples by use of automated liquid medium systems . Journal of Clinical Microbiology . 2018;56(8):e00219-18- . PMCID: PMC6062784

Miller KD, O’Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Dang CT, Sledge GW Jr . Double-blind phase III trial of adjuvant chemotherapy with and without bevacizumab in patients with lymph node-positive and high-risk lymph node-negative breast cancer (E5103) . Journal of Clinical Oncology . 2018;36(25):2621-2629 . PMCID: PMC6118403

Miloushev VZ, Granlund KL, Boltyanskiy R, Lyashchenko SK, DeAngelis LM, Mellinghoff IK, Brennan CW, Tabar V, Yang TJ, Holodny A I, Sosa RE, Guo YW, Chen AP, Tropp J, Robb F, Keshari KR . Metabolic imaging of the human brain with hyperpolarized (13)C pyruvate demonstrates (13)C lactate production in brain tumor patients . Cancer Research . 2018;78(14):3755-3760 . PMCID: PMC6050093

Miloushev VZ, Palmer AG 3rd . Optimized coherence selection . Journal of Magnetic Resonance . 2018;297:138-145 . PMCID: PMC6447090

Mimitou EP, Keeney S . S1-seq assay for mapping processed DNA ends . Methods in Enzymology . 2018;601:309-330 .

Minard-Colin V, Walterhouse D, Bisogno G, Martelli H, Anderson J, Rodeberg DA, Ferrari A, Jenney M, Wolden S, De Salvo G, Arndt C, Merks JHM, Gallego S, Schwob D, Haie-Meder C, Bergeron C, Stevens

MCG, Oberlin O, Hawkins D, International Society of Pediatric Oncology Sarcoma Committee, the Children’s Oncology Group, the Italian Cooperative Soft Tissue Sarcoma Group, and the European pediatric Soft tissue sarcoma Study Group . Localized vaginal/uterine rhabdomyosarcoma - Results of a pooled analysis from four international cooperative groups . Pediatric Blood and Cancer . 2018;65(9):e27096- .

Minzel W, Venkatachalam A, Fink A, Hung E, Brachya G, Burstain I, Shaham M, Rivlin A, Omer I, Zinger A, Elias S, Winter E, Erdman PE, Sullivan RW, Fung L, Mercurio F, Li D, Vacca J, Kaushansky N, Shlush L, Oren M, Levine R, Pikarsky E, Snir-Alkalay I, Ben-Neriah Y . Small molecules co-targeting CKIα and the transcriptional kinases CDK7/9 control AML in preclinical models . Cell . 2018;175(1):171-185 .e25 .

Mirpuri S, Gill P, Ocampo A, Roberts N, Narang B, Hwang SW, Gany F . Discrimination and health among taxi drivers in New York and Toronto . Journal of Community Health . 2018;43(4):667-672 . PMCID: PMC6033631

Mitchell SL, Seth AK, Matros E, Cordeiro PG . Maxillary reconstruction using a gullwing fibula osteofascial flap and flexor hallucis longus muscle . Plastic and Reconstructive Surgery-Global Open . 2018;6(6):e1821- . PMCID: PMC6157957

Miyahira AK, Pienta KJ, Morris MJ, Bander NH, Baum RP, Fendler WP, Goeckeler W, Gorin MA, Hennekes H, Pomper MG, Sartor O, Tagawa ST, Williams S, Soule HR . Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group . Prostate . 2018;78(11):775-789 .

Miyazawa M, Subbaramaiah K, Bhardwaj P, Zhou XK, Wang HH, Falcone DJ, Giri DD, Dannenberg AJ . Pioglitazone inhibits periprostatic white adipose tissue inflammation in obese mice . Cancer Prevention Research . 2018;11(4):215-226 . PMCID: PMC5882568

Mizrachi A, Migliacci JC, Montero PH, McBride S, Shah JP, Patel SG, Ganly I . Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution . Oral Oncology . 2018;78:94-101 . PMCID: PMC5836807

Mo Q, Shen R, Guo C, Vannucci M, Chan KS, Hilsenbeck SG . A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data . Biostatistics . 2018;19(1):71-86 . PMCID: PMC6455926

Mobley DL, Bannan CC, Rizzi A, Bayly C I, Chodera JD, Lim VT, Lim NM, Beauchamp KA, Slochower DR, Shirts MR, Gilson MK, Eastman PK . Escaping atom types in force fields using direct chemical perception . Journal of Chemical Theory and Computation . 2018;14(11):6076-6092 . PMCID: PMC6245550

Modak S, Le Luduec JB, Cheung IY, Goldman DA, Ostrovnaya I, Doubrovina E, Basu E, Kushner BH, Kramer K, Roberts SS, O’Reilly RJ, Cheung NK V, Hsu KC . Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study . OncoImmunology . 2018;7(8):e1461305- . PMCID: PMC6136849

Modelevsky L, Tizon R, Reiss SN, Smith M, Garonce R, Kaley T . Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma . CNS Oncology . 2018;7(3):CNS19- . PMCID: PMC6200062

Modlin IM, Kidd M, Malczewska A, Drozdov I, Bodei L, Matar S, Chung KM . The NETest: The clinical utility of multigene blood analysis in the diagnosis and management of neuroendocrine tumors . Endocrinology and Metabolism Clinics of North America . 2018;47(3):485-504 .

Moghanaki D, Simone CB 2nd, Rimner A, Karas TZ, Donington J, Shirvani SM, Daly M, Videtic GM, Movsas B, On behalf of the ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non–Small Cell Lung Cancer .

125 OF 288


Journal Articles

The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage I non–small cell lung cancer . Journal of Thoracic and Cardiovascular Surgery . 2018;155(1):429-431 .

Mohammed J, Flynt AS, Panzarino AM, Mondal MMH, DeCruz M, Siepel A, Lai EC . Deep experimental profiling of microRNA diversity, deployment, and evolution across the Drosophila genus . Genome Research . 2018;28(1):52-65 . PMCID: PMC5749182

Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, Canin B, Cohen HJ, Holmes HM, Hopkins JO, Janelsins MC, Khorana AA, Klepin HD, Lichtman SM, Mustian KM, Tew WP, Hurria A . Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology . Journal of Clinical Oncology . 2018;36(22):2326-2347 . PMCID: PMC6063790

Molena D . Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity . Journal of Thoracic and Cardiovascular Surgery . 2018;155(3):1292-1293 .

Molina AM, Hutson TE, Nosov D, Tomczak P, Lipatov O, Sternberg CN, Motzer R, Eisen T . Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: Crossover of a phase 3 study . European Journal of Cancer . 2018;94:87-94 .

Mondaca S, Yaeger R . Colorectal cancer genomics and designing rational trials . Annals of Translational Medicine . 2018;6(9):159- . PMCID: PMC5985274

Monk BJ, Kauderer JT, Moxley KM, Bonebrake AJ, Dewdney SB, Secord AA, Ueland FR, Johnston CM, Aghajanian C . A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study .

Gynecologic Oncology . 2018;151(3):422-427 . PMCID: PMC6392076

Montagut C, Tsui DW, Diaz LA Jr . Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: Are we ready for clinical use? . Annals of Oncology . 2018;29(5):1083-1084 .

Montecalvo J, Chang J, Rekhtman N, Antonescu CR, Bains MS, Fabbri N, Plodkowski AJ, Riely GJ, Travis WD, Sauter JL . Type A thymoma presenting with bone metastasis . Histopathology . 2018;73(4):701-703 .

Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Fürst A, Papamichael D, Desai AM, Cascinu S, Gèrard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, De Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA . Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer . European Journal of Surgical Oncology . 2018;44(11):1685-1702 .

Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M . Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? . Annals of Surgical Oncology . 2018;25(6):1488-1494 . PMCID: PMC5930130

Moo TA, El-Tamer M . ASO author reflections: Locoregional recurrence rates are low with the selective use of PMRT in patients with T1-2 tumors and one to three positive lymph nodes . Annals of Surgical Oncology . 2018;25(Suppl . 3):S691-S692 . PMCID: PMC6333514

Moo TA, Morrow M . ASO author reflections: Low-volume sentinel node disease after neoadjuvant chemotherapy is still an indication for axillary

dissection . Annals of Surgical Oncology . 2018;25(Suppl . 3):S685-S686 .

Moo TA, Sanford R, Dang C, Morrow M . Overview of breast cancer therapy . PET Clinics . 2018;13(3):339-354 .PMCID: PMC6092031

Moore AR, Ran L, Guan Y, Sher JJ, Hitchman TD, Zhang JQ, Hwang C, Walzak EG, Shoushtari AN, Monette S, Murali R, Wiesner T, Griewank KG, Chi P, Chen Y . GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in uveal melanoma . Cell Reports . 2018;22(9):2455-2468 . PMCID: PMC5854482

Moore JE, Oropello JM, Stoltzfus D, Masur H, Coopersmith CM, Nates J, Doig C, Christman J, Hite RD, Angus DC, Pastores SM, Kvetan V, for the Academic Leaders in Critical Care Medicine (ALCCM) Task Force of the Society of the Critical Care Medicine . Critical care organizations: Building and integrating academic programs . Critical Care Medicine . 2018;46(4):e334-e341 . PMCID: PMC5851809

Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, Gonzalez-Martin A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P . Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer . New England Journal of Medicine . 2018;379(26):2495-2505 .

Moore KN, Martin LP, O’Malley DM, Matulonis UA, Konner JA, Vergote I, Ponte JF, Birrer MJ . A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer . Future Oncology . 2018;14(2):123-136 .

Moore MJ, Blachere NE, Fak JJ, Park CY, Sawicka K, Parveen S, Zucker-Scharff I, Moltedo B, Rudensky AY, Darnell RB . ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity . eLife . 2018;7:e33057- . PMCID: PMC6033538

126 OF 288


Journal Articles

Moraes FY, Mendez LC, Taunk NK, Raman S, Suh JH, Souhami L, Slotman B, Weltman E, Spratt DE, Berlin A, Marta GN . Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials . Journal of Neuro-Oncology . 2018;136(3):585-593 .

Morales KA, Arevalo-Perez J, Peck KK, Holodny A I, Lis E, Karimi S . Differentiating atypical hemangiomas and metastatic vertebral lesions: The role of T1-weighted dynamic contrast-enhanced MRI . American Journal of Neuroradiology . 2018;39(5):968-973 . PMCID: PMC5955841

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Sahani D V, Pergolini I, Attiyeh MA, Al Efishat M, Rezaee N, Hruban RH, He J, Weiss MJ, Allen PJ, Wolfgang CL, Fernandez-del Castillo C . Intraductal papillary mucinous neoplasm of the pancreas in young patients: Tumor biology, clinical features, and survival outcomes . Journal of Gastrointestinal Surgery . 2018;22(2):226-234 .

Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J . Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions - A systematic review . Journal of Surgical Oncology . 2018;117(2):245-259 .

Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D . 2017 update on medical overuse: A systematic review . JAMA Internal Medicine . 2018;178(1):110-115 .

Morgan DJ, Dhruva SS, Korenstein D . Medical overuse of prostate-specific antigen testing and overprescription of antibiotics - Reply . JAMA Internal Medicine . 2018;178(3):432-433 .

Morgan SG, Good CB, Leopold C, Kaltenboeck A, Bach PB, Wagner A . An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries . Health Policy . 2018;122(9):1012-1017 .

Morgani SM, Metzger JJ, Nichols J, Siggia ED, Hadjantonakis AK . Micropattern differentiation

of mouse pluripotent stem cells recapitulates embryo regionalized cell fate patterning . eLife . 2018;7:e32839- . PMCID: PMC5807051

Morgani SM, Saiz N, Garg V, Raina D, Simon CS, Kang M, Arias AM, Nichols J, Schröter C, Hadjantonakis AK . A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice . Developmental Biology . 2018;441(1):104-126 .

Mori S, Lezcano C, Miraflor AP, Busam KJ, Lee EH . Solitary fibrous tumor presenting on the scalp: A potential diagnostic pitfall . Journal of Cutaneous Pathology . 2018;45(8):557-560 .

Mori S, Navarrete-Dechent C, Petukhova TA, Lee EH, Rossi AM, Postow MA, Dunn LA, Roman BR, Yin VT, Coit DG, Hollmann TJ, Busam KJ, Nehal KS, Barker CA . Tumor board conferences for multidisciplinary skin cancer management: A survey of US cancer centers . Journal of the National Comprehensive Cancer Network . 2018;16(10):1209-1215 . PMCID: PMC6446238

Morikawa A, Wang R, Patil S, Diab A, Yang J, Hudis CA, McArthur HL, Beal K, Seidman AD . Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection . Clinical Breast Cancer . 2018;18(5):353-361 .

Mormando J, Barbetta A, Molena D . Esophagectomy for benign disease . Journal of Thoracic Disease . 2018;10(3):2026-2033 . PMCID: PMC5906260

Moroz MA, Zanzonico P, Lee JT, Ponomarev V . Ex vivo radiolabeling and in vivo PET imaging of T cells expressing nuclear reporter genes . Methods in Molecular Biology . 2018;1790:153-163 .

Morris MJ, Rumble RB, Milowsky M I . Optimizing anticancer therapy in metastatic non-castrate prostate cancer: ASCO clinical practice guideline

summary . Journal of Oncology Practice . 2018;14(5):319-322 .

Morris MJ . The timing of molecular imaging in prostate cancer . Clinical Advances in Hematology & Oncology . 2018;16(3):195-197 .

Morris MJ, Rumble RB, Basch E, Hotte SJ, Loblaw A, Rathkopf D, Celano P, Bangs R, Milowsky M I . Optimizing anticancer therapy in metastatic non-castrate prostate cancer: American Society of Clinical Oncology clinical practice guideline . Journal of Clinical Oncology . 2018;36(15):1521-1539 .

Morris PG, Rota S, Cadoo K, Zamora S, Patil S, D’Andrea G, Gilewski T, Bromberg J, Dang C, Dickler M, Modi S, Seidman AD, Sklarin N, Norton L, Hudis CA, Fornier MN . Phase II study of paclitaxel and dasatinib in metastatic breast cancer . Clinical Breast Cancer . 2018;18(5):387-394 .

Morrow M . Management of the node-positive axilla in breast cancer in 2017: Selecting the right option . JAMA Oncology . 2018;4(2):250-251 . PMCID: PMC5837812

Morrow M, Abrahamse P, Katz SJ . Trend analysis on reoperation after lumpectomy for breast cancer - Reply . JAMA Oncology . 2018;4(5):747- .

Morrow M, Jagsi R, McLeod MC, Shumway D, Katz SJ . Surgeon attitudes toward the omission of axillary dissection in early breast cancer . JAMA Oncology . 2018;4(11):1511-1516 .

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, Lopez-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA, for the RELEVANCE Trial Investigators . Rituximab plus lenalidomide in advanced untreated follicular

127 OF 288


Journal Articles

lymphoma . New England Journal of Medicine . 2018;379(10):934-947 .

Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Horn SD, Inturrisi CE . Patient-reported outcomes and opioid use by outpatient cancer patients . Journal of Pain . 2018;19(3):278-290 . PMCID: PMC5811357

Moschini M, Fossati N, Sood A, Lee JK, Sammon J, Sun M, Pucheril D, Dalela D, Montorsi F, Karnes RJ, Briganti A, Trinh QD, Menon M, Abdollah F . Contemporary management of prostate cancer patients suitable for active surveillance: A North American population-based study . European Urology Focus . 2018;4(1):68-74 .

Moskowitz AJ . Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapy . Hematology-American Society of Hematology Education Program . 2018;2018(1):207-212 . PMCID: PMC6246031

Moskowitz CH . Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily . Blood Advances . 2018;2(7):821-824 . PMCID: PMC5894256

Moskowitz CH . Highlights in lymphoma from the 2017 American Society of Hematology Meeting: Commentary . Clinical Advances in Hematology & Oncology . 2018;16(2 Suppl . 3):20-23 .

Mossanen M, Ingham MD, Leow JJ, Tinay I, Wang Y, Krasnow RE, Preston MA, Bellmunt J, Chung B I, Rosenberg JE, Chang SL . Exploring patterns of mitomycin C use in community practice urology . Urology Practice . 2018;5(1):7-14 .

Motzer RJ, Russo P . Cytoreductive nephrectomy - Patient selection is key . New England Journal of Medicine . 2018;379(5):481-482 .

Motzer RJ, Escudier B, Ravaud A . Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni’s

letter to the editor re: Robert J . Motzer, Alain Ravaud, Jean-Jacques Patard, et al . Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results . Eur Urol 2018;73:62–8 . European Urology . 2018;73(3):e73- .

Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini B I, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B, for the CheckMate 214 Investigators . Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma . New England Journal of Medicine . 2018;378(14):1277-1290 .

Motzer RJ, Escudier B, Powles T, Scheffold C, Choueiri TK . Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma . British Journal of Cancer . 2018;118(9):1176-1178 .

Motzer RJ, McHenry MB, Chen AC . Immune checkpoint blockade in advanced renal-cell carcinoma - The authors reply . New England Journal of Medicine . 2018;379(1):92-93 .

Motzer RJ, Ravaud A, Patard JJ, Pandha HS, George DJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Casey M, Serfass L, Pantuck AJ, Staehler M . Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results . European Urology . 2018;73(1):62-68 .

Mrad C, Abougergi MS, Daly B . One step forward, two steps back: Trends in aggressive inpatient care at the end of life for patients with stage IV lung cancer . Journal of Oncology Practice . 2018;14(12):e746-e757 .

Mueller EL, Park ER, Kirchhoff AC, Kuhlthau K, Nathan PC, Perez GK, Rabin J, Hutchinson R, Oeffinger KC, Robison LL, Armstrong GT, Leisenring WM, Donelan K . Insurance, chronic health conditions, and utilization of primary and specialty outpatient services: A Childhood Cancer Survivor Study report . Journal of Cancer Survivorship . 2018;12(5):639-646 . PMCID: PMC6152932

Mueller JJ, Schlappe BA, Kumar R, Olvera N, Dao F, Abu-Rustum N, Aghajanian C, DeLair D, Hussein YR, Soslow RA, Levine DA, Weigelt B . Massively parallel sequencing analysis of mucinous ovarian carcinomas: Genomic profiling and differential diagnoses . Gynecologic Oncology . 2018;150(1):127-135 .

Mueller JJ, Lajer H, Mosgaard BJ, Bach Hamba S, Morice P, Gouy S, Hussein Y, Soslow RA, Schlappe BA, Zhou QC, Iasonos A, Høgdall C, Leary A, O’Cearbhaill RE, Abu-Rustum NR . International study of primary mucinous ovarian carcinomas managed at tertiary medical centers . International Journal of Gynecological Cancer . 2018;28(5):915-924 . PMCID: PMC5962416

Mughal T I, Gotlib J, Mesa R, Koschmieder S, Khoury HJ, Cortes JE, Barbui T, Hehlmann R, Mauro M, Saussele S, Radich JP, Van Etten RA, Saglio G, Verstovek S, Gale RP, Abdel-Wahab O . Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms . Leukemia Research . 2018;67:67-74 .

Mughal T I, Lion T, Abdel-Wahab O, Mesa R, Scherber RM, Perrotti D, Mauro M, Verstovsek S, Saglio G, Van Etten RA, Kralovics R . Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms . Hematological Oncology . 2018;36(5):740-748 .

Muhsen S, Moo TA, Patil S, Stempel M, Powell S, Morrow M, El-Tamer M . Most breast cancer patients with T1-2 tumors and one to three positive lymph

128 OF 288


Journal Articles

nodes do not need postmastectomy radiotherapy . Annals of Surgical Oncology . 2018;25(7):1912-1920 . PMCID: PMC5976529

Mulhall JP, Carlsson M, Stecher V, Tseng LJ . Predictors of erectile function normalization in men with erectile dysfunction treated with placebo . Journal of Sexual Medicine . 2018;15(6):866-872 .

Mulhall JP, Giraldi A, Hackett G, Hellstrom WJG, Jannini EA, Rubio-Aurioles E, Trost L, Hassan TA . The 2018 revision to the Process of Care Model for evaluation of erectile dysfunction . Journal of Sexual Medicine . 2018;15(9):1280-1292 .

Mulhall JP, Hassan TA, Rienow J . Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: A survey conducted in 7 countries . International Journal of Clinical Practice . 2018;72(4):e13074- .

Mulhall JP, Klein EA, Slawin K, Henning AK, Scardino PT . A randomized, double-blind, placebo-controlled trial to assess the utility of tacrolimus (FK506) for the prevention of erectile dysfunction following bilateral nerve-sparing radical prostatectomy . Journal of Sexual Medicine . 2018;15(9):1293-1299 .

Mulhall JP, Giraldi A, Hackett G, Hellstrom WJG, Jannini EA, Rubio-Aurioles E, Trost L, Hassan TA . The 2018 revision to the Process of Care Model for management of erectile dysfunction . Journal of Sexual Medicine . 2018;15(10):1434-1445 .

Mulvey JJ, Littmann ER, Ling L, McDevitt MR, Pamer EG, Scheinberg DA . The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota . International Journal of Nanomedicine . 2018;13:5275-5286 . PMCID: PMC6136419

Munck af Rosenschold P, Zelefsky MJ, Apte AP, Jackson A, Oh JH, Shulman E, Desai N, Hunt M, Ghadjar P, Yorke E, Deasy JO . Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and

improves biochemical control . Radiation Oncology . 2018;13:64- . PMCID: PMC5898030

Mungovan SF, Luiting HB, Graham PL, Sandhu JS, Akin O, Chan L, Patel M I . The measurement of membranous urethral length using transperineal ultrasound prior to radical prostatectomy . Scandinavian Journal of Urology . 2018;52(4):263-268 .

Munhoz RR, Postow MA . Clinical development of PD-1 in advanced melanoma . The Cancer Journal . 2018;24(1):7-14 . PMCID: PMC5819364

Munigala S, Gardner TB, O’Reilly EM, Castillo CFD, Ko AH, Pleskow D, Mills JB, Vollmer CM Jr, Searle NA, Alsante M, Holt JM, Gelrud A . Understanding pancreatic diseases using animated pancreas patient: Informing patients for better health outcomes with visual formats of learning . Pancreas . 2018;47(10):1256-1261 .

Munir A, Abdullahu L, Damha MJ, Shuman S . Two-step mechanism and step-arrest mutants of Runella slithyformis NAD(+)-dependent tRNA 2′-phosphotransferase Tpt1 . RNA . 2018;24(9):1144-1157 . PMCID: PMC6097658

Munir A, Banerjee A, Shuman S . NAD(+)-dependent synthesis of a 5’-phospho-ADP-ribosylated RNA/DNA cap by RNA 2’-phosphotransferase Tpt1 . Nucleic Acids Research . 2018;46(18):9617-9624 . PMCID: PMC6182162

Mupamombe CT, LoGiurato B, Kampel L, Cohen JM . Unilateral upper extremity lymphedema in metastatic prostate cancer . Clinical Case Reports . 2018;6(6):1014-1019 . PMCID: PMC5986019

Murali R, Delair DF, Bean SM, Abu-Rustum NR, Soslow RA . Evolving roles of histologic evaluation and molecular/genomic profiling in the management of endometrial cancer . Journal of the National Comprehensive Cancer Network . 2018;16(2):201-209 .

Murali R, Grisham RN, Soslow RA . The roles of pathology in targeted therapy of women with

gynecologic cancers . Gynecologic Oncology . 2018;148(1):213-221 . PMCID: PMC5756523

Murata K, Glaser L, Nardiello M, Ramanathan L V, Carlow DC . Data from the analytical performance of the Abaxis Piccolo Xpress point of care analyzer in whole blood, serum, and plasma . Data in Brief . 2018;16:81-89 .PMCID: PMC5694958

Murata K, McCash S I, Carroll B, Lesokhin AM, Hassoun H, Lendvai N, Korde NS, Mailankody S, Landau HJ, Koehne G, Chung DJ, Giralt SA, Ramanathan L V, Landgren O . Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood . Clinical Biochemistry . 2018;51:66-71 . PMCID: PMC5360528

Murray KS, Liu NW, Russo P . Progression from tubulovillous adenoma to high-grade adenocarcinoma in Indiana pouch urinary diversion . Urology Case Reports . 2018;16:129-131 . PMCID: PMC5726746

Murray KS, Vertosick EA, Spaliviero M, Mashni JW Jr, Sjoberg DD, Alektiar KM, Herr HW, Russo P, Coleman JA . Importance of wide re-resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution . Journal of Surgical Oncology . 2018;117(7):1464-1468 . PMCID: PMC6028307

Murray KS, Spaliviero M, Tonorezos ES, Lacouture ME, Tap WD, Oeffinger KC, Vargas HA, Eastham JA . Li-Fraumeni Syndrome-related malignancies involving the genitourinary tract: Review of a single-institution experience . Urology . 2018;119:55-61 .

Murry JB, Machini K, Ceyhan-Birsoy O, Kritzer A, Krier JB, Lebo MS, Fayer S, Genetti CA, VanNoy GE, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, Beggs AH, Rehm HL, BabySeq Project Team . Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: A BabySeq Project case

129 OF 288


Journal Articles

report . Cold Spring Harbor Molecular Case Studies . 2018;4(4):a002873- . PMCID: PMC6071571

Murthy SB, Cushman M, Bobrow D, Kamel H, Merkler AE, Elkind MS V, DeAngelis LM, Navi BB . Ability of the Khorana score to predict recurrent thromboembolism in cancer patients with ischemic stroke . Journal of Clinical Neuroscience . 2018;57:111-115 . PMCID: PMC6191324

Naber SK, Kuntz KM, Henrikson NB, Williams MS, Calonge N, Goddard KAB, Zallen DT, Ganiats TG, Webber EM, Janssens ACJW, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I . Cost effectiveness of age-specific screening intervals for people with family histories of colorectal cancer . Gastroenterology . 2018;154(1):105-116 .e20 . PMCID: PMC6104831

Nacev BA, Tap WD . TOMAS: Revisiting PARP inhibitor combination therapy . Lancet Oncology . 2018;19(10):1269-1270 .

Nagase R, Inoue D, Pastore A, Fujino T, Hou HA, Yamasaki N, Goyama S, Saika M, Kanai A, Sera Y, Horikawa S, Ota Y, Asada S, Hayashi Y, Kawabata KC, Takeda R, Tien HF, Honda H, Abdel-Wahab O, Kitamura T . Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation . Journal of Experimental Medicine . 2018;215(6):1729-1747 . PMCID: PMC5987913

Naing A, Infante JR, Papadopoulos KP, Chan IH, Shen C, Ratti NP, Rojo B, Autio KA, Wong DJ, Patel MR, Ott PA, Falchook GS, Pant S, Hung A, Pekarek KL, Wu V, Adamow M, McCauley S, Mumm JB, Wong P, Van Vlasselaer P, Leveque J, Tannir NM, Oft M . PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8+ T cell invigoration and polyclonal T cell expansion in cancer patients . Cancer Cell . 2018;34(5):775-791 .e3 .

Nakahara T, Narula J, Strauss HW . Molecular imaging of vulnerable plaque . Seminars in Nuclear Medicine . 2018;48(3):291-298 .

Nakahara T, Tanimoto T, Petrov AD, Ishikawa K, Strauss HW, Narula J . Rat model of cardiotoxic drug-induced cardiomyopathy . Methods in Molecular Biology . 2018;1816:221-232 .

Nakahara T, Narula J, Strauss HW . NaF uptake in unstable plaque: What does fluoride uptake mean? . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(13):2250-2252 .

Nakamura M, Xu C, Diack C, Ohishi N, Lee RM, Iida S, Kawanishi T, Ohtomo T, Abou-Alfa GK, Chen YC . Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma . British Journal of Clinical Pharmacology . 2018;84(5):944-951 . PMCID: PMC5903238

Namasivayam S, Sher A, Glickman MS, Wipperman MF . The microbiome and tuberculosis: Early evidence for cross talk . mBio . 2018;9(5):e01420-18- . PMCID: PMC6143735

Narayan AK, Elkin EB, Lehman CD, Morris EA . Quantifying performance thresholds for recommending screening mammography: A revealed preference analysis of USPSTF guidelines . Breast Cancer Research and Treatment . 2018;172(2):463-468 .

Nascimento B, Mulhall JP . Sexual headache . Journal of Sexual Medicine . 2018;15(12):1663-1666 .

Nashat MA, Arbona RJR, Riedel ER, Francino O, Ferrer L, Luchins KR, Lipman NS . Comparison of diagnostic methods and sampling sites for the detection of Demodex musculi . Journal of the American Association for Laboratory Animal Science . 2018;57(2):173-185 . PMCID: PMC5868384

Nashat MA, Ricart Arbona RJ, Lepherd ML, Santagostino SF, Livingston RS, Riedel ER, Lipman NS . Ivermectin-compounded Feed Compared with Topical Moxidectin-Imidacloprid for Eradication of Demodex musculi in Laboratory Mice . Journal of the

American Association for Laboratory Animal Science . 2018;57(5):483-497 . PMCID: PMC6159677

Nass SJ, Rothenberg ML, Pentz R, Hricak H, Abernethy A, Anderson K, Gee AW, Harvey RD, Piantadosi S, Bertagnolli MM, Schrag D, Schilsky RL . Accelerating anticancer drug development - Opportunities and trade-offs . Nature Reviews Clinical Oncology . 2018;15(12):777-786 .

Nath D, White JR, Bratslavsky G, Kotula L . Identification, histological characterization, and dissection of mouse prostate lobes for in vitro 3D spheroid culture models . Journal of Visualized Experiments . 2018;2018(139):e58397- . PMCID: PMC6235197

Nathan CAO, Asarkar A, Shaha M, Shaha A . In response to Does mutational analysis influence the management of differentiated thyroid cancers? . Laryngoscope . 2018;128(2):E85- .

Nattestad M, Goodwin S, Ng K, Baslan T, Sedlazeck FJ, Rescheneder P, Garvin T, Fang H, Gurtowski J, Hutton E, Tseng E, Chin CS, Beck T, Sundaravadanam Y, Kramer M, Antoniou E, McPherson JD, Hicks J, Richard McCombie W, Schatz MC . Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line . Genome Research . 2018;28(8):1126-1135 . PMCID: PMC6071638

Navarrete-Dechent C, Dusza SW, Liopyris K, Marghoob AA, Halpern AC, Marchetti MA . Automated dermatological diagnosis: Hype or reality? . Journal of Investigative Dermatology . 2018;138(10):2277-2279 .

Navarrete-Dechent C, Liopyris K, Cordova M, Busam KJ, Marghoob AA, Chen CSJ . Reflectance confocal microscopic and en face histopathologic correlation of the dermoscopic “circle within a circle” in lentigo maligna . JAMA Dermatology . 2018;154(9):1092-1094 .

130 OF 288


Journal Articles

Navarrete-Dechent C, Schwartz R, Gonzalez S, Gonzalez S, Abarzua Á, Uribe P . Reflectance confocal microscopy in the evaluation of targetoid haemosiderotic haemangioma apropos two cases . Australasian Journal of Dermatology . 2018;59(2):135-137 .

Navi BB, Marshall RS, Bobrow D, Singer S, Stone JB, DeSancho MT, DeAngelis LM . Enoxaparin vs aspirin in patients with cancer and ischemic stroke: The TEACH pilot randomized clinical trial . JAMA Neurology . 2018;75(3):379-381 .

Navi BB, Iadecola C . Ischemic stroke in cancer patients: A review of an underappreciated pathology . Annals of Neurology . 2018;83(5):873-883 . PMCID: PMC6021225

Navi BB, Howard G, Howard VJ, Zhao H, Judd SE, Elkind MS V, Iadecola C, DeAngelis LM, Kamel H, Okin PM, Gilchrist S, Soliman EZ, Cushman M, Muntner P . New diagnosis of cancer and the risk of subsequent cerebrovascular events . Neurology . 2018;90(23):e2025-e2033 . PMCID: PMC5993181

Necchi A, Pond GR, Pal SK, Agarwal N, Bowles DW, Plimack ER, Yu EY, Ladoire S, Baniel J, Crabb S, Niegisch G, Srinivas S, Berthold DR, Rosenberg JE, Powles T, Bamias A, Harshman LC, Bellmunt J, Galsky MD, on behalf of Retrospective International Study of Invasive/Advanced Cancer of the Urothelium Group . Bone metastases as the only metastatic site in patients with urothelial carcinoma: Focus on a special patient population . Clinical Genitourinary Cancer . 2018;16(2):e483-e490 .

Necchi A, Pond GR, Smaldone MC, Pal SK, Chan K, Wong YN, Viterbo R, Sonpavde G, Harshman LC, Crabb S, Alva A, Chowdhury S, De Giorgi U, Srinivas S, Agarwal N, Bamias A, Baniel J, Golshayan AR, Ladoire S, Sternberg CN, Cerbone L, Yu EY, Bellmunt J, Vaishampayan U, Niegisch G, Hussain S, Bowles DW, Morales-Barrera R, Milowsky M I, Theodore C, Berthold DR, Sridhar SS, Powles T, Rosenberg

JE, Galsky MD, on behalf of the Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) . Robot-assisted versus open radical cystectomy in patients receiving perioperative chemotherapy for muscle-invasive bladder cancer: The oncologist’s perspective from a multicentre study . European Urology Focus . 2018;4(6):937-945 .PMCID: PMC5626651

Nehal KS, Bichakjian CK . Update on keratinocyte carcinomas . New England Journal of Medicine . 2018;379(4):363-374 .

Nehmeh SA, Schwartz J, Grkovski M, Yeung I, Laymon CM, Muzi M, Humm JL . Inter-operator variability in compartmental kinetic analysis of (18)F-fluoromisonidazole dynamic PET . Clinical Imaging . 2018;49:121-127 .

Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, Hariharan S, Hammad TA, Lindenfeld J, Murphy MJ, Moslehi JJ, on behalf of the Checkpoint Inhibitor Safety Working Group . Myocarditis associated with immune checkpoint inhibitors: An expert consensus on data gaps and a call to action . The Oncologist . 2018;23(8):874-878 .

Nelson CJ, Tew WP, Hurria A . A tribute to Jimmie Holland: Pioneer for geriatric oncology . Journal of Geriatric Oncology . 2018;9(4):285-286 .

Nelson JA, Lee IT, Disa JJ . The functional impact of breast reconstruction: An overview and update . Plastic and Reconstructive Surgery-Global Open . 2018;6(3):e1640- . PMCID: PMC5908499

Nelson JA, Disa JJ . Clinical and quantitative isokinetic comparison of abdominal morbidity and dynamics following DIEP versus muscle-sparing free TRAM flap breast reconstruction . Plastic and Reconstructive Surgery . 2018;142(1):92e-94e .

Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM,

Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME . Management strategies of academic pigmented lesion clinic directors in the United States . Journal of the American Academy of Dermatology . 2018;79(2):367-369 .

Neppala P, Sherer M V, Larson G, Bryant AK, Panjwani N, Murphy JD, Gillespie EF . An interactive contouring module improves engagement and interest in radiation oncology among preclinical medical students: Results of a randomized trial . Practical Radiation Oncology . 2018;8(4):e190-e198 .

Neumann JL, Mau LW, Virani S, Denzen EM, Boyle DA, Boyle NJ, Dabney J, De KeselLofthus A, Kalbacker M, Khan T, Majhail NS, Murphy EA, Paplham P, Parran L, Perales MA, Rockwood TH, Schmit-Pokorny K, Shanafelt TD, Stenstrup E, Wood WA, Burns LJ . Burnout, moral distress, work-life balance, and career satisfaction among hematopoietic cell transplantation professionals . Biology of Blood and Marrow Transplantation . 2018;24(4):849-860 .

Neumeyer S, Banbury BL, Arndt V, Berndt S I, Bezieau S, Bien SA, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Casey G, Chan AT, Chanock SJ, Dai JY, Gallinger S, Giovannucci EL, Giles GG, Grady WM, Hampe J, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi A, Larsson SC, Le Marchand L, Lindblom A, Moreno V, Lemire M, Li L, Lin Y, Offit K, Newcomb PA, Pharaoh PD, Potter JD, Qi L, Rennert G, Schafmayer C, Schoen RE, Slattery ML, Song M, Ulrich CM, Win AK, White E, Wolk A, Woods MO, Wu AH, Gruber SB, Brenner H, Peters U, Chang-Claude J . Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer . British Journal of Cancer . 2018;118(12):1639-1647 .

Neuschmelting V, Harmsen S, Beziere N, Lockau H, Hsu HT, Huang R, Razansky D, Ntziachristos V, Kircher MF . Dual-modality surface-enhanced resonance Raman scattering and multispectral optoacoustic tomography nanoparticle approach for brain tumor delineation . Small . 2018;14(23):1800740- .

131 OF 288


Journal Articles

Neuschmelting V, Kim K, Malekzadeh-Najafabadi J, Jebiwott S, Prakash J, Scherz A, Coleman JA, Kircher MF, Ntziachristos V . WST11 vascular targeted photodynamic therapy effect monitoring by multispectral optoacoustic tomography (MSOT) in mice . Theranostics . 2018;8(3):723-734 . PMCID: PMC5771088

Nevel KS, Southerland AM, Kilgore SM, Gutmann L . Residency training: The Review Committee for Neurology: Revisions to the Common Program Requirements . Neurology . 2018;90(1):41-44 .

Nevel KS, Wilcox JA, Robell LJ, Umemura Y . The utility of liquid biopsy in central nervous system malignancies . Current Oncology Reports . 2018;20(8):60- .

Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N . Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network . Journal of Medical Imaging . 2018;5(1):011003- . PMCID: PMC5633866

Newsom E, Lee E, Rossi A, Dusza S, Nehal K . Modernizing the Mohs surgery consultation: Instituting a video module for improved patient education and satisfaction . Dermatologic Surgery . 2018;44(6):778-784 .

Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T . Role of radiation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group . International

Journal of Radiation Oncology, Biology, Physics . 2018;100(3):652-669 .

Ng PKS, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB . Systematic functional annotation of somatic mutations in cancer . Cancer Cell . 2018;33(3):450-462 .e10 .

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia N V, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R . Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models . Nature Communications . 2018;9:2024- . PMCID: PMC5964252

Nghiemphu PL, Ebiana VA, Wen P, Gilbert M, Abrey LE, Lieberman F, DeAngelis LM, Robins H I, Yung WKA, Chang SS, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados M, Kuhn J, Cloughesy TF . Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02 . Journal of Neuro-Oncology . 2018;136(1):79-86 . PMCID: PMC5756101

Nguyen B, Venet D, Azim HA Jr, Brown D, Desmedt C, Lambertini M, Majjaj S, Pruneri G, Peccatori F, Piccart M, Rothé F, Sotiriou C . Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency

signature and mucin mutations . npj Breast Cancer . 2018;4:23- . PMCID: PMC6078984

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA . Does subclassification of pathologically organ confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy? . Journal of Urology . 2018;199(6):1502-1509 .

Nguyen J, Hassoun H . Multiple myeloma with simultaneous cutaneous and central nervous system involvement . Clinical Case Reports . 2018;6(10):2015-2016 . PMCID: PMC6186883

Nguyen TH, Rustenburg AS, Krimmer SG, Zhang H, Clark JD, Novick PA, Branson K, Pande VS, Chodera JD, Minh DDL . Bayesian analysis of isothermal titration calorimetry for binding thermodynamics . PLoS ONE . 2018;13(9):e0203224- . PMCID: PMC6136728

Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V . Modified high-dose melphalan and autologous stem cell transplantation for immunoglobulin light chain amyloidosis . Biology of Blood and Marrow Transplantation . 2018;24(9):1823-1827 .

Ni A, Cai J . A regularized variable selection procedure in additive hazards model with stratified case-cohort design . Lifetime Data Analysis .2018;24(3):443-463 . PMCID: PMC5787409

Ni A, Cai J . Tuning parameter selection in cox proportional hazards model with a diverging number of parameters . Scandinavian Journal of Statistics . 2018;45(3):557-570 . PMCID: PMC6107315

Nicholson AG, Tsao MS, Travis WD, Patil DT, Galateau-Salle F, Marino M, Dacic S, Beasley MB, Butnor KJ, Yatabe Y, Pass H I, Rusch VW, Detterbeck FC,

132 OF 288


Journal Articles

Asamura H, Rice TW, Rami-Porta R, for the Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees . Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist . Archives of Pathology & Laboratory Medicine . 2018;142(5):645-661 .

Nicholson AG, Torkko K, Viola P, Duhig E, Geisinger K, Borczuk AC, Hiroshima K, Tsao MS, Warth A, Lantuejoul S, Russell PA, Thunnissen E, Marchevsky A, Mino-Kenudson M, Beasley MB, Botling J, Dacic S, Yatabe Y, Noguchi M, Travis WD, Kerr K, Hirsch FR, Chirieac LR, Wistuba I I, Moreira A, Chung JH, Chou TY, Bubendorf L, Chen G, Pelosi G, Poleri C, Detterbeck FC, Franklin WA . Interobserver variation among pathologists and refinement of criteria in distinguishing separate primary tumors from intrapulmonary metastases in lung . Journal of Thoracic Oncology . 2018;13(2):205-217 . PMCID: PMC6276791

Nicolas L, Cols M, Choi JE, Chaudhuri J, Vuong B . Generating and repairing genetically programmed DNA breaks during immunoglobulin class switch recombination . F1000Research . 2018;7:458- . PMCID: PMC5904731

Niethammer P . Multicellular interactions: Regeneration and mechanisms of disease . Molecular Biology of the Cell . 2018;29(6):690- .

Niethammer P . Wound redox gradients revisited . Seminars in Cell and Developmental Biology . 2018;80:13-16 . PMCID: PMC5783784

Nilsen TS, Scott JM, Michalski M, Capaci C, Thomas S, Herndon JE 2nd, Sasso J, Eves ND, Jones LW . Novel methods for reporting of exercise dose and adherence: An exploratory analysis . Medicine and Science in Sports and Exercise . 2018;50(6):1134-1141 . PMCID: PMC5953772

Nixon BG, Li MO . Tissue-resident cytolytic innate lymphocytes in cancer . Journal of Immunology . 2018;200(2):408-414 . PMCID: PMC5765876

Nixon IJ, Angelos P, Shaha AR, Rinaldo A, Williams MD, Ferlito A . Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications . Head & Neck . 2018;40(9):2103-2115 .

Nobel TB, Molena D . From standardization to personalized medicine: Moving beyond cookie-cutter treatment of esophageal cancer . Journal of Thoracic and Cardiovascular Surgery . 2018;156(4):1736-1738 .

Noch EK . Til neglect do us part . JAMA Neurology . 2018;75(7):785-786 .

Nolan C, Deangelis LM . Overview of metastatic disease of the central nervous system . Handbook of Clinical Neurology . 2018;149:3-23 .

Norton JA, Foster DS, Blumgart LH, Poultsides GA, Visser BC, Fraker DL, Alexander HR, Jensen RT . Incidence and prognosis of primary gastrinomas in the hepatobiliary tract . JAMA Surgery . 2018;153(3):e175083- . PMCID: PMC5885930

Norton JA, Kim T, Kim J, McCarter MD, Kelly KJ, Wong J, Sicklick JK . SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors . Journal of Gastrointestinal Surgery . 2018;22(1):32-42 . PMCID: PMC5742030

Nougaret S, Lakhman Y, Molinari N, Feier D, Scelzo C, Vargas HA, Sosa RE, Hricak H, Soslow RA, Grisham RN, Sala E . CT features of ovarian tumors: Defning key differences between serous borderline tumors and low-grade serous carcinomas . American Journal of Roentgenology . 2018;210(4):918-926 .

Novetsky Friedman D, Henderson TO . Late effects and survivorship issues in patients with neuroblastoma . Children . 2018;5(8):107- . PMCID: PMC6111874

Nowotschin S, Hadjantonakis AK . Lights, camera, action! Visualizing the cellular choreography of mouse gastrulation . Developmental Cell . 2018;47(6):684-685 .

O’Brien S, Patel M, Kahl BS, Horwitz SM, Foss FM, Porcu P, Jones J, Burger J, Jain N, Allen K, Faia K, Douglas M, Stern HM, Sweeney J, Kelly P, Kelly V, Flinn I . Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study . American Journal of Hematology . 2018;93(11):1318-1326 .

O’Cearbhaill RE . Using PARP inhibitors in advanced ovarian cancer . Oncology (Norwalk) . 2018;32(7):339-343 .

O’Donnell T, Christie EL, Ahuja A, Buros J, Aksoy BA, Bowtell DDL, Snyder A, Hammerbacher J . Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer . BMC Cancer . 2018;18:87- . PMCID: PMC5778667

O’Donoghue JA, Lewis JS, Pandit-Taskar N, Fleming SE, Schöder H, Larson SM, Beylergil V, Ruan S, Lyashchenko SK, Zanzonico PB, Weber WA, Carrasquillo JA, Janjigian YY . Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer . Journal of Nuclear Medicine . 2018;59(1):161-166 . PMCID: PMC5750520

O’Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, Chen C, Chen MM, Cheng THT, Clarke CL, Clendenning M, Cook LS, Couch FJ, Cox A, Crous-Bous M, Czene K, Day F, Dennis J, Depreeuw J, Doherty JA, Dörk T, Dowdy SC, Dürst M, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, Fritschi L, Fung J, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankison SE, Healey CS, Hein

133 OF 288


Journal Articles

A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hopper JL, Hunter DJ, Jones A, Krakstad C, Kristensen VN, Lambrechts D, Marchand LL, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Meindl A, Michailidou K, Milne RL, Mints M, Montgomery GW, Nassir R, Olsson H, Orlow I, Otton G, Palles C, Perry JRB, Peto J, Pooler L, Prescott J, Proietto T, Rebbeck TR, Risch HA, Rogers PAW, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Swerdlow AJ, Tham E, Trovik J, Turman C, Tyrer JP, Vachon C, VanDen Berg D, Vanderstichele A, Wang Z, Webb PM, Wentzensen N, Werner HMJ, Winham SJ, Wolk A, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Pharoah PDP, Dunning AM, Kraft P, De Vivo I, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ . Identification of nine new susceptibility loci for endometrial cancer . Nature Communications . 2018;9:3166- . PMCID: PMC6085317

O’Reilly EM, Lee JW, Lowery MA, Capanu M, Stadler ZK, Moore MJ, Dhani N, Kindler HL, Estrella H, Maynard H, Golan T, Segal A, Salo-Mullen EE, Yu KH, Epstein AS, Segal M, Brenner R, Do RK, Chen AP, Tang LH, Kelsen DP . Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma . Cancer . 2018;124(7):1374-1382 . PMCID: PMC5867226

O’Shaughnessy MJ, Murray KS, La Rosa SP, Budhu S, Merghoub T, Somma A, Monette S, Kim K, Corradi RB, Scherz A, Coleman JA . Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors . Clinical Cancer Research . 2018;24(3):592-599 .

O’Sullivan TE, Sun JC . Determination of the fate and function of innate lymphoid cells following adoptive transfer of innate lymphoid cell precursors . Methods in Molecular Biology . 2018;1799:109-119 .

Ochoa-Lizarralde B, Gao YG, Popov AN, Samygina VR, Zhai X, Mishra SK, Boldyrev IA, Molotkovsky JG, Simanshu DK, Patel DJ, Brown RE, Malinina L . Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into sphingolipid recognition by the glycolipid transfer protein family . Journal of Biological Chemistry . 2018;293(43):16709-16723 . PMCID: PMC6204895

Odorico J, Markmann J, Melton D, Greenstein J, Hwa A, Nostro C, Rezania A, Oberholzer J, Pipeleers D, Yang L, Cowan C, Huangfu D, Egli D, Ben-David U, Vallier L, Grey ST, Tang Q, Roep B, Ricordi C, Naji A, Orlando G, Anderson DG, Poznansky M, Ludwig B, Tomei A, Greiner DL, Graham M, Carpenter M, Migliaccio G, D’Amour K, Hering B, Piemonti L, Berney T, Rickels M, Kay T, Adams A . Report of the key opinion leaders meeting on stem cell-derived beta cells . Transplantation . 2018;102(8):1223-1229 .

Offin M, Liu D, Drilon A . Tumor-agnostic drug development . American Society of Clinical Oncology Educational Book . 2018;38:184-187 .

Ogba N, Arwood NM, Bartlett NL, Bloom M, Brown P, Brown C, Budde EL, Carlson R, Farnia S, Fry TJ, Garber M, Gardner RA, Gurschick L, Kropf P, Reitan JJ, Sauter C, Shah B, Shpall EJ, Rosen ST . Chimeric antigen receptor T-cell therapy . Journal of the National Comprehensive Cancer Network . 2018;16(9):1093-1106 .

Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP, Agaimy A, Amin MB, Argani P, Chen YB, Cheng L, Colecchia M, Compérat E, da Cunha IW, Epstein J I, Gill AJ, Hes O, Hirsch MS, Jochum W, Kunju LP, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Nesi G, Osunkoya AO, Picken MM, Rao P, Reuter VE, de Oliveira Salles PG, Schultz L, Tickoo SK, Tomlins SA, Trpkov K, Amin MB . Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient

renal cell carcinoma . American Journal of Surgical Pathology . 2018;42(3):279-292 .

Ohri N, Sittig MP, Tsai CJ, Hwang ESS, Mittendorf EA, Shi W, Zhang Z, Ho AY . Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis . Cancer . 2018;124(3):482-490 .

Oikonomou EK, Athanasopoulou SG, Kampaktsis PN, Kokkinidis DG, Papanastasiou CA, Feher A, Steingart RM, Oeffinger KC, Gupta D . Development and validation of a clinical score for cardiovascular risk stratification of long-term childhood cancer survivors . The Oncologist . 2018;23(8):965-973 .

Okhovat JP, Beaulieu D, Tsao H, Halpern AC, Michaud DS, Shaykevich S, Geller AC . The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014 . Journal of the American Academy of Dermatology . 2018;79(5):884-891 .e3 .

Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, Bachovchin DA . Inhibition of Dpp8/9 activates the Nlrp1b inflammasome . Cell Chemical Biology . 2018;25(3):262-267 .e5 . PMCID: PMC5856610

Olasehinde O, Alatise O, Arowolo O, Adisa A, Wuraola F, Boutin-Foster C, Lawal O, Kingham T . Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting . Journal of Surgical Oncology . 2018;118(6):861-866 .

Olsson CE, Jackson A, Deasy JO, Thor M . A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(5):1514-1532 .

Omuro A, Vlahovic G, Lim M, Sahebjam S, Baehring J, Cloughesy T, Voloschin A, Ramkissoon SH, Ligon KL, Latek R, Zwirtes R, Strauss L, Paliwal P, Harbison CT,

134 OF 288


Journal Articles

Reardon DA, Sampson JH . Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 . Neuro-Oncology . 2018;20(5):674-686 . PMCID: PMC5892140

Omuro A, Beal K, McNeill K, Young RJ, Thomas A, Lin X, Terziev R, Kaley TJ, DeAngelis LM, Daras M, Gavrilovic IT, Mellinghoff I, Diamond EL, McKeown A, Manne M, Caterfino A, Patel K, Bavisotto L, Gorman G, Lamson M, Gutin P, Tabar V, Chakravarty D, Chan TA, Brennan CW, Garrett-Mayer E, Karmali RA, Pentsova E . Multicenter phase IB trial of carboxyamidotriazole orotate and temozolomide for recurrent and newly diagnosed glioblastoma and other anaplastic gliomas . Journal of Clinical Oncology . 2018;36(17):1702-1709 . PMCID: PMC5993168

Orlacchio A, Chegai F, Francioso S, Merolla S, Monti S, Angelico M, Tisone G, Mannelli L . Repeated transarterial chemoembolization with degradable starch microspheres (DSMs-TACE) of unresectable hepatocellular carcinoma: A prospective pilot study . Current Medical Imaging Reviews . 2018;14(4):637-645 .PMCID: PMC6110039

Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ 3rd, Shaha AR, Shindo ML, Snyder SK, Stack BC Jr, Sunwoo JB, Wang MB, for the American Thyroid Association Surgical Affairs Committee Writing Task Force . American Thyroid Association Statement on postoperative hypoparathyroidism: Diagnosis, prevention, and management in adults . Thyroid . 2018;28(7):830-841 .

Orlow I, Shi Y, Kanetsky PA, Thomas NE, Luo L, Corrales-Guerrero S, Cust AE, Sacchetto L, Zanetti R, Rosso S, Armstrong BK, Dwyer T, Venn A, Gallagher RP, Gruber SB, Marrett LD, Anton-Culver H, Busam K, Begg CB, Berwick M, for the GEM Study Group . The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival . Pigment Cell

& Melanoma Research . 2018;31(2):287-296 . PMCID: PMC5809306

Orom H, Biddle C, Underwood W 3rd, Nelson CJ . Worse urinary, sexual and bowel function cause emotional distress and vice versa in men treated for prostate cancer . Journal of Urology . 2018;199(6):1464-1469 .

Orom H, Schofield E, Kiviniemi MT, Waters EA, Biddle C, Chen X, Li Y, Kaphingst KA, Hay JL . Low health literacy and health information avoidance but not satisficing help explain “don’t know” responses to questions assessing perceived risk . Medical Decision Making . 2018;38(8):1006-1017 . PMCID: PMC6226271

Osborn VW, Lee A, Yamada Y . Stereotactic body radiation therapy for spinal malignancies . Technology in Cancer Research & Treatment . 2018;17:1533033818802304- . PMCID: PMC6198394

Oseledchyk A, Gennarelli RL, Leitao MM Jr, Aghajanian CA, Iasonos A, Zivanovic O, Zamarin D . Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: A surveillance, epidemiology, and end results cohort study . Cancer Medicine . 2018;7(6):2280-2287 . PMCID: PMC6010870

Oseledchyk A, Ricca JM, Gigoux M, Ko B, Redelman-Sidi G, Walther T, Liu C, Iyer G, Merghoub T, Wolchok JD, Zamarin D . Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus . Oncotarget . 2018;9(47):28702-28716 . PMCID: PMC6033351

Osorio DS, Hu J, Mitchell C, Allen JC, Stanek J, Hagiwara M, Karajannis MA . Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2 . Journal of Neuro-Oncology . 2018;139(3):749-755 . PMCID: PMC6126973

Osorio DS, Dunkel IJ, Cervone KA, Goyal RK, Steve Lo KM, Finlay JL, Gardner SL . Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid

tumor malignancies . Pediatric Blood and Cancer . 2018;65(1):e26776- .

Osorio DS, Patel N, Ji L, Sposto R, Stanek J, Gardner SL, Allen JC, Cornelius A, McCowage GB, Termuhlen A, Dunkel IJ, Comito M, Garvin J, Finlay JL . Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: Report of the “Head-Start” I and II clinical trials . Journal of Neuro-Oncology . 2018;140(3):717-725 .

Osorio JC, Harding JJ . Understanding and quantifying the immune microenvironment in hepatocellular carcinoma . Translational Gastroenterology and Hepatology . 2018;3:107- .

Ostrom QT, Kinnersley B, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos C I, Bernstein JL, Claus EB, Eckel-Passow JE, Il’yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, on behalf of the GliomaScan Consortium, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Bondy ML, Barnholtz-Sloan JS . Age-specific genome-wide association study in glioblastoma identifies increased proportion of ‘lower grade glioma’-like features associated with younger age . International Journal of Cancer . 2018;143(10):2359-2366 . PMCID: PMC6205887

Ostrom QT, Kinnersley B, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos C I, Bernstein JL, Claus EB, Il’yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Lathia JD, Berens ME, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, GliomaScan consortium, Houlston RS, Jenkins RB, Melin B, Bondy ML, Barnholtz-Sloan JS . Sex-specific glioma genome-wide association study identifies new risk locus at 3p21 .31 in females, and finds sex-

135 OF 288


Journal Articles

differences in risk at 8q24 .21 . Scientific Reports . 2018;8:7352- . PMCID: PMC5943590

Otazo R . Motion-tolerant quantitative cardiovascular MRI . Nature Biomedical Engineering . 2018;2(4):199-200 .

Ou SH I, Socinski MA, Gadgeel S, Gandhi L, West H, Chiappori AA, Cohen V, Riely GJ, Smoljanovic V, Bordogna W, Wright E, Debusk K, Zeaiter A, Shaw AT . Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer . ESMO Open . 2018;3(5):e000364- . PMCID: PMC6045737

Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, Saltz LB, Mazard T, Vauthey JN, Hoff PM, Hobbs B, Loyer EM, Kopetz S . The addition of bevacizumab to oxaliplatin-based chemotherapy: Impact upon hepatic sinusoidal injury and thrombocytopenia . JNCI: Journal of the National Cancer Institute . 2018;110(8):888-894 .

Owen D, Chaft JE . Immunotherapy in surgically resectable non-small cell lung cancer . Journal of Thoracic Disease . 2018;10(Suppl . 3):S404-S411 . PMCID: PMC5861266

Owosho AA, Zhang L, Rosenblum MK, Antonescu CR . High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: A clinicopathologic and molecular study of nine cases . Genes Chromosomes and Cancer . 2018;57(2):89-95 . PMCID: PMC5732052

Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL . Medication-related osteonecrosis of the jaw: An update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention . Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology . 2018;125(5):440-445 .

Owosho AA, Estilo CL, Huryn JM, Chi P, Antonescu CR . A clinicopathologic study of head and neck malignant peripheral nerve sheath tumors . Head and Neck Pathology . 2018;12(2):151-159 . PMCID: PMC5953865

Ozkanli S, Basar MM, Selimoglu S, Erol B, Ozkanli O, Nurili F, Kahraman S . The ghrelin and orexin activity in testicular tissues of patients with idiopathic non-obstructive azoospermia . Kaohsiung Journal of Medical Sciences . 2018;34(10):564-568 .

Ozkaya N, Rosenblum MK, Durham BH, Pichardo JD, Abdel-Wahab O, Hameed MR, Busam KJ, Travis WD, Diamond EL, Dogan A . The histopathology of Erdheim-Chester disease: A comprehensive review of a molecularly characterized cohort . Modern Pathology . 2018;31(4):581-597 .

Pacheco S, Maldonado-Linares A, Marcet-Ortega M, Rojas C, Martínez-Marchal A, Fuentes-Lazaro J, Lange J, Jasin M, Keeney S, Fernandez-Capetillo O, Garcia-Caldés M, Roig I . ATR is required to complete meiotic recombination in mice . Nature Communications . 2018;9:2622- . PMCID: PMC6033890

Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ, Sloan J, Basch E, Major B, Novotny P, Taylor J, Buckner J, Parsons JK, Morris M, Tilburt JC . The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: A study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD . BMC Cancer . 2018;18:788- . PMCID: PMC6080528

Padda SK, Yao X, Antonicelli A, Riess JW, Shang Y, Shrager JB, Korst R, Detterbeck F, Huang J, Burt BM, Wakelee HA, Badve SS . Paraneoplastic syndromes and thymic malignancies: An examination of the International Thymic Malignancy Interest Group retrospective database . Journal of Thoracic Oncology . 2018;13(3):436-446 .

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci G V, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu D V, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J . International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study . Lancet . 2018;391(10135):2128-2139 .

Page DB, Wen H, Brogi E, Dure D, Ross D, Spinelli KJ, Patil S, Norton L, Hudis C, McArthur HL . Monosomy 17 in potentially curable HER2-amplified breast cancer: Prognostic and predictive impact . Breast Cancer Research and Treatment . 2018;167(2):547-554 .

Pak DJ, Gulati A . Real-time ultrasound-assisted thoracic epidural placement: A feasibility study of a novel technique . Regional Anesthesia and Pain Medicine . 2018;43(6):613-615 .

Pak LM, Gonen M, Seier K, Balachandran VP, D’Angelica M I, Jarnagin WR, Kingham TP, Allen PJ, Do RKG, Simpson AL . Can physician gestalt predict survival in patients with resectable

136 OF 288


Journal Articles

pancreatic adenocarcinoma? . Abdominal Radiology . 2018;43(8):2113-2118 . PMCID: PMC5967975

Pak LM, Schattner MA, Balachandran V, D’Angelica M I, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ . The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma . HPB . 2018;20(2):182-187 .

Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D’Angelica M I . Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential . Journal of Surgical Oncology . 2018;117(4):634-643 . PMCID: PMC5878699

Pak LM, Chakraborty J, Gonen M, Chapman WC, Do RKG, Groot Koerkamp B, Verhoef K, Lee SY, Massani M, van der Stok EP, Simpson AL, Memorial Sloan Kettering Cancer Center Hepatopancreatobiliary Service . Quantitative imaging features and postoperative hepatic insufficiency: A multi-institutional expanded cohort . Journal of the American College of Surgeons . 2018;226(5):835-843 . PMCID: PMC5924623

Paknejad N, Hite RK . Structural basis for the regulation of inositol trisphosphate receptors by Ca2(+) and IP(3) . Nature Structural and Molecular Biology . 2018;25(8):660-668 . PMCID: PMC6082148

Pal SK, Rosenberg JE, Hoffman-Censits JH, Berger R, Quinn D I, Galsky MD, Wolf J, Dittrich C, Keam B, Delord JP, Schellens JHM, Gravis G, Medioni J, Maroto P, Sriuranpong V, Charoentum C, Burris HA, Grünwald V, Petrylak D, Vaishampayan U, Gez E, De Giorgi U, Lee JL, Voortman J, Gupta S, Sharma S, Mortazavi A, Vaughn DJ, Isaacs R, Parker K, Chen X, Yu K, Porter D, Porta DG, Bajorin DF . Efficacy of BGJ398, a fibroblast growth factor receptor 1-3 inhibitor, in patients with previously treated advanced urothelial

carcinoma with FGFR3 alterations . Cancer Discovery . 2018;8(7):812-821 .

Palani CD, Ramanathapuram L, Lam-ubol A, Kurago ZB . Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases 1/2 . Oncotarget . 2018;9(6):6814-6829 . PMCID: PMC5805517

Palaniappan L, Garg A, Enas E, Lewis H, Bari S, Gulati M, Flores C, Mathur A, Molina C, Narula J, Rahman S, Leng J, Gany F . South Asian cardiovascular disease & cancer risk: Genetics & pathophysiology . Journal of Community Health . 2018;43(6):1100-1114 .

Palazzo M, Shah GL, Copelan O, Seier K, Devlin SM, Maloy M, Kenny S, Hassoun H, Korde NS, Lendvai N, Lesokhin AM, Mailankody S, Chung DJ, Koehne G, Landgren CO, Landau H, Giralt SA, Perales MA . Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance . Biology of Blood and Marrow Transplantation . 2018;24(4):871-876 .

Pallin DJ, Baugh CW, Postow MA, Caterino JM, Erickson TB, Lyman GH . Immune‐related adverse events in cancer patients . Academic Emergency Medicine . 2018;25(7):819-827 .

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes AJ, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Gontero P . Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: Not as bad as previously thought . World Journal of Urology . 2018;36(10):1621-1627 .

Pan Y, Yoon S, Sun J, Huang Z, Lee C, Allen M, Wu Y, Chang YJ, Sadelain M, Shung KK, Chien S, Wang

Y . Mechanogenetics for the remote and noninvasive control of cancer immunotherapy . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(5):992-997 . PMCID: PMC5798350

Pandit-Taskar N . Functional imaging methods for assessment of minimal residual disease in multiple myeloma: Current status and novel immunoPET based methods . Seminars in Hematology . 2018;55(1):22-32 .

Pandit-Taskar N, Zanzonico P, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko S, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S . Biodistribution and dosimetry of (18)F-meta-fluorobenzylguanidine: A first-in-human PET/CT imaging study of patients with neuroendocrine malignancies . Journal of Nuclear Medicine . 2018;59(1):147-153 . PMCID: PMC5750519

Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, Muglia VF, Salomon G, Thomas S, Vargas HA, Witjes JA, Takeuchi M, Barentsz J, Catto JWF . Multiparametric magnetic resonance imaging for bladder cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System) . European Urology . 2018;74(3):294-306 .

Pangeni RP, Zhang Z, Alvarez AA, Wan X, Sastry N, Lu S, Shi T, Huang T, Lei CX, James CD, Kessler JA, Brennan CW, Nakano I, Lu X, Hu B, Zhang W, Cheng SY . Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma . Epigenetics . 2018;13(4):432-448 . PMCID: PMC6140806

Paoletti C, Schiavon G, Dolce EM, Darga EP, Hedley Carr T, Geradts J, Hoch M, Klinowska T, Lindemann J, Marshall G, Morgan S, Patel P, Rowlands V, Sathiyayogan N, Aung K, Hamilton E, Patel M, Armstrong A, Jhaveri K, Im SA, Iqbal N, Butt F, Dive C, Harrington EA, Carl Barrett J, Baird R, Hayes DF .

137 OF 288


Journal Articles

Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 Oral SERD phase I trial . Clinical Cancer Research . 2018;24(23):5860-5872 .

Papanicolaou G . Predictive value of faecal adenoviral load for viraemia . The Lancet Haematology . 2018;5(9):e385-e386 .

Parameswaran L, Rao A, Chastain K, Ackelsburg J, Adams E, Jackson B, Voigt LP, Chen X, Boulad F, Taur Y . A case of adult intestinal toxemia botulism during prolonged hospitalization in an allogeneic hematopoietic cell transplant recipient . Clinical Infectious Diseases . 2018;66(Suppl . 1):S99-S102 .

Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, Da Cruz Paula A, Kumar R, Brown DN, Gularte-Mérida R, Alemar B, Bi R, Lim RS, de Bruijn I, Fujisawa S, Gardner R, Feng E, Li A, da Silva EM, Lozada JR, Blecua P, Cohen-Gould L, Jungbluth AA, Rakha EA, Ellis IO, Edelweiss MIA, Palazzo J, Norton L, Hollmann T, Edelweiss M, Rubin BP, Weigelt B, Reis-Filho JS . Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors . Nature Communications . 2018;9:3533- . PMCID: PMC6117336

Pareja F, Marchio C, Reis-Filho JS . Molecular diagnosis in breast cancer . Diagnostic Histopathology . 2018;24(2):71-82 .

Pareja F, Reis-Filho JS . Triple-negative breast cancers - a panoply of cancer types . Nature Reviews Clinical Oncology . 2018;15(6):347-348 .

Parekh N, Jiang J, Buchan M, Meyers M, Gibbs H, Krebs P . Nutrition literacy among cancer survivors: Feasibility results from the Healthy Eating and Living Against Breast Cancer (HEAL-BCa) study: A pilot randomized controlled trial . Journal of Cancer Education . 2018;33(6):1239-1249 .

Paris MT, Furberg HF, Petruzella S, Akin O, Hötker AM, Mourtzakis M . Influence of contrast administration on computed tomography–based

analysis of visceral adipose and skeletal muscle tissue in clear cell renal cell carcinoma . Journal of Parenteral and Enteral Nutrition . 2018;42(7):1148-1155 .

Park BJ . Reply to letter: “Long-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer: Comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy” . Annals of Surgery . 2018;267(2):e34-e35 .

Park CL, Elwy AR, Maiya M, Sarkin AJ, Riley KE, Eisen S V, Gutierrez I, Finkelstein-Fox L, Lee SY, Casteel D, Braun T, Groessl EJ . The Essential Properties of Yoga Questionnaire (EPYQ): Psychometric properties . International Journal of Yoga Therapy . 2018;28(1):23-38 .

Park JH, Romero FA, Taur Y, Sadelain M, Brentjens RJ, Hohl TM, Seo SK . Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells . Clinical Infectious Diseases . 2018;67(4):533-540 .PMCID: PMC6070095

Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, Sauter C, Wang Y, Santomasso B, Mead E, Roshal M, Maslak P, Davila M, Brentjens RJ, Sadelain M . Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia . New England Journal of Medicine . 2018;378(5):449-459 .

Park KJ, Roma AA . Pattern based classification of endocervical adenocarcinoma: A review . Pathology . 2018;50(2):134-140 .

Park KJ, Patel P, Linkov I, Jotwani A, Kauff N, Pike MC . Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy . Histopathology . 2018;72(5):766-776 . PMCID: PMC5849505

Park KJ . Case review: Gastric-type adenocarcinoma of the uterine cervix and precursor lesions . AJSP: Reviews and Reports . 2018;23(2):84-90 .

Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM . Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with nonhereditary breast cancer . Journal of Clinical Oncology . 2018;36(25):2630-2638 . PMCID: PMC6118404

Parker PA, Banerjee SC . Sharing serious news with cancer patients: Strategies that can help . Oncology (Norwalk) . 2018;32(7):334-338 .

Parker PA, Banerjee SC, Matasar MJ, Bylund CL, Rogers M, Franco K, Schofield E, Li Y, Levin TT, Jacobsen PB, Astrow AB, Leventhal H, Horwitz S, Kissane D . Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: A cluster randomized controlled trial . Cancer . 2018;124(23):4567 4576 . PMCID: PMC6289801

Parks MM, Kurylo CM, Dass RA, Bojmar L, Lyden D, Vincent CT, Blanchard SC . Variant ribosomal RNA alleles are conserved and exhibit tissue-specific expression . Science Advances . 2018;4(2):eaao0665- . PMCID: PMC5829973

Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Morris MJ, Small E, Hahn O, Humphrey P, Taylor J, Marshall J . Men’s Eating and Living (MEAL) study (CALGB 70807 [Alliance]): Recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer . BJU International . 2018;121(4):534-539 . PMCID: PMC5654696

Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan K V, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA . Patterns of involved-field radiation therapy protocol deviations in pediatric versus adolescent and young adults with Hodgkin lymphoma: A report from the

138 OF 288


Journal Articles

Children’s Oncology Group AHOD0031 . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1119-1125 .

Pasquali P, Segurado-Miravalles G, Gonzalez S . Sequential treatment of actinic keratosis with cryotherapy and ingenol mebutate: Reflectance confocal microscopy monitoring of efficacy and local skin reaction . International Journal of Dermatology . 2018;57(10):1178-1181 .

Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH . Blood and Marrow Transplant Clinical Trials Network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials . Biology of Blood and Marrow Transplantation . 2018;24(6):1274-1280 . PMCID: PMC5993573

Pasternak GW . Mu opioid pharmacology: 40 years to the promised land . Advances in Pharmacology . 2018;82:261-291 .

Pastores SM, Annane D, Rochwerg B, and the Corticosteroid Guideline Task Force of SCCM and ESICM . Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 . Critical Care Medicine . 2018;46(1):146-148 .

Pastores SM, Annane D, Rochwerg B, The Corticosteroid Guideline Task Force of SCCM and ESICM . Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 . Intensive Care Medicine . 2018;44(4):474-477 .

Pastores SM, Goldman DA, Shaz DJ, Kostelecky N, Daley RJ, Peterson TJ, Tan KS, Halpern NA . Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit . Cancer . 2018;124(14):3025-3036 .

Patel JJ, Kurman J, Al-Ghandour E, Thandra K, Mawari S, Graf J, Kovac J, Rein L, Simpson SQ . Predictors of 24-h mortality after inter-hospital transfer to a tertiary medical intensive care unit . Journal of the Intensive Care Society . 2018;19(4):319-325 . PMCID: PMC6259083

Patel KN, Angell TE, Babiarz J, Barth NM, Blevins T, Duh QY, Ghossein RA, Mack Harrell R, Huang J, Kennedy GC, Kim SY, Kloos RT, LiVolsi VA, Randolph GW, Sadow PM, Shanik MH, Sosa JA, Thomas Traweek S, Sean Walsh P, Whitney D, Yeh MW, Ladenson PW . Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules . JAMA Surgery . 2018;153(9):817-824 .

Patel KN, Ganly I, Shaha AR . Remote-access thyroid surgery - progress, assessment, and reflection . Journal of Surgical Oncology . 2018;118(3):388-389 .

Patel N, Pass A, Mason S, Gibson CR, Otto C . Optical coherence tomography analysis of the optic nerve head and surrounding structures in long-duration international space station astronauts . JAMA Ophthalmology . 2018;136(2):193-200 .

Patel S, Wang S, Snuderl M, Karajannis MA . Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma . Journal of Neuro-Oncology . 2018;136(3):541-544 . PMCID: PMC5807109

Patel SN, Mango VL, Jadeja P, Friedlander L, Desperito E, Wynn R, Feldman S, Ha R . Reflector-guided breast tumor localization versus wire localization for lumpectomies: A comparison of surgical outcomes . Clinical Imaging . 2018;47:14-17 .

Patel S V, Yu D, Elsolh B, Goldacre BM, Nash GM . Assessment of conflicts of interest in robotic surgical studies: Validating author’s declarations with the Open Payments database . Annals of Surgery . 2018;268(1):86-92 .PMCID: PMC6003408

Patel T, Bander ED, Venn RA, Powell T, Cederquist GYM, Schaefer PM, Puchi LA, Akhmerov A, Ogilvie S, Reiner AS, Moussazadeh N, Tabar V . The role of extent of resection in IDH1 wild-type or mutant low-grade gliomas . Neurosurgery . 2018;82(6):808-814 .

Patnaik MM, Abdel-Wahab O . SETD2 - Linking stem cell survival and transformation . Cell Research . 2018;28(4):393-394 .

Pavlova NN, Hui S, Ghergurovich JM, Fan J, Intlekofer AM, White RM, Rabinowitz JD, Thompson CB, Zhang J . As extracellular glutamine levels decline, asparagine becomes an essential amino acid . Cell Metabolism . 2018;27(2):428-438 .e5 . PMCID: PMC5803449

Peek J, Lilic M, Montiel D, Milshteyn A, Woodworth I, Biggins JB, Ternei MA, Calle PY, Danziger M, Warrier T, Saito K, Braffman N, Fay A, Glickman MS, Darst SA, Campbell EA, Brady SF . Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism . Nature Communications . 2018;9:4147- . PMCID: PMC6175910

Pekmezci M, Stevers M, Phillips JJ, Van Ziffle J, Bastian BC, Tsankova NM, Kleinschmidt-DeMasters BK, Rosenblum MK, Tihan T, Perry A, Solomon DA . Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway . Acta Neuropathologica . 2018;135(3):485-488 .

Pella L, Lambert C, McArthur B, West C, Hernandez M, Green K, Sousa M, Brast S, Long M . Systematic review to develop the clinical practice guideline for the use of capnography during procedural sedation in radiology and imaging settings: A report of

139 OF 288


Journal Articles

the Association for Radiologic & Imaging Nursing capnography task force . Journal of Radiology Nursing . 2018;37(3):163-172 .

Pellagatti A, Armstrong RN, Steeples V, Sharma E, Repapi E, Singh S, Sanchi A, Radujkovic A, Horn P, Dolatshad H, Roy S, Broxholme J, Lockstone H, Taylor S, Giagounidis A, Vyas P, Schuh A, Hamblin A, Papaemmanuil E, Killick S, Malcovati L, Hennrich ML, Gavin AC, Ho AD, Luft T, Hellström-Lindberg E, Cazzola M, Smith CWJ, Smith S, Boultwood J . Impact of spliceosome mutations on RNA splicing in myelodysplasia: Dysregulated genes/pathways and clinical associations . Blood . 2018;132(12):1225-1240 .

Peneyra SM, Cardona-Costa J, White J, Whipps CM, Riedel ER, Lipman NS, Lieggi C . Transmission of Pseudoloma neurophilia in laboratory zebrafish (Danio rerio) when using mass spawning chambers and recommendations for chamber disinfection . Zebrafish . 2018;15(1):63-72 . PMCID: PMC5792237

Peng XP, Lim S, Li S, Marjavaara L, Chabes A, Zhao X . Acute Smc5/6 depletion reveals its primary role in rDNA replication by restraining recombination at fork pausing sites . PLoS Genetics . 2018;14(1):e1007129- . PMCID: PMC5779651

Peng YC, Chen YB . Recognizing hereditary renal cancers through the microscope: A pathology update . Surgical Pathology Clinics . 2018;11(4):725-737 .

Peng Z, Ling L, Stratton CW, Li C, Polage CR, Wu B, Tang YW . Advances in the diagnosis and treatment of Clostridium difficile infections . Emerging Microbes & Infections . 2018;7:15- . PMCID: PMC5837143

Pennington Z, Ahmed AK, Molina CA, Ehresman J, Laufer I, Sciubba DM . Minimally invasive versus conventional spine surgery for vertebral metastases: A systematic review of the evidence . Annals of Translational Medicine . 2018;6(6):103- . PMCID: PMC5900071

Perales MA, Kebriaei P, Kean LS, Sadelain M . Building a safer and faster CAR: Seatbelts, airbags, and CRISPR . Biology of Blood and Marrow Transplantation . 2018;24(1):27-31 .

Peralta AR, Chawla M, Lee RP . Novel bronchoscopic management of airway bleeding with absorbable gelatin and thrombin slurry . Journal of Bronchology and Interventional Pulmonology . 2018;25(3):204-211 . PMCID: PMC6019569

Pereira PMR, Abma L, Henry KE, Lewis JS . Imaging of human epidermal growth factor receptors for patient selection and response monitoring – From PET imaging and beyond . Cancer Letters . 2018;419:139-151 .

Pereira PMR, Sharma SK, Carter LM, Edwards KJ, Pourat J, Ragupathi A, Janjigian YY, Durack JC, Lewis JS . Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy . Nature Communications . 2018;9:5137- . PMCID: PMC6277446

Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera E V, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM, Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM, on behalf of the African American Cancer Epidemiology Study, Ovarian Cancer Association Consortium . Racial/ethnic differences in the epidemiology of ovarian cancer: A pooled analysis of 12 case-control studies . International Journal of Epidemiology . 2018;47(2):460-472 . PMCID: PMC5913601

Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Duran I, Théodore C, Grande E, Shen X,

Wang J, Nelson B, Derleth CL, van der Heijden MS . Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Outcomes by prior number of regimens . European Urology . 2018;73(3):462-468 .

Perez-Johnston R, Deipolyi AR, Covey AM . Percutaneous biliary interventions . Gastroenterology Clinics of North America . 2018;47(3):621-641 .

Perica K, Curran KJ, Brentjens RJ, Giralt SA . Building a CAR garage: Preparing for the delivery of commercial CAR T cell products at Memorial Sloan Kettering Cancer Center . Biology of Blood and Marrow Transplantation . 2018;24(6):1135-1141 .

Perrier ND, Brierley JD, Tuttle RM . Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition Cancer Staging Manual . CA - A Cancer Journal for Clinicians . 2018;68(1):55-63 . PMCID: PMC5766386

Perrin T, Midya A, Yamashita R, Chakraborty J, Saidon T, Jarnagin WR, Gonen M, Simpson AL, Do RKG . Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging . Abdominal Radiology . 2018;43(12):3271-3278 . PMCID: PMC6209534

Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, Ahnen DJ, Smith RA, Zauber AG, Lansdorp-Vogelaar I . The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline . Cancer . 2018;124(14):2964-2973 . PMCID: PMC6033623

Petrovic I, Rosen EB, Matros E, Huryn JM, Shah JP . Oral rehabilitation of the cancer patient: A formidable challenge . Journal of Surgical Oncology . 2018;117(8):1729-1735 . PMCID: PMC6135661

140 OF 288


Journal Articles

Petrovic ID, Migliacci J, Ganly I, Patel S, Xu B, Ghossein R, Huryn J, Shah J . Ameloblastomas of the mandible and maxilla . Ear, Nose & Throat Journal . 2018;97(7):E26-E32 . PMCID: PMC6104513

Pham QT, Oue N, Sekino Y, Yamamoto Y, Shigematsu Y, Sakamoto N, Sentani K, Uraoka N, Yasui W . TDO2 overexpression is associated with cancer stem cells and poor prognosis in esophageal squamous cell carcinoma . Oncology . 2018;95(5):297-308 .

Phan TL, Carlin K, Ljungman P, Politikos I, Boussiotis V, Boeckh M, Shaffer ML, Zerr DM . Human herpesvirus-6B reactivation Is a risk factor for grades II to IV acute graft-versus-host disease after hematopoietic stem cell transplantation: A systematic review and meta-analysis . Biology of Blood and Marrow Transplantation . 2018;24(11):2324-2336 .

Phillips GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, Barrios DM, Ciccolini K, Marchetti MA, Deng L, Myskowski PL, Lee EH, Markova A, Lacouture ME . Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients . Journal of the American Academy of Dermatology . 2018;78(6):1102-1109 . PMCID: PMC5951751

Pianko MJ, Goldberg AD, Lesokhin AM . Clinical development of PD-1 blockade in hematologic malignancies . The Cancer Journal . 2018;24(1):31-35 . PMCID: PMC5785103

Pianko MJ, Moskowitz AJ, Lesokhin AM . Immunotherapy of lymphoma and myeloma: Facts and hopes . Clinical Cancer Research . 2018;24(5):1002-1010 . PMCID: PMC5844779

Pianko MJ, Funt SA, Page DB, Cattry D, Scott EC, Ansell SM, Borrello IM, Gutierrez M, Lendvai N, Hassoun H, Landgren CO, Lesokhin AM . Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma . Leukemia and Lymphoma . 2018;59(1):221-224 . PMCID: PMC5645787

Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, de Groot P, Sulman EP, Wistuba I I, Chen A, Fleisher M, Heymach J V, Kris MG, Rudin CM, Byers LA . Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer . Journal of Clinical Oncology . 2018;36(23):2386-2394 . PMCID: PMC6085179

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Morano F, Fuca G, Nikolinakos P, Drilon A, Hechtman JF, Christiansen J, Gowen K, Frampton GM, Gasparini P, Rossini D, Gigliotti C, Kim ST, Prisciandaro M, Hodgson J, Zaniboni A, Chiu VK, Milione M, Patel R, Miller V, Bardelli A, Novara L, Wang L, Pupa SM, Sozzi G, Ross J, Di Bartolomeo M, Bertotti A, Ali S, Trusolino L, Falcone A, de Braud F, Cremolini C . RET fusions in a small subset of advanced colorectal cancers at risk of being neglected . Annals of Oncology . 2018;29(6):1394-1401 .

Pietzak EJ, Donahue TF, Bochner BH . Male neobladder . Urologic Clinics of North America . 2018;45(1):37-48 .

Pietzak EJ, Assel M, Becerra MF, Tennenbaum D, Feldman DR, Bajorin DF, Motzer RJ, Bosl GJ, Carver BS, Sjoberg DD, Sheinfeld J . Histologic and oncologic outcomes following liver mass resection with retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumor . Urology . 2018;118:114-118 .

Pilewskie M, Morrow M . Margins in breast cancer: How much is enough? . Cancer . 2018;124(7):1335-1341 .PMCID: PMC5894883

Pinker K, Chin J, Melsaether AN, Morris EA, Moy L . Precision medicine and radiogenomics in breast cancer: New approaches toward diagnosis and treatment . Radiology . 2018;287(3):732-747 .

Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA, Helbich TH . Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: Comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging . Investigative Radiology . 2018;53(10):587-595 . PMCID: PMC6123254

Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA . Background, current role, and potential applications of radiogenomics . Journal of Magnetic Resonance Imaging . 2018;47(3):604-620 . PMCID: PMC5916793

Pinnix CC, Yahalom J, Specht L, Dabaja BS . Radiation in central nervous system leukemia: Guidelines from the International Lymphoma Radiation Oncology Group . International Journal of Radiation Oncology, Biology, Physics . 2018;102(1):53-58 .

Piotrowski AF, Nirschl TR, Velarde E, Blosser L, Ganguly S, Burns KH, Luznik L, Wong J, Drake CG, Grossman SA . Systemic depletion of lymphocytes following focal radiation to the brain in a murine model . OncoImmunology . 2018;7(7):e1445951- . PMCID: PMC5993500

Piscuoglio S, Ng CKY, Weigelt B, Chandarlapaty S, Reis-Filho JS . ESR1 and endocrine therapy resistance: More than just mutations . Annals of Oncology . 2018;29(4):787-789 . PMCID: PMC5913621

Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR . Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis . Nature Communications . 2018;9:1793- . PMCID: PMC5935683

141 OF 288


Journal Articles

Plusa B, Hadjantonakis AK . (De)constructing the blastocyst: Lessons in self-organization from the mouse . Current Opinion in Systems Biology . 2018;11:98-106 . Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause T, Mitterhauser M, Sonnenschein W, Bodei L, Delgado-Bolton RC, Gabriel M . EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(5):824-845 .

Politikos I, McMasters M, Bryke C, Avigan D, Boussiotis VA . Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor . Blood Advances . 2018;2(12):1367-1370 . PMCID: PMC6020801

Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long G V, Menzies AM, Eroglu Z, Johnson DB, Shoushtari AN . Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma . Annals of Oncology . 2018;29(1):250-255 . PMCID: PMC5834131

Pollom EL, Qian Y, Chin AL, Dirbas FM, Asch SM, Kurian AW, Horst KC, Tsai CJ . Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy . International Journal of Cancer . 2018;143(12):3262-3272 . PMCID: PMC6263854

Pommier A, Anaparthy N, Memos N, Kelley ZL, Gouronnec A, Yan R, Auffray C, Albrengues J, Egeblad M, Iacobuzio-Donahue CA, Lyons SK, Fearon DT . Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases . Science . 2018;360(6394):eaao4908- .

Ponde N, Bradbury I, Lambertini M, Ewer M, Campbell C, Ameels H, Zardavas D, Di Cosimo S, Baselga J, Huober J, Izquierdo M, Fumagalli

D, Bozovic-Spasojevic I, Maetens M, Harbeck N, Pusztai L, Berghorn M, Im YH, Borrego MR, Chen DR, Rodeheffer R, Piccart M, Suter T, de Azambuja E . Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: A NeoALTTO sub-study (BIG 1-06) . Breast Cancer Research and Treatment . 2018;168(3):631-638 . PMCID: PMC5843537

Postow MA . Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? [interview] . Clinical Advances in Hematology & Oncology . 2018;16(5):353-355 .

Postow MA, Hellmann MD . Adverse events associated with immune checkpoint blockade - Reply . New England Journal of Medicine . 2018;378(12):1165- .

Postow MA, Sidlow R, Hellmann MD . Immune-related adverse events associated with immune checkpoint blockade . New England Journal of Medicine . 2018;378(2):158-168 .

Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS . α-emitters for radiotherapy: From basic radiochemistry to clinical studies - Part 1 . Journal of Nuclear Medicine . 2018;59(6):878-884 . PMCID: PMC6004557

Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS . α-emitters for radiotherapy: From basic radiochemistry to clinical studies - Part 2 . Journal of Nuclear Medicine . 2018;59(7):1020-1027 .

Poty S, Membreno R, Glaser JM, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS . The inverse electron-demand Diels-Alder reaction as a new methodology for the synthesis of (225)Ac-labelled radioimmunoconjugates . Chemical Communications . 2018;54(21):2599-2602 . PMCID: PMC5843558

Pouryahya M, Oh JH, Mathews JC, Deasy JO, Tannenbaum AR . Characterizing cancer drug

response and biological correlates: A geometric network approach . Scientific Reports . 2018;8:6402- . PMCID: PMC5913269

Powell EA, Babady NE . Digital PCR in the clinical microbiology laboratory: Another tool on the molecular horizon . Clinical Microbiology Newsletter . 2018;40(4):27-32 .

Powles RL, Redmond D, Sotiriou C, Loi S, Fumagalli D, Nuciforo P, Harbeck N, de Azambuja E, Sarp S, Di Cosimo S, Huober J, Baselga J, Piccart-Gebhart M, Elemento O, Pusztai L, Hatzis C . Association of T-cell receptor repertoire use with response to combined trastuzumab-lapatinib treatment of HER2-positive breast cancer: Secondary analysis of the NeoALTTO randomized clinical trial . JAMA Oncology . 2018;4(11):e181564- .PMCID: PMC6224305

Powles T, Motzer RJ, Escudier B, Pal S, Kollmannsberger C, Pikiel J, Gurney H, Rha SY, Park SH, Geertsen PF, Gross-Goupil M, Grande E, Suarez C, Markby DW, Arroyo A, Dean M, Choueiri TK, George D . Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma . British Journal of Cancer . 2018;119(6):663-669 .

Prabakaran T, Bodda C, Krapp C, Zhang BC, Christensen MH, Sun C, Reinert L, Cai Y, Jensen SB, Skouboe MK, Nyengaard JR, Thompson CB, Lebbink RJ, Sen GC, van Loo G, Nielsen R, Komatsu M, Nejsum LN, Jakobsen MR, Gyrd-Hansen M, Paludan SR . Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1 . EMBO Journal . 2018;37(8):e97858- . PMCID: PMC5897779

Prager AJ, Habib LA, Gambogi T, Busam KJ, Marr BP . Long-term follow-up of 4 patients with conjunctival amyloidosis . Ocular Oncology and Pathology . 2018;4(5):313-317 . PMCID: PMC6167687

Prager AJ, Habib LA, Busam KJ, Marr BP . Two uveal melanomas in one eye: A choroidal nevus

142 OF 288


Journal Articles

giving rise to a melanoma in an eye with a separate large choroidal melanoma . Ocular Oncology and Pathology . 2018;4(6):355-358 . PMCID: PMC6288664

Prasad V, Kaestner V, Mailankody S . Cancer drugs approved based on biomarkers and not tumor type: FDA approval of pembrolizumab for mismatch repair-deficient solid cancers . JAMA Oncology . 2018;4(2):157-158 .

Prasad V, Mailankody S . In reply . JAMA Internal Medicine . 2018;178(4):588-589 .

Prasad V, McCabe C, Mailankody S . Low-value approvals and high prices might incentivize ineffective drug development . Nature Reviews Clinical Oncology . 2018;15(7):399-400 .

Prasad V, Kaestner V, Mailankody S . Clarification of the FDA accelerated agnostic approval of pembrolizumab and the opportunities arising from the required confirmatory studies - In reply . JAMA Oncology . 2018;4(9):1300-1301 .

Prasad V, McCabe C, Mailankody S . Addendum: Low-value approvals and high prices might incentivize ineffective drug development . Nature Reviews Clinical Oncology . 2018;15(12):787- .

Pratt EC, Shaffer TM, Zhang Q, Drain CM, Grimm J . Nanoparticles as multimodal photon transducers of ionizing radiation . Nature Nanotechnology . 2018;13(5):418-426 . PMCID: PMC5973484

Praud D, Rota M, Pelucchi C, Bertuccio P, Rosso T, Galeone C, Zhang ZF, Matsuo K, Ito H, Hu J, Johnson KC, Yu GP, Palli D, Ferraroni M, Muscat J, Lunet N, Peleteiro B, Malekzadeh R, Ye W, Song H, Zaridze D, Maximovitch D, Aragonés N, Castaño-Vinyals G, Vioque J, Navarrete-Muñoz EM, Pakseresht M, Pourfarzi F, Wolk A, Orsini N, Bellavia A, Hakansson N, Mu L, Pastorino R, Kurtz RC, Derakhshan MH, Lagiou A, Lagiou P, Boffetta P, Boccia S, Negri E, La Vecchia C . Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP)

Project . European Journal of Cancer Prevention . 2018;27(2):124-133 .Preite S, Cannons JL, Radtke AJ, Vujkovic-Cvijin I, Gomez-Rodriguez J, Volpi S, Huang B, Cheng J, Collins N, Reilley J, Handon R, Dobbs K, Huq L, Raman I, Zhu C, Li QZ, Li MO, Pittaluga S, Uzel G, Notarangelo LD, Belkaid Y, Germain RN, Schwartzberg PL . Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity . Nature Immunology . 2018;19(9):986-1000 . PMCID: PMC6140795

Prince JD, Mora O, Ansbrow J, Benedict A, DiCostanzo J, Schonebaum AD . Nine ways that clubhouses foster interpersonal connection for persons with severe mental illness: Lessons for other types of programs . Social Work in Mental Health . 2018;16(3):321-336 .

Priolo C, Khabibullin D, Reznik E, Filippakis H, Ogorek B, Kavanagh TR, Nijmeh J, Herbert ZT, Asara JM, Kwiatkowski DJ, Wu CL, Henske EP . Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(27):E6274-E6282 .

Pronier E, Bowman RL, Ahn J, Glass J, Kandoth C, Merlinsky TR, Whitfield JT, Durham BH, Gruet A, Hanasoge Somasundara A V, Rampal R, Melnick A, Koche RP, Taylor BS, Levine RL . Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis . Blood . 2018;132(12):1265-1278 . PMCID: PMC6148447

Pronier E, Cifani P, Merlinsky TR, Berman KB, Somasundara AVH, Rampal RK, LaCava J, Wei KE, Pastore F, Maag JL V, Park J, Koche R, Kentsis A, Levine RL . Targeting the CALR interactome in myeloproliferative neoplasms . JCI Insight . 2018;3(22):e122703- . PMCID: PMC6302938

Pronin IN, Batalov A I, Zakharova NE, Fadeeva LM, Pogosbekyan EL, Goryaynov SA, Buklina SB,

Ogurtsova AA, Kulikov AS, Rodionov P V, Voss HU, Peck KK, Holodny A I, Potapov AA . [Evaluation of vascular reactivity to overcome limitations of neurovascular uncoupling in BOLD fMRI of malignant brain tumors]. Zhurnal “Voprosy neirokhirurgii” imeni N .N . Burdenko . 2018;82(5):21-29 .

Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N . NCCN Guidelines® Insights: Colorectal cancer screening, version 1 .2018: Featured Updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(8):939-949 .

Provenzano E, Ulaner GA, Chin SF . Molecular classification of breast cancer . PET Clinics . 2018;13(3):325-338 .

Pryor KO, Veselis RA . Tenth International Symposium on Memory and Awareness in Anaesthesia . British Journal of Anaesthesia . 2018;121(1):189-191 .

Ptashkin RN, Mandelker DL, Coombs CC, Bolton K, Yelskaya Z, Hyman DM, Solit DB, Baselga J, Arcila ME, Ladanyi M, Zhang L, Levine RL, Berger MF, Zehir A . Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors . JAMA Oncology . 2018;4(11):1589-1593 . PMCID: PMC6224316

Puca L, Bareja R, Prandi D, Shaw R, Benelli M, Karthaus WR, Hess J, Sigouros M, Donoghue A, Kossai M, Gao D, Cyrta J, Sailer V, Vosoughi A, Pauli C, Churakova Y, Cheung C, Deonarine LD, McNary TJ, Rosati R, Tagawa ST, Nanus DM, Mosquera JM, Sawyers CL, Chen Y, Inghirami G, Rao RA, Grandori C, Elemento O, Sboner A, Demichelis F, Rubin MA, Beltran H . Patient derived organoids to model rare

143 OF 288


Journal Articles

prostate cancer phenotypes . Nature Communications . 2018;9:2404- . PMCID: PMC6008438

Puchalska P, Huang X, Martin SE, Han X, Patti GJ, Crawford PA . Isotope tracing untargeted metabolomics reveals macrophage polarization-state-specific metabolic coordination across intracellular compartments . iScience . 2018;9:298-313 . PMCID: PMC6240706

Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A . T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders . Histopathology . 2018;73(4):653-662 .PMCID: PMC6153041

Pun SC, Landau HJ, Riedel ER, Jordan J, Yu AF, Hassoun H, Chen CL, Steingart RM, Liu JE . Prognostic and added value of two-dimensional global longitudinal strain for prediction of survival in patients with light chain amyloidosis undergoing autologous hematopoietic cell transplantation . Journal of the American Society of Echocardiography . 2018;31(1):64-70 . PMCID: PMC5985664

Puno MR, Lima CD . Structural basis for MTR4-ZCCHC8 interactions that stimulate the MTR4 helicase in the nuclear exosome-targeting complex . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(24):E5506-E5515 . PMCID: PMC6004480

Puylaert CAJ, Schüffler PJ, Naziroglu RE, Tielbeek JAW, Li Z, Makanyanga JC, Tutein Nolthenius CJ, Nio CY, Pendsé DA, Menys A, Ponsioen CY, Atkinson D, Forbes A, Buhmann JM, Fuchs TJ, Hatzakis H, van Vliet LJ, Stoker J, Taylor SA, Vos FM . Semiautomatic assessment of the terminal ileum and colon in patients with Crohn disease using MRI (The VIGOR++ project) . Academic Radiology . 2018;25(8):1038-1045 .

Qadan M, Davies AR, Polk HC Jr, Allum WH, Brennan MF . Cancer care in the developed world: A comparison of surgical oncology training programs . American Journal of Surgery . 2018;215(1):1-7 . PMCID: PMC5793851

Qi Q, Hibler BP, Connolly KL, Rossi AM . Reconstruction of a combined nose and cheek defect . Dermatologic Surgery . 2018;44(11):1449-1452 .

Qi S, Huang MY, Yang Y, Schöder H, Teckie S, Noy A, Chau K, Yahalom J . Uptake of [(18)F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma . Blood Advances . 2018;2(6):649-655 . PMCID: PMC5873233

Qin H, Carroll VN, Sriram R, Villanueva-Meyer JE, von Morze C, Wang ZJ, Mutch CA, Keshari KR, Flavell RR, Kurhanewicz J, Wilson DM . Imaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probes . Scientific Reports . 2018;8:7928- . PMCID: PMC5962598

Qin LX, Huang HC, Villafania L, Cavatore M, Olvera N, Levine DA . A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples . Scientific Data . 2018;5:180084- . PMCID: PMC5952865

Quek L, David MD, Kennedy A, Metzner M, Amatangelo M, Shih A, Stoilova B, Quivoron C, Heiblig M, Willekens C, Saada V, Alsafadi S, Vijayabaskar MS, Peniket A, Bernard OA, Agresta S, Yen K, MacBeth K, Stein E, Vassiliou GS, Levine R, De Botton S, Thakurta A, Penard-Lacronique V, Vyas P . Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib . Nature Medicine . 2018;24(8):1167-1177 .

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW . Primary T cells from cutaneous T-cell lymphoma skin explants display

an exhausted immune checkpoint profile . Cancer Immunology Research . 2018;6(8):900-909 . PMCID: PMC6074045

Quintero CM, Laursen KB, Mongan NP, Luo M, Gudas LJ . CARM1 (PRMT4) acts as a transcriptional coactivator during retinoic acid-induced embryonic stem cell differentiation . Journal of Molecular Biology . 2018;430(21):4168-4182 . PMCID: PMC6186513

Qunaj L, Jain RH, Atoria CL, Gennarelli RL, Miller JE, Bach PB . Delays in the publication of important clinical trial findings in oncology . JAMA Oncology . 2018;4(7):e180264- .

Rabidas R, Midya A, Chakraborty J . Neighborhood structural similarity mapping for the classification of masses in mammograms . IEEE Journal of Biomedical and Health Informatics . 2018;22(3):826-834 .

Radich JP, Deininger M, Abboud CN, Altman JK, Berman E, Bhatia R, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hobbs G, Jagasia M, Kantarjian HM, Maness L, Metheny L, Moore JO, Pallera A, Pancari P, Patnaik M, Purev E, Rose MG, Shah NP, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H . Chronic Myeloid Leukemia, Version 1 .2019, Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(9):1108-1135 .

Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D’Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks D I, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres

144 OF 288


Journal Articles

MA, Litzow MR, Gale RP, Hashmi SK . Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma . Leukemia Research . 2018;74:130-136 . PMCID: PMC6219911

Radovich M, Pickering CR, Felau I, Ha G, Zhang HL, Jo H, Hoadley KA, Anur P, Zhang JX, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, Leiserson MDM, Sethi G, Lu C, Ryan M, Su X, Cherniack AD, Robertson G, Akbani R, Spellman P, Weinstein JN, Hayes DN, Raphael B, Lichtenberg T, Leraas K, Zenklusen JC, The Cancer Genome Atlas Network, Fujimoto J, Scapulatempo-Neto C, Moreira AL, Hwang D, Huang J, Marino M, Korst R, Giaccone G, Gokmen-Polar Y, Badve S, Rajan A, Ströbel P, Girard N, Tsao MS, Marx A, Tsao AS, Loehrer PJ . The integrated genomic landscape of thymic epithelial tumors . Cancer Cell . 2018;33(2):244-258 .e10 .

Rafiq S, Brentjens RJ . Tumors evading CARs—the chase is on . Nature Medicine . 2018;24(10):1492-1493 .

Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, van Leeuwen DG, Drakes DJ, Song M, Miele MM, Li Z, Wang P, Yan S, Xiang J, Ma X, Seshan VE, Hendrickson RC, Liu C, Brentjens RJ . Targeted delivery of a PD-1-blocking scFV by CAR-T cells enhances anti-tumor efficacy in vivo . Nature Biotechnology . 2018;36(9):847-856 . PMCID: PMC6126939

Raghunathan NJ, Benedict C, Thom B, Friedman DN, Kelvin JF . Young adult female cancer survivors’ concerns about future children’s health and genetic risk . Journal of Adolescent and Young Adult Oncology . 2018;7(1):125-129 . PMCID: PMC5813728

Raghunathan NJ, Korenstein D, Li QS, Tonorezos ES, Mao JJ . Determinants of mobile technology use and smartphone application interest in cancer patients . Cancer Medicine . 2018;7(11):5812-5819 . PMCID: PMC6246952

Raj N, Reidy-Lagunes D . The role of (68)Ga-DOTATATE positron emission tomography/computed tomography in well-differentiated neuroendocrine tumors: A case-based approach illustrates potential benefits and challenges . Pancreas . 2018;47(1):1-5 . PMCID: PMC5729934

Raj N, Fazio N, Strosberg J . Biology and systemic treatment of advanced gastroenteropancreatic neuroendocrine tumors . American Society of Clinical Oncology Educational Book . 2018;38:292-299 .

Rajendran S, Hussein Y, Park KJ, McCluggage WG . Fallopian tube mucosal involvement in cervical gastric-type adenocarcinomas: Report of a series with discussion of the distinction from synchronous in situ tubal lesions . American Journal of Surgical Pathology . 2018;42(6):813-820 . PMCID: PMC5943166

Rajshekar S, Yao J, Arnold PK, Payne SG, Zhang Y, Bowman T V, Schmitz RJ, Edwards JR, Goll M . Pericentromeric hypomethylation elicits an interferon response in an animal model of ICF syndrome . eLife . 2018;7:e39658- . PMCID: PMC6261255

Raju GK, Gurumurthi K, Domike R, Kazandjian D, Landgren O, Blumenthal GM, Farrell A, Pazdur R, Woodcock J . A benefit-risk analysis approach to capture regulatory decision-making: Multiple myeloma . Clinical Pharmacology & Therapeutics . 2018;103(1):67-76 .

Rakha EA, Miligy IM, Gorringe KL, Toss MS, Green AR, Fox SB, Schmitt FC, Tan PH, Tse GM, Badve S, Decker T, Vincent-Salomon A, Dabbs DJ, Foschini MP, Moreno F, Wentao Y, Geyer FC, Reis-Filho JS, Pinder SE, Lakhani SR, Ellis IO . Invasion in breast lesions: The role of the epithelial–stroma barrier . Histopathology . 2018;72(7):1075-1083 .

Rakhlin L, Fish S . Pregnancy as a risk factor for thyroid cancer progression . Current Opinion in Endocrinology, Diabetes and Obesity . 2018;25(5):326-329 .

Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Kirshner JJ, Krop IE, Levinson J, Modi S, Patt DA, Perlmutter J, Winer EP, Lin NU . Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO Clinical Practice Guideline update . Journal of Clinical Oncology . 2018;36(27):2804-2807 .

Ramanadhan S, Davis MM, Armstrong R, Baquero B, Ko LK, Leng JC, Salloum RG, Vaughn NA, Brownson RC . Participatory implementation science to increase the impact of evidence-based cancer prevention and control . Cancer Causes & Control . 2018;29(3):363-369 . PMCID: PMC5858707

Ramaswamy K, Forbes L, Minuesa G, Gindin T, Brown F, Kharas MG, Krivtsov A V, Armstrong SA, Still E, de Stanchina E, Knoechel B, Koche R, Kentsis A . Peptidomimetic blockade of MYB in acute myeloid leukemia . Nature Communications . 2018;9:110- . PMCID: PMC5760651

Rami-Porta R, Call S, Dooms C, Obiols C, Sanchez M, Travis WD, Vollmer I . Lung cancer staging: A concise update . European Respiratory Journal . 2018;51(5):1800190- .

Ramirez DC, Hwang S, Athanasian EA, Wang L, Hameed M . Atypical lipomatous tumor of the hand with transformation to dedifferentiated liposarcoma: A case report . Skeletal Radiology . 2018;47(5):703-709 .

Ramirez-Fort MK, Mahase SS, Osborne JR, Lange CS . Theragnostic target, prostate-specific membrane antigen - Also specific for nonprostatic malignancies . International Journal of Radiation Oncology, Biology, Physics . 2018;101(3):646-649 .

Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A . Safety and preliminary efficacy of vorinostat with R-EPOCH

145 OF 288


Journal Articles

in high-risk HIV-associated non-Hodgkin’s lymphoma (AMC-075) . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(3):180-190 .e2 .

Ramos JD, Wingate JT, Gulati R, Plimack ER, Harshman LC, Powles T, Crabb SJ, Niegisch G, Bellmunt J, Ladoire S, De Giorgi U, Hussain S, Alva AS, Baniel J, Agarwal N, Rosenberg JE, Vaishampayan UN, Galsky MD, Yu EY, RISC Investigators . Venous thromboembolism risk in patients with locoregional urothelial tract tumors . Clinical Genitourinary Cancer . 2018;16(1):e161-e167 . PMCID: PMC5826750

Rampal RK, Mascarenhas JO, Kosiorek HE, Price L, Berenzon D, Hexner E, Abboud CN, Kremyanskaya M, Singer Weinberg R, Salama ME, Menghrajani K, Najfeld V, Sandy L, Heaney ML, Levine RL, Mesa RA, Dueck AC, Goldberg JD, Hoffman R . Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms . Blood Advances . 2018;2(24):3572-3580 . PMCID: PMC6306885

Ran L, Chen Y, Sher J, Wong EWP, Murphy D, Zhang JQ, Li D, Deniz K, Sirota I, Cao Z, Wang S, Guan Y, Shukla S, Li KY, Chramiec A, Xie Y, Zheng D, Koche RP, Antonescu CR, Chen Y, Chi P . FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor . Cancer Discovery . 2018;8(2):234-251 . PMCID: PMC5809271

Rapp M, Wiedemann GM, Sun JC . Memory responses of innate lymphocytes and parallels with T cells . Seminars in Immunopathology . 2018;40(4):343-355 . PMCID: PMC6054893

Rathkopf DE, Scher H I . Apalutamide for the treatment of prostate cancer . Expert Review of Anticancer Therapy . 2018;18(9):823-836 .

Rathkopf DE, Beer TM, Loriot Y, Higano CS, Armstrong AJ, Sternberg CN, De Bono JS, Tombal B, Parli T, Bhattacharya S, Phung D, Krivoshik A, Scher H I, Morris MJ . Radiographic progression-

free survival as a clinically meaningful end point in metastatic castration-resistant prostate cancer: The PREVAIL randomized clinical trial . JAMA Oncology . 2018;4(5):694-701 . PMCID: PMC5885186

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Pigneux A, Horst HA, Récher C, Klimek VM, Cortes JE, Carella AM, Egyed M, Krug U, Fox JA, Craig AR, Ward R, Smith JA, Acton G, Kantarjian HM, Stuart RK . Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia . Haematologica . 2018;103(11):e514-e518 .

Ravi D, Ghasemiesfe M, Korenstein D, Cascino T, Keyhani S . Associations between marijuana use and cardiovascular risk factors and outcomes: A systematic review . Annals of Internal Medicine . 2018;168(3):187-194 .

Ravi P, Kumar SK, Roeker L, Gonsalves W, Buadi F, Lacy MQ, Go RS, Dispenzieri A, Kapoor P, Lust JA, Dingli D, Lin Y, Russell SJ, Leung N, Gertz MA, Kyle RA, Bergsagel PL, Rajkumar S V . Revised diagnostic criteria for plasma cell leukemia: Results of a Mayo Clinic study with comparison of outcomes to multiple myeloma . Blood Cancer Journal . 2018;8(12):116- . PMCID: PMC6238010

Rawla P, Sunkara T, Thandra KC, Gaduputi V . Efficacy and safety of budesonide in the treatment of eosinophilic esophagitis: Updated systematic review and meta-analysis of randomized and non-randomized studies . Drugs in R&D . 2018;18(4):259-269 . PMCID: PMC6277325

Rawla P, Thandra KC, Vellipuram A, Mohd Ali CD . Efficacy and safety of megestrol in the management of hepatocellular carcinoma: A systematic review of the literature . Wspolczesna Onkologia . 2018;22(4):209-214 .

Rawla P, Sunkara T, Thandra KC, Gaduputi V . Hypertriglyceridemia-induced pancreatitis: Updated

review of current treatment and preventive strategies . Clinical Journal of Gastroenterology . 2018;11(6):441-448 .

Ray E, Mitchell SL, Cordeiro PG . Miniature negative pressure dressings on forearm donor sites after radial forearm flap harvest . Plastic and Reconstructive Surgery-Global Open . 2018;6(6):e1838- . PMCID: PMC6157936

Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, Cai Y, Bielski CM, Donoghue MTA, Jonsson P, Penson A, Shen R, Pareja F, Kundra R, Middha S, Cheng ML, Zehir A, Kandoth C, Patel R, Huberman K, Smyth LM, Jhaveri K, Modi S, Traina TA, Dang C, Zhang W, Weigelt B, Li BT, Ladanyi M, Hyman DM, Schultz N, Robson ME, Hudis C, Brogi E, Viale A, Norton L, Dickler MN, Berger MF, Iacobuzio-Donahue CA, Chandarlapaty S, Scaltriti M, Reis-Filho JS, Solit DB, Taylor BS, Baselga J . The genomic landscape of endocrine-resistant advanced breast cancers . Cancer Cell . 2018;34(3):427-438 .e6 . PMCID: PMC6327853

Razzell W, Bustillo ME, Zallen JA . The force-sensitive protein Ajuba regulates cell adhesion during epithelial morphogenesis . Journal of Cell Biology . 2018;217(10):3715-3730 . PMCID: PMC6168262

Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade O I, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero E I, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomaki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmaña J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo SM, Chiquette J, Chung WK, Claes KBM, Collée JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C,

146 OF 288


Journal Articles

Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B, EMBRACE, Engel C, Engert S, Evans DG, Faivre L, Feliubadalo L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvão HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A, GEMO Study Collaborators, Gerdes AM, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J, HEBON, Henderson A, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Vijai J, Kaczmarek K, Karlan BY, Kast K, KConFab Investigators, Kim SW, Konstantopoulou I, Korach J, Laitman Y, Lasa A, Lasset C, Lazaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martínez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Öfverholm A, Ong KR, Osorio A, Papi L, Papp J, Pasini B, Pedersen IS, Peixoto A, Peruga N, Peterlongo P, Pohl E, Pradhan N, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte AB, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G, Sutter C, Szabo C I, Tan YY, Teixeira MR, Terry MB, Teulé A, Thomas A, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Topka S, Trainer AH, Tung N, van Asperen CJ, van der Hout AH, van der Kolk LE, van der Luijt RB, Van Heetvelde M, Varesco L, Varon-Mateeva R, Vega A, Villarreal-Garza C, von Wachenfeldt A, Walker L, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Yoon SY, Zanzottera C, Zidan J, Zorn KK, Hutten Selkirk CG, Hulick PJ, Chenevix-Trench G, Spurdle AB, Antoniou AC, Nathanson KL . Mutational spectrum in

a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations . Human Mutation . 2018;39(5):593-620 . PMCID: PMC5903938

Reckzeh K, Kizilkaya H, Helbo AS, Alrich ME, Deslauriers AG, Grover A, Rapin N, Asmar F, Grønæk K, Porse B, Borregaard N, Vestweber D, Nerlov C, Theilgaard-Mönch K . Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin . Blood Advances . 2018;2(13):1628-1632 . PMCID: PMC6039657

Redelman-Sidi G, Michielin O, Cervera C, Ribi C, Aguado JM, Fernandez-Ruiz M, Manuel O . ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: An infectious diseases perspective (immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors) . Clinical Microbiology and Infection . 2018;24(Suppl . 2):S95-S107 . PMCID: PMC5971148

Redelman-Sidi G, Binyamin A, Gaeta I, Palm W, Thompson CB, Romesser PB, Lowe SW, Bagul M, Doench JG, Root DE, Glickman MS . The canonical Wnt pathway drives macropinocytosis in cancer . Cancer Research . 2018;78(16):4658-4670 .

Redlich N, Robinson AM, Nickel KP, Stein AP, Wheeler DL, Adkins DR, Uppaluri R, Kimple RJ, Van Tine BA, Michel LS . Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma . Cell Death & Disease . 2018;9:5- . PMCID: PMC5849045

Regine WF, Winter K, Abrams RA, Safran H, Kessel IL, Chen Y, Fugazzi JA, Donnelly ED, DiPetrillo TA, Narayan S, Plastaras JP, Gaur R, Delouya G, Suh JH, Meyer JE, Haddock MG, Didolkar MS, Padula GDA, Johnson D, Hoffman JP, Crane CH . Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG Oncology RTOG trial 9704 .

Advances in Radiation Oncology . 2018;3(2):154-162 . PMCID: PMC6000159

Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Gupta N, Johung KL, Klopp A, LaCasce AS, Lin C, Makarova-Rusher O V, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Palella F, Ratner L, Rizza S, Rudek MA, Taylor J, Tomlinson B, Wang CCJ, Dwyer MA, Freedman-Cass DA . Cancer in people living with HIV, version 1 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(8):986-1017 .

Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W, for the AIDS Malignancy Consortium . Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas . Blood Advances . 2018;2(24):3618-3626 . PMCID: PMC6306883

Reilley MJ, McCoon P, Cook C, Lyne P, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Curran M, Liu Q, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, Nadella MVP, Xiao X, Hsu J, Revenko A, Monia BP, MacLeod AR, Hong DS . STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: Results of a phase 1b trial . Journal for ImmunoTherapy of Cancer . 2018;6:119- . PMCID: PMC6240242

Reimann JDR, Salim S, Velazquez EF, Wang L, Williams KM, Flejter WL, Brooke L, Sunder S, Busam KJ . Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms . Modern Pathology . 2018;31(11):1733-1743 .

Reiner AS, Goldman DA, Diamond EL, DeAngelis LM, Tabar V, Panageas KS . Letter to the editor regarding

147 OF 288


Journal Articles

“National trends for reoperation in older patients with glioblastoma” . World Neurosurgery . 2018;117:466- .

Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Capanu M, Tischkowitz M, Robson M, Liang X, Woods M, Conti D V, Duggan D, Shore R, Stram DO, Thomas DC, Malone KE, Bernstein L, The WECARE Study Collaborative Group, Bernstein JL . Breast cancer family history and contralateral breast cancer risk in young women: An update from the Women’s Environmental Cancer and Radiation Epidemiology study . Journal of Clinical Oncology . 2018;36(15):1513-1520 .

Reis H, Krafft U, Niedworok C, Modos O, Herold T, Behrendt M, Al-Ahmadie H, Hadaschik B, Nyirady P, Szarvas T . Biomarkers in urachal cancer and adenocarcinomas in the bladder: A comprehensive review supplemented by own data . Disease Markers . 2018;2018:7308168- . PMCID: PMC5867586

Reiter JG, Makohon-Moore AP, Gerold JM, Heyde A, Attiyeh MA, Kohutek ZA, Tokheim CJ, Brown A, DeBlasio RM, Niyazov J, Zucker A, Karchin R, Kinzler KW, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA . Minimal functional driver gene heterogeneity among untreated metastases . Science . 2018;361(6406):1033-1037 . PMCID: PMC6329287

Rekhtman N . Commentary on testing of non-adenocarcinomas . Archives of Pathology & Laboratory Medicine . 2018;142(7):798- .

Rekhtman N, Buonocore DJ, Rudomina D, Friedlander M, Dsouza C, Aggarwal G, Arcila M, Edelweiss M, Lin O . Novel modification of HistoGel-based cell block preparation method: Improved sufficiency for molecular studies . Archives of Pathology & Laboratory Medicine . 2018;142(4):529-535 .

Rekhtman N, Pietanza CM, Sabari J, Montecalvo J, Wang H, Habeeb O, Kadota K, Adusumilli P, Rudin CM, Ladanyi M, Travis WD, Joubert P .

Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations . Modern Pathology . 2018;31(1):111-121 . PMCID: PMC5937126

Ren Q, Wang L, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo SK, Reuter VE, Chen YB . Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features . American Journal of Surgical Pathology . 2018;42(6):767-777 .

Revelo A, Keshishyan S, Epelbaum O, Yaghoubian S, DeLorenzo L, Chandy D, Carroll F, Paul L, Harris K . Diagnostic and therapeutic challenges in managing persistent air leaks . Journal of Thoracic Disease . 2018;10(1):522-528 . PMCID: PMC5863194

Reyngold M, Niland J, ter Veer A, Bekaii-Saab T, Lai L, Meyer JE, Nurkin SJ, Schrag D, Skibber JM, Benson AB, Weiser MR, Crane CH, Goodman KA . Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers . Advances in Radiation Oncology . 2018;3(1):34-41 . PMCID: PMC5856979

Reznik E, Luna A, Aksoy BA, Liu EM, La K, Ostrovnaya I, Creighton CJ, Hakimi AA, Sander C . A landscape of metabolic variation across tumor types . Cell Systems . 2018;6(3):301-313 .e3 . PMCID: PMC5876114

Rhee JY, Foley K, Morrison RS, Centeno C, Krakauer EL . Training in global palliative care within palliative medicine specialist training programs: A moral imperative . Journal of Pain and Symptom Management . 2018;55(5):e2-e4 .

Rhodes J, Mato A, Sharman JP . Monitoring and management of toxicities of novel B cell signaling agents . Current Oncology Reports . 2018;20(6):49- .

Ribas A, Wolchok JD . Cancer immunotherapy using checkpoint blockade . Science . 2018;359(6382):1350-1355 .

Ricca JM, Oseledchyk A, Walther T, Liu C, Mangarin L, Merghoub T, Wolchok JD, Zamarin D . Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy . Molecular Therapy . 2018;26(4):1008-1019 .

Rice SL, Deipolyi AR, Martin ES . Percutaneous embolization of a pulmonary vein pseudoaneurysm secondary to vascular erosion of a metastatic mass . CardioVascular and Interventional Radiology . 2018;41(9):1440-1443 .

Richards RJ, Simon MS, Phillips CD, Lief L, Jenkins SG, Satlin MS . Rapid detection of Listeria monocytogenes rhombencephalitis in an immunocompetent patient by multiplexed PCR . BMJ Case Reports . 2018;2018:bcr-2018-225575- . PMCID: PMC6229098

Richardson DL, Sill MW, Coleman RL, Sood AK, Pearl ML, Kehoe SM, Carney ME, Hanjani P, Van Le L, Zhou XC, Alvarez Secord A, Gray HJ, Landrum LM, Lankes HA, Hu W, Aghajanian C . Paclitaxel with and without pazopanib for persistent or recurrent ovarian cancer: A randomized clinical trial . JAMA Oncology . 2018;4(2):196-202 . PMCID: PMC5838582

Richardson PG, Bensinger W I, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD Jr, Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R . Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: Phase 2 trial results . British Journal of Haematology . 2018;180(6):821-830 . PMCID: PMC5873373

Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh

148 OF 288


Journal Articles

JJ, Ho TH, Kanchi RS, Krishnan B, Kwaitkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WT, Robertson AG, The Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM . The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma . Cell Reports . 2018;23(1):313-326 .e5 .

Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Rice VM, Brawley OW, Torres MA, Rakha E, Aneja R . First International TNBC Conference meeting report . Breast Cancer Research and Treatment . 2018;169(3):407-412 . PMCID: PMC5955852

Rieken M, Kluth LA, Fajkovic H, Capitanio U, Briganti A, Krabbe LM, Margulis V, Abufaraj M, Mari A, Foerster B, Raman JD, Regelman M, Brookman-May S, Sjoberg DD, Karakiewicz P I, Shariat SF . Predictors of cancer-specific survival after disease recurrence in patients with renal cell carcinoma: The effect of time to recurrence . Clinical Genitourinary Cancer . 2018;16(4):e903-e908 .

Rieken M, Kluth LA, Seitz C, Abufaraj M, Foerster B, Mathieu R, Karakiewicz P I, Bachmann A, Briganti A, Roupre M, Gönen M, Shariat SF, Seebacher V . External validation of the pathologic nodal staging score for prostate cancer: A population-based study . Clinical Genitourinary Cancer . 2018;16(1):e59-e65 .

Rieken M, Shariat SF, Kluth L, Crivelli JJ, Abufaraj M, Foerster B, Mari A, Ilijazi D, Karakiewicz P I, Babjuk M, Gönen M, Xylinas E . Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer . Urologic Oncology: Seminars and Original Investigations . 2018;36(1):8 .e17-8 .e24 .

Riester M, Xu Q, Moreira A, Zheng J, Michor F, Downey RJ . The Warburg effect: Persistence of stem-cell metabolism in cancers as a failure of differentiation . Annals of Oncology . 2018;29(1):264-270 .

Rieth EF, Barnett KM, Simon JA . Implementation and organization of a prioperative lactation program: A descriptive study . Breastfeeding Medicine . 2018;13(2):97-105 . PMCID: PMC5863089

Rimawi MF, de Angelis C, Contreras A, Pareja F, Geyer FC, Burke KA, Herrera S, Wang T, Mayer IA, Forero A, Nanda R, Goetz MP, Chang JC, Krop IE, Wolff AC, Pavlick AC, Fuqua SAW, Gutierrez C, Hilsenbeck SG, Li MM, Weigelt B, Reis-Filho JS, Osborne CK, Schiff R . Low PETN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer . Breast Cancer Research and Treatment . 2018;167(3):731-740 . PMCID: PMC5821069

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA . A common classification framework for neuroendocrine neoplasms: An International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal . Modern Pathology . 2018;31(12):1770-1786 . PMCID: PMC6265262

Ring BZ, Murali R, Soslow RA, Bowtell DDL, Fereday S, deFazio A, Traficante N, on behalf of the Australian Ovarian Cancer Study, Kennedy CJ, Brand A, Sharma R, Harnett P, Samimi G . Transducin-like enhancer of split 3 (TLE3) expression is associated with taxane sensitivity in nonserous ovarian carcinoma in a three-cohort study . Cancer Epidemiology Biomarkers

and Prevention . 2018;27(6):680-688 . PMCID: PMC5984690

Rini B I, Hutson TE, Figlin RA, Lechuga MJ, Valota O, Serfass L, Rosbrook B, Motzer RJ . Sunitinib in patients with metastatic renal cell carcinoma: Clinical outcome according to International Metastatic Renal Cell Carcinoma Database Consortium risk group . Clinical Genitourinary Cancer . 2018;16(4):298-304 .

Rini B I, Escudier B, Martini JF, Magheli A, Svedman C, Lopatin M, Knezevic D, Goddard AD, Febbo PG, Li R, Lin X, Valota O, Staehler M, Motzer RJ, Ravaud A . Validation of the 16-gene recurrence score in patients with locoregional, high-risk renal cell carcinoma from a phase III trial of adjuvant sunitinib . Clinical Cancer Research . 2018;24(18):4407-4415 .

Rishpon A, Marchetti M, Marghoob A . Wide skin markings pattern: Melanoma descriptor or patient-related factor? . British Journal of Dermatology . 2018;178(5):1224-1225 .

Rishpon A, Braun R, Weinstock MA, Kulju S, Grenga A, Navarrete-Dechent C, Marghoob NG, Steffel J, Marghoob AA . Assessment of the safety risk of dermatoscope magnets in patients with cardiovascular implanted electronic devices . JAMA Dermatology . 2018;154(10):1204-1207 .

Riyahi S, Choi W, Liu CJ, Zhong H, Wu AJ, Mechalakos JG, Lu W . Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer . Physics in Medicine and Biology . 2018;63(14):145020- . PMCID: PMC6064042

Rizvi H, Sanchez-Vega F, La K, Chatila W, Jonsson P, Halpenny D, Plodkowski A, Long N, Sauter JL, Rekhtman N, Hollmann T, Schalper KA, Gainor JF, Shen R, Ni A, Arbour KC, Merghoub T, Wolchok J, Snyder A, Chaft JE, Kris MG, Rudin CM, Socci ND, Berger MF, Taylor BS, Zehir A, Solit DB, Arcila ME, Ladanyi M, Riely GJ, Schultz N, Hellmann

149 OF 288


Journal Articles

MD . Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing . Journal of Clinical Oncology . 2018;36(7):633-641 .

Rizzi A, Murkli S, McNeill JN, Yao W, Sullivan M, Gilson MK, Chiu MW, Isaacs L, Gibb BC, Mobley DL, Chodera JD . Overview of the SAMPL6 host-guest binding affinity prediction challenge . Journal of Computer-Aided Molecular Design . 2018;32(10):937-963 . PMCID: PMC6301044

Robert C, Ribas A, Hamid O, Daud A, Wolchok JD, Joshua AM, Hwu WJ, Weber JS, Gangadhar TC, Joseph RW, Dronca R, Patnaik A, Zarour H, Kefford R, Hersey P, Zhang J, Anderson J, Diede SJ, Ebbinghaus S, Hodi FS . Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma . Journal of Clinical Oncology . 2018;36(17):1668-1674 .

Roberts S, Andreou C, Choi C, Donabedian P, Jayaraman M, Pratt EC, Tang J, Pérez-Medina C, de la Cruz MJ, Mulder WJM, Grimm J, Kircher M, Reiner T . Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer . Chemical Science . 2018;9(25):5646-5657 . PMCID: PMC6049522

Robilotti E, Powell E, Usiak S, Taur Y, Babady NE, Kamboj M . The perils of multiplex gastrointestinal pathogen panels: Pseudo-outbreaks of Salmonellae and Entamoeba histolytica in immunocompromised hosts . Infection Control and Hospital Epidemiology . 2018;39(7):867-870 .

Robinson JK, Jain N, Marghoob AA, McGaghie W, MacLean M, Gerami P, Hultgren B, Turrisi R, Mallett K, Martin GJ . A randomized trial on the efficacy of mastery learning for primary care provider melanoma opportunistic screening skills and practice . Journal of General Internal Medicine . 2018;33(6):855-862 . PMCID: PMC5975143

Robson M . Selecting patients with triple negative breast cancer for platinum-based therapy: We still haven’t found what we’re looking for . Annals of Oncology . 2018;29(8):1609-1610 .

Robson M . Moderate-penetrance predisposition to breast cancer . Current Breast Cancer Reports . 2018;10(3):232-239 .

Rochwerg B, Meduri U, Pastores S, Annane D . Discrepancies in guidelines for acute respiratory distress syndrome . Lancet . 2018;392(10164):2550-2551 .

Rockson SG, Tian W, Jiang X, Kuznetsova T, Haddad F, Zampell J, Mehrara B, Sampson JP, Roche L, Kim J, Nicolls MR . Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema . JCI Insight . 2018;3(20):e123775- . PMCID: PMC6237444

Rodig SJ, Gusenleitner D, Jackson DG, Gjini E, Giobbie-Hurder A, Jin C, Chang H, Lovitch SB, Horak C, Weber JS, Weirather JL, Wolchok JD, Postow MA, Pavlick AC, Chesney J, Hodi FS . MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma . Science Translational Medicine . 2018;10(450):eaar3342- .

Rodon J, Pérez-Fidalgo A, Krop IE, Burris H, Guerrero-Zotano A, Britten CD, Becerra C, Schellens J, Richards DA, Schuler M, Abu-Khalaf M, Johnson FM, Ranson M, Edenfield J, Silva AP, Hackl W, Quadt C, Demanse D, Duval V, Baselga J . Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer . Cancer Chemotherapy and Pharmacology . 2018;82(2):285-298 .

Rodrigo JP, Grilli G, Shah JP, Medina JE, Robbins KT, Takes RP, Hamoir M, Kowalski LP, Suarez C, Lopez F, Quer M, Boedeker CC, de Bree R, Coskun H, Rinaldo A, Silver CE, Ferlito A . Selective neck dissection in surgically treated head and neck squamous cell

carcinoma patients with a clinically positive neck: Systematic review . European Journal of Surgical Oncology . 2018;44(4):395-403 .

Rodrigues DN, Rescigno P, Liu D, Yuan W, Carreira S, Lambros MB, Seed G, Mateo J, Riisnaes R, Mullane S, Margolis C, Miao D, Miranda S, Dolling D, Clarke M, Bertan C, Crespo M, Boysen G, Ferreira A, Sharp A, Figueiredo I, Keliher D, Aldubayan S, Burke KP, Sumanasuriya S, Fontes MS, Bianchini D, Zafeiriou Z, Mendes LST, Mouw K, Schweizer MT, Pritchard CC, Salipante S, Taplin ME, Beltran H, Rubin MA, Cieslik M, Robinson D, Heath E, Schultz N, Armenia J, Abida W, Scher H, Lord C, D’Andrea A, Sawyers CL, Chinnaiyan AM, Alimonti A, Nelson PS, Drake CG, Van Allen EM, de Bono JS . Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer . Journal of Clinical Investigation . 2018;128(10):4441-4453 . PMCID: PMC6159966

Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP, Ertel A, Lokareddy RK, Cuesta-Dominguez A, Kim RS, Rodriguez-Fernandez I, Li P, Gordon R, Hirschfield H, Prats JM, Reddy EP, Fatatis A, Petrylak DP, Gomella L, Kelly WK, Lowe SW, Knudsen KE, Galsky MD, Cingolani G, Lujambio A, Hoshida Y, Domingo-Domenech J . Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import . Cell . 2018;174(5):1200-1215 .e20 . PMCID: PMC6150493

Rodriguez ES . Using patient portals to increase engagement in patients with cancer . Seminars in Oncology Nursing . 2018;34(2):177-183 .

Rodriguez-Rodriguez JA, Lewis C, McKinley KL, Sikirzhytski V, Corona J, Maciejowski J, Khodjakov A, Cheeseman IM, Jallepalli P V . Distinct roles of RZZ and Bub1-KNL1 in mitotic checkpoint signaling and kinetochore expansion . Current Biology . 2018;28(21):3422-3429 .e5 .

150 OF 288


Journal Articles

Roediger B, Lee Q, Tikoo S, Cobbin JCA, Henderson JM, Jormakka M, O’Rourke MB, Padula MP, Pinello N, Henry M, Wynne M, Santagostino SF, Brayton CF, Rasmussen L, Lisowski L, Tay SS, Harris DC, Bertram JF, Dowling JP, Bertolino P, Lai JH, Wu W, Bachovchin WW, Wong JJL, Gorrell MD, Shaban B, Holmes EC, Jolly CJ, Monette S, Weninger W . An atypical parvovirus drives chronic tubulointerstitial nephropathy and kidney fibrosis . Cell . 2018;175(2):530-543 .e24 .

Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA . Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma . Journal of Clinical Oncology . 2018;36(10):942-950 . PMCID: PMC5877802

Rogers EM, Connolly KL, Nehal KS, Dusza SW, Rossi AM, Lee E . Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer . Journal of the American Academy of Dermatology . 2018;78(6):1119-1124 . PMCID: PMC5951753

Rogers T, Krakowski AC, Marino ML, Rossi A, Anderson RR, Marghoob AA . Nevi and lasers: Practical considerations . Lasers in Surgery and Medicine . 2018;50(1):7-9 .

Romaguera JE, Wang M, Feng L, Fayad LE, Hagemeister F, McLaughlin P, Rodriguez MA, Fanale M, Orlowski R, Kwak LW, Neelapu S, Oki Y, Pro B, Younes A, Samaniego F, Fowler N, Hartig K, Valentinetti M, Smith J, Ford P, Naig A, Medeiros LJ, Kantarjian HM, Goy A . Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and

dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma . Cancer . 2018;124(12):2561-2569 .

Romano-Keeler J, Shilts MH, Tovchigrechko A, Wang C, Brucker RM, Moore DJ, Fonnesbeck C, Meng S, Correa H, Lovvorn HN 3rd, Tang YW, Hooper L, Bordenstein SR, Das SR, Weitkamp JH . Distinct mucosal microbial communities in infants with surgical necrotizing enterocolitis correlate with age and antibiotic exposure . PLoS ONE . 2018;13(10):e0206366- . PMCID: PMC6203398

Romanoff A, Zabor EC, Petruolo O, Stempel M, El-Tamer M, Morrow M, Barrio A V . Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers? . Cancer . 2018;124(22):4314-4321 . PMCID: PMC6269196

Romanoff A, Zabor EC, Stempel M, Sacchini V, Pusic A, Morrow M . A comparison of patient-reported outcomes after nipple-sparing mastectomy and conventional mastectomy with reconstruction . Annals of Surgical Oncology . 2018;25(10):2909-2916 .

Romasko EJ, Devkota B, Biswas S, Jayaraman V, Rajagopalan R, Dulik MC, Thom CS, Choi J, Jairam S, Scarano M I, Krantz ID, Spinner NB, Conlin LK, Lambert MP . Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders . American Journal of Hematology . 2018;93(1):8-16 . PMCID: PMC6366456

Romero SAD, Brown JC, Bauml JM, Hay JL, Li QS, Cohen RB, Mao JJ . Barriers to physical activity: A study of academic and community cancer survivors with pain . Journal of Cancer Survivorship . 2018;12(6):744-752 .

Romero SAD, Jones L, Bauml JM, Li QS, Cohen RB, Mao JJ . The association between fatigue and pain symptoms and decreased physical activity after cancer . Supportive Care in Cancer . 2018;26(10):3423-3430 .PMCID: PMC6117206

Romesser PB, Pei X, Shi W, Zhang Z, Kollmeier M, McBride SM, Zelefsky MJ . Prostate-specific antigen (PSA) bounce after dose-escalated external beam radiation therapy is an independent predictor of PSA recurrence, metastasis, and survival in prostate adenocarcinoma patients . International Journal of Radiation Oncology, Biology, Physics . 2018;100(1):59-67 .

Rondon-Clavo C, Scordo M, Hilden P, Shah GL, Cho C, Maloy MA, Papadopoulos EB, Jakubowski AA, O’Reilly RJ, Gyurkocza B, Castro-Malaspina H, Tamari R, Shaffer BC, Perales MA, Jaimes EA, Giralt SA . Early fluid overload is associated with an increased risk of nonrelapse mortality after ex vivo CD34-selected allogeneic hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(12):2517-2522 . PMCID: PMC6286243

Rooney MK, Zhu F, Gillespie EF, Gunther JR, McKillip RP, Lineberry M, Tekian A, Golden DW . Simulation as more than a treatment-planning tool: A systematic review of the literature on radiation oncology simulation-based medical education . International Journal of Radiation Oncology, Biology, Physics . 2018;102(2):257-283 .

Root A, Allen P, Tempst P, Yu K . Protein biomarkers for early detection of pancreatic ductal adenocarcinoma: Progress and challenges . Cancers . 2018;10(3):67- . PMCID: PMC5876642

Root A, Ebhardt HA . A two-drug combination simulation study for metastatic castrate resistant prostate cancer . Prostate . 2018;78(15):1196-1200 .

Root A, Beizaei A, Ebhardt HA . Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer . Molecular Cancer . 2018;17:156- . PMCID: PMC6208026

Roper J, Tammela T, Akkad A, Almeqdadi M, Santos SB, Jacks T, Yilmaz ÖH . Colonoscopy-based colorectal cancer modeling in mice with CRISPR-

151 OF 288


Journal Articles

Cas9 genome editing and organoid transplantation . Nature Protocols . 2018;13(2):217-234 .

Rosa W . Transcultural holism: A global literacy for health and healing . Beginnings . 2018;38(2):12-16 .

Rosello-Díez A, Madisen L, Bastide S, Zeng H, Joyner AL . Cell-nonautonomous local and systemic responses to cell arrest enable long-bone catch-up growth in developing mice . PLoS Biology . 2018;16(6):e2005086- .PMCID: PMC6019387

Rosen LE, Karrison T, Ananthanarayanan V, Gallan AJ, Adusumilli PS, Alchami FS, Attanoos R, Brcic L, Butnor KJ, Galateau-Sallé F, Hiroshima K, Kadota K, Klampatsa A, Le Stang N, Lindenmann J, Litzky LA, Marchevsky A, Medeiros F, Montero MA, Moore DA, Nabeshima K, Pavlisko EN, Roggli VL, Sauter JL, Sharma A, Sheaff M, Travis WD, Vigneswaran WT, Vrugt B, Walts AE, Tjota MY, Krausz T, Husain AN . Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: A multi-institutional study . Modern Pathology . 2018;31(4):598-606 .

Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Ricart Arbona RJ, Monette S, Dyke JP, Ballon DJ, Kaminsky SM, Sondhi D, Petsko GA, Paul SM, Crystal RG . AAVrh .10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer’s disease . Human Gene Therapy Clinical Development . 2018;29(1):24-47 . PMCID: PMC5870071

Rosenberg JE, Hahn NM, Regan MM, Werner L, Alva A, George S, Picus J, Alter R, Balar A, Hoffman-Censits J, Grivas P, Lauer R, Guancial EA, Hoimes C, Sonpavde G, Albany C, Stein MN, Breen T, Jacobs C, Anderson K, Bellmunt J, Lalani AKA, Pal S, Choueiri TK . Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2) . British Journal of Cancer . 2018;118(11):1434-1441 .

Rosenfeld B, Cham H, Pessin H, Breitbart W . Why is Meaning-Centered Group Psychotherapy (MCGP) effective? Enhanced sense of meaning as the mechanism of change for advanced cancer patients . Psycho-Oncology . 2018;27(2):654-660 . PMCID: PMC5807154

Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC . The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) trial . Annals of Surgical Oncology . 2018;25(10):2858-2866 .

Roshal M . Minimal residual disease detection by flow cytometry in multiple myeloma: Why and how? . Seminars in Hematology . 2018;55(1):4-12 .

Rosillo C, Avila AM, Huang YT, Devlin S, Cho C, Montoro J, Maloy MA, Papanicolaou GA, Barba P, Perales MA . Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation . Transplant Infectious Disease . 2018;20(4):e12897- .

Rosner S, Kwong E, Shoushtari AN, Friedman CF, Betof AS, Brady MS, Coit DG, Callahan MK, Wolchok JD, Chapman PB, Panageas KS, Postow MA . Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma . Cancer Medicine . 2018;7(3):690-697 . PMCID: PMC5852343

Ross GA, Rustenburg AS, Grinaway PB, Fass J, Chodera JD . Biomolecular simulations under realistic macroscopic salt conditions . Journal of Physical Chemistry B . 2018;122(21):5466-5486 .

Rossi AM, Blank NR, Nehal K, Dusza S, Lee EH . Effect of laser therapy on quality of life in patients with

radiation-induced breast telangiectasias . Lasers in Surgery and Medicine . 2018;50(4):284-290 .

Rossi AM, Navarrete-Dechent C, Nehal KS . Beyond skin deep: Taking bedside dermatology to the next level with noninvasive technologies . British Journal of Dermatology . 2018;178(5):994-996 .

Roth AJ, Shuman S, Schwer B . Defining essential elements and genetic interactions of the yeast Lsm2-8 ring and demonstration that essentiality of Lsm2-8 is bypassed via overexpression of U6 snRNA or the U6 snRNP subunit Prp24 . RNA . 2018;24(6):853-864 . PMCID: PMC5959253

Roth RS, Qi J, Hamill JB, Wilkins EG, Kim HM, Ballard TNS, Pusic AL . Reply to Kendall and Castro-Alves: Reconstructive surgery and persistent postsurgical pain after mastectomy . Breast . 2018;38:189-190 .

Roth RS, Qi J, Hamill JB, Kim HM, Ballard TNS, Pusic AL, Wilkins EG . Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction . Breast . 2018;37:119-125 .PMCID: PMC5742544

Roti G, Qi J, Kitara S, Sanchez-Martin M, Conway AS, Varca AC, Su A, Wu L, Kung AL, Ferrando AA, Bradner JE, Stegmaier K . Leukemia-specific delivery of mutant NOTCH1 targeted therapy . Journal of Experimental Medicine . 2018;215(1):197-216 . PMCID: PMC5748843

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragon L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L . Gut microbiome influences efficacy of PD-1-based

152 OF 288


Journal Articles

immunotherapy against epithelial tumors . Science . 2018;359(6371):91-97 .

Rowlands MA, Mondesire-Crump I, Levin A, Mauguen A, Francis JH, Dunkel IJ, Brodie SE, Gobin YP, Abramson DH . Total retinal detachments due to retinoblastoma: Outcomes following intraarterial chemotherapy/ophthalmic artery chemosurgery . PLoS ONE . 2018;13(4):e0195395- . PMCID: PMC5919618

Roxburgh CS, Shia J, Vakiani E, Daniel T, Weiser MR . Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer . OncoImmunology . 2018;7(6):e1435227- . PMCID: PMC5980419

Roxburgh CS, Weiser MR . Selective use of radiation for locally advanced rectal cancer: One size does not fit all . Minerva Chirurgica . 2018;73(6):592-600 . PMCID: PMC6252280

Ruan Y, Kao K, Lefebvre S, Marchesi A, Corringer PJ, Hite RK, Scheuring S . Structural titration of receptor ion channel GLIC gating by HS-AFM . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(41):10333-10338 . PMCID: PMC6187180

Rubinstein PG, Moore PC, Rudek MA, Henry DH, Ramos JC, Ratner L, Reid E, Sharon E, Noy A, for the AIDS Malignancy Consortium (AMC) . Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma . AIDS . 2018;32(5):605-611 . PMCID: PMC5832596

Rudin CM . Looking ahead to new therapies in small cell lung cancer . Clinical Advances in Hematology & Oncology . 2018;16(4):269-272 .

Rudolf J, Garcia C, Hanna M, Williams C, Balis U, Pantanowitz L, Tuthill J, Gilbertson J, Pathology Informatics Alumni Group . Career paths of pathology

informatics fellowship alumni . Journal of Pathology Informatics . 2018;9:14- . PMCID: PMC5907454

Ruff EF, Muretta JM, Thompson AR, Lake EW, Cyphers S, Albanese SK, Hanson SM, Behr JM, Thomas DD, Chodera JD, Levinson NM . A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation . eLife . 2018;7:e32766- . PMCID: PMC5849412

Rugo HS, Roche H, Thomas E, Chung HC, Lerzo GL, Vasyutin I, Patel A, Vahdat L . Efficacy and safety of ixabepilone and capecitabine in patients with advanced triple-negative breast cancer: A pooled analysis from two large phase III, randomized clinical trials . Clinical Breast Cancer . 2018;18(6):489-497 .

Ruiz IR, Vicario R, Morancho B, Morales CB, Arenas EJ, Herter S, Freimoser-Grundschober A, Somandin J, Sam J, Ast O, Barriocanal ÁM, Luque A, Escorihuela M, Varela I, Cuartas I, Nuciforo P, Fasani R, Peg V, Rubio I, Cortés J, Serra V, Escriva-de-Romani S, Sperinde J, Chenna A, Huang W, Winslow J, Albanell J, Seoane J, Scaltriti M, Baselga J, Tabernero J, Umana P, Bacac M, Saura C, Klein C, Arribas J . P95HER2–T cell bispecific antibody for breast cancer treatment . Science Translational Medicine . 2018;10(461):eaat1445- . PMCID: PMC6498439

Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, Chen CC, Ho YJ, Sanchez-Rivera FJ, Feucht J, Baslan T, Tian S, Chen HA, Romesser PB, Poirier JT, Rudin CM, de Stanchina E, Manchado E, Sherr CJ, Lowe SW . NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination . Science . 2018;362(6421):1416-1422 .

Rusch VW . Has reconstruction of the central airways been transformed? From aorta to trachea . JAMA - Journal of the American Medical Association . 2018;319(21):2177-2178 .

Rusch VW, Chaft J, Hellmann M . KEYNOTE-024: Unlocking a pathway to lung cancer cure? .

Journal of Thoracic and Cardiovascular Surgery . 2018;155(4):1777-1780 .

Russo P . Editorial comment . Journal of Urology . 2018;199(1):59- .

Russo P . Editorial comment . Journal of Urology . 2018;199(2):400- .

Rutherford NJ, Thoren KL, Shajani-Yi Z, Colby JM . Voxelotor (GBT440) produces interference in measurements of hemoglobin S . Clinica Chimica Acta . 2018;482:57-59 .

Rutherford SC, Fachel AA, Li S, Sawh S, Muley A, Ishii J, Saxena A, Dominguez PM, Lopes EC, Agirre X, Chambwe N, Correa F, Jiang Y, Richards KL, Betel D, Shaknovich R . Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations . Blood . 2018;132(7):e13-e23 .

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA . Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: A modeling study . Cancer Epidemiology Biomarkers and Prevention . 2018;27(2):158-164 . PMCID: PMC5809257

Ryan CJ, Crawford ED, Shore ND, Underwood W 3rd, Taplin ME, Londhe A, Francis PSJ, Phillips J, McGowan T, Kantoff PW . The IMAAGEN study: Effect of abiraterone acetate and prednisone on prostate specific antigen and radiographic disease progression in patients with nonmetastatic castration resistant prostate cancer . Journal of Urology . 2018;200(2):344-351; discussion 351-352 .

Ryan CJ, Kheoh T, Li J, Molina A, De Porre P, Carles J, Efstathiou E, Kantoff PW, Mulders PFA, Saad F, Chi KN . Prognostic index model for progression-free survival in chemotherapy-naïve metastatic castration-

153 OF 288


Journal Articles

resistant prostate cancer treated with abiraterone acetate plus prednisone . Clinical Genitourinary Cancer . 2018;16(1):72-77 .e1 . PMCID: PMC5785489

Rychert J, Slechta ES, Barker AP, Miranda E, Babady NE, Tang YW, Gibas C, Wiederhold N, Sutton D, Hanson KE . Multicenter evaluation of the Vitek MS v3 .0 system for the identification of filamentous fungi . Journal of Clinical Microbiology . 2018;56(2):e01353-17- . PMCID: PMC5786734

Rydzewski NR, Khan AJ, Strauss JB, Chmura SJ . Mortality after stereotactic radiosurgery for brain metastases and implications for optimal utilization: A National Cancer Database Study . American Journal of Clinical Oncology: Cancer Clinical Trials . 2018;41(11):1142-1147 .

Saab J, Santos-Zabala ML, Loda M, Stack EC, Hollmann TJ . Fatty acid synthase and acetyl-CoA carboxylase are expressed in nodal metastatic melanoma but not in benign intracapsular nodal nevi . American Journal of Dermatopathology . 2018;40(4):259-264 .

Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai W V, Offin M, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A . PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers . Annals of Oncology . 2018;29(10):2085-2091 . PMCID: PMC6225900

Saha A, Arevalo-Perez J, Peck KK, Rosenblum M, Bilsky M, Lis E, Karimi S . Calcifying pseudoneoplasm of the spine: Imaging and pathological features . The Neuroradiology Journal . 2018;31(4):440-444 . PMCID: PMC6111419

Saha N, Robev D, Mason EO, Himanen JP, Nikolov DB . Therapeutic potential of targeting the Eph/ephrin signaling complex . International Journal of

Biochemistry and Cell Biology . 2018;105:123-133 . PMCID: PMC6457248

Sahin IH, Elias H, Chou JF, Capanu M, O’Reilly EM . Pancreatic adenocarcinoma: Insights into patterns of recurrence and disease behavior . BMC Cancer . 2018;18(1):769- . PMCID: PMC6064173

Sahu A, Yélamos O, Iftimia N, Cordova M, Alessi-Fox C, Gill M, Maguluri G, Dusza SW, Navarrete-Dechent C, Gonzalez S, Rossi AM, Marghoob AA, Rajadhyaksha M, Chen CSJ . Evaluation of a combined reflectance confocal microscopy-optical coherence tomography device for detection and depth assessment of basal cell carcinoma . JAMA Dermatology . 2018;154(10):1175-1183 . PMCID: PMC6179925

Salem DAR, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M . Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma . Leukemia and Lymphoma . 2018;59(1):178-186 . PMCID: PMC6193452

Salo-Mullen EE, Lynn PB, Wang L, Walsh M, Gopalan A, Shia J, Tran C, Man FY, McBride S, Schattner M, Zhang L, Weiser MR, Stadler ZK . Contiguous gene deletion of chromosome 2p16 .3-p21 as a cause of Lynch syndrome . Familial Cancer . 2018;17(1):71-77 . PMCID: PMC5708147

Salsman JM, Park CL, Hahn EA, Snyder MA, George LS, Steger MF, Merluzzi T, Cella D . Refining and supplementing candidate measures of psychological well-being for the NIH PROMIS®: Qualitative results from a mixed cancer sample . Quality of Life Research . 2018;27(9):2471-2476 .

Saltsman JA, Malek MM, Reuter VE, Hammond WJ, Danzer E, Herr HW, LaQuaglia MP . Urothelial neoplasms in pediatric and young adult patients:

A large single-center series . Journal of Pediatric Surgery . 2018;53(2):306-309 . PMCID: PMC5828877

Samet JM, de Gonzalez AB, Dauer LT, Hatch M, Kosti O, Mettler FA Jr, Satyamitra MM . Gilbert W . Beebe Symposium on 30 years after the Chernobyl accident: Current and future studies on radiation health effects . Radiation Research . 2018;189(1):5-18 . PMCID: PMC5810143

Samsel C, Kearney J, Meadows AL, Abrams A, Hirst JM, Muriel AC . Olanzapine for chemotherapy-induced nausea: Lessons learned from child and adolescent psychiatry . Pediatric Blood and Cancer . 2018;65(10):e27289- .

Samstein RM, Riaz N . The DNA damage response in immunotherapy and radiation . Advances in Radiation Oncology . 2018;3(4):527-533 . PMCID: PMC6200889

Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A . Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis . Head & Neck . 2018;40(4):855-866 .PMCID: PMC5849517

Sanchez A, Feldman AS, Hakimi AA . Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation . Journal of Clinical Oncology . 2018;36(36):3591-3600 .

Sanchez AM, Shuman S, Schwer B . Poly(A) site choice and Pol2 CTD Serine-5 status govern lncRNA control of phosphate-responsive tgp1 gene expression in fission yeast . RNA . 2018;24(2):237-250 . PMCID: PMC5769750

Sanchez AM, Shuman S, Schwer B . RNA polymerase II CTD interactome with 3′ processing and termination factors in fission yeast and its impact on phosphate homeostasis . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(45):E10652-E10661 . PMCID: PMC6233144

154 OF 288


Journal Articles

Sanchez E, Huse M . Spatial and temporal control of T cell activation using a photoactivatable agonist . Journal of Visualized Experiments . 2018;2018(134):e56655- .

Sanchez-Salas R, de la Rosette J, Polascik TJ, Carneiro A, Sivaraman A, Cathelineau X, Walz J . Focal therapy for prostate cancer: A more vehement view of the approach could translate into real benefits for our patients . European Urology . 2018;74(5):537-539 .

Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, and The Cancer Genome Atlas Research Network, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N . Oncogenic signaling pathways in The Cancer Genome Atlas . Cell . 2018;173(2):321-337 .e10 .

Santini FC, Hellmann MD . PD-1/PD-L1 axis in lung cancer . The Cancer Journal . 2018;24(1):15-19 . PMCID: PMC5784856

Santini FC, Rizvi H, Plodkowski AJ, Ni A, Lacouture ME, Gambarin-Gelwan M, Wilkins O, Panora E, Halpenny DF, Long NM, Kris MG, Rudin CM, Chaft JE, Hellmann MD . Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC . Cancer Immunology Research . 2018;6(9):1093-1099 . PMCID: PMC6125223

Santini V, Allione B, Zini G, Gioia D, Lunghi M, Poloni A, Cilloni D, Sanna A, Masiera E, Ceccarelli M, Abdel-Wahab O, Terenzi A, Angelucci E, Finelli C, Onida F, Pelizzari A, Ferrero D, Saglio G, Figueroa M, Levis A . A phase II, multicentre trial of decitabine in higher-

risk chronic myelomonocytic leukemia . Leukemia . 2018;32(2):413-418 . PMCID: PMC5808077

Santomasso BD, Park JH, Salloum D, Riviere I, Flynn J, Mead E, Halton E, Wang X, Senechal B, Purdon T, Cross JR, Liu H, Vachha B, Chen X, Deangelis LM, Li D, Bernal Y, Gonen M, Wendel HG, Sadelain M, Brentjens RJ . Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia . Cancer Discovery . 2018;8(8):958-971 .

Santosa KB, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL . Long-term patient-reported outcomes in postmastectomy breast reconstruction . JAMA Surgery . 2018;153(10):891-899 .

Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G . Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis . Gynecologic Oncology . 2018;151(3):573-578 .

Saracino RM, Rosenfeld B, Nelson CJ . Performance of four diagnostic approaches to depression in adults with cancer . General Hospital Psychiatry . 2018;51:90-95 . PMCID: PMC5869111

Sarkar SN, Hackney DB, Greenman RL, Vachha BA, Johnson EA, Nagle S, Moonis G . A subjective and objective comparison of tissue contrast and imaging artifacts present in routine spin echoes and in iterative decomposition of asymmetric spin echoes for soft tissue neck MRI . European Journal of Radiology . 2018;102:202-207 .

Sarpel U, Huang X, Austin C, Gany F . Barriers to care in Chinese immigrants with hepatocellular carcinoma: A focus group study in New York City . Journal of Community Health . 2018;43(6):1161-1171 .

Sarpel U, Heskel M, Spivack JH, Feferman Y, Ang C, Gany F . Disparities in access to sorafenib in communities with low socioeconomic status . Journal

of Health Care for the Poor and Underserved . 2018;29(3):1123-1134 .

Sartor O, Vogelzang NJ, Sweeney C, Fernandez DC, Almeida F, Iagaru A, Brown A Jr, Smith MR, Agrawal M, Dicker AP, Garcia JA, Lutzky J, Wong YN, Petrenciuc O, Gratt J, Shore ND, Morris MJ, for fortheUSexpandedaccessprograminvestigators . Radium-223 safety, efficacy, and concurrent use with abiraterone or enzalutamide: First U .S . experience from an expanded access program . The Oncologist . 2018;23(2):193-202 . PMCID: PMC5813754

Sauter CS, Matasar MJ, Schoder H, Devlin SM, Drullinsky P, Gerecitano J, Kumar A, Noy A, Palomba ML, Portlock CS, Straus DJ, Zelenetz AD, McCall SJ, Miller ST, Courtien A I, Younes A, Moskowitz CH . A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL . Blood . 2018;131(16):1805-1808 . PMCID: PMC5909762

Savage SA, Walsh MF . Myelodysplastic syndrome, acute myeloid leukemia, and cancer surveillance in Fanconi anemia . Hematology/Oncology Clinics of North America . 2018;32(4):657-668 .

Sawan P, Plodkowski AJ, Li AE, Li BT, Drilon A, Capanu M, Ginsberg MS . CT features of HER2-mutant lung adenocarcinomas . Clinical Imaging . 2018;51:279-283 .

Sayeed S, Xing D, Jenkins SM, Weisman PS, Buehler D, Warmke L, Uram-Tuculescu C, Bakkum-Gamez JN, Howitt BE, Cortese C, Park KJ, Schoolmeester JK . Criteria for risk stratification of vulvar and vaginal smooth muscle tumors: An evaluation of 71 cases comparing proposed classification systems . American Journal of Surgical Pathology . 2018;42(1):84-94 . PMCID: PMC5730467

Scarinci A, Di Cesare T, Cavaniglia D, Neri T, Colletti M, Cosenza G, Liverani A . The impact of log odds of positive lymph nodes (LODDS) in colon and rectal

155 OF 288


Journal Articles

cancer patient stratification: A single-center analysis of 323 patients . Updates in Surgery . 2018;70(1):23-31 .

Schadendorf D, Jiang J, Kelleher T, Postow MA . Reply to M . Horiguchi et al . Journal of Clinical Oncology . 2018;36(7):721- .

Schaff LR, Grommes C . Updates on primary central nervous system lymphoma . Current Oncology Reports . 2018;20(2):11- .

Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, Ayer DE, Hurlin PJ, Cherniack AD, Eisenman RN, Bernard B, Grandori C, Cancer Genome Atlas Network . Pan-cancer alterations of the MYC oncogene and Its proximal network across the Cancer Genome Atlas . Cell Systems . 2018;6(3):282-300 .e2 . PMCID: PMC5892207

Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM . MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial . American Journal of Roentgenology . 2018;210(6):1376-1385 .

Scher H I, Graf RP, Schreiber NA, Jayaram A, Winquist E, McLaughlin B, Lu D, Fleisher M, Orr S, Lowes L, Anderson A, Wang Y, Dittamore R, Allan AL, Attard G, Heller G . Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer . JAMA Oncology . 2018;4(9):1179-1186 . PMCID: PMC6139066

Scher MS, Breningstall G, Gilbert D, Jordan L, Khakoo Y, LePichon JB . The 2017 Pediatric Neurology Training Publication Award . Pediatric Neurosurgery . 2018;86:4- .

Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, Leitao MM Jr . Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy . Gynecologic Oncology . 2018;151(2):235-242 . PMCID: PMC6214768

Schleicher SM, Bach PB, Matsoukas K, Korenstein D . Medication overuse in oncology: Current trends and future implications for patients and society . Lancet Oncology . 2018;19(4):e200-e208 .

Schlemmer HP, Bittencourt LK, D’Anastasi M, Domingues R, Khong PL, Lockhat Z, Muellner A, Reiser MF, Schilsky RL, Hricak H . Global challenges for cancer imaging . Journal of Global Oncology . 2018;2018(4) PMCID: PMC6180759

Schlottmann F, Molena D, Patti MG . Gastroesophageal reflux and Barrett’s esophagus: A pathway to esophageal adenocarcinoma . Updates in Surgery . 2018;70(3):339-342 .

Schmier BJ, Shuman S . Deinococcus radiodurans HD-Pnk, a nucleic acid end-healing enzyme, abets resistance to killing by ionizing radiation and mitomycin C . Journal of Bacteriology . 2018;200(17):e00151-18- .PMCID: PMC6088165

Schmitz JE, Tang YW . The GenMark ePlex®: Another weapon in the syndromic arsenal for infection diagnosis . Future Microbiology . 2018;13(16):1697-1708 . PMCID: PMC6439521

Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP,

Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM . Genetics and pathogenesis of diffuse large B-cell lymphoma . New England Journal of Medicine . 2018;378(15):1396-1407 .

Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Dralle H . International Neural Monitoring Study Group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal . Laryngoscope . 2018;128(Suppl . 3):S1-S17 .

Schöder H, Strauss HW . Commentary from the editors of the continuing education section . Journal of Nuclear Medicine . 2018;59(8):1183- .

Schoen MW, Basch E, Hudson LL, Chung AE, Mendoza TR, Mitchell SA, St . Germain D, Baumgartner P, Sit L, Rogak LJ, Shouery M, Shalley E, Reeve BB, Fawzy MR, Bhavsar NA, Cleeland C, Schrag D, Dueck AC, Abernethy AP . Software for administering the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events: Usability study . JMIR Human Factors . 2018;5(3):e10070- .PMCID: PMC6066634

Schoenberg SO, Attenberger U I, Solomon SB, Weissleder R . Developing a roadmap for interventional oncology . The Oncologist . 2018;23(10):1162-1170 .

Schofield RC, Ramanathan L V, Pessin MS, Carlow DC . Data to support a simultaneous testosterone and estradiol assay in serum by LC-MS/MS . Data in Brief . 2018;20:1160-1165 . PMCID: PMC6141700

Scholz SL, Cosgarea I, Süßkind D, Murali R, Möller I, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker A, Steuhl

156 OF 288


Journal Articles

KP, Schadendorf D, Westekemper H, Griewank KG . NF1 mutations in conjunctival melanoma . British Journal of Cancer . 2018;118(9):1243-1247 .

Scholz SL, Murali R, Westekemper H, Schadendorf D, Griewank KG . Re: van Poppelen et al .: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology . 2018;125:904-912) . Ophthalmology . 2018;125(11):e78-e79 .

Schram AM, Gandhi L, Mita MM, Damstrup L, Campana F, Hidalgo M, Grande E, Hyman DM, Heist RS . A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours . British Journal of Cancer . 2018;119(12):1471-1476 .

Schrijver WAME, Selenica P, Lee JY, Ng CKY, Burke KA, Piscuoglio S, Berman SH, Reis-Filho JS, Weigelt B, van Diest PJ, Moelans CB . Mutation profiling of key cancer genes in primary breast cancers and their distant metastases . Cancer Research . 2018;78(12):3112-3121 .

Schvartzman JM, Thompson CB, Finley LWS . Metabolic regulation of chromatin modifications and gene expression . Journal of Cell Biology . 2018;217(7):2247-2259 . PMCID: PMC6028552

Scordo M . An old friend is trouble for double-expressor and double-hit lymphoma . Biology of Blood and Marrow Transplantation . 2018;24(3):421-422 .

Scordo M, Morjaria SM, Littmann ER, Bhatia A, Chung HH, Maloy M, DeAngelis LM, Giralt SA, Taur Y, Sauter CS . Distinctive infectious complications in patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(9):1914-1919 . PMCID: PMC6163063

Scordo M, Shah GL, Peled JU, Preston E V, Buchan ML, Epstein JB, Barasch A, Giralt SA . Unlocking the complex flavors of dysgeusia after hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(3):425-432 .

Scordo M, Shah GL, Kosuri S, Herrera DA, Cho C, Devlin SM, Maloy MA, Nieves J, Borrill T, Avecilla ST, Meagher RC, Carlow DC, O’Reilly RJ, Papadopoulos EB, Jakubowski AA, Koehne G, Gyurkocza B, Castro-Malaspina H, Tamari R, Perales MA, Giralt SA, Shaffer BC . Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(1):133-141 .

Scott JM, Iyengar NM, Nilsen TS, Michalski M, Thomas SM, Herndon J 2nd, Sasso J, Yu A, Chandarlapaty S, Dang CT, Comen EA, Dickler MN, Peppercorn JM, Jones LW . Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial . Cancer . 2018;124(12):2552-2560 . PMCID: PMC5990447

Scott JM, Nilsen TS, Gupta D, Jones LW . Exercise therapy and cardiovascular toxicity in cancer . Circulation . 2018;137(11):1176-1191 .

Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, Moskowitz CS, Matsoukas K, Iyengar NM, Dang CT, Jones LW . Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: A systematic review and meta-analysis . Journal of Clinical Oncology . 2018;36(22):2297-2305 .

Scott JM, Li N, Liu Q, Yasui Y, Leisenring W, Nathan PC, Gibson T, Armenian SH, Nilsen TS, Oeffinger KC, Ness KK, Adams SC, Robison LL, Armstrong GT, Jones LW . Association of exercise with mortality in adult survivors of childhood cancer . JAMA Oncology . 2018;4(10):1352-1358 . PMCID: PMC6181767

Scott JM, Martin D, Ploutz-Snyder R, Downs M, Dillon EL, Sheffield-Moore M, Urban RJ, Ploutz-Snyder LL .

Efficacy of exercise and testosterone to mitigate atrophic cardiovascular remodeling . Medicine and Science in Sports and Exercise . 2018;50(9):1940-1949 . PMCID: PMC6095799

Seamon LG, Java JJ, Monk BJ, Penson RT, Brown J, Mannel RS, Oaknin A, Leitao MM, Eisenhauer EL, Long HJ, Liao SY, Tewari KS . Impact of tumour histology on survival in advanced cervical carcinoma: An NRG Oncology/Gynaecologic Oncology Group Study . British Journal of Cancer . 2018;118(2):162-170 . PMCID: PMC5785748

Seddon AN, Chaim J, Akin O, Drill E, Michael AG, Adel N, Tallman MS . Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia . Leukemia Research . 2018;68:48-50 .

Sedhom R, Sedhom D, Jaimes E . Mini-review of kidney disease following hematopoietic stem cell transplant . Clinical Nephrology . 2018;89(6):389-402 .

Seeley E, Chimonas S, Kesselheim AS . Can outcomes-based pharmaceutical contracts reduce drug prices in the US? A mixed methods assessment . Journal of Law Medicine & Ethics . 2018;46(4):952-963 .

Seelige R, Saddawi-Konefka R, Adams NM, Picarda G, Sun JC, Benedict CA, Bui JD . Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection . Scientific Reports . 2018;8:13670- .PMCID: PMC6135835

Segal NH, He AR, Doi T, Levy R, Bhatia S, Pishvaian MJ, Cesari R, Chen Y, Davis CB, Huang B, Thall AD, Gopal AK . Phase I study of single-agent utomilumab (PF-05082566), a 4-1BB/CD137 agonist, in patients with advanced cancer . Clinical Cancer Research . 2018;24(8):1816-1823 .

Segurado-Miravalles G, Jiménez-Gomez N, Moreno-Arrones OM, Alarcon-Salazar I, Alegre-Sanchez A, Saceda-Corralo D, Jaén-Olasolo P, Gonzalez-Rodríguez S . Assessment of the effect of 3%

157 OF 288


Journal Articles

diclofenac sodium on photodamaged skin by means of reflectance confocal microscopy . Acta Dermato-Venereologica . 2018;98(10):963-969 .

Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Fallas Hayes J, Pearson Butler L, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, Zujewski JA, Korde LA . National Cancer Institute Breast Cancer Steering Committee working group report on meaningful and appropriate end points for clinical trials in metastatic breast cancer . Journal of Clinical Oncology . 2018;36(32):3259-3268 .

Seiler M, Yoshimi A, Darman R, Chan B, Keaney G, Thomas M, Agrawal AA, Caleb B, Csibi A, Sean E, Fekkes P, Karr C, Klimek V, Lai G, Lee L, Kumar P, Lee SCW, Liu X, MacKenzie C, Meeske C, Mizui Y, Padron E, Park E, Pazolli E, Peng S, Prajapati S, Taylor J, Teng T, Wang J, Warmuth M, Yao H, Yu L, Zhu P, Abdel-Wahab O, Smith PG, Buonamici S . H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers . Nature Medicine . 2018;24(4):497-504 .

Selby L V, Narain WR, Russo A, Strong VE, Stetson P . Autonomous detection, grading, and reporting of postoperative complications using natural language processing . Surgery . 2018;164(6):1300-1305 .

Senders ML, Que XC, Cho YS, Yeang C, Groenen H, Fay F, Calcagno C, Meerwaldt AE, Green S, Miu P, Lobatto ME, Reiner T, Fayad ZA, Witztum JL, Mulder WJM, Pérez-Medina C, Tsimikas S . PET/MR imaging of malondialdehyde-acetaldehyde epitopes with a human antibody detects clinically relevant atherothrombosis . Journal of the American College of Cardiology . 2018;71(3):321-335 .

Sengupta S, Sun SQ, Huang KL, Oh C, Bailey MH, Varghese R, Wyczalkowski MA, Ning J, Tripathi P, McMichael JF, Johnson KJ, Kandoth C, Welch J, Ma C, Wendl MC, Payne SH, Fenyö D, Townsend RR, Dipersio JF, Chen F, Ding L . Integrative omics

analyses broaden treatment targets in human cancer . Genome Medicine . 2018;10:60- . PMCID: PMC6064051

Sengupta U, Montalbano M, McAllen S, Minuesa G, Kharas M, Kayed R . Formation of toxic oligomeric assemblies of RNA-binding protein: Musashi in Alzheimer’s disease . Acta Neuropathologica Communications . 2018;6:113- . PMCID: PMC6203984

Seo SK, Gedrimaite Z, Paskovaty A, Seier K, Morjaria S, Cohen N, Riedel E, Tang YW, Babady NE . Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures . Clinical Microbiology and Infection . 2018;24(12):1339 .e7-1339 .e12 . PMCID: PMC6136986

Serganova I, Cohen IJ, Vemuri K, Shindo M, Maeda M, Mane M, Moroz E, Khanin R, Satagopan J, Koutcher JA, Blasberg R . LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response . PLoS ONE . 2018;13(9):e0203965- . PMCID: PMC6153000

Seth AK, Allen RJ Jr . Modern techniques and alternative flaps in microsurgical breast reconstruction . Journal of Surgical Oncology . 2018;118(5):768-779 .

Settleman J, Sawyers CL, Hunter T . Challenges in validating candidate therapeutic targets in cancer . eLife . 2018;7:e32402- . PMCID: PMC5805407

Setton JS, Powell SN . A new role for a tumor-suppressing protein . eLife . 2018;7:e35111- . PMCID: PMC5832416

Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D’Rozario J, Assouline S, Owen C, Gerecitano J, Robak T, De La Serna J, Jaeger U, Cartron G, Montillo M, Humerickhouse R, Punnoose EA, Li Y, Boyer M, Humphrey K, Mobasher M, Kater AP . Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia . New England Journal of Medicine . 2018;378(12):1107-1120 .

Shady W, Petre EN, Do KG, Gonen M, Yarmohammadi H, Brown KT, Kemeny NE, D’Angelica M, Kingham PT, Solomon SB, Sofocleous CT . Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: Ablation with clear margins (A0) provides the best local tumor control . Journal of Vascular and Interventional Radiology . 2018;29(2):268-275 .e1 . PMCID: PMC5803367

Shaffer KM, Nelson CJ, DuHamel KN . Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer . Psycho-Oncology . 2018;27(3):1082-1085 . PMCID: PMC5839984

Shaffer KM, Garland SN, Mao JJ, Applebaum AJ . Insomnia among cancer caregivers: A proposal for tailored cognitive behavioral therapy . Journal of Psychotherapy Integration . 2018;28(3):275-291 . PMCID: PMC6147560

Shafique K, Lee LH, Samad A, Wang L, Klimstra DS . Pancreatic-type mixed acinar neuroendocrine carcinoma arising in the common bile duct: A case report . AJSP: Reviews and Reports . 2018;23(6):266-270 .

Shah C, Vicini F, Shaitelman SF, Hepel J, Keisch M, Arthur D, Khan AJ, Kuske R, Patel R, Wazer DE . The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation . Brachytherapy . 2018;17(1):154-170 .

Shah GL, Moskowitz CH . Checkpoint inhibition in lymphoma . Clinical Advances in Hematology & Oncology . 2018;16(1):45-55 .

Shah GL, Majhail N, Khera N, Giralt S . Value-based care in hematopoietic cell transplantation and cellular therapy: Challenges and opportunities . Current Hematologic Malignancy Reports . 2018;13(2):125-134 .

158 OF 288


Journal Articles

Shah GL, Moskowitz CH . Transplant strategies in relapsed/refractory Hodgkin lymphoma . Blood . 2018;131(15):1689-1697 . PMCID: PMC5897866

Shah GL, Scordo M, Kosuri S, Herrera DA, Cho C, Devlin SM, Borrill T, Carlow DC, Avecilla ST, Meagher RC, O’Reilly RJ, Jakubowski AA, Papadopoulos EB, Koehne G, Gyurkocza B, Castro-Malaspina H, Shaffer BC, Perales MA, Giralt SA, Tamari R . Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(1):142-149 .

Shah JP . Staging for head and neck cancer: Purpose, process and progress . Indian Journal of Surgical Oncology . 2018;9(1):116-120 . PMCID: PMC5856705

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB 3rd, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G . NCCN Guidelines® Insights: Neuroendocrine and adrenal tumors, version 2 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(6):693-702 .

Shah MK, Kamboj M . Immunizing cancer patients: Which patients? Which vaccines? When to give? . Oncology (Norwalk) . 2018;32(5):254-258, C3 .

Shah N, Shi Q, Giralt S, Williams L, Bashir Q, Qazilbash M, Champlin RE, Cleeland CS, Wang XS . Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma . Quality of Life Research . 2018;27(4):979-985 .

Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen A I, Ciurea SO, Bachanova V, DeFilipp Z,

Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D’Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M . Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: A CIBMTR analysis . Blood Advances . 2018;2(8):933-940 .PMCID: PMC5916010

Shah NN, Nagle SJ, Torigian DA, Farwell MD, Hwang WT, Frey N, Nasta SD, Landsburg D, Mato A, June CH, Schuster SJ, Porter DL, Svoboda J . Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor – T-cell therapy in B-cell non-Hodgkin lymphomas . Cytotherapy . 2018;20(12):1415-1418 .

Shah S, Boucai L . Effect of age on response to therapy and mortality in patients with thyroid cancer at high risk of recurrence . Journal of Clinical Endocrinology and Metabolism . 2018;103(2):689-697 . PMCID: PMC5800839

Shah SP . Copy number signatures in ovarian cancer . Nature Genetics . 2018;50(9):1208-1209 .

Shah V V, Wikramanayake TC, DelCanto GM, van den Hurk C, Wu S, Lacouture ME, Jimenez JJ . Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: A review of controlled clinical trials . Journal of the European Academy of Dermatology and Venereology . 2018;32(5):720-734 .

Shaha AR . Central lymph node metastasis in papillary thyroid carcinoma . World Journal of Surgery . 2018;42(3):630-631 .

Shaha AR, Tuttle RM . Reply: Active surveillance in micropapillary carcinoma . Surgery . 2018;163(6):1327-1328 .

Shaha AR, Tuttle RM . Risk of disease progression during active surveillance of papillary thyroid cancer . Surgery . 2018;163(1):53-54 .

Shaha AR . Laryngeal nerve injury during thyroid surgery . Surgical Oncology . 2018;27(2):A19-A20 .

Shaha AR . Clinical significance of extrathyroidal extension according to size of papillary thyroid carcinoma . European Journal of Surgical Oncology . 2018;44(11):1669-1670 .

Shaha AR . Comment on “Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERT promoter mutations” . Gland Surgery . 2018;7(5):426-427 .

Shaha AR . Comment on “The diagnosis and management of thyroid nodules: A review” . Gland Surgery . 2018;7(5):424-425 .

Shahrokni A, Maggiore RJ, Ghassemzadeh H . New technologies in geriatric oncology care . Journal of Geriatric Oncology . 2018;9(6):687-689 .

Shahrokni A, Alexander K, Wildes TM, Puts MTE . Preventing treatment-related functional decline: Strategies to maximize resilience . American Society of Clinical Oncology Educational Book . 2018;38:415-431 .

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R . Translational radiomics: Defining the strategy pipeline and considerations for application - Part 1: From methodology to clinical implementation . Journal of the American College of Radiology . 2018;15(3 Pt . B):538-542 .

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R . Translational radiomics: Defining the strategy pipeline and considerations for application - Part 2: From clinical implementation to enterprise . Journal of the American College of Radiology . 2018;15(3 Pt . B):543-549 .

Shamay Y, Shah J, Işık M, Mizrachi A, Leibold J, Tschaharganeh DF, Roxbury D, Budhathoki-Uprety J, Nawaly K, Sugarman JL, Baut E, Neiman MR, Dacek

159 OF 288


Journal Articles

M, Ganesh KS, Johnson DC, Sridharan R, Chu KL, Rajasekhar VK, Lowe SW, Chodera JD, Heller DA . Quantitative self-assembly prediction yields targeted nanomedicines . Nature Materials . 2018;17(4):361-368 . PMCID: PMC5930166

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD . IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity . Nature . 2001 . 410: 1107-1111 . Journal of Immunology . 2018;201(3):827-831 .

Sharaf RN, Diamond LC . A letter to our daughter . JAMA - Journal of the American Medical Association . 2018;320(17):1755-1756 .

Sharifi H, Zhang H, Bagher-Ebadian H, Lu W, Ajlouni M I, Jin JY, Kong FM, Chetty IJ, Zhong H . Utilization of a hybrid finite-element based registration method to quantify heterogeneous tumor response for adaptive treatment for lung cancer patients . Physics in Medicine and Biology . 2018;63(6):065017- .

Sharma A, Toy W, Guillen VS, Sharma N, Min J, Carlson KE, Mayne CG, Lin S, Sabio M, Greene G, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA . Antagonists for constitutively active mutant estrogen receptors: Insights into the roles of antiestrogen-core and side-chain . ACS Chemical Biology . 2018;13(12):3374-3384 . PMCID: PMC6469989

Sharma MD, Rodriguez PC, Koehn BH, Baban B, Cui Y, Guo G, Shimoda M, Pacholczyk R, Shi H, Lee EJ, Xu H, Johnson TS, He Y, Mergoub T, Venable C, Bronte V, Wolchok JD, Blazar BR, Munn DH . Activation of p53 in immature myeloid precursor cells controls differentiation into Ly6c(+)CD103(+) monocytic antigen-presenting cells in tumors . Immunity . 2018;48(1):91-106 .e6 .

Sharma SK, Chow A, Monette S, Vivier D, Pourat J, Edwards KJ, Dilling TR, Abdel-Atti D, Zeglis BM, Poirier JT, Lewis JS . Fc-mediated anomalous biodistribution of therapeutic antibodies in

immunodeficient mouse models . Cancer Research . 2018;78(7):1820-1832 . PMCID: PMC5882577

Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ . Development of an unrelated donor selection score predictive of survival after HCT: Donor age matters most . Biology of Blood and Marrow Transplantation . 2018;24(5):1049-1056 . PMCID: PMC5953795

Shaz D, Pastores SM . Steroids to soften the blow in persistent acute respiratory distress syndrome . Critical Care Medicine . 2018;46(6):1011-1012 .

Sheckter CC, Matros E, Momeni A . Assessing value in breast reconstruction: A systematic review of cost-effectiveness studies . Journal of Plastic Reconstructive and Aesthetic Surgery . 2018;71(3):353-365 .

Sheckter CC, Yi D, Panchal HJ, Rubin D, Razdan SN, Pusic AL, McCarthy CM, Cordeiro PG, Disa JJ, Mehrara B, Matros E . Trends in physician payments for breast reconstruction . Plastic and Reconstructive Surgery . 2018;141(4):493e-499e . PMCID: PMC5880309

Sheckter CC, Razdan SN, Disa JJ, Mehrara BJ, Matros E . Conceptual considerations for payment bundling in breast reconstruction . Plastic and Reconstructive Surgery . 2018;141(2):294-300 .

Sheckter CC, Panchal HJ, Razdan SN, Rubin D, Yi D, Disa JJ, Mehrara B, Matros E . The influence of physician payments on the method of breast reconstruction: A national claims analysis . Plastic and Reconstructive Surgery . 2018;142(4):434e-442e . PMCID: PMC6156943

Sheffer CE, Hooper MW, Ostroff JS . Commentary: Educational and clinical training for addressing

tobacco-related cancer health disparities . Ethnicity & Disease . 2018;28(3):187-192 . PMCID: PMC6051502

Shelley DR, Kyriakos C, Campo A, Li Y, Khalife D, Ostroff J . An analysis of adaptations to multi-level intervention strategies to enhance implementation of clinical practice guidelines for treating tobacco use in dental care settings . Contemporary Clinical Trials Communications . 2018;11:142-148 . PMCID: PMC6072909

Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK, Thorsson V, Mungall AJ, Newton Y, Hegde AM, Armenia J, Sanchez-Vega F, Pluta J, Pyle LC, Mehra R, Reuter VE, Godoy G, Jones J, Shelley CS, Feldman DR, Vidal DO, Lessel D, Kulis T, Carcano FM, Leraas KM, Lichtenberg TM, Brooks D, Cherniack AD, Cho J, Heiman D I, Kasaian K, Liu M, Noble MS, Xi L, Zhang H, Zhou W, ZenKlusen JC, Hutter CM, Felau I, Zhang J, Schultz N, Getz G, Meyerson M, Stuart JM, The Cancer Genome Atlas Research Network, Akbani R, Wheeler DA, Laird PW, Nathanson KL, Nathanson KL, Cortessis VK, Hoadley KA . Integrated molecular characterization of testicular germ cell tumors . Cell Reports . 2018;23(11):3392-3406 .

Shen MJ, Peterson EB, Costas-Muñiz R, Hernandez MH, Jewell ST, Matsoukas K, Bylund CL . The effects of race and racial concordance on patient-physician communication: A systematic review of the literature . Journal of Racial and Ethnic Health Disparities . 2018;5(1):117-140 . PMCID: PMC5591056

Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, da Silva Medina T, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O’Kane GM, Liu J, Mansour M, McPherson JD, O’Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman S V, Hung RJ, De Carvalho DD . Sensitive tumour detection and classification using plasma cell-free DNA methylomes . Nature . 2018;563(7732):579-583 .

160 OF 288


Journal Articles

Shenaq DS, Matros E . Virtual planning and navigational technology in reconstructive surgery . Journal of Surgical Oncology . 2018;118(5):845-852 .

Shepherd A, James SS, Rengan R . The practicality of ICRU and considerations for future ICRU definitions . Seminars in Radiation Oncology . 2018;28(3):201-206 . PMCID: PMC6020146

Shepherd AF . Proton therapy for post-operative radiation therapy of non-small cell lung cancer . Translational Lung Cancer Research . 2018;7(2):205-209 . PMCID: PMC5960662

Sheppard S, Ferry A, Guedes J, Guerra N . The paradoxical role of NKG2D in cancer immunity . Frontiers in Immunology . 2018;9:1808- . PMCID: PMC6099450

Sheppard S, Schuster IS, Andoniou CE, Cocita C, Adejumo T, Kung SKP, Sun JC, Degli-Esposti MA, Guerra N . The murine natural cytotoxic receptor NKp46/NCR1 controls TRAIL protein expression in NK cells and ILC1s . Cell Reports . 2018;22(13):3385-3392 . PMCID: PMC5896200

Sherer M V, Bryant AK, Wu AJ, Barry PN, Lally BE, Yashar CM, Murphy JD, Gillespie EF . Assessment of contouring resource use and awareness of contouring guidelines among radiation oncologists . Journal of Radiation Oncology . 2018;7(1):103-109 .

Sherman S I, Kloos RT, Tuttle RM, Pontecorvi A, Völzke H, Harper K, Vance C, Alston JT, Usborne AL, Sloop KW, Lakshmanan M . No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer . Diabetic Medicine . 2018;35(3):381-385 . PMCID: PMC5838554

Shi C, Parker BC, Rong Y . Parallel/opposed editorial: DMP/residency programs are more sustainable than MPAs for the future of the medical physics profession . Journal of Applied Clinical Medical Physics . 2018;19(5):330-334 . PMCID: PMC6123128

Shi W, Ng CKY, Lim RS, Jiang T, Kumar S, Li X, Wali VB, Piscuoglio S, Gerstein MB, Chagpar AB, Weigelt B, Pusztai L, Reis-Filho JS, Hatzis C . Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity . Cell Reports . 2018;25(6):1446-1457 . PMCID: PMC6261536

Shickh S, Clausen M, Mighton C, Casalino S, Joshi E, Glogowski E, Schrader KA, Scheer A, Elser C, Panchal S, Eisen A, Graham T, Aronson M, Semotiuk KM, Winter-Paquette L, Evans M, Lerner-Ellis J, Carroll JC, Hamilton JG, Offit K, Robson M, Thorpe KE, Laupacis A, Bombard Y . Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: Protocol for a mixed methods randomised controlled trial . BMJ Open . 2018;8(4):e021876- . PMCID: PMC5922516

Shim YJ, Lee JM, Kim HS, Jung N, Lim YT, Yang EJ, Hah JO, Lee YH, Chueh HW, Lim JY, Park ES, Park JA, Park JK, Park SK, On the behalf of the Study Alliance of Yeungnam Pediatric Hematology-oncology . Comparison of survival outcome between donor types or stem cell sources for childhood acute myeloid leukemia after allogenic hematopoietic stem cell transplantation: A multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology-oncology . Pediatric Transplantation . 2018;22(6):e13249- .

Shipman WD, Chyou S, Ramanathan A, Izmirly PM, Sharma S, Pannellini T, Dasoveanu DC, Qing X, Magro CM, Granstein RD, Lowes MA, Pamer EG, Kaplan DH, Salmon JE, Mehrara BJ, Young JW, Clancy RM, Blobel CP, Lu TT . A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity . Science Translational Medicine . 2018;10(454):eaap9527- .

Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalcın, Fujitani K, Beretta GD, Van Cutsem E, Winkler RE, Makris L, Ilson DH, Tabernero J . Trifluridine/tipiracil versus placebo in patients with heavily

pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial . Lancet Oncology . 2018;19(11):1437-1448 .

Shiu YT, Jaimes EA . Transcription factor ETS-1 and reactive oxygen species: Role in vascular and renal injury . Antioxidants . 2018;7(7):84- .

Shivappa N, Hébert JR, Paddock LE, Rodriguez-Rodriguez L, Olson SH, Bandera E V . Dietary inflammatory index and ovarian cancer risk in a New Jersey case–control study . Nutrition . 2018;46:78-82 . PMCID: PMC5752117

Shlezinger N, Irmer H, Dhingra S, Beattie SR, Cramer RA, Braus GH, Sharon A, Hohl TM . Response to comment on “Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death” . Science . 2018;360(6395):eaas9457- .

Shliakhtsitsava K, Romero SAD, Dewald SR, Su H I . Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: A systematic review . Leukemia and Lymphoma . 2018;59(2):381-397 . PMCID: PMC5902177

Shoag J, Liu D, Blattner M, Sboner A, Park K, Deonarine L, Robinson BD, Mosquera JM, Chen Y, Rubin MA, Barbieri CE . SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG . Journal of Clinical Investigation . 2018;128(1):381-386 . PMCID: PMC5749531

Shojaeilangari S, Schmidtlein CR, Rahmim A, Ay MR . Recovery of missing data in partial geometry PET scanners: Compensation in projection space vs image space . Medical Physics . 2018;45(12):5437-5449 . PMCID: PMC6329391

Shono Y, van den Brink MRM . Gut microbiota injury in allogeneic haematopoietic stem cell transplantation . Nature Reviews Cancer . 2018;18(5):283-295 .

Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford

161 OF 288


Journal Articles

R, Walsh L, Dauer LT . Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection . Journal of Radiological Protection . 2018;38(3):1217-1233 .

Short K, Chung Y Jr . Solving alarm fatigue with smartphone technology . Nursing Critical Care . 2018;13(3):43-47 .

Shoushtari AN, Friedman CF, Navid-Azarbaijani P, Postow MA, Callahan MK, Momtaz P, Panageas KS, Wolchok JD, Chapman PB . Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma . JAMA Oncology . 2018;4(1):98-101 . PMCID: PMC5833656

Shukla A, Huangfu D . Decoding the noncoding genome via large-scale CRISPR screens . Current Opinion in Genetics and Development . 2018;52:70-76 .

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ . Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade . Cell . 2018;173(3):624-633 .e8 .

Shumway DA, Griffith KA, Hawley ST, Wallner LP, Ward KC, Hamilton AS, Morrow M, Katz SJ, Jagsi R . Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer . Cancer . 2018;124(13):2714-2723 .

Shumway DA, McLeod CM, Morrow M, Li Y, Kurian AW, Sabolch A, Hamilton AS, Ward KC, Katz SJ, Hawley ST, Jagsi R . Patient experiences and clinician views on the role of radiation therapy for ductal carcinoma in situ . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1237-1245 .

Shurell E, Olcese C, Patil S, McCormick B, Van Zee KJ, Pilewskie ML . Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ . Cancer . 2018;124(1):46-54 . PMCID: PMC5734990

Shyu I, Mirsadraei L, Wang X, Robila V, Mehra R, McHugh JB, Chen YB, Udager AM, Gill AJ, Cheng L, Amin MB, Lin O, Smith SC . Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples . Cancer Cytopathology . 2018;126(12):992-1002 .

Sidhom JW, Bessell CA, Havel JJ, Kosmides A, Chan TA, Schneck JP . ImmunoMap: A bioinformatics tool for T-cell repertoire analysis . Cancer Immunology Research . 2018;6(2):151-162 .

Sigel CS, Werneck Krauss Silva V, Reid MD, Chhieng D, Basturk O, Sigel KM, Daniel TD, Klimstra DS, Tang LH . Assessment of cytologic differentiation in high-grade pancreatic neuroendocrine neoplasms: A multi-institutional study . Cancer Cytopathology . 2018;126(1):44-53 . PMCID: PMC5766365

Sigel CS, Werneck Krauss Silva V, Reid MD, Chhieng D, Basturk O, Sigel KM, Daniel TD, Klimstra DS, Tang LH . Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study . Cancer Cytopathology . 2018;126(5):326-335 . PMCID: PMC5992011

Sigel CS . Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms . Cancer Cytopathology . 2018;126(12):980-991 .

Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS . Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns . American Journal of Surgical Pathology . 2018;42(10):1334-1345 .

Sigmund EE, Baete SH, Patel K, Wang D, Stoffel D, Otazo R, Parasoglou P, Bencardino J . Spatially resolved kinetics of skeletal muscle exercise response and recovery with multiple echo diffusion tensor imaging (MEDITI): A feasibility study . Magnetic Resonance Materials in Physics, Biology and Medicine . 2018;31(5):599-608 .

Signoretti S, Flaifel A, Chen YB, Reuter VE . Renal cell carcinoma in the era of precision medicine: From molecular pathology to tissue-based biomarkers . Journal of Clinical Oncology . 2018;36(36):3553-3559 . PMCID: PMC6299340

Silk MT, Mikkilineni N, Silk TC, Zabor EC, Ostrovnaya I, Hakimi AA, Hsieh JJ, Ziv E, Rekhtman N, Solomon SB, Durack JC . Prospective evaluation of unprocessed core needle biopsy DNA and RNA yield from lung, liver, and kidney tumors: Implications for cancer genomics . Analytical Cellular Pathology . 2018;2018:2898962- .PMCID: PMC6311765

Silverman JE, Gulati A . An overview of interventional strategies for the management of oncologic pain . Pain Management . 2018;8(5):389-403 .

Silverman LR, Norton L, Schilsky RL . In memoriam: James Frederick Holland, 1925 to 2018 . Journal of Clinical Oncology . 2018;36(26):2665-2668 .

Simoes PK, Woo KM, Shike M, Mendelsohn RB, Gerdes H, Markowitz AJ, Ludwig E, Shah PM, Schattner MA . Direct percutaneous endoscopic jejunostomy: Procedural and nutrition outcomes in a large patient cohort . Journal of Parenteral and Enteral Nutrition . 2018;42(5):898-906 .

Simon C . First person - Claire Simon [Interview] . Biology Open . 2018;7(12):bio040105- .

Simon CS, Hadjantonakis AK, Schröter C . Making lineage decisions with biological noise: Lessons from the early mouse embryo . Wiley Interdisciplinary Reviews: Developmental Biology . 2018;7(4):e319- . PMCID: PMC6002940

162 OF 288


Journal Articles

Simon CS, Hadjantonakis AK . Top to tail: Anterior-posterior patterning precedes regional nervous system identity . Cell . 2018;175(4):905-907 .

Simon CS, Zhang L, Wu T, Cai W, Saiz N, Nowotschin S, Cai CL, Hadjantonakis AK . A Gata4 nuclear GFP transcriptional reporter to study endoderm and cardiac development in the mouse . Biology Open . 2018;7(12):bio036517- . PMCID: PMC6310872

Simon JA, Carabetta M, Rieth EF, Barnett KM . Perioperative care of the breastfeeding patient . AORN Journal . 2018;107(4):465-474 .

Simpson A, Miga M . Technology platforms for treatment and discovery in human systems: Novel work in image-guided procedures, robotic interventions, and modeling . Journal of Medical Imaging . 2018;5(2):021201- .PMCID: PMC5969651

Simpson A . CPM 2018 preface . Lecture Notes in Computer Science . 2018;11042:XI- .

Singh I, Lee SH, Sperling AS, Samur MK, Tai YT, Fulciniti M, Munshi NC, Mayr C, Leslie CS . Widespread intronic polyadenylation diversifies immune cell transcriptomes . Nature Communications . 2018;9:1716- . PMCID: PMC5928244

Singhi AD, Klimstra DS . Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): Concepts, issues and a practical diagnostic approach to high-grade (G3) cases . Histopathology . 2018;72(1):168-177 .

Sirinian C, Papanastasiou AD, Schizas M, Spella M, Stathopoulos GT, Repanti M, Zarkadis IK, King TA, Kalofonos HP . RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling . Oncogene . 2018;37(37):5101-5114 .

Sirintrapun SJ . Preparing for a computational pathology future through informaticians and a

computational technologist workforce . American Journal of Clinical Pathology . 2018;149(5):369-372 .

Sirintrapun SJ, Lopez AM . Telemedicine in cancer care . American Society of Clinical Oncology Educational Book . 2018;38:540-545 .

Sivaraman A, Scardino P, Eastham J . Outcomes of salvage radical prostatectomy following more than one failed local therapy . Investigative and Clinical Urology . 2018;59(3):152-157 . PMCID: PMC5934276

Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J . Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? . Investigative and Clinical Urology . 2018;59(2):83-90 . PMCID: PMC5840122

Sjoberg DD, Vickers AJ, Assel M, Dahlin A, Poon BY, Ulmert D, Lilja H . Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men . European Urology . 2018;73(6):941-948 . PMCID: PMC5960423

Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Zalcberg JR, on behalf of the Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD) . Personalizing survival predictions in advanced colorectal cancer: The ARCAD nomogram project . JNCI: Journal of the National Cancer Institute . 2018;110(6):638-648 . PMCID: PMC6005015

Skalet AH, Gombos DS, Gallie BL, Kim JW, Shields CL, Marr BP, Plon SE, Chévez-Barrios P . Screening children at risk for retinoblastoma: Consensus report from the American Association of Ophthalmic Oncologists and Pathologists . Ophthalmology . 2018;125(3):453-458 .

Skalet AH, Gombos DS, Gallie BL, Kim JW, Shields CL, Marr BP, Plon SE, Chévez-Barrios P . Reply . Ophthalmology . 2018;125(9):e64-e65 .

Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR, Murad MH . Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: An Endocrine Society* Clinical Practice Guideline . Journal of Clinical Endocrinology and Metabolism . 2018;103(8):2761-2784 .

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SH I, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba I I, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Janne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach J V . STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma . Cancer Discovery . 2018;8(7):822-835 . PMCID: PMC6030433

Slovin S, Clark W, Carles J, Krivoshik A, Park JW, Wang F, George D . Seizure rates in enzalutamide-treated men with metastatic castration-resistant prostate cancer and risk of seizure: The UPWARD study . JAMA Oncology . 2018;4(5):702-706 .

Sly JR, Miller SJ, Li Y, Bolutayo K, Jandorf L . Low-dose computed tomography lung cancer screening as a teachable moment for smoking cessation among African American smokers: A feasibility study . Journal of Psychosocial Oncology . 2018;36(6):784-792 . PMCID: PMC6433542

163 OF 288


Journal Articles

Smith CJ, Ambs S, Landgren O . Biological determinants of health disparities in multiple myeloma . Blood Cancer Journal . 2018;8(9):85- . PMCID: PMC6127236

Smith EL, Staehr M, Masakayan R, Tatake IJ, Purdon TJ, Wang X, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Riviere I, Liu C, Brentjens RJ . Development and evaluation of an optimal human single-chain variable fragment-derived BCMA-targeted CAR T cell vector . Molecular Therapy . 2018;26(6):1447-1456 . PMCID: PMC5986730

Smith M, Zakrzewski J, James S, Sadelain M . Posttransplant chimeric antigen receptor therapy . Blood . 2018;131(10):1045-1052 . PMCID: PMC5865610

Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L . Trial Watch: Toll-like receptor agonists in cancer immunotherapy . OncoImmunology . 2018;7(12):e1526250- . PMCID: PMC6279325

Smith ML, Molina BJ, Dayan E, Jablonka EM, Okwali M, Kim JN, Dayan JH . Defining the role of free flaps in partial breast reconstruction . Journal of Reconstructive Microsurgery . 2018;34(3):185-192 .

Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M . Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure . Cancer . 2018;124(12):2541-2551 .PMCID: PMC5990449

Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J, Heguy A, Ray K, Faustin A, Aminova

O, Dolgalev I, Stapleton SL, Zagzag D, Chiriboga L, Gardner SL, Wisoff JH, Golfinos JG, Capper D, Hovestadt V, Rosenblum MK, Placantonakis DG, LeBoeuf SE, Papagiannakopoulos TY, Chavez L, Ahsan S, Eberhart CG, Pfister SM, Jones DTW, Karajannis MA . Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma . Nature Communications . 2018;9:2868- . PMCID: PMC6054684

Snyman LC, Bryant EP, Wethmar E I, de Greve T, Reyneke F, Sathekge MM, Lindeque BG, Abu-Rustum NR . Use of a sentinel lymph node biopsy algorithm in a South African population of patients with cervical cancer and high prevalence of human immunodeficiency virus infection . International Journal of Gynecological Cancer . 2018;28(7):1432-1437 .

Sobhani N, Roviello G, Corona SP, Scaltriti M, Ianza A, Bortul M, Zanconati F, Generali D . The prognostic value of PI3K mutational status in breast cancer: A meta-analysis . Journal of Cellular Biochemistry . 2018;119(6):4287-4292 . PMCID: PMC5995110

Soff GA . Use of direct oral anticoagulants for treating venous thromboembolism in patients with cancer . Journal of the National Comprehensive Cancer Network . 2018;16(5 Suppl .):670-673 .

Sofocleous CT, Boas FE . Radiation segmentectomy for hepatocellular carcinoma: Ready for prime time? . Radiology . 2018;287(3):1059-1060 .

Sohal DPS, Kennedy EB, Khorana A, Copur MS, Crane CH, Garrido-Laguna I, Krishnamurthi S, Moravek C, O’Reilly EM, Philip PA, Ramanathan RK, Ruggiero JT, Shah MA, Urba S, Uronis HE, Lau MW, Laheru D . Metastatic pancreatic cancer: ASCO Clinical Practice Guideline update . Journal of Clinical Oncology . 2018;36(24):2545-2556 .

Sokol K, Tremblay D, Bhalla S, Rampal R, Mascarenhas JO . Implications of mutation profiling in myeloid malignancies - Part 2: Myeloproliferative neoplasms

and other myeloid malignancies . Oncology (Norwalk) . 2018;32(5):e45-e51 .

Solomon BJ, Besse B, Bauer TM, Felip E, Soo RA, Camidge DR, Chiari R, Bearz A, Lin CC, Gadgeel SM, Riely GJ, Tan EH, Seto T, James LP, Clancy JS, Abbattista A, Martini JF, Chen J, Peltz G, Thurm H, Ou SH I, Shaw AT . Lorlatinib in patients with ALK-positive non-small-cell lung cancer: Results from a global phase 2 study . Lancet Oncology . 2018;19(12):1654-1667 .

Solovyov A, Vabret N, Arora KS, Snyder A, Funt SA, Bajorin DF, Rosenberg JE, Bhardwaj N, Ting DT, Greenbaum BD . Global cancer transcriptome quantifies repeat element polarization between immunotherapy responsive and T cell suppressive classes . Cell Reports . 2018;23(2):512-521 .

Son T, Lambert S, Jakubowski A, Dicicco-Bloom B, Loiselle CG . Adaptation of Coping Together - a self-directed coping skills intervention for patients and caregivers in an outpatient hematopoietic stem cell transplantation setting: A study protocol . BMC Health Services Research . 2018;18:669- . PMCID: PMC6114732

Song M, Sandoval TA, Chae CS, Chopra S, Tan C, Rutkowski MR, Raundhal M, Chaurio RA, Payne KK, Konrad C, Bettigole SE, Shin HR, Crowley MJP, Cerliani JP, Kossenkov A V, Motorykin I, Zhang S, Manfredi G, Zamarin D, Holcomb K, Rodriguez PC, Rabinovich GA, Conejo-Garcia JR, Glimcher LH, Cubillos-Ruiz JR . IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity . Nature . 2018;562(7727):423-428 . PMCID: PMC6237282

Sonnenblick A, Salgado R, Brohée S, Zahavi T, Peretz T, Van Den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, De Azambuja E, Lieveke A, Piccart MJ, Bromberg JF, Sotiriou C . p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and

164 OF 288


Journal Articles

results from the BIG 2-98 phase III trial . International Journal of Oncology . 2018;52(2):424-432 .

Sonnick MA, Oro F, Yan B, Desai A, Wu AJ, Shi W, Zhang Z, Gelblum DY, Paik PK, Yorke ED, Rosenzweig KE, Chaft JE, Rimner A . Identifying the optimal radiation dose in locally advanced non-small-cell lung cancer treated with definitive radiotherapy without concurrent chemotherapy . Clinical Lung Cancer . 2018;19(1):e131-e140 .

Sonpavde G, Pond GR, Rosenberg JE, Choueiri TK, Bellmunt J, Regazzi AM, Mullane SA, Necchi A, Raggi D, Lee JL, Lee S, Simpson J, Derleth CL, Lin SW, Bajorin DF . Nomogram to assess the survival benefit of new salvage agents for metastatic urothelial carcinoma in the era of immunotherapy . Clinical Genitourinary Cancer . 2018;16(4):e961-e967 .

Sonpavde GP, Mariani L, Lo Vullo S, Raggi D, Giannatempo P, Bamias A, Crabb SJ, Bellmunt J, Yu EY, Niegisch G, Vaishampayan UN, Theodore C, Berthold DR, Srinivas S, Sridhar SS, Plimack ER, Rosenberg JE, Powles T, Galsky MD, Necchi A . Impact of the number of cycles of platinum based first line chemotherapy for advanced urothelial carcinoma . Journal of Urology . 2018;200(6):1207-1214 .

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larre S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R . Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy . World Journal of Urology . 2018;36(11):1775-1781 .

Soria JC, Baselga J, Piccart M . The legacy of Thomas Tursz: Building a leading comprehensive cancer center in Europe . Annals of Oncology . 2018;29(9):1887-1888 .

Soslow RA, Murali R . A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract . Seminars in Diagnostic Pathology . 2018;35(2):95-107 . PMCID: PMC5821534

Soto-Perez-de-Celis E, Sun CL, Tew WP, Mohile SG, Gajra A, Klepin HD, Owusu C, Gross CP, Muss HB, Lichtman SM, Chapman AE, Cohen HJ, Dale W, Kim H, Fernandes S, Katheria V, Hurria A . Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer . Cancer . 2018;124(15):3249-3256 .

Soumerai TE, Donoghue MTA, Bandlamudi C, Srinivasan P, Chang MT, Zamarin D, Cadoo KA, Grisham RN, O’Cearbhaill RE, Tew WP, Konner JA, Hensley ML, Makker V, Sabbatini P, Spriggs DR, Troso-Sandoval TA, Charen AS, Friedman C, Gorsky M, Schweber SJ, Middha S, Murali R, Chiang S, Park KJ, Soslow RA, Ladanyi M, Li BT, Mueller J, Weigelt B, Zehir A, Berger MF, Abu-Rustum NR, Aghajanian C, DeLair DF, Solit DB, Taylor BS, Hyman DM . Clinical utility of prospective molecular characterization in advanced endometrial cancer . Clinical Cancer Research . 2018;24(23):5939-5947 . PMCID: PMC6279519

Souquet B, Freed E, Berto A, Andric V, Audugé N, Reina-San-Martin B, Lacy E, Doye V . Nup133 is required for proper nuclear pore basket assembly and dynamics in embryonic stem cells . Cell Reports . 2018;23(8):2443-2454 .

Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NK V, Larson SM, Dunkel IJ . Convection-enhanced delivery for diffuse intrinsic pontine glioma: A single-centre, dose-escalation, phase 1 trial . Lancet Oncology . 2018;19(8):1040-1050 .

Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren J, Russo P, Coleman JA . Intravenous mannitol versus placebo during partial nephrectomy in patients with normal kidney function: A double-blind, clinically-integrated, randomized trial . European Urology . 2018;73(1):53-59 .

Sparano J, O’Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, Sledge GW, Miller KD . Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer: A secondary analysis of a randomized clinical trial . JAMA Oncology . 2018;4(12):1700-1706 .

Specht L, Aleman B, Eich H, Illidge TM, Kirova Y, Mikhaeel NG, Ricardi U, Yahalom J, on behalf of the International Lymphoma Radiation Oncology Group (ILROG) . Recommendations for the clinical management of the elderly patient with malignant lymphoma . Annals of Oncology . 2018;29(4):1069-1070 .

Speers AD, Ma B, Jarnagin WR, Himidan S, Simpson AL, Wildes RP . Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery . Healthcare Technology Letters . 2018;5(5):208-214 . PMCID: PMC6222177

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP . Effect of targeted therapies on prognostic factors, patterns of care, and survival in patients with renal cell carcinoma and brain metastases . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):845-853 .

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick

165 OF 288


Journal Articles

JP, Braunstein S, Sneed P, Mehta MP . Estimating survival for renal cell carcinoma patients with brain metastases: An update of the Renal Graded Prognostic Assessment tool . Neuro-Oncology . 2018;20(12):1652-1660 . PMCID: PMC6231200

Spiciarich DR, Oh ST, Foley A, Hughes SB, Mauro MJ, Abdel-Wahab O, Press RD, Viner R, Thompson SL, Chen Q, Azadi P, Bertozzi CR, Maxson JE . A novel germline variant in CSF3R reduces N-glycosylation and exerts potent oncogenic effects in leukemia . Cancer Research . 2018;78(24):6762-6770 . PMCID: PMC6295230

Spiegler E, Kim YK, Hoyos B, Narayanasamy S, Jiang H, Savio N, Curley RW Jr, Harrison EH, Hammerling U, Quadro L . β-apo-10 -carotenoids support normal embryonic development during vitamin A deficiency . Scientific Reports . 2018;8:8834- . PMCID: PMC5995931

Spigel DR, Chaft JE, Gettinger S, Chao BH, Dirix L, Schmid P, Chow LQM, Hicks RJ, Leon L, Fredrickson J, Kowanetz M, Sandler A, Funke R, Rizvi NA . FIR: Efficacy, safety, and biomarker analysis of a phase II open-label study of atezolizumab in PD-L1–selected patients with NSCLC . Journal of Thoracic Oncology . 2018;13(11):1733-1742 .

Spratt DE, McHugh DJ, Morris MJ, Morgans AK . Management of biochemically recurrent prostate cancer: Ensuring the right treatment of the right patient at the right time . American Society of Clinical Oncology Educational Book . 2018;38:355-362 .

Spriggs DR, Zivanovic O . Ovarian cancer treatment - Are we getting warmer? . New England Journal of Medicine . 2018;378(3):293-294 .

Springer SU, Chen CH, Del Carmen Rodriguez Pena M, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R,

Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ . Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy . eLife . 2018;7:e32143- . PMCID: PMC5860864

Srimathveeravalli G, Abdel-Atti D, Pérez-Medina C, Takaki H, Solomon SB, Mulder WJM, Reiner T . Reversible electroporation-mediated liposomal doxorubicin delivery to tumors can be monitored With (89)Zr-labeled reporter nanoparticles . Molecular Imaging . 2018;17 PMCID: PMC5833236

Staehler M, Motzer RJ, George DJ, Pandha HS, Donskov F, Escudier B, Pantuck AJ, Patel A, DeAnnuntis L, Bhattacharyya H, Ramaswamy K, Zanotti G, Lin X, Lechuga M, Serfass L, Paty J, Ravaud A . Adjuvant sunitinib in patients with high-risk renal cell carcinoma: Safety, therapy management, and patient-reported outcomes in the S-TRAC trial . Annals of Oncology . 2018;29(10):2098-2104 . PMCID: PMC6247664

Staffas A, Burgos da Silva M, Slingerland AE, Lazrak A, Bare CJ, Holman CD, Docampo MD, Shono Y, Durham B, Pickard AJ, Cross JR, Stein-Thoeringer C, Velardi E, Tsai JJ, Jahn L, Jay H, Lieberman S, Smith OM, Pamer EG, Peled JU, Cohen DE, Jenq RR, van den Brink MRM . Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice . Cell Host & Microbe . 2018;23(4):447-457 .e4 . PMCID: PMC5897172

Stathis A, Flinn IW, Madan S, Maddocks K, Freedman A, Weitman S, Zucca E, Munteanu MC, Lia Palomba M . Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: A dose-escalation, phase I study . Investigational New Drugs . 2018;36(5):869-876 .

Stathis A, Iasonos A, Seymour JF, Thieblemont C, Ribrag V, Zucca E, Younes A . Report of the 14th International Conference on Malignant Lymphoma (ICML) closed workshop on future design of clinical trials in lymphomas . Clinical Cancer Research . 2018;24(13):2993-2998 .

Stearns G, Donahue T, Fathollahi A, Dalbagni G, Sandhu J . Formal sacrocolpopexy reduces hypercontinence rates in female neobladder formation . Neurourology and Urodynamics . 2018;37(7):2281-2285 .

Stein EM . Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia . Future Oncology . 2018;14(1):23-40 .

Stein EM, Walter RB, Erba HP, Fathi AT, Advani AS, Lancet JE, Ravandi F, Kovacsovics T, DeAngelo DJ, Bixby D, Faderl S, Jillella AP, Ho PA, O’Meara MM, Zhao B, Biddle-Snead C, Stein AS . A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia . Blood . 2018;131(4):387-396 .PMCID: PMC5813721

Stein EM, Garcia-Manero G, Rizzieri DA, Tibes R, Berdeja JG, Savona MR, Jongen-Lavrenic M, Altman JK, Thomson B, Blakemore SJ, Daigle SR, Waters NJ, Suttle AB, Clawson A, Pollock R, Krivtsov A, Armstrong SA, DiMartino J, Hedrick E, Löwenberg B, Tallman MS . The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia . Blood . 2018;131(24):2661-2669 .

Stein EM, Bonifacio G, Latremouille-Viau D, Guerin A, Shi S, Gagnon-Sanschagrin P, Briggs O, Joseph GJ . Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations . Journal of Medical Economics . 2018;21(6):556-563 .

166 OF 288


Journal Articles

Stein EM . FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia . Lancet Oncology . 2018;19(7):849-850 .

Stein EM, Yang M, Guerin A, Gao W, Galebach P, Xiang CQ, Bhattacharyya S, Bonifacio G, Joseph GJ . Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States . Health and Quality of Life Outcomes . 2018;16:193- . PMCID: PMC6151058

Steingart RM, Chandrashekhar Y, Marwick TH . Imaging in cardio-oncology: Where are we and where should we be going? . JACC: Cardiovascular Imaging . 2018;11(8):1209-1211 .

Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M, Baneyx G, Banerjee H, Aimone P, Motzer RJ . Pazopanib exposure relationship with clinical efficacy and safety in the adjuvant treatment of advanced renal cell carcinoma . Clinical Cancer Research . 2018;24(13):3005-3013 .

Stewart CM, Kothari PD, Mouliere F, Mair R, Somnay S, Benayed R, Zehir A, Weigelt B, Dawson SJ, Arcila ME, Berger MF, Tsui DWY . The value of cell-free DNA for molecular pathology . Journal of Pathology . 2018;244(5):616-627 .

Stewart CM, Tsui DWY . Circulating cell-free DNA for non-invasive cancer management . Cancer Genetics . 2018;228-229:169-179 .

Stolnicu S, Soslow RA . Inflammatory pseudotumor presenting as a mesosalpingeal mass . International Journal of Gynecological Pathology . 2018;37(5):473-476 . PMCID: PMC5832487

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA . International Endocervical Adenocarcinoma Criteria and Classification (IECC): A new pathogenetic classification for invasive adenocarcinomas of the

endocervix . American Journal of Surgical Pathology . 2018;42(2):214-226 . PMCID: PMC5762258

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Abu-Rustum NR, Pike MC, Soslow RA . Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV . Gynecologic Oncology . 2018;150(1):56-60 .

Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA . Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas . American Journal of Surgical Pathology . 2018;42(8):989-1000 . PMCID: PMC6041133

Stopsack KH, Gonzalez-Feliciano AG, Peisch SF, Downer MK, Gage RA, Finn S, Lis RT, Graff RE, Pettersson A, Pernar CH, Loda M, Kantoff PW, Ahearn TU, Mucci LA, behalf of the Transdisciplinary Prostate Cancer Partnership (ToPCaP) . A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status . Cancer Epidemiology Biomarkers and Prevention . 2018;27(10):1231-1233 . PMCID: PMC6170677

Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA . Regular aspirin use and gene expression profiles in prostate cancer patients . Cancer Causes & Control . 2018;29(8):775-784 .

Straus DJ, Jung SH, Pitcher B, Kostakoglu L, Grecula JC, Hsi ED, Schöder H, Popplewell LL, Chang JE, Moskowitz CH, Wagner-Johnston N, Leonard JP, Friedberg JW, Kahl BS, Cheson BD, Bartlett NL . CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET . Blood . 2018;132(10):1013-1021 . PMCID: PMC6128083

Straus DJ . Limited-stage Hodgkin lymphoma: Minimizing toxicity . The Cancer Journal . 2018;24(5):223-229 .

Strauss H, Zaret B, Pieri P, Lahiri A . Studies on the velocity of blood flow . Journal of Nuclear Cardiology . 2018;25(1):12-13 .

Streich FC Jr, Lima CD . Strategies to trap enzyme-substrate complexes that mimic Michaelis intermediates during E3-mediated ubiquitin-like protein ligation . Methods in Molecular Biology . 2018;1844:169-196 . PMCID: PMC6390966

Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee A I, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM . NCCN Guidelines® Insights: Cancer-associated venous thromboembolic disease, version 2 .2018: Featured updates to the NCCN Guidelines . Journal of the National Comprehensive Cancer Network . 2018;16(11):1289-1303 .

Stremmel C, Schuchert R, Schneider V, Weinberger T, Thaler R, Messerer D, Helmer S, Geissmann F, Frampton J, Massberg S, Schulz C . Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation . Journal of Immunological Methods . 2018;457:66-72 .

Stremmel C, Schuchert R, Wagner F, Thaler R, Weinberger T, Pick R, Mass E, Ishikawa-Ankerhold HC, Margraf A, Hutter S, Vagnozzi R, Klapproth S, Frampton J, Yona S, Scheiermann C, Molkentin JD, Jeschke U, Moser M, Sperandio M, Massberg S, Geissmann F, Schulz C . Yolk sac macrophage progenitors traffic to the embryo during defined stages of development . Nature Communications . 2018;9:75- . PMCID: PMC5758709

167 OF 288


Journal Articles

Strome A, Kossatz S, Zanoni DK, Rajadhyaksha M, Patel S, Reiner T . Current practice and emerging molecular imaging technologies in oral cancer screening . Molecular Imaging . 2018;17

Strong VE . Progress in gastric cancer . Updates in Surgery . 2018;70(2):157-159 .

Subbiah V, Velcheti V, Tuch BB, Ebata K, Busaidy NL, Cabanillas ME, Wirth LJ, Stock S, Smith S, Lauriault V, Corsi-Travali S, Henry D, Burkard M, Hamor R, Bouhana K, Winski S, Wallace RD, Hartley D, Rhodes S, Reddy M, Brandhuber BJ, Andrews S, Rothenberg SM, Drilon A . Selective RET kinase inhibition for patients with RET-altered cancers . Annals of Oncology . 2018;29(8):1869-1876 . PMCID: PMC6096733

Sudarov A, Zhang XJ, Braunstein L, LoCastro E, Singh S, Taniguchi Y, Raj A, Shi SH, Moore H, Ross ME . Mature hippocampal neurons require LIS1 for synaptic integrity: Implications for cognition . Biological Psychiatry . 2018;83(6):518-529 . PMCID: PMC5809292

Sullivan RJ, Infante JR, Janku F, Lee Wong DJ, Sosman JA, Keedy V, Patel MR, Shapiro G I, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT . First-in-class ERK1/2 inhibitor ulixertinib (BVD-523) in patients with MAPK mutant advanced solid tumors: Results of a phase I dose-escalation and expansion study . Cancer Discovery . 2018;8(2):184-195 .

Sulmasy DP, Finlay I, Fitzgerald F, Foley K, Payne R, Siegler M . Physician-assisted suicide: Why neutrality by organized medicine is neither neutral nor appropriate . Journal of General Internal Medicine . 2018;33(8):1394-1399 . PMCID: PMC6082198

Sultan KT, Shi SH . Generation of diverse cortical inhibitory interneurons . Wiley Interdisciplinary Reviews: Developmental Biology . 2018;7(2):e306- . PMCID: PMC5814332

Sultan KT, Liu WA, Li ZL, Shen Z, Li Z, Zhang XJ, Dean O, Ma J, Shi SH . Progressive divisions of multipotent neural progenitors generate late-born chandelier cells in the neocortex . Nature Communications . 2018;9:4595- . PMCID: PMC6214958

Sun HB, Li Y, Liu XB, Zhang RX, Wang ZF, Lerut T, Liu CC, Fiorelli A, Chao YK, Molena D, Cerfolio RJ, Ozawa S, Chang AC, written on behalf of the AME Thoracic Surgery Collaborative Group . Early oral feeding following McKeown minimally invasive esophagectomy: An open-label, randomized, controlled, noninferiority trial . Annals of Surgery . 2018;267(3):435-442 . PMCID: PMC5937132

Sun JC, Lanier LL . Is there natural killer cell memory and can it be harnessed by vaccination? NK cell memory and immunization strategies against infectious diseases and cancer . Cold Spring Harbor Perspectives in Medicine . 2018;10(10):a029538- . PMCID: PMC6005716

Sun L, Mao JJ, Vertosick E, Seluzicki C, Yang Y . Evaluating cancer patients’ expectations and barriers toward traditional Chinese medicine utilization in China: A patient-support group–based cross-sectional survey . Integrative Cancer Therapies . 2018;17(3):885-893 .

Sun T, Du SY, Armenia J, Qu F, Fan J, Wang X, Fei T, Komura K, Liu SX, Lee GSM, Kantoff PW . Expression of IncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer . Oncogenesis . 2018;7(3):30- . PMCID: PMC5852960

Sun Y, Zhou B, Mao F, Xu J, Miao H, Zou Z, Phuc Khoa LT, Jang Y, Cai S, Witkin M, Koche R, Ge K, Dressler GR, Levine RL, Armstrong SA, Dou Y, Hess JL . HOXA9 reprograms the enhancer landscape to promote leukemogenesis . Cancer Cell . 2018;34(4):643-658 .e5 . PMCID: PMC6179449

Sun Y, Reuter VE, Magi-Galluzzi C, Sankin A, Epstein J I . Granular cell tumor of the bladder: A report of six cases . Urology . 2018;121:203 .e1-203 .e5 .

Sun Y, Argani P, Tickoo SK, Epstein J I . Acquired cystic disease-associated renal cell carcinoma (ACKD-RCC)-like cysts . American Journal of Surgical Pathology . 2018;42(10):1396-1401 .

Sung JS, Corben AD, Brooks JD, Edelweiss M, Keating DM, Lin C, Morris EA, Patel P, Robson M, Woods M, Bernstein JL, Pike MC . Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI . Breast Cancer Research and Treatment . 2018;172(2):487-496 .

Suntharalingam M, Winter K, Ilson D . Questions about a clinical trial evaluating the addition of cetuximab to definitive chemoradiation therapy with paclitaxel and cisplatin for patients with esophageal cancer: In reply . JAMA Oncology . 2018;4(6):888-889 .

Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CDM, Antonescu CR . A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes . Genes Chromosomes and Cancer . 2018;57(12):611-621 .

Suyama K, Yao J, Liang H, Benard O, Loudig OD, Amgalan D, McKimpson WM, Phillips GR, Segall J, Wang Y, Fineberg S, Norton L, Kitsis RN, Hazan RB . An Akt3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis . Cancer Research . 2018;78(1):103-114 .

Suzuki M, Kushner BH, Kramer K, Basu EM, Roberts SS, Hammond WJ, LaQuaglia MP, Wolden SL, Cheung NK V, Modak S . Treatment and outcome of adult-onset neuroblastoma . International Journal of Cancer . 2018;143(5):1249-1258 . PMCID: PMC6103828

Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite

168 OF 288


Journal Articles

H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C, for the BERENICE Study Group . Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): A phase II, open-label, multicenter, multinational cardiac safety study . Annals of Oncology . 2018;29(3):646-653 . PMCID: PMC5888999

Swift L, Jayanthan A, Ruan Y, Anderson R, Boklan J, Trippett T, Narendran A . Targeting the proteasome in refractory pediatric leukemia cells: Characterization of effective cytotoxicity of carfilzomib . Targeted Oncology . 2018;13(6):779-793 .

Syn NLX, Roudi R, Wang LZ, Wang L, Loh M, Huang Y, Ou SH I, Soong R, Drilon A, Wee I . Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: A generic protocol . Cochrane Database of Systematic Reviews . 2018;2018(4):CD013009- .

Tadros AB, Wen HY, Morrow M . Breast cancers of special histologic subtypes are biologically diverse . Annals of Surgical Oncology . 2018;25(11):3158-3164 . PMCID: PMC6128764

Tadros AB, Morrow M . ASO author reflections: Biological diversity of histologic subtypes . Annals of Surgical Oncology . 2018;25(Suppl . 3):S636-S637 . PMCID: PMC6333530

Tageja N, Korde N, Kazandjian D, Panch S, Manasanch E, Bhutani M, Kwok M, Mailankody S, Yuan C, Stetler-Stevenson M, Leitman SF, Sportes C, Landgren O . Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma . Bone Marrow Transplantation . 2018;53(11):1445-1449 .

Taggar AS, Charas T, Cohen GN, Boonyawan K, Kollmeier M, McBride S, Mathur N, Damato AL,

Zelefsky MJ . Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103 . Brachytherapy . 2018;17(2):251-258 .

Taggar AS, Pitter KL, Cohen GN, Schattner M, Gerdes H, Markowitz AJ, Ilson D, Brady P, Cuaron JJ, Goodman KA, Wu AJ . Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer . Brachytherapy . 2018;17(3):621-627 .

Takahashi H, Cornish AJ, Sud A, Law PJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Turnbull C, Houlston RS . Mendelian randomisation study of the relationship between Vitamin D and risk of glioma . Scientific Reports . 2018;8:2339- . PMCID: PMC5799201

Takahashi Y, Eguchi T, Lu S, Downey RJ, Jones DR, Travis WD, Adusumilli PS . Preponderance of high-grade histologic subtype in autologous metastases in lung adenocarcinoma . American Journal of Respiratory and Critical Care Medicine . 2018;197(6):816-818 . PMCID: PMC5855066

Takahashi Y, Eguchi T, Kameda K, Lu S, Vaghjiani RG, Tan KS, Travis WD, Jones DR, Adusumilli PS . Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance . Oncotarget . 2018;9(87):35742-35751 .

Takeda T, Tin AL, Corradi RB, Mamoor M, Benfante NE, Sjoberg DD, Scardino PT, Eastham JA, Fine SW, Touijer KA . Topography of prostate cancer recurrence after radiation therapy: A detailed mapping study of salvage radical prostatectomy specimens . European Urology . 2018;73(4):488-490 . PMCID: PMC6050029

Takpradit C, Prockop SE, Kernan NA, Scaradavou A, Curran K, Ruggiero J, Zakak N, O’Reilly RJ, Boulad F . Allogeneic matched related donor bone marrow transplantation for pediatric patients with severe aplastic anemia using “low-dose” cyclophosphamide, ATG plus fludarabine . Journal of Pediatric Hematology/Oncology . 2018;40(4):e220-e224 . PMCID: PMC5916036

Talenfeld AD, Gennarelli RL, Elkin EB, Atoria CL, Durack JC, Huang WC, Kwan SW . Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer: A population-based analysis . Annals of Internal Medicine . 2018;169(2):69-78 .

Tallman M . Prognostic significance of molecular markers and targeted regimens in the management of acute myeloid leukemia . Journal of the National Comprehensive Cancer Network . 2018;16(5 Suppl .):656-659 .

Talmi YP, Takes RP, Alon EE, Nixon IJ, Lopez F, de Bree R, Rodrigo JP, Shaha AR, Halmos GB, Rinaldo A, Ferlito A . Prognostic value of lymph node ratio in head and neck squamous cell carcinoma . Head & Neck . 2018;40(5):1082-1090 .

Tamari R, Oran B, Hilden P, Maloy M, Kongtim P, Papadopoulos EB, Rondon G, Jakubowski AA, Andersson BS, Devlin SM, Ahmed S, Popat UR, Ponce D, Chen J, Sauter C, Young JW, de Lima M, Perales MA, O’Reilly RJ, Giralt SA, Champlin RE, Castro-Malaspina H . Allogeneic stem cell transplantation for advanced myelodysplastic syndrome: Comparison of outcomes between CD34(+) selected and unmodified hematopoietic stem cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(5):1079-1087 .

Tamura K, Yu J, Hata T, Suenaga M, Shindo K, Abe T, MacGregor-Das A, Borges M, Wolfgang CL, Weiss MJ, He J, Canto M I, Petersen GM, Gallinger S, Syngal S, Brand RE, Rustgi A, Olson SH, Stoffel E, Cote ML, Zogopoulos G, Potash JB, Goes FS, McCombie RW,

169 OF 288


Journal Articles

Zandi PP, Pirooznia M, Kramer M, Parla J, Eshleman JR, Roberts NJ, Hruban RH, Klein AP, Goggins M . Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(18):4767-4772 . PMCID: PMC5939087

Tamura R, Pratt EC, Grimm J . Innovations in nuclear imaging instrumentation: Cerenkov imaging . Seminars in Nuclear Medicine . 2018;48(4):359-366 .

Tan AC, Li BT, Nahar K, Danieletto S, Fong ES, Currer T, Parasyn A, Middleton P, Wong H, Smart D, Rutovitz JJ, McCloud P, Hughes TM, Marx GM . Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer . Asia-Pacific Journal of Clinical Oncology . 2018;14(2):e161-e166 .

Tan ASL, Young-Wolff KC, Carter-Harris L, Salloum RG, Banerjee SC . Disparities in the receipt of tobacco treatment counseling within the US context of the Affordable Care Act and Meaningful Use implementation . Nicotine & Tobacco Research . 2018;20(12):1474-1480 . PMCID: PMC6454423

Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A . Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: A comparison within one prospective trial AMC034 . Leukemia and Lymphoma . 2018;59(8):1851-1860 . PMCID: PMC5962410

Tan IL, Wojcinski A, Rallapalli H, Lao Z, Sanghrajka RM, Stephen D, Volkova E, Korshunov A, Remke M, Taylor MD, Turnbull DH, Joyner AL . Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(13):3392-3397 . PMCID: PMC5879676

Tan KS, Eguchi T, Adusumilli PS . Competing risks and cancer-specific mortality: Why it matters . Oncotarget . 2018;9(7):7272-7273 . PMCID: PMC5800900

Tanderup K, Kirisits C, Damato AL . Treatment delivery verification in brachytherapy: Prospects of technology innovation . Brachytherapy . 2018;17(1):1-6 .

Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG, Ehman EC, Fowler KJ, Hussain HK, Jha RC, Karam AR, Mamidipalli A, Marks RM, Mitchell DG, Morgan TA, Ohliger MA, Shah A, Vu KN, Sirlin CB, for the LI-RADS Evidence Working Group . Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: A systematic review . Radiology . 2018;286(1):29-48 .

Tang LA, Dixon BN, Maples KT, Poppiti KM, Peterson TJ . Current and investigational agents targeting the phosphoinositide 3-kinase pathway . Pharmacotherapy . 2018;38(10):1058-1067 .

Tang X, Wang B, Rong Y . Artificial intelligence will reduce the need for clinical medical physicists . Journal of Applied Clinical Medical Physics . 2018;19(1):6-9 .

Tanioka M, Fan C, Parker JS, Hoadley KA, Hu Z, Li Y, Hyslop TM, Pitcher BN, Soloway MG, Spears PA, Henry LN, Tolaney S, Dang CT, Krop IE, Harris LN, Berry DA, Mardis ER, Winer EP, Hudis CA, Carey LA, Perou CM . Integrated analysis of RNA and DNA from the phase III trial CALGB 40601 identifies predictors of response to trastuzumab-based neoadjuvant chemotherapy in HER2-positive breast cancer . Clinical Cancer Research . 2018;24(21):5292-5304 . PMCID: PMC6214737

Tanner EJ, Filippova OT, Gardner GJ, Long Roche KC, Sonoda Y, Zivanovic O, Fischer M, Chi DS . A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer . Gynecologic Oncology . 2018;151(3):433-437 .

Tannir NM, Figlin RA, Gore ME, Michaelson MD, Motzer RJ, Porta C, Rini B I, Hoang C, Lin X, Escudier B . Long-term response to sunitinib treatment in metastatic renal cell carcinoma: A pooled analysis of clinical trials . Clinical Genitourinary Cancer . 2018;16(1):6-12 .e4 .

Tao JJ, Schram AM, Hyman DM . Basket studies: Redefining clinical trials in the era of genome-driven oncology . Annual Review of Medicine . 2018;69:319-331 .

Tao JJ, Schram AM, Harding JJ, Drilon A, Hyman DM . Learning all that we can from MyPathway . Journal of Clinical Oncology . 2018;36(23):2450-2451 .

Targeted Alpha Therapy Working Group . Targeted alpha therapy, an emerging class of cancer agents: A review . JAMA Oncology . 2018;4(12):1765-1772 .

Taunk NK, Oh JH, Shukla-Dave A, Beal K, Vachha B, Holodny A, Hatzoglou V . Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery . Neuro-Oncology . 2018;20(4):567-575 . PMCID: PMC5909646

Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB . Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant . Science Translational Medicine . 2018;10(460):eaap9489- . PMCID: PMC6468978

Tavakkoli M, Chung SS, Park CY . Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes? . Expert Opinion on Therapeutic Targets . 2018;22(5):381-383 .

170 OF 288


Journal Articles

Tavakol M, Montazeri A, Naghdabadi R, Hajipour MJ, Zanganeh S, Caracciolo G, Mahmoudi M . Disease-related metabolites affect protein-nanoparticle interactions . Nanoscale . 2018;10(15):7108-7115 .

Tavazoie MF, Pollack I, Tanqueco R, Ostendorf BN, Reis BS, Gonsalves FC, Kurth I, Andreu-Agullo C, Derbyshire ML, Posada J, Takeda S, Tafreshian KN, Rowinsky E, Szarek M, Waltzman RJ, McMillan EA, Zhao C, Mita M, Mita A, Chmielowski B, Postow MA, Ribas A, Mucida D, Tavazoie SF . LXR/ApoE activation restricts innate immune suppression in cancer . Cell . 2018;172(4):825-840 .e18 . PMCID: PMC5846344

Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani N I, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K . Combined nivolumab and ipilimumab in melanoma metastatic to the brain . New England Journal of Medicine . 2018;379(8):722-730 .

Taylor BP, Weitz JS, Brussaard CPD, Fischer MG . Quantitative infection dynamics of cafeteria roenbergensis virus . Viruses . 2018;10(9):468- . PMCID: PMC6163432

Taylor J . Calculated decisions: MASCC Risk Index for febrile neutropenia . Emergency Medicine Practice . 2018;20(Suppl . 1):3-4 .

Taylor J, Pavlick D, Yoshimi A, Marcelus C, Chung SS, Hechtman JF, Benayed R, Cocco E, Durham BH, Bitner L, Inoue D, Chung YR, Mullaney K, Watts JM, Diamond EL, Albacker LA, Mughal T I, Ebata K, Tuch BB, Ku N, Scaltriti M, Roshal M, Arcila M, Ali S, Hyman DM, Park JH, Abdel-Wahab O . Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies . Journal of Clinical Investigation . 2018;128(9):3819-3825 .PMCID: PMC6118587

Tchekmedyian V, Sherman EJ . Targeting VEGF and EGFR: A combination worth re-exploring? . Lancet Oncology . 2018;19(8):1007-1009 .

Teater M, Dominguez PM, Redmond D, Chen Z, Ennishi D, Scott DW, Cimmino L, Ghione P, Chaudhuri J, Gascoyne RD, Aifantis I, Inghirami G, Elemento O, Melnick A, Shaknovich R . AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis . Nature Communications . 2018;9:222- . PMCID: PMC5768781

Tee SS, Suster I, Truong S, Jeong S, Eskandari R, DiGialleonardo V, Alvarez JA, Aldeborgh HN, Keshari KR . Targeted AKT inhibition in prostate cancer cells and spheroids reduces aerobic glycolysis and generation of hyperpolarized [1-(13)C] lactate . Molecular Cancer Research . 2018;16(3):453-460 .

Teijeiro V, Yang D, Majumdar S, Gonzalez F, Rickert RW, Xu C, Koche R, Verma N, Lai EC, Huangfu D . DICER1 is essential for self-renewal of human embryonic stem cells . Stem Cell Reports . 2018;11(3):616-625 .PMCID: PMC6135725

Teixeira RJ, Applebaum AJ, Bhatia S, Brandão T . The impact of coping strategies of cancer caregivers on psychophysiological outcomes: An integrative review . Psychology Research and Behavior Management . 2018;11:207-215 . PMCID: PMC5973462

Teo MY, Scher H I . Lessons from the SWITCH trial: Changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC) . British Journal of Cancer . 2018;119(9):1041-1043 .

Teo MY, O’Shaughnessy MJ, McBride SM, Vargas HA, Scher H I . Drug development for noncastrate prostate cancer in a changed therapeutic landscape . Nature Reviews Clinical Oncology . 2018;15(3):168-182 .

Teo MY, Rosenberg JE . Nivolumab for the treatment of urothelial cancers . Expert Review of Anticancer Therapy . 2018;18(3):215-221 .

Teo MY, Rosenberg JE . Perioperative immunotherapy in muscle-invasive bladder cancer and upper tract

urothelial carcinoma . Urologic Clinics of North America . 2018;45(2):287-295 .

Teo MY, Seier K, Ostrovnaya I, Regazzi AM, Kania BE, Moran MM, Cipolla CK, Bluth MJ, Chaim J, Al-Ahmadie H, Snyder A, Carlo M I, Solit DB, Berger MF, Funt S, Wolchok JD, Iyer G, Bajorin DF, Callahan MK, Rosenberg JE . Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers . Journal of Clinical Oncology . 2018;36(17):1685-1694 .

Teo MY, Seier K, Ostrovnaya I, Rosenberg JE . Reply to S . Zhang et al . Journal of Clinical Oncology .2018;36(30):3057-3058 .

Teo MY, Rosenberg JE . EMA and FDA prune the checkpoint inhibitor treatment landscape . Nature Reviews Urology . 2018;15(10):596-597 .

ter Veer E, van Rijssen LB, Besselink MG, Mali RMA, Berlin JD, Boeck S, Bonnetain F, Chau I, Conroy T, Van Cutsem E, Deplanque G, Friess H, Glimelius B, Goldstein D, Herrmann R, Labianca R, Van Laethem JL, Macarulla T, van der Meer JHM, Neoptolemos JP, Okusaka T, O’Reilly EM, Pelzer U, Philip PA, van der Poel MJ, Reni M, Scheithauer W, Siveke JT, Verslype C, Busch OR, Wilmink JW, van Oijen MGH, van Laarhoven HWM . Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease . Lancet Oncology . 2018;19(3):e151-e160 .

Terrier JE, Masterson M, Mulhall JP, Nelson CJ . Decrease in intercourse satisfaction in men who recover erections after radical prostatectomy . Journal of Sexual Medicine . 2018;15(8):1133-1139 .

Terrier JE, Tal R, Nelson CJ, Mulhall JP . Penile sensory changes after plaque incision and grafting surgery for Peyronie’s disease . Journal of Sexual Medicine . 2018;15(10):1491-1497 .

171 OF 288


Journal Articles

Tessier-Cloutier B, Soslow RA, Stewart CJR, Köbel M, Lee CH . Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas . Histopathology . 2018;73(2):299-305 .

Teuliere J, Kovacevic I, Bao Z, Garriga G . The Caenorhabditis elegans gene ham-1 regulates daughter cell size asymmetry primarily in divisions that produce a small anterior daughter cell . PLoS ONE . 2018;13(4):e0195855- .

Tew WP, Sill MW, Walker JL, Secord AA, Bonebrake AJ, Schilder JM, Stuckey A, Rice L, Tewari KS, Aghajanian CA . Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG Oncology/Gynecologic Oncology Group study . Gynecologic Oncology . 2018;151(2):257-263 .

Thakur SB, Durando M, Milans S, Cho GY, Gennaro L, Sutton EJ, Giri D, Morris EA . Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3 .0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score . Journal of Magnetic Resonance Imaging . 2018;47(2):401-409 . PMCID: PMC5741548

Thampi P, Liu J, Zeng Z, MacLeod JN . Changes in the appendicular skeleton during metamorphosis in the axolotl salamander (Ambystoma mexicanum) . Journal of Anatomy . 2018;233(4):468-477 . PMCID: PMC6131964

Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos M V, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM . Beyond maximum

grade: Modernising the assessment and reporting of adverse events in haematological malignancies . The Lancet Haematology . 2018;5(11):e563-e598 . PMCID: PMC6261436

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borras FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman MLD, Bromberg JF, Bryl-Gorecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzas E I, Byrd JB, Camussi G, Carter DRF, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FAW, Coyle B, Crescitelli R, Criado MF, D’Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF Jr, De Wever O, del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TAP, Duarte F V, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcon-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gamez-Valero A, Gardiner C, Gartner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC I, Görgens A, Gorski S, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AGE, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano S I, Kaur

S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kym KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovacs ÁF, Kramer-Albers EM, Krasemann S, Krause M, Kurochkin I V, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lasser C, Laurent LC, Lavieu G, Lazaro-Ibañez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li ITS, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowrey MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SLN, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-’t Hoen ENM, Noren Hooten N, O’Driscoll L, O’Grady T, O’Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BCH, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IKH, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez M I, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KMA, Rughetti A, Russell AE, Saa P, Sahoo S, Salas-Huenuleo E, Sanchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke G V, Shetty AK, Shiba K, Siljander PRM, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sodar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BWM, van der Grein

172 OF 288


Journal Articles

SG, Van Deun J, van Herwijnen MJC, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman K V, Wahlgren J, Watson DC, Wauben MHM, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yañez-Mo M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines . Journal of Extracellular Vesicles . 2018;7(1):1535750- .

Thom B, Benedict C, Friedman DN, Kelvin JF . The intersection of financial toxicity and family building in young adult cancer survivors . Cancer . 2018;124(16):3284-3289 . PMCID: PMC6108923

Thomas A, Rosenblum M, Karimi S, DeAngelis LM, Omuro A, Kaley TJ . Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab . CNS Oncology . 2018;7(1):7-13 .PMCID: PMC6001559

Thomas NE, Edmiston SN, Orlow I, Kanetsky PA, Luo L, Gibbs DC, Parrish EA, Hao H, Busam KJ, Armstrong BK, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Conway K, on behalfoftheGEMStudyGroup . Inherited genetic variants associated with melanoma BRAF/NRAS subtypes . Journal of Investigative Dermatology . 2018;138(11):2398-2404 . PMCID: PMC6200630

Thomas R, Marks DH, Chin Y, Benezra R . Whole chromosome loss and associated breakage-fusion-bridge cycles transform mouse tetraploid cells . EMBO Journal . 2018;37(2):201-218 . PMCID: PMC5770879

Thompson JA, Motzer RJ, Molina AM, Choueiri TK, Heath E I, Redman BG, Sangha RS, Ernst DS, Pili R, Kim SK, Reyno L, Wiseman A, Trave F, Anand B, Morrison K, Doñate F, Kollmannsberger CK . Phase I trials of anti-ENPP3 antibody–drug conjugates in advanced refractory renal cell carcinomas . Clinical Cancer Research . 2018;24(18):4399-4406 .

Thong AE, Poon BY, Lee JK, Vertosick E, Sjoberg DD, Vickers AJ, Ehdaie B . Concordance between patient-reported and physician-reported sexual function after radical prostatectomy . Urologic Oncology: Seminars and Original Investigations . 2018;36(2):80e .1-80 .e6 .

Thor M, Olsson CE, Oh JH, Hedström J, Pauli N, Johansson M, Deasy JO, Finizia C . Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study . Clinical Otolaryngology . 2018;43(1):22-30 .

Thor M, Jackson A, Zelefsky MJ, Steineck G, Karlsdottir A, Høyer M, Liu M, Nasser NJ, Petersen SE, Moiseenko V, Deasy JO . Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy . Radiotherapy and Oncology . 2018;127(1):88-95 .

Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Steingrimsdottir L, Korde N, Mailankody S, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Landgren O, Torfadottir JE, Kristinsson SY . Dietary intake is associated with risk of multiple myeloma and its precursor disease . PLoS ONE . 2018;13(11):e0206047- .PMCID: PMC6211667

Thoren KL . Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease . Seminars in Hematology . 2018;55(1):41-43 .

Thorsteinsdottir S, Dickman PW, Landgren O, Blimark C, Hultcrantz M, Turesson I, Björkholm M, Kristinsson SY . Dramatically improved survival in multiple

myeloma patients in the recent decade: Results from a Swedish population-based study . Haematologica . 2018;103(9):e412-e415 . PMCID: PMC6119139

Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y . Immunohistochemistry of pulmonary biomarkers: A perspective from members of the Pulmonary Pathology Society . Archives of Pathology & Laboratory Medicine . 2018;142(3):408-419 .

Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinos E, Lorentz A, Martinez-Salamanca J I, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP . Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) . Urologic Oncology: Seminars and Original Investigations . 2018;36(2):79 .e11-79 .e17 .

Tio M, Rai R, Ezeoke OM, McQuade JL, Zimmer L, Khoo C, Park JJ, Spain L, Turajlic S, Ardolino L, Yip D, Goldinger SM, Cohen J V, Millward M, Atkinson V, Kane AY, Ascierto PA, Garbe C, Gutzmer R, Johnson DB, Rizvi HA, Joshua AM, Hellmann MD, Long G V, Menzies AM . Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection . European Journal of Cancer . 2018;104:137-144 .

Tiriac H, Belleau P, Engle DD, Plenker D, Deschenes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed

173 OF 288


Journal Articles

AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal D V, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O’Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA . Organoid profiling identifies common responders to chemotherapy in pancreatic cancer . Cancer Discovery . 2018;8(9):1112-1129 . PMCID: PMC6125219

Tischer B, Bilang M, Kraemer M, Ronga P, Lacouture ME . A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies . Supportive Care in Cancer . 2018;26(4):1169-1179 . PMCID: PMC5847041

Tollinche LE, Burrows Walters C, Radix A, Long M, Galante L, Goldstein ZG, Kapinos Y, Yeoh C . The perioperative care of the transgender patient . Anesthesia and Analgesia . 2018;127(2):359-366 . PMCID: PMC6054537

Tollinche LE, Goldstein ZG, Yeoh C . In response . Anesthesia and Analgesia . 2018;127(6):e109-e110 .

Tollinche LE, Yang G, Tan KS, Borchardt R . Interrater variability in ASA physical status assignment: An analysis in the pediatric cancer setting . Journal of Anesthesia . 2018;32(2):211-218 . PMCID: PMC5886792

Tom A, Bennett A V, Rothenstein D, Law E, Goodman KA . Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer . Quality of Life Research . 2018;27(1):97-103 .

Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, Hjorth L, Ishida Y, Kruseova J, Kuehni CE, Kurkure PA, Langer T, Nathan PC,

Skeen JE, Skinner R, Tacyildiz N, van Den Heuvel-Eibrink MM, Winther JF, Hudson MM, Oeffinger KC . Models of care for survivors of childhood cancer from across the globe: Advancing survivorship care in the next decade . Journal of Clinical Oncology . 2018;36(21):2223-2230 .

Topp MS, Stelljes M, Zugmaier G, Barnette P, Heffner LT Jr, Trippett T, Duell J, Bargou RC, Holland C, Benjamin JE, Klinger M, Litzow MR . Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia . Leukemia . 2018;32(2):562-565 . PMCID: PMC5808068

Touijer K . Reply to Pim J . van Leeuwen and Henk G . van der Poel’s letter to the editor re: Karim A . Touijer, Robert J . Karnes, Niccolo Passoni, et al . Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: A comparative analysis of different postoperative management strategies . Eur Urol 2018;73:890-6 . European Urology . 2018;74(1):e18-e19 .

Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N, Gandaglia G, Eastham JA, Scardino PT, Vickers A, Cozzarini C, Montorsi F, Briganti A . Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: A comparative analysis of different postoperative management strategies . European Urology . 2018;73(6):890-896 . PMCID: PMC6049832

Tracy S I, Habermann TM, Feldman AL, Maurer MJ, Dogan A, Perepu US, Syrbu S, Ansell SM, Thompson CA, Weiner GJ, Nowakowski GS, Allmer C, Slager SL, Witzig TE, Cerhan JR, Link BK . Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression . Haematologica . 2018;103(2):297-303 . PMCID: PMC5792274

Traina TA, Miller K, Yardley DA, Eakle J, Schwartzberg LS, O’Shaughnessy J, Gradishar W, Schmid P, Winer

E, Kelly C, Nanda R, Gucalp A, Awada A, Garcia-Estevez L, Trudeau ME, Steinberg J, Uppal H, Tudor IC, Peterson A, Cortes J . Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer . Journal of Clinical Oncology . 2018;36(9):884-890 . PMCID: PMC5858523

Traina TA, Cortes J . Reply to K .S . Shohdy et al . Journal of Clinical Oncology . 2018;36(23):2458-2459 .

Travers JL, Weis M, Merrill JA . Relationships among DNP and PhD students after implementing a doctoral student organization . Nursing Education Perspectives . 2018;39(5):271-279 . PMCID: PMC6086730

Treger S, Masciale JN . Domains of similarity and attraction in three types of relationships . Interpersona . 2018;12(2):254-266 .

Tremblay D, Sokol K, Bhalla S, Rampal R, Mascarenhas JO . Implications of mutation profiling in myeloid malignancies - Part 1: Myelodysplastic syndromes and acute myeloid leukemia . Oncology (Norwalk) . 2018;32(4):e38-e44 .

Tretiakova M, Mehta V, Kocherginsky M, Minor A, Shen SS, Sirintrapun SJ, Yao JL, Alvarado-Cabrero I, Antic T, Eggener SE, Picken MM, Paner GP . Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum . Virchows Archiv . 2018;473(1):85-93 .

Trevino KM, Litz B, Papa A, Maciejewski PK, Lichtenthal W, Healy C, Prigerson HG . Bereavement challenges and their relationship to physical and psychological adjustment to loss . Journal of Palliative Medicine . 2018;21(4):479-488 . PMCID: PMC5867503

Trichter S, Soares CG, Zaider M, DeWyngaert JK, DeWerd LA, Kleiman NJ . 15 years of (106)Ru eye plaque dosimetry at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical Center using radiochromic film in a Solid Water phantom .

174 OF 288


Journal Articles

Biomedical Physics and Engineering Express . 2018;4(4):045017- .

Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD Jr, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD . Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): A dose escalation and expansion phase 1 trial . Lancet Oncology . 2018;19(12):1641-1653 .

Trusheim MR, Cassidy WM, Bach PB . Alternative state-level financing for hepatitis C treatment - The “Netflix model” . JAMA - Journal of the American Medical Association . 2018;320(19):1977-1978 .

Tsai CJ, Zheng J, Zhang Z . Lymph node yield as quality metric for clinically NO oral cancer - In reply . JAMA Otolaryngology - Head and Neck Surgery . 2018;144(4):386-387 .

Tsai JJ, Velardi E, Shono Y, Argyropoulos K V, Holland AM, Smith OM, Yim NL, Rao UK, Kreines FM, Lieberman SR, Young LF, Lazrak A, Youssef S, Fu YY, Liu C, Lezcano C, Murphy GF, Na IK, Jenq RR, Hanash AM, Dudakov JA, van den Brink MRM . Nrf2 regulates CD4(+) T cell-induced acute graft-versus-host disease in mice . Blood . 2018;132(26):2763-2774 . PMCID: PMC6307985

Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J . Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):794-808 .

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak

AK, Pass H I, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM . Current and future management of malignant mesothelioma: A consensus report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation . Journal of Thoracic Oncology . 2018;13(11):1655-1667 .

Tsao MS, Kerr KM, Kockx M, Beasley MB, Borczuk AC, Botling J, Bubendorf L, Chirieac L, Chen G, Chou TY, Chung JH, Dacic S, Lantuejoul S, Mino-Kenudson M, Moreira AL, Nicholson AG, Noguchi M, Pelosi G, Poleri C, Russell PA, Sauter J, Thunnissen E, Wistuba I, Yu H, Wynes MW, Pintilie M, Yatabe Y, Hirsch FR . PD-L1 immunohistochemistry comparability study in real-life clinical samples: Results of Blueprint phase 2 project . Journal of Thoracic Oncology . 2018;13(9):1302-1311 .

Tseng JH, Aloisi A, Sonoda Y, Gardner GJ, Zivanovic O, Abu-Rustum NR, Leitao MM Jr . Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival . Gynecologic Oncology . 2018;150(1):44-49 .

Tseng JH, Aloisi A, Sonoda Y, Gardner GJ, Zivanovic O, Abu-Rustum NR, Leitao MM Jr . Long-term oncologic outcomes of uterine-preserving surgery in young women with stage Ib1 cervical cancer . International Journal of Gynecological Cancer . 2018;28(7):1350-1359 . PMCID: PMC6108950

Tseng JH, Cowan RA, Afonso AM, Zhou Q, Iasonos A, Ali N, Thompson E, Sonoda Y, O’Cearbhaill RE, Chi DS, Abu-Rustum NR, Long Roche K . Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer . Gynecologic Oncology . 2018;151(2):287-293 . PMCID: PMC6214778

Tseng JH, Cowan RA, Zhou Q, Iasonos A, Byrne M, Polcino T, Polen-De C, Gardner GJ, Sonoda Y, Zivanovic O, Abu-Rustum NR, Long Roche K, Chi DS . Continuous improvement in primary debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival? . Gynecologic Oncology . 2018;151(1):24-31 .

Tsimberidou AM, Levit LA, Schilsky RL, Averbuch SD, Chen D, Kirkwood JM, McShane LM, Sharon E, Mileham KF, Postow MA . Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer statement . Journal for ImmunoTherapy of Cancer . 2018;6:108- . PMCID: PMC6195705

Tun HW, Johnston PB, DeAngelis LM, Atherton PJ, Pederson LD, Koenig PA, Reeder CB, Omuro AMP, Schiff D, O’Neill B, Pulido J, Jaeckle KA, Grommes C, Witzig TE . Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma . Blood . 2018;132(21):2240-2248 . PMCID: PMC6265643

Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez J I, Nicol D, O’Brien T, Larkin J, Horswell S, Stares M, Au L, Jamal-Hanjani M, Challacombe B, Chandra A, Hazell S, Eichler-Jonsson C, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Jabbar F, Spain L, Lall S, Guarch R, Falzon M, Proctor I, Pickering L, Gore M, Watkins TBK, Ward S, Stewart A, DiNatale R, Becerra MF, Reznik E, Hsieh JJ, Richmond TA, Mayhew GF, Hill SM, McNally CD, Jones C, Rosenbaum H, Stanislaw S, Burgess DL, Alexander NR, Swanton C, PEACE, and the TRACERx Renal Consortium . Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal . Cell . 2018;173(3):581-594 .e12 .

Turashvili G, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY . Breast carcinoma with 21-gene recurrence score lower than 18: Rate of locoregional

175 OF 288


Journal Articles

recurrence in a large series with clinical follow-up . BMC Cancer . 2018;18:42- . PMCID: PMC5756373

Turashvili G, Grisham RN, Chiang S, DeLair DF, Park KJ, Soslow RA, Murali R . BRAF(V600E) mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary . Histopathology . 2018;73(3):438-443 . PMCID: PMC6105553

Turashvili G, Gonzalez-Loperena M, Brogi E, Dickler M, Norton L, Morrow M, Wen HY . The 21-gene recurrence score in male breast cancer . Annals of Surgical Oncology . 2018;25(6):1530-1535 . PMCID: PMC5930124

Turcan S, Makarov V, Taranda J, Wang Y, Fabius AWM, Wu W, Zheng Y, El-Amine N, Haddock S, Nanjangud G, LeKaye HC, Brennan C, Cross J, Huse JT, Kelleher NL, Osten P, Thompson CB, Chan TA . Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence . Nature Genetics . 2018;50:62-72 .PMCID: PMC5769471

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T, Feitosa MF, Masca NGD, Manning AK, Medina-Gomez C, Mudgal P, Ng MCY, Reiner AP, Vedantam S, Willems SM, Winkler TW, Abecasis G, Aben KK, Alam DS, Alharthi SE, Allison M, Amouyel P, Asselbergs FW, Auer PL, Balkau B, Bang LE, Barroso I, Bastarache L, Benn M, Bergmann S, Bielak LF, Blüher M, Boehnke M, Boeing H, Boerwinkle E, Böger CA, Bork-Jensen J, Bots ML, Bottinger EP, Bowden DW, Brandslund I, Breen G, Brilliant MH, Broer L, Brumat M, Burt AA, Butterworth AS, Campbell PT, Cappellani S, Carey DJ, Catamo E, Caulfield MJ, Chambers JC, Chasman D I, Chen YD I, Chowdhury R, Christensen C, Chu AY, Cocca M, Collins FS, Cook JP, Corley J, Corominas Galbany J, Cox AJ, Crosslin DS, Cuellar-Partida G, D’Eustacchio A, Danesh J, Davies G, Bakker PIW, Groot MCH, Mutsert R, Deary

IJ, Dedoussis G, Demerath EW, Heijer M, Hollander A I, Ruijter HM, Dennis JG, Denny JC, Di Angelantonio E, Drenos F, Du M, Dubé MP, Dunning AM, Easton DF, Edwards TL, Ellinghaus D, Ellinor PT, Elliott P, Evangelou E, Farmaki AE, Farooqi IS, Faul JD, Fauser S, Feng S, Ferrannini E, Ferrieres J, Florez JC, Ford I, Fornage M, Franco OH, Franke A, Franks PW, Friedrich N, Frikke-Schmidt R, Galesloot TE, Gan W, Gandin I, Gasparini P, Gibson J, Giedraitis V, Gjesing AP, Gordon-Larsen P, Gorski M, Grabe HJ, Grant SFA, Grarup N, Griffiths HL, Grove ML, Gudnason V, Gustafsson S, Haessler J, Hakonarson H, Hammerschlag AR, Hansen T, Harris KM, Harris TB, Hattersley AT, Have CT, Hayward C, He L, Heard-Costa NL, Heath AC, Heid IM, Helgeland Ø, Hernesniemi J, Hewitt AW, Holmen OL, Hovingh GK, Howson JMM, Hu Y, Huang PL, Huffman JE, Ikram MA, Ingelsson E, Jackson AU, Jansson JH, Jarvik GP, Jensen GB, Jia Y, Johansson S, Jørgensen ME, Jørgensen T, Jukema JW, Kahali B, Kahn RS, Kahönen M, Kamstrup PR, Kanoni S, Kaprio J, Karaleftheri M, Kardia SLR, Karpe F, Kathiresan S, Kee F, Kiemeney LA, Kim E, Kitajima H, Komulainen P, Kooner JS, Kooperberg C, Korhonen T, Kovacs P, Kuivaniemi H, Kutalik Z, Kuulasmaa K, Kuusisto J, Laakso M, Lakka TA, Lamparter D, Lange EM, Lange LA, Langenberg C, Larson EB, Lee NR, Lehtimaki T, Lewis CE, Li H, Li J, Li-Gao R, Lin H, Lin KH, Lin LA, Lin X, Lind L, Lindström J, Linneberg A, Liu CT, Liu DJ, Liu Y, Lo KS, Lophatananon A, Lotery AJ, Loukola A, Luan J, Lubitz SA, Lyytikainen LP, Mannistö S, Marenne G, Mazul AL, McCarthy M I, McKean-Cowdin R, Medland SE, Meidtner K, Milani L, Mistry V, Mitchell P, Mohlke KL, Moilanen L, Moitry M, Montgomery GW, Mook-Kanamori DO, Moore C, Mori TA, Morris AD, Morris AP, Müller-Nurasyid M, Munroe PB, Nalls MA, Narisu N, Nelson CP, Neville M, Nielsen SF, Nikus K, Njølstad PR, Nordestgaard BG, Nyholt DR, O’Connel JR, O’Donoghue ML, Olde Loohuis LM, Ophoff RA, Owen KR, Packard CJ, Padmanabhan S, Palmer CNA, Palmer ND, Pasterkamp G, Patel AP, Pattie A, Pedersen O, Peissig PL, Peloso GM, Pennell CE, Perola M, Perry JA, Perry JRB, Pers TH,

Person TN, Peters A, Petersen ERB, Peyser PA, Pirie A, Polasek O, Polderman TJ, Puolijoki H, Raitakari OT, Rasheed A, Rauramaa R, Reilly DF, Renström F, Rheinberger M, Ridker PM, Rioux JD, Rivas MA, Roberts DJ, Robertson NR, Robino A, Rolandsson O, Rudan I, Ruth KS, Saleheen D, Salomaa V, Samani NJ, Sapkota Y, Sattar N, Schoen RE, Schreiner PJ, Schulze MB, Scott RA, Segura-Lepe MP, Shah SH, Sheu WHH, Sim X, Slater AJ, Small KS, Smith A V, Southam L, Spector TD, Speliotes EK, Starr JM, Stefansson K, Steinthorsdottir V, Stirrups KE, Strauch K, Stringham HM, Stumvoll M, Sun L, Surendran P, Swift AJ, Tada H, Tansey KE, Tardif JC, Taylor KD, Teumer A, Thompson DJ, Thorleifsson G, Thorsteinsdottir U, Thuesen BH, Tönjes A, Tromp G, Trompet S, Tsafantakis E, Tuomilehto J, Tybjaerg-Hansen A, Tyrer JP, Uher R, Uitterlinden AG, Uusitupa M, Laan SW, Duijn CM, Leeuwen N, van Setten J, Vanhala M, Varbo A, Varga T V, Varma R, Velez Edwards DR, Vermeulen SH, Veronesi G, Vestergaard H, Vitart V, Vogt TF, Völker U, Vuckovic D, Wagenknecht LE, Walker M, Wallentin L, Wang F, Wang CA, Wang S, Wang Y, Ware EB, Wareham NJ, Warren HR, Waterworth DM, Wessel J, White HD, Willer CJ, Wilson JG, Witte DR, Wood AR, Wu Y, Yaghootkar H, Yao J, Yao P, Yerges-Armstrong LM, Young R, Zeggini E, Zhan X, Zhang W, Zhao JH, Zhao W, Zhao W, Zhou W, Zondervan KT, CHD Exome+ Consortium, EPIC-CVD Consortium, ExomeBP Consortium, Global Lipids Genetic Consortium, GoT2D Genes Consortium, EPIC InterAct Consortium, INTERVAL Study, ReproGen Consortium, T2D-Genes Consortium, The MAGIC Investigators, Understanding Society Scientific Group, Rotter J I, Pospisilik JA, Rivadeneira F, Borecki IB, Deloukas P, Frayling TM, Lettre G, North KE, Lindgren CM, Hirschhorn JN, Loos RJF . Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity . Nature Genetics . 2018;50(1):26-41 .

Turesson I, Bjorkholm M, Blimark CH, Kristinsson S, Velez R, Landgren O . Rapidly changing myeloma

176 OF 288


Journal Articles

epidemiology in the general population: Increased incidence, older patients, and longer survival . European Journal of Haematology . 2018;101(2):237-244 .

Turner SR, Buonocore D, Desmeules P, Rekhtman N, Dogan S, Lin O, Arcila ME, Jones DR, Huang J . Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients . Lung Cancer . 2018;119:85-90 . PMCID: PMC5905717

Turner SR, Huang J . Moving beyond case numbers: How should we assess technical competence? . Journal of Thoracic and Cardiovascular Surgery . 2018;156(4):1723-1724 .

Turner SR, Molena DR . The role of intraoperative fluorescence imaging during esophagectomy . Thoracic Surgery Clinics . 2018;28(4):567-571 . PMCID: PMC6166438

Tuttle RM, Zhang L, Shaha A . A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management . Expert Review of Endocrinology and Metabolism . 2018;13(2):77-85 .

Tuttle RM . Controversial issues in thyroid cancer management . Journal of Nuclear Medicine . 2018;59(8):1187-1194 . PMCID: PMC6071505

Twining CL, Lupo MA, Tuttle RM . Implementing key changes in the American Thyroid Association 2015 thyroid nodules/differentiated thyroid cancer guidelines across practice types . Endocrine Practice . 2018;24(9):833-840 .

Udeagu CCN, Shah S, Misra K, Sepkowitz KA, Braunstein SL . Where are they now? Assessing if persons returned to HIV care following loss to follow-up by public health case workers were engaged in care in follow-up years . AIDS Patient Care and STDs . 2018;32(5):181-190 .

Ueshima E, Schattner M, Mendelsohn R, Gerdes H, Monette S, Takaki H, Durack JC, Solomon SB, Srimathveeravalli G . Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency . Gastrointestinal Endoscopy . 2018;87(1):300-304 .e1 . PMCID: PMC5681441

Ugai T, Kelemen LE, Mizuno M, Ong JS, Webb PM, Chenevix-Trench G, on behalf of the Australian Ovarian Cancer Study Group, Wicklund KG, Doherty JA, Rossing MA, Thompson PJ, Wilkens LR, Carney ME, Goodman MT, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Cai H, Shu XO, Gao YT, Xiang YB, Van Den Berg D, Pike MC, Wu AH, Pearce CL, Matsuo K, on behalf of the Ovarian Cancer Association Consortium . Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium . Cancer Science . 2018;109(2):435-445 . PMCID: PMC5797830

Ulaner GA, Schuster DM . Amino acid metabolism as a target for breast cancer imaging . PET Clinics . 2018;13(3):437-444 . PMCID: PMC6092023

Ulaner GA, Lyashchenko SK, Riedl C, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O’Donoghue JA . First-in-human human epidermal growth factor receptor 2-targeted imaging using (89)Zr-Pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer . Journal of Nuclear Medicine . 2018;59(6):900-906 . PMCID: PMC6004559

Unkelbach J, Alber M, Bangert M, Bokrantz R, Chan TCY, Deasy JO, Fredriksson A, Gorissen BL, van Herk M, Liu W, Mahmoudzadeh H, Nohadani O, Siebers J V, Witte M, Xu H . Robust radiotherapy planning . Physics in Medicine and Biology . 2018;63(22):22TR02- .

Untch BR, Dos Anjos V, Garcia-Rendueles MER, Knauf JA, Krishnamoorthy GP, Saqcena M, Bhanot UK, Socci ND, Ho AL, Ghossein R, Fagin JA .

Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers . Cancer Research . 2018;78(16):4642-4657 . PMCID: PMC6095730

Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB, Dhawan P . MASTL induces colon cancer progression and chemoresistance by promoting Wnt/β-catenin signaling . Molecular Cancer . 2018;17:111- . PMCID: PMC6090950

Uson ML, Carl A, Goldgur Y, Shuman S . Crystal structure and mutational analysis of Mycobacterium smegmatis FenA highlight active site amino acids and three metal ions essential for flap endonuclease and 5’ exonuclease activities . Nucleic Acids Research . 2018;46(8):4164-4175 . PMCID: PMC5934675

Ustaine RP, Shama LK, Marghoob AA, Jaimes N . Dermoscopy in family medicine: A primer . The Journal of Family Practice . 2018;67(12):E1-E11 .

Ustun C, Morgan E, Moodie EEM, Pullarkat S, Yeung C, Broesby-Olsen S, Ohgami R, Kim Y, Sperr W, Vestergaard H, Chen D, Kluin PM, Dolan M, Mrozek K, Czuchlewski D, Horny HP, George T I, Kristensen TK, Ku NK, Yi CA, Møller MB, Marcucci G, Baughn L, Schiefer A I, Hilberink JR, Pullarkat V, Shanley R, Kohlschmidt J, Coulombe J, Salhotra A, Soma L, Cho C, Linden MA, Akin C, Gotlib J, Hoermann G, Hornick J, Nakamura R, Deeg J, Bloomfield CD, Weisdorf D, Litzow MR, Valent P, Huls G, Perales MA, Borthakur G . Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit) . Cancer Medicine . 2018;7(9):4447-4455 . PMCID: PMC6144246

Vaisey G, Long SB . An allosteric mechanism of inactivation in the calcium-dependent chloride channel BEST1 . Journal of General Physiology . 2018;150(11):1484-1497 . PMCID: PMC6219684

Vakoc CR, Kentsis A . Disabling an oncogenic transcription factor by targeting of control kinases .

177 OF 288


Journal Articles

Oncotarget . 2018;9(64):32276-32277 . PMCID: PMC6122356

Valiente M, Ahluwalia MS, Boire A, Brastianos PK, Goldberg SB, Lee EQ, Le Rhun E, Preusser M, Winkler F, Soffietti R . The evolving landscape of brain metastasis . Trends in Cancer . 2018;4(3):176-196 .

van Beek EJAH, Hernandez JM, Goldman DA, Davis JL, McLaughlin K, Ripley RT, Kim TS, Tang LH, Hechtman JF, Zheng J, Capanu M, Schultz N, Hyman DM, Ladanyi M, Berger MF, Solit DB, Janjigian YY, Strong VE . Rates of TP53 mutation are significantly elevated in African American patients with gastric cancer . Annals of Surgical Oncology . 2018;25(7):2027-2033 .

Van Blarigan EL, Ou FS, Niedzwiecki D, Zhang S, Fuchs CS, Saltz L, Mayer RJ, Venook A, Ogino S, Song M, Benson A, Hantel A, Atkins JN, Giovannucci EL, Meyerhardt JA . Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance) . Cancer Epidemiology Biomarkers and Prevention . 2018;27(10):1227-1230 . PMCID: PMC6170705

Van Blarigan EL, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Meyerhardt JA . Marine ω-3 polyunsaturated fatty acid and fish intake after colon cancer diagnosis and survival: CALGB 89803 (Alliance) . Cancer Epidemiology Biomarkers and Prevention . 2018;27(4):438-445 .

Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA . Association of survival with adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors after colon

cancer diagnosis: The CALGB 89803/Alliance Trial . JAMA Oncology . 2018;4(6):783-790 .

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW . Reporting and interpreting decision curve analysis: A guide for investigators . European Urology . 2018;74(6):796-804 . PMCID: PMC6261531

van de Wetering RAW, Sleijfer S, Feldman DR, Funt SA, Bosl GJ, de Wit R . Controversies in the management of clinical stage I seminoma: Carboplatin a decade in - Time to start backing out . Journal of Clinical Oncology . 2018;36(9):837-840 .

van den Brink M, Uhrberg M, Jahn L, DiPersio JF, Pulsipher MA . Selected biological issues affecting relapse after stem cell transplantation: Role of T-cell impairment, NK cells and intrinsic tumor resistance . Bone Marrow Transplantation . 2018;53(8):949-959 .

van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley F V, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME . ACR Appropriateness Criteria® pretreatment staging of muscle-invasive bladder cancer . Journal of the American College of Radiology . 2018;15(5 Suppl .):S150-S159 .

van der Spek N, Jansen F, Holtmaat K, Vos J, Breitbart W, van Uden-Kraan CF, Tollenaar RAEM, Cuijpers P, Coupé VM, Verdonck-de Leeuw IM . Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors . Psycho-Oncology . 2018;27(7):1772-1779 . PMCID: PMC6043397

van der Velden BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, Morris EA, Gilhuijs KGA . Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients . European Radiology . 2018;28(11):4705-4716 . PMCID: PMC6182741

van Dijk D, Sharma R, Nainys J, Yim K, Kathail P, Carr AJ, Burdziak C, Moon KR, Chaffer CL, Pattabiraman D, Bierie B, Mazutis L, Wolf G, Krishnaswamy S, Pe’er D . Recovering gene interactions from single-cell data using data diffusion . Cell . 2018;174(3):716-729 .e27 .

van Dijk L V, Thor M, Steenbakkers RJHM, Apte A, Zhai TT, Borra R, Noordzij W, Estilo C, Lee N, Langendijk JA, Deasy JO, Sijtsema NM . Parotid gland fat related magnetic resonance image biomarkers improve prediction of late radiation-induced xerostomia . Radiotherapy and Oncology . 2018;128(3):459-466 .

Vandeven N, Lewis CW, Makarov V, Riaz N, Paulson KG, Hippe D, Bestick A, Doumani R, Marx T, Takagishi S, Chan TA, Choi J, Nghiem P . Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival . Clinical Cancer Research . 2018;24(4):963-971 . PMCID: PMC5815931

Vardhana S, Hamlin PA, Yang J, Zelenetz A, Sauter CS, Matasar MJ, Ni A, Yahalom J, Moskowitz CH . Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant . Biology of Blood and Marrow Transplantation . 2018;24(10):2133-2138 .

Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher H I, Lammertsma AA, Hoekstra OS, Morris MJ . Reproducibility and repeatability of semiquantitative(18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study . Journal of Nuclear Medicine . 2018;59(10):1516-1523 . PMCID: PMC6167532

178 OF 288


Journal Articles

Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Hassanadeh C, Beitler JJ, Reddy CA, Marcrom S, Boggs DH, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Ferris RL, Heron DE . A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;100(3):595-605 .

Varughese T, Taur Y, Cohen N, Palomba ML, Seo SK, Hohl TM, Redelman-Sidi G . Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer . Clinical Infectious Diseases . 2018;67(5):687-692 .PMCID: PMC6093991

Vaughn DJ, Bellmunt J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn D I, Culine S, Sternberg CN, Mai Y, Li H, Perini RF, Bajorin DF, de Wit R . Health-related quality-of-life analysis from KEYNOTE-045: A phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer . Journal of Clinical Oncology . 2018;36(16):1579-1587 .

Veeraraghavan H, Dashevsky BZ, Onishi N, Sadinski M, Morris E, Deasy JO, Sutton EJ . Appearance constrained semi-automatic segmentation from DCE-MRI is reproducible and feasible for breast cancer radiomics: A feasibility study . Scientific Reports . 2018;8:4838- . PMCID: PMC5859113

Vegas O, Poligone B, Blackcloud P, Gilmore ES, VanBuskirk J, Ritchlin CT, Pentland AP, Walter SA, Nousari Y, Tausk F . Chronic social stress ameliorates psoriasiform dermatitis through upregulation of the Hypothalamic-Pituitary-Adrenal axis . Brain, Behavior, and Immunity . 2018;68:238-247 . PMCID: PMC5767548

Velazquez P, Williams C, Leiner I, Pamer EG, Dustin ML . Distinct behavior of myelomonocytic cells and CD8 T cells underlies the hepatic response to Listeria

monocytogenes [version 1; referees: 2 approved] . Wellcome Open Research . 2018;3:48- . PMCID: PMC5958313

Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos K V, Jae-Hung S, Young LF, Lazrak A, Smith OM, Lieberman S, Kreines F, Shono Y, Wertheimer T, Jenq RR, Hanash AM, Narayan P, Lei Z, Moore MA, Kiem HP, van den Brink MRM, Dudakov JA . Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury . Nature Medicine . 2018;24(2):239-246 . PMCID: PMC5803436

Venkataramani V, Küffer S, Cheung KCP, Jiang X, Trümper L, Wulf GG, Ströbel P . CD31 expression determines redox status and chemoresistance in human angiosarcomas . Clinical Cancer Research . 2018;24(2):460-473 .

Ventura A, Dow LE . Modeling cancer in the CRISPR era . Annual Review of Cancer Biology . 2018;2:111-131 .

Venturini M, Manganoni AM, Zanca A, Bassissi S, Pavoni L, Gonzales S, Cesinaro A, Calzavara-Pinton P . Pigmented actinic lichen planus (PALP) mimicking lentigo maligna melanoma: Usefulness of in vivo reflectance confocal microscopy in diagnosis and follow-up . JAAD Case Reports . 2018;4(6):568-572 . PMCID: PMC6038262

Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D’Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti L V, Mariani-Costantini R . Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib . Acta Neuropathologica . 2018;135(5):779-798 .

Verma N, Pan H, Doré LC, Shukla A, Li Q V, Pelham-Webb B, Teijeiro V, Gonzalez F, Krivtsov A, Chang CJ, Papapetrou EP, He C, Elemento O, Huangfu D . TET proteins safeguard bivalent promoters from de novo

methylation in human embryonic stem cells . Nature Genetics . 2018;50:83-95 . PMCID: PMC5742051

Veronesi G, Park B, Cerfolio R, Dylewski M, Toker A, Fontaine JP, Hanna WC, Morenghi E, Novellis P, Velez-Cubian FO, Amaral MH, Dieci E, Alloisio M, Toloza EM . Robotic resection of Stage III lung cancer: An international retrospective study . European Journal of Cardio-Thoracic Surgery . 2018;54(5):912-919 .

Verrill C, Perry-Keene J, Srigley JR, Zhou M, Humphrey PA, Lopez-Beltran A, Egevad L, Ulbright TM, Tickoo SK, Epstein J I, Compérat E, Berney DM, and the Members of the ISUP Testicular Tumor Panel . Intraoperative consultation and macroscopic handling: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference recommendation . American Journal of Surgical Pathology . 2018;42(6):e33-e43 .

Versluys AB, Boelens JJ . Morbidity and mortality associated with respiratory virus infections in allogeneic hematopoietic cell transplant: Too little defense or harmful immunity? . Frontiers in Microbiology . 2018;9:2795- . PMCID: PMC6258814

Verzi AE, Quan VL, Walton KE, Martini MC, Marghoob AA, Garfield EM, Kong BY, Isales MC, VandenBoom T, Zhang B, West DP, Gerami P . The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: A retrospective, case-control study . Journal of the American Academy of Dermatology . 2018;78(5):913-919 .

Veselis RA . Complexities of human memory: Relevance to anaesthetic practice . British Journal of Anaesthesia . 2018;121(1):210-218 .

Vickers A, Nordström T, Assel M, Lilja H, Grönberg H, Eklund M . Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund . Comparison between the four-kallikrein panel and Prostate Health Index for predicting prostate

179 OF 288


Journal Articles

cancer . Eur Urol 2015;68:139–46 . European Urology . 2018;74(2):e35-e36 .

Vickers A, Weber R . Re: Decision support with the personal patient profile-prostate: A multicenter randomized trial: D . L . Berry, F . Hong, T . M . Blonquist, B . Halpenny, C . P . Filson, V . A . Master, M . G . Sanda, P . Chang, G . W . Chien, R . A . Jones, T . L . Krupski, S . Wolpin, L . Wilson, J . H . Hayes, Q .-D . Trinh, M . Sokoloff and P . Somayaji: J Urol 2018; 199: 89–97 - To the editor . Journal of Urology . 2018;199(6):1632-1633 .

Vickers A, Vertosick EA, Sjoberg DD, Hamdy F, Neal D, Bjartell A, Hugosson J, Donovan JL, Villers A, Zappala S, Lilja H . Value of intact prostate specific antigen and human kallikrein 2 in the 4 kallikrein predictive model: An individual patient data meta-analysis . Journal of Urology . 2018;199(6):1470-1474 .

Vickers A, Ehdaie B . MRI-targeted biopsy for prostate-cancer diagnosis - To the editor . New England Journal of Medicine . 2018;379(6):589- .

Vickers A, Young-Afat D, Ehdaie B, Kim SYH . Rejoinder . Clinical Trials . 2018;15(1):25-26 .

Vickers AJ . Reply . Ophthalmology . 2018;125(5):e35- .

Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, Irnich D, Witt CM, Linde K, o behalf of the Acupuncture Trialists’ Collaboration . Acupuncture for chronic pain: Update of an individual patient data meta-analysis . Journal of Pain . 2018;19(5):455-474 . PMCID: PMC5927830

Vickers AJ . Pharmacogenomics of antioxidant supplementation to prevent age-related macular degeneration . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(25):E5639- .PMCID: PMC6016817

Vickers AJ, Steineck G . Prognosis, effect modification, and mediation . European Urology . 2018;74(3):243-245 .

Vickers AJ, Vertosick EA, Sjoberg DD . Value of a statistical model based on four kallikrein markers in blood, commercially available as 4Kscore, in all reasonable prostate biopsy subgroups . European Urology . 2018;74(4):535-536 .

Vickers AJ, Young-Afat DA, Ehdaie B, Kim SYH . Just-in-time consent: The ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care . Clinical Trials . 2018;15(1):3-8 . PMCID: PMC5799028

Villarreal-Martinez A, Bennassar A, Gonzalez S, Malvehy J, Puig S . Application of in vivo reflectance confocal microscopy and ex vivo fluorescence confocal microscopy in the most common subtypes of basal cell carcinoma and correlation with histopathology . British Journal of Dermatology . 2018;178(5):1215-1217 .

Viny AD, Levine RL . Cohesin mutations in myeloid malignancies made simple . Current opinion in Hematology . 2018;25(2):61-66 .

Virgen CA, Belum VR, Kamboj M, Goldfarb SB, Blinder VS, Gucalp A, Lacouture ME . The microbial flora of taxane therapy–associated nail disease in cancer patients . Journal of the American Academy of Dermatology . 2018;78(3):607-609 . PMCID: PMC5821143

Vishnevetsky J, Walters CB, Tan KS . Interrater reliability of the Patient Education Materials Assessment Tool (PEMAT) . Patient Education and Counseling . 2018;101(3):490-496 . PMCID: PMC5839932

Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM . Fallopian tube lesions in women at high risk for ovarian cancer: A multicenter study . Cancer Prevention Research . 2018;11(11):697-705 .

Vitiello GA, Medina BD, Zeng S, Bowler TG, Zhang JQ, Loo JK, Param NJ, Liu M, Moral AJ, Zhao JN, Rossi F, Antonescu CR, Balachandran VP, Cross JR, DeMatteo RP . Mitochondrial inhibition augments the efficacy of imatinib by resetting the metabolic phenotype of gastrointestinal stromal tumor . Clinical Cancer Research . 2018;24(4):972-984 . PMCID: PMC5815929

Vittoria MA, Shenk EM, O’Rourke KP, Bolgioni AF, Lim S, Kacprzak V, Quinton RJ, Ganem NJ . A genome-wide microRNA screen identifies regulators of tetraploid cell proliferation . Molecular Biology of the Cell . 2018;29(14):1682-1692 .

Vivier D, Sharma SK, Zeglis BM . Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging . Journal of Labelled Compounds and Radiopharmaceuticals . 2018;61(9):672-692 . PMCID: PMC6432633

Vogt MS, Volpel SL, Albers S V, Essen LO, Banerjee A . Crystal structure of an Lrs14-like archaeal biofilm regulator from Sulfolobus acidocaldarius . Acta Crystallographica Section D: Structural Biology . 2018;74(11):1105-1114 .

Voineskos SH, Nelson JA, Klassen AF, Pusic AL . Measuring patient-reported outcomes: Key metrics in reconstructive surgery . Annual Review of Medicine . 2018;69:467-479 .

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry S V, Meyer C, Morris ZS, O’Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL . Soft tissue sarcoma, version 2 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(5):536-563 .

180 OF 288


Journal Articles

von Morgen P, Maciejowski J . The ins and outs of telomere crisis in cancer . Genome Medicine . 2018;10:89- .PMCID: PMC6258172

von Reibnitz D, Shaikh F, Wu AJ, Treharne GC, Dick-Godfrey R, Foster A, Woo KM, Shi W, Zhang Z, Din SU, Gelblum DY, Yorke ED, Rosenzweig KE, Rimner A . Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC) . Acta Oncologica . 2018;57(11):1567-1573 .

von Reibnitz D, Chaft JE, Wu AJ, Samstein R, Hellmann MD, Plodkowski AJ, Zhang Z, Shi W, Dick-Godfrey R, Panchoo KH, Barker CA, Rimner A . Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition . Advances in Radiation Oncology . 2018;3(3):391-398 . PMCID: PMC6128092

von Rundstedt FC, Aghazadeh MA, Scovell J, Slawin J, Armstrong J, Silay S, Goh AC . Validation of a simulation-training model for robotic intracorporeal bowel anastomosis using a step-by-step technique . Urology . 2018;120:125-130 .

Vorkas CK, Wipperman MF, Li K, Bean J, Bhattarai SK, Adamow M, Wong P, Aubé J, Juste MAJ, Bucci V, Fitzgerald DW, Glickman MS . Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection . JCI Insight . 2018;3(19):e121899- . PMCID: PMC6237486

Voss MH, Reising A, Cheng Y, Patel P, Marker M, Kuo F, Chan TA, Choueiri TK, Hsieh JJ, Hakimi AA, Motzer RJ . Genomically annotated risk model for advanced renal-cell carcinoma: A retrospective cohort study . Lancet Oncology . 2018;19(12):1688-1698 .

Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, Mann RM . The frequency of missed breast cancers in women participating in a high-risk MRI screening program . Breast Cancer

Research and Treatment . 2018;169(2):323-331 . PMCID: PMC5945731

Vu LP, Kharas MG . Targeting the residual leukemia cells after chemotherapy . Cancer Cell . 2018;34(3):353-355 .

Wach MM, van Beek E, Ayabe R, Ruff S, Brown Z, Goldman DA, Zambirinis CP, Gholami S, Pulitzer M, Hernandez J, Coit D . Metastatic squamous cell carcinoma of known and unknown primary origin treated with axillary or inguinal lymphadenectomy . American Journal of Surgery . 2018;216(5):963-968 .

Wages NA, Chiuzan C, Panageas KS . Design considerations for early-phase clinical trials of immune-oncology agents . Journal for ImmunoTherapy of Cancer . 2018;6:81- . PMCID: PMC6103998

Wagner J, Marquart J, Ruby J, Lammers A, Mailankody S, Kaestner V, Prasad V . Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: Retrospective observational study . BMJ: British Medical Journal (International Edition) . 2018;360:k668- . PMCID: PMC5838851

Wala SJ, Fallon EM, Forlenza CJ, Shukla N, LaQuaglia MP . Unicentric Castleman disease in the mediastinum . Journal of Pediatric Surgery Case Reports . 2018;34:51-53 .

Waller RG, Darlington TM, Wei X, Madsen MJ, Thomas A, Curtin K, Coon H, Rajamanickam V, Musinsky J, Jayabalan D, Atanackovic D, Rajkumar S V, Kumar S, Slager S, Middha M, Galia P, Demangel D, Salama M, Joseph V, McKay J, Offit K, Klein RJ, Lipkin SM, Dumontet C, Vachon CM, Camp NJ . Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk . PLoS Genetics . 2018;14(2):e1007111- . PMCID: PMC5794067

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Jarvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O’Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivela TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK . Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide . JNCI: Journal of the National Cancer Institute . 2018;110(12):1328-1341 .PMCID: PMC6292796

Walsh MF, Ritter D I, Kesserwan C, Sonkin D, Chakravarty D, Chao E, Ghosh R, Kemel Y, Wu G, Lee K, Kulkarni S, Hedges D, Mandelker D, Ceyhan-Birsoy O, Luo M, Drazer M, Zhang L, Offit K, Plon SE . Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes . Human Mutation . 2018;39(11):1542-1552 . PMCID: PMC6310222

Wang AWT, Bouchard LC, Gudenkauf LM, Jutagir DR, Fisher HM, Jacobs JM, Blomberg BB, Lechner SC, Carver CS, Antoni MH . Differential psychological effects of cognitive-behavioral stress management among breast cancer patients with high and low initial cancer-specific distress . Journal of Psychosomatic Research . 2018;113:52-57 . PMCID: PMC6130907

Wang F, Li H, Markovsky E, Glass R, de Stanchina E, Powell SN, Schwartz GK, Haimovitz-Friedman

181 OF 288


Journal Articles

A . Pazopanib radio-sensitization of human sarcoma tumors . Oncotarget . 2018;9(10):9311-9324 . PMCID: PMC5823639

Wang H, Deng J, Tang YW . Profile of the Alere i Influenza A & B assay: A pioneering molecular point-of-care test . Expert Review of Molecular Diagnostics . 2018;18(5):403-409 .

Wang J, Cho NL, Zauber AG, Hsu M, Dawson D, Srivastava A, Mitchell-Richards KA, Markowitz SD, Bertagnolli MM . Chemopreventive efficacy of the cyclooxygenase-2 (Cox-2) inhibitor, celecoxib, is predicted by adenoma expression of Cox-2 and 15-PGDH . Cancer Epidemiology Biomarkers and Prevention . 2018;27(7):728-736 .

Wang J, Yao Z, Jonsson P, Allen AN, Qin ACR, Uddin S, Dunkel IJ, Petriccione M, Manova K, Haque S, Rosenblum MK, Pisapia DJ, Rosen N, Taylor BS, Pratilas CA . A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF(V600E)-mutant brain tumor . Cancer Discovery . 2018;8(9):1130-1141 . PMCID: PMC6125191

Wang J, Sheridan R, Sumer SO, Schultz N, Xu D, Gao J . G2S: A web-service for annotating genomic variants on 3D protein structures . Bioinformatics . 2018;34(11):1949-1950 . PMCID: PMC5972642

Wang L, Basturk O, Wang J, Benayed R, Middha S, Zehir A, Linkov I, Rao M, Aryeequaye R, Cao L, Chmielecki J, Ross J, Stephens PJ, Adsay V, Askan G, Balci S, Klimstra DS . A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms . Modern Pathology . 2018;31(1):132-140 .

Wang L, Hong BY, Kennedy SA, Chang Y, Hong CJ, Craigie S, Kwon HY, Romerosa B, Couban RJ, Reid S, Khan JS, McGillion M, Blinder V, Busse JW . Predictors of unemployment after breast cancer surgery: A systematic review and meta-analysis of observational studies . Journal of Clinical Oncology . 2018;36(18):1868-1879 .

Wang L, Guillen VS, Sharma N, Flessa K, Min J, Carlson KE, Toy W, Braqi S, Katzenellenbogen BS, Katzenellenbogen JA, Chandarlapaty S, Sharma A . New class of selective estrogen receptor degraders (SERDs): Expanding the toolbox of PROTAC degrons . ACS Medicinal Chemistry Letters . 2018;9(8):803-808 .PMCID: PMC6088359

Wang L, Zhang Y, Chen YB, Skala SL, Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, Cieslik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin ET, Epstein J I, Zhou M, Sangoi AR, Trpkov K, Osunkoya AO, Giannico GA, McKenney JK, Argani P, Tickoo SK, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R . VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney . American Journal of Surgical Pathology . 2018;42(12):1571-1584 .

Wang LY, Ganly I . Post-treatment surveillance of thyroid cancer . European Journal of Surgical Oncology . 2018;44(3):357-366 .

Wang M, Liang L, Lei X, Multani A, Meric-Bernstam F, Tripathy D, Wu Y, Chen H, Zhang H . Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers . Annals of Diagnostic Pathology . 2018;35:69-76 .

Wang Q, Armenia J, Zhang C, Penson A V, Reznik Ed, Zhang L, Minet T, Ochoa A, Gross BE, Iacobuzio-Donahue CA, Betel D, Taylor BS, Gao J, Schultz N . Unifying cancer and normal RNA sequencing data from different sources . Scientific Data . 2018;5:180061- . PMCID: PMC5903355

Wang S, Liechty B, Patel S, Weber JS, Hollmann TJ, Snuderl M, Karajannis MA . Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors . Journal of Neuro-Oncology . 2018;138(1):183-190 . PMCID: PMC5930071

Wang SS, Carrington M, Berndt S I, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Doo NW, Giles GG, Southey MC, Milne RL, Offit K, Musinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF . HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes . Cancer Research . 2018;78(14):4086-4096 . PMCID: PMC6065509

Wang T, Stadler ZK, Zhang L, Weiser MR, Basturk O, Hechtman JF, Vakiani E, Saltz LB, Klimstra DS, Shia J . Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations . Familial Cancer . 2018;17(2):225-228 .PMCID: PMC5908711

Wang W, Liu W, Fidler T, Wang Y, Tang Y, Woods B, Welch C, Cai B, Silvestre-Roig C, Ai D, Yang YG, Hidalgo A, Soehnlein O, Tabas I, Levine RL, Tall AR, Wang N . Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2(V617F) mice . Circulation Research . 2018;123(11):e35-e47 . PMCID: PMC6309796

Wang Z, Wang D, Li C, Xu Y, Li H, Bao Z . Deep reinforcement learning of cell movement in the early stage of C .elegans embryogenesis . Bioinformatics . 2018;34(18):3169-3177 . PMCID: PMC6137980

182 OF 288


Journal Articles

Ward DS, Williams MR, Berkenbosch JW, Bhatt M, Carlson D, Chappell P, Clark RM, Constant I, Conway A, Cravero J, Dahan A, Dexter F, Dionne R, Dworkin RH, Gan TJ, Gozal D, Green S, Irwin MG, Karan S, Kochman M, Lerman J, Lightdale JR, Litman RS, Mason KP, Miner J, O’Connor RE, Pandharipande P, Riker RR, Roback MG, Sessler D I, Sexton A, Tobin JR, Turk DC, Twersky RS, Urman RD, Weiss M, Wunsch H, Zhao-Wong A . Evaluating patient-centered outcomes in clinical trials of procedural sedation, part 2 safety: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research recommendations . Anesthesia and Analgesia . 2018;127(5):1146-1154 .

Ward J, Noy A, Ulaner G, Riedl C . Adalimumab-induced Epstein-Barr virus-related lymphoproliferative disorder on FDG PET/CT . Clinical Nuclear Medicine . 2018;43(5):344-345 .

Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Marcrom S, Boggs DH, Hassanzadeh C, Reddy CA, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, on behalf of the Multi-Institution Reirradiation (MIRI) Collaborative . Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: A multi-institution cohort study by the MIRI collaborative . International Journal of Radiation Oncology, Biology, Physics . 2018;100(3):586-594 .

Warner AB, Postow MA . The brim of uncertainty in adjuvant treatment of melanoma . Lancet Oncology . 2018;19(4):436-437 .

Warner AB, Postow MA . Combination controversies: Checkpoint inhibition alone or in combination for the treatment of melanoma? . Oncology (Norwalk) . 2018;32(5):228-234 .

Warner AB, Postow MA . Bigger is not always better: Tumor size and prognosis in advanced melanoma . Clinical Cancer Research . 2018;24(20):4915-4917 .

Warren S, Kheterpal M, Myskowski PL, Moskowitz A, Horwitz SM, Pulitzer MP . Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study . Journal of the American Academy of Dermatology . 2018;78(3):530-539 . PMCID: PMC5815943

Waters EA, Biddle C, Kaphingst KA, Schofield E, Kiviniemi MT, Orom H, Li Y, Hay JL . Examining the interrelations among objective and subjective health literacy and numeracy and their associations with health knowledge . Journal of General Internal Medicine . 2018;33(11):1945-1953 . PMCID: PMC6206359

Watkins AJ, Pearce G, Unak P, Guldu OK, Yasakci V, Akin O, Aras O, Wong J, Ma X . Tissue morphology and gene expression characterisation of transplantable adenocarcinoma bearing mice exposed to fluorodeoxyglucose-conjugated magnetic nanoparticles . Journal of Biomedical Nanotechnology . 2018;14(11):1979-1991 .

Wax DB, McCormick PJ, Joseph TT, Levin MA . An automated critical event screening and notification system to facilitate preanesthesia record review . Anesthesia and Analgesia . 2018;126(2):606-610 .

Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, Luna A, Sander C, Cherniack AD, Mina M, Ciriello G, Schultz N, The Cancer Genome Atlas Research Network, Sanchez Y, Greene CS . Machine learning detects pan-cancer Ras pathway activation in The Cancer Genome Atlas . Cell Reports . 2018;23(1):172-180 .e3 . PMCID: PMC5918694

Weant MP, Mejías-De Jesus C, Yerram P . Immunotherapy in gliomas . Seminars in Oncology Nursing . 2018;34(5):501-512 .

Weber W . 2017 SNMMI highlights lecture: Oncology . Journal of Nuclear Medicine . 2018;59(1):7N-13N .

Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blattler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M . Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy . Breast Cancer Research and Treatment . 2018;172(3):523-537 . PMCID: PMC6245050

Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, Verrill C, Berney DM, Dennis N, Merson S, Hawkins S, Howat W, Lu YJ, Lambert A, Kay J, Kremeyer B, Karaszi K, Luxton H, Camacho N, Marsden L, Edwards S, Matthews L, Bo V, Leongamornlert D, McLaren S, Ng A, Yu Y, Zhang H, Dadaev T, Thomas S, Easton DF, Ahmed M, Bancroft E, Fisher C, Livni N, Nicol D, Tavaré S, Gill P, Greenman C, Khoo V, Van As N, Kumar P, Ogden C, Cahill D, Thompson A, Mayer E, Rowe E, Dudderidge T, Gnanapragasam V, Shah NC, Raine K, Jones D, Menzies A, Stebbings L, Teague J, Hazell S, Corbishley C, CAMCAP Study Group, de Bono J, Attard G, Isaacs W, Visakorpi T, Fraser M, Boutros PC, Bristow RG, Workman P, Sander C, TCGA Consortium, Hamdy FC, Futreal A, McDermott U, Al-Lazikani B, Lynch AG, Bova GS, Foster CS, Brewer DS, Neal DE, Cooper CS, Eeles RA . Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets . Nature Genetics . 2018;50(5):682-692 .

183 OF 288


Journal Articles

Wee CW, Kang HC, Wu HG, Chie EK, Choi N, Park JM, Kim J I, Huang CM, Wang JY, Ng SY, Goodman KA . Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: A meta-analysis and pooled-analysis of acute toxicity . Japanese Journal of Clinical Oncology . 2018;48(5):458-466 .

Wei IH, Garcia-Aguilar J . Non-operative management of rectal cancer: Understanding tumor biology . Minerva Chirurgica . 2018;73(6):601-618 . PMCID: PMC6252165

Wei X, Calvo-Vidal MN, Chen S, Wu G, Revuelta M V, Sun J, Zhang J, Walsh MF, Nichols KE, Joseph V, Snyder C, Vachon CM, McKay JD, Wang SP, Jayabalan DS, Jacobs LM, Becirovic D, Waller RG, Artomov M, Viale A, Patel J, Phillip J, Chen-Kiang S, Curtin K, Salama M, Atanackovic D, Niesvizky R, Landgren O, Slager SL, Godley LA, Churpek J, Garber JE, Anderson KC, Daly MJ, Roeder RG, Dumontet C, Lynch HT, Mullighan CG, Camp NJ, Offit K, Klein RJ, Yu H, Cerchietti L, Lipkin SM . Germline lysine-specific demethylase 1 (LSD1/KDM1A) mutations confer susceptibility to multiple myeloma . Cancer Research . 2018;78(10):2747-2759 . PMCID: PMC5955848

Weick EM, Puno MR, Januszyk K, Zinder JC, DiMattia MA, Lima CD . Helicase-dependent RNA decay illuminated by a cryo-EM structure of a human nuclear RNA exosome-MTR4 complex . Cell . 2018;173(7):1663-1677 .e21 .

Weidman EK, Plodkowski AJ, Halpenny DF, Hayes SA, Perez-Johnston R, Zheng J, Moskowitz C, Ginsberg MS . Dual-energy CT angiography for detection of pulmonary emboli: Incremental benefit of iodine maps . Radiology . 2018;289(2):546-553 . PMCID: PMC6209063

Weigelt B, Bi R, Kumar R, Blecua P, Mandelker DL, Geyer FC, Pareja F, James PA, for the kConFab Investigators, Couch FJ, Eccles DM, Blows F, Pharoah

P, Li A, Selenica P, Lim RS, Jayakumaran G, Waddell N, Shen R, Norton L, Wen HY, Powell SN, Riaz N, Robson ME, Reis-Filho JS, Chenevix-Trench G . The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers . JNCI: Journal of the National Cancer Institute . 2018;110(9):1030-1034 . PMCID: PMC6136925

Weil BR, Madenci AL, Liu Q, Howell RM, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Smith SA, Tonorezos ES, Friedman DN, Constine LS, Tinkle CL, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB . Late infection-related mortality in asplenic survivors of childhood cancer: A report from the Childhood Cancer Survivor Study . Journal of Clinical Oncology . 2018;36(16):1571-1578 . PMCID: PMC5978467

Weinberg DS, Pickhardt PJ, Bruining DH, Edwards K, Fletcher JG, Gollub MJ, Keenan EM, Kupfer SS, Li T, Lubner SJ, Markowitz AJ, Ross EA . Computed tomography colonography vs colonoscopy for colorectal cancer surveillance after surgery . Gastroenterology . 2018;154(4):927-934 .e4 . PMCID: PMC5847443

Weiner A, D’Andrea GM . Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer . Breast Journal . 2018;24(4):642-643 .

Weinreb I, Bishop JA, Chiosea S I, Seethala RR, Perez-Ordonez B, Zhang L, Sung YS, Chen CL, Assaad A, Oliai BR, Antonescu CR . Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland . American Journal of Surgical Pathology . 2018;42(4):442-452 . PMCID: PMC5844775

Weiser MR . AJCC 8th edition: Colorectal cancer . Annals of Surgical Oncology . 2018;25(6):1454-1455 .

Weiser MR . Expert commentary on locally recurrent rectal cancer . Diseases of the Colon and Rectum . 2018;61(6):654-655 .

Weiser MR, Gonen M, Usiak S, Pottinger T, Samedy P, Patel D, Seo S, Smith JJ, Guillem JG, Temple L, Nash GM, Paty PB, Baldwin-Medsker A, Cheavers CE, Eagan J, Garcia-Aguilar J, on behalf of the Memorial Sloan Kettering Multidisciplinary Surgical-Site Infection Reduction Team . Effectiveness of a multidisciplinary patient care bundle for reducing surgical-site infections . British Journal of Surgery . 2018;105(12):1680-1687 . PMCID: PMC6190910

Wellberg EA, Kabos P, Gillen AE, Jacobsen BM, Brechbuhl HM, Johnson SJ, Rudolph MC, Edgerton SM, Thor AD, Anderson SM, Elias A, Zhou XK, Iyengar NM, Morrow M, Falcone DJ, El-Hely O, Dannenberg AJ, Sartorius CA, MacLean PS . FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation . JCI Insight . 2018;3(14):e120594- . PMCID: PMC6124402

Wells EM, Ullrich NJ, Seidel K, Leisenring W, Sklar CA, Armstrong GT, Diller L, King A, Krull KR, Neglia JP, Stovall M, Whelan K, Oeffinger KC, Robison LL, Packer RJ . Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: A Childhood Cancer Survivor Study report . Neuro-Oncology . 2018;20(1):132-142 . PMCID: PMC5761581

Wen HY, Brogi E . Lobular carcinoma in situ . Surgical Pathology Clinics . 2018;11(1):123-145 . PMCID: PMC5841603

Wendlandt B, Ceppe A, Choudhury S, Nelson JE, Cox CE, Hanson LC, Danis M, Tulsky JA, Carson SS . Risk factors for post-traumatic stress disorder symptoms in surrogate decision-makers of patients with chronic critical illness . Annals of the American Thoracic Society . 2018;15(12):1451-1458 . PMCID: PMC6322020

Weng C, Goldstein A, Yuan C, Zhou Z . The ranking of scientists . Journal of Biomedical Informatics . 2018;79:145-146 .

Wengert GJ, Helbich TH, Kapetas P, Baltzer PAT, Pinker K . Density and tailored breast cancer

184 OF 288


Journal Articles

screening: Practice and prediction - An overview . Acta Radiologica Open . 2018;7(9) PMCID: PMC6144518

Wertheimer T, Velardi E, Tsai J, Cooper K, Xiao S, Kloss CC, Ottmuller KJ, Mokhtari Z, Brede C, deRoos P, Kinsella S, Palikuqi B, Ginsberg M, Young LF, Kreines F, Lieberman SR, Lazrak A, Guo P, Malard F, Smith OM, Shono Y, Jenq RR, Hanash AM, Nolan DJ, Butler JM, Beilhack A, Manley NR, Rafii S, Dudakov JA, van den Brink MRM . Production of BMP4 by endothelial cells is crucial for endogenous thymic regeneration . Science Immunology . 2018;3(19):eaal2736- . PMCID: PMC5795617

Westhoff CL, Pike MC . Hormonal contraception and breast cancer . American Journal of Obstetrics and Gynecology . 2018;219(2):169-171, 169 .e1 .

Westhoff CL, Pike MC . Hormonal contraception and breast cancer . Contraception . 2018;98(3):171-173 .

Wexler LH . When treatment does not work: Failure to understand failure . Lancet Oncology . 2018;19(8):1004-1006 .

Wheelden M, Cream L, Sivik J, Robson M . A novel adverse event associated with olaparib therapy in a patient with metastatic breast cancer . Case Reports in Oncological Medicine . 2018;2018:9529821- . PMCID: PMC6040243

White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes JH 4th, Hung S I, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ . SJS/TEN 2017: Building multidisciplinary networks to drive science and translation . Journal of Allergy and Clinical

Immunology: In Practice . 2018;6(1):38-69 . PMCID: PMC5857362

Wibmer AG, Vargas HA, Hricak H . Prostate cancer in 2017: Advances in imaging . Nature Reviews Urology . 2018;15(2):81-82 .

Wickert NM, Wong Riff KWY, Mansour M, Forrest CR, Goodacre TEE, Pusic AL, Klassen AF . Content validity of patient-reported outcome instruments used with pediatric patients with facial differences: A systematic review . Cleft Palate-Craniofacial Journal . 2018;55(7):989-998 .

Widger A, Mahadevaiah SK, Lange J, Elinati E, Zohren J, Hirota T, Pacheco S, Maldonado-Linares A, Stanzione M, Ojarikre O, Maciulyte V, de Rooij DG, Toth A, Roig I, Keeney S, Turner JMA . ATR is a multifunctional regulator of male mouse meiosis . Nature Communications . 2018;9:2621- . PMCID: PMC6033951

Wiener L, Rosenberg AR, Lichtenthal WG, Tager J, Weaver MS . Personalized and yet standardized: An informed approach to the integration of bereavement care in pediatric oncology settings . Palliative and Supportive Care . 2018;16(6):706-711 . PMCID: PMC6070438

Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D’Angelica M I, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR . Preoperative risk score to predict occult metastatic or locally advanced disease in patients with resectable perihilar cholangiocarcinoma on Imaging . Journal of the American College of Surgeons . 2018;227(2):238-246 .e2 .

Wildes TM, Maggiore RJ, Tew WP, Smith D, Sun CL, Cohen H, Mohile SG, Gajra A, Klepin HD, Owusu C, Gross CP, Muss H, Chapman A, Lichtman SM, Katheria V, Hurria A, On behalf of the Cancer and Aging Research Group . Factors associated with falls in older adults with cancer: A validated model from the Cancer and Aging Research Group . Supportive

Care in Cancer . 2018;26(10):3563-3570 . PMCID: PMC6117216

Wilkins EG, Hamill JB, Kim HM, Kim JY, Greco RJ, Qi J, Pusic AL . Complications in postmastectomy breast reconstruction: One-year outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) Study . Annals of Surgery . 2018;267(1):164-170 . PMCID: PMC5904787

William BM, Wang T, Haagenson MD, Fleischhauer K, Verneris M, Hsu KC, de Lima MJ, Fernandez-Viña M, Spellman SR, Lee SJ, Hill BT . Impact of HLA alleles on outcomes of allogeneic transplantation for B cell non-Hodgkin lymphomas: A Center for International Blood and Marrow Transplant Research analysis . Biology of Blood and Marrow Transplantation . 2018;24(4):827-831 . PMCID: PMC5902644

Williams RM, Shah J, Tian HS, Chen X, Geissmann F, Jaimes EA, Heller DA . Selective nanoparticle targeting of the renal tubules . Hypertension . 2018;71(1):87-94 . PMCID: PMC5730475

Williams RM, Lee C, Galassi T V, Harvey JD, Leicher R, Sirenko M, Dorso MA, Shah J, Olvera N, Dao F, Levine DA, Heller DA . Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant . Science Advances . 2018;4(4):eaaq1090- . PMCID: PMC5906074

Williams RM, Lee C, Heller DA . A fluorescent carbon nanotube sensor detects the metastatic prostate cancer biomarker uPA . ACS Sensors . 2018;3(9):1838-1845 .

Williamson SR, Rao P, Hes O, Epstein J I, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez J I, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K . Challenges in pathologic staging of renal cell carcinoma: A study of interobserver variability among urologic

185 OF 288


Journal Articles

pathologists . American Journal of Surgical Pathology . 2018;42(9):1253-1261 .

Willmann J, Rimner A . The expanding role of radiation therapy for thymic malignancies . Journal of Thoracic Disease . 2018;10(Suppl . 21):S2555-S2564 . PMCID: PMC6123186

Winer AG, Zabor EC, Vacchio MJ, Hakimi AA, Russo P, Coleman JA, Jaimes EA . The effect of patient and surgical characteristics on renal function after partial nephrectomy . Clinical Genitourinary Cancer . 2018;16(3):191-196 .

Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žak P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A, on behalf of the V212 Protocol 001 Trial Team . Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: An international, multicentre, randomised, double-blind, placebo-controlled trial . Lancet . 2018;391(10135):2116-2127 .

Wipperman MF, Heaton BE, Nautiyal A, Adefisayo O, Evans H, Gupta R, van Ditmarsch D, Soni R, Hendrickson R, Johnson J, Krogan N, Glickman MS . Mycobacterial mutagenesis and drug resistance are controlled by phosphorylation- and cardiolipin-mediated inhibition of the RecA coprotease . Molecular Cell . 2018;72(1):152-161 .e7 .

Woitek R, Pfeiler G, Farr A, Kapetas P, Furtner J, Bernathova M, Schöpf V, Clauser P, Marino MA, Pinker K, Baltzer PA, Helbich TH . MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies . European Journal of Radiology . 2018;104:1-7 .

Wolchok J . Putting the immunologic brakes on cancer . Cell . 2018;175(6):1452-1454 .

Wolchok JD . Altered self: The not-so-neo-antigens . Nature Reviews Immunology . 2018;18(3):152- .

Wolner ZJ, Bajaj S, Flores E, Carrera C, Navarrete-Dechent C, Dusza SW, Rabinovitz HS, Marchetti MA, Marghoob AA . Variation in dermoscopic features of basal cell carcinoma as a function of anatomical location and pigmentation status . British Journal of Dermatolgy . 2018;178(2):e136-e137 . PMCID: PMC5812817

Wolner ZJ, Marghoob AA, Pulitzer MP, Postow MA, Marchetti MA . A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma . British Journal of Dermatology . 2018;178(1):265-269 . PMCID: PMC5533648

Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L . Total body irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) . International Journal of Radiation Oncology, Biology, Physics . 2018;101(3):521-529 .

Wong Riff KWY, Tsangaris E, Goodacre TEE, Forrest CR, Lawson J, Pusic AL, Klassen AF . What matters to patients with cleft lip and/or palate: An international qualitative study informing the development of the CLEFT-Q . Cleft Palate-Craniofacial Journal . 2018;55(3):442-450 .

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH . Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline update . Annals of Surgical Oncology . 2018;25(2):356-377 .

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH . Sentinel lymph node

biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update . Journal of Clinical Oncology . 2018;36(4):399-413 .

Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL . Outcome of patients with newly diagnosed systemic light-chain amyloidosis associated with deletion of 17p . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(11):e493-e499 .

Woo KM, Gönen M, Schnorr G, Silvestri GA, Bach PB . Surrogate markers and the association of low-dose CT lung cancer screening with mortality . JAMA Oncology . 2018;4(7):1006-1008 .

Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Makani SS, Massion PP, Mazzone P, Merritt RE, Meyers BF, Midthun DE, Pipavath S, Pratt C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Schiebler ML, Tong BC, Travis WD, Wei B, Yang SC, Gregory KM, Hughes M . Lung cancer screening, version 3 .2018: Clinical Practice Guidelines in Oncology . Journal of the National Comprehensive Cancer Network . 2018;16(4):412-441 .

Wood DE, White JR, Georgiadis A, Van Emburgh B, Parpart-Li S, Mitchell J, Anagnostou V, Niknafs N, Karchin R, Papp E, McCord C, LoVerso P, Riley D, Diaz LA Jr, Jones S, Sausen M, Velculescu VE, Angiuoli S V . A machine learning approach for somatic mutation discovery . Science Translational Medicine . 2018;10(457):eaar7939- .

Woodbridge A, Abraham A, Ahn R, Saba S, Korenstein D, Madden E, Keyhani S . A cross-sectional analysis of spin in randomized controlled trials .

186 OF 288


Journal Articles

Journal of General Internal Medicine . 2018;33(3):247-248 . PMCID: PMC5834969

Wound Ostomy and Continence Nurses Society Guideline Development Task Force . WOCN Society Clinical Guideline: Management of the Adult Patient With a Fecal or Urinary Ostomy - An executive summary . Journal of Wound Ostomy and Continence Nursing . 2018;45(1):50-58 .

Wrzeszczynski KO, Felice V, Abhyankar A, Kozon L, Geiger H, Manaa D, London F, Robinson D, Fang X, Lin D, Lamendola-Essel MF, Khaira D, Dikoglu E, Emde AK, Robine N, Shah M, Arora K, Basturk O, Bhanot U, Kentsis A, Mansukhani MM, Bhagat G, Jobanputra V . Analytical validation of clinical whole-genome and transcriptome sequencing of patient-derived tumors for reporting targetable variants in cancer . Journal of Molecular Diagnostics . 2018;20(6):822-835 . PMCID: PMC6198246

Wu AY, Gervasio KA, Gergoudis KN, Wei C, Oestreicher JH, Harvey JT . Conservative therapy for chalazia: Is it really effective? . Acta Ophthalmologica . 2018;96(4):e503-e509 . PMCID: PMC6047938

Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC Jr, Tolley NS, Van Slycke S, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Randolph GW . International Neuromonitoring Study Group guidelines 2018 part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer - Incorporation of surgical, laryngeal, and neural electrophysiologic data . Laryngoscope . 2018;128(Suppl . 3):S18-S27 .

Wu J, Kwong BY, Martires KJ, Rieger KE, Chung WH, Iyer G V, Lacouture ME . Granuloma annulare

associated with immune checkpoint inhibitors . Journal of the European Academy of Dermatology and Venereology . 2018;32(4):e124-e126 . PMCID: PMC5867195

Wu J, Lacouture ME . Pruritus associated with targeted anticancer therapies and their management . Dermatologic Clinics . 2018;36(3):315-324 . PMCID: PMC6020829

Wu YP, Parsons BG, Mooney R, Aspinwall LG, Cloyes K, Hay JL, Kohlmann W, Grossman D, Leachman SA . Barriers and facilitators to melanoma prevention and control behaviors among at-risk children . Journal of Community Health . 2018;43(5):993-1001 . PMCID: PMC6119479

Wu Z, Santich BH, Liu H, Liu C, Cheung NK V . Targeting intracellular antigens with pMHC-Binding antibodies: A phage display approach . Methods in Molecular Biology . 2018;1701:255-269 .

Wu Z, Cheung N V . T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics . Pharmacology & Therapeutics . 2018;182:161-175 . PMCID: PMC5785550

Wu Z, Guo HF, Xu H, Cheung NK V . Development of a tetravalent anti-GPA33/anti-CD3 bispecific antibody for colorectal cancers . Molecular Cancer Therapeutics . 2018;17(10):2164-2175 . PMCID: PMC6168351

Xiao W, Rampal R, Zhang Y, Cimera R, Jungbluth AA, Arcila M, Roshal M, Park DC . JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation . Leukemia . 2018;32(8):1842-1845 .

Xiao W, Yabe M, Offin M, Khattar P, Baik J, Daley RJ, Pappacena JJ, Roshal M, Zhang Y, Tallman MS, Cai SF . Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation . Blood Advances . 2018;2(13):1517-1521 . PMCID: PMC6039660

Xiao W, Bharadwaj M, Levine M, Farnhoud N, Pastore F, Getta BM, Hultquist A, Famulare C, Medina JS, Patel MA, Gao Q, Lewis N, Pichardo J, Baik J, Shaffer B, Giralt S, Rampal R, Devlin S, Cimera R, Zhang Y, Arcila ME, Papaemmanuil E, Levine RL, Roshal M . PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation . Blood Advances . 2018;2(23):3526-3539 . PMCID: PMC6290101

Xie Y, Cao Z, Wong EWP, Guan Y, Ma W, Zhang JQ, Walczak EG, Murphy D, Ran L, Sirota I, Wang S, Shukla S, Gao D, Knott SR V, Chang K, Leu J, Wongvipat J, Antonescu CR, Hannon G, Chi P, Chen Y . COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors . Journal of Clinical Investigation . 2018;128(4):1442-1457 . PMCID: PMC5873878

Xu B, Ghossein RA . Crucial parameters in thyroid carcinoma reporting - Challenges, controversies and clinical implications . Histopathology . 2018;72(1):32-39 . PMCID: PMC5730489

Xu B, Ghossein RA . The contribution of molecular pathology to the classification of thyroid tumors . Diagnostic Histopathology . 2018;24(3):87-94 .

Xu B, Ghossein R . Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management . European Journal of Surgical Oncology . 2018;44(3):338-347 . PMCID: PMC5694380

Xu B, Katabi N . Evolving concepts and new entities in the 2017 WHO classification of salivary gland tumors . Diagnostic Histopathology . 2018;24(5):172-179 .

Xu B, Farhat N, Barletta JA, Hung YP, de Biase D, Casadei GP, Onenerk AM, Tuttle RM, Roman BR, Katabi N, Nosé V, Sadow P, Tallini G, Faquin WC, Ghossein R . Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features

187 OF 288


Journal Articles

category? . Endocrine . 2018;59(1):143-150 . PMCID: PMC5766404

Xu B, Katabi N . Salivary gland epithelial neoplasms in pediatric population: A single-institute experience with a focus on the histologic spectrum and clinical outcome — Reply . Human Pathology . 2018;73:194- .

Xu B, Aryeequaye R, Wang L, Katabi N . Sinonasal secretory carcinoma of salivary gland with high grade transformation: A case report of this under-recognized diagnostic entity with prognostic and therapeutic implications . Head and Neck Pathology . 2018;12(2):274-278 . PMCID: PMC5953877

Xu C, Offin M, Paik PK, Li BT . Liquid biopsy guided precision therapy for lung cancers . Journal of Thoracic Disease . 2018;10(Suppl . 33):S4173-S4175 .

Xue X, Sun Y, Resto-Irizarry AM, Yuan Y, Aw Yong KM, Zheng Y, Weng S, Shao Y, Chai Y, Studer L, Fu J . Mechanics-guided embryonic patterning of neuroectoderm tissue from human pluripotent stem cells . Nature Materials . 2018;17(7):633-641 .

Xylinas E, Kent M, Dabi Y, Rieken M, Kluth LA, Al Awamlh BAH, Ouzaid I, Pycha A, Comploj E, Svatek RS, Lotan Y, Karakiewicz P I, Holmang S, Shariat SF . Impact of age on outcomes of patients with non–muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C . Urologic Oncology: Seminars and Original Investigations . 2018;36(3):89 .e1-89 .e5 .

Yélamos O, Jain M, Busam KJ, Marghoob AA . Recurrent nevus as a pitfall of melanoma diagnosis under reflectance confocal microscopy . Australasian Journal of Dermatology . 2018;59(3):227-229 .

Yabe M, Miranda RN, Medeiros LJ . Hepatosplenic T-cell lymphoma: A review of clinicopathologic features, pathogenesis, and prognostic factors . Human Pathology . 2018;74:5-16 .

Yadav RR, Ngo-Huang AT, Ng A, Fu JB, Custodio C, Wisotzky E, Mitra R, Bruera E . Characteristics

of cancer rehabilitation fellowship training programs in the USA . Journal of Cancer Education . 2018;33(6):1364-1367 .

Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A, Donoghue MTA, You D, Viale A, Kemeny N, Segal NH, Stadler ZK, Varghese AM, Kundra R, Gao J, Syed A, Hyman DM, Vakiani E, Rosen N, Taylor BS, Ladanyi M, Berger MF, Solit DB, Shia J, Saltz L, Schultz N . Clinical sequencing defines the genomic landscape of metastatic colorectal cancer . Cancer Cell . 2018;33(1):125-136 .e3 . PMCID: PMC5765991

Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M . Therapeutic potential of afatinib for cancers with ERBB2 (HER2) transmembrane domain mutations G660D and V659E . The Oncologist . 2018;23(2):150-154 . PMCID: PMC5813752

Yamamoto-Imoto H, Zamolodchikov D, Chen ZL, Bourne SL, Rizvi S, Singh P, Norris EH, Weis-Garcia F, Strickland S . A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer’s pathology and cognitive impairment . Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring . 2018;10:480-489 . PMCID: PMC6178129

Yamashita R, Nishio M, Do RKG, Togashi K . Convolutional neural networks: An overview and application in radiology . Insights into Imaging . 2018;9(4):611-629 . PMCID: PMC6108980

Yamazaki T, Liu L, Lazarev D, Al-Zain A, Fomin V, Yeung PL, Chambers SM, Lu CW, Studer L, Manley JL . TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency . Genes and Development . 2018;32(17-18):1161-1174 . PMCID: PMC6120717

Yan BY, Hibler BP, Connolly KL, Rossi AM . Intraoral laser hair removal of a palate free flap: Tips and technique . Dermatologic Surgery . 2018;44(1):122-124 .

Yan SQ, Seyboth B, Kobos R, Eaton A, Seo SK, Cohen N . Voriconazole dosing in children younger than 3 years undergoing cancer chemotherapy or hematopoietic stem cell transplantation . Journal of the Pediatric Infectious Diseases Society . 2018;7(2):169-171 . PMCID: PMC5954300

Yan Y, An J, Yang Y, Wu D, Bai Y, Cao W, Ma L, Chen J, Yu Z, He Y, Jin X, Pan Y, Ma T, Wang S, Hou X, Weroha SJ, Karnes RJ, Zhang J, Westendorf JJ, Wang L, Chen Y, Xu W, Zhu R, Wang D, Huang H . Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer . EMBO Molecular Medicine . 2018;10(4):e8478- . PMCID: PMC5887910

Yang A, Sokolof J, Gulati A . The effect of preoperative exercise on upper extremity recovery following breast cancer surgery: A systematic review . International Journal of Rehabilitation Research . 2018;41(3):189-196 .

Yang A, Baxi S, Korenstein D . ClinicalTrials .gov for facilitating rapid understanding of potential harms of new drugs: The case of checkpoint inhibitors . Journal of Oncology Practice . 2018;14(2):72-76 . PMCID: PMC5812307

Yang A, Chimonas S, Bach PB, Taylor DJ, Lipitz-Snyderman A . Critical choices: What information do patients want when selecting a hospital for cancer surgery? . Journal of Oncology Practice . 2018;14(8):e505-e512 .

Yang C, Jairam S, Amoroso KA, Robson ME, Walsh MF, Zhang L . Characterization of a novel germline BRCA1 splice variant, c .5332+4delA . Breast Cancer Research and Treatment . 2018;168(2):543-550 .

Yang H, Wright L, Negishi T, Negishi K, Liu J, Marwick TH . Research to practice: Assessment

188 OF 288


Journal Articles

of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic-related cardiac dysfunction . JACC: Cardiovascular Imaging . 2018;11(8):1196-1201 .

Yang J, Veeraraghavan H, Armato SG 3rd, Farahani K, Kirby JS, Kalpathy-Kramer J, van Elmpt W, Dekker A, Han X, Feng X, Aljabar P, Oliveira B, van der Heyden B, Zamdborg L, Lam D, Gooding M, Sharp GC . Autosegmentation for thoracic radiation treatment planning: A grand challenge at AAPM 2017 . Medical Physics . 2018;45(10):4568-4581 .

Yang JC, Fox J, Chen C, Yu AF . Cardiac ATTR amyloid nuclear imaging - Not all bone scintigraphy radionuclide tracers are created equal . Journal of Nuclear Cardiology . 2018;25(5):1879-1884 . PMCID: PMC5975116

Yang JC, Yahalom J . Early-stage follicular lymphoma: What is the preferred treatment strategy? . Journal of Clinical Oncology . 2018;36(29):2904-2906 . PMCID: PMC5975116

Yang L, Alyasova A, Ye D, Ridolfi A, Dezzani L, Motzer RJ . RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis . BMC Cancer . 2018;18:195- . PMCID: PMC5816475

Yang Q, Roehrl MH, Wang JY . Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers . Oncotarget . 2018;9(3):3996-4019 . PMCID: PMC5790517

Yang TT, Chong WM, Wang WJ, Mazo G, Tanos B, Chen Z, Tran TMN, Chen YD, Weng RR, Huang CE, Jane WN, Tsou MFB, Liao JC . Super-resolution architecture of mammalian centriole distal appendages reveals distinct blade and matrix functional components . Nature Communications . 2018;9:2023- . PMCID: PMC5964178

Yarmohammadi H, Gonzalez-Aguirre AJ, Maybody M, Ziv E, Boas FE, Erinjeri JP, Sofocleous CT, Solomon SB, Getrajdman G . Evaluation of the effect of operator experience on outcome of hepatic artery embolization of hepatocellular carcinoma in a tertiary cancer center . Academic Radiology . 2018;25(7):856-860 .

Yates LR, Seoane J, Le Tourneau C, Siu LL, Marais R, Michiels S, Soria JC, Campbell P, Normanno N, Scarpa A, Reis-Filho JS, Rodon J, Swanton C, Andre F . The European Society for Medical Oncology (ESMO) Precision Medicine Glossary . Annals of Oncology . 2018;29(1):30-35 .

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL, on behalf of the North American Consortium for Histiocytosis . Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas . Pediatric Blood and Cancer . 2018;65(1):e26784- .

Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J . Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance . Phytotherapy Research . 2018;32(5):865-891 . PMCID: PMC5938102

Yeung KS, Gubili J, Mao JJ . Herb-drug interactions in cancer care . Oncology (Norwalk) . 2018;32(10):516-520 .

Yi F, Frazzette N, Cruz AC, Klebanoff CA, Siegel RM . Beyond cell death: New functions for TNF family cytokines in autoimmunity and tumor immunotherapy . Trends in Molecular Medicine . 2018;24(7):642-653 .

Yin W, Zhu J, Gonzalez-Rivas D, Okumura M, Rocco G, Pass H, Jiang G, Yang Y . Construction of a novel bispecific antibody to enhance antitumor activity against lung cancer . Advanced Materials . 2018;30(51):1805437- .

Yokota T, Bendell J, Lorusso P, Tsushima T, Desai V, Kenmotsu H, Watanabe J, Ono A, Murugesan B, Silva J, Naito T, Greenberg J, Kumar P, Wang Y, Jikoh T, Shiga R, Hyman DM, Ho AL, Spriggs DR, Schwartz GK, Gounder MM . Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials . British Journal of Cancer . 2018;118(12):1571-1579 .

Yoon AP, Qi J, Brown DL, Kim HM, Hamill JB, Erdmann-Sager J, Pusic AL, Wilkins EG . Outcomes of immediate versus delayed breast reconstruction: Results of a multicenter prospective study . Breast . 2018;37:72-79 .PMCID: PMC5902735

Yoon SS . The new American Joint Commission on Cancer staging system for soft tissue sarcomas: Splitting versus lumping . Annals of Surgical Oncology . 2018;25(5):1101-1102 . PMCID: PMC5893369

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Lee NY, Ho AS, Zumsteg ZS . Facility volume and survival in nasopharyngeal carcinoma . International Journal of Radiation Oncology, Biology, Physics . 2018;100(2):408-417 .

Yoshimi A, Abdel-Wahab O . Targeting mRNA decapping in AML . Cancer Cell . 2018;33(3):339-341 .

Yu F, Lv J, Niu S, Du H, Tang YW, Bonomo RA, Kreiswirth BN, Chen L . In vitro activity of ceftazidime-avibactam against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates . Antimicrobial Agents and Chemotherapy . 2018;62(8):e01031-18- . PMCID: PMC6105775

Yu F, Lv J, Niu S, Du H, Tang YW, Pitout JDD, Bonomo RA, Kreiswirth BN, Chen L . Multiplex PCR analysis for rapid detection of Klebsiella pneumoniae carbapenem-resistant (sequence type 258 [ST258] and ST11) and hypervirulent (ST23, ST65, ST86, and ST375) strains . Journal of Clinical Microbiology . 2018;56(9):e00731-18- .PMCID: PMC6113471

Yu HA, Planchard D, Lovly CM . Sequencing therapy for genetically defined subgroups of non-small cell

189 OF 288


Journal Articles

lung cancer . American Society of Clinical Oncology Educational Book . 2018;38:726-739 .

Yu HA, Suzawa K, Jordan E, Zehir A, Ni A, Kim R, Kris MG, Hellmann MD, Li BT, Somwar R, Solit DB, Berger MF, Arcila M, Riely GJ, Ladanyi M . Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance . Clinical Cancer Research . 2018;24(13):3108-3118 .

Yu KH, Ricigliano M, McCarthy B, Chou JF, Capanu M, Cooper B, Bartlett A, Covington C, Lowery MA, O’Reilly EM . Circulating tumor and invasive cell gene expression profile predicts treatment response and survival in pancreatic adenocarcinoma . Cancers . 2018;10(12):467- . PMCID: PMC6315371

Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, Fer N, Strathern LA, Powell K, Smith B, Waters AM, Drubin D, Thomson T, Liao R, Greninger P, Stein GT, Murchie E, Cortez E, Egan RK, Procter L, Bess M, Cheng KT, Lee CS, Lee LC, Fellmann C, Stephens R, Luo J, Lowe SW, Benes CH, McCormick F . Differential effector engagement by oncogenic KRAS . Cell Reports . 2018;22(7):1889-1902 .

Zabor EC, Coit D, Gershenwald JE, McMasters KM, Michaelson JS, Stromberg AJ, Panageas KS . Variability in predictions from online tools: A demonstration using internet-based melanoma predictors . Annals of Surgical Oncology . 2018;25(8):2172-2177 .

Zabor EC . ASO author reflections: Careful development and thoughtful interpretation are needed when developing online prognostic tools . Annals of Surgical Oncology . 2018;25(Suppl . 3):S916-S917 .

Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P . Long-term renal function recovery following radical nephrectomy for kidney cancer: Results from a multicenter confirmatory study .

Journal of Urology . 2018;199(4):921-926 . PMCID: PMC6226274

Zafra MP, Schatoff EM, Katti A, Foronda M, Breinig M, Schweitzer AY, Simon A, Han T, Goswami S, Montgomery E, Thibado J, Kastenhuber ER, Sanchez-Rivera FJ, Shi J, Vakoc CR, Lowe SW, Tschaharganeh DF, Dow LE . Optimized base editors enable efficient editing in cells, organoids and mice . Nature Biotechnology . 2018;36(9):888-893 . PMCID: PMC6130889

Zahid H, Subbaramaiah K, Iyengar NM, Zhou XK, Chen IC, Bhardwaj P, Gucalp A, Morrow M, Hudis CA, Dannenberg AJ, Brown KA . Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: A novel mechanism for the obesity-breast cancer link . International Journal of Obesity . 2018;42(4):711-720 . PMCID: PMC5936686

Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC Jr, Sesso HD, Einhorn LH, Fossa SD, Travis LB, for the Platinum Study Group . Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular cancer survivors . Journal of the National Comprehensive Cancer Network . 2018;16(3):257-265 .

Zamarin D . Vanadium: A panacea for resistance to oncolytic immunotherapy? . Molecular Therapy . 2018;26(1):9-12 . PMCID: PMC5763147

Zamarin D, Ricca JM, Sadekova S, Oseledchyk A, Yu Y, Blumenschein WM, Wong J, Gigoux M, Merghoub T, Wolchok JD . PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy . Journal of Clinical Investigation . 2018;128(4):1413-1428 . PMCID: PMC5873884

Zanzonico P . Guest editorial . Seminars in Nuclear Medicine . 2018;48(4):309-310 .

Zappasodi R, Merghoub T, Wolchok JD . Emerging concepts for immune checkpoint blockade-based combination therapies . Cancer Cell . 2018;33(4):581-598 . PMCID: PMC5896787

Zappasodi R, Budhu S, Hellmann MD, Postow MA, Senbabaoglu Y, Manne S, Gasmi B, Liu C, Zhong H, Li Y, Huang AC, Hirschhorn-Cymerman D, Panageas KS, Wherry EJ, Merghoub T, Wolchok JD . Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity . Cancer Cell . 2018;33(6):1017-1032 .e7 .

Zappasodi R, Wolchok JD, Merghoub T . Strategies for predicting response to checkpoint inhibitors . Current Hematologic Malignancy Reports . 2018;13(5):383-395 .

Zardavas D, te Marvelde L, Milne RL, Fumagalli D, Fountzilas G, Kotoula V, Razis E, Papaxoinis G, Joensuu H, Moynahan ME, Hennessy BT, Bieche I, Saal LH, Stal O, Iacopetta B, Dupont Jensen J, O’Toole S, Lopez-Knowles E, Barbaraeschi M, Noguchi S, Azim HA Jr, Lerma E, Bachelot T, Wang Q, Perez-Tenorio G, can de Velde CJH, Rea DW, Sabine V, Bartlett JMS, Sotiriou C, Michiels S, Loi S . Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data . Journal of Clinical Oncology . 2018;36(10):981-990 .

Zareba P, Pinthus JH, Russo P . The contemporary role of lymph node dissection in the management of renal cell carcinoma . Therapeutic Advances in Urology . 2018;10(11):335-342 . PMCID: PMC6180379

Zarepisheh M, Xing L, Ye Y . A computation study on an integrated alternating direction method of multipliers for large scale optimization . Optimization Letters . 2018;12(1):3-15 .

Zarnegar S, Gosiengfiao Y, Rademaker A, Casey R, Albritton KH . Recall of fertility discussion by adolescent female cancer patients: A survey-based pilot study . Journal of Adolescent and Young Adult Oncology . 2018;7(2):249-253 .

190 OF 288


Journal Articles

Zarnegar S, Durham BH, Khattar P, Shukla NN, Benayed R, Lacouture ME, Lavi E, Lyden DC, Diamond EL, Dunkel IJ, Abdel-Wahab O . Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis . Pediatric Blood and Cancer . 2018;65(1):e26699- . PMCID: PMC6053915

Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin S, Tandon N, Weber WA, Low PS . Synthesis and evaluation of a novel (64)Cu- and (67)Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts . Bioconjugate Chemistry . 2018;29(4):1319-1326 .

Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, Fang J, Rampersaud S, Hoshino A, Matei I, Kenific CM, Nakajima M, Mutvei AP, Sansone P, Buehring W, Wang H, Jimenez JP, Cohen-Gould L, Paknejad N, Brendel M, Manova-Todorova K, Magalhães A, Ferreira JA, Osorio H, Silva AM, Massey A, Cubillos-Ruiz JR, Galletti G, Giannakakou P, Cuervo AM, Blenis J, Schwartz R, Brady MS, Peinado H, Bromberg J, Matsui H, Reis CA, Lyden D . Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation . Nature Cell Biology . 2018;20(3):332-343 .

Zhang J, Li S, Krol A, Schmidtlein CR, Lipson E, Feiglin D, Xu Y . Infimal convolution-based regularization for SPECT reconstruction . Medical Physics . 2018;45(12):5397-5410 .

Zhang J, Markova S, Garcia A, Huang K, Nie X, Choi W, Lu W, Wu A, Rimner A, Li G . Evaluation of automatic contour propagation in T2-weighted 4DMRI for normal-tissue motion assessment using internal organ-at-risk volume (IRV) . Journal of Applied Clinical Medical Physics . 2018;19(5):598-608 . PMCID: PMC6123161

Zhang JQ, Zeng S, Vitiello GA, Seifert AM, Medina BD, Beckman MJ, Loo JK, Santamaria-Barria

J, Maltbaek JH, Param NJ, Moral JA, Zhao JN, Balachandran V, Rossi F, Antonescu CR, DeMatteo RP . Macrophages and CD8(+) T cells mediate the antitumor efficacy of combined CD40 ligation and imatinib therapy in gastrointestinal stromal tumors . Cancer Immunology Research . 2018;6(4):434-447 .

Zhang K, Peng T, Yan Q, Sun L, Miao H, Yuan L, Hong Y, Zhou M, Guo K, Zhang L, Fang J, Shen M, Ruan S . Jiedu Sangen Decoction inhibits migration and invasion of colon cancer SW480 cells via suppressing epithelial mesenchymal transition . Evidence-Based Complementary and Alternative Medicine . 2018;2018:1495768- .PMCID: PMC6176311

Zhang L, Wang Z, Shi C, Long T, Xu XG . The impact of robustness of deformable image registration on contour propagation and dose accumulation for head and neck adaptive radiotherapy . Journal of Applied Clinical Medical Physics . 2018;19(4):185-194 . PMCID: PMC6036371

Zhang M, Zou W, Teo BKK . Image guidance in proton therapy for lung cancer . Translational Lung Cancer Research . 2018;7(2):160-170 . PMCID: PMC5960660

Zhang M, Lykke-Andersen S, Zhu B, Xiao W, Hoskins JW, Zhang X, Rost LM, Collins I, van de Bunt M, Jia J, Parikh H, Zhang T, Song L, Jermusyk A, Chung CC, Zhu B, Zhou W, Matters GL, Kurtz RC, Yeager M, Jensen TH, Brown KM, Ongen H, Bamlet WR, Murray BA, McCarthy M I, Chanock SJ, Chatterjee N, Wolpin BM, Smith JP, Olson SH, Petersen GM, Shi J, Amundadottir L . Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues . Gut . 2018;67(3):521-533 . PMCID: PMC5762429

Zhang M, Di Martino JS, Bowman RL, Campbell NR, Baksh SC, Simon-Vermot T, Kim IS, Haldeman P, Mondal C, Yong-Gonzales V, Abu-Akeel M, Merghoub T, Jones DR, Zhu XG, Arora A, Ariyan CE, Birsoy K, Wolchok JD, Panageas KS, Hollmann T, Bravo-Cordero JJ, White RM . Adipocyte-derived lipids

mediate melanoma progression via FATP proteins . Cancer Discovery . 2018;8(8):1006-1025 .

Zhang P, Hunt M, Telles AB, Pham H, Lovelock M, Yorke E, Li G, Happersett L, Rimner A, Mageras G . Design and validation of a MV/kV imaging-based markerless tracking system for assessing real-time lung tumor motion . Medical Physics . 2018;45(12):5555-5563 .

Zhang P, Yorke E, Mageras G, Rimner A, Sonke JJ, Deasy JO . Validating a predictive atlas of tumor shrinkage for adaptive radiotherapy of locally advanced lung cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(4):978-986 .

Zhang Q, Shi C, Han L, Jain N, Roberts KG, Ma H, Cai T, Cavazos A, Tabe Y, Jacamo RO, Mu H, Zhao Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y, Jabbour EJ, Levine R, Tasian SK, Mullighan CG, Weinstock DM, Fruman DA, Konopleva M . Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia . Oncotarget . 2018;9(8):8027-8041 . PMCID: PMC5814279

Zhang SY, Clark NE, Freije CA, Pauwels E, Taggart AJ, Okada S, Mandel H, Garcia P, Ciancanelli MJ, Biran A, Lafaille FG, Tsumura M, Cobat A, Luo J, Volpi S, Zimmer B, Sakata S, Dinis A, Ohara O, Garcia Reino EJ, Dobbs K, Hasek M, Holloway SP, McCammon K, Hussong SA, DeRosa N, Van Skike CE, Katolik A, Lorenzo L, Hyodo M, Faria E, Halwani R, Fukuhara R, Smith GA, Galvan V, Damha MJ, Al-Muhsen S, Itan Y, Boeke JD, Notarangelo LD, Studer L, Kobayashi M, Diogo L, Fairbrother WG, Abel L, Rosenberg BR, Hart PJ, Etzioni A, Casanova JL . Inborn errors of RNA lariat metabolism in humans with brainstem viral infection . Cell . 2018;172(5):952-965 .e18 .PMCID: PMC5886375

Zhang X, Ko HM, Torres J, Panchal HJ, Cai Z, Wagner M, Sands BE, Colombel JF, Cho J, Taouli B, Harpaz N .

191 OF 288


Journal Articles

Luminally polarized mural and vascular remodeling in ileal strictures of Crohn’s disease . Human Pathology . 2018;79:42-49 .

Zhang Y, Zoltan M, Riquelme E, Xu H, Sahin I, Castro-Pando S, Montiel MF, Chang K, Jiang Z, Ling J, Gupta S, Horne W, Pruski M, Wang H, Sun SC, Lozano G, Chiao P, Maitra A, Leach SD, Kolls JK, Vilar E, Wang TC, Bailey JM, McAllister F . Immune cell production of interleukin 17 induces stem cell features of pancreatic intraepithelial neoplasia cells . Gastroenterology . 2018;155(1):210-223 .e3 . PMCID: PMC6035075

Zhang Y, Linder MH, Shojaie A, Ouyang Z, Shen R, Baggerly KA, Baladandayuthapani V, Zhao H . Dissecting pathway disturbances using network topology and multi-platform genomics data . Statistics in Biosciences . 2018;10(1):86-106 .

Zhang YM, Zimmer MA, Guardia T, Callahan SJ, Mondal C, Di Martino J, Takagi T, Fennell M, Garippa R, Campbell NR, Bravo-Cordero JJ, White RM . Distant insulin signaling regulates vertebrate pigmentation through the sheddase bace2 . Developmental Cell . 2018;45(5):580-594 .e7 . PMCID: PMC5991976

Zhang Z, Trevino V, Hoseini SS, Belciug S, Boopathi AM, Zhang P, Gorunescu F, Subha V, Dai S . Variable selection in logistic regression model with genetic algorithm . Annals of Translational Medicine . 2018;6(3):45- .PMCID: PMC5879502

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper L V, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL . Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease . Journal of Clinical Investigation . 2018;128(11):4970-4979 . PMCID: PMC6205404

Zhao X . SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes . Molecular Cell . 2018;71(3):409-418 . PMCID: PMC6095470

Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D’Angelica M I, DeMatteo RP, Lyden D, Jarnagin WR . Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer . HPB . 2018;20(7):597-604 .

Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D’Angelica M I, DeMatteo RP, Jarnagin WR, Ventura A . Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing . PLoS ONE . 2018;13(7):e0200776- . PMCID: PMC6063411

Zhi W I, Ingram E, Li SQ, Chen P, Piulson L, Bao T . Acupuncture for bortezomib-induced peripheral neuropathy: Not just for pain . Integrative Cancer Therapies . 2018;17(4):1079-1086 . PMCID: PMC6247555

Zhou L, Lim MYT, Kaur P, Saj A, Bortolamiol-Becet D, Gopal V, Tolwinski N, Tucker-Kellogg G, Okamura K . Importance of miRNA stability and alternative primary miRNA isoforms in gene regulation during Drosophila development . eLife . 2018;7:e38389- . PMCID: PMC6066331

Zhou T, Kim TW, Chong CN, Tan L, Amin S, Sadat Badieyan Z, Mukherjee S, Ghazizadeh Z, Zeng H, Guo M, Crespo M, Zhang T, Kenyon R, Robinson CL, Apostolou E, Wang H, Xiang JZ, Evans T, Studer L, Chen S . A hPSC-based platform to discover gene-environment interactions that impact human-cell and dopamine neuron survival . Nature Communications . 2018;9:4815- . PMCID: PMC6240096

Zhou YJ, Wang G, Tang YW . Companion diagnostics: New opportunities for safe and effective anti-infectious disease therapies . Emerging Microbes & Infections . 2018;7:9- . PMCID: PMC5837138

Zibetti MVW, Baboli R, Chang G, Otazo R, Regatte RR . Rapid compositional mapping of knee cartilage with compressed sensing MRI . Journal of Magnetic Resonance Imaging . 2018;48(5):1185-1198 . PMCID: PMC6231228

Zimmer B, Ewaleifoh O, Harschnitz O, Lee YS, Peneau C, McAlpine JL, Liu B, Tchieu J, Steinbeck JA, Lafaille F, Volpi S, Notarangelo LD, Casanova JL, Zhang SY, Smith GA, Studer L . Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection . Proceedings of the National Academy of Sciences of the United States of America . 2018;115(37):E8775-E8782 .PMCID: PMC6140487

Zimran E, Tripodi J, Rampal R, Rappoport F, Zirkiev S, Hoffman R, Najfeld V . Genomic characterization of spleens in patients with myelofibrosis . Haematologica . 2018;103(10):e446-e449 . PMCID: PMC6165826

Ziv E, Rice SL, Filtes J, Yarmohammadi H, Boas FE, Erinjeri JP, Petre EN, Brody LA, Brown KT, Covey AM, Getrajdman G I, Maybody M, Raj N, Sofocleous CT, Solomon SB, Reidy-Lagunes D . DAXX mutation status of embolization-treated neuroendocrine tumors predicts shorter time to hepatic progression . Journal of Vascular and Interventional Radiology . 2018;29(11):1519-1526 .

Zivanovic O, Chi DS, Filippova O, Randall LM, Bristow RE, O’Cearbhaill RE . It’s time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer . Gynecologic Oncology . 2018;151(3):555-561 .

Zocca J, Valimahomed A, Yu J, Gulati A . A review of recent advances in the management of breast cancer related pain . Breast Cancer Management . 2018;7(2):BMT03- .

Zook EC, Li ZY, Xu Y, de Pooter RF, Verykokakis M, Beaulieu A, Lasorella A, Maienschein-Cline M, Sun JC, Sigvardsson M, Kee BL . Transcription

192 OF 288


Journal Articles

factor ID2 prevents E proteins from enforcing a naive T lymphocyte gene program during NK cell development . Science Immunology . 2018;3(22):eaao2139- .

Zorina Y, Stricker J, Caggiano AO, Button DC . Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia . Scientific Reports . 2018;8:9392- . PMCID: PMC6010437

Zou W, Burgdorf B, Yue NJ, Yin L, Zhang M, Khan A, Jabbour SK, McDonough J, Dong L, Teo BKK . Efficient double-scattering proton therapy with a patient-specific bolus . Physica Medica . 2018;50:1-6 .

Zucker A, Tsai CJ, Loscalzo J, Calves P, Kao J . The NEAT predictive model for survival in patients with advanced cancer . Cancer Research and Treatment . 2018;50(4):1433-1443 . PMCID: PMC6192914

Zuckerman SL, Bilsky MH, Laufer I . Chordomas of the skull base, mobile spine, and sacrum: An epidemiologic investigation of presentation, treatment, and survival . World Neurosurgery . 2018;113:e618-e627 .

Zuckerman SL, Lim J, Yamada Y, Bilsky MH, Laufer I . Brachytherapy in spinal tumors: A systematic review . World Neurosurgery . 2018;118:e235-e244 .

193 OF 288

Conference Papers (36)


194 OF 288


Conference Papers

Ancker JS, Stabile C, Carter J, Chen LY, Stein D, Stetson PD, Vickers AJ, Simon BA, Temple LK, Pusic AL . Informing, reassuring, or alarming? Balancing patient needs in the development of a postsurgical symptom reporting system in cancer . AMIA Annual Symposium . Proceedings . 2018;2018:166-174 . PMCID: PMC6371281

Atkinson TM . Latent dirichlet allocation in discovering goals in patients undergoing bladder cancer surgery . IEEE 5th International Conference on Data Science and Advanced Analytics . Proceedings . 2018;:540-546 .

Bozkurt A, Kose K, Alessi-Fox C, Gill M, Dy J, Brooks D, Rajadhyaksha M . A multiresolution convolutional neural network with partial label training for annotating reflectance confocal microscopy images of skin . Lecture Notes in Computer Science . 2018;11071:292-299 .

Chakraborty J, Pulvirenti A, Yamashita R, Midya A, Gönen M, Klimstra DS, Reidy DL, Allen PJ, Do RKG, Simpson AL . Quantitative CT analysis for the preoperative prediction of pathologic grade in pancreatic neuroendocrine tumors . Proceedings of SPIE . 2018;10575:10575 1N- .

Choi W, Nadeem S, Riyahi S, Deasy JO, Tannenbaum A, Lu W . Interpretable spiculation quantification for lung cancer screening . Lecture Notes in Computer Science . 2018;11167:38-48 .

Codella NCF, Gutman D, Celebi ME, Helba B, Marchetti MA, Dusza SW, Kalloo A, Liopyris K, Mishra N, Kittler H, Halpern A . Skin lesion analysis toward melanoma detection: A challenge at the 2017 International Symposium on Biomedical Imaging (ISBI), hosted by the International Skin Imaging Collaboration (ISIC) . International Symposium on Biomedical Imaging . Proceedings . 2018;:168-172 .

Codella NCF, Lin CC, Halpern A, Hind M, Feris R, Smith JR . Collaborative Human-AI (CHAI): Evidence-based interpretable melanoma classification in

dermoscopic images . Lecture Notes in Computer Science . 2018;11038 LNCS:97-105 .

Dauer LT, Yorke E, Williamson M, Gao Y, Dauer ZL, Miller DL, Vaño E . Radiotherapeutic implications of the updated ICRP thresholds for tissue reactions related to cataracts and circulatory diseases . Annals of the ICRP . 2018;47(3-4):196-213 .

Dickensheets DL, Liu T, Kreitinger S, Peterson G, Rajadhyaksha M . Toward smaller, more useable clinical confocal microscopes with advanced scanning and integrated wide-field guidance . OSA Technical Digest . 2018;MW4A .1-

Elkin R, Nadeem S, Haber E, Steklova K, Lee H, Benveniste H, Tannenbaum A . GlymphVIS: Visualizing glymphatic transport pathways using regularized optimal transport . Lecture Notes in Computer Science . 2018;11070:844-852 .

Hao J, Kim Y, Mallavarapu T, Oh JH, Kang M . Cox-PASNet: Pathway-based sparse deep neural network for survival analysis . IEEE International Conference on Bioinformatics and Biomedicine . Proceedings . 2018;:381-386 .

Harmon ES, Thompson MO, Mandal KC, Schmidtlein CR, Turner JN, Beaumont J, Krol A . Development of ultrafast detector for advanced time-of-flight brain PET . Progress in Biomedical Optics and Imaging - Proceedings of SPIE . 2018;10578:10578 08- .

Heiselman JS, Collins JA, Clements LW, Weis JA, Simpson AL, Geevarghese SK, Kingham TP, Jarnagin WR, Miga M I . Technical note: Nonrigid registration for laparoscopic liver surgery using sparse intraoperative data . Proceedings of SPIE . 2018;10576:10576 0D- .

Hoffman ZR, Kivanc K, Dimarzio CA . Single image structured illumination (SISIM) for in-vivo imaging . Proceedings of SPIE . 2018;10499:10499 18- .

Hossain MS, Nakamura T, Kimura F, Yagi Y, Yamaguchi M . Practical image quality evaluation for

whole slide imaging scanner . Proceedings of SPIE . 2018;10711:10711 1S- .

Illan IA, Ramirez J, Gorriz JM, Pinker K, Meyer-Baese A . Reproducible evaluation of registration algorithms for movement correction in dynamic contrast enhancing magnetic resonance imaging for breast cancer diagnosis . Lecture Notes in Computer Science . 2018;11040:124-131 .

Illan IA, Tahmassebi A, Ramirez J, Gorriz JM, Foo SY, Pinker-Domenig K, Meyer-Baese A . Machine learning for accurate differentiation of benign and malignant breast tumors presenting as non-mass enhancement . Proceedings of SPIE . 2018;10669:10669 0W- .

Jiang J, Hu YC, Tyagi N, Zhang P, Rimner A, Mageras GS, Deasy JO, Veeraraghavan H . Tumor-aware, adversarial domain adaptation from CT to MRI for lung cancer segmentation . Lecture Notes in Computer Science . 2018;11071:777-785 . PMCID: PMC6169798

Judd N, Smith J, Jain M, Mukherjee S, Icaza M, Gallagher R, Szeligowski R, Wu B . A pilot study for distinguishing chromophobe renal cell carcinoma and oncocytoma using second harmonic generation imaging and convolutional neural network analysis of collagen fibrillar structure . Proceedings of SPIE . 2018;10489:10489 19- .

Kose K, Bozkurt A, Alessi-Fox C, Gill M, Brooks DH, Dy JG, Rajadhyaksha M . A multiresolution deep learning framework for automated annotation of reflectance confocal microscopy images . OSA Technical Digest . 2018;:MTh2A .1- .

Lacouture M, Sibaud V . Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails . American Journal of Clinical Dermatology . 2018;19(Suppl . 1):S31-S39 . PMCID: PMC6244569

Liu M, Jiang J, Guo Z, Wang Z, Liu Y . Crowd counting with fully convolutional neural network . International

195 OF 288


Conference Papers

Conference on Image Processing . Proceedings . 2018;:953-957 .

Lyu Y, Jiang W, Lin Y, Voros L, Zhang M, Mueller B, Mychalczak B, Song Y . Motion-blind blur removal for CT images with Wasserstein Generative Adversarial Networks . Proceedings of the 11th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI 2018) . 2018;:8633203- .

Mallavarapu T, Hao J, Kim Y, Oh JH, Kang M . PASCL: Pathway-based sparse deep clustering for identifying unknown cancer subtypes . IEEE International Conference on Bioinformatics and Biomedicine . Proceedings . 2018;:470-475 .

McMurry TL, Stukenborg GJ, Kessler LG, Colditz GA, Wong ML, Francescatti AB, Jones DR, Schumacher JR, Greenberg CC, Chang GJ, Winchester DP, McKellar DP, Kozower BD . More frequent surveillance following lung cancer resection is not associated with improved survival: A nationally representative cohort study . Annals of Surgery . 2018;268(4):632-639 .

Midya A, Chakraborty J, Pak LM, Zheng J, Jarnagin WR, Do RKG, Simpson AL . Deep convolutional neural network for the classification of hepatocellular carcinoma and intrahepatic cholangiocarcinoma . Proceedings of SPIE . 2018;10575:10575 28- .

Mock C, Debas H, Balch CM, Brennan M, Buyske J, Cusack J, DeMeester S, Herndon D, Le Holterman AX, Jaffe B, Kandil E, Kauffman G, Mazariegos G,

Merchant N, Numann P, Oleynikov D, Olutoye O, O’Neill J, Shackford S, Stock P, Tarpley JL, Tuttle T, Wolf S, Wren SM, Yang GP . Global surgery: Effective involvement of US academic surgery: Report of the American Surgical Association Working Group on Global Surgery . Annals of Surgery . 2018;268(4):557-563 .

Muhammad H, Haggström I, Klimstra DS, Fuchs TJ . Survival modeling of pancreatic cancer with radiology using convolutional neural networks . Lecture Notes in Computer Science . 2018;11042:187-192 .

Partain L, Boyd D, Song S, Ziskin V, Seppi E, Rand R, Ely A, Kim N, Foletta K, Weil M, Daly M, Boone J, Benedict S, Tognina C, Shapiro E, Okamoto G, Prionas S, Pham H, Mageras G . Lung cancer, respiratory 3D motion imaging, with a 19 focal spot kV x-ray tube and a 60 fps flat panel imager . Progress in Biomedical Optics and Imaging - Proceedings of SPIE . 2018;10573:10573 0X- .

Rabidas R, Midya A, Chakraborty J, Sadhu A, Arif W . Multi-resolution analysis using integrated microscopic configuration with local patterns for benign-malignant mass classification . Proceedings of SPIE . 2018;10575:10575 2N- .

Riyahi S, Choi W, Liu CJ, Nadeem S, Tan S, Zhong H, Chen W, Wu AJ, Mechalakos JG, Deasy JO, Lu W . Quantification of local metabolic tumor volume changes by registering blended PET-CT images for

prediction of pathologic tumor response . Lecture Notes in Computer Science . 2018;11076:31-41 .

Tahmassebi A, Ngo D, Garcia A, Castillo E, Morales DP, Pinker-Domenig K, Lobbes M, Meyer-Base A . Multi-level analysis of spatio-temporal features in non-mass enhancing breast tumors . Proceedings of SPIE . 2018;10662:106620H- .

Tahmassebi A, Amani AM, Pinker-Domenig K, Meyer-Baese A . Determining disease evolution driver nodes in dementia networks . Progress in Biomedical Optics and Imaging - Proceedings of SPIE . 2018;10578:10578 29- .

Tahmassebi A, Pinker-Domenig K, Wengert G, Helbich T, Bago-Horvath Z, Meyer-Baese A . Determining the importance of parameters extracted from multi-parametric MRI in the early prediction of the response to neo-adjuvant chemotherapy in breast cancer . Progress in Biomedical Optics and Imaging - Proceedings of SPIE . 2018;10578:10578 18- .

Yin C, Wei L, Abeytunge S, Peterson G, Glaser AK, Mandella MJ, Rajadhyaksha M, Liu JTC . A handheld MEMS-scanned in vivo optical-sectioning microscope for early detection and surgical guidance . IEEE Photonics Society Conference, 2018 Proceedings . 2018;:153-154 .

Yu K . Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma . Clinical Advances in Hematology & Oncology . 2018;16(9 Suppl . 17):9-10 .

196 OF 288

Meeting Abstracts (1,459)


197 OF 288


Meeting Abstracts

AbdelBaki M, Abu Arja M, Funk Z, Stanek J, Davidson T, Fangusaro J, Dunkel I, Dhall G, Gardner S, Finlay J . Pineoblastoma in children: The Head Start experience . Neuro-Oncology . 2018;20(Suppl . 6):vi203- . PMCID: PMC6216117

Abida W, Bryce AH, Balar A V, Chatta GS, Dawson NA, Guancial EA, Hussain A, Jha GG, Lipsitz DU, Patnaik A, Petrylak DP, Ryan CJ, Stanton TS, Vogelzang NJ, Zhang J, Simmons A, Go J, Golsorkhi T, Chowdhury S, Scher H I . TRITON2: An international, multicenter, open-label, phase II study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Abida W . Lineage plasticity in antiandrogen resistance . Cancer Research . 2018;78(16 Suppl .):22- .

Abida W, Bryce AH, Vogelzang NJ, Amato RJ, Percent I, Shapiro JD, McDermott R, Hussain A, Patnaik A, Petrylak D, Ryan CJ, Stanton T, Zhang J, Simmons AD, Despain D, Collins M, Golsorskhi T, Scher H I, Chowdhury S . Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .002- .

Abou-Alfa GK, Valle JW, Kelley RK, Goyal L, Shroff RT, Javle MM, Borad MJ, Cleary JM, El-Khoueiry AB, Bendell JC, Macarulla TM, Vogel A, Korth C, Jiang L, Gliser C, Wu B, Agresta S V, Pandya SS, Zhu AX . ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Abou-Alfa GK, El-Khoueiry AB, Meyer T, Rimassa L, Merle P, Chan SL, Tran A, Parnis F, Tam VC, Cattan

S, Markby DW, Clary DO, Cheng AL, Kelley RK . Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC) . Hepatology . 2018;68(Suppl . 1):533A-534A .

Abramson JS, Gordon L I, Palomba ML, Lunning MA, Arnason JE, Forero-Torres A, Wang M, Maloney DG, Sehgal A, Andreadis C, Purev E, Solomon SR, Ghosh N, Albertson TM, Xie B, Garcia J, Siddiqi T . Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL . Journal of Clinical Oncology . 2018;36(15 Suppl .):401s- .

Abramson JS, Siddiqi T, Palomba ML, Gordon L I, Lunning MA, Arnason JE, Wang M, Forero-Torres A, Albertson T, Dehner C, Garcia J, Li D, Xie B, Maloney DG . High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive B-NHL (TRANSCEND NHL 001 study): A defined composition CD19-directed CAR T cell product with potential for outpatient administration . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S23- .

Abramson JS, Siddiqi T, Palomba ML, Gordon L I, Lunning MA, Arnason JE, Wang M, Forero-Torres A, Albertson T, Dehner C, Garcia J, Li D, Xie B, Maloney DG . High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive b-NHL (TRANSCEND NHL 001 Study): A defined composition CD19-directed CAR T-cell product with potential for outpatient administration . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Acuna-Villaorduna A, Gonzalez-Lugo JD, Ye BH, Shah UA, Kaur G, Shah N, Mantzaris I, Shastri A, Braunschweig I, Kornblum N, Derman O, Verma A, Zalta B, Janakiram M . Differentiating lung involvement in adult T-cell leukemia lymphoma (ATLL) versus HTLV infection: Results from a large

single-center cohort with implications for staging and response criteria . Blood . 2018;132(Suppl . 1)

Adams S, DeLorey D, Davenport M, Fairey A, North S, Courneya K . A randomized controlled trial of the effects of high-intensity aerobic interval training on fatigue, psychosocial function, and health-related quality of life in testicular cancer survivors . Psycho-Oncology . 2018;27(Suppl . 1):68- .

Adumeau P, Davydova M, Zeglis B . 68Ga-labeled tracer for pretargeted immunoPET imaging of colorectal cancer . Abstracts of Papers of the American Chemical Society . 2018;255

Adusumilli P . CAR-T and ADC’s in MPM . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S307- .

Adusumilli PS, Zauderer M, Rusch V, O’Cearbhaill R, Ngai D, Chintala N, Halton E, Diamonte C, Modi S, Solomon S, Brentjens R, Riviere I, Sadelain M . A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy - A preliminary report . Molecular Therapy . 2018;26(5 Suppl . 1):158-159 .

Advani AS, Moseley A, O’Dwyer KM, Wood B, Fang M, Wieduwilt MJ, Aldoss I, Park JH, Klisovic R, Baer MR, Stock W, Bhave R, Othus M, Litzow MR, Stone RM, Erba HP . Results of SWOG 1318: A phase 2 trial of blinatumomab followed by POMP (prednisone, vincristine, methotrexate, 6-mercaptopurine) maintenance in elderly patients with newly diagnosed Philadelphia chromosome negative B-cell acute lymphoblastic leukemia . Blood . 2018;132(Suppl . 1)

Advani RH, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Christian BA, Ansell SM, Moskowitz CH, Fenton K, Ogden CA, Taft D, Zak DE, Sacchi M, Galderisi F, Herrera AF . Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: Part 3 (concurrent dosing) results and updated progression-

198 OF 288


Meeting Abstracts

free survival results from parts 1 and 2 (staggered dosing) . Blood . 2018;132(Suppl . 1)

Agura E, Gyurkocza B, Nath R, Litzow MR, Tomlinson BK, Abhyankar S, Seropian S, Stiff PJ, Choe HK, Kebriaei P, Foran JM, Chen G, Levy MY, Lazarus HM, Giralt S, Berger MS, Reddy V, Pagel JM . Targeted conditioning of Iomab-B ((131)I-anti-CD45) prior to allogeneic hematopoietic cell transplantation versus conventional care in relapsed or refractory acute myeloid leukemia (AML): Preliminary feasibility and safety results from the prospective, randomized phase 3 SIERRA trial . Blood . 2018;132(Suppl . 1)

Ahr K, Famulare C, Koche R, Spitzer B, Levine RL, Tallman MS, Goldberg AD, Stein EM, Glass JL . AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival . Blood . 2018;132(Suppl . 1)

Alapati SK, Unsal A, Cracchiolo J, Roman BR, Lee N, Cohen M . Incidence and distribution of nodal metastases in sinonasal malignancy . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1384- .

Aleem U, Grant C, Gallagher DJ, Sukor S, Kennedy J, Kelleher CF, Lowery MA, O’Donnell DM, Gleeson J, Glennon L, Cuffe S . Immunotherapy awareness in the oncology patient population: An Irish hospital experience . Journal of Clinical Oncology . 2018;36(15 Suppl .)

Alex D, Suehara Y, Bowman A, Middha S, Zehir A, Wang L, Jour G, Nafa K, Meyers P, Healey J, Hameed M, Ladanyi M . Clinical genomic sequencing of 72 pediatric and adult osteosarcomas reveals distinct molecular subsets with potentially targetable alterations . Modern Pathology . 2018;31(Suppl . 2):18- .

Alex D, Nafa K, Middha S, Zehir A, Baldi T, Casanova J, Salazar PA, Arcila M, Lin O . Residual cytology material for the detection of targetable genetic alterations by next generation sequencing:

An institutional experience . Modern Pathology . 2018;31(Suppl . 2):130- .

Alex D, Travis W, Rekhtman N, Buonocore D, Ni A, Rizvi H, Hellmann M, Sauter JL . Histologic features predictive of response to PD-1 blockade in patients with non small cell lung carcinoma (NSCLC) . Modern Pathology . 2018;31(Suppl . 2):723- .

Alexander B, Supko J, Agar N, Ahluwalia M, Desai A, Dietrich J, Kaley T, Peereboom D, Takebe N, Desideri S, Fisher J, Sims M, Ye X, Ligon K, Nabors LB, Grossman S, Wen P . Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM . Neuro-Oncology . 2018;20(Suppl . 6):vi13-vi14 . PMCID: PMC6216117

Alexander K, Manna R, Gangai N, Costas-Muniz R, Grodzicki BK . Educational initiative to promote knowledge of cognitive impairment in minority older communities, caregivers, and clinicians . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S75- .

Alexander K, Shahrokni A, Sarraf S, Grodzicki BK . Geriatric assessment in older cancer patients and its potential impact on surgical treatment decisions . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S233- .

Ali H, Abdel-Rahman Z, Favazza L, Chitale D . Utilization of the three Magee equations to select patients for genomic testing . European Journal of Cancer . 2018;92(Suppl . 3):S91-S92 .

Alig S, Pastore A, Jurinovic V, Bararia D, Habe S, Passerini V, Keay W, Hellmuth J, Rosenwald A, Klapper W, Stein H, Feller A, Ott G, Staiger A, Horn H, Hansmann ML, Pott C, Forstpointner R, Hofmann WK, Schmitz N, Hess G, Unterhalt M, Dreyling M, Zollner A, Schmidt C, Hoster E, Hiddemann W, Weigert O, German Low-Grade Lymphoma Study Group (GLSG) . Clinicogenetic risk factors in patients receiving autologous stem-cell transplantation after

frontline R-CHOP for advanced follicular lymphoma: An analysis from the GLSG2000 trial . Oncology Research and Treatment . 2018;41(Suppl . 4):250-251 .

Alig S, Pastore A, Jurinovic V, Habe S, Bararia D, Passerini V, Keay W, Hellmuth J, Rosenwald A, Klapper W, Stein H, Feller A, Ott G, Staiger AM, Horn H, Hansmann ML, Pott C, Forstpointner R, Hofmann WK, Schmitz N, Hess G, Unterhalt M, Dreyling MH, Zoellner AK, Schmidt C, Hoster E, Hiddemann W, Weigert O . Clinicogenetic risk models in patients randomized to receive consolidative autologous stem-cell transplantation after frontline R-CHOP for advanced follicular lymphoma: An analysis from the GLSG2000 trial . Blood . 2018;132(Suppl . 1)

Allan JN, Wierda WG, Patel K, O’Brien SM, Mato AR, Davids MS, Furman RR, Pagel JM, Fox JA, Ward R, Taverna P, Brown JR . Preliminary safety, pharmacokinetic, and pharmacodynamic results from a phase 1b/2 dose-escalation and cohort-expansion study of the noncovalent, reversible Bruton’s tyrosine kinase inhibitor (BTKi), vecabrutinib, in B-lymphoid malignancies . Blood . 2018;132(Suppl . 1)

Aly R, Eguchi T, Kadota K, Rekhtman N, Tan KS, Adusumilli P, Travis W . Impact of tumor spread through air spaces (STAS) in lung neuroendocrine tumors (NETs) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S434-S435 .

Aly RG, Eguchi T, Kadota K, Rekhtman N, Adusumilli PS, Travis W . Spread through air spaces (STAS) correlates with prognosis in lung neuroendocrine tumors (LNET) . Modern Pathology . 2018;31(Suppl . 2):724- .

Aly RG, Eguchi T, Emoto K, Montecalvo J, Rekhtman N, Tan KS, Adusumilli PS, Travis W . Micropapillary and solid but not lepidic components correlate with worse prognosis in 1522 invasive predominant nonmucinous lung adenocarcinoma (LADC) . Modern Pathology . 2018;31(Suppl . 2):723- .

199 OF 288


Meeting Abstracts

Anderson ES, Lockney NA, Lockney DT, Samstein R, Higginson DS, Bilsky M, Laufer I, Yamada Y, Schmitt A . KEAP1 mutation is correlated to increased rates of local failure after radiation therapy for spine metastases from non-small cell lung cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S187- .

Antonescu C . Emerging genetic mechanisms in undifferentiated round cell sarcomas . Clinical Cancer Research . 2018;24(2 Suppl .):23-24 .

Antonia S, Gettinger S, Borghaei H, Goldman JW, Brahmer J, Ready N, Gerber D, Chow L, Juergens R, Laurie S, Shepherd F, Li X, Li A, Geese W, Hellmann M . Long-term outcomes with first-line nivolumab plus ipilimumab in advanced NSCLC: 3-year follow-up from CheckMate 012 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S458- .

Applebaum A . Emerging models and methods of implementing psychosocial care for cancer caregivers . Psycho-Oncology . 2018;27(Suppl . 1):16- .

Applebaum A, Buda K, Masterson M, Reisch S, Rosenfeld B . Identifying and measuring prognostic understanding in advanced cancer patients . Psycho-Oncology . 2018;27(Suppl . 1):58- .

Applebaum A, Cannady R, Sharpe K, Breitbart W . Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S673- .

Apte A, Iyer A, van Dijk L V, Thor M, Veeraraghavan H, Fontenla S, Oh J, Mechalakos J, Hunt M, Deasy J . Bagged Atlas Based Segmentation (BABS): Bagging atlas segmentations from multiple image representations . Medical Physics . 2018;45(6):e363- .

Arbour K, Shen R, Plodkowski A, Rizvi H, Ni A, Long N, Halpenny D, Sanchez-Vega F, Rudin C, Riely G, Hellmann M . Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite

high TMB . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S424- .

Arcila ME, Salazar PA, Rijo I, Elezovic D, Rekhtman N, Buonocore DJ, Lin O, Chaft JE, Ladanyi M, Nafa K . Ultra-rapid EGFR mutation assessment in lung adenocarcinoma without prior DNA extraction . Journal of Molecular Diagnostics . 2018;20(6):976- .

Argani P, Pawel B, Szabo S, Reyes-Mugica M, Antonescu CR . Specificity of BCOR immunohistochemistry in pediatric renal neoplasia . Modern Pathology . 2018;31(Suppl . 2):713- .

Argyropoulos K, Velardi E, Tsai JJ, Lazrak A, Jahn L, Dudakov JA, van den Brink MRM . The damage sensory molecule TRPA1 positively regulates endogenous thymic regeneration after damage . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S360- .

Arias-Stella JA, Lewis N, Benayed R, Oliva E, Young R, Hoang L, Lee CH, Soslow R, Antonescu CR, Ladanyi M, Chiang S, Jungbluth A . Novel PLAG1 gene rearrangement distinguishes uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors . Modern Pathology . 2018;31(Suppl . 2):405- .

Arias-Stella JA, Rana S, Gounder MM, Ladanyi M, Dogan S . Pathogenic SMARCA4 mutations in head and neck and thyroid carcinomas are rare . Modern Pathology . 2018;31(Suppl . 2):471- .

Arkenau HT, Tabernero J, Shitara K, Dvorkin M, Mansoor W, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid EA, Nishikawa K, Hosokawa A, Ganea D, Yalcın Ş, Beretta GD, Winkler RE, Makris L, Doi T, Ilson DH . TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .027- .

Armand P, Chen YB, Redd RA, Joyce RM, Bsat J, Merryman RW, Coleman K, Dahi PB, Nieto Y, LaCasce AS, Fisher DC, Ng SY, Odejide OO, Freedman AS, Kim A I, Crombie JL, Jacobson CA, Jacobsen ED, Wong JL, Lipschitz M, Patel SS, Ritz J, Rodig SJ, Shipp MA, Herrera AF . PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation . Blood . 2018;132(Suppl . 1)

Armand P, Engert A, Younes A, Lee HJ, Santoro A, Zinzani PL, Timmerman JM, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Savage KJ, Kuruvilla J, Trnený M, Shipp MA, Sacchi M, Ansell Assm, Ansell SM . Nivolumab for relapsed or refractory classical Hodgkin lymphoma (cHL) after autologous hematopoietic cell transplantation (auto-HCT): Extended follow-up of the phase 2 single-arm CheckMate 205 study . Blood . 2018;132(Suppl . 1)

Arthur DW, Moughan J, Kuerer HM, Haffty BG Jr, Cuttino LW, Woodward WA, Todor DA, Simone NL, Anderson PR, Strom EA, McCormick B, Cohen RJ, Sahijdak WM, Matunlonis U, Brown DR, Currey AD, Fisher CM, Jagsi R, Winter K, White JR . NRG Oncology/RTOG 1014: Patient reported outcomes (PRO) and cosmesis from a phase II study of repeat breast preserving surgery and 3D conformal (3D-CRT) partial breast re-irradiation (PBrI) for in-breast recurrence . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S42-S43 .

Askan G, Shia J, Kombak E, Balci S, Basturk O . Expression of calretinin, marker of mesothelial differentiation, in pancreatic ductal adenocarcinoma: A potential diagnostic pitfall . Modern Pathology . 2018;31(Suppl . 2):671- .

Askar M, Sayer D, Wang T, Haagenson M, Spellman SR, Lee SJ, Fleischhauer K, Hsu KC, Verneris MR, Thomas D, Zhang A, Sobecks RM, Majhail NS . Analysis of single nucleotide polymorphisms (SNP) donor/recipient mismatches in the Gamma block of the major histocompatibility complex (MHC) and their

200 OF 288


Meeting Abstracts

association with hematopoietic cell transplantation (HCT) outcomes: A CIBMTR study . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S354-S355 .

Atallah EL, Orozco JJ, Craig M, Levy MY, Finn LE, Khan SS, Perl AE, Park JH, Roboz GJ, Tse W, Begna KH, Mawad R, Rizzieri DA, Berger MS, Jurcic JG . A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) - Interim analysis of 1 .5 µci/kg/dose . Blood . 2018;132(Suppl . 1)

Atkins KM, Chen MH, Wu J, Renshaw AA, Loffredo M, Kantoff PW, Small EJ, D’Amico A V . Low testosterone at first PSA failure and assessment of the risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Atkinson TM, Bochner BH, Li Y, Rapkin BD . Challenges of measuring patient-reported urinary function in cystectomy patients . Quality of Life Research . 2018;27(Suppl . 1):S125-S126 .

Autio KA, Naing A, Hung A, Oft M, Leveque J, Falchook GS . Durability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .019- .

Bach P, Miranda EP, Jenkins L, Nelson C, Mulhall J . Bother associated with climacturia after radical prostatectomy: Prevalence, degree and predictors . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S230- .

Bach P, Miranda E, Nascimento B, Nelson C, Mulhall J . Correlation between penile deformity and perceived partner bother in men with Peyronie’s disease . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S364- .

Bach P V, Miranda E, Nascimento B, Nelson C, Mulhall JP . Correlation between penile deformity,

patient bother, and perceived partner bother in men with Peyronie’s disease . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S86- .

Bachanova V, Weisdorf DJ, Wang T, Spellman SR, Zhu X, Lee SJ, Fleischhauer K, Hsu KC, Verneris MR, Cooley S, Miller JS . Graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) are not influenced by natural killer cell (NK) KIR immunogenetics: A CIBMTR analysis . Biology of Blood and Marrow Transplantation . 2018;24( 3 Suppl . 1):S80- .

Bachier-Rodriguez L, Shah GL, Knezevic A, Devlin SM, Maloy M, Koehne G, Chung DJ, Landau H, Giralt SA . Engraftment kinetics after high-dose melphalan autologous stem cell transplant in patients with multiple myeloma . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S142-S143 .

Bachier Rodriguez L, Shah GL, Knezevic A, Devlin SM, Maloy M, Koehne G, Chung DJ, Landau HJ, Giralt S . Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma . Blood . 2018;132(Suppl . 1)

Bachireddy P, Azizi E, Nguyen VN, Li S, Neuberg DS, Soiffer RJ, Ritz J, Alyea EP 3rd, Pe’er D, Wu CJ . Mapping the evolution of T cell transcriptional states during DLI response and resistance using single-cell data . Blood . 2018;132(Suppl . 1)

Bailey K, Pandit-Taskar N, Humm J, Zanzonico P, Gilheeney SW, Kramer K . Treatment of Embryonal Tumor with Multilayered Rosettes (ETMR) with targeted radioimmunotherapy . Neuro-Oncology . 2018;20(Suppl . 2):i69- . PMCID: PMC6012612

Bajaj B, Lawell M, Laack NN 2nd, Kwok Y, Wolden SL, Mangona VS, Gallotto S, Hess CB, Patteson B, Weyman EA, Yock T I . Trajectory of HRQOL scores in pediatric patients receiving proton therapy: Results from the Pediatric Proton Consortium Registry

(PPCR) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E740- .

Bajic D, Su A, Hillmer K, Mejias-Luque R, Bluemel S, Docampo M, Schmid R, Schnabl B, van den Brink M, Gerhard M, Stein-Thoeringer C . Microbial dysbiosis increases experimental colitis by interfering with short-chain fatty acid-dependent mucosal Reg3B expression . Journal of Crohns & Colitis . 2018;12(Suppl . 1):S088-S089 .

Baker JL, Muhsen S, Zabor E, Stempel M, Gemignani ML . Does lymph node status prior to neoadjuvant chemotherapy influence the number of sentinel nodes removed? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S103- .

Bakhoum S, Ngo B, Bakhoum A, Cavallo-Fleming JA, Murphy CW, Powell SN, Cantley L . Chromosomal instability drives metastasis through a cytosolic DNA response . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S118- .

Bal S, Choi K, Landau HJ, Starczynowski DT, Girnius SK . Clinical outcomes of newly diagnosed multiple myeloma patients with elevated lactate dehydrogenase who underwent autologous hematopoietic stem cell transplantation . Blood . 2018;132(Suppl . 1)

Bal S, Girnius SK, Starczynowski DT, Landau HJ, Choi K . Genomic landscape of multiple myeloma with elevated lactate dehydrogenase . Blood . 2018;132(Suppl . 1)

Banerjee S, Zielaskowski K, White K, Rodríguez V, Robers E, Guest D, Sussman A, Talamantes Y, Schwartz M, Bigney J, Hunley K, Buller D, Kaphingst K, Berwick M, Hay J . “Let’s talk about skin cancer”: Examining association between family communication about skin cancer, perceived risk, and sun protection behaviors . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S177- .

201 OF 288


Meeting Abstracts

Banerjee S, Manna R, Gangai N, Alici Y, Nelson CJ, Alexander K, Parker PA, Grodzicki BK . Geriatric communication skills training for clinicians to improve the care of older cancer patients . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S150- .

Bang Y, Van Cutsem E, Fuchs C, Ohtsu A, Tabernero J, Ilson D, Hyung W, Strong V, Goetze T, Yoshikawa T, Tang L, Hwang P, Shitara K . A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress . Annals of Oncology . 2018;29(Suppl . 5):mdy151 .095- .

Bang YJ, Van Cutsem E, Fuchs CS, Ohtsu A, Tabernero J, Ilson DH, Hyung WJ, Strong VE, Goetze TO, Yoshikawa T, Tang LH, Hwang PMT, Adelberg D, Shitara K . Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer . Annals of Oncology . 2018;29(Suppl . 8):mdy282 .167- .

Bannan C, Bayly C, Gilson M, Wang LP, Shirts M, Chodera J, Mobley D . Automated chemical perception for force field parameterization . Abstracts of Papers of the American Chemical Society . 2018;256

Barac A, Lynce F, Medvedofsky DA, Geng X, Dang C, Yu A, Tan M, Isaacs C, Swain SM, Asch FM . Global longitudinal strain in the SAFE-HEaRT study (Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function) . European Heart Journal . 2018;39(Suppl . 1):304-305 .

Barker CA, Postow MA, Goldman DA, Panageas KS, Halpenny D, McCabe D, Macri M, Schwarzenberger P, Ricciardi T, Ryan A, Venhaus R, Knox SJ . A phase 1 clinical trial of ipilimumab, nivolumab and radiation therapy for patients with metastatic melanoma .

International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S78-S79 .

Barker JN, Kempenich J, Duffy M, Brunstein CG, Delaney C, Kurtzberg J, Milano F, Politikos I, Scaradavou A, Shpall EJ, Dehn J . Analysis of the CD34(+) cell content of 126, 341 cord blood (CB) units in the NMDP Be the Match inventory: Implications for CB transplantation and public banking . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S40-S41 .

Barney C, Beckham T, Healy E, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Mitchell DL, Wobb JL, Blakaj DM, Lee N, Bhatt AD . A multi-institutional comparison of carboplatin-based regimens versus cetuximab in chemoradiation for p16(-) head and neck cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S200-S201 .

Bartlett E, Ferraro RA, Stacruz JM, Postow MA, Coit D, Ariyan CE . Neutrophil to lymphocyte ratio (NLR) is associated with survival but varies with disease burden in melanoma patients treated with PD-1 inhibitor monotherapy . Annals of Surgical Oncology . 2018;25(Suppl . 1):S41- .

Barzilai O, Versteeg A, Sahgal A, Rhines L, Bilsky M, Sciubba D, Schuster J, Webber M, Varga P, Boriani S, Bettegowda C, Fehlings M, Yamada Y, Clarke M, Arnold P, Gokaslan Z, Fisher C, Laufer I . Survival, local control, and health related quality of life in oligometastatic and polymetastatic spinal tumors: A multicenter, international study . Neuro-Oncology . 2018;20(Suppl . 6):vi221- . PMCID: PMC6216117

Baselga J, Dent SF, Cortés J, Im YH, Diéras V, Harbeck N, Krop IE, Verma S, Wilson TR, Jin H, Wang L, Schimmoller F, Hsu JY, He J, DeLaurentiis M, Drullinsky P, Jacot W . Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-

mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER . Journal of Clinical Oncology . 2018;36(18 Suppl .)

Baselga J, Petersen JA, Clark E, Barton C, Restuccia E, Procter MJ, Sonnenblick A, Fumagalli D, Parlier D, Arahmani A, Viale G, Reaby LL, Frank E, Gelber RD, Piccart-Gebhart MJ, Bines J, von Minckwitz G, Gasper SM . Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC) . Journal of Clinical Oncology . 2018;36(15 Suppl .):14s- .

Basturk O, Weigelt B, Askan G, Wang L, Arcila M, Zamboni G, Fukushima N, Pareja F, Selenica P, Kumar R, Doyle L, Reynolds SJ, Adsay N V, Reis-Filho J, Klimstra D . Sclerosing epithelioid mesenchymal neoplasm of the pancreas . Modern Pathology . 2018;31(Suppl . 2):671- .

Bates JE, Keshavarz H, Rancati T, Yorke ED, Gagliardi G, Aznar MC, Moiseenko V, Armenian S, Kremer L, Chen MH, Ronckers CM, van der Pal H, Cutter D, Constine LS, Hodgson D . Modeling radiation therapy-related risk of heart failure in survivors of pediatric malignancy: Early results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) group . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S53- .

Batlevi CL, De Frank S, Stewart C, Hamlin PA, Matasar MJ, Gerecitano JF, Moskowitz AJ, Hamilton AM, Zelenetz AD, Drullinsky P, Straus DJ, Kumar A, Moskowitz CH, Dicostanzo J, Callan D, Tsui D, Rademaker J, Schoder H, Ni A, Younes A . Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma . Journal of Clinical Oncology . 2018;36(15 Suppl .):404s- .

Batra J, Srinivasan S, Kryza T, Bock N, Stephens C, Dong Y, Panchadsaram J, Moya L, Röhl J, Perry-Keene

202 OF 288


Meeting Abstracts

JL, Buzacott K, Dadaev T, Brook MN, Lilja H, Spurdle A, Koistinen H, Stenman UH, Kote-Jarai Z, Eeles R, the Practical Consortium, the Australian Prostate Cancer Bioresource, Clements J . A functional variation in PSA (KLK3) gene that confers lower risk is also associated with more aggressive disease and lower survival in men with prostate cancer . BJU International . 2018;122(Suppl . 2):23- .

Bauer S, George S, Kang YK, Tap WD, Zhou T, Picazio N, Boral AL, Heinrich M . VOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST) . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .058-595 .

Baughn LB, Smoley SA, Aypar U, Pitel BA, Vasmatzis G, Johnson SH, Smadbeck JB, Peterson JF, Geiersbach KB, Van Dyke DL, Thorland EC, Ketterling RP, Jenkins RB, Hoppman NL, Kearney HM, Greipp PT . Clinical utility of mate pair sequencing to detect diagnostic and prognostic chromosomal rearrangements and copy number changes in patients with acute myeloid leukemia . Cancer Genetics . 2018;224-225:55- .

Beckham T, Yang JC, Chau K, Noy A, Yahalom J . Local therapy in the definitive management of Castleman disease . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E230- .

Begg CB . Strategies for investigating etiologic heterogeneity of cancer . Journal of Pathology . 2018;246(Suppl . 1):S9- .

Bekaii-Saab T, Ou F, Anderson D, Ahn D, Boland P, Ciombor K, Jacobs N, Desnoyers R, Cleary J, Meyers J, Chiorean E, Pedersen K, Barzi A, Sloan J, McCune J, Lacouture M, Lenz H, Grothey A . Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for Regorafenib in refractory metastatic colorectal cancer (mCRC) - An ACCRU

Network study . Annals of Oncology . 2018;29(Suppl . 5):mdy149 .013- .

Bekaii-Saab TS, Ou FS, Anderson DM, Ahn DH, Boland PM, Ciombor KK, Jacobs NL, Desnoyers RJ, Cleary JM, Meyers JP, Chiorean EG, Pedersen K, Barzi A, Sloan J, McCune JS, Lacouture ME, Lenz HJ, Grothey A . Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Bell A, Ma J, Lok B, Leeman JE, Tsai CJ, Anderson ES, Riaz N, McBride SM, Ganly I, Shaha A, Sherman E, Lee N . Outcomes following radiation therapy for anaplastic thyroid cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1380- .

Bellmunt J, De Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn D I, Culine S, Sternberg CN, Nam K, Frenkl TL, Perini RF, Bajorin DF . Two-year follow-up from the phase 3 KEYNOTE-045 trial of pembrolizumab (pembro) vs investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak D, Choueiri TK, Necchi A, Gerritsen WR, Gurney H, Quinn D I, Culine S, Sternberg CN, Jensen E, Frenkl T, Perini RF, Bajorin D . Impact of prognostic factors and risk groups on overall survival (OS) in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer (UC): Post hoc analysis of KEYNOTE-045 . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .110- .

Bello D, Russell C, McCullough D, Tierno M, Morrow M . Lymph node status does not predict tumor

biology . Annals of Surgical Oncology . 2018;25(Suppl . 2):18-19 .

Bello DM, Panageas KS, Hollmann TJ, Shoushtari AN, Chapman P, Postow MA, Callahan MK, Wolchok JD, Brady MS, Coit D, Ariyan CE . Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy . Annals of Surgical Oncology . 2018;25(Suppl . 1):S7-S8 .

Beltran L, North B, Moller H, Scardino P, Cuzick J, Berney D . Prognostic value of cancer extent assessment in a conservatively treated prostate biopsy cohort of 988 men using prostate cancer death as outcome . Modern Pathology . 2018;31(Suppl . 2):327- .

Bendau E, Iyer A, Thor M, Apte A, Hotca A, Yorke E, Rimner A, Deasy J, Jackson A . Using multivariate dose-response models to help select radiotherapy prescriptions . Medical Physics . 2018;45(6):e616- .

Bendell J, Ciardiello F, Tabernero J, Tebbutt N, Eng C, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal N, Sobrero A, Shi Y, Roberts L, Yan Y, Chang I, Uyei A, Kim T . Efficacy and safety results from IMblaze370, a randomised phase III study comparing atezolizumab + cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer . Annals of Oncology . 2018;29(Suppl . 5):mdy208 .003- .

Benedict C, McLeggon JA, Thom B, Kelvin J, Ford J, Landwehr M, Watson S . “Creating a family after battling cancer is exhausting and maddening”: Young adult survivors’ family-building experiences . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S690- .

Benhamida J, Rajanna A, Sirintrapun SJ, Fuchs T . Generation of realistic (in silico) histopathologic images using generative models based on deep neural networks . Modern Pathology . 2018;31(Suppl . 2):584- .

203 OF 288


Meeting Abstracts

Benhamida J, Ladanyi M, Wang J . Determination of MLH1 and MGMT promoter methylation status using the Illumina high-throughput methylationEPIC (850k) platform . Modern Pathology . 2018;31(Suppl . 2):801- .

Benhamida J, Arcila M, Bale T, Nafa K, Sadowska J, Villafania L . Clinical validation of MLH1 promoter methylation testing using the high-throughput methylationEPIC (850k) array platform . Journal of Molecular Diagnostics . 2018;20(6):991- .

Bennett JA, Costa Braga A, Morales-Oyarvide V, Cornejo KM, Pesci A, Pinto A, Van de Vijver K, Carlson J, Slavik T, Kiyokawa T, Zannoni G, Tornos C, Antonescu CR, Oliva E . Clinicopathological, immunohistochemical, and molecular characterization of 30 uterine perivascular epithelioid neoplasms (PEComas) . Modern Pathology . 2018;31(Suppl . 2):407-408 .

Bergerot CD, Clark KL, Bergerot PG, Ashing KT, Hahn AW, Obenchain R, Dizman N, Hsu J, Philip EJ, Loscalzo MJ, Pal SK . Association of somatic mutational burden with depression and anxiety in patients with metastatic urothelial cancer (mUC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Bergmann L, Donskov F, Motzer RJ, Voog E, Hovey EJ, Grüllich C, Nott LM, Cuff KE, Gil T, Jensen N V, Chevreau C, Negrier S, Depenbusch R, Cornelio I, Champsaur A, Escudier BJ, Pal SK, Powles T, Choueiri TK . Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):200-201 .

Berman E, Assal A, Maloy M, Zheng J, Devlin SM, Papadopoulos EB, Jakubowski AA . Role of consolidation therapy prior to CD34 - Selected allogeneic stem cell transplantation for adult patients with acute myeloid leukemia in first remission . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S311-S312 .

Bernie H, Miranda E, Terrier J, Nelson C, Mulhall J . Low PSA level in men diagnosed with prostate cancer predicts testosterone deficiency (TD) . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S162- .

Berry S, Senra C, Haq R, Veeraraghavan H . Using knowledge based planning to determine whether geometric variability in segmentation correlates with dosimetric variability . Medical Physics . 2018;45(6):e472- .

Besse B, Subbiah V, Drilon A, Shah M, Wirth LJ, Bauer TM, Velcheti V, Lakhani N, Boni V, Solomon BJ, Johnson M, Park K, Patel J, Cabanillas ME, Sherman E, Zhu E, Gordon K, Ebata K, Tuch B, Oxnard G . Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated

with LOXO-292 . Annals of Oncology . 2018;29(Suppl . 8):mdy269 .103- .

Bessell C, Bessell C, Isser A, Havel J, Lee S, Zhou R, Schneck J, Bell D . Commensal bacteria Bifidobacterium stimulates an anti-tumor response via cross-reactivity . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Bessell CA, Isser A, Havel J, Chan T, Schneck JP . Cross reactivity of CD8+ T cell neo-epitopes to bifidobacterium boosts the tumor specific population . Journal of Immunology . 2018;200(1 Suppl .)

Bex A, Grünwald V, Russo P, Tomita Y, Berghorn E, McHenry MB, Motzer RJ . A phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914) . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .136- .

Bhanot U, Ray-Kirton J, Akturk G, Ruh PA, Hamrokulova A, Silbe J, Roehrl MH . The rapidly growing role of pathology in clinical trials at a major

cancer center . Modern Pathology . 2018;31(Suppl . 2):766- .

Bhanot U, Kenney J, Lin E, Roehrl MH . The Precision Pathology Biobanking Center (PPBC) experience at international IBBL biobank Proficiency Testing . Modern Pathology . 2018;31(Suppl . 2):766- .

Bhatia A, Ulaner G, Rampal R, Hyman DM, Abdel-Wahab O, Durham B, Hajdenberg J, Ganzel C, Diamond E . Single-agent dabrafenib for intracranial BRAFV600E-mutated histiocytosis . Neurology . 2018;90(15 Suppl .)

Bhatt V, Politikos I, Devlin SM, Jacob AG, Maloy M, Naputo K, Afuye A, Scaradavou A, O’Reilly RJ, Castro-Malaspina H, Dahi PB, Giralt SA, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Peled JU, Hanash AM, Perales MA, Sauter CS, Shaffer BC, Shah GL, Tamari R, van den Brink MRM, Young JW, Ponce DM, Barker JN . Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S154-S155 .

Blanc JF, Meyer T, Cheng AL, El-Khoueiry AB, Cicin I, Chen Y, Bolondi L, Dadduzio V, Baron A, Lin ZZ, Adriani J, Kelly RK, Abou-Alfa GK . Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) . Annals of Oncology . 2018;29(Suppl . 8):mdy282 .086- .

Blandin AF, Graham M, Ramkissoon S, Ramkissoon L, Pelton K, Pages M, Jones R, Becker S, Watkinson F, Schoolcraft K, Haemels V, Goumnerova L, Chi S, Wright K, Kieran M, Tauziede-Espariat A, Varlet P, Alexandrescu S, Reardon D, Carcamo B, Charest A, De Smet F, Beroukhim R, Dubuc A, Kittler R, Wen P, Alexander B, Bandopadhayay P, Bachoo R, Ligon K . ALK amplification and rearrangements are recurrent

204 OF 288


Meeting Abstracts

targetable events in glioblastoma . Neuro-Oncology . 2018;20(Suppl . 6):vi204- . PMCID: PMC6216117

Blattmann C, Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM . Efficacy of larotrectinib in TRK fusion cancer in adults and children . Oncology Research and Treatment . 2018;41(Suppl . 4):154-155 .

Blouin A, Pastores S, Halpern N, Fleisher M, Ramanathan L . Procalcitonin and cytokine levels in cancer patients with neutropenia and bloodstream infections . Critical Care Medicine . 2018;46(1 Suppl . 1):697- .

Blum KA, Abramson J, Maris M, Flinn I, Goy A, Mertz J, Sims R, Garner F, Senderowicz A, Younes A . A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma . Annals of Oncology . 2018;29(Suppl . 3):mdy048- .

Blum W, Ruppert AS, Mims AS, Stein EM, Duong VH, Odenike O, Patel PA, Kovacsovics T, Heerema NA, Vergilio JA, Rosenberg L, Marcus S, Stefanos M, Weiner H, Brandt J, Shoben A, Druker BJ, Burd A, Levine RL, Byrd JC, Borate U . Phase 1b dose escalation study of BI 836858 and azacitidine in previously untreated AML: Results from Beat AML S2 . Blood . 2018;132(Suppl . 1)

Bodei L, Kidd M, Van der Zwan W, Singh A, Severi S, Drozdov I, Cwikla J, Baum RP, Paganelli G, Kwekkeboom D, Krenning E, Modlin I . Predicting response to PRRT: Development and validation of a blood-based predictive biomarker . Neuroendocrinology . 2018;106(Suppl . 1):241- .

Bodei L, Kidd M, van der Zwan W, Singh A, Severi S, Drozdov I, Cwikla J, Kolasinska-Cwikla A, Baum R, Kwekkeboom D, Krenning E, Paganelli G, Modlin I . The Predictive Quotient Index comprising gene cluster analysis and grading is specifically predictive of PRRT efficacy . Pancreas . 2018;47(3):333- .

Bodei L, Cremonesi M, Ferrari M, Krenning E, Sierra ML, Erion JL, Santoro P, Chicco D, Mariani MF . Dosimetry of LUTATHERA in patients with advanced midgut neuroendocrine tumors: Results of the phase III NETTER-1 sub-study . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S30-S31 .

Bodei L, Cremonesi M, Ferrari M, Krenning E, Sierra ML, Erion JL, Santoro P, Chicco D, Mariani MF . Renal protection during LUTATHERA treatment using lysine and arginine solutions . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S288-S289 .

Boire A, Zou Y, Shieh J, Macalinao D, Pentsova E, Massague J . Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis . Neurology . 2018;90(15 Suppl .)

Bolton K, Ptashkin R, Braunstein L, Kelly D, Devlin SM, Coombs CC, Moarii M, Patel M, Bernard E, Berthon A, Glodzik D, Walsh MF, Mandelker D, Patel A, Schulman J, Gundem G, Lee C, García-Closas M, Gardos S, Baselga J, Hyman DM, Tallman MS, Scher H, Bajorin D, Yabe M, Klimek VM, Diaz LA, Chatterjee N, Berger MF, Morton LM, Levine RL, Zehir A, Papaemmanuil E . Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis . Blood . 2018;132(Suppl . 1)

Boni V, Garcia-Corbacho J, Ott PA, Cho DC, Autio KA, Uboha N, Spira A I, Humphrey R, Will M, Naing A, Thistlethwaite F, de Vries EGE, Arkenau HT . Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts)

with advanced solid tumors . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .422- .

Booher RN, Nowakowski GS, Patel K, Lunning MA, Samson MES, Atoyan R, Ma AW, Xu GX, Dellarocca S, Modafferi H, Borek M, Zhang Z, Parker J, Whitney D, Wang H, Tuck DP, Younes A . Preclinical activity of IRAK4 kinase inhibitor CA-4948 alone or in combination with targeted therapies and preliminary phase 1 clinical results in non-Hodgkin lymphoma . Blood . 2018;132(Suppl . 1)

Borad MJ, Shroff RT, Abou-Alfa GK, Hecht JR, Bullock AJ, Ritch PS, Chondros D, Muhsin M, Oh DY . HALO 110-101: A phase Ib, randomized, open-label study of PEGPH20 (pegvorhyaluronidase alfa) in combination with cisplatin (CIS) + gemcitabine (GEM) (PEGCISGEM) or atezolizumab and CIS + GEM (PEGCISGEMATEZO) in hyaluronan-high subjects with locally advanced or metastatic cholangiocarcinoma and gallbladder cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Boudot A, Huang X, Murphy S, Appleman V, Xu H, Cheung NK, Macbeath G . ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .043- .

Bouffet E, Kieran M, Hargrave D, Roberts S, Aerts I, Broniscer A, Geoerger B, Dasgupta K, Tseng L, Russo M, Mookerjee B, Moertel C . Trametinib therapy in pediatric patients with low-grade gliomas (LGG) with BRAF gene fusion; a disease-specific cohort in the first pediatric testing of trametinib . Neuro-Oncology . 2018;20(Suppl . 2):i114- . PMCID: PMC6012612

Bowden J . Experience and data on spiritual screening in one hospital . Psycho-Oncology . 2018;27(Suppl . 1):24- .

Bowers JM, Hamilton JG, Miller BC, Hay JL . Awareness of DNA testing for health issues in a nationally representative sample . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S268- .

205 OF 288


Meeting Abstracts

Bowers JM, Hay JL . Acculturation to the United States is associated with increased unintentional tanning and desire for tanned skin among Asian college students . Psycho-Oncology . 2018;27(Suppl . 3):95-96 .

Bowman AS, Middha S, Vanderbilt C, Ladanyi M, Berger M, Zehir A . Identification of viral integration sites in cancer genomes using unmapped reads in targeted next-generation sequencing data . Journal of Molecular Diagnostics . 2018;20(6):963-964 .

Brümmendorf TH, Gambacorti-Passerini C, Kim DW, Mauro MJ, Aguiar J, Viqueira A, Leip E, Cortes JE . Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia . Oncology Research and Treatment . 2018;41(Suppl . 4):139-140 .

Brümmendorf TH, Hochhaus A, Isfort S, le Coutre P, Jentsch-Ullrich K, Schafhausen P, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Kota V, Lipton JH, Crescenzo RJ, Leip E, Viqueira A, Bardy-Bouxin N, Cortes JE . Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels . Oncology Research and Treatment . 2018;41(Suppl . 4):138- .

Bradbury M . Ultrasmall core-shell silica nanoparticles as targeted imaging probes for cancer nanomedicine: Design, evaluation and clinical translation . Abstracts of Papers of the American Chemical Society . 2018;256

Bradley JA, Kayton M, Breneman J, Chi YY, Donaldson S, Hawkins DS, Rodeberg D, Walterhouse D, Wolden S . Treatment approach and outcomes in infants with localized rhabdomyosarcoma (RMS): Analysis of Children’s Oncology Group (COG) protocols ARST0331 and ARST0531 . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):1007- .

Bragilovski D, Tzadok I, Ben-Hur R, Alani S, Kindler J, Popovtzer A, Cohen G, Koren S . Patient specific 3D template printing for temporary brachytherapy treatments . Medical Physics . 2018;45(6):e205- .

Brannon A, Jayakumaran G, Patel J, Johnson I, Diosdado M, Hasan M, Perera D, Meng F, Jing X, Reichel J, Hu Y, Syed A, Li B, Zehir A, Houck-Loomis B, Ladanyi M, Arcila M, Benayed R . Clinical validation of MSK-ACCESS: An ultrasensitive next-generation sequencing assay for liquid biopsies in the clinic . Journal of Molecular Diagnostics . 2018;20(6):1001- .

Brooks MA, Carlsson S V, Zajichek A, Chagin KM, Hugosson J, Kattan MW, Stephenson AJ . Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Brown JR, Davids MS, Chang JL, Ma S, Biondo J, Mobasher M, Mun Y, Mato AR . Outcomes of ibrutinib therapy given after prior venetoclax therapy in ibrutinib-naïve patients with relapsed/

refractory (R/R) chronic lymphocytic leukemia (CLL) . Blood . 2018;132(Suppl . 1)

Bruneus M, Koranteng L, Moryl N . Exploring approaches to the management of acute neoplasm related pain in patients on buprenorphine or methadone for opioid dependence . Journal of Pain and Symptom Management . 2018;55(2):692- .

Bruno R, Claret L, Wu B, Jin JY, Winter H, Cui N, Derleth CL, Shen X, Girish S, Rosenberg JE, Powles T . A tumor growth rate/overall survival model for atezolizumab as an early predictor of OS in patients with first or second line metastatic urothelial carcinoma . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Bryant A, Devlin SM, Castro-Malaspina H, Jakubowski AA, Maloy M, Papadopoulos EB, Giralt SA, Perales

MA . Efficacy of donor lymphocyte infusion in CD34(+) selected allogeneic hematopoietic stem cell transplant for myeloid and lymphoid malignancies: A single center experience . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S303-S304 .

Bryant A, Hilden P, Maloy M, Perales MA, Koehne G . Outcome predictors in CD34 selected allogeneic hematopoietic stem cell transplant for multiple myeloma . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S304-S305 .

Bryant A, Hilden P, Giralt S, Perales MA, Koehne G . Pre-salvage ISS and other important outcome predictors in CD34 selected allogeneic hematopoietic cell transplant for multiple myeloma . Blood . 2018;132(Suppl . 1)

Buchan ML, Gomes A, Stein-Thoeringer C, Slingerland J, Slingerland AE, Gyurkocza B, Jenq RR, Peets T, Jordan B, Giralt SA, van den Brink MRM, Peled JU . Intensive nutritional monitoring demonstrates association between dietary intake and microbiota injury in the intestinal tract and the oral cavity . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S45-S46 .

Buckley MT, Lengfellner JM, Koch MJ, Pacheco HO, Hoidra C, Damron DJ, Cambria R, Rodavitch A, Sabbatini P . The Memorial Sloan Kettering (MSK) electronic informed consent (eIC) platform for clinical trials: An operational model and suite of tools for obtaining informed consent, and managing consent documents . Journal of Clinical Oncology . 2018;36(15 Suppl .)

Budde LE, Sehn LH, Assouline S, Flinn IW, Isufi I, Yoon SS, Kim WS, Matasar MJ, Nastoupil LJ, Santiago R, Koh Y, Hernandez G, Li CC, Kulkarni PR, McCall B, McClellan S, Yin S, Gupta V, Chu YW, Bartlett NL . Mosunetuzumab, a full-length bispecific CD20/CD3 antibody, displays clinical activity in relapsed/refractory B-cell non-Hodgkin lymphoma (NHL):

206 OF 288


Meeting Abstracts

Interim safety and efficacy results from a phase 1 study . Blood . 2018;132(Suppl . 1)

Budha S, Giese R, Gupta A, De Henau O, Zappasodi R, Campesato LF, Barker C, Shan J, Wolchok JD, Merghoub T . Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma . Journal of Immunology . 2018;200(1 Suppl .)

Budhathoki-Uprety J, Langenbacher R, Jena P, Heller D . Polymer-functionalized carbon nanotubes as optical probes . Abstracts of Papers of the American Chemical Society . 2018;256

Budhu S, Giese R, Gupta A, Schad S, De Henau O, Zappasodi R, Campesato L, Barker C, Wolchok J, Merghoub T . Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):114- . PMCID: PMC6220480

Buonocore D, Lin O, Cohen JM . Misleading clinical significance of Bethesda category IV for thyroid nodules . Modern Pathology . 2018;31(Suppl . 2):135- .

Burd A, Levine RL, Shoben A, Mims AS, Borate U, Stein EM, Patel PA, Baer MR, Stock W, Deininger MW, Ruppert AS, Heerema NA, Vergilio JA, Brennan T, Vietz C, Vittorio M, Rosenberg L, Marcus S, Stefanos M, Druker BJ, Byrd JC . Initial report of the beat AML umbrella study for previously untreated AML: Evidence of feasibility and early success in molecularly driven phase 1 and 2 studies . Blood . 2018;132(Suppl . 1)

Burkhalter J, Atkinson TM, Li YL, Webb A, Rogers MC, Berry-Lawhorn JM, Levine R, Wilkin TJ, Bucher G, Cella D, Lee JY, Taylor J, Palefsky J . Psychosocial and symptom assessment in persons treated or monitored for anal high-grade squamous intraepithelial lesions . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S558- .

Burris J, Carpenter MJ, Cummings KM, Ostroff J, Smith GT, Studts J . The day-to-day process of smoking cessation after cancer diagnosis: A naturalistic, prospective study . Psycho-Oncology . 2018;27(Suppl . 1):48- .

Buske C, Tedeschi A, Trotman J, García-Sanz R, MacDonald D, Leblond V, Mahe B, Herbaux C, Tam CS, Palomba ML, Matous J V, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Dimopoulos MA, on behalf of the iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia . Ibrutinib/rituximab versus placebo/rituximab in Waldenström’s macroglobulinemia (WM): Results of a randomized phase 3 trial . Oncology Research and Treatment . 2018;41(Suppl . 4):252- .

Buske C, Tedeschi A, Trotman J, García-Sanz R, MacDonald D, Leblond V, Mahe B, Herbaux C, Tam CS, Palomba ML, Matous J V, Shustik C, Kastritis E, Treon SP, Lih CJ, Li J, Salman Z, Graef T, Dimopoulos MA . Ibrutinib treatment in Waldenström’s macroglobulinemia: Follow-up efficacy and safety from the iNNOVATE™ study . Blood . 2018;132(Suppl . 1)

Byrd JC, Wierda WG, Davids MS, Choi MY, Furman RR, Mato AR, Zhou L, Verdugo ME, Potluri J, Coutre S . Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib . Journal of Clinical Oncology . 2018;36(15 Suppl .):402s- .

Byrne ME, Spross J, Zivanovic O, Gardner G, Chi D, Roche KL . Risk of ovarian malignancy in patients undergoing surgery for an adnexal mass at a high-volume cancer center . Obstetrics and Gynecology . 2018;131(Suppl . 1):18S- .

Cañete-Portillo S, Sanchez DF, Fernandez MJ, Lezcano C, Velazquez E, Delgadillo LA, Silvero-Isidre A, Gauto GA, Goossen T V, Ocampos-Rojas S, Urizar C, Encina F, Rodríguez IM, Cabanas ML, Ayala ES, Cubilla A . The heterogeneous morphological spectrum of differentiated penile intraepithelial

neoplasia (D-PeIN) . A proposal of a grading system . Modern Pathology . 2018;31(Suppl . 2):331- .

Cañete-Portillo S, Sanchez DF, Piris A, Lezcano C, Silvero-Isidre A, Delgadillo LA, Barreto J, Rodríguez IM, Zarza P, Oneto S, Campagnoli T, Gonzalez L, Mihm M Jr, Velazquez E, Cubilla A . Lymphocytic depleted lichen sclerosus (LS) is preferentially associated with penile neoplasia . Modern Pathology . 2018;31(Suppl . 2):331-332 .

Campesato LF, Budhu S, Tchaicha J, Pourpe S, Liu C, Manfredi MG, McGovern K, Wolchok JD, Merghoub T . Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target . Journal of Immunology . 2018;200(1 Suppl .)

Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Sellami D, El-Hashimy M, Le Mouhaer S, Sankaran B, Bourdeau L, Baselga J . Buparlisib (BUP) or placebo (PBO) plus fulvestrant (FUL) in postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Overall survival (OS) results

from BELLE-2, a randomized, phase III study . Cancer Research . 2018;78(4 Suppl .)

Canty J, Milli L, Seidel S, Stabile C, Goldfrank D, Carter J . Evaluation of patient-report outcomes (PROs), medical and patient characteristics of colorectal/anal cancer patients/survivors . Journal of Sexual Medicine . 2018;15(6 Suppl . 2):S105- .

Cao C, Rimner A, Huang J, Jones D . A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S634-S635 .

207 OF 288


Meeting Abstracts

Carniello JS, Edelweiss M . Invasive lobular carcinoma of the breast with extracellular mucin production: A case report and review of the literature . American Journal of Clinical Pathology . 2018;149(Suppl . 1):S50- .

Carpenter ML, Wang G, Kaplan S, Nagesh V, McMillen T, Wall G, Tang Y . The Galileo Pathogen Solution next-generation sequencing pipeline detects and identifies RNA respiratory viruses in haematopoietic stem cell transplant patients . Journal of Molecular Diagnostics . 2018;20(6):954- .

Casares Magaz O, Bulow S, Pettersson N, Moiseenko V, Thor M, Einck J, Hopper A, Knopp R, Muren L . A case-control study of the relations between planned vs actually delivered rectal dose surface maps . Radiotherapy and Oncology . 2018;127(Suppl . 1):S97-S98 .

Casey D, Kushner B, Cheung NK, Modak S, La Quaglia M, Wolden S . Local control with reduced-dose radiation therapy for high-risk neuroblastoma: 3-year results from a prospective trial . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S242- .

Casey DL, Pitter KL, Imber BS, Parhar PK, Chan TA, Beal K, Yamada Y, Feldman D, Yang TJ . High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain

metastases . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E234- .

Casey DL, Pitter KL, Setton J, Braunstein LZ, Robson ME, Reis-Filho J, Weigelt B, Lu C, Powell SN, Chan TA, Lee N, Riaz N . Pathogenic mutations in ATM enhance radio-sensitivity and local control in patients with primary and metastatic breast cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S66- .

Casey DL, Wexler L, Wolden SL . Proton versus photon radiation therapy for pediatric head and neck rhabdomyosarcoma: Disease control, overall survival,

and toxicity . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E473- .

Cassell RJ, Robins MT, Gutridge AM, Uprety R, Majumdar S, Van Rijn RM . Preclinical characterization of Mitragyna speciosa alkaloids for the treatment of alcohol use disorder . Alcoholism-Clinical and Experimental Research . 2018;42(Suppl . 1):98A- .

Castro D, Diamond E, Moung C, Rosenblum M, Liu J, Baisre A . Histiocytic neoplasm harboring a MAP2K1 gene mutation presenting as a dural mass . A case presentation . Journal of Neuropathology and Experimental Neurology . 2018;77(6):524- .

Castro-Figueroa EM, Torres-Blasco N, Costas-Muñiz R, Jimenez J . Preferences, use of and satisfaction with mental health services among a sample of Puerto Rican cancer patients . Psycho-Oncology . 2018;27(Suppl . 3):49- .

Cavo M, Hofmeister CC, Chari A, Cohen YC, Spencer A, Voorhees P, Estell J, Venner C, Sandhu I, Jenner M, Williams C, van de Donk N, Beksac M, Kuppens S, Bandekar R, Neff T, Heuck C, Qi M, Goldschmidt H, Ola Landgren C . A randomized, open-label, multicenter phase 2 study of daratumumab monotherapy for patients (Pts) with intermediate or high-risk smoldering multiple myeloma (SMM): Centaurus . Haematologica . 2018;103(Suppl . 1):40-41 .

Cercek A, Dos Santos Fernandes G, Roxburgh C, Ng S, Yaeger R, Segal N, Ganesh K, Reidy D, Smith JJ, Nash G, Guillem J, Paty P, Shia J, Garcia-Aguilar J, Diaz L, Crane C, Goodman K, Saltz L, Weiser M, Stadler Z . Mismatch repair deficient rectal cancer is resistant to induction combination chemotherapy . Annals of Oncology . 2018;29(Suppl . 8):mdy281 .047- .

Cha YM, McCormick PJ, Wasey JO, Wu L, Tan J, Fiadjoe JE, Galvez JA . Pediatric difficult airway diagnoses mapping to SNOMED CT terminology . Anesthesia and Analgesia . 2018;126(4 Suppl .):551-552 .

Chaft J . Immunotherapy and surgery: Neoadjuvant or adjuvant? Is it safe? . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S284- .

Chaft JE, Dahlberg SE, Khullar O V, Edelman MJ, Simone CB, Heymach J, Rudin CM, Ramalingam SS . EA5142 adjuvant nivolumab in resected lung cancers (ANVIL) . Journal of Clinical Oncology . 2018;36(15 Suppl .):457s- .

Chaligne R, Gaiti F, Izzo F, Kothen-Hill S, Gu H, Huang K, Risso D, Schulman R, Brand RM, Lee SC, Poran A, Kim KT, Pastore A, Alonso A, Gnirke A, Wu CJ, Abdel-Wahab O I, Meissner A, Landau DA . Multimodal single-cell profiling defines the epigenetic determinants of chronic lymphocytic leukemia evolution . Blood . 2018;132(Suppl . 1)

Chan D, Freites-Martinez A, Ciccolini K, Samuels A, Lacouture M . Impact of persistent anticancer therapy-induced alopecia on quality of life . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB160- .

Chan J, Imber B, Cheung C, Banerjee A, Tihan T, Bollen A, Raleigh D, Haas-Kogans D, Mueller S, Braunstein S . Management and outcomes of non-irradiated recurrences of intracranial non-germinomatous germ cell tumors . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S430- .

Chang J, Arcila M, Montecalvo J, Desmeules P, Benayed R, Teed S, Sabari J, Borsu L, Travis W, Ladanyi M, Drilon A, Rekhtman N . Next-generation sequencing and clinicopathologic analysis of 101 pulmonary invasive mucinous adenocarcinomas focusing on comparison among molecular subtypes . Modern Pathology . 2018;31(Suppl . 2):727- .

Chapman W, Roxburgh C, Makhdoom B, Roy A, Youssef FF, Brady P, Olsen JR, Kim H, Pedersen K, Mutch M, Hunt S, Markovina S, Hajj C, Cercek A, Weiser M, Parikh PJ . Rectal cancer downstaging is significantly improved with different regimens of total neoadjuvant therapy . International Journal of

208 OF 288


Meeting Abstracts

Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S65-S66 .

Charbonnier LM, Lopez D, Bleesing J, Garcia-Lloret M, Chen K, Ozen A, Li M, Pellegrini M, Chatila TA . Functional reprogramming of regulatory T cells in the absence of Foxp3 . Journal of Immunology . 2018;200(1 Suppl .)

Chau I, Chen LT, Kang YK, Satoh T, Kato K, Chung HC, Kang WK, Chao Y, Chen JS, Ott PA, Le DT, Zhao H, Jimenez-Exposito MJ, Janjigian YY, Boku N . Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Chau I, Chen LT, Kang YK, Satoh T, Kato K, Chung HC, Kang WK, Chao Y, Chen JS, Ott PA, Le DT, Zhao H, Jimenez-Exposito MJ, Janjigian YY, Boku N . Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials . Journal of Clinical Oncology . 2018;36(15 Suppl .)

Chau K, Yang JC, Hajj C, Chelius MR, Yahalom J . Response rates of nodal versus extranodal follicular and marginal zone lymphomas to very low dose radiation therapy of only 4 Gy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E235- .

Chaudhury S, Nemecek ER, Mahadeo KM, Prockop SE, Horn B, Neudorf S, Hayes J, Skerrett D, Kurtzberg J . A phase 3 single-arm, prospective study of remestemcel-L, ex-vivo cultured adult human mesenchymal stromal cells, for the treatment of steroid refractory acute GVHD in pediatric patients . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S171-S172 .

Chavez-MacGregor M, Lei X, Morrow M, Giordano SH . Impact of the SSO-ASTRO consensus guidelines on invasive margins on the re-excision rate among patients undergoing breast conserving surgery (BCS) . Cancer Research . 2018;78(4 Suppl .)

Chelius MR, Chau K, Yang JC, Yahalom J . Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E196- .

Chen BR, Deshpande A, Kleppe M, Yeddula N, Yoh S, Armstrong SA, Levine RL, Chanda S, Deshpande AJ . Genomic and proteomic profiling of AF10-fusion oncoproteins reveal mechanisms of leukemogenesis and actionable targets . Blood . 2018;132(Suppl . 1)

Chen C, Del Rosario G, Han Z, Rydquist L, Liu H, Zeng C, Sine K, Lee C, Cahlon O, Mah D . Dosimetric robustness comparisons of treating around and through the metallic-ports embedded tissue expanders of post-mastectomy breast patients using spot-scanning proton beams . Medical Physics . 2018;45(6):e431- .

Chen L, Kit Y, Gale M, Halpern N . An unusual etiology of ventricular tachycardia . American Journal of Respiratory and Critical Care Medicine . 2018;197

Chen L, Mead E, D’Agostino R, Halpern N . Point-of-care ultrasound training program for critical care medicine advanced practice providers . Critical Care Medicine . 2018;46(1 Suppl . 1):163- .

Chen X, Hay JL, Kiviniemi MT, Waters E, Biddle C, Schofield E, Li Y, Orom H . Individualism and hierarchism are associated with lower trust in government health information . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S59- .

Chen X, Hay JL, Waters E, Kiviniemi MT, Biddle C, Schofield E, Li Y, Kaphingst K, Orom H . Examining the association between health literacy and health

information seeking . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S58- .

Chen X, Orom H, Hay JL, Waters E, Biddle C, Schofield E, Li Y, Kiviniemi MT . Comparing health information access between U .S . rural and urban populations . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S817- .

Chen YB, Armand P, Redd RA, Bsat J, Merryman RW, Coleman K, Herrera AF, Dahi PB, Nieto Y, LaCasce AS, Fisher DC, Ng SY, Odejide OO, Freedman AS, Kim A I, Crombie JL, Jacobson CA, Jacobsen ED, Wong JL, Patel SS, Ritz J, Rodig SJ, Shipp MA, Joyce RM . PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation . Blood . 2018;132(Suppl . 1)

Cheng A, Abou-Alfa G, Ren Z, Assenat E, Cubillo A, Pluntke S, Rimassa L, Ross P, Wyrwicz L, Hou J, Li C, Wu J, Ducreux M . Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress . Annals of Oncology . 2018;29(Suppl . 5):mdy151 .099- .

Cheng Y, Luo H, Izzo F, Pickering BF, Vu LP, Schurer A, Gourkanti S, Jaffrey SR, Landau DA, Kharas MG . m(6)A maintains hematopoietic stem and progenitor cell identity . Blood . 2018;132(Suppl . 1)

Chernich M, Dengina N, Degnin C, Chen Y, Gillespie EF, Hoffe SE, Latifi K, Nabavizadeh N, Usychkin S, Kharitonova E, Egorova Y, Pankratov A, Tsimafeyeu I, Tjulandin S, Thomas CR Jr, Shirvani S, Likhacheva A, Mitin T . Radiation therapy for hepatocellular carcinoma in Russia: A survey-based analysis of current practice and the impact of an educational workshop on clinical expertise . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E387- .

209 OF 288


Meeting Abstracts

Cheung J, Frederiksen R, Heller D . Facilitating targeted drug screening: A nanosensor quantifies metabolite-enzyme interactions at the single molecule level . Abstracts of Papers of the American Chemical Society . 2018;255

Chi A, Arrillaga-Romany I, Gardner S, Wen P, Batchelor T, Hall M, Odia Y, Khatua S, Zaky W, McGovern S, Harrison R, de Groot J, Sumrall A, Shonka N, Khatib Z, Karajannis M, Mueller S, Tarapore R, Merdinger K, Schalop L, Allen J, Oster W, Mehta MP . Integrated clinical experience with ONC201 in previously-treated H3 K27M-mutant glioma patients . Neuro-Oncology . 2018;20(Suppl . 6):vi19- . PMCID: PMC6216117

Chiang S, Cotzia P, Hyman D, Drilon A, Hechtman J, Jungbluth A, Murali R, Soslow R, Oliva E, Benayed R, Ladanyi M, Antonescu CR . NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma . Modern Pathology . 2018;31(Suppl . 2):412- .

Chiosis G . The chaperome in cancer - A chemical biology approach . Abstracts of Papers of the American Chemical Society . 2018;255

Chiu VK, Gallupalli R, Osman D, Zeng Z, Shia J, Paty P, Le Rolle AF . Effect of tumor progression on colon cancer stem cell plasticity . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Chmielowski B, Sullivan RJ, Postow M, Patnaik A, Shapiro G, Cohen E, Gutierrez M, Steuer C, Ribas A, Lee L, O’Connell B, Kutok J, Roberts J, Mahabhashyam S, Fjallskog ML, Wolchok JD, Hong D . The first clinical/translational data from the expansion cohorts of a Ph1/1b study of IPI-549, a tumor macrophage-reprogramming small molecule, in combination with nivolumab in advanced solid tumors . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 2):434- .

Cho C, Politikos I, Hilden P, Borrill T, Maloy M, Smith K, Giralt SA, Maslak P, O’Reilly RJ, van den Brink

MRM, Barker JN, Perales MA . Comparison of T cell subset recovery after cord blood and CD34-selected PBSC transplantation . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S363-S364 .

Cho C, Flynn J, Devlin SM, Maloy M, Giralt SA, Koehne G, Maslak P, O’Reilly RJ, Smith K, Tonon JA, Avecilla ST, Perales MA . Universal engraftment after allogeneic HCT using cryopreserved CD34(+) cell-selected grafts . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S167- .

Cho C, Maloy M, Devlin SM, Aras O, Castro-Malaspina H, Dauer LT, Jakubowski AA, O’Reilly RJ, Papadopoulos EB, Perales MA, Rappaport TS, Tamari R, van den Brink MRM, Giralt SA . Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S211-S212 .

Choi S, Yoon C, Park M, Lee D, Hong K, Ashktorab H, Smoot D, Cho S . Metformin attenuates CagA-positive Helicobacter pylori-induced gastric cancer stem-like cell phenotype mediated by CDX1 suppression . Helicobacter . 2018;23(Suppl . 1):e12525- .

Choi S I, Yoon C, Park MR, Lee D, Hong KO, Ashktorab H, Smoot DT, Cho SJ . Metformin attenuates CagA-positive Helicobacter pylori-induced gastric cancer stem-like cell phenotype mediated by CDX1 suppression . Journal of Gastroenterology and Hepatology . 2018;33(Suppl . 4):50- .

Chong CR, Park V, Harding JJ, Brite J, Wolchok JD, Kamboj M . Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer . Journal of Clinical Oncology . 2018;36(15 Suppl .)

Chong EA, Svoboda J, Nasta SD, Landsburg DJ, Winchell N, Napier E, Mato AR, Melenhorst JJ, Ruella M, Lacey SF, June CH, Schuster SJ . Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with

pembrolizumab in patients with relapsed or refractory B-cell non-Hodgkin lymphomas . Blood . 2018;132(Suppl . 1)

Choueiri TK, Flaifel A, Xie W, Braun D, Ficial M, Jennings R, Nassar A, Escudier B, George DJ, Motzer RJ, Morris MJ, Powles T, Wang E, Huang Y, Freeman G, Signoretti S . PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .040- .

Chowdhury S, McDermott R, Piulats JM, Shapiro JD, Mejlholm I, Morris D, Ostler P, Hussain A, Dumbadze I, Goldfischer ER, Pintus E, Benjelloun A, Gross ME, Tejwani S, Chatta G, Font A, Loehr A, Simmons AD, Watkins SP, Abida W . Genomic profiling of circulating tumour DNA (ctDNA) and tumour tissue for the evaluation of rucaparib in metastatic castration-resistant prostate cancer (mCRPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .004- .

Chu SHH, Chabon J, Minehart J, Matovina CN, Zhang J, Chen BR, Callen-Moreu E, Hung PJ, Feng Z, Koche R, Liu XS, Chaudhuri J, Nussenzweig A, Sleckman B, Armstrong SA . The lysine histone methyltransferase SETD2 is required for appropriate immunoglobulin VDJ recombination . Blood . 2018;132(Suppl . 1)

Cimino PJ, Kim Y, Wu HJ, Alexander J, Wirsching HG, Szulzewsky F, Pitter K, Ozawa T, Wang J, Vazquez J, Arora S, Rabadan R, Levine R, Michor F, Holland E . Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in proneural glioblastoma . Journal of Neuropathology and Experimental Neurology . 2018;77(6):482-483 .

Clark RE, Gambacorti-Passerini C, Deininger M, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, Le Coutre P, Garcia-Gutierrez V, Crescenzo R, Leip E, Bardy-Bouxin N, Hochhaus A, Bruemmendorf TH, Cortes JE, The BFORE investigators . Efficacy and safety of first-line bosutinib versus imatinib in the

210 OF 288


Meeting Abstracts

BFORE trial: 18-month follow-up . British Journal of Haematology . 2018;181(Suppl . 1):7-8 .

Clarke R, Van Der Stegen S, Chang CW, Husain M, Lai YS, Peralta E, Stokely L, Abujarour R, Dinella J, Lee T, Pribadi M, Chu H, Truong C, Sabouri-Ghomi M, Meza M, Feucht J, Eyquem J, Mansilla-Soto J, Riviere I, Sadelain M, Valamehr B . Pluripotent cell-derived off-the-shelf TCR-less CAR-targeted cytotoxic T cell therapeutic for the allogeneic treatment of B cell malignancies . Blood . 2018;132(Suppl . 1)

Clay-Gilmour A I, Camp NJ, Wei X, Norman AD, Sinnwell JP, Demangel D, Waller RG, Dumontet C, McKay J, Offit K, Chen S, O’Brien DR, Rajkumar S V, Klein R, Kumar SK, Lipkin S, Slager SL, Vachon CM . Large-scale linkage analysis of multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) families . Blood . 2018;132(Suppl . 1)

Cohen EEW, Rischin D, Pfister DG, Vermorken JB, Zhao Y, Gowda H, Ge JY, Jin F, Harrington KJ . A phase 3, randomized, open-label study of epacadostat plus pembrolizumab, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (R/M SCCHN): ECHO-304/KEYNOTE-669 . Journal of Clinical Oncology . 2018;36(15 Suppl .):344s- .

Cohen JB, Kuruvilla J, Engert A, Ansell SM, Younes A, Lee HJ, Trnený M, Savage KJ, Ramchandren R, Collins GP, Zinzani PL, De Boer JP, Shipp MA, Santoro A, Timmerman JM, Sacchi M, Sy O, Armand P . Nivolumab treatment beyond investigator-assessed progression: Extended follow-up in patients with relapsed/refractory classical Hodgkin lymphoma from the phase 2 CheckMate 205 study . Blood . 2018;132(Suppl . 1)

Cohen JB, Engert A, Ansell SM, Younes A, Trneny M, Savage KJ, Ramchandren R, Collins GP, Fanale MA, Armand P, Zinzani PL, de Boer JP, on behalf of

LLPC (Lunenburg PhaseI/II Consortium), Shipp MA, Santoro A, Timmerman JM, Sacchi M, Sy O, Kuruvilla J . Nivolumab treatment beyond investigator-assessed progression: Outcomes in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 CheckMate 205 study . British Journal of Haematology . 2018;181(Suppl . 1):87-88 .

Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals J I, Clamp A, Scambia G, Leary A, Holloway RW, O’Malley DM, Cameron T, Maloney L, Goble S, Lin K, Sun J, Giordano H, Ledermann JA . ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC) . Clinical Cancer Research . 2018;24(15 Suppl .):30-31 .

Collett D, Feder S, Aaron E, Conley S, Schulman-Green D . An assessment of palliative care educational needs and the development of advanced practice nursing in Israel . Journal of Pain and Symptom Management . 2018;55(2):573-574 .

Collins GP, Horwitz SM, Davies A, Karnad A, Samaniego F, Spira A I, Fields PA, Menne T, Boni J, Cruz H, Feingold J, He S, Wuerthner J, Hamadani M . ADCT-301 (camidanlumab tesirine), a novel pyrrolobenzodiaze-based CD25-targeting antibody drug conjugate, in a phase 1 study of replased/refractory non-Hodgkin lymphoma shows activity in T-cell lymphoma . Blood . 2018;132(Suppl . 1)

Cook DN, Peled J, van den Brink M, Jayaraman L . Drugging the human microbiome for combination with tumor immunotherapy . Cancer Immunology Research . 2018;6(9 Suppl .)

Cook RJ, Moyo T, Liesveld JL, Rizzieri DA, Stein EM, De Botton S, Roboz GJ, Sekeres MA, Jurcic JG, Raza A, Redner RL, Bixby DL, Cortes JE, Stephens K, Volkert A, Kang Q, Di Tomaso E, Roth DA, Vigil CE . Early results from a biomarker-directed phase 2 trial of SY-1425 in combination with azacitidine or

daratumumab in non-APL acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) . Blood . 2018;132(Suppl . 1)

Cooney T, Onar-Thomas A, Huang J, Lulla R, Fangusaro J, Kramer K, Baxter P, Fouladi M, Dunkel IJ, Warren KE, Monje M . A phase 1 trial of the histone deacetylase inhibitor panobinostat in pediatric patients with recurrent or refractory diffuse intrinsic pontine glioma: A Pediatric Brain Tumor Consortium (PBTC) Study . Neuro-Oncology . 2018;20(Suppl . 2):i53- .

Cope S, Toor K, Fonseca R, Landgren O, Mateos M V, Weisel K, Jansen JP . Why clinicians are not relying on evidence from indirect comparison studies evaluating comparative efficacy of interventions for relapsed or refractory multiple myeloma: A critical review . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S251-S252 .

Corbacioglu S, Kernan NA, Pagliuca A, Ryan R, Tappe W, Richardson P . Incidence of post-hematopoietic stem cell transplantation (HSCT) veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) without hyperbilirubinemia at diagnosis and efficacy of defibrotide in an expanded-access program . Blood . 2018;132(Suppl . 1)

Corbett V, Wang R, Lowery M, Reidy-Lagunes D, Raj N . Treatment response and clinical outcomes of poorly differentiated (PD) grade 3 (G3) gallbladder neuroendocrine carcinomas (NEC): A single institution experience . Pancreas . 2018;47(3):336-337 .

Corcoran S, Thom B, Decker K . Electronic patient-reported outcomes (ePRO) in survivorship practice . Journal of Clinical Oncology . 2018;36(7 Suppl .)

Correa D, Kryza-Lacombe M, Zhou X, Baser R, Beattie B, Beiene Z, Orlow I, Humm J, DeAngelis L, Weber W, Osborne J . A pilot study of neuropsychological functions, APOE, and amyloid imaging in patients with gliomas . Cancer

211 OF 288


Meeting Abstracts

Epidemiology Biomarkers and Prevention . 2018;27(7 Suppl .)

Cortes JE, Chen C, Mauro MJ, Sen GP, Gajavelli S, Davis C, Goldberg SL . Dosing patterns of dasatinib use in simplicity, an observational study in chronic phase chronic myeloid leukemia (CP-CML) patients (pts) in routine clinical practice . Blood . 2018;132(Suppl . 1)

Costas-Muñiz R, Torres N, Garduño-Ortega O, Castro E, Gonzalez CJ, Gany F . Cultural adaptation of meaning-centered psychotherapy for Latinos in the US and Puerto Rico . Psycho-Oncology . 2018;27(Suppl . 3):25-26 .

Costas-Muñiz R, Galindo-Vazquez O, Montaña MF, Castro-Figueroa EM . FIPOL: A Latin American network developing collaborations and educational opportunities in psychosocial oncology . Psycho-Oncology . 2018;27(Suppl . 3):48- .

Costas-Muniz R, Garduño-Ortega O . Adapting meaning-centered psychotherapy for Latinos . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S673- .

Cotzia P, Al-Ahmadie H, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo S, Reuter V, Fine SW . Grade group 2 prostate cancer with poorly formed glands alone on needle biopsy: Histologic features and pathologic outcomes at radical prostatectomy . Modern Pathology . 2018;31(Suppl . 2):335-336 .

Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow R, Antonescu CR, Ladanyi M, Chiang S . Undifferentiated uterine sarcomas represent underrecognized high-grade endometrial stromal sarcomas . Modern Pathology . 2018;31(Suppl . 2):415-416 .

Cotzia P, Ptashkin R, Gounder MM, Pfister DG, Berger MF, Ladanyi M, Ghossein R, Antonescu CR, Dogan S . Genetic and histologic spectrum of SMARCB1-deficient carcinomas of the head and neck

including sinonasal tract, thyroid and skin . Modern Pathology . 2018;31(Suppl . 2):474-475 .

Crago AM, Socci ND, Qin LX, Wilder F, O’Connor R, Craig A, van Houdt W, Weinhold N, Kandoth C, Viale A, Antonescu C, Singer S . Multiplatform analysis of paired primary and recurrent well- and dedifferentiated liposarcoma samples defines copy number alterations as dominant drivers of initiation and progression . Clinical Cancer Research . 2018;24(2 Suppl .):35-36 .

Crivello P, Arrieta-Bolaños E, Shaw BE, Ahn KW, Wang HL, Verneris MR, Hsu K, Pidala J, Lee SJ, Fleischhauer K, Spellman S . In silico prediction of non-permissive HLA-DPB1 mismatches in unrelated HCT by functional distance . HLA . 2018;91(5):399-400 .

Crosswell HE, LaCasce AS, Bartlett NL, Straus DJ, Savage KJ, Fenton K, Engley G, Jolin H, Liu R, Zinzani PL, Collins GP, Grigg AP . Brentuximab vedotin with chemotherapy in adolescents and young adults (AYA) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 ECHELON-1 study . Blood . 2018;132(Suppl . 1)

Cuesta-Domínguez A, Mosialou I, Zhao J, Yoshimi A, Panitsas K, Friedman RA, Abdel-Wahab O, Rabadan R, Kousteni S . Activation of ß-catenin signaling in mature osteoblasts versus osteoblast progenitors defines a transcriptional and mutational profile for the transformation of MDS to AML . Journal of Bone and Mineral Research . 2018;33(Suppl . 1):71- .

Cwikla J, Kolasinska-Cwikla A, Lewczuk-Myslinska A, Palucki J, Roszkowska-Purska K, Kidd M, Bodei L, Modlin I . Clinical use of Lanreotide AG as initial therapy in patients with advanced, non-resectable well (G1) and moderate (G2) differentiated pancreatic neuroendocrine neoplasms (p-NEN) . Neuroendocrinology . 2018;106(Suppl . 1):187- .

D’Angelo S, Stadanlick J, Druta M, Liebner D, Schuetze S, Van Tine B, Tap W, Britten C, Chagin K, Hasan A, Norry E, Trivedi T . Preliminary clinical

data from a pilot study of NY-ESO-1c259T-cells in advanced myxoid/round cell liposarcoma . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

D’Angelo SP, Hunger M, Schlichting M, Hennessy MG, Bharmal M . Association between objective responses (OR) and overall survival (OS) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab . Journal of Clinical Oncology . 2018;36(5 Suppl .)

D’Angelo SP, Russell JS, Bhatia S, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Hennessy M, Bajars M, Zwiener I, Nghiem P . 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy . Journal of Clinical Oncology . 2018;36(5 Suppl .)

D’Angelo SP, Fofana F, Schlichting M, Henry-Szatkowski M, Hennessy M, Bharmal M . Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab . Annals of Oncology . 2018;29(Suppl . 8):mdy289 .038- .

Dahi PB, Rondon Clavo C, Maloy M, Seier K, Devlin SM, Robinson K, Scordo M, Shah GL, Tamari R, Matasar MJ, Hamlin P, Jakubowski AA, Sauter CS, Moskowitz CH, Giralt SA . Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S130- .

Dai P, Meyer C, Shaw K, Wang Y, Anderson L, Shuman S, Tuschl T, Deng L . The cytosolic dsRNA-sensing pathway mediated by MDA5/MAVS/IRF3 is critical for the induction of type I and III IFNs after viral infection of skin keratinocytes . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S154- .

212 OF 288


Meeting Abstracts

Daigle S, Stacchiotti S, Schöffski P, Villalobos V, Cote G, Chugh R, Chen TWW, Jahan T, Loggers ET, Italiano A, Gupta A, Agulnik M, Attia S, Jones RL, van Tine BA, Demetri GDD, Clawson A, Roche M, Blakemore S, Gounder M . Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950) . Annals of Oncology . 2018;29(Suppl . 8):mdy304- .

Dandoy CE, Chen M, Kim S, Komanduri K, Lindemans CA, Perales MA, Riches ML . Burden and outcomes of mucosal barrier injury-laboratory confirmed bloodstream infections (MBI-LCBI) in the first 100 days after allogeneic stem cell transplant: A CIBMTR analysis . Blood . 2018;132(Suppl . 1)

Dang C, Ewer MS, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, de la Cruz Merino L, Lucas J, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Eng-Wong J, Swain SM . Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE study . Cancer Research . 2018;78(4 Suppl .)

Das RK, Furchtgott L, Ou FS, Swanson D, Hayete B, Harms B, Cunha D, Latourelle J, Wuest D, Khalil I, Washburn C, Rich K, Blanke CD, Meyerhardt J, Niedzwiecki D, Nixon A, O’Reilly EM, Innocenti F, Lenz HJ, Venook A . Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC) . Annals of Oncology . 2018;29(Suppl . 8):mdy281 .006- .

Dason S, McPherson V, Teo MY, Isharwal S, Audenet F, Bagrodia A, Cha EK, Berger MF, Zehir A, Schultz N, Bajorin DF, Rosenberg JE, Al-Ahmadie H, Bochner BH, Pietzak EJ, Solit DB, Iyer G . Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Davick J, Williams E, Barrionuevo C, Pulitzer M, Sanchez JA, Miyashiro D, Casavilca S, Duenas D, Ratner L, Ramos JC, Servitje O, Esteller FC, Gru A . Genomic alterations using OncoScan in adult T-cell leukemia/lymphoma: A characterization of 69 cases from Peru, the United States, Brazil, and Spain . European Journal of Cancer . 2018;101(Suppl . 1):S15- .

Davids M, Roberts A, Seymour J, Wierda W, Puvvada S, Gressick L, Alter D, Zhou L, Kim S, Verdugo M, Gerecitano J . Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) . British Journal of Haematology . 2018;181 (Suppl . 1):74- .

Davids MS, Seymour JF, Roberts AW, Eichhorst B, Kipps TJ, Mato AR, Stilgenbauer S, Mobasher M, Desai MB, Potluri J, Pena GE, Verdugo ME, Nielsen J, Cyr A, Fleming LL, Hallek MJ . Mitigation of tumor lysis syndrome (TLS) complications with venetoclax (VEN) in CLL . Journal of Clinical Oncology . 2018;36(15 Suppl .):406s- .

de Azambuja E, Saura C, Nuciforo P, Frantal S, Oliveira M, Zardavas D, Jallitsch-Halper A, de la Pena L, Dubsky P, Lombard JM, Vuylsteke P, Altamirano CC, Sanchez C, Ballestrero A, Colleoni M, Borges GS, Ciruelos E, Bardia A, Fornier M, Boer K, Wilson TR, Stout TJ, Hsu JY, Shi Y, Piccart M, Baselga J, Gnant M . Ki67 changes and PEPI score in the LORELEI trial: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative early-stage breast cancer . Cancer Research . 2018;78(4 Suppl .)

de Blank P, Li N, Ullrich N, Fisher MJ, Bhatia S, Yasui Y, Sklar C, Leisenring W, Howell R, Oeffinger K, Hardy K, Okcu MF, Gibson T, Robison L, Armstrong GT, Krull K . Effect of neurofibromatosis type 1 on long-term health outcomes in adult survivors of childhood astrocytoma: A report from the Childhood Cancer Survivor Study . Neuro-Oncology . 2018;20(Suppl . 2):i142- . PMCID: PMC6012612

de Bono JS, Hansen A, Choudhury AD, Cook N, Heath E I, Higano C, Linch M, Martin-Liberal J, Rathkopf DE, Wisinski KB, Barry S, de Bruin E, Brugger W, Colebrook S, Klinowska T, Moschetta M, Mortimer PGS, Siu LL, Shapiro G . AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .042- .

De Braganca K, Benitez V, Gilheeney S, Karajannis M, Khakoo Y, Kramer K, Wolden S . Delayed RT in select patients with DIPG . Neuro-Oncology . 2018;20(Suppl . 2):i51-i52 .

de Wit R, Kulkarni GS, Uchio E, Singer EA, Krieger L, Grivas P, Bajorin D, Seo HK, Mourey L, Kamat A, Nishiyama H, Kapadia E, Nam K, Frenkl T, Balar A . Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG): Phase II KEYNOTE-057 trial . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .073- .

Deasy J, Lee SK, Oh JH, Kerns S, Orstrer H, Rosenstein B . Machine learning of radiogenomics SNP GWAS to predict complication risk and to identify key biological correlates . Radiotherapy and Oncology . 2018;127(Suppl . 1):S249- .

DeLair D, Fix D, Soslow R, Chiang S, Park K, Murali R, Makker V, Cadoo K, Aghajanian C, Mueller J, Leitao M, Abu-Rustum N, Weigelt B . Integration of massively parallel sequencing and immunohistochemistry for the classification of prospectively collected endometrial cancers into prognostically relevant subgroups . Modern Pathology . 2018;31(Suppl . 2):416- .

DeMatteo R . Immune mechanisms in gastrointestinal stromal tumor . Clinical Cancer Research . 2018;24(2 Suppl .):24-25 .

Deng L, Yang N, Dai P, Wang Y, Wang W, Merghoub T, Wolchok JD, Shuman S . Investigation

213 OF 288


Meeting Abstracts

of the immunological mechanisms underlying the attenuation of vaccinia virus lacking host-range factor C7 . Journal of Immunology . 2018;200(1 Suppl .)

Dent R, Tan T, Kim SB, Traina T, McArthur H, Im YH, Creel T, Blackwell K . The DORA trial: A non-comparator randomised phase II multi-center maintenance study of olaparib alone or olaparib in combination with durvalumab in platinum treated advanced triple negative breast cancer (TNBC) . Cancer Research . 2018;78(4 Suppl .)

Deshpande A, Chen B, Ramezani-Rad P, Pastore A, Zhao L, Weigert O, Armstrong SA, Rickert RC, Ren B, Deshpande AJ . Targeting MYC-driven B-cell lymphoma by inhibition of the histone methyltransferase DOT1L . Blood . 2018;132(Suppl . 1)

Di Cosimo S, Triulzi T, De Cecco L, Pizzamiglio S, de Azambuja E, Fumagalli D, Pusztai L, Harbeck N, Izquierdo M, de la Pena L, Huober J, Baselga J, Piccart M, Verderio P, Tagliabue E . Identifying clinically relevant subgroups of women with HER2-positive breast cancer: An analysis of Neo-ALTTO using the 41-gene TRAR score . Cancer Research . 2018;78(4 Suppl .)

Di Leo A, Dickler M, Sledge GW, Toi M, Forrester T, Nanda S, Koustenis A, Bourayou N, Johnston S . Efficacy and safety of abemaciclib in patients with liver metastases in the MONARCH 1, 2, and 3 studies . Cancer Research . 2018;78(4 Suppl .)

Di Meglio A, El-Mouhebb M, Michiels S, Jones L, Annonay M, Zingarello A, Matias M, Everhard S, Martin AL, Arveux P, Tredan O, Soulie P, Cottu PH, Partridge AH, Del Mastro L, Ligibel JA, André F, Vaz-Luis I . Overweight, obesity and weight gain after breast cancer (BC): A prospective clinical study . Annals of Oncology . 2018;29(Suppl . 8):mdy300 .055- .

Di Meglio A, El-Mouhebb M, Michiels S, Jones L, Martin E, Matias M, Palhares AEL, Joly F, Vanlemmens L, Everhard S, Martin AL, Lemonnier J, Arveux P, Cottu PH, Coutant C, Del Mastro L, Partridge AH,

André F, Ligibel JA, Vaz-Luis I . Weight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC) . Annals of Oncology . 2018;29(Suppl . 8):mdy300 .056- .

Di Meglio A, El-Mouhebb M, Michiels S, Carene D, Everhard S, Martin AL, Cottu PH, Lerebours F, Coutant C, Lesur A, Tredan O, Soulie P, Vanlemmens L, Arveux P, Delaloge S, Ganz P, André F, Partridge AH, Jones L, Vaz-Luis I . Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC) . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .086- .

Diab A, Marcondes M, Tagliaferri MA, Hoch U, Zhang J, Rubas W, Kivimae S, Zalevsky J, Conley AP, Borazanci E, D’Angelo SP . REVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .433- .

Diamond JR, Standifer N, Ascierto ML, Morehouse C, Ghadially H, Canales JR, Rebelatto MC, Naidoo J, Mazzarella L, Patel S, Oncala MJF, Gordoa TA, Wang D, Song X, Jones DC, Li X, Marshall S, Abdullah S, Jure-Kunkel M, Hellmann MD . Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A) . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .067- .

Diamond LC, Gregorich S, Pathak S, Kaplan CP, Livaudais-Toman J, Karliner LS . Comparing physician and patient ratings of physicians’ non-English language skills . Journal of General Internal Medicine . 2018;33(Suppl . 2):S145- . PMCID: PMC5913041

Dickler MN, Villanueva R, Fidalgo JAP, Mayer IA, Boni V, Winer EP, Hamilton EP, Bellet M, Urruticoechea

A, Gonzalez-Martin A, Cortes J, Martin M, Giltnane J, Gates M, Cheeti S, Fredrickson J, Wang X, Friedman LS, Spoerke JM, Metcalfe C, Liu L, Li R, Morley R, McCurry U, Chan IT, Mueller L, Milan S, Lauchle J, Humke EW, Bardia A . A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC) . Cancer Research . 2018;78(4 Suppl .)

Dickson BC, Rosenblum M, Swanson D, Wunder JS, Antonescu CR . NUT carcinoma: A midline shift - Identification of a subset of undifferentiated soft tissue and visceral tumors defined by NUTM1 gene fusions . Modern Pathology . 2018;31(Suppl . 2):23- .

Dierov D, Ciolino C, Fatmi S, Prockop SE, Perales MA, Ponce DM . Establishing a standardized system to capture chronic graft-versus-host disease (GVHD) data in accordance to the National Institutes of Health (NIH) consensus criteria . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S103- .

DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Swords R, Collins RH, Mannis GN, Pollyea DA, Donnellan W, Fathi AT, Pigneux A, Erba HP, Prince GT, Stein AS, Uy GL, Foran JM, Traer E, Stuart RK, Arellano ML, Slack JL, Sekeres MA, Willekens C, Choe S, Wang H, Zhang V, Yen KE, Kapsalis SM, Yang H, Dai D, Fan B, Goldwasser M, Liu H, Agresta S, Wu B, Attar EC, Tallman MS, Stone RM, Kantarjian HM . Ivosidenib (AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia: Results of a phase 1 study . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S204-S205 .

DiNardo CD, Watts JM, Stein EM, de Botton S, Fathi AT, Prince GT, Stein AS, Foran JM, Stone RM, Patel PA, Tallman MS, Choe S, Wang H, Zhang V, Dai D, Fan B, Yen KE, Kapsalis SM, Hickman D, Agresta S V, Liu H, Wu B, Attar EC, Kantarjian HM . Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant relapsed

214 OF 288


Meeting Abstracts

or refractory myelodysplastic syndrome: Results from a phase 1 dose escalation and expansion study . Blood . 2018;132(Suppl . 1)

Dinares GM, Albanese SK, Chow A, Schurer A, Park SM, Rotsides CZ, Taggart J, Rizzi A, Naden LN, Chou T, Gourkanti S, Cappel D, Passarelli MC, Fairchild L, Adura C, Glickman JF, Schulman J, Famulare C, Patel M, Eibl JK, Ross GM, Tan D, Leslie C, Beuming T, Goldgur Y, Chodera JD, Kharas MG . Small-molecule targeting of Musashi RNA-binding activity in acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Docampo MD, Stein-Thoeringer CK, Lazrak A, Burgos da Silva MD, Cross J, van den Brink MRM . Expression of the butyrate/niacin receptor, GPR109a on T cells plays an important role in a mouse model of graft versus host disease . Blood . 2018;132(Suppl . 1)

Dodd T, Collum K, Conway HJ, Johnson P, Kasow KA, Stentz J . Increasing work resilience of the Quality Manager (QM) in order to improve their effectiveness in contributing to program success . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S428-S429 .

Doebele R, Ahn M, Siena S, Drilon A, Krebs M, Lin C, De Braud F, John T, Tan D, Seto T, Dziadziuszko R, Arkenau H, Barlesi F, Rolfo C, Wolf J, Chow-Maneval E, Multani P, Cui N, Riehl T, Cho BC . Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S321-S322 .

Dogan S, Xu B, Middha S, Zehir A, Ganly I, Ladanyi M . NKX2-1 amplification is associated with aggressive features in a subset of differentiated thyroid carcinomas of follicular cell origi . Modern Pathology . 2018;31(Suppl . 2):230-231 .

Dolan R, McSorley ST, Park JH, Roxburgh CSD, Horgan PG, McMillan DC . The prognostic value of systemic inflammation in patients undergoing surgery for rectal cancer: Comparison of composite ratios

and cumulative scores . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Domchek SM, Robson M, Im SA, Senkus E, Xu B, Masuda N, Delaloge S, Li W, Armstrong A, Conte P, Bannister W, Goessl C, Runswick S, Goel S, Tung N . Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD . Cancer Research . 2018;78(4 Suppl .)

Donzelli M . Programmable VP shunts: Indications, safety and warnings . Neuro-Oncology . 2018;20(Suppl . 2):i152- . PMCID: PMC6012612

Dos Santos Fernandes G, Chatila W, Yaeger R, Mendelsohn R, Stadler Z, Segal NH, Varghese A, Reidy D, Diaz L, Shia J, Vakiani E, Hechtman J, Schultz N, Berger M, Hyman D, Solit D, Saltz L, Garcia Aguilar J, Cercek A . Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically? . Annals of Oncology . 2018;29(Suppl . 8):mdy281 .137- .

Downs-Canner S, Zabor E, Wind T, Cobovic A, Morrow M, Heerdt A . Radiation therapy after breast conserving therapy in women 70 and older: How wisely do we choose? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S94-S95 .

Dozier J, Chen N, Saini J, Chintala N, Adusumilli P . Comparative efficacy of T-cell intrinsic versus extrinsic PD-1 blockade to overcome PD-L1+ tumor-mediated exhaustion . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S392- .

Drain C, Wall M, Kircher M . Surfactant-free shape control of gold nanoparticles enabled by unified theoretical framework of nanocrystal synthesis . Abstracts of Papers of the American ChemicalSociety . 2018;255

Drilon A, Clark J, Weiss J, Ou S, Camidge DR, Solomon B, Otterson G, Villaruz L, Riely G, Heist R, Shapiro G, Murphy D, Wang S, Usari T, Li S, Wilner K, Paik P . Updated antitumor activity of crizotinib in patients with MET exon 14-altered advanced non-small cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S348- .

Drilon AE, Subbiah V, Oxnard GR, Bauer TM, Velcheti V, Lakhani NJ, Besse B, Park K, Patel JD, Cabanillas ME, Johnson ML, Reckamp KL, Boni V, Loong HHF, Schlumberger M, Solomon B, Cruickshank S, Rothenberg SM, Shah MH, Wirth LJ . A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers . Journal of Clinical Oncology . 2018;36(15 Suppl .):6s- .

DuHamel K, Valdimarsdottir H, Granski J, Tigershtrom A, Prescott N, Chen J, Winkel G, Redd W . Expectancy and retention of participants in an RCT of systematic light exposure in the treatment for HSCT survivors’ fatigue . Psycho-Oncology . 2018;27(Suppl . 3):183- .

Durham BH, Lopez-Rodrigo E, Abramson DH, Picarsic J, Pastore A, Mandelker D, Walsh MF, Arcila ME, Ladanyi M, Solit D, Berger MF, Hyman DM, Ki M, Dunkel I, Geissmann F, Diamond EL, Abdel-Wahab O I . Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms . Blood . 2018;132(Suppl . 1)

Eastburn DJ, McMahon CM, Viny A, Bowman R, Miles L, Durruthy-Durruthy R, Levine RL, Carroll M, Smith CC, Perl AE . Longitudinal monitoring of AML tumors with high-throughput single-cell DNA sequencing reveals rare clones prognostic for disease progression and therapy response . Journal of Molecular Diagnostics . 2018;20(6):928-929 .

El Asmar M, Zhang J, Caushi J, Ji Z, Anagnostou V, Cottrell T, Chan HY, Suri P, Guo H, Marrone K, Naidoo J, Merghoub T, Chaft J, Hellmann M, Taube J, Brahmer J, Forde P, Velculescu V, Pardoll D, Ji H, Smith K . Neoantigen targeting and T cell reshaping in

215 OF 288


Meeting Abstracts

resectable NSCLC patients treated with neoadjuvant PD-1 blockade . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S370- .

Elias A, Gucalp A, Bardia A, Resaul A, Eisner J, Baskin-Bey E, Traina TA . Men with advanced breast cancer (BC): Initial phase (Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor . Cancer Research . 2018;78(4 Suppl .)

Elrick A, Wu YP, Banerjee S, Kaphingst K . Family communication of cancer genetic information . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S175- .

Emoto K, Aly RG, Montecalvo J, Rekhtman N, Eguchi T, Tan KS, Adusumilli PS, Travis W . Clinical significance of morphological patterns of micropapillary lung adenocarcinoma: Classical and filigree patterns . Modern Pathology . 2018;31(Suppl . 2):731- .

Emoto K, Eguchi T, Vaghjiani R, Takahashi Y, Rekhtman N, Adusumilli P, Travis W . The newly recognized filigree pattern of micropapillary (MIP) lung adenocarcinoma (LADC) is as clinically important as the classical pattern . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S386-S387 .

Eng ET, Yang H, Raczkowski AM, Patel D, Potter CS, Carragher B . Cryo-EM studies on the mechanism and inhibition of target DNA binding in the type I-F Csy surveillance complex . Biophysical Journal . 2018;114(3 Suppl . 1):164a- .

Ennin E, De Braganca K, Haque S, Marghoob A, Khakoo Y . Characteristics of patients with neurocutaneous melanosis: The MSK experience from 2003-2018 . Neuro-Oncology . 2018;20(Suppl . 6):vi236- . PMCID: PMC6216117

Epstein A, Campbell T, Fahy-Chandon B, Cammy R, Jones J, Chow K, Finlay E . Moving forward together: Enhancing the oncologist-palliative care clinician relationship for comanagement care models . Journal

of Pain and Symptom Management . 2018;55(2):652-653 .

Epstein A, Klimek V, Chow K, Desai A, Anderson K, Rawlins-Duell R, Goldberg J, Nelson J . Palliative care from cancer diagnosis for all: Memorial Sloan Kettering’s “One-Two-Three’’ program . Journal of Pain and Symptom Management . 2018;55(2):623-624 .

Epstein-Peterson ZD, Soff GA, Fenelus M, Korenstein D . Folate testing and deficiency in hospitalized cancer patients . Blood . 2018;132(Suppl . 1)

Ercolano E, Lazenby M, Grant M, Holland J, Badger T, McCorkle R . Screening for psychosocial distress program curriculum: Structure and process . Psycho-Oncology . 2018;27(Suppl . 1):96- .

Eyquem J, Mansilla-Soto J, Sadelain M . TCR integration into the TRAC loci enhances T cell function . Molecular Therapy . 2018;26(5 Suppl . 1):342-343 .

Ezeoke OM, Brooks G, Postow MA, Baxi S, Diamond L . Associations between race/ethnicity and enrollment in cancer research protocols . Cancer Epidemiology Biomarkers and Prevention . 2018;27(7 Suppl .)

Fabrizio D, Chen SJ, Xie M, Chen W, Quin KJ, Zhao C, Zehir A, Funari V, Dickey JS, Gupta V, Cyanam D, McShane LM, Rizvi NA, Hellmann M, Stewart M, Merino DM, Allen J, Friends of Cancer Research TMB Harmonization Team . In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 2):434- .

Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, Khatua S, Boyett J, Williams-Hughes C, Souweidane M, Lu HM, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, Gajjar A, Dhall G . A Phase 2 trial of response-based radiation therapy for patients with localized central nervous system germ cell

tumors (CNS GCT): A Children’s Oncology Group (COG) study . Neuro-Oncology . 2018;20(Suppl . 2):i86- .

Farago A, Kummar S, Ibabekci S, Corsi-Travali S, Cruickshank S, Cox M, Ku N, Drilon A . Rapid, robust and durable responses to larotrectinib in patients with TRK fusion non-small cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S597-S598 .

Faramand R, Kotani H, Morrissey D, Yu B, Locke FL, Jain MD, Chavez JC, Wang X, Mishra A, Bachmeier CA, Brentjens RJ, Yoo S, Park JH, Davila ML . Prediction of CAR T-related toxicities in R/R DLBCL patients treated with axicabtagene ciloleucel using point of care cytokine measurements . Blood . 2018;132(Suppl . 1)

Farouk Sait S, Trippett T, Lyden D, Haque S, Rosenblum M . Extraneural metastases in pediatric glioblastoma multiforme: A case report and literature review . Pediatric Blood and Cancer . 2018;65(S1):S28-S29 .

Fasani R, Comerma L, Pagliuca F, Thyparambil S, Peg V, Jimenez J, Cecchi F, Hembrough T, Perez J, Arribas J, Cortes J, Scaltriti M, Saura C, Nuciforo P . Tumor-infiltrating lymphocytes density correlates with HER2 gene copy number but not with protein levels in HER2-positive breast cancer . European Journal of Cancer . 2018;92(Suppl . 3):S128- .

Favazza L, Soslow R, Leitao M, DeLair D . Clinical outcomes of patients with tumoral displacement into fallopian tubes in patients treated by robotically assisted hysterectomy for newly diagnosed endometrial cancer . Modern Pathology . 2018;31(Suppl . 2):419-420 .

Feit N, Smith E, Cambria R, Anopa J, Deighan J, Pamer E, Wilson R, Greenfield J, Zivanovic O, Hyman D . Utilization, safety, and efficacy of the FDA compassionate use program . European Journal of Cancer . 2018;103(Suppl . 1):e112- .

216 OF 288


Meeting Abstracts

Feldman DR, Lee CH, Molina AM, Knezevic A, Chen Y, Chaim J, Coskey DT, Ged Y, Tickoo S, Reuter VE, Patil S, Xiao H, Aghalar J, Apollo AJ, Carlo M I, Motzer RJ, Voss MH . Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Feliciano J, Mueller K, Korol EE, He Z, Khan N, Matasar MJ . Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in the United States . Blood . 2018;132(Suppl . 1)

Felip E, Sakai H, Patel J, Horn L, Veillon R, Griesinger F, Bruns R, Scheele J, Paik P . Phase II data for the MET inhibitor tepotinib in patients with advanced NSCLC and MET exon 14-skipping mutations . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S347- .

Fenelus M, Peerschke E . Testing for heparin-induced thrombocytopenia in cancer patients . American Journal of Clinical Pathology . 2018;149(Suppl . 1):S180-S181 .

Ferraro DA, Zalcberg JR, Shi Q, Meyers JP, Seymour MT, Saltz L, Maughan T, Goldberg RM, Van Cutsem E, Heinemann V, Hurwitz H, Falcone A, Diaz-Rubio E, Chibaudel B, Fuchs CS, Porschen R, Bokemeyer C, De Gramont A, Price T, Adams R . Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Feucht J, Sun J, Eyquem J, Ho YJ, Zhao Z, Leibold J, Dobrin A, Cabriolu A, Hamieh M, Sadelain M . Calibrated CAR activation potential directs alternative T cell fates and therapeutic potency . Blood . 2018;132(Suppl . 1)

Filosso PL, Kidd M, Roffinella M, Chung KM, Lewczuk A, Kolasinska-Cwikla A, Cwikla J, Malczewska A, Tesselaar M, Kos-Kudla B, Papotti M, Bodei L, Drozdov I, Modlin I . The clinical utility of blood neuroendocrine gene transcript measurement in defining surgical resection and residual disease in bronchopulmonary neuroendocrine tumors . Pancreas . 2018;47(3):338- .

Fine SW, Al-Ahmadie H, Vertosick E, Sjoberg D, Vickers A, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo S, Reuter V . Impact of zone of origin in anterior-dominant prostatic tumors: Long-term biochemical recurrence-free survival in an anatomically well-annotated series . Modern Pathology . 2018;31(Suppl . 2):340- .

Finlayson C, Fu M, Squires A, Van Cleave J, Applebaum A . The experience of being aware of disease status among women with recurrent ovarian cancer: A phenomenological study . Nursing Research . 2018;67(2):E61- .

Fitzgerald KJ, Flynn J, Zhigang Z, Gillespie EF, Khan AJ, Cahlon O, McCormick B, Powell SN, Braunstein LZ . Accelerated partial breast irradiation in guideline-defined suitable and cautionary patients . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E585- .

Flanagan M, Zabor E, Stempel M, Mangino D, Morrow M, Pilewskie M . Chemoprevention uptake for breast cancer risk reduction varies by risk factors . Annals of Surgical Oncology . 2018;25(Suppl . 1):S10- .

Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HS . At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required? . Journal of Clinical Oncology . 2018;36(15 Suppl .):23s- .

Fleischhauer K, Toffalori C, Ahci M, Lange V, Lang K, Todaro S, Stempelmann K, Heinold A, Stölzel F, Waterhouse M, Claus R, Gendzekhadze K, Onozawa M, Devillier R, Tang R, Ulman M, Lazarevic D,

Stanghellini MTL, Peccatori J, Steckel NK, Horn PA, Picardi A, Manetta S, Pinana JL, Sanz J, Schaffer B, Arcese W, Sanz G, Benedetto B, Pini M, Kobbe G, Hsu KC, Al Malki M, Teshima T, Kröger N, Finke J, Nagler A, Blaise D, Mohty M, Bornhauser M, Beelen DW, Schmidt A, Ciceri F, Vago L . Investigation of HLA loss relapse after allogeneic stem cell transplantation in a global multicentric cohort (HLALOSS Consortium) . Oncology Research and Treatment . 2018;41(Suppl . 4):237-238 .

Florescu D, Grimley M, Papanicolaou G, Prasad V, Vainorius E, Chittick G, Brundage T, Nichols G . Brincidofovir was used to successfully treat adenovirus infections in solid organ transplant recipients and other immunocompromised patients . American Journal of Transplantation . 2018;18(Suppl . 4):360- .

Flory J, Taur Y . Identifying adverse drug effects from granular longitudinal inpatient data . Pharmacoepidemiology and Drug Safety . 2018;27(Suppl . 2):247- .

Fong L, Fong L, Powderly J, Luke J, Hotson D, Sznol M, George S, Choueiri T, Rini B, Hellmann M, Kummar S, Hernandez-Aya L, Mahadevan D, Hughes B, Markman B, Riese M, Brody J, Renouf D, Heist R, Goodwin R, Weise A, Emens L, Willingham S, Kwei L, Laport G, Miller R . Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444 . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Fonseca M, Jakubowski AA, Devlin SM, Young JW, Fatmi SA, Maloy M, Giralt S, Ponce D, Markova A . HLA-a*0101 expression correlates with increased risk of severe cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation . Blood . 2018;132(Suppl . 1)

217 OF 288


Meeting Abstracts

Fontanella A, Wild A, Lim SB, Mechalakos JG, Popple RA, Fiveash JB, Yamada Y, Lovelock DM . A dosimetric analysis of dorsal nerve root ablation therapy using a virtual cone technique . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E510- .

Foran JM, Sun Z, Paietta E, Racevskis J, Claxton DF, Lazarus HM, Arber DA, Rowe JM, Godwin J, Zhang Y, Tallman MS, Litzow MR, Pratz KW, Luger S . FLT3-ITD mutations are prevalent and significantly impact outcome after intensive therapy in elderly adults with acute myeloid leukemia (AML): Analysis of the North

American Intergroup E2906 phase III trial in patients age ≥ 60 years . Blood . 2018;132(Suppl . 1)

Foran JM, Sun Z, Paietta E, Racevskis J, Claxton DF, Lazarus HM, Arber DA, Rowe JM, Altman JK, Al-Kali A, Zheng H, Pratz KW, Broun ER, Powell BL, O’Dwyer KM, Godwin J, Zhang Y, Tallman MS, Luger S, Litzow MR . Minimal residual disease (MRD) at time of complete remission is commonly detected in acute myeloid leukemia (AML) patients age ≥ 60 years and significantly impacts outcome based on post-remission treatment strategies: Prospective analysis of ECOG-ACRIN (E-A) E2906 phase III trial . Blood . 2018;132(Suppl . 1)

Forbes L, Isaac K, Dinares GM, Kharas MG, Kentsis A . Therapeutic disassembly of leukemogenic enhancer complexes . Blood . 2018;132(Suppl . 1)

Friedlander M, Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza AM, Gonzalez-Martin A, Aghajanian C, Bradley W, Lowe ES, Bloomfield R, Disilvestro P . Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial . Annals of Oncology . 2018;29(Suppl . 9):mdy483 .002- .

Friedman G, Bag A, Madan-Swain A, Li R, Kachurak K, Osorio D, Hukin J, Martin A, Pastakia D, Karajannis M, Bernstock J, Fiveash J, Reddy A, Whitley R, Gillespie Y, Markert J, Johnston J . Phase I trial (NCT02457845) safety, tolerability and preliminary efficacy of immunovirotherapy with HSV G207 in children with progressive malignant supratentorial brain tumors . Neuro-Oncology . 2018;20(Suppl . 2):i100- . PMCID: PMC6012612

Frydman JL, Coffman K, Uppal A . Aligning education and efficiency on ICU bedside rounds: A qualitative study . American Journal of Respiratory and Critical Care Medicine . 2018;197

Fu YY, Egorova A, Sobieski C, Calafiore M, Clevers H, Hanash AM . The intestinal stem cell compartment is the initial target of T cell invasion in GI GVHD . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S63-S64 .

Fuchs CS, Shitara K, Di Bartolomeo M, Lonardi S, Al-Batran SE, Van Cutsem E, Ilson DH, Tabernero J, Chau I, Ducreux M, Mendez GA, Alavez AM, Takahari D, Mansoor W, Lacy J, Gorbunova V, Ferry D, Lin J, Das M, Shah MA . RAINFALL: A randomized, double-blind, placebo-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy in patients with metastatic gastric or gastroesophageal junction (G-GEJ) adenocarcinoma . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Fuzesi S, Zabor E, Stempel M, Pusic AL, Gemignani ML . Satisfaction with breast-conserving therapy after re-excision: A study using the Breast-Q, a patient reported outcomes measure in breast surgery . Annals of Surgical Oncology . 2018;25(Suppl . 1):S102- .

Gagniere J, Gholami S, Dupre A, Pezet D, Kingham P, Allen P, Balachandran V, DeMatteo R, Drebin J, Kemeny N, Jarnagin W, D’Angelica M . Is hepatectomy justified for BRAF mutant colorectal

liver metastases? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S31- .

Gale M, Kostelecky N, Halpern N, Voigt LP . International transport of critically-iII cancer patients for end-of-life care in their countries of origin: A retrospective analysis . American Journal of Respiratory and Critical Care Medicine . 2018;197

Gale M, Thandra K, Synborski E, Chen L, Mead E, Halpern N, Voigt L . Considerations for the international transport of critically ill patients at the end of life . Critical Care Medicine . 2018;46(1 Suppl . 1):232- .

Galindo-Vazquez O, Espinoza-Bello M, Acosta-Santos A, Lerma-Talamantes A, Meneses-Garcia A, Costas-Muñiz R, Herrera-Gomez A, Aguilar-Ponce JL . Symptoms of anxiety, depression, and distress in Mexico: Findings in psycho-oncology . Psycho-Oncology . 2018;27(Suppl . 3):48-49 .

Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, Hartmann A, van den Eynde M, Roehrl M, Ohashi P, Zavadova E, Torigoe T, Patel P, Wang Y, Kawakami Y, Marincola FM, Ascierto PA, Fox B, Pagès F . MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies . Annals of Oncology . 2018;29(Suppl . 10):mdy493 .011- .

Galsky MD, Banchereau R, Kadel EE 3rd, Ramirez-Montagut T, Mariathasan S, Thåström A, Rosenberg J, Powles T, van der Heijden MS, Necchi A . Biological features and clinical outcomes in atezolizumab (atezo)-treated patients (pts) with metastatic urothelial cancer (mUC) of the upper vs lower urinary tract (UTUC vs LTUC) . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .111- .

Gambacorti-Passerini C, Brummendorf TH, Kim DW, Mauro MJ, Aguiar J, Viqueira A, Leip E, Cortes JE . Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-

218 OF 288


Meeting Abstracts

positive leukemia . Haematologica . 2018;103(Suppl . 3):S97-S98 .

Gambacorti-Passerini C, Brummendorf TH, Abruzzese E, Rambaldi A, Ciceri F, Martino B, Hochhaus A, Deininger MW, Mauro MJ, Chuah C, Kim DW, Kota V, Lipton JH, Crescenzo RJ, Leip E, Viqueira A, Bardy-Bouxin N, Cortes JE . Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE Trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels . Haematologica . 2018;103(Suppl . 3):S96-S97 .

Gangai N, Eichner C, Ho A, Manna R, Grodzicki BK . Fall prevention education for providers and the diverse, aging community . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S148- .

Gangat N, Stein BL, Marinaccio C, Swords R, Watts JM, Gurbuxani S, Frankfurt O, Altman JK, Wen JQ, Farnoud N, Famulare C, Patel A, Tapia R, Handlogten A, Dinh YT, Englund K, Patel S, Nobrega JC, Tejera D, Thomassen A, Stein H, Gao J, Ji P, Rampal RK, Giles FJ, Tefferi A, Crispino JD . Alisertib (MLN8237), an oral selective inhibitor of aurora kinase A, has clinical activity and restores GATA1 expression in patients with myelofibrosis . Blood . 2018;132(Suppl . 1)

Gao D, Di W, Mao NH, Wang S, Wongvipat J, Sher JJ, Li F, Guo WX, Chi P, Carver B, Chen Y . ERG enforces prostate cells luminal differentiation . Cancer Science . 2018;109(Suppl . 1):432- . PMCID: PMC5770438

Gao Y, Quinn B, Mahmood U, Xu X, Dauer L . Adult oncology CT patient organ dose and effective dose estimates . Medical Physics . 2018;45(6):e599- .

Garon E, Wong D, Schneider J, Aliumaily R, Korn W, Infante J, Patel M, Autio K, Papadopoulos K, Naing A, Gabrail N, Munster P, Goldman J, Hung A, Van Vlasselaer P, Leveque J, Oft M, Spigel D . Responses and durability in NSCLC treated with pegilodecakin and anti-PD-1 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S366-S367 .

Garon EB, Wong DJ, Schneider JG, Aljumaily R, Korn WM, Patel MR, Autio KA, Papadopoulos KP, Naing A, Gabrail N, Munster PN, Goldman J, Hung A, Oft M, Leveque J, Spigel DR . Responses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .017- .

Gaulin C, Chan A, Geyer MB, Park JH, Mantha S, Tallman MS . Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naive acute lymphoblastic leukemia . Blood . 2018;132(Suppl . 1)

Gautschi O, Drilon A, Milia J, Lusque A, Mhanna L, Li B, Sabari J, Cortot A, Besse B, Mezquita L, Solomon B, Thai A, Couraud S, Veilion R, Mascaux C, Barlesi F, Van den Heuvel M, Schouten R, Wakelee H, Mah A, Camidge DR, Ng T, Peled N, Lilach Y, Popat S, Ou S, Zhu V, Velcheti V, Fontecedro AC, Akhoundova D, Fruh M, Zalcman G, Gounant V, Novello S, Bironzo P, Felip E, Martinez-Marti A, Moro-Sibilot D, Rosell R, Karachaliou N, Schuler M, Wiesweg M, Diebold J, Mazieres J . Immunotherapy for non-small cell lung cancers (NSCLC) with oncogenic driver mutations: New results from the global IMMUNOTARGET registry . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S367- .

Ged Y, Knezevic A, Chen Y, Redzematovic A, Carlo M I, Lee CH, Feldman DR, Patil S, Motzer RJ, Voss MH . Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Gelblum D, Ho AY, Cost Z, Arnold BB, Tyagi N, Zhigang Z, McCormick B, Powell SN . Reconstruction failure rates in breast cancer patients with two-stage expander/implant reconstruction receiving regional nodal irradiation with VMAT: Early results of a phase II trial . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S43- .

Gelfarb L, Straus E, Tutino R, Buda K, Demirjian C, Schofield E, Napolitano S, Nelson C . The relationship between depression, anxiety, and quality of sleep among testicular cancer survivors . Psycho-Oncology . 2018;27(Suppl . 3):188- .

George DJ, Hessel C, Halabi S, Sanford BL, Michaelson MD, Hahn OM, Walsh MK, Olencki T, Picus J, Small EJ, Dakhil SR, Feldman DR, Mangeshkar M, Scheffold C, Morris MJ, Choueiri TK . Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: Subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial . Journal of Clinical Oncology . 2018;36(6 Suppl .)

George DJ, Martini JF, Staehler MD, Chang YH, Breza J, Patard JJ, Motzer RJ, Magheli A, Carteni G, Donskov F, Escudier B, Li S, Casey M, Valota O, Laguerre B, Pantuck AJ, Pandha HS, Patel A, Lechuga M, Ravaud A . Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis . Journal of Clinical Oncology . 2018;36(6 Suppl .)

George DJ, Figlin R, Motzer RJ, Paty J, Lechuga Frean MJ, Zanotti G, Bhattacharyya H, Ramaswamy K, Deannuntis L, Ravaud A . Sunitinib tolerance following an initial exposure period: Results of longitudinal PRO data from S-TRAC study . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .125- .

George G, Atallah EL, Mauro MJ, Goldberg SL, Baim A, Guhl J, Hinman A, Cortes JE, Deininger MW, Druker BJ, Kota VK, Larson RA, Lipton JH, Moore JO, Oehler VG, Ibarz JP, Radich J, Ritchie EK, Schiffer CA, Shah NP, Silver RT, Sweet KL, Thompson JE, Wadleigh M, Flynn KE . Patients’ perspectives on the definition of cure in chronic myeloid Leukemia: A US based survey . Blood . 2018;132(Suppl . 1)

George I, Kheterpal M, Miller A . Lymphomatoid papulosis in a 37-year-old woman with relapsing

219 OF 288


Meeting Abstracts

multiple sclerosis treated with dimethyl fumarate . Neurology . 2018;90(15 Suppl .)

George L, Rosenfeld B, Crespo I, Breitbart W . Meaning-centered psychotherapy for advanced cancer patients: An examination of moderators of treatment efficacy . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S686- .

George S, Bauer S, Jones RL, Serrano C, von Mehren M, Kang YK, Schöffski P, Cassier P, Eskens FA, Mir O, Tap WD, Chawla SP, Rutkowski P, Shi H, Schmidt-Kittler O, Mar B, Heinrich M . Correlation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinib . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .021- .

George S, Heinrich M, Chi P, Razak A, von Mehren M, Gordon M, Ganjoo KN, Somaiah N, Trent JC, Rodon Ahnert J, Wolf J, Ruiz-Soto R, Rosen O, Janku F . Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .002- .

Georgiadis A, Durham JN, Keefer L, Bartlett BR, Zielonka M, Murphy D, White JR, Lu S, Verner E, Ruan F, Riley D, Anders RA, Angiuoli S V, Jones S, Velculescu VE, Le DT, Diaz LA Jr, Sausen M . Analysis of cell-free plasma DNA to identify tumors with microsatellite instability and exceptionally high tumor mutation burden in patients treated with PD-1 blockade . European Journal of Cancer . 2018;103(Suppl . 1):e24-e25 .

Gerber DE, Reck M, Hellmann MD, Paz-Ares L, Borghaei H, Brahmer J, O’Byrne KJ, Bhagavatheeswaran P, Nathan F, Ramalingam SS . CheckMate 227: Nivolumab + ipilimumab vs platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB) . Journal of Oncology Navigation & Survivorship . 2018;9(11):26- .

Gertz M, Comenzo RL, Landau H, Sanchorawala V, Weiss BM, Zonder JA, Merlini G, Schonland S, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie SD, Liu E, Liedtke M . NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematological response . Oncology Research and Treatment . 2018;41(Suppl . 1):19- .

Gervasio KA, Marlow E, Lee MN, Lelli GJ . Visual acuity trends of patients wearing PROSE for exposure keratopathy after oculoplastic surgery . Investigative Ophthalmology & Visual Science (IOVS) . 2018;59(9)

Geyer A, Maloy M, Hilden P, Jakubowski AA . Association of DLCO, age and HLA matching with hematopoietic stem cell transplantation in patients with AML and MDS . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S320-S321 .

Geyer F, Li A, Pareja F, Burke KA, Edelweiss M, Wen HY, Jungbluth A, Varga Z, Rubin BP, Rakha E, Ellis I, Weigelt B, Reis J . HMGA2 rearrangement in breast adenomyoepitheliomas lacking HRAS and PI3K pathway-related gene mutations . Modern Pathology . 2018;31(Suppl . 2):61- .

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R, Brandes A, Lozada J, Macedo GS, Muenst S, Terracciano LM, Jungbluth A, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha E, Chandarlapatty S, Weigelt B, Reis-Filho JS . Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis . Cancer Research . 2018;78(4 Suppl .)

Geyer MB, Ritchie EK, Rao A V, Cazacu M I, Vemuri S, Tallman MS, Douer D, Park JH . Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults

ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma . Blood . 2018;132(Suppl . 1)

Geyer MB, Burke PW, King AC, Mauro MJ, Tallman MS, Levine RL, Sherr CJ, Douer D, Park JH . Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial . Blood . 2018;132(Suppl . 1)

Ghanem A I, Schymick MA, Xiao R, Tsai CJ, Lee N, Liu H, Tam L, Woody NM, Caudell JJ, Reddy CA, Joshi NP, Geiger JL, Lamarre E, Dunlap NE, Burkey BB, Adelstein DJ, Koyfman S, Porceddu S, Siddiqui F . The influence of smoking and age on pathologic features and outcomes in oral cavity squamous cell cancer: A multi-institutional collaborative study . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S21-S22 .

Ghasemiesfe M, Ravi D, Vali M, Korenstein DR, Arjomandi M, Frank J, Keyhani S . Effects of chronic marijuana use on respiratory symptoms and pulmonary function: A systematic review and meta-analysis . Journal of General Internal Medicine . 2018;33(Suppl . 2):S180- . PMCID: PMC5913041

Ghione P, Ozkaya N, Faruque P, Mehta-Shah N, Lunning MA, Ruan J, Galasso N, Moskowitz AJ, Dogan A, Horwitz SM . Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials . Journal of Clinical Oncology . 2018;36(15 Suppl .):402s- .

Gholami S, Kemeny N, Gonen M, Cercek A, Kingham P, Balachandran V, Allen P, DeMatteo R, Jarnagin W, D’Angelica M . Adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases is associated with improved survival in patients with both right and left-sided primary tumors . Annals of Surgical Oncology . 2018;25(Suppl . 1):S156- .

220 OF 288


Meeting Abstracts

Ghosh M, Xu Y, Morales AA, El Maarouf A, Rutishauser U, Pearse DD . Biochemical and genetic methods for enhancing polysialic acid on transplanted cells after spinal cord injury . Cell Transplantation . 2018;27(4):693- .PMCID: PMC6041886

Ghosh S, Rubtsov YP, Jung H, Roy-Chowdhuri S, Kang K, Im SH, Surh CD, Rudensky AY, Rudra D . A mechanism involving sibling transcription factor assistance preserves the integrity of an active Foxp3 locus in peripherally induced regulatory T cells . Journal of Immunology . 2018;200(1 Suppl .)

Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Sadelain M . Restraining macrophages alleviates CAR T cell-induced cytokine release syndrome and informs novel therapeutic interventions . Molecular Therapy . 2018;26(5 Suppl . 1):173- .

Gigoux M, Elf S, Ciboddo M, Zappasodi R, Pourpe S, Abdelfattah N, Chan T, Abdel-Wahab O, Mullally A, Merghoub T, Wolchok J . Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):114- . PMCID: PMC6220480

Glassman DC, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O’Reilly EM, Yu KH . Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Glincher R . The need for blood return when utilizing a central venous catheter . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S607- .

Glincher R, Modak S, Basu E . Feasibility of outpatient stem cell rescue in high risk neuroblastoma patients . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S251- .

Glincher R, Lin Y, Durney C . Nursing management of patients with high risk neuroblastoma receiving

outpatient autologous stem cell rescue . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S606- .

Goldberg AD, Famulare C, Devlin SM, Farnoud N, Menghrajani K, Patel M, Cai S, Dunbar A, Epstein-Peterson ZD, McGovern E, Schulman J, Glass JL, Taylor J, Viny AD, Getta B, Arcila ME, Levine RL, Shaffer BC, Gyurkocza B, Papadopoulos EB, Perales MA, Papaemmanuil E, Giralt S, Zhang Y, Roshal M, Tallman MS . Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML) . Blood . 2018;132(Suppl . 1)

Goldberg AD, Talati C, Desai P, Famulare C, Devlin SM, Farnoud N, Sallman DA, Lancet JE, Roboz GJ, Sweet KL, Tallman MS . TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Goldberg AD, Collins RH, Stone RM, Walter RB, Karanes C, Vigil CE, Wang ES, Tallman MS . Addition of crenolanib to induction chemotherapy overcomes the poor prognostic impact of co-occurring driver mutations in patients with newly diagnosed FLT3-mutated AML . Blood . 2018;132(Suppl . 1)

Goldberg J, Goldman D, McCaskey S, Koo D, Epstein A . Illness understanding, prognostic awareness and end of life care after drainage percutaneous endoscopic gastrostomy for malignant bowel obstruction in metastatic gastrointestinal cancer . Journal of Pain and Symptom Management . 2018;55(2):633- .

Goldfarb SB, Kamer S, Baser R, Quistorff J, Gemignani ML, Dickler M . Improvement in sexual function over time in premenopausal women with breast cancer . Cancer Research . 2018;78(4 Suppl .)

Goldman S, Pollack I, Kun L, Billups C, Broniscer A, Robinson G, Dhall G, Robison N, Panigrahy A, Poussaint TY, Adesina A, Onar-Thomas A, Jakacki R, Dunkel I, Fouladi M . Phase II study of peginterferon alfa-2b (PegIntron)/Sylatron for pediatric patients

with progressive or recurrent craniopharyngioma following radiotherapy: A Pediatric Brain Tumor Consortium study (PBTC-039) . Neuro-Oncology . 2018;20(Suppl . 2):i40-i41 . PMCID: PMC6012612

Goldman S, Hwang E, Lai JS, Kocak M, Lulla R, Dhall G, Robison N, Onar-Thomas A, Dunkel IJ . Feasibility trial of TTFields (Tumor Treating Fields) for children with recurrent or progressive supratentorial high-grade glioma (HGG) and ependymoma: A Pediatric Brain Tumor Consortium study: PBTC-048 . Neuro-Oncology . 2018;20(Suppl . 6):vi201-vi202 . PMCID: PMC6216117

Gonzalez Y, Shen C, Klages P, Albuquerque K, Jia X . On the importance of inverse treatment planning in high-dose-rate brachytherapy with a tandem-and-ovoid applicator for cervical cancer . Medical Physics . 2018;45(6):e482-e483 .

Gonzalez Y, Shen C, Klages P, Albuquerque K, Jia X . A deep-learning approach to predict planning objectives in cervical cancer high-dose-rate brachytherapy with a tandem-and-ovoid applicator . Medical Physics . 2018;45(6):e445- .

Goodings-Harris C, Zhang H, Zhao X, Xu H, Abdel-Wahab O I, McKinney-Freeman S, Yang JJ . Leukemia risk gene ARID5B is a crucial regulator of B-cell development . Blood . 2018;132(Suppl . 1)

Gopalan A, Al-Ahmadie H, Chen YB, Sirintrapun SJ, Tickoo S, Reuter V, Fine SW . Neuroendocrine differentiation in the setting of prostate cancer: Contemporary assessment of 76 consecutive cases from a single institution . Modern Pathology . 2018;31(Suppl . 2):345- .

Gordon MS, Tsai F, Postow M, Hellmann M, Harding JJ, Korn RL, Farwell MD, Mitchell TC, Schuchter LM, Ziolkowska M, O’Donoghue J, Lewis JS, Wu AM, Le W, Wilson I, Weber WA, Wolchok JD, Behera D, Pandit-Taskar N . Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human

221 OF 288


Meeting Abstracts

study . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 2):434- .

Gorovets D, Lichtenwalner P, Shi C, Borofsky KL, Parhar PK, Zelefsky MJ, Chan MF . Dosimetric impact of inter-fraction variations in bladder filling and rectal emptying in patients undergoing prostate SBRT . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E511- .

Gounder M, Schöffski P, Villalobos V, Cote G, Chugh R, Chen TWW, Jahan T, Loggers ET, Italiano A, Gupta A, Agulnik M, Attia S, Jones RL, van Tine BA, Demetri GDD, Roche M, Sapir I, Daigle S, Clawson A, Stacchiotti S . A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950) . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .014- .

Gowin KL, Ballen KK, Ahn KW, Hu ZH, Liu Y, Masarova L, Verstovsek S, Coakley M, Jain T, Kuykendall A, Komrokji R, Wadleigh M, Patches S, Arcasoy M, Green M, Kandarpa M, Talpaz M, Ali H, Gupta V, Devlin R, Michaelis LC, Hobbs GS, Stein BL, Pariser A, Gerds AT, Kuber K, Rampal R, Alyea EP, Popat U, Sobecks R, Scott BL, Mesa R, Saber W . Survival advantage to allogeneic transplant in patients with myelofibrosis with intermediate-1 or higher DIPSS score . Blood . 2018;132(Suppl . 1)

Grüllich C, Motzer RJ, Powles T, Atkins M, Escudier BJ, McDermott D, Suarez C, Bracarda S, Stadler W, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, Donaldson F, Li S, Huseni M, Schiff C, Rini B I . IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):41-42 .

Grüllich C, Powles T, Motzer RJ, George DJ, Jonasch E, Pal SK, Tannir NM, Signoretti S, Mai TH, Scheffold C, Wang E, Aftab DT, Escudier BJ, Choueiri TK . Outcomes based on plasma biomarkers in METEOR,

a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (RCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):201- .

Grabenstetter A, Brogi E, Chou JF, Morrow M, Dickler M, Norton L, Wen HY . Oncotype DX recurrence score in multifocal/multicentric ipsilateral invasive breast carcinomas . Modern Pathology . 2018;31(Suppl . 2):64- .

Gradishar WJ, Robson ME, Flake DD, Schwartzberg LS, Sharma P, Soliman HH, Magliocco AM, Brown K, Wehnelt S, Gutin A, Kronenwett R, Lancaster JM . Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay . Journal of Clinical Oncology . 2018;36(15 Suppl .):15s- .

Graham M, Jagannathan R, Rubens E, Wolchok J, Wu S . Leptomeningeal melanoma metastasis presenting as intraventricular and subarachnoid hemorrhage . Neuro-Oncology . 2018;20(Suppl . 6):vi56- . PMCID: PMC6216117

Gray R, Bradley R, Braybrooke J, Davies C, Pan H, Peto R, Bliss J, Cameron D, Mackey J, Del Mastro L, Swain S, Untch M, Bergh J, Pritchard K, Norton L, and For the EBCTCG . Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials . Cancer Research . 2018;78(4 Suppl .)

Greally M, Harrold E, Fenlon HM, Eaton D, McCarthy J, Redmond KC, Conneely JB, McEntee GP, Brannigan AE, Shields CJ, Mulsow J, Gallagher DJ, Carney DN, Higgins MJ, Kelly CM, McCaffrey J . Contemporary multi-modal management of colorectal cancer: Evolving patterns of care in an Irish cohort . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Greco C, Pares O, Pimentel N, Possanzini M, Louro V, Morales J, Nunes B, Castanhera J, Oliveira C, Silva A, Vaz S, Costa D, Kolesnick R, Fuks Z . Phase II prospective trial to assess the feasibility and efficacy of dynamic 24Gy single dose ablative stereotactic radiation therapy in oligometastatic human cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E222- .

Griffin M, Zheng J, Lin A, Maloy M, Glezerman I, Jakubowski AA . Outcomes in elderly hematopoietic stem cell transplant patients receiving tacrolimus graft-versus-host disease prophylaxis . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S198- .

Grnüwald V, Cella D, Escudier BJ, Hammers HJ, George S, Nathan P, Grimm MO, Rini B I, Doan J, Ivanescu C, Paty J, Mekan S, Motzer RJ . Quality of life in patients with advanced renal cell carcinoma in the randomized, open-label CheckMate 214 trial . Oncology Research and Treatment . 2018;41(Suppl . 4):42- .

Groen A, Beckham T, Links T, Sherman E, Tuttle RM, Fagin J, Shaha A, Sabol C, Tsai CJ, McBride S, Bijl HP, Wong RJ, Plukker J, Lee N . Impact of surgery and external beam radiation therapy on local control in the treatment of medullary thyroid carcinoma . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E230- .

Gru A, Barrionuevo C, Pulitzer M, Sanches JA, Miyashiro D, Duenas D, Servitje O, Esteller FC, Ratner L, Zambrano SC, Williams E, Davick J . Clinicopathologic characteristics, prognostic and predictive biomarkers in adult T-cell leukemia/lymphoma (ATLL): A characterization of 79 cases from the Western Hemisphere . European Journal of Cancer . 2018;101(Suppl . 1):S16- .

Gru A, Battistella M, Pulitzer M, Pawade J, Beltraminelli H, Cabala CT, Guitart J, Piris MA, Harris NL, Feldman A, Hong E, Scarisbrick J, Kim Y . Updates

222 OF 288


Meeting Abstracts

from the central pathology review in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) for the global PROCLIPI study . European Journal of Cancer . 2018;101(Suppl . 1):S16-S17 .

Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Devidas M, Dai Y, Reshmi SC, Foster JG, Raetz EA, Borowitz MJ, Wood B, Carroll WL, McKay PZ, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich J, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Recevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrozek K, Bloomfield CD, Stock W, Kornblau SM, Kantarjian HM, Konopleva MY, Evans WE, Jeha S, Pui CH, Yang JJ, Paietta EM, Downing JR, Relling M V, Zhang J, Loh ML, Hunger SP, Mullighan CG . Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia . Blood . 2018;132(Suppl . 1)

Gucalp A, Edelweiss M, Patil S, Gounder MM, Feigin KN, Corben A, Arumov A, Traina TA . Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC) . Cancer Research . 2018;78(4 Suppl .)

Guo T, Alex D, Rudomina D, Cao F, Lin O . Impact of the Paris System for Reporting Urinary Cytology atypical urothelial cells category at a major cancer center . Modern Pathology . 2018;31(Suppl . 2):145-146 .

Gupta A, Millevoi R, El Sebai N, Goyal S, Khan AJ, Jabbour SK, Yue NJ, Haffty BG Jr, Parikh RR . Impact of insurance preauthorization requirements on delays in administering proton beam therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E416- .

Gupta A, Khan AJ, Wang SJ, Yegya-Raman N, Ahlawat S, Ohri N, Goyal S, Moore DF,

Eladoumikdachi F, Toppmeyer D, Haffty BG . Five-year results of a prospective phase 2 trial evaluating three-week hypofractionated whole breast radiation therapy with boost . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S79- .

Gupta K, Patail H, Goldman DA, Feinstein MB, Stover DE . MAC attack: Clinical correlates of MAC infection among patients with and without cancer . American Journal of Respiratory and Critical Care Medicine . 2018;197

Gupta K, Stover DE . A new foe: IgG4-related disease presenting as isolated pulmonary nodules . American Journal of Respiratory and Critical Care Medicine . 2018;197

Gupta P, Migliacci JC, Hay A, Rosenthal M, Lee N, Wong RJ, Shah J, Patel S, Ganly I . Evaluation of the AJCC 7th, ICON-S, and HPV-Path Staging systems for surgically managed HPV/p16+ve oropharyngeal squamous cell carcinoma patients . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1333- .

Gupta S, Zarei S, Sukov WR . Clear cell renal cell carcinomas with PDGFRA/KIT (4q12) co-amplification and PDGFRB (5q32) amplification . Modern Pathology . 2018;31(Suppl . 2):346- .

Gupta S, Middha S, Benayed R, Arcila M, Zehir A, Berger MF, Ladanyi M, Dogan S . TERT promoter mutation and amplification: A pan-cancer study on 20,184 tumors profiled by clinical genomic sequencing . Modern Pathology . 2018;31(Suppl . 2):700- .

Gupta S, Won HH, Nanjangud GJ, Chen YB, Al-Ahmadie H, Sirintrapun SJ, Fine SW, Strong V, Raj NP, Reidy DL, Middha S, Berger MF, Tickoo S, Dogan S, Reuter V, Gopalan A . TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas: Clinico-pathologic and molecular analysis of 62 cases . Modern Pathology . 2018;31(Suppl . 2):231- .

Gutgarts V, Jaffer Sathick I, Rosenbaum C, Muthukumar T, Hassoun H, Flombaum C, Landau H . Outcomes after kidney transplantation in patients with AL amyloid following autologous stem cell transplantation . American Journal of Transplantation . 2018;18(Suppl . 4):929-930 .

Ha CS, Li H, Schoder H, Pinnix CC, Brem E, Bartlett NL, Evens AM, Hsi ED, Rimsza LM, Leonard JP, Kahl BS, Leblanc ML, Smith SM, Constine LS, Friedberg JW . Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: A secondary modeling of SWOG S0816 with receiver operating characteristic analysis . Blood . 2018;132(Suppl . 1)

Haag GM, Chen LT, Kang YK, Satoh T, Kato K, Chung HC, Kang WK, Chao Y, Chen JS, Ott PA, Le DT, Zhao H, Exposito MJJ, Janjigian YY, Boku N, Chau I . Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials . Oncology Research and Treatment . 2018;41(Suppl . 4):285-286 .

Habous M, Giona S, Muir G, Binsaleh S, Abdelwahab O, Nassar M, Abdelrahman Z, Elserafy A, Mulhall J, Ralph D . Penile prosthesis implantation preserves penile length . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S226- .

Habous M, Giona S, Binsaleh S, Abdelrahman Z, Nassar M, Tealab A, Mulhall J, Muir G . Serum testosterone in diabetic men is not linked to diabetic control . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S281- .

Habous M, Teloken P, Abdelrahman Z, Binsaleh S, Ralph D, Elserafy A, Tealab A, Mulhall J . Evaluation of the outcome of penile implants surgery in seniors . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S166-S167 .

223 OF 288


Meeting Abstracts

Hajiyeva S, Moo TA, Friedlander MA, McCormack MA, Lopez K, Stempel M, Raiss M, Barrio A, Morrow M, Edelweiss M . Frozen section of sentinel lymph nodes in 702 breast cancer patients treated with neoadjuvant chemotherapy . Modern Pathology . 2018;31(Suppl . 2):66-67 .

Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM, Chi KN, De Bono JS, Fandi A, Araujo JC, Eisenberger MA, Logothetis C, Quinn D I, Fizazi K, Higano CS, George DJ, Morris MJ, Small EJ, Tannock I, Kelly WK . Overall survival between African-American (AA) and Caucasian (C) men with metastatic castration-resistant prostate cancer (mCRPC) . Journal of Clinical Oncology . 2018;36(18 Suppl .)

Hall M, Bradley JA, Jackson A, Ronckers CM, Kremer L, Constine LS . Dose response for veno-occlusive disease after whole-liver radiation therapy: A preliminary report from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) group . International Journal of Radiation Oncology, Biology, Physics . 2018;101(4):1005- .

Hamadani M, Collins GP, Samaniego F, Spira A I, Davies A, Radford J, Caimi P, Menne T, Boni J, Cruz H, Feingold J, He S, Wuerthner J, Horwitz SM . Phase 1 study of ADCT-301 (camidanlumab tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in relapsed/refractory classical Hodgkin lymphoma . Blood . 2018;132(Suppl . 1)

Hamann HA, Shen MJ, Price SN, Ostroff J . The role of psychosocial processes and demographic characteristics in understanding stigma among lung cancer patients . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S26- .

Hamilton JG, Garzon MG, Westerman JS, Cadet K, Hay JL, Offit K, Robson ME . Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S455- .

Hamlin PA, Cheson BD, Farber CM, Feldman T, Fenske TS, Hess BT, Khatcheressian JL, Miller CB, Munoz J, Patel MR, Smith SM, Smith SD, Stevens DA, Ye JC, Steele A, Pandey A, Birrell M, Leeds J, Coffey G, Curnutte JT . The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL) . Journal of Clinical Oncology . 2018;36(15 Suppl .):402s- .

Hancock L, Evans A, Gilger E, Petriccione M, Urban M, Chapman L . Mutli-institutional neuro-oncology nursing collaboration: The Pediatric Brain Tumor Consortium nursing committee experience . Neuro-Oncology . 2018;20(Suppl . 2):i151-i152 . PMCID: PMC6012612

Hanna MG, Grabenstetter A, Ross D, Tan L . Invasive lobular carcinoma with an unusual immunophenotypic profile . Modern Pathology . 2018;31(Suppl . 2):68-69 .

Hanna MG, Reuter V, Samboy J, England C, Corsale L, Fine SW, Agaram N, Stamelos E, Hameed M, Klimstra D, Sirintrapun SJ . Implementation of digital pathology offers clinical and operational increase in efficiency and cost savings . Modern Pathology . 2018;31(Suppl . 2):588-589 .

Haq R, Berry S, Iyer A, Apte A, Hunt M, Deasy J, Veeraraghavan H . Interactive refinement of head and neck structures using multi-atlas based probabilistic segmentation maps . Medical Physics . 2018;45(6):e556- .

Hardy K, Gioia A, Kairalla J, Winick N, Noll R, Patel S, Sands S, Embry L . Executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group (COG) . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S35-S36 .

Hargrave D, Witt O, Cohen K, Packer R, Lissat A, Kordes U, Laetsch TW, Hoffman L, Lassaletta A, Gerber NU, Gilheeney S, Holm S, Kramm C,

Sumerauer D, Reitmann C, Russo MW, Bouffet E . Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600-mutant high-grade glioma (HGG) or low-grade glioma (LGG) . Annals of Oncology . 2018;29(Suppl . 8):mdy273 .395- .

Harrison MR, Davis PG, Khouri MG, Gupta RT, Armstrong AJ, McNamara MA, Zhang T, Anand M, Onyenwoke K, Hood H, Edwardson S, Craig D, Wu Y, Healy P, Coyne B, Jones L, George DJ . EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naive prostate cancer (HSPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy300 .064- .

Haseltine J, Mueller BA, Yang TJ, Yamada Y, Schmitt A, Higginson DS, Kohutek ZA . Evaluation of factors affecting local failure of radiation for long bone metastasis following orthopedic stabilization . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E441- .

Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Finn S, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Penney KL, Lotan T, Kantoff PW, Mucci LA, Graff RE . Family history of prostate cancer and the incidence of ERG- and PTEN-defined prostate cancer . Cancer Research . 2018;78(16 Suppl .):91- .

Hasserjian R, Altman J, Denzen E, Block A, Klepin H, Medeiros B, Noe A, Scales W, Tallman M, Wiley K, Burns L . National survey of pathologists on the application of ancillary testing in the diagnosis of acute myeloid leukemia . Modern Pathology . 2018;31(Suppl . 2):520- .

Hauser K, Negron C, Albanese S, Ray S, Wang LL, Lupyan D, Steinbrecher T, Abel R, Chodera J . Predicting targeted kinase inhibitor resistance to clinical ABL mutations using alchemical free-energy

224 OF 288


Meeting Abstracts

calculations . Abstracts of Papers of the American Chemical Society . 2018;255

Hawerkamp HC, Kislat A, Gerber P, Pollet M, Soshilov AA, Denison MS, Momin AA, Arold ST, Datsi A, Braun SA, Lacouture ME, Haarmann-Stemmann T, Homey B, Meller S . Vemurafenib acts as an aryl hydrocarbon receptor antagonist . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S179- .

Hawerkamp HC, Kislat A, Gerber PA, Pollet M, Soshilov AA, Denison MS, Momin AA, Arold ST, Datsi A, Braun SA, Lacouture ME, Haarmann-Stemmann T, Homey B, Meller S . Vemurafenib acts as an aryl hydrocarbon receptor antagonist . Allergy . 2018;73(Suppl . 105):111- .

Haxaire C, Hakobyan N, Panellini T, Carballo C, McIlwain D, Mak TW, Acharya S, Li D, Szymonifka J, Rodeo S, Song X, Monette S, Srivastava A, Salmon J, Blobel C . Blood-induced bone loss in a mouse model of hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNFα pathway . Journal of Bone and Mineral Research . 2018;33(Suppl . 1):369- .

Hecht JR, Naing A, Falchook GS, Patel MR, Aljumaily R, Wong DJ, Autio KA, Wainberg ZA, Javle M, Bendell J, Pant S, Hung A, Oft M, Leveque J, Papadopoulos KP . Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX) . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .016- .

Heidenreich A, Carl S, Feyerabend S, Gleissner J, Grullich C, Heinrich B, Merseburger A, Miller K, Stenzl A, Steuber T, Wirth M, Watkins S, Simmons A, Go J, Golsorkhi T, Abida W, Scher H I . TRITON2: An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) . Oncology Research and Treatment . 2018;41(Suppl . 1):75- .

Heller D, Shamay Y, Shah J, Isik M, Budhathoki-Uprety J, Roxbury D, Sridharan R, Chodera J, Lowe S . Development of targeted nanomedicines via machine learning processes . Abstracts of Papers of the American Chemical Society . 2018;256

Hellmann M, Janne P, Opyrchal M, Hafez N, Raez L, Gabrilovich D, Wang F, Ordentlich P, Brouwer S, Sankoh S, Schmidt E, Meyers M, Ramalingam S . Efficacy/safety of entinostat (ENT) and pembrolizumab (PEMBRO) in NSCLC patients previously treated with anti-PD-(L) 1 therapy . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S330- .

Hellmann MD, Antonia SJ, Balmanoukian AS, Brahmer JR, Ou SH I, Kim SW, Ahn MJ, Kim DW, Gutierrez M, Liu S V, Schoffski P, Jaeger D, Jamal R, Leach JW, Jerusalem GHM, Lutzky J, Nemunaitis JJ, Gu Y, Abdullah SE, Segal NH . Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Hevey M, Crane J, Patil S, Patel R . No discontinuations of TDF-based PrEP use due to changes in renal function in a longitudinal clinical cohort . AIDS Research and Human Retroviruses . 2018;34(Suppl . 1):104- .

Hill-Kayser CE, Hua CH, Yorke ED, Keene KS, Ronckers CM, van Dulmen-den Broe E, Kremer L, Gracia CR, Ginsberg J, Metzger ML, Constine LS . Ovarian toxicity in pediatric cancer survivors after abdominopelvic radiation therapy: A report from the PENTEC (Pediatric Normal Tissue Effects in the Clinic) initiative . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E475- .

Hillmen P, Soumerai J, Zelenetz A, Darif M, Londhe A, Xing G, Huang J, Lin M, Byrd J, Chanan-Khan A, Furman R, Hallek M, Jones J, Sharman J, Ferrante L, Reddy V, Dreiling L, Adewoye H, Dubowy R, Howes A, James D . A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia

applicable to patients treated with novel therapies and standard of care . British Journal of Haematology . 2018;181(Suppl . 1):75- .

Hillmen P, Brown J, Zelenetz A, Furman R, Lamanna N, Mato A, Montillo M, O’Brien S, Dreiling L, Dubowy R, Kim Y, Munugalavada V, Robak T . Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukaemia treated with idelalisib . British Journal of Haematology . 2018;181(Suppl . 1):86- .

Hills RK, Gale R, Linch DC, Huntly BJP, Papaemmanuil E, Vyas P, Burnett AK, Russell NH . Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: Results from the NCRI AML trials . Blood . 2018;132(Suppl . 1)

Hirschhorn-Cymerman D, Ricca J, Gasmi B, De Henau O, Mangarin L, Budhu S, Li Y, Cortez C, Liu C, Zappasodi R, Houghton S, Betof A, Panageas K, Lacuoture M, Hollmann T, Albrengues J, Egeblad M, Merghoub T, Wolchok J . T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- .PMCID: PMC6220479

Hirschhorn D, Ricca J, Gasmi B, DeHanau O, Mangarin LM, Budhu S, Li Y, Cortez C, Liu C, Zappasodi R, Houghton S, Betof A, Lacouture M, Hollman T, Albrengues J, Egeblad M, Wolchok JD, Merghoub T . A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation . Journal of Immunology . 2018;200(1 Suppl .)

Ho A, Chau N, Brana Garcia I, Ferte C, Even C, Burrows F, Kessler L, Mishra V, Magnuson K, Scholz C, Gualberto A . Preliminary results from a phase 2 trial of tipifarnib in HRAS-mutant head and neck squamous cell carcinomas . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1367- .

225 OF 288


Meeting Abstracts

Ho AL, Chau N, Bauman J, Bible K, Chintakuntlawar A, Cabanillas ME, Wong DJ, Garcia IB, Brose MS, Boni V, Even C, Razaq M, Mishra V, Bracken K, Wages D, Scholz C, Gualberto A . Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations . Annals of Oncology . 2018;29(Suppl . 8):mdy287 .002- .

Ho C, Syed M, Roshal M, Petrova-Drus K, Moung C, Yao JJ, Yu W, Maciag L, Benayed R, Hultcrantz M, Dogan A, Nafa K, Landgren O, Arcila ME . Next-generation sequencing-based assay shows high clonal characterization success rate for plasma cell neoplasms, and concordance with flow cytometry in minimal residual disease detection . Blood . 2018;132(Suppl . 1)

Ho C, Zhang Y, Aypar U, Yabe M, Sen F, Arcila ME, Dogan A, Petrova-Drus K . Myeloid/histiocytic neoplasms associated with germ cell tumors harbor shared genetic abnormalities indicating a clonal relationship, unique molecular pathogenesis and cellular origin . Blood . 2018;132(Suppl . 1)

Hodgson AJ, Park K, Djordjevic B, Howitt BE, Nucci M, Oliva E, Stolnicu S, Xu B, Soslow R, Parra-Herran C . International endocervical adenocarcinoma criteria and classification: Validation and interobserver reproducibility . Modern Pathology . 2018;31(Suppl . 2):423- .

Hodi FS, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Cowey CL, Lao C, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hill AG, Hogg D, Marquez-Rodas I, Jiang J, Rizzo J, Larkin J, Wolchok J . Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067) . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .054- .

Hoimes CJ, Petrylak DP, Flaig TW, Carret AS, Melhem-Bertrandt A, Rosenberg JE . EV-103 study: A phase 1b dose-escalation and dose-expansion study of

enfortumab vedotin in combination with immune checkpoint inhibitor (CPI) therapy for treatment of patients with locally advanced or metastatic urothelial cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Hollebecque A, Borad M, Sahai V, Catenacci DVT, Murphy A, Vaccaro G, Paulson A, Oh DY, Féliz L, Lihou C, Zhen H, Abou-Alfa GK . Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations . Annals of Oncology . 2018;29(Suppl . 8):258- .

Holtmaat K, Van der Spek N, Lissenberg-Witte B, Breitbart W, Cuijpers P, Verdonck-de Leeuw I . Long-term efficacy of meaning-centered group psychotherapy for cancer survivors . Psycho-Oncology . 2018;27(Suppl . 3):175- .

Hong L, Zarepisheh M, Zhou Y, Yamada Y, Mechalakos J, Mageras G, Hunt M, Deasy J . Clinical experience of automated SBRT paraspinal planning with constrained hierarchical optimization . Radiotherapy and Oncology . 2018;127(Suppl . 1):S107- .

Hooberman L, Howell F, Garzon MG, Rubin LR, Keegan R . Decision-making practices surrounding choosing a vaginal birth after prior cesarean delivery . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S271- .

Hornberger J, Graf RP, Hulling M, Attard G, Allan A, Dittamore R, Scher H I . Overall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .057- .

Horwitz SM, Soto J, Youssoufian H, Lloyd D, Le NT . The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or

refractory peripheral t-cell lymphoma (PTCL) . Journal of Clinical Oncology . 2018;36(15 Suppl .):422s- .

Horwitz SM, O’Connor OA, Pro B, Illidge TM, Fanale MA, Advani RH, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman TA, Lennard A, Belada D, Illés A, Tobinai K, Tsukasaki K, Yeh SP, Shustov AR, Hüttmann A, Savage KJ, Yuen S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L . The ECHELON-2 trial: Results of a randomized, double-blind, active-controlled phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas . Blood . 2018;132(Suppl . 1)

Horwitz SM, Feldman TA, Hess BT, Khodadoust MS, Kim YH, Munoz J, Patel MR, Phillips TJ, Smith SD, Smith SM, Wilcox RA, Steele A, Pandey A, Birrell MR, Leeds JM, Conley PB, Michelson G, Coffey GP, Curnutte JT, Hamlin PA . The novel SYK/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in a phase 2a study in relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma . Blood . 2018;132(Suppl . 1)

Horwitz SM, Moskowitz AJ, Jacobsen ED, Mehta-Shah N, Khodadoust MS, Fisher DC, Myskowski P, Wang EBK, Tawa M, Davey T, Blouin W, Hancock H, Ganesan N, Galasso N, Marzouk E, Bahgat A, Jester H, Fong S, Butt A, Dogan A, Kim YH, Weinstock DM . The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts . Blood . 2018;132(Suppl . 1)

Hossain M, Sher F, Seruggia D, Schoonenberg V, Cole MA, Cifani P, Dassama L, Macias-Trevino C, Canver MC, Kurita R, Nakamura Y, Pinello L, Maeda T, Kentsis A, Orkin SH, Bauer DE . Rational targeting of a NuRD sub-complex for fetal hemoglobin induction

226 OF 288


Meeting Abstracts

following comprehensive in situ mutagenesis . Blood . 2018;132(Suppl . 1)

Hotca A, Thor M, Deasy JO, Rimner A . Association of dose to cardio-vascular structures with treatment-induced electrocardiogram changes in stage III non-small cell lung cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S91- .

Hovelson D, Salami SS, Kaplan JB, Mathieu R, Udager A, Curci N, Lee M, De La Vega LL, Susani M, Rioux-Leclercq N, Spratt DE, Morgan TM, Davenport M, Rubin MA, Shariat SF, Tomlins SA, Palapattu GS . Integrative molecular profiling challenges robustness of prognostic signature scores in multifocal prostate cancer . Journal of Clinical Oncology . 2018;36(6)

Hu-Lieskovan S, Govindan R, Naing A, Friedlander T, Margolin K, Lin J, Bhardwaj N, Hellmann M, Srinivasan L, Greshock J, Moles M, Gaynor R, Goldstein M, Ott P . The personal vaccine, NEO-PV-01 with anti-PD1, induces neoantigenspecific de novo tumor-related immunity in patients with advanced cancer . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Hu Y, Fontenla S, Tyagi N, Mechalakos J, Zhang P, Polvorosa C, Allgood N, Mageras G, Hunt M . Developing and validating an automatic system of tracking parotid shrinkage in weekly MRIs for adaptive radiotherapy . Medical Physics . 2018;45(6):e494- .

Huang CH, Kenzik K, Duhamel K, Williams C, Partridge E, Pisu M, Rocque G, Kvale E . Association between posttraumatic stress symptoms and health care utilization in geriatric patients with cancer: Findings from the Patient Care Connect Program . Journal of Pain and Symptom Management . 2018;55(2):614-615 .

Huang Y, Jacobsen A, Panganiban J, Vigil E, Hutt K, Heilman J, Blankfard M, Stenzel T, Rustad EH, Hultcrantz M, Landgren O, Miller JE . Detection of

clonal rearrangements in multiple myeloma samples using LymphoTrack Assays . Journal of Molecular Diagnostics . 2018;20(6):930- .

Huang YJ, Yan M, Chen JY, Chen L, Kim E, Shima T, Davis AG, Miyauchi S, Stoner SA, Fu XD, Abdel-Wahab O I, Zhang DE . RUNX1 deficiency cooperates with SRSF2 mutation to further disrupt RNA splicing and exacerbate myelodysplastic syndromes in mouse models . Blood . 2018;132(Suppl . 1)

Hughes ME, Landsburg DJ, Rubin DJ, Schuster SJ, Svoboda J, Tsai DE, Robinson K, Gill S I, Mato AR, Gerson JN, Land D, Shelly B, McLeish A, Rago A, Gill J, Walsh K, Latorre T, Altman JK, Timlin C, Capozzi D, Nasta SD . Clinical outcomes of venetoclax therapy in patients with relapsed/refractory (r/r) non Hodgkin lymphomas (NHL) . Blood . 2018;132(Suppl . 1)

Hultcrantz M, Rustad EH, Yellapantula V, Akhlaghi T, Jacob A, Patel A, Korde N, Mailankody S, Lendvai N, Lesokhin AM, Hassoun H, Smith EL, Lahoud OB, Landau HJ, Shah GL, Scordo M, Chung DJ, Giralt S, Papaemmanuil E, Landgren O . Capture rate of the adaptive next generation sequencing VDJ assay in multiple myeloma . Blood . 2018;132(Suppl . 1)

Huntington SF, Schuster SJ, He W, Shen T, Walker H, Leary L, Boyhen K, Gill J, Chatburn ET, Kennard K, Dwivedy S, Landsburg DJ, Porter DL, Napier E, Hughes ME, Latorre T, Walsh K, Dorsey C, Svoboda J, Addis V, Anderson BD, Leblond E, Song Y, Zhu J, Deng L, Brander DM, Ding W, Rosenthal AC, Tun H, Mato AR . Phase I study of first-in-class oral triplet therapy DTRM-555 in relapsed/refractory lymphoma patients through fixed-dose combination and synthetic lethality . Blood . 2018;132(Suppl . 1)

Hurvitz SA, Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, Mina LA, Balmaña J, Fasching PA, Tudor C, Quek RGW, Hannah AL, Robson ME, Wardley AM . Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2

mutations (ABRAZO) . Cancer Research . 2018;78(4 Suppl .)

Hussain Y, Dang C, Steingart R, Liu J, Yu AF . Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced ejection fraction . Journal of the American College of Cardiology . 2018;71(11 Suppl .)

Hutchings D, Roberts NJ, Skaro M, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Klimstra D, Klein AP, Hruban R . Histopathology of pancreatic cancer in patients with germline mutations in ataxia telangiectasia mutated (ATM) gene . Modern Pathology . 2018;31(Suppl . 2):678- .

Hwang E, Onar A, Young-Poussaint T, Mitchell D, Kilburn L, Margol A, Gilheeny S, Lin T, Dunkel I, Fouladi M . Outcome of patients with recurrent diffuse intrinsic pontine glioma (DIPG) treated with pembrolizumab (Anti-PD-1): A Pediatric Brain Tumor Consortium study (PBTC045) . Neuro-Oncology . 2018;20(Suppl . 2):i100- . PMCID: PMC6012612

Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JWD, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz M, Pollack A, Moghanaki D, Anscher M, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA . Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Hyun M, Ma R, Diener T . Commissioning and accuracy of on-board imaging and optical surface tracking for three varian linear accelerators . Medical Physics . 2018;45(6):e592- .

Ignatiadis M, Silva MJ, Campbell C, Bradbury I, de Azambuja E, Maetens M, Fumagalli D, Rodrik-Outmezguine V, Di Cosimo S, Rosa D, Chia S, Wardley A, Ueno T, Janni W, Huober J, Baselga J, Piccart M, Sotiriou C, Loi S, Rothé F, Dawson S . Circulating tumor DNA in HER2 amplified breast cancer: A

227 OF 288


Meeting Abstracts

translational research substudy of the NeoALTTO phase 3 trial . Cancer Research . 2018;78(4 Suppl .)

Im SA, Xu B, Li W, Robson M, Ouyang Q, Yeh DC, Iwata H, Park YH, Sohn JH, Tseng LM, Goessl C, Wu W, Runswick S, Masuda N . Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial . Cancer Research . 2018;78(4 Suppl .)

Imber BS, Casey DL, Neal B, Darwish H, Cahlon O, Hug EB, Tsai HK, Chon BH, Yamada Y, Yang TJ . Proton beam re-irradiation as salvage therapy for recurrent intracranial meningiomas . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E249- .

Imber BS, Yang TJ, Zhigang Z, Beal K, Cohen M, Tabar VS, Geer EB, Lin A, Young RJ . Comparison of radiographic approaches to assess treatment response in pituitary adenomas: Are RECIST/RANO good enough? . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S213-S214 .

Iocolano M, Jackson A, Yorke ED, Pham H, Dick-Godfrey R, Wu AJ, Rimner A, Shepherd AF . Dose-volume and clinical correlates of radiation pneumonitis in non-small cell lung cancer patients treated with post-operative radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E685-E686 .

Irie T, Shum R, Deni I, Wilson R, Fischer G, Pan YX, Pasternak G . Identification of abundant and evolutionarily conserved opioid receptor circular RNAs, and their modulation in the mouse nervous system by chronic morphine . Anesthesia and Analgesia . 2018;126(4 Suppl .):72-76 .

Isharwal S, Audenet F, Drill EN, Ostrovnaya I, Pietzak EJ, Al-Ahmadie H, Cha EK, Donahue TF, Teo MY, Funt S, Arcila ME, Berger MF, Rosenberg JE, Bajorin

DF, Coleman J, Dalbagni G, Bochner BH, Solit DB, Iyer G . Next generation sequencing of urothelial bladder cancer: Memorial Sloan Kettering Cancer Center experience in 454 patients . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Ishizawa K, Horii A, Romel R, Cheng E, Drilon A . MDM2 amplification mediates resistance to cabozantinib in RET-rearranged lung cancers . Cancer Science . 2018;109(Suppl . 1):351- .

Isobe T, Zarnegar MA, Abdel-Wahab O I, Clarke MF . Effect of ASXL1 on the stemness of colorectal cancer initiating cells . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Isobe T, Zarneger MA, Matsubara J, Abdel-Wahab O, Clarke MF . ASXL1 regulates cellular differentiation and initiates tumorigenesis in colon . Cancer Science . 2018;109(Suppl . 2):342- . PMCID: PMC6298205

Itchaki G, Paludo J, Palomba ML, Varettoni M, Talaulikar D, Chavez JC, Buske C, Tedeschi A, Simpson D, Tam CS, Issa S, Ansell SM, Treon SP, Castillo JJ . Ibrutinib for the treatment of Bing-Neel syndrome . Blood . 2018;132(Suppl . 1)

Iukuridze A, Xiao M, Brandyn L, Teh JB, Mascarenhas K, Xu S, Rosen N, McCune JS, Zain JM, Chen RW, Popplewell L, Scott J, Slavin T, Jones L, Forman SJ, Nakamura R, Wong FL, Armenian SH . Muscle depletion is an important and clinically relevant predictor of outcomes after autologous hematopoietic cell transplantation . Blood . 2018;132(Suppl . 1)

Iwasa S, Shitara K, Takahashi S, Park H, Kadowaki S, Modi S, Nonagase Y, Tamura K, Yamaguchi K, Muro K, Tsurutani J, Shahidi J, Lee CC, Sugihara M, Kawaguchi Y, Doi T . Updated results of phase 1 study of DS-8201a in subjects with HER2-expressing gastric cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Iyer A, Jackson A, Apte A, Thor M, Fontanella A, Oh J, Deasy J . Updates to Radiotherapy Outcomes

Estimator (ROE) for protocol comparison and display of clinical constraints . Medical Physics . 2018;45(6):e256- .

Iyer A, Fontenla S, Haq R, Veeraraghavan H, Oh J, Mechalakos J, Hunt M, Deasy J, Apte A . Machine learning-based post-processing method for improved segmentation of parotid glands . Medical Physics . 2018;45(6):e686- .

Iyer R, Konda B, Owen D, Attwood K, Sarker S, Suffren SA, Reidy D, Shah M . Multicenter phase 2 study of nintedanib in patients with advanced progressing carcinoid tumors . Pancreas . 2018;47(3):342- .

Janne P, Yu H, Shipitofsky N, Vigliotti M, Goldberg T, Li J, Mcgill J, Zhang H, Yu C . Phase 1 study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S801- .

Janne P, Yu H, Johnson M, Steuer C, Vigliotti M, Shipitofsky N, Guevara FM, Chen S, Yu C . Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S815-S816 .

Jacobsen PB, Derosa AP, Henderson TO, Mayer D, Moskowitz CS, Paskett ED, Rowland JH . Impact of cancer survivorship care plans (SCPs) on health outcomes and health care delivery: A systematic review . Journal of Clinical Oncology . 2018;36(7 Suppl .)

Jagasia M, Perales MA, Schroeder MA, Ali H, Shah NN, Chen YB, Arbushites MC, Dawkins F, Tian C, Khoury HJ . Results from REACH1, a single-arm phase 2 study of ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease . Blood . 2018;132(Suppl . 1)

228 OF 288


Meeting Abstracts

Jahn N, Panina E, Bullinger L, Dolnik A, Herzig J, Blatte TJ, Benner A, Krzykalla J, Gathmann I, Larson RA, Lo-Coco F, Amadori S, Prior TW, Brandwein JM, Appelbaum FR, Medeiros BC, Tallman MS, Tiecke E, Pallaud C, Ehninger G, Heuser M, Ganser A, Stone RM, Thiede C, Döhner H, Bloomfield CD, Döhner K . Comprehensive molecular profiling of FLT3-mutated acute myeloid leukemia (AML) patients treated within the RATIFY trial (Alliance C10603) . Blood . 2018;132(Suppl . 1)

Jain T, Mountjoy L, Kunze KL, Noel P, Khera N, Leis JF, Slack JL, Sproat LZ, Palmer J . Does early T cell chimerism predict outcomes after allogeneic hematopoietic cell transplantation? . Blood . 2018;132(Suppl . 1)

Jain V, O’Reilly SE, Huang Q, Teo K, Zhang M, Diffenderfer ES, Levin WP, Xiao Y, Dong L, Feigenberg SJ, Zou W, Berman AT . Avoiding highly functional ventilation zones as defined by 4D simulation decreases the risk of radiation pneumonitis during proton radiation therapy for lung cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E686-E687 .

Jameel Z, Brogi E, Ross D, Weigelt B, Reis J, Wen HY . Targeted next generation sequencing analysis of metaplastic breast carcinoma . Modern Pathology . 2018;31(Suppl . 2):77- .

Janjigian Y, Hess L, Zhu Y, Fang Y, Liepa A, Kuder C, Chin S . Treatment and testing patterns among patients with HER2+ advanced/metastatic gastric, esophageal or gastroesophageal junction (GEJ) adenocarcinoma in the United States . Annals of Oncology . 2018;29(Suppl . 5):mdy151 .085- .

Janjigian YY, Le DT, Ott PA, Korytowsky B, Le H, Le TK, Zhang Y, Sanchez T, Maglinte G, Laurie M, Patel D, Shangguan T, Chau I . Survival of chemotherapy (chemo) refractory gastric or gastroesophageal junction cancer (GC/GEJC) patients from Flatiron Health (FH): Matched clinical characteristics to

ATTRACTION-2 and CHECKMATE-032 . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Janku F, Tan D, Martin-Liberal J, Takahashi S, Geva R, Gucalp A, Chen X, Subramanian K, Mataraza J, Wheler J, Bedard P . First-in-human study of FAZ053, an anti-PD-L1 mAb, alone and in combination with spartalizumab, an anti-PD-1 mAb, in patients with advanced malignancies . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Janne P, Li B, Murakami H, Shiga R, Lee C, Wang K, Planchard D . A phase 2 study of DS-8201a in HER2-overexpressing or -mutated advanced non-small-cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S476- .

Javle M, Kelley RK, Roychowdhury S, Weiss KH, Abou-Alfa GK, Macarulla T, Sadeghi S, Waldschmidt D, Zhu AX, Goyal L, Borad M, Yong WP, Borbath I, El-Khoueiry A, Philip P, Moran S, Ye Y, Ising M, Lewis N, Bekaii-Saab T . Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .030- .

Jelloul FZ, Bhavsar T, Pichardo JD, Yabe M, Rao M, Zhang Y, Dogan A, Xiao W . Extramedullary plasmablastic transformation of plasma cell myeloma: Clinicopathologic study of 10 cases . Modern Pathology . 2018;31(Suppl . 2):526- .

Jelloul FZ, Pichardo JD, Khattar P, Ananthamurthy A, Rao M, Areeyqur R, Jungbluth A, Wang L, Zhang Y, Dogan A . MHC class II transactivator (CIITA) abnormalities are frequent in B-cell lineage lymphomas and are associated with loss of MHC class II (MHCII) . Modern Pathology . 2018;31(Suppl . 2):525- .

Jhaveri K, Syed U, Wong S, D’Andrea G, Lake D, Goldfarb S, Gajria D, Ligresti L, Rogado A, Reis-Filho J, Chandarlapaty S . Co-targeting ER and FGFR in patients with ER+/HER2- FGFR amplified (amp)

metastatic breast cancer (MBC) . European Journal of Cancer . 2018;103(Suppl . 1):e42- .

Jhaveri KL, Makker V, Wang X V, Chen AP, Flaherty K, Conley BA, O’Dwyer PJ, Williams PM, Hamilton SR, Harris L, McShane L, Rubinstein L, Gray RJ, Li SL, Mitchell EP, Patton D, Moscow J, Zwiebel JA, Arteaga CL, Luoh SW . Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial . Journal of Clinical Oncology . 2018;36(15 Suppl .):6s- .

Jia L, Jayakumaran G, Al-Ahmadie H, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo S, Reuter V, Chen YB . Clear cell renal cell carcinoma with prominent papillary architecture: A rare morphologic variant supported by molecular evidence . Modern Pathology . 2018;31(Suppl . 2):353- .

Jia L, Carlo M I, Khan H, Nanjangud GJ, Rana S, Hakimi AA, Verma AK, Al-Ahmadie H, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo S, Reuter V, Gartrell BA, Chen YB . Morphologic and molecular characterization of renal medullary carcinoma: A study of 18 cases . Modern Pathology . 2018;31(Suppl . 2):352-353 .

Jiang J, Hu Y, Tyagi N, Zhang P, Rimner A, Deasy J, Mageras G, Veeraraghavan H . Best in physics (Joint imaging-therapy): Deep learning mapping of CT to MRI for longitudinal tracking of lung tumors for MRI-guided radiotherapy . Medical Physics . 2018;45(6):e449- .

Jo J, Nevel K, Sutyla R, Smolkin M, Lopes MB, Schiff D . Predictors of early and recurrent seizure in low-grade glioma . Neurology . 2018;90(15 Suppl .)

Johncilla ME, Brown I, Shia J, Hornick JL, Jessurun J, Yantiss R . Are enterocolic mucosal mast cell aggregates clinically relevant in patients without

229 OF 288


Meeting Abstracts

suspected systemic mastocytosis? . Modern Pathology . 2018;31(Suppl . 2):273- .

Johnson CB, Postow MA, Chapman P, Wolchok JD, Brennan CW, Tabar VS, Chan TA, Yamada Y, Yang TJ, Beal K . Safety and clinical outcomes of ipilimumab and nivolumab plus concurrent stereotactic radiosurgery for brain metastases . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E228- .

Jomenez Alguilar E, Gainor J, Kravets S, Khosrowjerdi S, Lydon C, Adeni A, Subegdjo S, Rizvi H, Hellmann M, Awad M . Outcomes in NSCLC patients treated with first-line pembrolizumab and a PD-L1 TPS of 50-74% vs 75-100% or 50-89% vs 90-100% . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S367-S368 .

Jones RL, Blay JY, Agulnik M, Chugh R, Mir O, Italiano A, Thomas D, Gupta A, Jahan T, Cote G, Villalobos V, Demetri GDD, Roche M, Sapir I, Daigle S, Clawson A, Gounder M . A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950) . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .011- .

Jonsdottir G, Björkholm M, Turesson I, Hultcrantz M, Porwit A, Jethava Y, Landgren O, Kristinsson SY . Risk factors for acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma: An updated analysis . Blood . 2018;132(Suppl . 1)

Jung H, Klages P, Shen C, Gonzalez Y, Albuquerque K, Jia X . A deep-learning approach toward automated digitization of high dose-rate brachytherapy applicators . Medical Physics . 2018;45(6):e572- .

Jung J, Ky B, Kenworthy W, Bosch W, Lee C, Mille M, MacDonald S, Cahlon O, Bekelman J, Lee C . Automatic delineation of cardiac substructures: Analyses from the RadComp randomized trial in breast cancer . Medical Physics . 2018;45(6):e520- .

Jungbluth A, Frosina D, Fayad M, Lezcano C, Busam K . Cancer testis antigen PRAME is abundantly expressed in metastatic melanoma and other malignancies . Modern Pathology . 2018;31(Suppl . 2):702- .

Jungbluth A, Fayad M, Akturk G, Roehrl MH, Frosina D . Carrier-based multi-tissue block (CBMTB) of normal tissues as on-slide quality control for automated immunohistochemical staining procedures . Modern Pathology . 2018;31(Suppl . 2):778- .

Jungbluth A, Dogan A, Frosina D, Fayad M, Smith E . In-situ protein expression analysis of B-cell maturation antigen (BCMA) . Modern Pathology . 2018;31(Suppl . 2):526- .

Juric D, Curigliano G, Cresta S, Yap YS, Terret C, Duhoux FP, Takahashi S, Kundamal N, Bhansali S, Liao S, Crystal A, Jhaveri K . Phase I/Ib study of the SERD LSZ102 alone or in combination with ribociclib in ER+ breast cancer . Cancer Research . 2018;78(4 Suppl .)

Jutagir DR, Blomberg BB, Carver CS, Lechner S, Timpano K, Bouchard LC, Gudenkauf L, Jacobs J, Diaz A, Lutgendorf S, Cole S, Heller A, Antoni MH . Challenges in inflammation measurement: Associations between social well-being and multiple inflammatory biomarkers . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S308- .

Kabadi S, Goyal RK, Nagar SP, Kaye JA, Davis KL, Mato AR . Treatment patterns, adverse events, and economic burden in a privately insured population of newly diagnosed patients with chronic lymphocytic leukemia in the United States . Blood . 2018;132(Suppl . 1)

Kahn J, Gupta A, Mukhopadhyay ND, Khan AJ, Haffty BG Jr, Brown SE Jr, Chen PY, Cuttino LW, Vicini FA, Arthur DW . Short course, two day accelerated hypofractionated partial breast balloon brachytherapy: A phase II multi-institutional trial . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E576-E577 .

Kalinsky K, Harding JJ, DeMichele A, Infante JR, Gogineni K, Owonikoko TK, Isakoff S, Iliopoulos O, Patel MR, Munster P, Telli ML, Jenkins Y, Fiji GP, Whiting SH, Meric-Bernstam F . Phase 1 study of CB-839, a first-in-class oral inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer . Cancer Research . 2018;78(4 Suppl .)

Kammerer-Jacquet SF, Ahmad A, Moller H, Scardino P, Beltran L, Cuzick J, Berney D . Ki-67 is an independent predictor of prostate cancer death in routine sections: Potential use in active surveillance . Modern Pathology . 2018;31(Suppl . 2):354- .

Kato S, Suehara Y, Hayashi T, Saito T, Yamaguchi S, Nozaki Y, Ladanyi M . Experience of multi-genetic diagnosis by cancer panel MSK-IMPACT . Cancer Science . 2018;109(Suppl . 1):1132- . PMCID: PMC5770438

Katsoulakis E, Oh JH, Leeman JE, Yu Y, Tsai CJ, McBride S, Katabi N, Apte A, Deasy JO, Lee N, Hatzoglou V, Riaz N . Identifying biological subtypes of head and neck squamous cell carcinoma (HNSCC) from contrast enhanced CT scans using radiomic and The Cancer Genome Atlas (TCGA) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S60-S61 .

Kaur G, Dunkel I, Shukla N, Zahir A, Karajannis M . Novel PTCH1-INPPL1 fusion in a patient with extraneural metastatic ependymoma - A case report . Neuro-Oncology . 2018;20(Suppl . 2):i75-i76 .

Kaur G, Wolden S, Donzelli M, Haque S, Kramer K . Incidence of cavernomatous lesions on brain MR of pediatric patients treated with intraventricular radioimmunotherapy . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S437-S438 .

Kaur G, Wolden S, Donzelli M, Haque S, Kramer K . Incidence of cavernomatous lesions on brain MR of pediatric patients treated with intraventricular

230 OF 288


Meeting Abstracts

radioimmunotherapy . Neuro-Oncology . 2018;20(Suppl . 6):vi185- . PMCID: PMC6216117

Kaur M, Pusic A, Xie F, Bordeleau L, Matros E, Zhong T, Cano S, Dimitry S, Klassen A . Development of health-state classification system for a new breast cancer-specific preference-based measure: The BREAST-Q-U . Quality of Life Research . 2018;27(Suppl . 1):S18-S19 .

Kaur M, Klassen A, David P, Pieris D, Sharma M, Louise B, Andrea P, Xie F . Improving breast cancer care by understanding health utilities: The work before the work . Quality of Life Research . 2018;27(Suppl . 1):S14- .

Keall P, Nguyen D, O’Brien R, Zhang P, Happersett L, Bertholet J, Poulsen P . Multiple clinical implementations of real-time 3D IGRT on standard-equipped cancer radiotherapy systems: The tipping point for the era of real-time radiotherapy? . Medical Physics . 2018;45(6):e478- .

Keane F, Greally M, Power DG, Leonard GD . A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program . Journal of Clinical Oncology . 2018;36(7 Suppl .)

Keaney T, Cavallini M, Leys C, Rossi A, Mao C, Garcia JK, Gallagher CJ, Shumate GT . Efficacy, safety, and patient-reported outcomes in male subjects treated with onabotulinumtoxinA for improvement of moderate to severe horizontal forehead lines . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB126- .

Kearney JA . A clinical pathway: Preventing, recognizing, and managing delirium in pediatric hospital setting . Journal of the American Academy of Child and Adolescent Psychiatry . 2018;57(10 Suppl .):S103- .

Keene KS, King T, Hwang ES, Peng B, McGuire K, Tapia C, Zhang H, Bae S, Nakhlis F, Klauber-Demore N, Meszoely I, Sabel MS, Willey SC, Eterovic KA,

Hudis C, Wolff A, De Los Santos J, Thompson A, Mills GB, Meric-Bernstam F . Molecular determinants of post-mastectomy breast cancer recurrence . Cancer Research . 2018;78(4 Suppl .)

Kelley RK, El-Khoueiry AB, Meyer T, Rimassa L, Merle P, Chan SL, Tran A, Parnis F, Tam VC, Cattan S, Markby DW, Clary DO, Cheng AL, Abou-Alfa GK . Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC) . Annals of Oncology . 2018;29(Suppl . 8):mdy282 .085- .

Kelly WK, Godwin JL, Hoffman-Censits JH, Knudsen KE, De Leeuw R, Leiby BE, Southwell T, Hubert C, Smith DC, Chatta GS, Aghalar J, Scher H I, Bose R, Autio KA, Abida W, Slovin SF . c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naive prostate cancer that retains RB expression . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Kenny S, Collum K, Featherstone C, Bhatt V, Irby S, Kelly S, Montefusco M, Morcerf B, Patterson E, Taylor J, Farooki A, Jakubowski AA . Impact of hematopoietic stem cell transplant (HSCT) Vitamin D algorithm on vitamin D levels of HSCT patients - Part II . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S113-S114 .

Kernan NA, Smith AR, Lehmann L, Ryan R, Liang W, Hume R, Tappe W, Grupp SA . Efficacy and safety of defibrotide in pediatric patients with veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final results from the expanded-access program (T-IND) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S294- .

Kerr K, Tsao M, Yatabe Y, Thunnissen E, Nicholson A, Moreira A, Chou T, Borczuk A, Bubendorf L, Mino-Kenudson M, Boding J, Beasley MB, Chirieac L, Dacic

S, Lantuejoul S, Pelosi G, Chung J, Chen G, Russell P, Poleri C, Sauter J, Yu H, Noguchi M, Wistuba I, Pintilie M, Wynes M, Hirsch F . Phase 2B of blueprint PD-L1 immunohistochemistry assay comparability study . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S325- .

Kesner AL, Olguin E, Zanzonico P, Lafontaine D, Bolch WE . MIRDcalc Internal dosimetry software: Initial development and validation . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S179-S180 .

Kfoury Y, Jain E, Myers JR, Ji F, Sykes DB, Mercier F, Papazian A, Le C, Randolph MA, Steensma DP, Abdel-Wahab O I, Calvi LM, Sadreyev R I, Becker MW, Scadden DT . Specific bone marrow mesenchymal subsets in patients with myelodysplastic syndromes harbor molecular perturbations that alter the dynamics of competition between pre-leukemic clones and normal cells . Blood . 2018;132(Suppl . 1)

Khan N, Peled JU, Gomes ALC, Devlin SM, Rondon-Clavo C, Clurman A, Slingerland JB, Slingerland AE, Maloy M, Sung AD, Chao NJ, Sauter CS, Landau HJ, Ponce D, Gyurkocza B, Shah GL, Scordo M, Dahi PB, Perales MA, Jenq RR, Giralt S, Pamer EG, van den Brink MRM . Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant . Blood . 2018;132(Suppl . 1)

Kharas M . Towards therapeutic targeting of the MUSASHI RNA binding protein network . Abstracts of Papers of the American Chemical Society . 2018;256

Khattar P, Pichardo JD, Jelloul FZ, Robert C, Areeyqur R, Rao M, Zhang Y, Arcila M, Wang L, Dogan A . t(14;18) negative inguinal follicular lymphoma is characterized by genetic abnormalities of 1p36/TNFRSF14 and 16p/CREBBP regions . Modern Pathology . 2018;31(Suppl . 2):527-528 .

Khodadoust MS, Rook A, Porcu P, Foss FM, Moskowitz AJ, Shustov AR, Shanbhag S, Sokol L,

231 OF 288


Meeting Abstracts

Fling SP, Li S, Davis A, Fong S, Kim J, Yang Y, Yearley JH, Subrahmanyam PB, Maecker HT, Budovskaya Y, Das B, Patidar R, Datta V, Karlovich C, Horwitz SM, Sharon E, Kohrt H, Cheever MA, Kim YH . Durable responses with pembrolizumab in relapsed/refractory mycosis fungoides and Sezary syndrome: Final results from a phase 2 multicenter study . Blood . 2018;132(Suppl . 1)

Khodadoust MS, Rook AH, Porcu P, Foss F, Moskowitz A, Shustov AR, Shanbhag S, Sokol L, Fling SP, Li S, Fong S, Kim J, Yang Y, Yearley J, Subrahmanyam P, Maecker H, Horwitz SM, Sharon E, Cheever MA, Kim YH . Pembrolizumab in mycosis fungoides and Sezary syndrome: Updated results of the CITN multicenter Phase 2 study . European Journal of Cancer . 2018;101(Suppl . 1):S37- .

Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani C, O’Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane RD, Bauer KA, Kuderer NM, Lyman GH . Rivaroxaban thromboprophylaxis in high risk ambulatory cancer patients receiving systemic therapy: Results of a randomized clinical trial (CASSINI) . Blood . 2018;132(Suppl . 1)

Khoury T, Hanna MG, Nayak A, Mokhtar Desouki M, Sanati S, Fang Y, Li X, Peng X, Yan L, Fadare O, Fung-Kee-Fung SD, Gaudioso C, Karabakhtsian RG . The clinical significance of metastatic breast carcinoma to intra-mammary lymph node . Modern Pathology . 2018;31(Suppl . 2):79- .

Khoury T, Karabakhtsian RG, Nayak A, Hanna MG, Fang Y, Peng X, Yan L, Li X, Fadare O, Ambrosone C, Fung-Kee-Fung SD, Gaudioso C, Mokhtar Desouki M . A nomogram for predicting the likelihood of additional axillary nodal metastases in breast cancer patients with a positive intramammary nymph node . Modern Pathology . 2018;31(Suppl . 2):79- .

Kiguchi H, Shamay Y, Shah J, Vaynshteyn J, Heller D, Raju P . Vismodegib nanoparticle enhances tumor targeting in an in vivo medulloblastoma model . Neuro-Oncology . 2018;20(Suppl . 2):i140- . PMCID: PMC6012612

Kiguchi H, Singh S, Gulati N, Kivovich V, Kothari P, Nicoletti E, Sait S, Taylor D, Davis M, Saldivar R, Kearney J, Roberts S . Building resilience during pediatric hematology/oncology fellowship: Implementing systematic debriefing sessions and resiliency curriculum to support trainees . Pediatric Blood and Cancer . 2018;65(S1):S184-S185 .

Kim J, Geyer FC, Martelotto LG, Ng CKY, Lim RS, Selenica P, Li A, Pareja F, Fusco N, Edelweiss M, Mariani O, Badve S, Vincent-Salomon A, Norton L, Reis-Filho JS, Weigelt B . Novel driver genetic alterations in MYB-NFIB-negative breast adenoid cystic carcinomas . Cancer Research . 2018;78(4 Suppl .)

Kim J, Schattner MA, Ludwig E, Mendelsohn R, Markowitz AJ, Flynn J, Riedel E, Gerdes H, Shah P . Efficacy and long-term outcomes of endoscopic self-expanding metal stents in malignant gastric outlet obstruction . Gastrointestinal Endoscopy . 2018;87(6 Suppl .):AB310- .

Kim JK, McBride S, Riaz N, Leeman JE, Spielsinger D, Sabol C, Waldenberg T, Brinkman T, Lee N, Tsai CJ . Patterns of care and radiation therapy utilization among patients with soft tissue sarcoma of the head and neck: A National Cancer Database analysis . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1384- .

Kim JK, Beckham T, McBride S, Alektiar KM, Riaz N, Leeman JE, Spielsinger D, Sabol C, Brinkman T, Waldenberg T, Lee N, Tsai CJ . Long term outcomes and prognostic factors of head and neck soft tissue sarcoma (HNSTS) treated with definitive therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E265- .

Kim S, Gangai N, Manna R, Grodzicki BK . Meeting the nursing needs: An interprofessional team education approach to enhance care for older adults . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S226-S227 .

Kim T, Da Silva EM, Coit D, Tang LH . Intratumoral immune response to gastric cancer varies by molecular and histologic subtype . Annals of Surgical Oncology . 2018;25(Suppl . 1):S46- .

Kim YH, Prince HM, Whittaker S, Horwitz SM, Duvic M, Bechter O, Sanches JA, Stadler R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Eradat H, Pinter-Brown LC, Ortiz-Romero PL, Akilov OE, Trotman J, Taylor K, Weichenthal M, Walewski J, Fisher DC, McNeeley M, Gru AA, Wang Y, Palanca-Wessels MC, Lisano J, Li M, Lin HM, Little M, Trepicchio WL, Dummer R . Superior clinical benefit of brentuximab vedotin in mycosis fungoides versus physician’s choice irrespective of CD30 level or large cell transformation status in the phase 3 ALCANZA study . Blood . 2018;132(Suppl . 1)

Kim YS, Roehrl MH . Computer science approaches to extract immunohistochemistry (IHC) results from surgical pathology full text reports using machine learning and natural language processing (NLP) techniques . Modern Pathology . 2018;31(Suppl . 2):591- .

Kim YS, Silber J, Gardos S, Roehrl MH . The big data opportunity in research biobanking: Design and development of a web-based application to unify and connect biospecimen information and to overcome data silo challenges . Modern Pathology . 2018;31(Suppl . 2):591- .

King AC, Pappacena J, Tallman MS, Park JH, Geyer MB . Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia . Blood . 2018;132(Suppl . 1)

232 OF 288


Meeting Abstracts

Kirches E, Sahm F, Blücher C, Boekhoff S, Schüller U, Schittenhelm J, Snuderl M, Karajannis M, Perry A, Pietsch T, Müller H, Rubin J, Capper D, Beck K, Schlesner M, Kropf S, Brastianos P, Korshunov A, Pfister S, Mawrin C . Pediatric meningiomas are molecularly distinct from adult counterparts . Neuro-Oncology . 2018;20(Suppl . 2):i144-i145 .

Kirschbrown WP, Kagedal M, Wang B, Lindbom L, Knott A, Mack R, Monemi S, Baselga J, von Minckwitz G, Bines J, Garg A . Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer . Clinical Pharmacology & Therapeutics . 2018;103(Suppl . 1):S74- .

Klager SA, Devlin SM, Hannum M, Jakubowski AA, Markova A . Rash in patients after T-cell-depleted peripheral blood stem cell transplantation: Eosinophilia and pruritus do not distinguish acute graft-versus-host disease from drug rash . Blood . 2018;132(Suppl . 1)

Klages P, Jiang J, Farjam R, Deasy J, Hunt M, Veeraraghavan H, Tyagi N . Conditional generative adversarial networks (cGANs) for magnetic resonance (MR) based synthetic computed tomography (sCT) images in head and neck dose calculations . Medical Physics . 2018;45(6):e700- .

Klatt M, Gejman R, Mun SS, Dao T, Scheinberg D . Improved sensitivity and specificity for mutated and unmutated class I HLA ligand identifications lead to better immunotherapy target discovery . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S297- .

Klatt MG, Mun SS, Socci ND, Korontsvit T, Dao T, Scheinberg DA . Epigenetic drug treatment induces presentation of new class of non-exonic cryptic neoantigens in acute myeloid leukemia cells . Blood . 2018;132(Suppl . 1)

Klein ME, Kovatcheva M, Dickson MA, Liu D, Crago AM, Schwartz GK, Tap WD, Singer S, Koff A . CDK4

inhibition and senescence: Pathway understanding leads to rational drug combinations . Clinical Cancer Research . 2018;24(2 Suppl .):20- .

Klein W, Biesecker B, Ferrer RA, Hamilton JG, Peters E, Taber JM . Panel discussion: Incorporating basic research on cognition and affect into clinical genomics . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S171- .

Kleinerman R, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM . Mortality in 1,948 long-term survivors of retinoblastoma . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S688- .

Kloetgen A, Serrano J, Patel S, Bowman C, Shen G, Zagzag D, Karajannis M, Golfinos J, Placantonakis D, Tsirigos A, Chi A, Snuderl M . DNA methylation of circulating tumor educated leukocytes as a biomarker of IDH1/2 mutation in diffuse gliomas . Journal of Neuropathology and Experimental Neurology . 2018;77(6):482- .

Kobel M, Tessier-Cloutier B, Soslow R, Stewart C, Lee CH . Loss of claudin-4 is expression is common in undifferentiated/dedifferentiated endometrial carcinomas . Modern Pathology . 2018;31(Suppl . 2):429- .

Koenig JL, Kozak M, Sabolch A, Wapnir IL, Horst KC, Tsai CJ, Pollom E . Use of preoperative radiation therapy in early and advanced stage breast cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E589- .

Koff A, Klein ME, Dickson MA, Antonescu C, Qin LX, Dooley SJ, Schwartz G, Crago AM, Singer S, Tap WD . Senescence after growth arrest: A mechanism by which CDK4/6 inhibitors can mediate their activity suppressing tumor progression . Annals of Oncology . 2018;29(Suppl . 3):mdy046 .011- .

Koffman B, Dennison B, Kennard K, Byrd JC, Pagel JM, Davids MS, Nabhan C, Kay NE, Siddiqi T, Brander DM, Stephens DM, Hill BT, Pinilla-Ibarz J, Cheson BD,

Rosen ST, Awan FT, Choi MY, Mato AR . A US-based survey: The experiences of 1147 chronic lymphocytic leukemia (CLL) patients (pts) . Journal of Clinical Oncology . 2018;36(15 Suppl .):407s- .

Kolasinska-Cwikla A, Lewczuk-Myslinska A, Bednarczuk T, Palucki J, Roszkowska-Purska K, Cichocki A, Dobkowski P, Kidd M, Bodei L, Modlin I, Cwikla J . Efficacy of Octreotide LAR in treatment of naive patients with advanced, non-resectable well and moderate differentiated pancreatic neuroendocrine neoplasms (p-NENs) . Neuroendocrinology . 2018;106(Suppl . 1):198- .

Kolasinska-Cwikla A, Lewczuk-Myslinska A, Cichocki A, Roszkowska-Purska K, Dobkowski P, Bodei L, Cwikla J . PRRT in hindgut and cancer of unknown primary NEN . Neuroendocrinology . 2018;106(Suppl . 1):246- .

Kollmeier MA, McBride S, Lochansingh S, Varghese M, Debonis D, Cohen G, Damato AL, Zelefsky MJ . A phase II trial of low dose rate brachytherapy combined with ultra-hypofractionated, image-guided, intensity-modulated radiation therapy for clinically localized, intermediate risk prostate cancer: A preliminary analysis . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E123- .

Kollmeier MA, Zelefsky MJ, McBride S, Debonis D, Lochansingh S, Varghese M, Bochner B, Rosenberg J, Bajorin D . A phase I trial of dose-escalated image-guided, intensity modulated radiation therapy in combination with concurrent gemcitabine chemotherapy for node-negative, muscle-invasive bladder cancer (MIBC) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E87-E88 .

Kong SG, Yang EJ, Park KM, Lee JM, Hah JO, Park SK, Suh JK, Kim JY, Lee KS, Park J, Park ES, Lim JY, Shim YJ, Kim HS, Chueh H, Choi EJ, Park JA, Lim YT . Treatment outcome of ETV6/RUNX1

233 OF 288


Meeting Abstracts

positive pediatric acute lymphoblastic leukemia in Yeungnam region: A multicenter retrospective study in Korea . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S129-S130 .

Konsek S, Kolasinska-Cwikla A, Lewczuk-Myslinska A, Kidd M, Buscombe JR, Bodei L, Cichocki A, Cwikla J, Modlin I . Value of somatostatin receptor scintigraphy (SRS) in patients with appendiceal neuroendocrine neoplasms (ANEN) based on clinical follow-up and results of NETest . Neuroendocrinology . 2018;106(Suppl . 1):248- .

Konsek SJ, Kolasinska-Cwikla AD, Lewczuk A, Kidd M, Buscombe JR, Bodei L, Cichocki A, Roszkowska-Purska K, Cwikla JB, Modlin IM . The value of somatostatin receptor scintigraphy (SRS) in patients with NETG1/G2 neuroendocrine neoplasms of the small intestine (SI-NENs) . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S468-S469 .

Korde N, Mastey D, Mailankody S, Hassoun H, Lesokhin AM, Smith EL, Lendvai N, Hultcrantz M, Tavitian E, Salcedo M, Sams A, Diab V, Chung DJ, Scordo M, Lahoud OB, Landau HJ, Arcila ME, Giralt S, Ho C, Roshal M, Devlin SM, Dogan A, Landgren O . MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone . Blood . 2018;132(Suppl . 1)

Kothari P, Slotkin E, Yang J, Stewart C, Gedvilaite E, Berger M, Ladanyi M, Shukla N, Modak S, Tsui D . Noninvasive molecular profiling by circulating cell-free DNA in pediatric solid tumors . Pediatric Blood and Cancer . 2018;65(S1):S253- .

Koyfman S, Joshi NP, Lamarre E, Tsai CJ, Schymick MA, Liu H, Tam L, Rybicki L, Dunlap NE, Porceddu S, Ghanem A I, Siddiqui F, Caudell JJ, Lee N, Geiger JL, Burkey BB, Adelstein DJ, Woody NM . Validating the AJCC 8th edition of the oral cavity cancer staging

system: A multi-institutional collaborative study . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S22- .

Kramer K, Wolden S, Donzelli M, Haque S . Incidence of cavernomatous lesions on brain MR of pediatric patients treated with intraventricular radioimmunotherapy . Neuro-Oncology . 2018;20(Suppl . 2):i175- . PMCID: PMC6012612

Kramer K, Donzelli M, Grkovski M, Greenfield J, Souweidane M, Taskar NP . Diversion of CSF with programmable ventriculoperitoneal shunts: Role with intraventricular radioimmunotherapy . Neuro-Oncology . 2018;20(Suppl . 2):i147- . PMCID: PMC6012612

Kramer K, Kushner B, Modak S, Pandit-Taskar N, Tomlinson U, Donzelli M, Wolden S, Zanzonico P, Humm J, Haque S, Souweidane M, Greenfield J, Basu E, Roberts S, Carrasquillo J, Lewis J, Lyashchenko S, Larson S, Cheung NK . Intraventricular 131I-labeled monoclonal antibody 8H9 (omburtomab) targeting the surface glycoprotein B7-H3 in patients with CNS malignancies . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S439- .

Kramer K, Taskar NP, Humm J, Zanzonico P, Donzelli M, Haque S, Khakoo Y, Lewis J, Cheung NK . Recurrent ependymoma: Role of intraventricular targeted radioimmunotherapy . Neuro-Oncology . 2018;20(Suppl . 2):i74- .

Kramer K, Kushner B, Modak S, Taskar NP, Tomlinson U, Donzelli M, Wolden S, Zanzonico P, Humm J, Haque S, Souweidane M, Greenfield J, Basu E, Roberts S, Carrasquillo J, Lewis J, Lyashchenko S, Larson S, Cheung NK . Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 . Neuro-Oncology . 2018;20(Suppl . 2):i99- .

Kramer K, Haque S, Wolden S, Greenfield J, Kushner B, Modak S, Cheung NK, Donzelli M, Eljalby M, Souweidane M . Impact of disease site, size and

surgical resection on survival from metastatic CNS neuroblastoma . Neuro-Oncology . 2018;20(Suppl . 6):vi59-vi60 . PMCID: PMC6216117

Krebs M, Lopez J, El-Khoueiry A, Bang YJ, Postel-Vinay S, Abidah W, Im SA, Khoja LT, Standifer N, Jones GN, Marco-Casanova P, Frewer P, Berges A, Cheung A, Stephens C, Felicetti B, Dean E, Pierce A, Hollingsworth S . Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .401- .

Krebs S, O’Donoghue J, Biegel E, Beattie BJ, Reidy D, Bodei L, Weber WA, Pandit-Taskar N . Comparison of (68)Ga-DOTA-JR11 PET/CT with (dosimetric) (177)Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S63-S64 .

Krishnan A, Li B, Pagane M, McGovern E, Stone-Molloy Z, Chen J, Brooks C, Levine RL, Rampal RK . Evaluation of combination tagraxofusp (SL-401) and hypomethylating agent (HMA) therapy for the treatment of chronic myelomonocytic leukemia (CMML) . Blood . 2018;132(Suppl . 1)

Krop I, Abramson V, Colleoni M, Traina T, Holmes F, Estevez L, Hart L, Awada A, Zamagni C, Morris P, Schwartzberg L, Chan S, Wheatley D, Gucalp A, Biganzoli L, Steinberg J, Gianni L, Trudeau M, Tudor IC, Markova D, Barry E, Tarazi J, Stewart R, Winer E, Yardley DA . Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor-positive breast cancer . Cancer Research . 2018;78(4 Suppl .)

Krop IE, Hillman D, Polley MY, Tanioka M, Parker J, Huebner L, Henry NL, Tolaney SM, Dang C, Harris L, Berry DA, Perou CM, Partridge A, Winer EP,

234 OF 288


Meeting Abstracts

Carey LA . Invasive disease-free survival and gene expression signatures in CALGB (Alliance) 40601, a randomized phase III neoadjuvant trial of dual HER2-targeting with lapatinib added to chemotherapy plus trastuzumab . Cancer Research . 2018;78(4 Suppl .)

Ku GY, Mukherjee S, Okoro C, Sharma M, Ravichandran V, Offit K, Joseph V, Janjigian YY, Stadler ZK, Kelsen DP . Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC) . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Kumar A, Zelenetz AD, Batlevi CL, Caron P, Dogan A, Drullinsky P, Gerecitano J, Hamilton A, Hamlin PA, Laraque L, Matasar MJ, McCall SJ, Moskowitz AJ, Moskowitz CH, Owens C, Pichardo J, Schoder H, Sigler A, Straus DJ, Younes A . Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma . Blood . 2018;132(Suppl . 1)

Kumar P, Pichardo JD, Lewis N, Chan A, Gao Q, Roshal M, Dogan A . Hairy cell leukemia expresses programmed death 1 (PD-1): A new diagnostic marker . Modern Pathology . 2018;31(Suppl . 2):529-530 .

Kumthekar P, Gradishar W, Lin N, Pentsova E, Groves M, Jeyapalan S, Melisko M, Grimm S, Lassman AB, Raizer J . Intrathecal (IT) traztuzumab (T) for the treatment of leptomeningeal metastases (LM) in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) cancer: A multicenter phase 1/2 study . Neuro-Oncology . 2018;20(Suppl . 6):vi58- . PMCID: PMC6216117

Kuo CY, Puck JM, Logan BR, Haddad E, Cuvelier GDE, Yin Z, Prockop SE, Buckley R, Griffith LM, Kohn DB . Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): Analysis of cases enrolled in protocols of the Primary Immune

Deficiency Treatment Consortium (PIDTC) . Journal of Clinical Immunology . 2018;38(3):342-343 .

Kuo H, Berry S, Ballangrud A, Atwal PS, Della Biancia C, Pathare P, Shasha D, Lovelock D, Hunt M . Accuracy of 3D/3D and 3D/2D registration in intracranial radiosurgery using 6DOF robotic couch . Medical Physics . 2018;45(6):e436- .

Kuo L, Zhang P, Rimner A, Deasy J . Feasibility of dose escalation based on geometric and biological predictions of tumor response to radiotherapy for non-small-cell lung cancer . Medical Physics . 2018;45(6):e213- .

Kuo L, Ballangrud A . Gradient Index as quality measure of multi lesion SRS VMAT plans . Medical Physics . 2018;45(6):e213- .

Kurlander LS, Srinivasan A, Ghobadi A, Suser S, Doubrovina E, Boulad F, Mascarenhas L, Laquaglia M, Price A, Behr G, Shulkin B, Sudhindra A, Wei Y, Hiremath M, Navarro W, O’Reilly R, Prockop S . Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV(+)LMS) . Annals of Oncology . 2018;29(Suppl . 10):mdy485 .003- .

Kwon D, Hamann H, Shen M, Ostroff J . The association of social constraints to lung cancer stigma . Psycho-Oncology . 2018;27(Suppl . 1):66-67 .

Kwon D, Park E, Perez GK, Rabin JT, Friedman E, Ostroff J . Smoking status differences in partner support for smoking cessation in cancer patients . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S703- .

Labuhn M, Perkins K, Papaemmanuil E, Garnett C, Matzk S, Amstislavskiy V, Metzner M, Kennedy A, Scheer C, Yoshida K, Schwarzer A, Crispino JD, Taub JW, Weiss MJ, Ito E, Ogawa S, Reinhardt D, Yaspo ML, Campbell PJ, Heckl D, Klusmann JH, Vyas P . Modelling the progression of a preleukemic stage to overt

leukemia in children with Down syndrome . Blood . 2018;132(Suppl . 1)

Lacouture M, Dion H, Ravipaty S, Akmaev VR, Sarangarajan R, Jimenez JJ, Narain NR, Berman B, Goldfarb S . A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results . Annals of Oncology . 2018;29(Suppl . 8):mdy300 .011- .

Lacouture M, Hershkovich H, Giladi M, Blat R, Bomzon Z, Kirson E, Weinberg U, Palti Y . Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma . Neuro-Oncology . 2018;20(Suppl . 3):iii293- . PMCID: PMC6144305

Lacouture M, Hershkovich H, Giladi M, Bomzon Z, Kirson E, Weinberg U, Plati Y . Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma . Neuro-Oncology . 2018;20(Suppl . 6):vi85- . PMCID: PMC6216117

Lacouture M . PROTECT study: Prophylactic skin toxicity therapy with clindamycin and clobetasol or skin barrier in glioblastoma patients treated with tumor treating fields . Neuro-Oncology . 2018;20(Suppl . 6):vi138- .PMCID: PMC6216117

Lafay-Cousin L, Robinson G, Rudneva V, Northcott P, Billups C, Onar-Thomas A, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Strother D, Fouladi M, Bouffet E, Gajjar A . Sonic hedgehog methylation subgrouping is a prognostic factor for young children with nodular desmoplastic medulloblastoma: A report of Children’s Oncology Group study ACNS1221 . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S24- .

Laird JH Jr, Lok BH, Ma J, Bell A, De Stanchina E, Poirier J, Rudin CM . PARP trapping by talazoparib is a potent mechanism of radiosensitization in small cell lung cancer cell lines and patient-derived xenografts .

235 OF 288


Meeting Abstracts

International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E184-E185 .

Landau HJ, Shah GL, Reeds M, Hilden P, Andrejko M, Applebaum A, Batalha J, Cazeau N, Chung DJ, Cortes M, Gerber Jenkelowitz J, Kiss C, Devlin SM, Lestrange N, Lynch K, McElrath C, Palumbo D, Rodriguez ES, Scordo M, Giralt S . Homebound autologous hematopoietic cell transplantation for plasma cell disorders in an urban setting is safe for patients and preferred by patients and caregivers . Blood . 2018;132(Suppl . 1)

Landgren O, Siegel DS, Auclair D, Chari A, Boedigheimer M, Welliver T, Mezzi K, Iskander K, Jakubowiak A . Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: Results from the prospective, longitudinal, observational CoMMpass study . Blood . 2018;132(Suppl . 1)

Landgren O, Cavo M, Chari A, Cohen YC, Spencer A, Voorhees PM, Estell J, Sandhu I, Jenner M, Williams C, van de Donk NWCJ, Beksac M, Goldschmidt H, Moreau P, Kuppens S, Bandekar R, Neff T, Cortoos A, Clemens PL, Qi M, Adams H 3rd, Hofmeister CC . Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM) . Blood . 2018;132(Suppl . 1)

Landsburg DJ, Ramchandren R, Lugtenburg PJ, Kelly KR, Younes A, Gharavi R, Tuck DP, Barta SK . A pooled analysis of relapsed/refractory diffuse large B-cell lymphoma patients treated with the duel PI3K and HDAC inhibitor fimepinostat (CUDC-907), including patients with MYC-altered disease . Blood . 2018;132(Suppl . 1)

Lassen UN, Albert CM, Kummar S, van Tilburg CM, Dubois SG, Geoerger B, Mascarenhas L, Federman N, Schilder RJ, Doz F, Berlin JD, Oh DY, Bielack SS, McDermott R, Tan DS, Cruickshank S, Ku NC, Cox MC,

Drilon A, Hong DS . Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .397- .

Latham Schwark A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D, Dubard-Gault M, Tran C, Middha S, Hechtman JF, Penson A, Varghese AM, Zhang L, Robson ME, Solit DB, Diaz LA, Taylor BS, Offit K, Berger MF, Stadler ZK . Pan-cancer microsatellite instability to predict for presence of Lynch syndrome . Journal of Clinical Oncology . 2018;36(18 Suppl .)

Lau C, Politikos I, Devlin SM, Jacob AG, Maloy M, Naputo K, Afuye A, Bhatt V, Dahi PB, Perales MA, Giralt SA, O’Reilly RJ, Ponce DM, Prockop SE, Shah GL, Papanicolaou GA, Scaradavou A, Barker JN . Analysis of cytomegalovirus (CMV) infections in the first 180 days in adult sero-positive cord blood transplantation (CBT) recipients reveals high infection rates and treatment burden . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S379-S380 .

Lavallee VP, Azizi E, Kiseliovas V, Masilionis I, Mazutis L, Levine RL, Pe’er D . Comprehensive single-cell RNA-sequencing mapping of primary acute myeloid leukemias and profiling of NPM1-mutated cells . Blood . 2018;132(Suppl . 1)

Lawrence SA, Chakraborty J, Al Efishat M, Attiyeh M, Askan G, Chou Y, Pulvirenti A, McIntyre CA, Gonen M, Basturk O, Balachandran V, Kingham P, D’Angelica M, Jarnagin W, Drebin J, Do RK, Simpson AL, Allen P . Use of quantitative image analysis and cyst fluid inflammatory markers to predict risk in intraductal papillary mucinous neoplasms . Annals of Surgical Oncology . 2018;25(Suppl 1 .):S131- .

Lazarev S, Kushner B, Wolden SL . Short hypofractionated radiation therapy in palliation of pediatric malignancies: Outcomes and toxicities .

International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E471- .

Lazenby M, Alward Z, Gatarny R, Ayash C, Gany F . Culturally congruent individual meaning-centered psychotherapy for Muslims who are in treatment for advanced cancer in non-Muslim majority settings . Psycho-Oncology . 2018;27(Suppl . 3):26- .

Le D, Kavan P, Kim T, Burge M, Van Cutsem E, Hara H, Boland P, Van Laethem J, Geva R, Taniguchi H, Crocenzi T, Sharma M, Atreya C, Diaz L, Liang L, Marinello P, Dai T, O’Neill B . Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164 . Annals of Oncology . 2018;29(Suppl . 5):mdy149 .020- .

Leboulleux S, Lee EK, Bastholt L, Tahara M, Wirth LJ, Sherman S I, Robinson BG, Teng A, Joshi P, Misir S, Dutcus CE, Tuttle RM, Schlumberger MJ . Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer . Annals of Oncology . 2018;29(Suppl . 8):mdy302- .

Lee A, Pitter KL, Chow CHJ, Sine K, Cahlon O, McBride S, Tsai CJ, Leeman JE, Riaz N, Higginson DS, Waldenberg T, Cohen M, Ganly I, Boyle JO, Wong RJ, Brennan CW, Baxi SS, Sherman E, Michel L, Lee N . Temporal lobe radiation necrosis after re-irradiation involving the skull base with proton therapy: A single-institutional experience . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1397-1398 .

Lee A, Pitter KL, Neal B, Chow CHJ, Sine K, Cahlon O, McBride S, Leeman JE, Riaz N, Waldenberg T, Cohen M, Ganly I, Boyle JO, Wong RJ, Brennan CW, Sherman E, Michel L, Lee N, Tsai CJ . Temporal lobe radiation necrosis after proton re-irradiation therapy involving the skull base . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E296-E297 .

236 OF 288


Meeting Abstracts

Lee A, Tsai CJ, Schreiber D, Pitter KL, Lee N, McBride S . Impact of postoperative chemoradiation for HPV positive oropharyngeal cancers with extranodal extension and/or positive margins . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E296- .

Lee A, McBride S, Schreiber D, Riaz N, Leeman JE, Xie P, Li X, Osborn VW, Waldenberg T, Sabol C, Spielsinger D, Brinkman T, Kim JK, Lee N, Tsai CJ . Trends and patterns of proton therapy utilization among patients with head and neck cancer: Analysis from the National Cancer Database (2005-2014) . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1355- .

Lee CH, Motzer RJ, Glen H, Michaelson MD, Larkin J, Minoshima Y, Kanekiyo M, Dairiki R, Sachdev P, Dutcus CE, Funahashi Y, Voss MH . Correlative analyses of serum biomarkers and efficacy outcomes in the randomized phase II trial of lenvatinib (LEN), everolimus (EVE), or LEN+EVE in patients with metastatic renal cell carcinoma . Annals of Oncology . 2018;29(Suppl . 8):mdy269 .074- .

Lee J, Sholi A, Gong C, Magruder M, Albakry S, Edusei E, Botticelli B, Dadhania D, Lubetzky M, Taur Y, Ling L, Pamer E, Suthanthiran M . Gut microbiota dysbiosis is an independent risk factor for development of urinary tract infections in kidney transplantation . American Journal of Transplantation . 2018;18(Suppl . 4):416-417 .

Lee J, Magruder M, Zhang L, Dadhania D, Satlin M, Westblade L, Robertson A, Taur Y, Ling L, Pamer E, Suthanthiran M . Gut microbiota, mycophenolate mofetil, and post-transplant diarrhea in kidney transplant recipients . American Journal of Transplantation . 2018;18(Suppl . 4):301-302 .

Lee J, Gong C, Sholi A, Magruder M, Albakry S, Botticelli B, Edusei E, Dadhania D, Taur Y, Ling L, Pamer E, Suthanthiran M . Decreased gut microbiota

diversity after kidney transplantation . American Journal of Kidney Diseases . 2018;71(4):561- .

Lee J, Sharifai N, Dahiya S, Kleinschmidt-DeMasters B, Rosenblum M, Reis G, Solomon D, Tihan T, Perry A . Clinicopathologic features of anaplastic myxopapillary ependymomas . Modern Pathology . 2018;31(Suppl . 2):660- .

Lee JM, Hah JO, Yang EJ, Parl KM, Lim YT, Park SK, Suh JK, Kim JY, Lee KS, Park J, Park ES, Lim JY, Shim YJ, Kim HS, Chueh H, Kong SG, Choi EJ, Park JA . Analysis of poor treatment outcome of older children with acute lymphoblastic leukemia: Multi-center retrospective study of Yeungnam region . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S132- .

Lee JO, Kim DW, Abruzzese E, Apperley J, Caldwell L, Mauro MJ . Kinetics of BCR-ABL after TKI interruption during pregnancy in CML: A multinational retrospective analysis . Blood . 2018;132(Suppl . 1)

Lee JO, Flynn J, Maloy M, Jakubowski AA, Papadopoulos EB, Cho C, Ponce D, Sauter CS, Perales MA, Devlin SM, Giralt S, Castro-Malaspina HR, Tamari R . CD34+ selected hematopoietic stem cell transplants conditioned with a myeloablative regimen is well tolerated and results in good outcomes in patients with myelofibrosis . Blood . 2018;132(Suppl . 1)

Lee JY, Bi R, Geyer F, Wen HY, Lim RS, Hicks J, Weigelt B, Reis-Filho J . Clonal evolution in the progression from ductal carcinoma in situ to invasive ductal carcinoma . Modern Pathology . 2018;31(Suppl . 2):84-85 .

Lee S, Oh J, Kerns S, Rosenstein B, Ostrer H, Deasy J . Predicting genitourinary toxicity by machine learning on genome-wide single nucleotide polymorphisms . Radiotherapy and Oncology . 2018;127(Suppl . 1):S297-S298 .

Lee SC, North K, Chen CC, Kim E, Lu SX, Ki M, Garippa R, Lowe SW, Bradley RK, Abdel-Wahab O I .

Dependency of spliceosomal mutant MDS on innate immune signaling . Blood . 2018;132(Suppl . 1)

Leeman JE, McBride S, Spielsinger D, Sherman E, Wong RJ, Riaz N, Lee N, Tsai CJ . Head and neck cancers associated with exposure to the September 11, 2001, World Trade Center terrorist attacks . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1356- .

Leeman JE, Zumsteg ZS, Kollmeier MA, Gardner G, Abu-Rustum N, Alektiar KM . Are all high-intermediate risk early stage endometrioid carcinomas of the uterus created equal? . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E650- .

Leeman JE, Beckham T, Xie P, Li X, Spielsinger D, Goldman DA, Zhigang Z, Sherman E, McBride S, Riaz N, Lee N, Tsai CJ . Metastasis directed therapy with definitive intent is associated with improved survival in metastatic head and neck cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E323-E324 .

Leeman JE, Lee N, Zhou Y, Sine K, Tabar VS, Cohen M . Endoscopic resection followed by proton beam therapy with pencil beam scanning: A multidisciplinary approach to tumors of the skull base . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1348- .

Leibold J, Ruscetti M, Sanchez-Rivera FJ, Zamechek-Slais L, Lowe SW . Rapid generation of carcinoma mouse models using in vivo electroporation . Cancer Research . 2018;78(10 Suppl .):35- .

Leiding JW, Logan BR, Yin Z, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs L, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar M, Chen K, Shenoy S, Saldana BD, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Knutsen A, Chong H, Miller HK, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Pai SY, Stenger E, Puck J, Kapoor N, Pulsipher MA, Haddad

237 OF 288


Meeting Abstracts

E, Griffith LM, Shearer W, Malech HL, Parikh S, Marsh RA, Kang EM . Resolution of CGD related colitis after allogeneic hematopoietic stem cell transplantation in patients with chronic granulomatous disease - Early results from the 6903 study of the Primary Immune Deficiency Treatment Consortium (PIDTC) . Biology of Blood and Marrow Transplantation . 2018;24( 3 Suppl . 1):S53-S54 .

Leng J, Lui F, Huang X, Breitbart W, Gany F . Adapting meaning-centered psychotherapy in advanced cancer for the Chinese immigrant population . Psycho-Oncology . 2018;27(Suppl . 3):26-27 .

Leon A, McAlpine JN, Nout R, McConechy MK, Ganesan R, Matias-Guiu X, Oliva E, Harrison BT, Soslow R, Church D, Gilks CB, Bosse T . Clinicopathological characterization of endometrial carcinomas with more than one molecular classifying feature . Modern Pathology . 2018;31(Suppl . 2):434- .

Lesokhin AM, Raje N, Gasparetto CJ, Walker J, Krupka H I, Joh T, Taylor CT, Jakubowiak A . A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 bispecific antibody, in patients with relapsed/refractory advanced multiple myeloma . Blood . 2018;132(Suppl . 1)

Levey Bernie H, Kagacan C, Miranda E, Jenkins L, Tal R, Mulhall JP . Increased orgasmic intensity after radical prostatectomy: Prevalence and predictors . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S56- .

Levey Bernie H, Miranda EP, Terrier JE, Nelson CJ, Mulhall JP . Low PSA level in men diagnosed with prostate cancer predicts testosterone deficiency (TD) . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S21- .

Lewis N, Soslow R, DeLair D, Park K, Murali R, Hollmann T, Davidson B, Micci F, Panagopoulos I, Hoang L, Arias-Stella JA, Oliva E, Young R, Hensley

M, Leitao M, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth A, Antonescu CR, Chiang S . ZC3H7B-BCOR high-grade endometrial stromal sarcomas: A report of 17 cases of a newly defined entity . Modern Pathology . 2018;31(Suppl . 2):434-435 .

Lewis N, Yao J, Zhang Y, Roshal M, Xiao W . Myeloid neoplasms with features of both myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis and myelodysplastic syndrome with del(5q) . Modern Pathology . 2018;31(Suppl . 2):531- .

Lewis N, Pastore F, Kumar P, Getta B, Hultquist A, Shaffer B, Giralt S, Rampal R, Arcila M, Levine R, Roshal M, Xiao W . PHF6 mutations define a subgroup of mixed phenotype acute leukemia with aberrant T-cell differentiation . Modern Pathology . 2018;31(Suppl . 2):530-531 .

Li B, Offin M, Hembrough T, Cecchi F, Shen R, Olah Z, Panora E, Myers M, Brzostowski E, Buonocore D, Ginsberg M, Rudin C, Kris M, Weitsman G, Barber P, Ng T, Ulaner G, Arcila M, Scaltriti M . Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S599- .

Li G, Xu X, Agaram N, Socci N, Singer S . Rb-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma have oncogene addiction to Skp2 and show high sensitivity to Skp2 inhibitors . Annals of Surgical Oncology . 2018;25(Suppl . 1):S47- .

Li G, Nie X, Kadbi M, Saleh Z, Zakian K, Mechalakos J, Hunt M, Deasy J, Rimner A . Feasibility of achieving T2w super-resolution time-resolved (TR) 4DMRI using T1w TR-4DMRI as the guidance . Medical Physics . 2018;45(6):e518-e519 .

Li GZ, Socci ND, Shen RL, Singer S . Genomic clustering identifies an aggressive subset of myxofibrosarcoma and undifferentiated pleomorphic sarcoma sensitive to mammalian target of rapamycin

(mTOR) and insulin-like growth factor 1 (IGF1) receptor inhibitors . Journal of the American College of Surgeons . 2018;227(4 Suppl . 1):S238-S239 .

Li J, Shi C, Chan M . Dynamic model for late radiation injury of spinal cord . Medical Physics . 2018;45(6):e346- .

Li JW, Zhang H, Carlin SD, Raj N, Klimstra DS, Libutti SK, Weber WA, Reidy-Lagunes D, Untch BR . Somatostatin receptor imaging and therapy in MEN1-driven murine pancreatic neuroendocrine tumors . Pancreas . 2018;47(3):345-346 .

Li X, Eguchi T, Aly R, Chintala N, Tan KS, Messinger J, Zauderer M, Ghebrehiwet B, Adusumilli P, Peerschke E . gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S398- .

Li Y, Atkinson TM, Bochner BH, Rapkin BD . Leveraging Big Data analytics in processing free-text entries of personal goals among patients undergoing bladder cancer surgery . Quality of Life Research . 2018;27(Suppl . 1):S1- .

Li Y . Using Bayesian hierarchical linear modeling to analyze willful habits and their moderators . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S2- .

Lichtenwalner P, Chan M, Gorovets D, Shi C . Evaluation of dosimetric impact of variations in bladder and rectal fillings for SBRT prostate . Medical Physics . 2018;45(6):e208- .

Liebling D, Gulati A, Mehta N, Eisenberg R . Drug toxicology screening in cancer pain . Journal of Pain . 2018;19(3 Suppl .):S77- .

Ligon K, Lupo J, Molinaro A, Block S, Charbonneau S, Geduldig J, Stemmer-Rachamimov A, DeAngelis L, Yong W, Schultz N, Young R, Huang R, Chang S, Arrillaga-Romany I, Alexander B, Reardon D, Phillips JJ, de Groot J, Cloughesy T, Colman H, Prados M, Wen P, Butowski N, Mellinghoff I, Ellingson B . The Ivy

238 OF 288


Meeting Abstracts

Glioblastoma Patient Atlas: A novel clinical and radio-genomics resource for early phase clinical trial design and interpretation . Neuro-Oncology . 2018;20(Suppl . 6):vi159- . PMCID: PMC6216117

Lilja H . Early, highly specific risk stratification for lethal prostate cancer using a prespecified statistical model based on four kallikrein markers in blood . Cancer Research . 2018;78(16 Suppl .):18-19 .

Lim M, Ye X, Nabors LB, Piotrowski A, Ahluwalia M, Desai A, Walbert T, Fisher J, Desideri S, Sims M, Wen P, Grossman S . Updated results of a phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM . Neuro-Oncology . 2018;20(Suppl . 6):vi5- . PMCID: PMC6216117

Lim S, LoSasso T, Wild A, Mechalakos J, Yamada J, Lovelock D . The commissioning of AAA and AcurosXB with 10MV flattening-filter-free beam for stereotactic radiosurgery . Medical Physics . 2018;45(6):e335- .

Lim SB, Tsai CJ, Yu Y, Greer P, Fuangrod T, Hwang K, Fontenla S, Lee N, Lovelock DM . The investigation of a decision support metric for head and neck adaptive radiation therapy using a real-time in vivo portal dosimetry system . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E538- .

Lin A, Hilden P, Maloy M, Jakubowski AA, Papadopoulos EB, Sauter CS, Tamari R, Ponce DM, Giralt SA, Gyurkocza B . Impact of omitting post-transplant mini-methotrexate doses in allogeneic hematopoietic cell transplantation: A single-center retrospective study . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S201-S202 .

Lin A, Jonsson P, Ogilvie S, Chavan S, Nolan C, Gavrilovic I, Kaley T, Grommes C, Pentsova E, Diamond E, Daras M, Stone J, DeAngelis L, Tabar V, Brennan C, Young R, Rosenblum M, Taylor B, Mellinghoff I . Genomic attributes of tumor evolution

and treatment response in diffuse glioma . Neuro-Oncology . 2018;20(Suppl . 6):vi169- .

Lin AL, Jonsson P, Ogilvie S, Chavan S, Nolan C, Gavrilovic I, Kaley T, Grommes C, Pentsova E, Diamond E, Daras M, Stone J, DeAngelis L, Tabar V, Brennan C, Young RJ, Rosenblum M, Taylor BS, Mellinghoff IK . Genomic attributes of tumor evolution and treatment response in diffuse glioma . Neuro-Oncology . 2018;20(Suppl . 3):iii218- . PMCID: PMC6144305

Lin J, Kim D, Drilon A, Doebele R, Lee J, Zhu V, Ahn M, Lim J, Stopatschinskaja S, Cui JJ, Hyman D, Camidge R, Ou S, Shaw A, Cho BC . Safety and preliminary clinical activity of ropotrectinib ( TPX-0005), a ROS1/TRK/ALK inhibitor, in advanced ROS1 fusion-positive NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S322- .

Lin RJ, Ho C, Hilden P, Barker J, Giralt S, Hamlin PA, Jakubowski AA, Castro-Malaspina HR, Papadopoulos EB, Perales MA, Sauter CS . Allogeneic stem cell transplantation overcomes the negative prognostic impact of TP53 alterations in mantle cell lymphoma . Blood . 2018;132(Suppl . 1)

Lin RJ, Perales MA, Shahrokni A, Maloy M, Devlin SM, Jakubowski AA, Dahi PB, Shah GL, Korc-Grodzicki B, Giralt SA . Prevalence of functional impairment and geriatric vulnerability during pre-transplant geriatric assessment in an academic hematopoietic cell transplantation center . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S261-S262 .

Lin RJ, Elko TA, Devlin SM, Jakubowski AA, Shahrokni A, Dahi PB, Perales MA, Tamari R, Shaffer BC, Sauter CS, Papadopoulos EB, Castro-Malaspina HR, Barker J, Maloy M, Korc-Grodzicki B, Giralt S . A simple geriatric vulnerability index for older patients undergoing allogeneic hematopoietic cell transplantation . Blood . 2018;132(Suppl . 1)

Lin RJ, Elko TA, Hilden P, Dahi PB, Jakubowski AA, Perales MA, Barker J, Castro-Malaspina HR, Shaffer

BC, Shahrokni A, Tamari R, Papadopoulos EB, Sauter CS, Maloy M, Korc-Grodzicki B, Giralt S . Burden and impact of geriatric syndromes associated with allogeneic hematopoietic cell transplantation in older adults . Blood . 2018;132(Suppl . 1)

Lisberg A, Hu-Lieskovan S, Grogan T, Carroll J, Shintaku P, Han M, Slamon D, Dubinett S, Goldman J, Elashoff D, Hellmann M, Ribas A, Garon E . Evaluation of PD-L1-stained tumor cells via the 22C3 and SP-142 antibodies in cohort of patients treated on KEYNOTE-001 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S761- .

Liu E, Paulson S, Gulati A, Freudman J, Grosh W, Kafer S, Wickremesinghe P, Salem R, Bodei L . Assessment of the clinical utility of the NETest in a US registry-based study . Neuroendocrinology . 2018;106(Suppl . 1):157- .

Liu H, Shen C, Klages P, Yang M, Albuquerque K, Wu Z, Li J, Jia X . Interactive treatment plan optimization of high-dose-rate brachytherapy for gynecological cancer . Medical Physics . 2018;45(6):e573-e574 .

Liu J, Pusic AL, Hall BL, Ko CY, Temple LK . Combining clinical outcomes and patient-reported experiences to evaluate hospital cancer surgery quality . Annals of Surgical Oncology . 2018;25(Suppl . 1):S14-S15 .

Liu MC, Cummings S, Vachon CM, Kerlikowske K, Couch FJ, Morris EA, Olson JE, Polley EC, Conners AL, Ellis RL, Patel B, Maimone S 4th, Zhang N, Hamilton S, Clarke CA, Allen BA, Maddala T, Hartman AR . Development of cell-free nucleic acid-based tests for early detection of breast cancer: The STRIVE study . Cancer Research . 2018;78(4 Suppl .)

Liu MC, Maddala T, Aravanis A, Hubbell E, Beausang JF, Filippova D, Gross S, Jamshidi A, Kurtzman K, Shen L, Valouev A, Venn O, Zhang N, Smith DA, Couch F, Curtis C, Williams RT, Klein EA, Hartman AR, Baselga J . Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The

239 OF 288


Meeting Abstracts

Circulating Cell-Free Genome Atlas (CCGA) study . Journal of Clinical Oncology . 2018;36(15 Suppl .):17s- .

Liu S, Tan X, Zhao X, Li L, Lu W, Tan S . A comparative study with multiple losses in deep learning for tumor segmentation in PET . Medical Physics . 2018;45(6):e187- .

Liu S, Tan X, Zhao X, Li L, Lu W, Tan S . Hand-crafted feature offset learning for tumor segmentation in PET . Medical Physics . 2018;45(6):e397- .

Liu S, Vyas M, Stadler Z, Weiser M, King S, Hechtman J, Vakiani E, Klimstra D, Shia J . In colorectal carcinoma (CRC), true tumor cell staining for PD-L1 is uncommon and occurs in sporadic microsatellite-instable tumors with loss of MHC-I . Modern Pathology . 2018;31(Suppl . 2):282- .

Loh T, Hau J, Jiang S . Removal of incidental skin cancer during Mohs micrographic surgery indicated for a different primary tumor . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB244- .

Lok B, Laird J, Ma J, De Stanchina E, Poirier J, Rudin C . PARP inhibitor radiosensitization of small cell lung cancer differs by PARP trapping potency . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S433- .

Lopez Rodrigo E, Joyner A . A mouse model of postnatal Hedgehog-driven muscle tumors shows a common progenitor that relies on loss of Tp53 expression for malignant transformation . Clinical Cancer Research . 2018;24(2 Suppl .):46- .

Lorusso D, Coleman RL, Oza AM, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals J I, Clamp AR, Scambia G, Leary A, Holloway RW, Amenedo Gancedo M, Fong PC, Goh JC, O’Malley DM, Banerjee S, Goble S, Cameron T, Ledermann JA . Subgroup analysis of rucaparib in platinum-sensitive recurrent

ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3 . Annals of Oncology . 2018;29(Suppl . 8):mdy285 .155- .

Loupakis F, Hurwitz H I, Saltz L, Arnold D, Grothey A, Nguyen QL, Osborne S, Yau L, Talbot J, Srock S, Lenz HJ . Efficacy outcomes with bevacizumab added to chemotherapy (bev + CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC) . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Lovelock D, Lim S, Fontanella A, Mostafavi H, Mechalakos J, Wild A, Yamada J . Accuracy of template matching in the localization of a vertebral body during SBRT dose delivery . Medical Physics . 2018;45(6):e608-e609 .

Lowe SW . Interrogating cancer drivers and dependencies using non-germline mouse models . Cancer Research . 2018;78(10 Suppl .):21- .

Lowe SW . Tumor suppressor and tumor maintenance genes . Clinical Cancer Research . 2018;24(1 Suppl .):19- .

Lowenthal BM, Gupta S, Aron M, Cheville J, Hansel D . Female urethral carcinoma: Analysis of 29 cases and proposal for a new staging system . Modern Pathology . 2018;31(Suppl . 2):359-360 .

Lozada J, Geyer F, de Oliveira TB, Alemar B, Pareja F, Querzoli P, Cserni G, Foschini M, Rakha E, Brogi E, Weigelt B, Reis J . Solid papillary carcinomas with reverse polarity (solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms) harbor recurrent mutations affecting IDH2: A validation study . Modern Pathology . 2018;31(Suppl . 2):87- .

Lozano L, Chen X, Moreno A, Torroba A, Wang Y, Tang Y . Evaluation of a novel isothermal amplification assay for detection and genotyping of human papillomavirus in formalin-fixed paraffin-embedded tissue of oropharyngeal carcinomas . Journal of Molecular Diagnostics . 2018;20(6):936- .

Lu C, Hameed M, Ramirez D . Histone H3K36M mutation and trimethylation patterns in

chondroblastoma . Modern Pathology . 2018;31(Suppl . 2):30- .

Lu C, Pitter KL, Casey DL, Riaz N, Lee N, McBride S, Reis-Filho J, Powell SN, Zelefsky MJ, Chan TA, Setton J . Pathogenic mutations in ATM predict for enhanced local control in prostate cancers treated with radiation thearpy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E126-E127 .

Lu C, Jain S, Hoelper D, Bechet D, Ran L, Andrulis I, Dickson B, Majewski J, Thompson C, Chi P, Garcia B, Jabado N, Lewis P, Allis CD . Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape . Clinical Cancer Research . 2018;24(2 Suppl .):33- .

Lu S, Lu S, Danilova L, Rimm D, Hoyt C, Hellmann M, Taube J . Comparison of biomarker assay modalities in anti-PD-(L)1 monotherapy: A meta-analysis . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- .PMCID: PMC6220479

Lu SX, Wang E, Pastore A, Xufeng C, Imig J, Lee SC, Ghebrechristos Y, Yoshimi A, Bitner LE, Ki M, Kloetgen A, Lin KT, Tibes R, Krainer AR, Uehara T, Owa T, Aifantis I, Abdel-Wahab O I . Therapeutic targeting of an RNA splicing factor network for the treatment of myeloid neoplasms . Blood . 2018;132(Suppl . 1)

Lu W, Li G, Gillespie E, Hong L, Yorke E, Mechalakos J, Hunt M, Powell S, Tang X . Comparison of setup uncertainty using AlignRT-guided and RPM-guided DIBH for left-sided breast irradiation . Medical Physics . 2018;45(6):e549- .

Lu Z, Assumpcao ALF V, Viny AD, Levine RL, Pan X . YY1 controls hematopoietic stem cell quiescence by repressing cohesin expression . Blood . 2018;132(Suppl . 1)

Luo L, Samstein R, Dick-Godfrey R, Oro F, Sonnick M, Paik P, Chaft J, Rimner A, Wu AJ . Genetic predictors

240 OF 288


Meeting Abstracts

of response to chemoradiation in stage III non-small-cell lung cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S226- .

Luo L, Samstein R, Dick-Godfrey R, Sidiqi B, Wang C, Oro F, Sonnick M, Paik P, Chaft J, Rimner A, Wu A . Genetic predictors of response to chemoradiation in stage III non-small-cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S657-S658 .

Lyman SK, Gordon J, DuPage A, Pramanik P, Howng B, Winter MB, Popova IK, Vasiljeva O, Jones J, Wong K, Singson V, Richardson J, Zheng B, Stroh M, Carman L, Huels V, Autio K, Boni V, Cho D, Garcia-Corbacho J, Ruiz I V, Hamid O, Uboha N, de Vries E, El-Khoueiry A, Spira A, Sanborn R, Thistlethwaite F, Arkenau HT, Bendell J, Ott . P, Rizvi N, Will M, Kavanaugh WM, Naing A, Desnoyers LR . Preliminary evidence of intratumoral activation and immunomodulatory effect of CX-072, a Probody therapeutic antibody prodrug targeting PD-L1, in a phase 1/2a trial . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):114- . PMCID: PMC6220480

Lyons T, Gucalp A, Arumov A, Patil S, Edelweiss M, Gorsky M, Troso-Sandoval TA, Bromberg J, Sanford RA, Iyengar NM, Modi S, Gupta R, Traina TA . Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer . Journal of Clinical Oncology . 2018;36(15 Suppl .):16s- .

Ma AQ, Veschi V, Yu WY, Babault N, Li FL, Butler K, Wang J, Luo M, Vedadi M, Brown P, Smith CA, Thiele C, Jin J . Developing selective SETD8 inhibitors for treating high-risk neuroblastoma . Abstracts of Papers of the American Chemical Society . 2018;256

Ma J, Bell A, Lok BH, Leeman JE, Anderson ES, Spielsinger D, Brinkman T, Sabol C, Waldenberg T, Temares D, Riaz N, McBride SM, Ganly I, Shaha A, Sherman E, Lee N, Tsai CJ . Radiation therapy demonstrates persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid

cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E285-E286 .

Ma J, Laird JH Jr, Chau K, Chelius M, Lok BH, Yahalom J . Treatment modality choices and outcome in Langerhans cell histiocytosis: Radiation therapy versus other modalities . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E285- .

Maachani UB, Zhou Z, Martinez D, Santi M, Dahmane N, Souweidane M . B7-H3 expression as a potential biomarker of prognosis and target in pediatric glial and non-glial CNS tumors . Neuro-Oncology . 2018;20(Suppl . 2):i181- . PMCID: PMC6012612

Macias B, Patel NB, Gibson CR, Samuels BC, Lee S, Ploutz-Snyder R, Sargsyan A, Alexander D, Riascos R, Kramer L, Laurie S, Mader T, Brunstetter T, Otto C, Stenger MB . Anterior and posterior ocular structures change during long-duration spaceflight and one year after landing . Investigative Ophthalmology & Visual Science (IOVS) . 2018;59(9)

Maeda Y, Tokunaga A, Sugiyama D, Warner AB, Wolchok JD, Nishikawa H . Immune suppressive mechanism of corticosteroids used for immune-related adverse events . Cancer Science . 2018;109(Suppl . 2):1121- . PMCID: PMC6298205

Magbanua MJ, Hendrix L, Hyslop T, Barry WT, Winer EP, Hudis C, Toppmeyer D, Burnstein H, Qadir M, Ma C, Scott JH, Park JW, Rugo HS . Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study . Cancer Research . 2018;78(4 Suppl .)

Maglantay RJ, Ostrovnaya I, Begg C, Ernst WL, Barbi de Moura M, Miller M, Priddy A, Chiosea S I, Dacic S, Nikiforov YE, Nikiforova MN, Roy S . Determining clonal relatedness between tumors using a targeted next-generation sequencing (NGS) assay . Journal of Molecular Diagnostics . 2018;20(6):1007- .

Magnusson C, Undvall E, Laurell T, Lilja H . A novel two-step tumor cell isolation system, combining acoustophoresis and negative selection of white blood cells using CD45-conjugated elastomeric particles . Cancer Research . 2018;78(16 Suppl .):38-39 .

Mahadeo NK, Cai W, Lafreniere M, Rottmann J, Williams C . Delivered dose calculation using PCA motion modeling and ESAPI . Medical Physics . 2018;45(6):e149-e150 .

Mahal BA V, Yang DD, Wang N, Alshalalfa M, Davicioni E, Choeurng V, Spratt DE, Martin NE, Mouw KW, Orio PF, Choueiri TK, Trinh QD, Feng FY, Nguyen PL . Clinical and genomic characterization of low-prostate-specific antigen, high-grade prostate cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Maher CA, Silva-Fisher J, Eteleeb A, Tang C, Perou C, Reis-Filho JS, Mardis ER, Ellis MJ . Discovery and characterization of an estrogen bound lncRNA in late-stage breast cancer . Cancer Research . 2018;78(4 Suppl .)

Mailankody S, Htut M, Lee KP, Bensinger W, Devries T, Piasecki J, Ziyad S, Blake M, Byon J, Jakubowiak A . JCARH125, anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: Initial proof of concept results from a phase 1/2 multicenter study (EVOLVE) . Blood . 2018;132(Suppl . 1)

Mailankody S, Ghosh A, Staehr M, Purdon TJ, Roshal M, Halton E, Diamonte C, Pineda J, Anant P, Bernal Y, Wills A, Korde N, Lendvai N, Lesokhin AM, Hassoun H, Hultcrantz M, Landau HJ, Shah GL, Scordo M, Chung DJ, Lahoud OB, Khattar P, Fernandez de Larrea C, Gao Q, Jungbluth A, Park JH, Curran KJ, Sauter CS, Palomba ML, Senechal B, Wang X, Dogan A, Giralt S, Riviere I, Landgren O, Brentjens RJ, Smith EL . Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial . Blood . 2018;132(Suppl . 1)

241 OF 288


Meeting Abstracts

Makkar P, Pillai M V, Mehta V . Rasburicase induced methemoglobinemia in a patient with G6PD deficiency: A review of pathophysiology and treatment considerations . American Journal of Respiratory and Critical Care Medicine . 2018;197

Malani R, Bhatia A, Wolfe J, Grommes C . Systemic staging in patients with lymphomatous brain lesions . Neurology . 2018;90(15 Suppl .)

Malani R, Haggiagi A, Holder J, Shames Y, Briggs S, Callahan M, Santomasso B . Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis . Neurology . 2018;90(15 Suppl .)

Malczewska A, Kidd M, Matar S, Lewczuk A, Kolasinska-Cwikla A, Cwikla J, Bodei L, Kos-Kudla B, Modlin I . Chromogranin A is an inadequate circulating biomarker for bronchopulmonary neuroendocrine neoplasia management . Pancreas . 2018;47(3):346- .

Malik A, Chaudhuri J . Insights into immune mechanisms through immunoblot analysis of activation induced cytidine deaminase (AID) point mutations . Abstracts of Papers of the American Chemical Society . 2018;255

Malone AK, Litzow MR, Perales MA, Costa LJ, Wood WA, Komanduri K V, Selby GB, Khan SP, Roy V, Domm J, Burns LJ . Should BMT become a certified subspecialty? Results of the 2017 Board Certification Survey . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S267-S268 .

Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Curran WJ Jr, Wolmark N . NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-

FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC) . Cancer Research . 2018;78(4 Suppl .)

Manji GA, Bendell JC, Oh DY, Kim KP, Macarulla T, Ponz-Sarvisé M, Ajani JA, Oberstein P, Janjigian YY, Chau I, Abdullah H, He X, Zhang X, Wang J, Barak H, Cha E, Grossman W, Bang YJ . MORPHEUS: A phase Ib/II multi-trial platform evaluating the efficacy and safety of cancer immunotherapy (CIT)-based combinations in patients (pts) with gastric or pancreatic cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Manna R, Banerjee SC, Shen MJ, Korc-Grodzicki B, Alici Y, Gangai N, Alexander K, Holland J, Parker PA, Nelson CJ . Geriatric communication skills training: Shared decision making and care planning for the older cancer patient and the caregiver . Journal of Clinical Oncology . 2018;36(7 Suppl .)

Marcadis AR, Marti JL, Morris LG . Racial differences in presentation and survival with papillary thyroid cancer (PTC) result from overdiagnosis of small, localized tumors in white patients . Annals of Surgical Oncology . 2018;25(Suppl . 1):S19- .

Markey KA, Gomes ALC, Littmann ER, Devlin SM, Slingerland AE, Slingerland JB, Clurman A, Moore G, Fatmi SA, Maloy M, Pamer EG, Taur Y, Giralt S, Perales MA, Ponce D, Peled JU, van den Brink MRM . Pre-transplant and peri-d100 gastrointestinal dysbiosis is associated with the subsequent development of chronic graft-versus-host disease . Blood . 2018;132(Suppl . 1)

Markova A, Pulitzer M, Jain M, Dierov D, Dahi PB, Gyurkocza B, Sauter CS, Spitzer B, Barker JN, Ponce DM . De novo skin xerosis in cord blood transplantation is associated with distinct histopathology and treatment response: First literature report of cord dermatosis . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S159-S160 .

Markowitz GJ, Philip M, Wong S, Schietinger A, Mittal V . Identification and characterization of novel mediators of tumor-induced T-cell dysfunction . Journal of Immunology . 2018;200(1 Suppl .)

Marks L, Diolaiti D, Mundi P, Gaviria E, Rainey A, Dela Cruz F, Andrea C, Kung A . Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S394-S395 .

Maron SB, Joshi SS, Lomnicki S, Oliwa T, Landron S, Johnson J, Kiedrowski LA, Nagy RJ, Lanman RB, Janjigian YY, Kelly KJ, Kim ST, Lee J, Catenacci DVT . Circulating tumor DNA (ctDNA) landscape and prognostic implications in advanced gastroesophageal adenocarcinoma (GEC) . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Martens JWM, Sieuwerts A, Ponchet C, Smid M, de Weerd V, Slaets L, Piper T, van Deurzen CHM, Schroder CP, Stangle C, Kloosterman W, van Leeuwen-Stok E, Nilsson C, Vermeij J, Peeters S, Goulioti T, Nowaczyk M, Aebi S, Rubio IT, Kelly C, Bayani J, Porter P, Murray M, Hudis C, Middleton L, Korde L, Ruddy K, Winer E, Bogler O, van den Weyngaert D, dal Lago L, Fraser J, Benstead K, van Asperen C, Linderholm B, Hedenfalk I, Tryfonidis K, Giordano S, Bartlett J, Cardoso F . Molecular subtyping of male breast cancer by the International Male Breast Cancer Program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04 . Cancer Research . 2018;78(4 Suppl .)

Marziliano A, Applebaum A, Costas-Muniz R, Diefenbach MA . Adaptations of meaning-centered psychotherapy for parents bereaved by cancer, cancer caregivers, and Latinos with cancer . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S672- .

Marziliano A, Slivjak E, Schofield E, Breitbart W, Lichtenthal W . Effects of Meaning-Centered Grief Therapy for parents bereaved by cancer . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S672- .

242 OF 288


Meeting Abstracts

Mascarenhas J, Kosiorek HE, Prchal JT, Rambaldi A, Berenzon D, Yacoub A, Harrison CN, McMullin MF, Vannucchi AM, Ewing J, O’Connell CL, Kiladjian JJ, Mead AJ, Winton EF, Leibowitz DS, De Stefano V, Arcasoy MO, Kessler CM, Catchatourian R, Rondelli D, Silver RT, Bacigalupo A, Nagler A, Kremyanskaya M, Sandy L, Salama ME, Najfeld V, Tripodi J, Weinberg RS, Price L, Goldberg JD, Rampal RK, Mesa RA, Dueck AC, Hoffman R . Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) therapy for the treatment of high risk polycythemia vera (PV) and high risk essential thrombocythemia (ET) . Blood . 2018;132(Suppl . 1)

Massard C, Segal NH, Cho DC, Papadimitrakopoulou VA, Rizvi NA, Cho BC, Yu L, Yang H, Hsieh HJ, Zhang J, Zhao W, Gao G, Guo X, Abdullah S, Englert J, Soria JC, Dar M, Roskos L, Ferte C, Antonia SJ . Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .426- .

Masson GS, Assel M, Pusic A, Laudone V, Twersky R, Heerdt A, Lilavois M, Baron R, Stein D, Simon B . Electronic patient recovery tracker aims to assess and improve patient recovery in an ambulatory cancer center . European Journal of Cancer . 2018;92(Suppl . 3):S10- .

Masterson M, Rosenfeld B, Applebaum A, Buda K, Reisch S . Prognostic understanding: Perspectives of advanced cancer patients . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S73- .

Mateos M V, Oriol Rocafiguera A, Rodríguez-Otero P, Bladé J, Larocca A, Moreb SJ, Cavo M, Mazumder A, Alegre A, Hassoun H, Maisel C, Paner A, Gabrail N, Halka K, Zonder J, Ocio E, Byrne C, Harmenberg J, Lindberg J, Nordström E, Thuresson S, Richardson GP . Melflufen therapy for heavily pretreated relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide:

Early efficacy data (Horizon) . Haematologica . 2018;103(Suppl . 1):32- .

Mathias C, Reck M, Hellmann M, Ramalingam S, Brahmer J, O’Byrne K, Bhagavatheeswaran P, Nathan F, Borghaei H, Paz-Ares L . CheckMate 227: Nivolumab + ipilimumab vs chemotherapy as 1L treatment for advanced NSCLC with high tumor mutational burden . Journal of Thoracic Oncology . 2018;13(9 Suppl .):S152-S153 .

Mato AR, Schuster SJ, Lamanna N, Flinn I, Barrientos JC, Kambhampati S, Cheson BD, Barr PM, Pagel JM, Reeves JA, Lansigan F, Pu JJ, Skarbnik AP, Fonseca GA, Dorsey C, Prak EL, Paskalis D, Sportelli P, Miskin HP, Brander DM . A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy . Journal of Clinical Oncology . 2018;36(15 Suppl .):407s- .

Mato AR, Yazdy MS, Hill BT, Shadman M, Tuncer H, Winter AM, Kennard K, Allan JN, Ujjani CS, Brander DM, Nabhan C, Barr P, Brown JR, Fox CP, Rhodes J, Schuh A, Eyre TA, Lamanna N, Jain N, Wierda WG, Skarbnik AP, Roeker LE, Bannerji R, Evens AM, Lansigan F, Samp JC, Nielsen J, Pauff JM, Kipps TJ, Schuster SJ, Follows GA, Cheson B, Eichhorst B . Treatment patterns and outcomes of patients with CLL treated with chemoimmuno- and novel agent-based therapy: A multicenter study . Blood . 2018;132(Suppl . 1)

Mato AR, Roeker LE, Eyre TA, Nabhan C, Lamanna N, Hill BT, Brander DM, Barr P, Lansigan F, Cheson B, Singavi AK, Yazdy M, Shah NN, Allan JN, Bhavsar EB, Rhodes J, Kennard K, Schuster SJ, Williams AM, Skarbnik AP, Goy A, Coombs CC, Tuncer HH, Ujjani CS, Jacobs R, Winter AM, Pagel JM, Bailey N, Schuh A, Shadman M, Sitlinger A, Weissbrot H, Muralikrishnan S, Kirkwood AA, Fox CP . Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients . Blood . 2018;132(Suppl . 1)

Mato AR, Barrientos JC, Brander DM, Pagel JM, Gutierrez M, Kadish K, Tomlinson B, Ghosh N, Giafis N, Ipe D, Upasani S, Sundaram M, Ferrante L, Amaya-Chanaga C, Iyengar R, Sharman J . Prognostic testing and treatment approaches in patients with chronic lymphocytic leukemia: Clinical experience from an interim analysis of the informCLL (TM) real-world registry . Blood . 2018;132(Suppl . 1)

Mato AR, Svoboda J, Prak ETL, Schuster SJ, Tsao P, Dorsey C, Becker PS, Brander DM, Nasta SD, Landsburg DJ, King CM, Morrigan B, Kennard K, Roeker LE, Zelenetz AD, Purdom M, Paskalis D, Sportelli P, Miskin HP, Weiss MS, Shadman M . Phase I/II study of umbralisib (TGR-1202) in combination with ublituximab (TG-1101) and pembrolizumab in patients with relapsed/refractory CLL and Richter’s transformation . Blood . 2018;132(Suppl . 1)

Matsuda KM, Phillips A, Hanna MG, Grabenstetter A, Brogi E . Developing an efficient approach for the assessment of tumor extension by ex vivo imaging of breast specimens . A pilot study using x-ray tomosynthesis with histopathologic correlation . Modern Pathology . 2018;31(Suppl . 2):813-814 .

Mauro MJ, Lang F, Kim DW, Cortes JE, Hughes TP, Hochhaus A, Minami H, Boquimpani C, Minami Y, Breccia M, Goh YT, Ottmann O, Sondhi M, Hois S, Bédoucha V, Perraud K, Rea D, DeAngelo DJ . Clinical development of asciminib (ABL001): A randomized phase 3 study of asciminib vs bosutinib in patients with chronic myeloid leukemia (CML) . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S223- .

Mauro MJ, Lang F, Kim DW, Cortes JE, Hughes TP, Hochhaus A, Minami H, Boquimpani C, Minami Y, DeAngelo DJ, Breccia M, Talpaz M, Goh YT, Ottmann O, Sondhi M, Hois S, Bédoucha V, Schmitz SFH, Rea D . Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs . bosutinib . Journal of Clinical Oncology . 2018;36(15 Suppl .):398s- .

243 OF 288


Meeting Abstracts

Mauro MJ, Chen C, Cortes JE, Gambacorti-Passerini C, Sen GP, Gajavelli S, Davis C, Michallet M . Cardiovascular hospitalization in patients treated with dasatinib or nilotinib in SIMPLICITY, an observational studyof chronic-phase chronic myeloid leukemia (CP-CML) patients in routine clinical practice . Blood . 2018;132(Suppl . 1)

Maw A, Anderson SL, Gee E, Jannat-Khah D, Daugherty S . Using lung ultrasound obtained by an internist to assess elevated left atrial pressure in hospitalized patients . Journal of General Internal Medicine . 2018;33(Suppl . 2):S384- . PMCID: PMC5913041

Mawrin C, Kirches E, Sahm F, Bluecher C, Boekhoff S, Schuller U, Schittenhelm J, Snuderl M, Karajannis M, Perry A, Pietsch T, Mueller H, Capper D, Beck K, Schlesner M, Kropf S, Brastianos P, Korshunov A, Pfister S . Pediatric meningiomas are characterized by distinct methylation profiles different from adult meningiomas . Neuro-Oncology . 2018;20(Suppl . 6):vi212- . PMCID: PMC6216117

Maya S, Chittem M, Banerjee S, Parker P . Experiences and attitudes towards disclosure versus nondisclosure of a poor prognosis to advanced cancer patients: Indian physicians’ perspectives . Psycho-Oncology . 2018;27(Suppl . 3):108- .

Mazis C, Politikos I, Devlin SM, Maloy M, Davis E, Cooper C, Nhaissi M, Suri B, Wells D, Giralt S, Shah GL, van den Brink MRM, Kernan NA, Scaradavou A, Barker J . Evaluation of cord blood (CB) unit TNC & CD34+ cell content & donor-recipient high-resolution 8 HLA-allele match by patient ancestry: An evaluation of 513 CB units in a racially & ethnically diverse population of adults with hematologic malignancies . Blood . 2018;132(Suppl . 1)

McBride A, Usman M, Khalil MJ, Tariq MJ, Fraz MA, Ijaz A, Ahmad MQ, Khan AY, Samuel S, Selene I I, Camamo J, Chang C, Jose JA, Anwer F . A single center retrospective evaluation of daratumumab

infusion related reactions with split-first dose day 1 and day 2 infusion . Blood . 2018;132(Suppl . 1)

McCarthy PL, Richardson P, Suman V, Cooper M, Saunders O, Dhanasiri S, Giralt S, Anderson K, Stadtmauer E, Holstein SA . Survival analysis from the CALGB study of lenalidomide maintenance therapy in newly diagnosed multiple myeloma post-autologous stem cell transplantation adjusted for crossover (Alliance 100104) . Blood . 2018;132(Suppl . 1)

McCormick B . Randomized trial evaluating radiation following surgical excision for “good risk” DCIS: 12-year report from NRG/RTOG 9804 . International Journal of Radiation Oncology, Biology, Physics . 2018;102(5):1603- .

McDermott DF, Rini B I, Motzer RJ, Tannir NM, Escudier B, Kollmannsberger CK, Hammers HJ, Porta C, George S, Donskov F, Gurney HP, Grimm MO, Harrison M, Hutson TE, Doan J, Yang S, Rao S, Mekan S, Ambavane A, Powles T . Treatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .083- .

McDonald A, Thomas E, Daigle S, Morschhauser F, Salles G, Ribrag V, McKay P, Tilly H, Schmitt A, Batlevi CL, Fruchart C, Johnson P, Dickinson M, Opat S, Jurczak W, Cartron G, Lamy T, Zinzani PL, Assouline S, Radford J, Gribben JG, Haioun C, Chaidos A, Le Gouill S, Clawson A, Larus J, Blakemore SJ . Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study . Blood . 2018;132(Suppl . 1)

McFarland D, Holland J . Associations of routine inflammatory markers (C-reactive protein and albumin) and distress, depression, and anxiety in patients with lung cancer . Psycho-Oncology . 2018;27(Suppl . 1):88-89 .

McHugh DJ, Funt S, Silber D, Knezevic A, Patil S, O’Donnell D, Tsai S, Reuter VE, Sheinfeld J, Carver BS, Motzer RJ, Bajorin DF, Bosl GJ, Feldman DR . Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

McIntyre CA, Lawrence SA, Pulvirenti A, Seier K, Gonen M, D’Angelica M, Kingham P, Balachandran V, Drebin J, Jarnagin W, Allen P . Neutrophil-to-lymphocyte ratio as a predictor of invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas . Annals of Surgical Oncology . 2018;25(Suppl . 1):S131- .

McMillen T, Chow H, Babady E . Evaluation of the ARIES Bordetella Assay for detection and identification of Bordetella pertussis in nasopharyngeal swab specimens . Journal of Molecular Diagnostics . 2018;20(6):953- .

Meadows J, Baser R . Factors predicting platelet transfusions at the end-of-life in cancer inpatients . Journal of Pain and Symptom Management . 2018;55(2):632-633 .

Meadows J, Goldberg J, Collett D, Seier K . Is fentanyl patch end-of-dose failure associated with body mass index? . Journal of Pain and Symptom Management . 2018;55(2):615-616 .

Mechalakos J, Della Biancia C, Wang P, Niyazov G, Hipp E, Morris K . Quantifying treatment planning workload using complexity-based metrics . Medical Physics . 2018;45(6):e200- .

Medek S, De B, Breneman JC, Pater LE, Laack NN 2nd, Mahajan A, Wolden SL, Vatner RE . Physician practice patterns with respect to vertebral body target delineation in the treatment of pediatric patients with craniospinal irradiation . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E467- .

244 OF 288


Meeting Abstracts

Medin PM, Hrycushko BA, Phillips L, Sayre J, Folkert MR, Vernino S, Foster RD, Rezaeian NH, Yamada Y, Van Der Kogel AJ . The dose-length effect in spinal nerves receiving single-session stereotactic ablative radiation therapy (SAbR) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S74- .

Mellinghoff I, Maher E, Wen P, Cloughesy T, Peters K, Choi C, Ellingson B, Lin A, Li Y, Soher B, Young R, Steelman L, Le K, Yin F, Wu B, Lu M, Zhang Y, Nicolay B, Schoenfeld S, Yen K, Pandya S, Clarke J . A Phase 1, multicenter, randomized, open-label, perioperative study of AG-120 (ivosidenib) and AG-881 in patients with recurrent, nonenhancing, IDH1-mutant, low-grade glioma . Neuro-Oncology . 2018;20(Suppl . 6):vi234- . PMCID: PMC6216117

Mellinghoff I, Penas-Prado M, Peters K, Cloughesy T, Burris H, Maher E, Janku F, Cote G, De La Fuente M, Clarke J, Steelman L, Le K, Xu H, Sonderfan A, Hummel D, Schoenfeld S, Yen K, Pandya S, Wen P . Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population . Neuro-Oncology . 2018;20(Suppl . 6):vi18- . PMCID: PMC6216117

Menon J, Willis CW, Unni S, Au T, Ndife B, Joseph G, Brixner D, Stein EM, Tantravahi S, Shami P, Kovacsovics T, Stenehjem D . FLT3 mutated and wildtype acute myeloid leukemia treatment patterns and outcomes at a comprehensive cancer center . Value in Health . 2018;21(Suppl . 1):S249- .

Merle P, Rimassa L, Ryoo B, Cicin I, Harris W, Banu E, Sarker D, Tan B, Van Vlierberghe H, Sen S, Love C, Cheng A, Meyer T, Kelley R, Abou-Alfa G . Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) . Annals of Oncology . 2018;29(Suppl . 5):mdy149 .010- .

Mesa RA, Kosiorek HE, Mascarenhas J, Prchal JT, Rambaldi A, Berenzon D, Yacoub A, Harrison CN, McMullin MF, Vannucchi AM, Ewing J, O’Connell CL, Kiladjian JJ, Mead AJ, Winton EF, Leibowitz DS, De Stefano V, Arcasoy MO, Kessler CM, Catchatourian R,

Rondelli D, Silver RT, Bacigalupo A, Nagler A, Kremyanskaya M, Sandy L, Salama ME, Najfeld V, Tripodi J, Weinberg RS, Rampal RK, Hoffman R, Dueck AC . Impact on MPN symptoms and quality of life of front line pegylated interferon alpha-2a vs . hydroxyurea in high risk polycythemia vera and essential thrombocythemia: Results of myeloproliferative disorders research consortium (MPD-RC) 112 global phase III trial . Blood . 2018;132(Suppl . 1)

Meyer AE, Stelloh C, Fisher JB, Pulakanti K, Vassiliou GS, Viny AD, Levine RL, Rao S . Combinatorial genetics uncovers novel targets for the treatment of NPM1/cohesin mutated AML . Blood . 2018;132(Suppl . 1)

Mezquita L, Park W, Arbour K, Auclin E, Hendriks L, Planchard D, Saravia D, Ponce Aix S, Nadal E, Audigier-Valette C, Carnio S, Adam J, Ruffinelli JC, Zalcman G, Numico G, Sullivan I, Paz-Ares L, Dingemans A, Novello S, Hellmann M, Lopes G, Besse B . Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 status with outcomes for immune checkpoint inhibitors in advanced NSCLC patients . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S488- .

Mezquita L, Arbour K, Auclin E, Saravia D, Rizvi H, Hendriks L, Planchard D, Park W, Nadal E, Ruffinelli Rodriguez JC, Ponce S, Audigier-Valette C, Marilniello AP, Zalcman G, Majem M, Schiavone G, Dingemans AMC, Lopes G, Hellmann MD, Besse B . Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC)

patients . Annals of Oncology . 2018;29(Suppl . 8):mdy292 .029- .

Mhanna L, Milia J, Lusque A, Couraud S, Mascaux C, Veillon R, Frueh M, Moro-Sibilot D, Lattuca-Truc M, Tomasini P, Barlesi F, Drilon AE, Gautschi O, Mazieres J . Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Michallet M, Cortes J, Gambacorti-Passerini C, Hehlmann R, Williams LA, Goldberg SL, Davis C, De Solda F, Sen GP, Gajavelli S, Mauro MJ . An observational study of survival in patients with chronic-phase chronic myeloid leukemia (CML-CP) after 1, 3, and 5 years of tyrosine kinase inhibitor (TKI) therapy (SIMPLICITY) . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S229- .

Michalski M, Capaci C, Rowed K, Happel R, Scott J . Does estimated cardiorespiratory fitness accurately predict directly measured Vo(2peak) in breast cancer survivors? . Medicine and Science in Sports and Exercise . 2018;50(5 Suppl .):357- .

Milrad SF, Hall DL, Jutagir D, Czaja S, Perdomo D, Fletcher MA, Klimas N, Antoni MH . Relationship satisfaction, communication self-efficacy, and chronic fatigue syndrome (CFS) . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S822- .

Mims AS, Kohlschmidt J, Borate U, Norris B, Bucy T, Blachly JS, Orwick S, Eisfeld AK, Papaioannou D, Nicolet D, Mrozek K, Bhatnagar B, Stein EM, Stone RM, Kolitz JE, Wang ES, Powell BL, Burd A, Levine RL, Druker BJ, Bloomfield CD, Byrd JC . A precision medicine heirarchical classification developed using variant allele frequency (VAF) for treatment of older patients (Pts) with acute myeloid leukemia (AML): Alliance Clinical Trials in Oncology (Alliance) historical patient control . Blood . 2018;132(Suppl . 1)

Minnie SA, Smith D, Gartlan KH, Watkins TS, Markey KA, Guillerey C, Kuns RD, Locke KR, Varelias A,

245 OF 288


Meeting Abstracts

Zhang P, Huntington N, Chesi M, Miles JJ, Smyth MJ, Vuckovic S, Hill GR . Donor T cells maintain myeloma-immune equilibrium after autologous stem cell transplantation and concurrent immunotherapy promotes cure . Blood . 2018;132(Suppl . 1)

Miranda C, Miller A, Andersen B, Hatzoglou V, DeAngelis L . The development of ventriculomegaly in glioblastoma (GBM) patients . Neurology . 2018;90(15 Suppl .)

Miranda E, Zelefsky M, Jenkins L, Nelson C, Mulhall J . Preservation of baseline erectile function in radiotherapy patients using phosphodiesterase type 5 inhibitors . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S79-S80 .

Miranda E, Schofield E, Jenkins L, Nelson C, Mulhall J . Testosterone recovery profiles after cessation of androgen deprivation therapy (ADT) . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S18- .

Miranda EP, Nascimento B, Terrier JE, Mulhall J . Critical analysis of penile duplex doppler ultrasound (PDDU) in erectile dysfunction (ED): Technical and interpretation deficiencies . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S80- .

Miranda EP, Jenkins L, Nelson C, Zelefsky M, Mulhall J . Preservation of baseline erectile function in radiotherapy patients using PDE5i . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S156- .

Miranda EP, Jenkins L, Zelefsky M, Schofield E, Nelson C, Mulhall J . Impact of PDE5 inhibitor (PDE5i) use on biochemical recurrence rates in prostate cancers patients following radiotherapy (RT) . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S165-S166 .

Mirsadraei L, Chen YB, Reuter V, Lin O . Cytological characteristics of hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cell carcinomas . Modern Pathology . 2018;31(Suppl . 2):163- .

Modi S, Pusztai L, Forero A, Mita M, Miller KD, Weise A, Krop I, Burris H 3rd, Kalinsky K, Tsai M, Liu MC, Hurvitz SA, Wilks S, Ademuyiwa F, Diab S, Han HS, Kato G, Nanda R, O’Shaughnessy J, Kostic A, Li M, Specht J . Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer . Cancer Research . 2018;78(4 Suppl .)

Modi S, Tsurutani J, Takahashi S, Iwata H, Park H, Redfern CH, Doi T, Li B, Iwasa T, Taira S, Hattori M, Ma CX, Fisher JM, Naito Y, Yonemori K, Kawasaki Y, Saito K, Jikoh T, Shahidi J, Lee CC, Yver A, Tamura K . Safety and efficacy results from a phase 1 study of DS-8201a in patients with HER2 expressing breast cancers . Cancer Research . 2018;78(4 Suppl .)

Modlin I, Kidd M, Lewczuk A, Chung KM, Kolasinska-Cwikla A, Cwikla J, Tesselaar M, Malczewska A, Kos-Kudla B, Bodei L, Drozdov I . Blood neuroendocrine transcript analysis for the diagnosis and clinical status assessment of bronchopulmonary neuroendocrine tumors . Pancreas . 2018;47(3):347- .

Modlin LA, Kuriakose RK, Francis JH, Abramson DH, Shoustari AN, Barker CA . Outcomes of uveal melanoma with distant metastasis at initial staging: Impact of primary tumor therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E306- .

Montalbano M, Sengupta U, McAllen S, Kharas MG, Kayed R . Formation and interaction of toxic oligomeric assemblies of RNA-binding proteins Musashi with Tau oligomers in Alzheimer’s disease . Annals of Neurology . 2018;84(Suppl . 22):S169-S170 .

Montecalvo J, Wang LC, Chen CJ, Rekhtman N, Katabi N, Ghossein R, Antonescu CR, Travis W . Thoracic hyalinizing clear cell carcinoma: A series of 3 cases . Modern Pathology . 2018;31(Suppl . 2):741-742 .

Montecalvo J, Alex D, Ptashkin R, Ni A, Sauter JL, Chang J, Beras A, Namakydoust A, Rudin C, Ladanyi M, Antonescu CR, Travis W, Rekhtman N . SMARCA4

(BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior . Modern Pathology . 2018;31(Suppl . 2):742- .

Montecalvo J, Alex D, Ptashkin R, Ni A, Sauter JL, Chang J, Jungbluth A, Beras A, Namakydoust A, Rudin C, Ladanyi M, Antonescu CR, Travis W, Rekhtman N . Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma:

Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma . Modern Pathology . 2018;31(Suppl . 2):742- .

Montesinos P, Di Nardo CD, Stein AS, Stein EM, Fathi AT, Schuh AC, Odenike O, Kantarjian HM, Stone RM, Collins R, Martinelli G, Arnan M, Wu B, Zhang V, Gong J, MacBeth KJ, Vyas P . Inhibidores de la isocitrato deshidrogenasa mutata (mIDH), ivosidenib o enasidenib, en combinacion con azacitidina (AZA) en pacientes con leucemia mieloide aguda (LMA) . Haematologica . 2018;103(Suppl . 2):25-26 .

Montoya C, Deville C Jr, Vapiwala N, Both S . Updated acute and late gastrointestinal and genitourinary toxicity of dose-escalated image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E131- .

Moo T, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Barrio A V, Morrow M . Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S25- .

Moore KN, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza AM, Gonzalez-Martín A, Aghajanian C, Bradley W, Lowe ES, Bloomfield R, DiSilvestro P . Maintenance olaparib following platinum-based chemotherapy

246 OF 288


Meeting Abstracts

in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .041- .

Morcerf B, Willumsen S, Rodriguez ES . Improving access to bone marrow transplant care by building a shared care model: Memorial Sloan Kettering and Hartford Health Care . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S452- .

Moreno Alonso de Celada R, Najera Botello L, Gonzalez Rodríguez S, Juarranz A, Gilaberte Y . Serum vitamin D level modifies the response of actinic keratosis to photodynamic therapy with methylaminolevulinate . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S83- .

Mori S, Busam K, Nehal K . Microcystic adnexal carcinoma-A rare and deceptive tumor . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB192- .

Moro-Sibilot D, Ahn MJ, Halmos B, Kim DW, Riely GJ, Shaw AT, Yang PC, Lanzalone S, Polli A, Wilner KD, De Castro Carpeño J . Efficacy and safety of crizotinib in previously treated patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y) . Annals of Oncology . 2018;29(Suppl . 8):mdy292 .019- .

Morris MJ, Vogelzang NJ, Sartor AO, Armour AA, Messmann RA, Groaning M, Robarts A, Tolcher AW, Gordon MS, Babiker HM, Kuo P, Kearney M, Jendrisak A, Wang YP, Landers MA, Petrylak DP . PSMA heterogeneity analysis in patients with metastatic castrate-resistant prostate cancer (mCRPC): Imaging versus CTCs . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Morris MJ, Vogelzang NJ, Sartor O, Armour A, Messmann R, Groaning M, Robarts A, Tolcher AW, Gordon M, Babiker HM, Kuo P, Kearney M, Jendrisak A, Wang Y, Landers M, Petrylak DP . CTC-based biomarkers & PSMA-targeted imaging in patients

with metastatic castrate-resistant prostate cancer (mCRPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .051- .

Morschhauser F, Feugier P, Flinn IW, Gasiorowski RE, Greil R, Illes A, Johnson NA, Larouche JF, Lugtenburg PJ, Patti C, Salles G, Trneny M, de Vos S, Mir F, Kornacker M, Punnoose EA, Samineni D, Szafer-Glusman E, Petrich A, Sinha A, Mobasher M, Zelenetz AD . Venetoclax plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP)

improves outcomes in BCL2-positive first-line diffuse large B-cell lymphoma (DLBCL): First safety, efficacy and biomarker analyses from the phase II CAVALLI study . Blood . 2018;132(Suppl . 1)

Moskowitz AJ, Jacobsen E, Ruan J, Schatz JH, Obadi O, Motylinski K, Jarjies C, Galasso N, Hancock H, Davey T, Myskowski P, Dogan A, Inghirami G, Weinstock DM, Horwitz SM . Durable responses observed with JAK inhibition in T-cell lymphomas . Blood . 2018;132(Suppl . 1)

Moskowitz AJ, Santoro A, Gritti G, Brice P, Cunningham D, Barr P, Kline J, Kuruvilla J, Johnson NA, Mehta-Shah N, Manley T, Sharma M, Francis S, Cohen J, Zinzani PL . Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Preliminary results from the phase 2 CheckMate 436 trial . Blood . 2018;132(Suppl . 1)

Mosquera J, Sugita M, Wilkes D, Bareja R, Eng KW, Croyle J, MacDonald TY, Flores RJ, Noorzad Z, Pancirer D, Cheng S, Xiang JZ, Olson L, Van Besien K, Rickman D, Tam W, Chiosis G, Rubin MA . Novel PML-SYK fusion in acute myeloid leukemia constitutively activates targetable pathways . Journal of Molecular Diagnostics . 2018;20(6):922-923 .

Motzer RJ, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins RE, Ravaud A, Alekseev BY, Staehler MD, Uemura M, Donaldson F, Li S, Huseni

MA, Schiff C, Rini B I . IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Motzer RJ, Grunwald V, Hutson TE, Porta C, Powles T, Eto M, Dutcus CE, Baig MA, Dutta L, Li D, Choueiri TK . A phase 3 trial to compare efficacy and safety of lenvatinib in combination with everolimus or pembrolizumab versus sunitinib alone in first-line treatment of patients with metastatic renal cell carcinoma . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Motzer RJ, Penkov K, Haanen JBAG, Rini B I, Albiges L, Campbell MT, Kollmannsberger CK, Negrier S, Uemura M, Lee JL, Gurney H, Berger R, Schmidinger M, Larkin J, Atkins MB, Wang J, Robbins PB, Chudnovsky A, Di Pietro A, Choueiri TK . JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC) . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .036- .

Mountjoy L, Kunze KL, Jain T, Slack JL, Khera N, Leis JF, Noel P, Sproat LZ, Palmer J . Clinical outcomes of matched unrelated allogeneic stem cell transplant patients: Low dose ATG Vs . no ATG . Blood . 2018;132(Suppl . 1)

Mountjoy L, Chirackal S, Jain T, Girardo M, Larsen J, Fonseca R . Results of a flow cytometry assay measuring oxidative stress relief as a predictor of immunomodulatory drugs (IMIDs) sensitivity in myeloma . Blood . 2018;132(Suppl . 1)

Muhsen S, Dang C, Plitas G, Seier K, Stempel M, Patil S, Morrow M, El-Tamer M . Chemotherapy with and without trastuzumab or no treatment in elderly patients with HER2 amplified breast cancer at a single center . Cancer Research . 2018;78(4 Suppl .)

Muhsen S, Dang C, Plitas G, Knezevic A, Stempel M, Patil S, Morrow M, El-Tamer M . Frequency of delivery

247 OF 288


Meeting Abstracts

of systemic chemotherapy in elderly versus younger patients with triple negative breast cancer . Cancer Research . 2018;78(4 Suppl .)

Muhsen S, Moo T, Zabor E, Stempel M, Pusic AL, Gemignani ML, Morrow M, Sacchini V . Increase in utilization of nipple sparing mastectomy for breast cancer: Indications, complications, and oncologic outcomes . Annals of Surgical Oncology . 2018;25(Suppl . 1):S104- .

Muhsen S, Moo TA, Zabor E, Stempel M, Pusic A, Gemignani M, Morrow M, Sacchini V . Prophylactic nipple-sparing mastectomy: Indications, complications, and oncologic outcomes . Annals of Surgical Oncology . 2018;25(Suppl . 2):121-122 .

Mukherjee S, Hong L, Deasy J, Zarepisheh M . A computationally efficient algorithm for integrating dose-volume constraints into IMRT fluence optimization for automated treatment planning . Medical Physics . 2018;45(6):e444- .

Mulhall J, Kunzel B, Miranda EP, Nelson C . A randomized, controlled, three-arm study to define the utility of PDE5 inhibitors and intracavernosal injections in the radical prostatectomy population . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S158- .

Mulhall J, Kunzel B, Miranda EP, Nelson C . A randomized, controlled, three-arm study to define the utility of PDE5 inhibitors and intracavernosal injections in the radical prostatectomy population . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S81-S82 .

Mulhall J, Nascimento B, Bernie H, Schofield E, Miranda E . Testosterone recovery profiles after cessation of androgen deprivation therapy (ADT) . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S162-S163 .

Mulhall JP, Chopra I, Patel D, Tang WY, Hassan TA . Medication utilization in patients receiving phosphodiesterase type 5 inhibitor for erectile

dysfunction . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S370- .

Muller S, Zauderer M, Desmeules P, Jungbluth A, Fayad M, Frosina D, Ni A, Ladanyi M, Sauter JL . Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM) . Modern Pathology . 2018;31(Suppl . 2):743- .

Mungovan SF, Luiting HB, Graham PL, Sandhu JS, Akin O, Chan L, Patel M I . Transperineal ultrasound measurement of membranous urethral length in men prior to radical prostatectomy . Neurourology and Urodynamics . 2018;37(Suppl . 5):S191-S192 .

Mungovan SF, Graham PL, Sandhu JS, Scardino PT, Coakley F V, Matsushita K, Ha HK, Tienza A, Choi S, Kim SC, Jeong SJ, Patel ML . An individual patient data meta-regression for continence recovery following radical prostatectomy . Neurourology and Urodynamics . 2018;37(Suppl . 5):S197-S198 .

Muraki T, Pehlivanoglu B, Memis B, Reid M, Uehara T, Basturk O, Klimstra D, Jarnagin WR, Golia Pernicka JS, Ito T, Hasebe O, Okaniwa S, Horigome N, Hisa T, Mittal P, Maithel S, Sarmiento JM, Krasinskas A, Koshiol J, Lomberk G, Urrutia R, Tsai S, Christians KK, Evans D, Adsay N V . Pancreatobiliary maljunction-associated gallbladder cancer is as common in the west as in the east, shows distinct clinicopathologic characteristics and offers an invaluable model for reflux-associated physio-chemical carcinogenesis . Modern Pathology . 2018;31(Suppl . 2):683-684 .

Murali R, Kracun M, Chiang S, DeLair D, Soslow R, Park K . Gastric-type cervical adenocarcinoma in small biopsy and cytology specimens . Modern Pathology . 2018;31(Suppl . 2):440- .

Murphy ES, Fangusaro J, Dhall G, Bartels U, Fouladi M, Shaw D, Khatua S, Hughes CW, Panigraphy A, Souweidane M, Morris D, Lu HM, Gajjar A, Onar A, Wu S, Haas-Kogan DA, MacDonald S . A phase 2 trial of response-based radiation therapy for patients with

localized central nervous system germ cell tumors (CNS GCT): A Children’s Oncology Group (COG) study . Patterns of failure and radiation dosimetry for nongerminomatous germ cell tumors . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S49-S50 .

Murphy K . Improving cardiac tamponade outcomes through less invasive interventions and earlier recognition . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S937- .

Muthukumarana V, Fix D, Park K, Soslow R, Chiang S . BCOR expression in mullerian adenosarcoma: A potential diagnostic pitfall . Modern Pathology . 2018;31(Suppl . 2):440- .

Nabhan C, Klink A, Samp J, Pauff JM, Nielsen J, Meissner B, Keim H, Kennard K, Mato AR . Management and outcomes of 222 CLL patients (pts) treated with venetoclax (VEN) in the real world . Journal of Clinical Oncology . 2018;36(15 Suppl .):407s- .

Nabhan C, Mato AR, Kish JK, Nero D . Comparison of costs and health care resource utilization (HRU) in chronic lymphocytic leukemia (CLL) patients treated with venetoclax (VEN) or chemotherapy (CT)/chemoimmunotherapy (CIT) . Blood . 2018;132(Suppl . 1)

Nabhan C, Nero D, Lee CH, Kish JK, Mato AR . Cost-effectiveness comparison between ibrutinib, chemotherapy, and chemoimmunotherapy in front-line treatment of chronic lymphocytic leukemia (CLL) . Blood . 2018;132(Suppl . 1)

Nafa K, Salazar PA, Rijo I, Elezovi D, Ladanyi M, Arcila ME . Rapid assessment of microsatellite instability status using the Idylla MSI Test . Journal of Molecular Diagnostics . 2018;20(6):1005- .

Naing A, Autio KA, Falchook GS, Meric-Bernstam F, Litton JK, Ibrahim NK, Hung A, Oft M, Leveque J, Patel MR . Responses and durability of clinical benefit

248 OF 288


Meeting Abstracts

in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .018- .

Nakajima M, Guo H, Hoseini SS, Xu H, Cheung NK . Potent anti-tumor effect using T cells armed with recombinant anti-GD2 bispecific antibodies against GD2 positive tumor . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S54- .

Nakajima R, Ito K, Weber W, Schoder H . Metabolic parameters measured by (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the outcome of patients with non-small cell lung cancer treated with pembrolizumab . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S507- .

Nam AS, Kim KT, Chaligne R, Izzo F, Ang C, Omans N, Pastore A, Taylor J, Alonso A, Tam W, Hoffman R, Scandura J, Rabadan R, Abdel-Wahab O I, Smibert P, Landau DA . High throughput droplet single-cell genotyping of transcriptomes (GoT) reveals the cell identity dependency of the transcriptional output of somatic mutations . Blood . 2018;132(Suppl . 1)

Narang B, Park SY, Norrmen-Smith I, Lange M, Ocampo A, Gany F, Diamond LC . The use of a mobile application to increase access to interpreters for cancer patients with limited English proficiency . Journal of General Internal Medicine . 2018;33(Suppl . 2):S368- . PMCID: PMC5913041

Nathenson M, Demetri G, Lassen U, Hong D, Boni V, Deeken J, Dowlati A, Cox M, Ku N, Cruickshank S, Qamoos H, Drilon A . Activity of larotrectinib in patients with TRK fusion GI malignancies . Annals of Oncology . 2018;29(Suppl . 5):mdy149 .019- .

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Panageas KS, De Angelis LM . Arterial thromboembolism risk before a diagnosis of lung,

pancreas, or gastric cancer . Thrombosis Research . 2018;164(Suppl . 1):S179-S180 .

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, Panageas KS, DeAngelis LM . Risk of arterial thromboembolic events before the diagnosis of cancer . Annals of Neurology . 2018;84(Suppl . 22):S132- .

Neal J, Doebele R, Riely G, Spira A, Horn L, Piotrowska Z, Costa D, Zhang S, Bottino D, Zhu J, Kerstein D, Li S, Janne P . Safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 in NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S599- .

Necchi A, Mariani L, Lo Vullo S, Raggi D, Giannatempo P, Bamias A, Crabb SJ, Bellmunt J, Yu EY, Niegisch G, Vaishampayan UN, Theodore C, Berthold DR, Srinivas S, Sridhar SS, Plimack ER, Rosenberg JE, Powles T, Galsky M, Sonpavde G . Impact of number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma . Journal of Clinical Oncology . 2018;36(6)

Necchi A, Pond GR, Plimack ER, Niegisch G, Yu EY, Pal SK, Bamias A, Agarwal N, Alva AS, Srinivas S, Crabb SJ, Vaishampayan UN, Bowles DW, Berthold DR, Theodore C, Sridhar SS, Powles T, Rosenberg JE, Bellmunt J, Galsky MD . Nomogram-based risk prediction of local and distant relapse after radical cystectomy, and role of perioperative chemotherapy, in patients with muscle-invasive bladder cancer (MIBC): A multicenter study . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Necchi A, Nishiyama H, Matsubara N, Lee JL, Petrylak DP, De Wit R, Drakaki A, Liepa AM, Zimmermann A, Bell-McGuinn KM, Powles T . Quality-of-life (QoL) in RANGE: A phase 3 study of ramucirumab (RAM) plus docetaxel (DOC) versus placebo (P) plus DOC in platinum-refractory locally advanced or metastatic urothelial carcinoma (UC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Nelson AM, Hoogland A I, Hyland KA, Christy SM, Kennedy B, Root JC, Ahles T, Jacobsen P, Jim H . Perceived cognitive problems among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S22- .

Nelson CJ, Saraccino R . Exploring the conceptualization of depression in older adults with cancer . Psycho-Oncology . 2018;27(Suppl . 3):39-40 .

Nelson E, Nasrallah M, Viaene A, Faust P, Antonescu C, Li M, Surrey L, Luo MJ, Cho ES, Sharer L . Supratentorial clear cell ependymoma associated with RELA fusion and long term survival . Journal of Neuropathology and Experimental Neurology . 2018;77(6):489- .

Nelson M, Yock T, Wolden S, Wang J, Cheng Y, Hess C, Kim A, Meany H, Schulte R, Stavas M, Terezakis S, Ladra M . High incidence of local and regional failure

in pediatric rhabdomyosarcoma of the nasal ala . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S332- .

Nevel K, Davis ME, Skakodub A, Ali J, Sullivan-Henry A, Gilman J, Harrison M, Huang M, Bailey L, Mack K, Rawlins-Peters G, Jean-Charles D, Kilkenny D, Martin A, Kelly B, Cohen L, Saliu A, Trapani M, Zavolas S, Padro Guzman J, Diamond E, Carver A, DeAngelis L, Barnett K, Ruppert L, Pentsova E . A novel multidisciplinary care clinic model for frail patients with central nervous system malignancies . Neuro-Oncology . 2018;20(Suppl . 6):vi216-vi217 . PMCID: PMC6216117

Nevel K, Cowan A, Reiner A, Ogilvie S, Skakodub A, Distefano N, Pentsova E, Boire A . Outcomes of lung cancer patients with leptomeningeal metastases in the targeted therapy era . Neuro-Oncology . 2018;20(Suppl . 6):vi59- . PMCID: PMC6216117

Newman A, Gentile L, Zabor E, Stempel M, Van Zee K, Morrow M, Kirstein L . Invasive recurrence after DCIS: Characteristics after initial BCT vs mastectomy .

249 OF 288


Meeting Abstracts

Annals of Surgical Oncology . 2018;25(Suppl . 2):102-103 .

Newman AM, Braunstein LZ, Khan AJ, Turashvili G, Wen YH, Zabor E, Stempel M, Morrow M, Kirstein L . OncotypeDX risk stratification in early stage breast cancer: When is accelerated partial breast irradiation (APBI) safe? . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E591- .

Newton AD, Predina JD, Connolly CT, Shin MT, Frenzel-Sulyok L, Drebin J, Singhal S, Lee MK 4th . Near infrared intraoperative imaging with second window indocyanine green can improve visualization of pancreatic neoplasms during distal pancreatectomy . Annals of Surgical Oncology . 2018;25(Suppl 1 .):S118- .

Nguy S, Wu P, Lee A, Tam M, Schreiber D, Du KL . Survival outcomes and prognostic factors for gastric cancer in the adjuvant setting: An analysis of the National Cancer Database . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E49- .

Nguyen D, Lu Y, Choo Z, Chin C, Prieto C, Gourkanti S, Leslie C, Kharas MG . The RNA binding protein MSI2 has increased RNA binding activity in leukemic stem cells compared to normal hematopoietic stem cells . Blood . 2018;132(Suppl . 1)

Nguyen PL, Zhang JB, Yousefi K, Davicioni E, Den RB, Feng FY, Spratt DE . Prospective analysis of 4,474 prostate biopsies to evaluate potential treatment management impact of combined clinical-genomic risk classification . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Nichol D, Jones S, Angiouli S V, Keefer L, Nesselbush M, Sengamalay N, White J, Simmons J, Diaz LA, Velculescu VE, Sausen M . Pan-cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Nichols R, Morris C, Prabhu K, Hartsell W, Cahlon O, Apisarnthanarax S, McGee L, Vargas C . Postoperative proton therapy for pancreas cancer patients on the Proton Collaborative Group registry . Radiotherapy and Oncology . 2018;127(Suppl . 1):S770-S771 .

Nichols RC, Morris CG, Prabhu K, Hartsell WF, Cahlon O, Apisarnthanarax S, McGee L, Vargas CE . Postoperative proton therapy for pancreatic cancer patients enrolled on the Proton Collaborative Group (PCG) registry . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Nicolas G, Bodei L, Baum R, Herrmann K, Lassmann M, Hicks R, Navalkissoor S, Haug A, Oberwittler H, Wang T, Wild D . Phase 1/2 open-label trial to assess the safety and preliminary efficacy of (177)Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumors . Pancreas . 2018;47(3):349- .

Nie X, Huang K, Sharma S, Deasy J, Rimner A, Li G . Enhancement of super-resolution time-resolved 4DMRI reconstruction in low-contrast tissue by two-step deformable image registration . Medical Physics . 2018;45(6):e401-e402 .

Noch E, Sait S, Miller A . A case series of metastatic glioblastoma at Memorial Sloan Kettering Cancer Center . Neuro-Oncology . 2018;20(Suppl . 6):vi80-vi81 . PMCID: PMC6216117

Nunez DA, Fontenla S, Rydquist L, Del Rosario G, Han Z, Chen C, Hunt M, Mah D, Tyagi N . Dosimetric evaluation of MR-derived synthetic-CTs for MR-only proton treatment planning . Medical Physics . 2018;45(6):e468- .

O’Cearbhaill RE, Wolfer A, Disilvestro P, O’Malley DM, Sabbatini P, Shohara L, Schwarzenberger PO, Ricciardi T, Macri M, Ryan A, Venhaus RR, Bryan JK, Wong P, Homicsko K, Kandalaft L, Rusakiewicz S, Harari A, Monk BJ, Coukos G . A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-

resistant recurrent ovarian cancer (PROC) . Annals of Oncology . 2018;29(Suppl . 8):mdy285 .153- .

O’Reilly S, Jain V, Huang Q, Teo B, Yin L, Zhang M, Diffenderfer E, Levin W, Xiao Y, Dong L, Feigenberg S, Berman A, Zou W . Best in physics (Joint imaging-therapy): Avoiding highly functional ventilation zones decreases the risk of radiation pneumonitis during proton and photon radiotherapy for lung cancer . Medical Physics . 2018;45(6):e671- .

Obar JJ, Caffrey AK, Wang X, Espinosa V, Tang YW, Hohl T, Rivera A, Cramer R . Mda5/MAVS signaling is essential for resistance against Aspergillus fumigatus . Journal of Immunology . 2018;200(1 Suppl .)

Oberg JA, Sireci AN, Hsiao SJ, Pendrick D, Turk AT, Chung WK, Sulis ML, Kung AL, Mansukhani MM, Bender JLG . Expanded genomic testing for pediatric cancers is clinically impactful but reimbursement lags behind . Value in Health . 2018;21(Suppl . 1):S34- .

Oezkan F, He K, Owen D, Pietrzak M, Kitzler R, Pearson R, Nicholas A, Bunn P Jr, Kris M, Kwiatkowski D, Johnson B, Hirsch F, Wistuba I, Rusch V, Lee J, Gandhi M, Schulze K, Shames D, Lozanski G, Carbone D . Comprehensive peripheral blood immunophenotyping and T-cell clonal analysis during neoadjuvant immunotherapy with atezolizumab in NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S369- .

Offin M, Dienstag J, Wilkins O, Sabari J, Ni A, Feldman D, Van Voorthuysen M, Suzawa K, Yu H, Riely G, Arcila M, Ladanyi M, Kris M, Rudin C, Somwar R, Li B, Drilon A . MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S491- .

Offin M, Tenet M, Shen R, Rekhtman N, Rizvi H, Hellmann M, Arcila M, Ladanyi M, Rudin C, Kris M, Yu H . Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1

250 OF 288


Meeting Abstracts

mutations . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S412- .

Offin M, Myers M, Josyula S, Shen R, Borsu L, Tsui D, Riely G, Rudin C, Yu H, Li B, Arcila M . Utility of cfDNA testing for acquired resistance: The Memorial Sloan Kettering experience with plasma EGFR T790M clinical testing . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S491-S492 .

Oh DY, Park JO, Charoentum C, Stein S, Noel M, Chung V, Wu W, Alton R, Muhsin M, Javle M, Abou-Alfa GK, Borad MJ . HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin plus gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) plus CIS plus GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer . Annals of Oncology . 2018;29(Suppl . 9):mdy432 .061- .

Oh J, Katsoulakis E, Leeman J, Yu Y, Tsai J, McBride S, Katabi N, Apte A, Lee N, Hatzoglou V, Riaz N, Deasy J . Radiomics characteristics correlate with immune activation: A TCIA/TCGA data analysis in head and neck squamous cell carcinoma . Medical Physics . 2018;45(6):e366- .

Oh P, Zhang M, Brady P, Yorke E, Won E, Goodman KA, Wu AJC . Impact of lung and heart dose on survival after radiotherapy for esophageal cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Oh P, Zhang M, Brady P, Sihag S, Molena D, Ilson DH, Janjigian YY, Ku GY, Wu AJC . Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Oktay K, Bedoschi G, Goldfarb S, Titus S, Palomaki G, Dickler M . Increased chemotherapy-induced ovarian reserve loss in women with BRCA mutations: A prospective longitudinal study with mechanistic confirmation . Fertility and Sterility . 2018;110(4 Suppl .):e430- .

Olsson C, Thor M . A systematic review and quantitative synthesis of tolerance doses for distinct late toxicities . Radiotherapy and Oncology . 2018;127(Suppl . 1):S168-S169 .

Oran B, de Lima M, Garcia-Manero G, Thall PF, Lin RT, Alousi AM, Hosing C, Kebriaei P, Popat U, Giralt S, Ahmed S, Shpall EJ, Andersson BS, Bashir Q, Ciurea SO, Rezvani K, Woodworth G, Champlin RE . Maintenance with 5-azacytidine for acute myeloid leukemia and myelodysplastic syndrome patients . Blood . 2018;132(Suppl . 1)

Orom H, Schofield E, Kiviniemi MT, Waters E, Biddle C, Li YL, Hay JL . Why do some people not know their risk for diabetes and colorectal cancer? . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S276- .

Osborn V, Imber B, Samstein R, Chan T, Yamada Y, Beal K . Possible synergy of radiation and immunotherapy for less common brain metastases . Journal of Radiation Oncology . 2018;7(2):119- .

Osborn VW, Tsai CJ, Sherman E, Pfister DG, Baxi SS, Dunn L, Ho A, Michel L, Riaz N, Higginson DS, Leeman JE, Patel S, Xie P, Li X, Lee N, McBride S . Bolus versus weekly chemotherapy in definitive chemoradiation for nasopharyngeal cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1332- .

Ostroff J . Measurement of clinically meaningful lung cancer stigma . Psycho-Oncology . 2018;27(Suppl . 1):27-28 .

Ostrom Q, Armstrong G, Amos C, Bernstein J, Claus E, Eckel-Passow J, Il’yasova D, Johansen C, Lachance D, Lai R, Merrell R, Olson S, Schildkraut J, Shete S, Houlston R, Jenkins R, Wrensch M, Melin B, Barnholtz-Sloan J, Bondy M . Previously identified common glioma risk SNPs are associated with familial glioma . Neuro-Oncology . 2018;20(Suppl . 6):vi108- . PMCID: PMC6216117

Ott PA, Govindan R, Naing A, Friedlander TW, Margolin K, Lin JJ, Bhardwaj N, Hellman MD, Srinivasan L, Greshock J, Moles M, Gaynor RB, Goldstein MJ, Hu-Lieskovan S . A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer . Annals of Oncology . 2018;29(Suppl . 8):mdy288- .

Ou FS, Lou Y, Van Cutsem E, Saltz L, Schmoll HJ, Goldberg RM, Hoff P, Douillard JY, Hecht JR, Hurwitz H, Punt CJA, Bokemeyer C, Fuchs CS, Diaz-Rubio E, Tebbut N, Falcone A, Kabbinavar FF, De Gramont A, Grothey A, Shi Q . Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Ou S, Shaw A, Riely G, Chiari R, Bauman J, Clancy J, Thurm H, Peltz G, Abbattista A, Solomon B . Clinical activity of lorlatinib in patients with ROS1+ advanced non-small cell lung cancer: Phase 2 study cohort EXP-6 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S322-S323 .

Ou S, Cho BC, Kim D, Drilon A, Lee J, Lin J, Zhu V, Ahn M, Camidge DR, Shanna Stopatschinskaja S, Liu J, Cui J, Hyman D, Doebele R, Shaw A . Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer . Journal of Thoracic Oncology . 2018;13(12 Suppl .):S1047- .

Owonikoko T, Dahlberg S, Sica G, Poirier J, Byers L, Rudin C, Wistuba I, Ramalingam S . SLFN11 expression and efficacy of PARP inhibitor therapy in extensive stage small cell lung cancer: ECOG-ACRIN 2511 study . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S972- .

Oxnard G, Mandrekar S, Hillman S, Tan A, Govindan R, Wigle D, Malik S, Watt C, Gerber D, Chaft J, Dahlberg S, Kelly K, Faggen M, Stella P, Tazi K, Gandara D,

251 OF 288


Meeting Abstracts

Ramalingam S, Stinchcombe T . Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (Alliance A151216) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S646-S647 .

Oxnard G, Subbiah V, Park K, Bauer T, Wirth L, Velcheti V, Shah M, Besse B, Boni V, Reckamp K, Loong H, Bazhenova L, Solomon B, Tan D, Patel J, Johnson M, Gazzah A, Mok T, Smith S, Tuch B, Ebata K, Zhu E, Nguyen M, Huang X, Cruickshank S, Rothenberg S, Drilon A . Clinical activity of LOXO-292, a highly selective RET inhibitor, in patients with RET fusion+ non-small cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S349-S350 .

Paganelli G, Nicolini S, Grana CM, Bodei L, Di Mauro F, Tardelli E, Monti M, Ferroni F, Caroli P, Ibrahim T, Severi S . Combined 177Lu-DOTATATE and metronomic capecitabine in gastro-entero-pancreatic neuroendocrine tumors with high glucose metabolism: Preliminary data of a phase II prospective trial . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S62- .

Pai SY, Brazauskas R, Bleesing J, Dvorak CC, Kletzel M, Petrovic A, Prockop SE, Quinones R, Goldman FD, Quigg TC, Hanson IC, Stenger E, Thakar MS, Saldaña BJD, Bednarski JJ, Smith AR, Parikh SH, Leiding JW, Miller HK, Shereck E, Chong HJ, DeSantes K, Cuvelier GDE, Chen K, Weinacht KG, Abu-Arja RF, Kapoor N, Moore TB, Gillio AP, Joshi AY, Barnum JL, Chandrakasan S, Haddad E, Keller M, Rozmus J, Sullivan K, Griffith LM, Ochs H, Notarangelo LD, Puck JM, Kohn DB, Cowan MJ, Rawlings D, Burroughs L . Recent outcome of hematopoietic cell transplantation for Wiskott-Aldrich syndrome is excellent in all donor types: A Primary Immune Deficiency Treatment Consortium (PIDTC) study . Journal of Clinical Immunology . 2018;38(3):399-400 .

Paik P, Sakai H, Bruns R, Scheele J, Straub J, Felip E . Tepotinib in non-small cell lung cancer with MET exon

14-skipping mutations or MET amplification: A phase 2 trial in progress . Journal of Thoracic Oncology . 2018;13(12 Suppl .):S1046- .

Paik P, Ahn L, Ginsberg M, McFarland D, Doyle L, Rudin C . Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK-228 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S816- .

Paik P, Sakai H, Bruns R, Scheele J, Straub J, Felip E . Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp): A phase II trial in progress . Annals of Oncology . 2018;29(Suppl . 9):mdy425 .056- .

Paik P, Kim R, Ahn L, Plodkowski A, Ng K, McFarland D, Iqbal A, Eng J, Rudin C . A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S492- .

Palma G, Monti S, Thor M, Soscia E, Sirignano C, Rimner A, Deasy JO, Cella L . Redesign of voxel-based analysis for SBRT lung cancer patients and refinement of findings on regional dose differences associated with radiation-induced acute lung damage . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S95-S96 .

Palomba ML, Dimopoulos MA, Tedeschi A, Trotman J, García-Sanz R, MacDonald D, Leblond V, Mahe B, Herbaux C, Tam C, Matous J V, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C . Ibrutinib/rituximab versus placebo/rituximab: A randomized, phase 3 trial in Waldenström’s macroglobulinemia (iNNOVATE) . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S283- .

Palomba ML, Garcia J, Wang L, Dehner C, Chung KC, Maloney DG . TRANSCEND: Lisocabtagene maraleucel (liso-cel; JCAR017) healthcare resource utilization in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) . Blood . 2018;132(Suppl . 1)

Pandya R, Iyer A, Apte A, Deasy J . Updates to the Computational Environment for Radiological Research (CERR) software: Inter-software radiomics test suite, data import and segmentation . Medical Physics . 2018;45(6):e157- .

Pappacena J, Bhatt V, Shah GL, Hilden P, Maloy M, Buie LW, Giralt SA, Scordo M . More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (allo-HCT) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S279-S280 .

Pareja F, Geyer FC, Piscuoglio S, Selenica P, Kumar R, Lim RS, Guerini-Rocco E, Marchio C, Mariani O, Ng CKY, Brogi E, Norton L, Vincent-Salomon A, Weigelt B, Reis-Filho JS . Mucinous breast carcinomas: A genomically distinct subtype of estrogen receptor-positive invasive breast cancers . Cancer Research . 2018;78(4 Suppl .)

Pareja F, Li A, Wen HY, Geyer F, Gularte-Merida R, Kumar R, Nanjangud GJ, Katabi N, Varga Z, Rakha E, Brogi E, Weigelt B, Reis J . Pleomorphic adenoma and mucoepidermoid carcinoma of the breast are underpinned by fusion genes . Modern Pathology . 2018;31(Suppl . 2):98- .

Park E, Perez G, Regan S, Muzikansky A, Borderud S, Rabin J, Friedman E, Rigotti N, Ostroff J . Assessing implementation of tobacco treatment into cancer care: Feasibility, treatment fidelity, and acceptability . Implementation Science . 2018;13(Suppl . 4):46- . PMCID: PMC5883105

Park JA, Xu H, Santich B, Cheung NK V . Exceptionally potent cytotherapy using T cells armed with novel tetravalent recombinant bispecific antibodies specific for GD2 and HER2 . Blood . 2018;132(Suppl . 1)

Park JH, Grant L, Quinn JA, Roxburgh CSD, McMillan DC, Edwards J . Tumour infiltrating lymphocyte

252 OF 288


Meeting Abstracts

expression of PD-1 as a favourable prognostic factor in patients with mismatch repair competent colorectal cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Park JH, Palomba ML, Batlevi CL, Riviere I, Wang X, Senechal B, Furman RR, Bernal Y, Hall M, Pineda J, Diamonte C, Halton E, Brentjens RJ, Sadelain M . A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL “armored” CAR T cells in patients with relapsed or refractory NHL and CLL including Richter’s transformation . Blood . 2018;132(Suppl . 1)

Park JH, Lee JO, Stone RM, Saven A, Altman JK, Grever MR, Rai KR, Vemuri S, Abdel-Wahab O I, Tallman MS . Acquired resistance to BRAF inhibition in HCL is rare and retreatment with vemurafenib at relapse can induce high response rates: Final results of a phase II trial of vemurafenib in relapsed HCL . Blood . 2018;132(Suppl . 1)

Park K, Turashvili G, Horn LC . Morphologic patterns of secondary involvement of the uterine cervix by non-gynecologic neoplasms . Modern Pathology . 2018;31(Suppl . 2):444- .

Park K, Lee J, Sakai H, Lee K, Ohe Y, Kim S, Fukuhara T, Kang J, Yu C, Daga H, Hotta K, Yokoyama T, Tanaka H, Takeda M, Hellmann M, Sheng J, Nathan F, Yang R, Nishio M . First-line nivolumab + ipilimumab in Asian patients with advanced NSCLC and high TMB (≥ 10 mut/Mb): Results from CheckMate 227 . Journal of Thoracic Oncology . 2018;13(12 Suppl .):S1048- .

Park SM, Cho H, Thornton A, Barlowe TS, Chou T, Chhangawala S, Fairchild L, Chow A, Taggart J, Schurer A, Gruet A, Witkin M, Kim JH, Shevach E, Krivstov A, Armstrong SA, Leslie C, Kharas MG . IKZF2 drives self-renewal and blocks myeloid differentiation programs in myeloid leukemic stem cells . Blood . 2018;132(Suppl . 1)

Park W, Park LC, Florou V, Saravia D, Chang S, Wang S, Chiec L, Rahbari A, Viveiros P, Sukhadia B, Sheikh MM, Mohindra N, Villaflor V, Lopes G, Chae

YK, Park W . Frameshift indel selectively correlates with immunotherapy outcome for advanced NSCLC . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Patel AJ, Sher JJ, Chen Y, Chi P . Development and characterization of novel/genetically defined mouse models of malignant peripheral nerve sheath tumor for preclinical therapeutics testing . Clinical Cancer Research . 2018;24(2 Suppl .):32- .

Patel MA, Kollmeier MA, McBride S, Gorovets D, Varghese M, Knezevic A, Zhigang Z, Zelefsky MJ . The first prostate specific antigen value after androgen deprivation therapy initiation and after definitive radiation therapy completion as a biomarker for disease relapse and mortality in intermediate and high risk prostate cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E133- .

Pathak P, Shah GL, Tsyvkin E, Maloy M, Knezevic A, Devlin SM, Giralt SA, Matasar MJ, Moskowitz CH, Sauter CS, Perales MA . Transformed indolent lymphoma outcomes similar to de novo diffuse large B-cell lymphoma after autologous hematopoietic stem cell transplantation (AHCT), but not allogeneic

HCT (allo-HCT) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S244-S245 .

Pavlick D, Montesion M, Heerema NA, Severson EA, Brennan T, Frampton GM, He J, Byrd JC, Levine RL, Burd A, Vergilio JA, Albacker LA . A next-generation sequencing-based karyotyping algorithm reveals the genomic structure of acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Paz-Ares L, Planchard D, Yang JC, Lee K, Garrido P, Park K, Kim J, Lee DH, Mao H, Chao B, Yu H . CNS activity of ramucirumab in combination with osimertinib in patients with advanced T790M-positive EGFR-mutant NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S453-S454 .

Pekmezci M, Stevers M, Phillips J, Van Ziffle J, Bastian B, Tsankova N, Kleinschmidt-DeMasters B, Rosenblum M, Tihan T, Perry A, Solomon D . Multinodular and vacuolating neuronal tumor of the cerebrum is defined by genetic alterations activating the MAP kinase signaling pathway . Journal of Neuropathology and Experimental Neurology . 2018;77(6):487- .

Peled JU, Gomes A, Buchan ML, Stein-Thoeringer C, Slingerland J, Slingerland AE, Weber D, Sung AD, Maloy M, Peets T, Gyurkocza B, Giralt SA, Jenq RR, Taur Y, Xavier J, Pamer EG, Chao NJ, Holler E, van den Brink MRM . Intestinal microbiota injury during allo-HCT is generalizable across transplantation centers and is associated with increased mortality, broad-spectrum antibiotics, and decreased calorie intake . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S21-S22 .

Peled JU, Gomes ALC, Stein-Thoeringer CK, Slingerland JB, Slingerland AE, Weber D, Markey KA, Smith M, Ponce D, Clurman A, Sung AD, Hashimoto D, Maloy M, Khan N, Gyurkocza B, Giralt S, Perales MA, Jenq RR, Taur Y, Joao XB, Pamer EG, Teshima T, Chao NJ, Holler E, van den Brink MRM . Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival . Blood . 2018;132(Suppl . 1)

Peng YC, Abida W, DeLair D, Sirintrapun SJ, Chen YB, Al-Ahmadie H, Fine SW, Tickoo S, Scher H, Reuter V, Gopalan A . Pathologic characterization of speckle-type POZ protein (SPOP)-mutated prostate cancer . Modern Pathology . 2018;31(Suppl . 2):374- .

Pentsova E, Malani R, Fleisher M, Lin X, Omuro A, Groves M, Lin N, Melisko M, Lassman A, Jeyapalan S, Boire A, DeAngelis L, Raizer J . Prospective evaluation of cerebrospinal fluid circulating tumor cells (CSF CTC) in patients with HER2 positive cancers and leptomeningeal metastases receiving treatment with intrathecal trastuzumab . Neuro-Oncology . 2018;20(Suppl . 3):iii304- . PMCID: PMC6144305

253 OF 288


Meeting Abstracts

Pereira-Martins DA, Ortiz C, Franca-Neto PL, Weinhauser I, Schiavinato JL, Palma PVB, Bonaldo C, Koury LCA, Do Nascimento MC, Melo RAM, Bittencourt R, Pagnano KBB, Pasquini R, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille MD, Keating A, Tallman MS, Ribeiro R, Dillon R, Ganser A, Lowenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Lucena-Araujo AR, Rego EM . Metforminintreatment overcomes ATRA-resistance in acute promyelocytic leukemia FOXO3A expression . Blood . 2018;132(Suppl . 1)

Pernas S, Villagrasa P, Vivancos A, Scaltriti M, Rodon J, Burgues O, Nuciforo PG, Canes J, Dueñas M, Vidal M, Lluch A, Perello A, Llombart A, Dorca J, Montaño A, Oliveira M, Ribas G, Rapado I, Prat A, Ciruelos EM . Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study) . Annals of Oncology . 2018;29(Suppl . 8):mdy272 .276- .

Pesce C, Kuchta K, Erdogan B, Wang C, Yao K, El-Tamer M . Predicting Oncotype DX scores using clinicopathologic features: A report from the National Cancer Database . Journal of Clinical Oncology . 2018;36(15 Suppl .):20s- .

Petrylak DP, Smith DC, Flaig TW, Zhang J, Sridhar SS, Ruether JD, Plimack ER, Merchan JR, Quinn D I, Kilari D, Srinivas S, Baranda JC, Lang JM, Milowsky M I, Galsky MD, Spira A I, Gartner EM, Wu C, Melhem-Bertrandt A, Rosenberg JE . Enfortumab vedotin (EV) in patients (Pts) with metastatic urothelial carcinoma (mUC) with prior checkpoint inhibitor (CPI) failure: A prospective cohort of an ongoing phase 1 study . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Petrylak DP, Rosenberg J, Duran I, Loriot Y, Sonpavde G, Wu C, Gartner E, Melhem-Bertrandt A, Powles T . EV-301: An open-label, randomized phase III study to evaluate enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC) . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .131- .

Pfaff E, Snuderl M, Karajannis MA, Aichmüller C, Sill M, Orr BA, Ellison DW, Pfister SM, Jones DTW . Tumors of the pineal region can be classified into distinct subgroups based on molecular characteristics correlating with clinical parameters and genetic alterations . Neuro-Oncology . 2018;20(Suppl . 2):i69-i70 . PMCID: PMC6012612

Philip M, Pilkinton M, Ramesh R, McDonnell WJ, Gangula RD, Camara S, Chopra A, Schietinger A, Mallal SA . Population dynamics of tumor-specific CD8 T cell differentiation from plastic to fixed dysfunctional states . Journal of Immunology . 2018;200(1 Suppl .)

Phillips R, Smith R, Funato K, Liang Y, Thompson B, Mitsche M, Jeffrey M, Tabar V, Allis CD . Therapeutic modulation of cholesterol homeostasis in DIPG through massive generation of 24,25-epoxycholesterol . Neuro-Oncology . 2018;20(Suppl . 6):vi204- . PMCID: PMC6216117

Pianko MJ, Devlin SM, Littmann ER, Chansakul A, Mastey D, Salcedo M, Fontana E, Ling LL, Tavitian E, Slingerland JB, Slingerland AE, Clurman A, Gomes ALC, Taur Y, Pamer EG, Peled JU, van den Brink MRM, Landgren O, Lesokhin AM . Intestinal microbiota composition is associated with minimal residual disease negativity in patients with multiple myeloma . Blood . 2018;132(Suppl . 1)

Pianko MJ, Tiutan T, Flynn J, Devlin SM, Jaffer-Sathick I, Rossi AC, Salvatore SP, Landau HJ, Lendvai N, Smith EL, Korde N, Mailankody S, Lesokhin AM, Hultcrantz M, Chung DJ, Giralt S, Landgren O, Hassoun H . Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience . Blood . 2018;132(Suppl . 1)

Pikman Y, Tasian SK, Sulis ML, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown P, Gossai N, Cole P, McNeer J, Shukla N, Winger BA, Adhav AA, Blonquist TM, Conway A, Place AE, Gore L, Hunger SP, Janeway K, Silverman LB, Tyner JW, Harris MH,

Loh ML, Stegmaier K . Matched targeted therapy for pediatric patients with relapsed, refractory or high-risk leukemias: A report from the LEAP Consortium . Blood . 2018;132(Suppl . 1)

Pitroda S, Khodarev N, Huang L, Uppal A, Wightman S, Ganai S, Joseph N, Xue L, Weber C, Segal J, Stack M, Khan S, Paty P, Kaul K, Andrade J, White K, Talamonti M, Posner M, Hellman S, Weichselbaum RR . Integrated molecular subtyping of clinical metastasis: Implications for defining a curable oligometastatic state . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S12- .

Pitter KL, Lee A, Neal B, Chow CHJ, Sine K, Cahlon O, McBride SM, Leeman JE, Riaz N, Waldenberg T, Cohen M, Ganly I, Boyle JO, Wong RJ, Sherman E, Michel L, Lee N, Tsai CJ . Temporal lobe radiation necrosis after primary radiation involving the skull base with proton therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E321- .

Pitter KL, Casey DL, Setton J, Lu C, Rimner A, Reis-Filho J, Powell SN, Lee N, Chan TA, Riaz N . Pathogenic mutations in ATM as determinants of local control in non-small cell lung cancers treated with radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S226- .

Pitter KL, Lee A, Chow CHJ, Sine K, Cahlon O, McBride S, Tsai CJ, Leeman JE, Riaz N, Higginson DS, Waldenberg T, Cohen M, Ganly I, Boyle JO, Wong RJ, Brennan CW, Baxi SS, Sherman E, Michel L, Lee N . Temporal lobe radiation necrosis after primary radiation involving the skull base with proton therapy: An institutional experience . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1394-1395 .

Place AE, Blonquist TM, Stieglitz E, Cooper TM, Gore L, Aplenc R, Loh ML, Pauly M, Rau RE, Burke MJ, Etchin J, Look AT, Sulis ML, Silverman LB .

254 OF 288


Meeting Abstracts

Phase I study of the selinexor in relapsed/refractory childhood acute leukemia . Blood . 2018;132(Suppl . 1)

Planchard D, Janne PA, Yu HA, Moro-Sibilot D, Goldberg T, Gu X, Li J, McGill J, Yu C, Slosberg E . Phase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC . Annals of Oncology . 2018;29(Suppl . 8):mdy292 .127- .

Plotkin S, Tonsgard J, Ullrich N, Allen J, Blakeley J, Rosser T, Clapp D, Campion J, Fisher M, Cutter G, Korf B, Packer R, Thomas C, Karajannis M . Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study . Neurology . 2018;90(15 Suppl .)

Plummer R, Sanborn RE, de Vries EGE, Lorusso P, Arkenau HT, Uboha N, Wydmanski J, Fidler MJ, Boni V, Garcia-Corbacho J, Humphrey R, Will M, Autio KA, El-Khoueiry AB, Menke-van der Houven van Oordt CW, Thistlethwaite F . Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors . Annals of Oncology . 2018;29(Suppl . 8):mdy279 .423- .

Poirier J . Epigenetic targets . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S310- .

Politikos I, Devlin SM, Jacob AG, Maloy M, Mazis C, Naputo K, Afuye A, Scaradavou A, O’Reilly RJ, Avecilla ST, Castro-Malaspina H, Dahi PB, Giralt SA, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Peled JU, Perales MA, Sauter CS, Shaffer BC, Shah GL, Tamari R, van den Brink MRM, Young JW, Ponce DM, Barker JN . Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen . Biology

of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S153-S154 .

Politikos I, Devlin SM, Maloy M, Mazis C, Naputo K, Afuye AO, Scaradavou A, Avecilla ST, Castro-Malaspina HR, Cho C, Dahi PB, Giralt S, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Perales MA, Sauter CS, Scordo M, Shaffer BC, Shah GL, Tamari R, van den Brink MRM, Young JW, Ponce D, Barker J . A high degree of engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies . Blood . 2018;132(Suppl . 1)

Politikos I, Devlin SM, Mazis C, Maloy M, Naputo K, Afuye AO, Bhatt V, Scaradavou A, O’Reilly RJ, Avecilla ST, Castro-Malaspina HR, Cho C, Dahi PB, Giralt S, Gyurkocza B, Hsu KC, Jakubowski AA, Papadopoulos EB, Perales MA, Sauter CS, Scordo M, Shaffer BC, Shah GL, Tamari R, van den Brink MRM, Young JW, Ponce D, Barker J . Double-unit cord blood (CB) transplantation with haplo-identical CD34+ cells (haplo-dCBT) may speed neutrophil recovery although successful bridging is contingent on close haplo-winning CB unit HLA-match . Blood . 2018;132(Suppl . 1)

Pollom E, Qian Y, Dirbas F, Horst K, Tsai CJ . National trends in mastectomy for operable breast cancers

treated with neoadjuvant chemotherapy . Cancer Research . 2018;78(4 Suppl .)

Polvorosa C, Hu Y, Hunt M, Mechalakos J, Zhang P, Fontenla S, Shi C, Li X, Allgood N, McBride S, Riaz N, Lee N, Tsai CJ . A prospective weekly volumetric magnetic resonance imaging (MRI) study of parotid glands and neck nodes in oropharyngeal cancer (OPC) patients treated on a phase II trial of adaptive radiotherapy (ART) . Medical Physics . 2018;45(6):e495- .

Ponce DM, Gomes A, Dierov D, Slingerland J, Gyurkocza B, Pamer EG, Taur Y, Peled JU, van den Brink MRM . High intestinal microbiota diversity is associated with sparing of the lower GI tract in acute GVHD patients . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S62-S63 .

Ponce DM, Peled JU, Gomes A, Jenq RR, Giralt SA, Perales MA, Pamer EG, Taur Y, Paczesny S, Barker JN, van den Brink MRM . Microbiota diversity is inversely correlated plasma concentrations of acute GVHD biomarkers ST2, REG3α and TNFR1 in cord-blood transplant recipients . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S64-S65 .

Pond GR, Sonpavde G, Galsky MD, Sharma P, Rosenberg JE, Choueiri TK, Bellmunt J, Lee JL, Lee S I, Azrilevich A, Yang S, Gooden KM, Bajorin DF . Nivolumab demonstrates benefit over nomogram-predicted 12-month survival as salvage therapy for metastatic urothelial carcinoma . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Pond GR, Niegisch G, Rosenberg JE, Dreicer R, Powles T, Necchi A, Wei XX, Grivas P, Balar A V, Galsky MD, Srinivas S, Choueiri TK, Bellmunt J, Bajorin DF, Sonpavde G . New 6-factor prognostic model for patients (pts) with advanced urothelial carcinoma (UC) receiving post-platinum atezolizumab . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Popat R, Trudel S, Lendvai N, Voorhees P, Reeves B, Libby E, Richardson P, Anderson L Jr, Sutherland H, Yong K, Hoos A, Gorczyca M, Lahiri S, He Z, Jewell R, Opalinska J, Cohen A . Targeting B-cell maturation antigen (BCMA) with GSK2857916 antibody-drug conjugate provides durable responses in patients (Pts) with heavily-pretreated relapsed/refractory multiple myeloma (RRMM): Preliminary results from study BMA117159 . Haematologica . 2018;103(Suppl . 1):30- .

255 OF 288


Meeting Abstracts

Porceddu S, Siddiqui F, Caudell JJ, Koyfman S, Tsai CJ, Liu H, Reddy CA, Joshi N, Geiger JL, Ghanem A I, Schymick MA, Burkey BB, Lamarre E, Adelstein DJ, Lee N, Dunlap N, Woody NM . Loco-regional relapse and predictors of outcome in early stage oral cavity cancers (pT1-2N0) treated with surgical monotherapy with or without neck dissection: A multi-institutional study . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E321-E322 .

Poulos M, Redmond D, Gutkin M, Ramalingam P, Butler JM . Single-cell characterization of the HSC-supportive bone marrow vascular microenvironment . Blood . 2018;132(Suppl . 1)

Powles R, Redmond D, Sotiriou C, Loi S, Fumagalli D, Nuciforo P, Harbeck N, de Azambuja E, Sarp S, Di Cosimo S, Huober J, Baselga J, Piccart-Gebhart M, Elemento O, Hatzis C, Pusztai L . T-cell receptor beta chain variable region (TRBV) expression patterns predict response to combined trastuzumab/lapatinib treatment in the NeoALTTO/BIG-1-06 trial . Cancer Research . 2018;78(4 Suppl .)

Prasad V, Srirajaskanthan R, Grana CM, Baldari S, Shah T, Lamarca A, Courbon F, Scheidhauer K, Baudin E, Truong-Thanh XM, Houchard A, Bodei L . Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs) . Annals of Oncology . 2018;29(Suppl . 8):mdy293 .024- .

Prat A, Brase JC, Cheng Y, Nuciforo P, Paré L, Pascual T, Martínez D, Galvan P, Vidal M, Adamo B, Hortobagyi G, Baselga J, Ciruelos E . PAM50 intrinsic subtype in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) treated with exemestane (EXE) in combination with everolimus (EVE) or placebo (PBO): A correlative analysis of the phase III BOLERO-2 trial . European Journal of Cancer . 2018;92(Suppl . 3):S117- .

Premsrirut PK, Wang CL, Yang YT, Pelossof R, Leslie C, Fellmann C, Dow L, Zuber J, Lowe S . RNAi and CRISPR/Cas9-based in vivo models for drug discovery . Cancer Research . 2018;78(10 Suppl .):73- .

Preston E V, Chinapen S, Borrill T, Davis E, Shaffer BC, Tamari R, Jakubowski AA, Perales MA, Ponce DM, Shah GL, Dahi PB, Barker JN, Berman E, Tallman M, Giralt SA, Stein E, Gyurkocza B . Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S323-S324 .

Preston E V, Malard F, Seier K, Cho C, Devlin SM, Maloy M, Borrill T, Palazzo M, Smith K, Maslak P, van den Brink MRM, Shah GL, Perales MA . Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S360-S361 .

Preston E V, Palazzo MA, Seier K, Devlin SM, Giralt S, Scordo M, Dahi PB, Matasar MJ, Moskowitz CH, Sauter CS, Shah GL, Perales MA . Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell translation . Blood . 2018;132(Suppl . 1)

Prieto C, Nguyen D, Vu LP, Perez A, Gourkanti S, Schurer A, Chou T, Chow A, Taggart J, Barlowe TS, Leslie C, Kharas MG . RNA binding protein RBMX is required in acute myeloid leukemia by regulating the transcriptional activity of the heterochromatin protein HP1 alpha . Blood . 2018;132(Suppl . 1)

Prins R, Mochizuki A, Orpilla J, Lee A, Davidson T, Gaffey S, Sanders C, Rytlewski J, Ellingson B, Li G, Yong W, Clarke J, Arrillaga-Romany I, Colman H, Reardon D, Kaley T, de Groot J, Liau L, Wen P, Cloughesy T . Neoadjuvant anti-PD-1 immunotherapy promotes intratumoral and systemic immune

responses in recurrent glioblastoma: An Ivy Consortium trial . Neuro-Oncology . 2018;20(Suppl . 6):vi3- . PMCID: PMC6216117

Prockop S, Suser S, Doubrovina E, Castro-Malaspina HR, Papadopoulos EB, Sauter CS, Young JW, Szenes V, Slocum A, Baroudy K, O’Reilly RJ . Adoptive therapy with EBV-specific T cells for treatment of CNS EBV post-transplant lymphoproliferative disease arising after hematopoietic stem cell transplant or solid organ transplant . Blood . 2018;132(Suppl . 1)

Prockop SE, Li A, Baiocchi R, Bunin NJ, Mahadeo KM, Nemecek ER, Nikiforow S, Reshef R, Tsai DE, Navarro WH, O’Reilly RJ . Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post transplant lymphoproliferative disorder . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S35-S36 .

Puchalski C, Ferrell B, Foley K, Pettus K, Flohr A . Global palliative care: Improving the quality of spiritual care in global palliative care . Journal of Pain and Symptom Management . 2018;55(2):652- .

Pulvirenti A, Rao D, Tang L, Gonen M, Fleisher M, Reidy-Lagunes D, Allen P . Relevance of serum chromogranin A as diagnostic and prognostic marker for well-differentiated pancreatic neuroendocrine tumors . Pancreas . 2018;47(3):352-353 .

Pulvirenti A, Chakraborty J, Yamashita R, Lawrence SA, McIntyre CA, Midya A, Koszalka MA, Gonen M, Klimstra DS, Reidy DL, Allen P, Do RK, Simpson AL . Quantitative CT analysis for the preoperative prediction of pathologic grade in pancreatic neuroendocrine tumors . Annals of Surgical Oncology . 2018;25(Suppl . 1):S110- .

Radosevic-Robin N, Cocco E, Privat M, Abrial C, Penault-Llorca F, Scaltriti M . Potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy, revealed by genomic

256 OF 288


Meeting Abstracts

analyses and assessment of tumor-infiltrating lymphocytes . Cancer Research . 2018;78(4 Suppl .)

Raffin C, Zhou Y, Piccoli L, Lanzavecchia A, Sadelain M, Tareen SU, Fontenot JD, Bluestone JA . Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis . Journal of Immunology . 2018;200(1 Suppl .)

Rafiq S, Yeku O, Jackson H, Purdon T, van Leeuwen D, Yan S, Wang P, Xiang J, Liu C, Brentjens R . CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy . Molecular Therapy . 2018;26(5 Suppl . 1):439-440 .

Raj NP, Kelly V, Chan JA, Dasari A, Capanu M, Tang L, Reidy DL . A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Rajeeve S, Shah GL, Moskowitz CH, Moskowitz AJ . Survival for relapsed/refractory Hodgkin lymphoma patients with recurrent or persistent disease following autologous hematopoietic stem cell transplantation treated in the modern era . Blood . 2018;132(Suppl . 1)

Raman P, Rathi K, Kalletla K, Zhu Y, Zhang B, Schultz N, Cerami E, Mackay A, Jones C, Mueller S, Nazarian J, Maris JM, Storm PB, Waanders AJ, Resnick AC . PedcBioPortal, a cancer data visualization tool for integrative pediatric cancer analyses . Neuro-Oncology . 2018;20(Suppl . 2):i186- . PMCID: PMC6012612

Ramaswamy K, Forlenza C, Kobos R, Steinherz PG, Shukla N . Clofarabine with topotecan, vinorelbine, and thiotepa (TVTC) in children and young adults with relapsed or refractory acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Rampal RK, Mascarenhas J, Kosiorek HE, Bhave R, Hexner EO, Wang ES, Gerds AT, Heaney ML, Abboud CN, Kremyanskaya M, Berenzon D, Odenike O, Virtgaym E, Sandy L, Weinberg RS, Najfeld V,

Salama ME, Levine RL, Mesa RA, Dueck AC, Hoffman R . Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: Results of a phase II study (MPN-RC109 trial) . Blood . 2018;132(Suppl . 1)

Rampal RK, Verstovsek S, Devlin SM, Stein EM, Kadia TM, Mauro MJ, Pemmaraju N, Alvarez K, Ard N, Goodman T, Marek K, Bose P . Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: Initial results of a phase II study . Blood . 2018;132(Suppl . 1)

Ran L, Murphy D, Sher J, Cao Z, Wang S, Walczak E, Guan Y, Xie Y, Shukla S, Zhan Y, Antonescu CR, Chen Y, Chi P . Modeling sporadic gastrointestinal stromal tumor with BRAFV600E mutation . Clinical Cancer Research . 2018;24(2 Suppl .):43- .

Rana S, Middha S, Chavan S, Penson A, Huberman K, Hampton O, Viale A, Solit D, Berger M, Zehir A . Identification of mutation signatures in tumors using panel-based targeted sequencing . Journal of Molecular Diagnostics . 2018;20(6):915- .

Rathkopf DE, Saleh MN, Tsai FYC, Rosen LS, Adams BJ, Liu L, Theuer CP, Freddo JL, Agarwal N . An open-label phase 1/2a study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in patients with metastatic castration-resistant prostate cancer (mCRPC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Ravindranath B, Cohen G, Episcopia K, Damato A . Use of in vivo dosimeters for catching guide tube errors in HDR prostate brachytherapy . Medical Physics . 2018;45(6):e475-e476 .

Razanamahery J, Diamond E, Cohen-Aubart F, Karl-Heinz P, Charlotte F, Helias-Rodzewicz Z, Dogan A, Abdel-Wahab O, Durham B, Ozkaya N, Amoura Z, Emiles JF, Haroche J . Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1 .

Annals of the Rheumatic Diseases . 2018;77(Suppl . 2):1677- .

Rea D, Lang F, Kim DW, Cortes JE, Hughes TP, Minami H, Breccia M, Deangelo DJ, Hochhaus A, Talpaz M, Goh YT, le Coutre P, Deininger MW, Etienne G, Sondhi M, Mishra K, Aimone P, Ng-Sikorski J, Mauro MJ . Asciminib, a specific allosteric BCR-ABL1 inhibitor, in patients with chronic myeloid leukemia carrying the T315I mutation in a phase 1 trial . Blood . 2018;132(Suppl . 1)

Reardon D, Kaley T, Iwamoto F, Baehring J, Subramaniam D, Rawls T, He Y, Keler T, Yellin M . Anti-CD27 agonist antibody varlilumab in combination with nivolumab for recurrent glioblastoma (rGBM): Phase 2 clinical trial results . Neuro-Oncology . 2018;20(Suppl . 6):vi6- . PMCID: PMC6216117

Reardon D, Kaley T, Dietrich J, Clarke J, Dunn G, Lim M, Cloughesy T, Gan H, Park A, Schwarzenberger P, Ricciardi T, Macri M, Ryan A, Venhaus R . Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab, durva) + bevacizumab (BEV) in bev-naive patients with recurrent glioblastoma (GBM) . Neuro-Oncology . 2018;20(Suppl . 6):vi10- . PMCID: PMC6216117

Reck M, Hellmann MD, Paz-Ares Rodriguez L, Ramalingam SS, Brahmer J, O’Byrne KJ, Bhagavatheeswaran P, Nathan F, Borghaei H . CheckMate 227: Nivolumab (Nivo) + ipilimumab (Ipi) vs platinum-doublet chemotherapy (Chemo) as first-line treatment for advanced non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB) . Oncology Research and Treatment . 2018;41(Suppl . 4):268-269 .

Reidy-Lagunes D, Pandit-Taskar N, Krebs S, O’Donoghue J, Raj NP, Cruz E, Pham H, Lashley A, Bodei L, Weber W . Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201 . Pancreas . 2018;47(3):353- .

257 OF 288


Meeting Abstracts

Reis H, Serrette RN, Gopalan A, Chen YB, Fine SW, Tickoo S, Sirintrapun SJ, Iyer G, Funt SA, Teo MY, Rosenberg JE, Bajorin DF, Solit D, Dalbagni G, Bochner BH, Reuter V, Al-Ahmadie H . PD-L1 expression in urothelial carcinoma with divergent differentiation, concordance among three antibodies . Modern Pathology . 2018;31(Suppl . 2):377-378 .

Reisch S, Polacek LC, Pessin H, DuHamel K, Breitbart W . Extending our reach: Preliminary results disseminating meaning-centered psychotherapy (MCP) across settings & disciplines . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S545- .

Rha SY, Ku GY, Kim HS, Chung HC, Amlashi FG, Maru DM, Fein C, Tang L, Savage MJ, Zhou W, Wu T, Peter SA, Kelsen DP, Ajani JA . PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC) . Annals of Oncology . 2018;29(Suppl . 8):mdy282 .037- .

Rhodes J, Mato AR, Winchell N, Kennard K, Gerson JN, Landsburg DJ, Nasta SD, Svoboda J, Schuster SJ . Characteristics and outcomes of ibrutinib-associated musculoskeletal toxities in CLL patients . Blood . 2018;132(Suppl . 1)

Riaz N, Blecua P, Lim RS, Shen R, Higginson DS, Weinhold N, Norton L, Weigelt B, Powell SN, Reis-Filho JS . Bi-allelic alterations in homologous recombination (HR) DNA repair-related genes as the basis for HR defects in human cancers: A pan-cancer genomics and functional analysis . Cancer Research . 2018;78(4 Suppl .)

Richards R, Cheteyan L, Papadopoulos EB, Jakubowski AA, Castro-Malaspina H, Papanicolaou GA, Lee YJ . High survival rates in adult allogenic hematopoietic cell transplant patients with adenovirus viremia treated with brincidofovir . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S383-S384 .

Richardson P, Ocio E, Oriol A, Larocca A, Otero PR, Moreb J, Blade J, Hassoun H, Cavo M, Alegre A,

Mazumder A, Maisel C, Paner A, Gabrail N, Zonder JA, Chauhan D, Harmenberg J, Thuresson S, Zubairand H, Mateos M V . OP-106 Horizon - Melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide: Updated results and first report on PFS . Blood . 2018;132(Suppl . 1)

Richardson PG, Smith AR, Kernan NA, Lehmann L, Ryan R, Hume R, Tappe W, Grupp SA . Final analysis of day +100 survival by prior hematopoietic stem cell transplant type from an expanded-access study of defibrotide for hepatic veno-occlusive disease/sinusoidal obstruction syndrome . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S316- .

Richardson PG, Smith AR, Kernan NA, Antin JH, Lehmann L, Ryan R, Hume R, Tappe W, Grupp SA . Pooled analysis of day +100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) and ventilator or dialysis dependence following hematopoietic stem cell transplantation (HSCT) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S317-S318 .

Richardson PG, Antin JH, Giralt SA, Ryan R, Liang W, Hume R, Tappe W, Kernan NA . Adults receiving defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final results from the expanded-access program (T-IND) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S300-S301 .

Richter JR, Wermke M, Kauh JS, Back J, Salhi Y, Reddy V, Bayever E, Landgren CO . Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Riely G, Hui R, Carbone D, Park K, Carrigan M, Xu X, Dang T, Yang JCH . Phase 3 study of pemetrexed-platinum with or without pembrolizumab for TKI-resistant/EGFR-mutated advanced NSCLC: KEYNOTE-789 . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S494- .

Riley KE, Kwon D, Ostroff J . Understanding reach and uptake of tobacco cessation treatment delivery in a comprehensive cancer center . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S8- .

Riley KE, Hay JL, Waters E, Kiviniemi MT, Schofield E, Biddle C, Li YL, Orom H . Examining the role of intuitive beliefs about risk in the risk perception-health behavior relationship . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S266- .

Rimm DL, Carvajal-Hausdorf D, Harbeck N, Fumagalli D, Rodrik-Outmezguine V, delaPena L, deAzambuja E, Huober J, Baselga J, Piccart M, Holmes E, Pusztai L . Low levels of HER2 extracellular domain (ECD) compared to intracelluar domain (ICD) in NeoALTTO may segregate benefit from lapatinib and trastuzumab in breast cancer . Cancer Research . 2018;78(4 Suppl .)

Rimner A . From radiation oncology perspective . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S212-S213 .

Rini B I, Huseni M, Atkins MB, McDermott DF, Powles TB, Escudier B, Banchereau R, Liu LF, Leng N, Fan J, Doss J, Nalle S, Carroll S, Li S, Schiff C, Green M, Motzer RJ . Molecular correlates differentiate response to atezolizumab (atezo) plus bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC) . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .037- .

Rini B I, Tannir NM, Escudier B, McDermott DF, Grimm MO, Porta C, Powles T, Kollmannsberger CK, Gurney HP, Tykodi SS, Harrison M, Heng DYC, Grünwald V, Choueiri TK, Mekan S, McHenry MB, Hammers HJ,

258 OF 288


Meeting Abstracts

Motzer RJ, George S . Characterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (pts) with previously untreated advanced renal cell carcinoma (aRCC): CheckMate 214 . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .084- .

Risi E, Biagioni C, Benelli M, Migliaccio I, McCartney A, Bonechi M, Guarducci C, Hilbers F, Di Cosimo S, Baselga J, Romagnoli D, Boccalini G, Vitale S, Grilli A, Bicciato S, Sotiriou C, Biganzoli L, Di Leo A, Malorni L . A RB-1 loss of function gene-signature (RBsig) as a tool to predict response to neoadjuvant chemotherapy (CT) plus anti-HER2 agents (H): A substudy of the NeoALTTO trial (BIG 1-06) . Journal of Clinical Oncology . 2018;36(15 Suppl .):25s- .

Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan WB, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta S V, Wu B, Attar EC, Stone RM . Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant untreated AML: Results from a phase 1 dose escalation and expansion study . Blood . 2018;132(Suppl . 1)

Roboz GJ, Sugita M, Mosquera JM, Wilkes DC, Nataraj S, Jimenez-Flores RA, Bareja R, Yan LB, Eng KW, Croyle JA, MacDonald TY, Noorzad Z, Pancirer D, Cheng S, Xiang JZ, Olson L, Rickman D, Tam W, Rubin MA, Beltran H, Sboner A, Van Besien K, Morgan B, Hassane DC, Elemento O, Chiosis G, Guzman ML . Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Robson M, Hettle R, Degboe A, Saunders O, Cain T, Kilvert H, Johnson H . Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data

collected in the OlympiAD clinical trial . Value in Health . 2018;21(Suppl . 1):S12- .

Rodriguez-Flores JL, O’Beirne SL, Salit J, Kaner RJ, Downey RJ, Mezey JG, Crystal RG . Identification of large clones of potentially deleterious somatic mutations in the small airway epithelium of smokers without cancer . American Journal of Respiratory and Critical Care Medicine . 2018;197

Roeker LE, Kabadi S, Burudpakdee C, Near A, Wada K, Mato AR . Real-world treatment patterns among a contemporary cohort of commercially insured mantle cell lymphoma patients in the United States . Blood . 2018;132(Suppl . 1)

Rognvaldsson S, Thorsteinsdottir S, Turesson I, Bjorkholm M, Landgren O, Kristinsson SY . Peripheral neuropathy is associated with an increased risk of fractures in individuals with monoclonal gammopathy of undetermined significance: A population-based study including 15,351 MGUS cases . Blood . 2018;132(Suppl . 1)

Romanoff A, Petruolo O, El-Tamer M, Zabor E, Morrow M, Barrio A V . Does inflammatory breast cancer have a worse prognosis than other T4 cancers? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S100- .

Romanoff A, Zabor E, Stempel M, Morrow M, Gemignani ML . Effect on re-excision rates after adoption of SSO-ASTRO-ASCO ductal carcinoma in situ (DCIS) margin consensus guidelines . Annals of Surgical Oncology . 2018;25(Suppl . 1):S108- .

Romanoff A, Zabor E, Stempel M, Sacchini V, Pusic A, Morrow M . Long-term patient satisfaction after nipple-sparing mastectomy and conventional mastectomy with reconstruction does not differ significantly . Annals of Surgical Oncology . 2018;25(Suppl . 2):29-30 .

Romero R, Sayin V I, Shawn DM, Bauer M, Singh SX, LeBoeuf S, Karakousi TR, Ellis DC, Bhutkar A,

Sanchez-Rivera F, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, Thomas CJ, Davies A, Dolgalev I, Heguy A, Allaj V, Piorier JT, Moreira AL, Rudin CM, Pass H I, Vander Heiden MG, Jacks T, Papagiannakopoulos T . Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities . Cancer Research . 2018;78(10 Suppl .):50- .

Rondon-Clavo C, Scordo M, Hilden P, Shah GL, Cho C, Maloy M, Papadopoulos EB, Jakubowski AA, O’Reilly RJ, Gyurkocza B, Castro-Malaspina H, Tamari R, Shaffer BC, Perales MA, Jaimes EA, Giralt SA . Early fluid overload is a serious toxicity associated with an increased risk of non-relapse mortality after ex-vivo CD34-selected allogeneic hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S314-S316 .

Rooper L, Jo VY, Antonescu CR, Nosé V, Westra W, Swartz BR, Seethala R, Bishop J . Adamantinoma-like Ewing sarcoma of the salivary glands . Modern Pathology . 2018;31(Suppl . 2):483-484 .

Root CW, Beilin Y, Curatolo C, McCormack P, Hyman J . Differences in anesthesia-related adverse outcomes between geriatric and non-geriatric patients at a large tertiary care center . Journal of the American Geriatrics Society . 2018;66(Suppl . 2):S308- .

Root JC, Rocha-Cadman X, Kasven-Gonzalez N, Campbell C, Maloy M, Flynn J, Devlin SM, Jakubowski AA . Pre-transplant cognitive dysfunction in hematologic cancers, predictors and associated outcomes . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S308- .

Rosenberg J . Immunotherapy for urothelial cancer: Current strategies, new directions, and biomarker approaches . International Journal of Urology . 2018;25(Suppl . 1):80- .

Rosenberg J, Necchi A, Sweis RF, Nakajima K, Lu C, Nogai H . Phase Ib/II study to evaluate the safety,

259 OF 288


Meeting Abstracts

tolerability and pharmacokinetics of rogaratinib in combination with atezolizumab in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer and FGFR mRNA overexpression . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .134- .

Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Ricart Arbona RJ, Monette S, Dyke JP, Ballon DJ, Kaminsky SM, Sondhi D, Petsko GA, Paul SM, Crystal RG . Safety of an AAVrh-mediated APOE2 treatment of Alzheimer’s disease in a large animal model . Molecular Therapy . 2018;26(5 Suppl . 1):137- .

Rosenberg JE, Heath E I, O’Donnell PH, Hahn NM, Balar A V, Gartner EM, Melhem-Bertrandt A, Petrylak DP . EV-201 study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Rosenberg JE, Sharma P, de Braud FGM, Basso U, Calvo E, Bono P, Morse M, Ascierto PA, Lopez-Martin JA, Brossart P, Rohrberg KS, Reguart N, Lin WH, Meadows-Shropshire S, Saci A, Callahan M, Siefker-Radtke AO . Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032 . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .038- .

Rosenberg JE, Balar A, O’Donnell PH, Heath E I, Hahn NM, Cavazos NM, Melhem-Bertrandt A, Petrylak DP . EV-201: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .127- .

Rosenberg JE, Bajorin DF, Smith A, D’Cruz C, Lanasa M . BAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC) . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .138- .

Roseweir AK, Park JH, ten Hoorn S, Powell AGMT, Roxburgh CSD, McMillan DC, Horgan PG, Vermeulen L, Edwards J . Phenotypic subtypes as a novel validated prognostic classification system for patients with colorectal cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Rossi AM, Hibler BP, Nehal KS, Cordova M, Yelamos O . Carbon dioxide laser ablation of basal cell carcinoma guided by reflectance confocal microscopy . Lasers in Surgery and Medicine . 2018;50(Suppl . 29):S34- .

Rowlands M, Mondesire-Crump I, Levin A, Mauguen A, Francis JH, Dunkel I, Brodie SE, Gobin YP, Abramson DH . Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery . Investigative Ophthalmology & Visual Science (IOVS) . 2018;59(9)

Roxburgh C, Strombom P, Lynn P, Paty P, Guillem JG, Nash GM, Smith J, Wei I, Garcia-Aguilar J, Weiser MR . Influence of timing of surgery on perioperative morbidity after neoadjuvant therapy for locally advanced rectal cancer . Annals of Surgical Oncology . 2018;25(Suppl . 1):S6-S7 .

Roxburgh CSD, Strombom P, Lynn PB, Paty P, Guillem JG, Nash GM, Smith JJ, Wei IH, Garcia-Aguilar J, Weiser MR . Influence of timing of surgery on perioperative morbidity after neoadjuvant therapy for locally advanced rectal cancer . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande P V, Efstathiou JA . Comparative effectiveness of bladder-preserving tri-modality

therapy versus radical cystectomy for muscle-invasive

bladder cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E89- .

Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande P, Efstathiou JA . Comparative effectiveness of bladder-preserving tri-modality therapy versus radical cystectomy for muscle-invasive bladder cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Rucker FG, Du L, Blatte TJ, Benner A, Krzykalla J, Gathmann I, Larson RA, Lo-Coco F, Amadori S, Prior TW, Brandwein JM, Appelbaum FR, Medeiros BC, Tallman MS, Geddes M, Sierra J, Tiecke E, Pallaud C, Sanz MA, de Witte TM, Niederwieser D, Ehninger G, Heuser M, Ganser A, Bullinger L, Bloomfield CD, Stone RM, Dohner H, Thiede C, Dohner K . Prognostic impact of insertion site in acute myeloid leukemia (AML) with FLT3 internal tandem duplication: Results from the ratify study (Alliance 10603) . Blood . 2018;132(Suppl . 1)

Rudin C . Biological subsets of SCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S217-S218 .

Rudin C, Cervantes A, Dowlati A, Besse B, Ma B, Costa D, Schmid P, Heist R, Villaflor V, Sarkar I, Hernandez G, Foster P, Spahn J, O’Hear C, Gettinger S . Long-term safety and clinical activity results from a phase Ib study of erlotinib plus atezolizumab in advanced NSCLC . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S407- .

Rudin CM, Pandha HS, Gupta S, Zibelman MR, Akerley W, Day D, Hill AG, Sanborn RE, O’Day SJ, Clay TD, Wright GM, Jennens R, Gerber DE, Rosenberg JE, Ralph C, Campbell DC, Curti BD, Schmidt E V, Grose M, Shafren D . Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients . Annals of Oncology . 2018;29(Suppl . 8):mdy424 .050- .

260 OF 288


Meeting Abstracts

Rudqvist NP, Lhuillier C, Wennerberg E, Sims J, Demaria S . TCR repertoire correlates of response in tumor-bearing mice treated with radiotherapy and CTLA-4 block

adeRudqvis . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Rugo HS, Barry WT, Moreno-Aspitia A, Lyss A, Huebner L, Mayer EL, Naughton M, Layman RM, Carey LA, Somer RA, Toppmeyer D, Velasco M, Perez EA, Hudis CA, Winer E . Long-term follow-up of CALGB 40502/NCCTG N063H (Alliance): A randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) +/- bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer (MBC) . Cancer Research . 2018;78(4 Suppl .)

Ruscetti M, Leibold J, Bott MJ, Shields M, Chen CC, Fennell M, Chen HC, Baslan T, Salgado NR, Manchado E, Low V, Poirier JT, Rudin CM, de Stanchina E, Egeblad M, Sherr CJ, Lowe SW . Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers . Cancer Research . 2018;78(10 Suppl .):51-52 .

Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P Jr, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, Nicholas A, Schulze K, Phan S, Gandhi M, Carbone D . Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Updated results from a multicenter study (LCMC3) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S369- .

Russo AE, Da Silva EM, Kandoth C, Hernandez JM, Van Beek E, Taylor BS, Janjigian YY, Tang LH, Solit D, Strong VE . Copy number gains in HER2 and VEGFα may predict poor outcome in early gastric cancer . Annals of Surgical Oncology . 2018;25(Suppl . 1):S68- .

Rustad EH, Hultcrantz M, Yellapantula VD, Akhlaghi T, Ho C, Arcila ME, Roshal M, Patel A, Devlin SM, Jacobsen A, Huang Y, Miller JE, Papaemmanuil E,

Landgren O . V(D)J sequence capture for DNA-based minimal residual disease detection in multiple myeloma . Blood . 2018;132(Suppl . 1)

Ruuge A, Erdi Y . The influence of monitor periodic GSDF calibration on luminance measurements . Medical Physics . 2018;45(6):e194- .

Ryan CJ, Abida W, Bryce AH, Balar A V, Dumbadze I, Given RW, Morris D, Petrylak DP, Redfern CH, Scher H I, Watkins SP, Simmons A, Passler L, Golsorkhi T, Chowdhury S . TRITON3: An international, randomized, open-label, phase III study of the PARP inhibitor rucaparib vs . physician’s choice of therapy for patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Ryan CJ, Dutta S, Kelly W, Morris MJ, Taplin ME, Halabi S . Androgen decline and outcome in castration resistant prostate cancer (mCRPC) patients treated with docetaxel (Doc), prednisone +/- bevacizumab (B) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .025- .

Safonov A, Pluta J, Qian L, Amaravadi R, Applegate A, Buchbinder E, Cohen J, Friedman C, Halaban R, Hodi FS, Horak C, Johnson D, Kirkwood J, Mitchell T, Robinson W, Schuchter L, Sosman J, Sznol M, Wind-Rotolo M, Wolchok J, Li M, Kanetsky P, Nathanson KL . HLA class I subtypes are associated with immune-related adverse events in patients with melanoma treated with ipilimumab . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):114- . PMCID: PMC6220480

Sakai H, Felip E, Cortot AB, Veillon R, Griesinger F, Patel J, Horn L, Mazieres J, De Castro Carpeno J, Morise M, Sakamoto T, Bruns R, Scheele J, Straub J, Paik P . Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data . Annals of Oncology . 2018;29(Suppl . 9):mdy425 .004- .

Salem H, Andersen EW, Dalton SO, Schmiegelow K, Winther JF, Lichtenthal WG, Johansen C, Bidstrup PE . Risk of first prescription of psychotropic medication in parents of children diagnosed with cancer . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S60-S61 .

Salles G, Ghosh N, Lossos IS, Palomba ML, Mehta A, Casasnovas O, Stevens D, Abajo A, Nielsen T, Chitra S, Wenger M, Morschhauser F . Atezolizumab in combination with obinutuzumab and lenalidomide demonstrates favorable activity and manageable toxicity in patients with relapsed/refractory follicular lymphoma (FL): An interim analysis of a phase Ib/II trial . Blood . 2018;132(Suppl . 1)

Salner AL, Baxi SS, Fortier E, Salz T . Tailored survivorship care plans for head and neck cancer patients . Journal of Clinical Oncology . 2018;36(7 Suppl .)

Sanchez-Escamilla M, Hilden P, Maloy M, Fatmi SA, Ponce D, Sauter CS, Giralt S, Perales MA . The prognostic calculator EASIX predicts acute GVHD, non-relapse mortality and overall survival in adult patients undergoing reduced intensity conditioning allogeneic HCT . Blood . 2018;132(Suppl . 1)

Sandhu S, Nghiem P, Bhatia S, Brohl AS, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Hennessy M, Bajars M, Hicking C, D’Angelo SP . Two-year efficacy and safety update from JAVELIN Merkel 200 Part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy . Asia-Pacific Journal of Clinical Oncology . 2018;14(Suppl . 3):52-53 .

Sandhu S, Flower A, Geyer M, Harrison L, Shi Q, Pulsipher M, Giller R, Morris E, Klejmont L, Ayello J, Van De Ven C, Zhang X, Gurney J, Lowe LAB, Cairo M . A comparison of immune reconstitution following human placenta-derived stem cells (HPDSC) with umbilical cord blood transplantation (UCBT) vs .

261 OF 288


Meeting Abstracts

UCBT alone in pediatric recipients with malignant and non-malignant diseases . Journal of Clinical Immunology . 2018;38(3):334-335 .

Sandler KA, Chu F I, Ciezki JP, Stock R, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa E I, Pomerantz M, Ross A, Tran PT, Nguyen PL, Wedde TB, Lilleby W, Krauss D, Alam R, Steinberg ML, Horwitz EM, King CR, Kishan AU . Clinical outcomes following biochemical recurrence among patients with Gleason score 9-10 prostate adenocarcinoma . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Santomasso B, D’Angelo S . Anti-CRMP5-associated paraneoplastic neurologic syndrome developing in a patient with metastatic Merkel cell carcinoma during immune checkpoint inhibitor treatment . Neurology . 2018;90(15 Suppl .)

Santomasso B, Park JH, Riviere I, Mead E, Li D, Senechal B, Purdon T, Halton E, Diamonte C, Sadelain M, Brenjens R . Neurotoxicity associated with CD19-specific chimeric antigen receptor T cell therapy for adult acute lymphoblastic leukemia (B-ALL) . Neurology . 2018;90(15 Suppl .)

Santos FPS, Getta B, Masarova L, Famulare C, Schulman J, Puga RD, Paiva RDA, Hamerschlak N, Kantarjian HM, Levine RL, Campregher P V, Rampal RK, Verstovsek S . Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF) . Blood . 2018;132(Suppl . 1)

Santos FPS, Getta B, Masarova L, Famulare C, Schulman J, Datoguia TS, Goncalves GAR, Hamerschlak N, Kantarjian HM, Levine RL, Campregher P V, Rampal RK, Verstovsek S . A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF) . Blood . 2018;132(Suppl . 1)

Saracino R . Understanding depression subtypes among adult oncology patients via latent profile analysis . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S309- .

Sarungbam J, Isharwal S, Chen YB, Gopalan A, Fine SW, Tickoo S, Sirintrapun SJ, Jadallah S, Loo F, Pietzak EJ, Cha EK, Dalbagni G, Bochner BH, Iyer G, Berger MF, Solit D, Reuter V, Al-Ahmadie H . Molecular pro

filing of urothelial papilloma and inverted papilloma of the bladder . Modern Pathology . 2018;31(Suppl . 2):382- .

Sarva H, Hellmers N, Ellsworth H, De Melo-Martin I, Henchcliffe C . Improving informed consent for high risk early phase clinical trials: A systematic review of tested interventions . Molecular Therapy . 2018;26(5 Suppl . 1):142- .

Satty A, Kahn S, Lehrman R, Boulad F, Kernan N, Papadopoulos E, Prockop S . The role of tonsillectomy in patients with localized Epstein-Barr Virus-related post-transplant lymphoproliferative disorder . Pediatric Blood and Cancer . 2018;65(S1):S280-S281 .

Saussele S, Shah N, García-Gutiérrez J V, Jiménez-Velasco A, Larson S, Rea D, Mahon FX, Levy MY, Gomez-Casares MT, Pane F, Nicolini FE, Mauro MJ, Sy O, Martin-Regueira P, Lipton JH . Treatment-free remission (TFR) in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) . Oncology Research and Treatment . 2018;41(Suppl . 4):138-139 .

Sauter J . Diagnosis of mesothelioma based on cytology alone . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S193-S194 .

Scaltriti M . Why is PI3K so hard? . Annals of Oncology . 2018;29(Suppl . 3):mdy046 .014- .

Scher H I, Graf RP, Schreiber NA, Winquist E, McLaughlin B, Lu D, Orr S, Fleisher M, Lowes L, Anderson AKL, Wang Y, Dittamore R V, Allan AL, Attard G, Heller G . Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Scher H I, Graf RP, Hulling M, Carbone E, Dittamore R . Use of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .045- .

Schizas M, Lee JY, Selenica P, Geyer F, Piscuoglio S, Sakr RA, Ng CK, Lim RS, Carniello J V, Towers R, Martelotto LG, Giri D, Papanastasiou A, Viale A, Solit D, Weigelt B, Reis-Filho J, King T . Lobular carcinomas in situ display intra-lesion genetic heterogeneity and clonal evolution in the progression to invasive disease . Modern Pathology . 2018;31(Suppl . 2):103- .

Schmidinger M, Tannir NM, Powles T, Escudier BJ, Donskov F, Grünwald V, Sternberg CN, Schoffski P, Szczylik C, Peltola KJ, Nosov D, Melichar B, Clary DO, Scheffold C, Motzer RJ, Choueiri TK . Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):200- .

Scordo M, Morjaria SM, Bhatia A, Littman E, Maloy M, DeAngelis L, Giralt SA, Taur Y, Sauter CS . Patients with central nervous system lymphoma (CNSL) undergoing thiotepa, busulfan, cyclophosphamide-conditioned autologous stem cell transplantation (TBC-ASCT) are at a higher risk for DNA virus infections than patients receiving traditional

262 OF 288


Meeting Abstracts

conditioning . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S37-S38 .

Scordo M, Bhatt V, Smith M, Thoren K, Hilden P, Cho C, Shah GL, Maloy M, Papadopoulos EB, Jakubowski AA, O’Reilly RJ, Castro-Malaspina H, Tamari R, Shaffer BC, Perales MA, Giralt SA . Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S71-S72 .

Scordo M, Shah GL, Preston E V, Rodriguez N, Lin A, Maloy M, Mastrogiacomo B, Carlow D, Schofield R, Knezevic A, Devlin SM, Landau HJ, Chung DJ, Peled JU, Buchan ML, Giralt S . Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma . Blood . 2018;132(Suppl . 1)

Scott AC, Philip M, Camara S, Shakiba M, Levy O, Glickman M, Chang K, Schietinger A . The role of thymocyte selection-associated HMG box protein (TOX) in CD8 T cell differentiation and dysfunction . Journal of Immunology . 2018;200(1 Suppl .)

Segura SE, Bi R, Kumar R, Vidal A, Gatius S, Abu-Rustum N, Matias-Guiu X, DeLair D, Weigelt B . Hotspot TERT promoter mutations in adult-type granulosa cell tumors of the ovary as potential drivers of progression . Modern Pathology . 2018;31(Suppl . 2):451- .

Sehn LH, Kamdar M, Herrera AF, McMillan A, Flowers C, Kim WS, Kim TM, Özcan M, Demeter J, Hertzberg M, Trněný M, Salles GA, Davies A, Hirata JH, Cheng J, Ku G, Matasar MJ . Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL . Journal of Clinical Oncology . 2018;36(15 Suppl .):401s- .

Sehn LH, Herrera AF, Matasar MJ, Kamdar M, Assouline S, Hertzberg M, Kim TM, Kim WS, McMillan A, Ozcan M, Hirata JM, Penuel E, Cheng J, Ku G, Flowers CR . Polatuzumab vedotin (pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Updated results of a phase (Ph) Ib/II study . Blood . 2018;132(Suppl . 1)

Seiter D, Miller B, Fung E, Cheal S, Maitrejean S, Zanzonico P, Larson S, Solomon S, Humm JL, Furenlid LR, Kirov AS . Particle counting autoradiography of radioactive biopsy specimens . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S711- .

Seiverling E, Ahrns H, Butt M, Khalsa A, Yelamoso O, Dusza S, Marghoob A . Teaching benign skin lesions to family physicians as a strategy to improve the triage amalgamated dermoscopic algorithm . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S88- .

Senechal B, Baptiste R, Wasielewska T, Riviere I . Validation of a fluorescence-based staining method to determine CAR T-cell products viability . Molecular Therapy . 2018;26(5 Suppl . 1):291- .

Senechal B, Wasielewska T, Baptiste R, Riviere I . Sensitive QPCR approach to monitor CAR T-cell persistence and expansion in patient’s samples . Molecular Therapy . 2018;26(5 Suppl . 1):416- .

Senkus-Konefka E, Domchek SM, Im SA, Xu B, Armstrong A, Masuda N, Delaloge S, Li W, Tung N, Conte P, Wu W, Goessl C, Runswick S, Robson M . Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD . European Journal of Cancer . 2018;92(Suppl . 3):S19-S20 .

Sequeira A, Mao D, Chen X, Avila E, Mead E, Sauter CS, Palomba ML, Dahi PB, Batlevi CL, Shah G, Chan

J, Giralt SA, Perales MA, Santomasso BD . Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC) . Neuro-Oncology . 2018;20(Suppl . 6):vi194-vi195 . PMCID: PMC6216117

Shaffer K, Applebaum A, DuHamel K, Garland S, Gehrman P, Mao J . “Folk theories” of the causes of insomnia among cancer survivors: Associations with survivor characteristics . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S12- .

Shaffer K, Schofield E, Diefenbach MA, Nelson C . Decisional conflict about treatment is persistent in men with low-grade prostate cancer and their close allies after diagnosis . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S206- .

Shah GL, Landau H, Sarubbi C, Schofield R, Lin A, Bhatt V, Harnicar S, Devlin SM, Castro-Malaspina H, Chung DJ, Dahi PB, Gyurkocza B, Koehne G, Matasar MJ, Moskowitz CH, Papadopoulos EB, Sauter CS, Shaffer BC, Tamari R, Carlow D, Giralt SA . Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S79-S80 .

Shah GL, Lin A, Schofield R, Sarubbi C, Preston E V, Devlin SM, Bhatt V, Harnicar S, Hoover E, Chung DJ, Dahi PB, Koehne G, Tamari R, Wang P, Giese R, Carlow D, Giralt SA, Landau H . Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S127-S128 .

263 OF 288


Meeting Abstracts

Shah GL, Seier K, Devlin SM, Chung DJ, Scordo M, Hultcrantz M, Korde N, Lendvai N, Lesokhin AM, Mailankody S, Smith EL, Landgren O, Landau HJ, Giralt S . Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation . Blood . 2018;132(Suppl . 1)

Shah GL, Park JH, Sauter CS, Duck E, Halton E, Palomba ML, Batlevi CL, Younes A, Geyer MB, Smith EL, Mailankody S, Mead E, Santomasso B, Perales MA, Sabbatini P, Giralt S, Brentjens RJ, Bach P . Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies . Blood . 2018;132(Suppl . 1)

Shah N, Jasra S, Acuna-Villaorduna A, Shah UA, Kaur G, Kazemi M, Mantzaris I, Shastri A, Derman O, Kornblum N, Braunschweig I, Verma A, Janakiram M . Plasma cell dyscrasias in HIV, epidemiology, presentation and treatment characteristics and its strong association with hepatitis C - Report form a large HIV cohort . Blood . 2018;132(Suppl . 1)

Shah NP, Garcia-Gutierrez J V, Jimenez-Velasco A, Larson S, Saussele S, Rea D, Mahon FX, Levy MY, Gomez-Casares MT, Pane F, Nicolini FE, Mauro MJ, Sy O, Martin-Regueira P, Lipton JH . Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) . British Journal of Haematology . 2018;181(Suppl . 1):5- .

Shah NP, Garcia-Gutiérrez J V, Jiménez-Velasco A, Larson S, Saussele S, Rea D, Mahon FX, Levy MY, Gomez-Casares MT, Pane F, Nicolini FE, Mauro MJ, Sy O, Martin-Regueira P, Lipton JH . Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S220-S221 .

Shah NP, Gutiérrez JVG, Jiménez-Velasco A, Larson S, Saussele S, Rea D, Mahon FX, Levy MY, Gomez-Casares MT, Pane F, Nicolini FE, Mauro MJ, Sy O, Regueira PM, Lipton JH . Updated 18-month results from DASFREE: A study evaluating dasatinib discontinuation in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR) . Blood . 2018;132(Suppl . 1)

Shah UA, Shah N, Qiao B, Villaorduna AA, Shastri A, Mantzaris I, Derman O, Kornblum N, Braunschweig I, Ye BH, Verma A, Janakiram M . The rising number of adult T cell leukemia lymphoma (ATLL) cases in non-Hispanic blacks and its association with poor outcomes . Blood . 2018;132(Suppl . 1)

Shahi M, Eguchi T, Zauderer M, Travis W, Jungbluth A, Frosina D, Fayad M, Asher M, Adusumilli PS, Ladanyi M, Sauter JL . Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM) . Modern Pathology . 2018;31(Suppl . 2):750-751 .

Shaigany S, Busam K, Horst B . Genetic overlap between primary dermal melanoma and cutaneous melanoma metastases . Modern Pathology . 2018;31(Suppl . 2):209- .

Shakiba M, Philip M, Camara S, Socci ND, Schietinger A . The impact of TCR affinity on T cell differentiation and dysfunction in tumors . Journal of Immunology . 2018;200(1 Suppl .)

Shanafelt TD, Wang V, Kay NE, Hanson CA, O’Brien SM, Barrientos JC, Erba HP, Stone RM, Litzow MR, Tallman MS . A randomized phase III study of ibrutinib (PCI-32765)-based therapy vs . standard fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in untreated younger patients with chronic lymphocytic leukemia (CLL): A trial of the ECOG-ACRIN Cancer Research Group (E1912) . Blood . 2018;132(Suppl . 1)

Sharma P, Tykodi SS, Escudier B, Carducci M, Oudard S, Hammers HJ, George S, Gauna DC, Alva AS, Richardet ME, Chevreau C, Plimack ER, Srinivas S, Procopio G, Sosman JA, McDermott D, Choueiri TK, Gauler T, Berghorn E, Yang L, Motzer R . Three-year efficacy and safety update from the phase III Checkmate 025 study of nivolumab (NIVO) v everolimus (EVE) in patients with advanced renal cell carcinoma (aRCC) . Oncology Research and Treatment . 2018;41(Suppl . 1):78- .

Sharma P, Callahan MK, Bono P, Kim JW, Spiliopoulou P, Calvo E, Pillai RN, Ott PA, De Braud FG, Morse M, Le DT, Taylor MH, Bendell JC, Jager D, Chism DD, Antonia SJ, Aanur N, Yang L, Rosenberg JE . Nivolumab monotherapy in metastatic urothelial carcinoma: Longer-term efficacy and safety results from the CheckMate 032 study . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Sharman J, Barrientos JC, Brander DM, Pagel JM, Gutierrez M, Kadish K, Tomlinson B, Ghosh N, Giafis N, Ipe D, Upasani S, Sundaram M, Ferrante L, Amaya-Chanaga C, Iyengar R, Mato AR . Chronic lymphocytic leukemia treatment patterns, dosing, and sequencing in the era of novel targeted therapies: Interim analysis results from the prospective informCLL (TM) real-world registry . Blood . 2018;132(Suppl . 1)

Shepherd A, Gelblum D, Wu A, Rimner A . Outcomes of hypofractionated radiation therapy (HFRT) with concurrent chemotherapy in patients with stage III non small cell lung cancer (NSCLC) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S661-S662 .

Shepherd A, Gelblum D, Wu A, Rimner A . The role of post-operative radiation therapy in patients with locally advanced NSCLC after nodal down-staging with systemic chemotherapy . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S661- .

Shepherd AF, Wild A, Wu AJ, Gelblum D, Rimner A . Patterns of care and outcomes of hypofractionated radiation therapy (HFRT) alone in patients with stage

264 OF 288


Meeting Abstracts

III non-small cell lung cancer (NSCLC) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E705- .

Sheth N, Osborn VW, Adedoyin P, Safdieh J, Schreiber DP Jr . Hepatocellular carcinoma: Patterns of care and outcomes for patients receiving stereotactic radiation therapy . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E62- .

Shi C, Lim S, Chan M . Evaluation of a transmission detector on IMRT QA using Structure SIMilarity index (SSIM) . Medical Physics . 2018;45(6):e500- .

Shipman WD, Izmirly PM, Sharma S, Magro CM, Granstein RD, Kaplan DH, Mehrara BJ, Young JW, Clancy RM, Lu TT . A protective Langerhans cell-keratinocyte axis exists that is dysfunctional in photosensitivity . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB20- .

Shipman WD, Chyou S, Ramanathan A, Izmirly PM, Sharma S, Pannellini T, Dasoveanu D, Qing X, Magro C, Granstein R, Lowes M, Pamer E, Kaplan D, Salmon JE, Mehrara B, Young J, Clancy RM, Blobel C, Lu TT . A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity . Arthritis & Rheumatology . 2018;70(Suppl . 9)

Shitara K, Tabernero J, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Ganea D, Yalcin S, Fujitani K, Beretta G, Winkler R, Doi T, Ilson DH . Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS) . Annals of Oncology . 2018;29(Suppl . 9):mdy432 .027- .

Shukla S, Cyrta J, Murphy D, Walczak E, Ran LL, Agrawal P, Xie Y, Chen Y, Wang S, Zhan Y, Wong WPE, Sboner A, Beltran H, Mosquera JM, Sher J, Cao Z, Wongvipat J, Koche RP, Gopalan A, Zheng D, Rubin M, Scher H I, Chi P, Chen Y . Aberrant activation

of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance . Cancer Research . 2018;78(16 Suppl .):65- .

Shyu I, Wang X, Robila V, Mehra R, McHugh J, Chen YB, Udager A, Gill A, Cheng L, Amin M, Smith S . Fumarate hydratase-deficient renal cell carcinoma: Aspiration and effusion cytologic features . American Journal of Clinical Pathology . 2018;149(Suppl . 1):S39-S40 .

Siddiqi T, Abramson JS, Palomba ML, Gordon L I, Lunning MA, Arnason JE, Wang M, Forero-Torres A, Maloney DG, Heipel M, Smith J, Brown W, Karimi M, Xie B, Li D, Albertson T, Garcia J, Dave K, DeVries T, Sutherland C . Correlation of patient characteristics and biomarkers with clinical outcomes of JCAR017 in R/R aggressive BNHL (TRANSCEND NHL 001 study) . Journal of Clinical Oncology . 2018;36(5 Suppl .)

Sidiqi BU, Wang C, Dawson M, Wu AJ . Analysis of “gap year” prevalence, productivity, and funding among radiation oncology residency applicants . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E397-E398 .

Sigel CS, Werneck Krauss Silva V, Reid M, Chhieng D, Sigel K, Basturk O, Daniel T, Klimstra D, Tang L . Cytologic features of well differentiated G3 pancreatic neuroendocrine tumors . Modern Pathology . 2018;31(Suppl . 2):175- .

Simoes PK, Schattner MA, Gerdes H, Shah P, Kurtz RC, Mendelsohn R . Endoscopic biliary stenting for malignant biliary obstruction is technically successful in patients with pre-existing duodenal stents . Gastrointestinal Endoscopy . 2018;87(6 Suppl .):AB597- .

Singer S . Integrin-α10 drives metastasis and sarcomagenesis in mxyofibrosarcoma and undifferentiated pleomorphic sarcoma . Clinical Cancer Research . 2018;24(2 Suppl .):23- .

Sirintrapun SJ, Gopalan A, Al-Ahmadie H, Chen YB, Fine SW, Tickoo S, Teplov A, Tabata K, Reuter V, Yagi Y . Three-dimensional morphology of the prostate by MicroCT . Modern Pathology . 2018;31(Suppl . 2):598-599 .

Sklar B, Gervasio KA, Kaur K, Sivak M, Wu A . Multi-electrode recording as a novel technique in electromyography of the orbicularis oculi muscle . Investigative Ophthalmology & Visual Science (IOVS) . 2018;59(9)

Sklar C . Hypogonadism in girls after cancer therapy: Causes, diagnosis, and treatment . Hormone Research in Paediatrics . 2018;90(Suppl . 1):6- .

Slingluff CL, Zarour HM, Postow MA, Friedlander PA, Devoe CE, Smith K, Deacon D, Macri MJ, Ryan A, Venhaus RR, Wolchok JD . Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma . Journal of Clinical Oncology . 2018;36(15 Suppl .)

Slovin SF, Melloni C, Mansor-Lefebvre S, Neijber A, Roe M . A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Small B, Jim H, Ahles T, Luta G, McDonald BC, Nudelman KNH, Tometich D, Mandelblatt J . Leisure activities and cognitive performance among older breast cancer patients and non-cancer controls . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S474- .

Smith EL . Novel CAR T cells for multiple myeloma . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S134-S136 .

Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long T, Ghoddusi M, Purdon TJ, Do T, Wang

265 OF 288


Meeting Abstracts

X, Pham M, Brown JM, Peguero E, De Larrea CF, Wang P, Liu H, Xu Y, Garrett S, Almo S, Riviere I, Liu C, Sather BD, Brentjens RJ . CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma . Blood . 2018;132(Suppl . 1)

Smith M, Littmann ER, Slingerland JB, Clurman A, Slingerland AE, Taur Y, Schluter J, Park JH, O’Cearbhaill R, Mailankody S, Smith EL, Palomba ML, Yeku O, Peled JU, Halton E, Diamonte C, Chan J, Hall M, Anant P, Kane P, Giralt S, Riviere I, Brentjens RJ, Pamer EG, van den Brink MRM . Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity . Blood . 2018;132(Suppl . 1)

Smyth LM, Oliveira M, Ciruelos E, Tamura K, El-Khoueiry A, Mita A, You B, Renouf DJ, Sablin MP, Lluch A, Mayer IA, Bando H, Yamashita H, Ambrose H, de Bruin E, Carr TH, Corcoran C, Foxley A, Lindemann JPO, Maudsley R, Pass M, Rutkowski A, Schiavon G, Banerji U, Scaltriti M, Taylor BS, Chandarlapaty S, Baselga J, Hyman DM . AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer . Cancer Research . 2018;78(4 Suppl .)

Snuderl M, Kannan K, Pfaff E, Wang S, Stafford J, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton S, Zagzag D, Chiriboga L, Gardner S, Wisoff J, Golfinos J, Capper D, Hovestadt V, Rosenblum M, Placantonakis D, LeBoeuf S, Papagiannakopoulos T, Chavez L, Ahsan S, Eberhart C, Pfister S, Jones D, Karajannis M . Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP containing the ancestral DUF1220 domain in pineoblastoma . Neuro-Oncology . 2018;20(Suppl . 2):i69- . PMCID: PMC6012612

Soff GA, Batista J, Sarasohn DMM, Mones J V, Wilkins C, Haegler-Laube ES, Devlin SM, Miao Y, Bendheim G, Wills J, Mantha SH . Cancer-associated thrombosis: Anatomic distribution of the index event is not a reliable predictor of recurrence risk . Blood . 2018;132(Suppl . 1)

Soff GA, Sarasohn DMM, Haegler-Laube ES, Devlin SM, Miao Y, Bendheim G, Batista J, Wills J, Mones J V, Wilkins C, Mantha SH . Safe and effective use of rivaroxaban for treatment of cancer associated venous thromboembolic disease . Blood . 2018;132(Suppl . 1)

Soliman HH, Robson ME, Wagner S, Flake DD, Schwartzberg LS, Sharma P, Magliocco AM, Kronenwett R, Lancaster JM, Lanchbury JS, Gutin A, Gradishar WJ . In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer . Journal of Clinical Oncology . 2018;36(15 Suppl .):17s- .

Solit DB . Defining the actionable genome . Cancer Science . 2018;109(Suppl . 1):797- .

Solomon BJ, Martini JF, Ou SH I, Chiari R, Soo RA, Bearz A, Li S, Thurm H, Lin CC, Riely GJ, Bauer TM, Shaw AT . Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations . Annals of Oncology . 2018;29(Suppl . 8):mdy292 .003- .

Solomon JP, Gupta S, Zehir A, Berger MF, Arcila ME, Ladanyi M, Dogan S . Molecular epidemiology of CREBBP and EP300 mutations in solid tumors . Journal of Molecular Diagnostics . 2018;20(6):973-974 .

Song Q, Wu X, Zeng D, Jenq RR, Van den Brink MRM, Riggs AD, Chen Y, Zeng D . Tc17 cells mediate gut GVHD via IL-22 and dysbiosis . Journal of Immunology . 2018;200(1 Suppl .)

Song Q, Wu X, Zeng D, Xu S, Jenq RR, van den Brink MRM, Riggs AD, Chen Y, Zeng D . Tc17 cells mediate gut GVHD via IL-22 and dysbiosis . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S51-S52 .

Song Y, Velton C, Tang X, Saleh Z, Zhang M, Mueller B, Mychalczak B . Investigation of off-isocenter field misalignment in single-isocenter multiple-target

VMAT SRS and its implication on CTV margin . Medical Physics . 2018;45(6):e508- .

Song Y, Zhu H, Tang X, Voros L, Zhang M, Saleh Z, Jeong J, Cai W, Mueller B, Mychalczak B . Determination of evidence-based action thresholds for DIBH treatment monitored with 3D optical surface imaging system . Medical Physics . 2018;45(6):e151- .

Song Y, Zhu HJ, Tang X, Zhang M, Laguna J, Saleh Z, Jeong J, Cai W, Mueller BA, Mychalczak BR . A practical algorithm to improve tracking accuracy of symmetric body surface using optical surface imaging system . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E482-E483 .

Sonnenblick A, Bailey A, Uziely B, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Cameron D, Bell R, Zardavas D, Al-Sakaff N, Gelber R, Dowsett M, Leyland-jones B, Piccart M, de Azambuja E . Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial . Annals of Oncology . 2018;29(Suppl . 8):mdy270 .213- .

Sotiriou C, Rothé F, Maetens M, Fumagalli D, Brown DN, Salgado R, Bradbury I, Pusztai L, Harbeck N, Ignatiadis M, Sarp S, de la Pena L, de Azambuja E, Huober J, Nuciforo P, Baselga J, Piccart M, Loi S, Venet D . Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: Results from the NeoALTTO phase III trial . Cancer Research . 2018;78(4 Suppl .)

Soumerai JD, Pagel JM, Jagadeesh D, Salman HS, Kenkre VP, Asch AS, Stathis A, Reddy NM, Iasonos A, Ghalie R, Zelenetz AD . Initial results of a dose escalation study of a selective and structurally differentiated PI3K-δ delta inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) . Journal of Clinical Oncology . 2018;36(15 Suppl .):404s- .

266 OF 288


Meeting Abstracts

Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, Kay NE, Shanafelt TD, Chaffee KG, Furman RR, Hillmen P, Sharman J, Seymour JF, Chanan-Khan AA, Byrd JC, Jones JA, Ferrante LA, Dreiling LK, Mobasher M, Stark T, Reddy V, Howes AJ, James D, Bhargava P, Zelenetz AD . Risk model for overall survival for patients with relapsed/refractory chronic lymphocytic leukemia: Validated for patients on ibrutinib, idelalisib, venetoclax, or chemoimmuniotheraphy . Blood . 2018;132(Suppl . 1)

Spanheimer P, Murray M, Zabor E, Stempel M, Morrow M, Van Zee K, Barrio A . Long-term outcomes after surgical treatment of malignant phyllodes tumors . Annals of Surgical Oncology . 2018;25(Suppl . 2):178-179 .

Sparano JA, O’Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang C, Sledge GW Jr, Miller KD . Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer . Cancer Research . 2018;78(4 Suppl .)

Specht J, Pusztai L, Forero-Torres A, Mita M, Weise A, Krop I, Grosse-Wilde A, Wang Z, Li M, Hengel S, Garfin P, Means G, Onsum M, Modi S . Post-treatment biopsies show evidence of cell cycle arrest and immune cell infiltration into tumors of ladiratuzumab vedotin-treated advanced breast cancer patients . Annals of Oncology . 2018;29(Suppl . 8):mdy272 .278- .

Sperduto PW, Fang P Sr, Li J, Breen W, Brown PD, Cagney DN, Myrehaug SD, Jain S, Cameron B, Molitoris JK, Wu CC, Lockney NA, Parkhurst JR, Shanley R, Tandberg DJ, Shi DD, Chuong MD, Saito H, Masucci L, Mehta MP . Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E314-E315 .

Spevak C, Elias H, Kannan L, Martin G, Selvaraj S, Eng W, Ernlund A, Rajasekhar V, Woolthuis C, Schneider R, Park CY . mTOR-independent translation in early

hematopoietic development . Blood . 2018;132(Suppl . 1)

Spitzer B, Gundem G, Farnoud N, Millard N, McGovern E, Patel M, Levine M, Medina J, Zhou Y, Arango Ossa JE, Walsh MF, Levine RL, Cheung IY, Armstrong SA, Cheung NK V, Papaemmanuil E . Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols . Blood . 2018;132(Suppl . 1)

Spraggon L, Hmeljak J, Magnan H, Somwar R, Asher M, Hartono AB, Lee SB, Ladanyi M . Therapeutic potential of NTRK3 in desmoplastic small round cell tumor . Clinical Cancer Research . 2018;24(2 Suppl .):61- .

Spraggon L, Martelotto L, Hmeljak J, Hitchman T, Wang J, Wang L, Slotkin E, Fan PD, Reis-Filho J, Ladanyi M . Modeling of oncogenic chromosomal translocations of aggressive fusion-positive sarcomas by CRISPR-Cas9 genomic engineering . Clinical Cancer Research . 2018;24(2 Suppl .):46-47 .

Spratt DE, Alshalalfa M, Weiner A, Fishbane N, Mehra R, Walter R, Erho N, Dicker A, Freedland SJ, Karnes J, Glass A, Weinmann S, Davicioni E, Ross A, Den RB, Feng FY, Schaeffer EM . Transcriptomic heterogeneity of androgen receptor activity in primary prostate cancer: Identification and characterization of a low AR-active subclass . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Spriggs D, O’Cearbhaill R, Yeku O, Stasenko M, Rao TD, Brentjens R . Strategies for glycosylation-based immunotargeting of MUC16 . Clinical Cancer Research . 2018;24(15 Suppl .):26-27 .

Srivastava AK, Paria BC, Chandran S, Kammula US . T cell co-stimulation reprograms the metabolic fitness of highly differentiated CD8+T cells for improved adoptive T-cell therapy . Journal of Immunology . 2018;200(1 Suppl .)

Stabile C, Pusic A, Simon B, Stein D, Stetson P, Salvaggio R, Vickers A, Lilavois M, Laudone V, Twersky R, Levine M, Carter J, Dueck A, Basch E, Temple L . The electronic collection of patient-reported outcomes (PROs) to assess symptom burden after ambulatory cancer surgery . Quality of Life Research . 2018;27(Suppl . 1):S25-S26 .

Stabile C, Temple LKF, Simon BA, Stetson PD, Stein D, Vickers AJ, Pusic A . Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: A randomized controlled trial . Journal of Clinical Oncology . 2018;36(15 Suppl .):378s- .

Stacchiotti S, Blay JY, Jones RL, Demetri GDD, Mir O, Italiano A, Thomas D, Chen TWW, Schöffski P, Gil T, Jahan T, Cote G, Ratan R, Attia S, Roche M, Daigle S, Sapir I, Clawson A, Gounder M . A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950) . Annals of Oncology . 2018;29(Suppl . 8):mdy299 .010- .

Staffas A, Burgos da Silva M, Slingerland AE, Lazrak A, Docampo M, Shono Y, Durham B, Cross JR, Pickard A, Stein-Thoeringer C, Velardi E, Tsai JJ, Jahn L, Jay H, Lieberman S, Smith OM, Pamer EG, Peled JU, Jenq RR, van den Brink MRM . Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S75- .

Stecklein SR, Rosso KJ, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA . Excellent locoregional control in inflammatory breast cancer with a personalized radiation therapy approach . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E574- .

Stein E, Dinardo CD, Jang JH, Miyazaki Y, Martinez RO, Auer J, Zhang V, Koralek DO, Wu B . AGILE: A phase 3, multicenter, randomized, placebo-controlled study of ivosidenib in combination with azacitidine

267 OF 288


Meeting Abstracts

in adult patients with previously untreated acute myeloid leukemia with an IDH1 mutation . Journal of Clinical Oncology . 2018;36(15 Suppl .):397s- .

Stein EM, DiNardo CD, Fathi AT, Mims AS, Pratz KW, Savona MR, Stein AS, Stone RM, Winer ES, Seet CS, Dohner H, Pollyea DA, McCloskey JK, Odenike O, Lowenberg B, Ossenkoppele GJ, Patel PA, Roshal M, Lersch F, Nabhan S, Choe S, Wang H, Hua L, Almon C, Cooper M, Tallman MS . Ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation is safe, effective, and leads to MRD-negative complete remissions . Blood . 2018;132(Suppl . 1)

Stein EM, Shoben A, Borate U, Baer MR, Stock W, Patel PA, Kovacsovics T, Blum W, Vergilio JA, Heerema NA, Rosenberg L, Marcus S, Stefanos M, Chervin J, Druker BJ, Burd A, Byrd JC, Levine RL, Mims AS . Enasidenib is highly active in previously untreated IDH2 mutant AML: Early results from the Beat AML Master Trial . Blood . 2018;132(Suppl . 1)

Stein-Thoeringer C, Peled JU, Lazrak A, Slingerland AE, Shono Y, Staffas A, Gomes A, Argyropoulos K, Docampo M, Xavier J, Taur Y, Pamer EG, van den Brink MRM . Domination of the gut microbiota with enterococcus species early after allogeneic bone marrow transplantation is an important contributor to the development of acute graft-versus-host disease (GHVD) in mouse and man . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S34-S35 .

Stein-Thoeringer CK, Peled JU, Gomes ALC, Lazrak A, Docampo MD, Slingerland AE, Nichols K, Shono Y, Weber D, Sung AD, Hashimoto D, Cross J, Teshima T, Holler E, Chao NJ, Pamer EG, van den Brink MRM . Intestinal enterococcus is a major risk factor for the development of acute GVHD . Blood . 2018;132(Suppl . 1)

Steingart RM . Follow up of adult cancer survivors: How and how often . Chemotherapy . 2018;63(2):128- .

Stephens DM, Li H, Schoder H, Straus DJ, Moskowitz CH, Leblanc ML, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr P, Knopp M V, Hsi ED, Leonard JP, Kahl BS, Smith SM, Friedberg JW . Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin lymphoma demonstrates limitations of PET-adapted approach . Blood . 2018;132(Suppl . 1)

Stephens DM, Boucher K, Kander E, Parikh SA, Parry E, Shadman M, Pagel JM, Cooperrider J, Rhodes J, Mato AR, Winter AM, Hill BT, Gaballa S, Danilov A V, Phillips TJ, Brander DM, Smith SM, Davids MS, Rogers KA, Glenn M, Byrd JC . Chronic lymphocytic leukemia (CLL) transformed into Hodgkin lymphoma (HL): Clinical characteristics and outcomes from a large multi-center collaboration . Blood . 2018;132(Suppl . 1)

Stevenson NR, Simon J, Cooper L, Frank RK, Strauss HW, Gonzales GR . A novel molecule for the systemic imaging and treatment of rheumatoid arthritis . European Journal of Nuclear Medicine and Molecular Imaging . 2018;45(Suppl . 1):S651- .

Stivala S, Baerenwaldt A, Codilupi T, Ghosh N, Hao-Shen H, Dirnhofer S, Dettmer MS, Simillion C, Chiu S, Keller M, Kleppe M, Hilpert M, Buser A, PasswegJR, Radimerski T, Skoda RC, Levine RL, Meyer SC .ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation . Swiss Medical Weekly . 2018;148(Suppl . 230):28S- .

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park K, Pike MC, Soslow R . Silva-type patterns of invasion and correlates (tumor size, lymph-vascular invasion and lymph node metastasis) in HPV unassociated endocervical adenocarcinomas . Modern Pathology . 2018;31(Suppl . 2):454- .

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park K, Pike MC, Soslow R . Clinical

outcomes of HPV-associated and unassociated endocervical adenocarcinomas (ECAs) support the IECC classification . Modern Pathology . 2018;31(Suppl . 2):454-455 .

Stone AE, Friedman DN, Kushner BH, Wolden S, Modak S, LaQuaglia MP, Costello J, Veler H, Wu X, Cheung N, Sklar CA . Assessment of late pulmonary outcomes and exercise capacity among pediatric survivors of high-risk neuroblastoma . American Journal of Respiratory and Critical Care Medicine . 2018;197

Straus DJ . Treatment of newly-diagnosed classical Hodgkin lymphoma . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S86-S87 .

Straus E, Gelfarb L, Buda K, Dienfenbach M, Nelson C . Differences between decisional conflict in men with early stage prostate cancer and their partners . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S271- .

Strowd R, Ellingson B, Wen P, Ahluwalia M, Piotrowski A, Desai A, Clarke J, Lieberman F, Desideri S, Nabors LB, Grossman S . Safety and preliminary activity of PT2385, a first-in-class HIF2-alpha inhibitor, planned interim analysis of an open label, single-arm phase II study in patients with recurrent glioblastoma . Neuro-Oncology . 2018;20(Suppl . 6):vi14- . PMCID: PMC6216117

Stuver R, Khan N, Schwartz M, Acosta M, Federico M,Gisselbrecht C, Lansigan F, Pinter-Brown LC, Pro B, Shustov AR, Horwitz SM, Foss FM, Jain S . Role of single agent and combination chemotherapy strategies in relapsed/refractory peripheral T-cell lymphoma: Results from the complete registry .Blood . 2018;132(Suppl . 1)

Suarez C, Choueiri TK, McDermott DF, Escudier B, Atkins MB, Powles TB, Rini B I, Motzer RJ, Pal SK, Fong L, De Giorgi U, Wang Y, Khaznadar T, Di Nucci F, Kaiser C, Tayama D, Donskov F . Safety and tolerability of atezolizumab (atezo) plus bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell

268 OF 288


Meeting Abstracts

carcinoma (mRCC): Pooled analysis of IMmotion150 and IMmotion151 . Annals of Oncology . 2018;29(Suppl . 8):mdy283 .082- .

Suero-Abreu GA, Gonzalez Velez M, McKenna M, Duma N, Krishnasamy SR, Proverbs-Singh TA, Gutierrez M . Characterization of genomic alterations and biomarker expression patterns of gastrointestinal cancers using a multiplatform molecular profiling tool . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Sullivan J, Bernie H, Ortega Y, Chiles K, Jenkins L, Mulhall J . Comparing plaque morphology between men developing Peyronie’s disease (PD) after radical prostatectomy (RP) to that of de novo Peyronie’s disease patients . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S364-S365 .

Sullivan J, Bernie H, Ortega Y, Mulhall J . Comparative analysis of the natural history of de novo Peyronie’s disease versus post-radical prostatectomy Peyronie’s disease . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S359- .

Sullivan JS, Ortega YO, Mulhall JPM . Comparative analysis of the natural history of de novo Peyronie’s disease versus post-radical prostatectomy Peyronie’s disease . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S86- .

Sullivan MR, Prakash R, Mihalevic MJ, Baird JM, Jasin M, Bernstein KA . A novel system determines the functional significance of ovarian tumor mutations in the homologous recombination gene RAD51C . Clinical Cancer Research . 2018;24(15 Suppl .):42- .

Sumanasuriya S, Omlin AG, Armstrong AJ, Attard G, Chi KN, Bevan CL, Waugh DJ, Ijzerman MJ, De Laere B, Lolkema MP, Lorente D, Luo J, Mehra N, Olmos D, Scher H I, Soule HR, Stoecklein NH, Terstappen LWMM, De Bono JS . Consensus statement on circulating biomarkers for advanced prostate cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Sun D, Parada L . A restricted cell population propagates MPNST growth after treatment . Clinical Cancer Research . 2018;24(2 Suppl .):62- .

Sun D, Farouk Sait S, Wang Z, Parada L . Cancer stem cells promote relapse in neurofibromatosis type 1 associated malignant peripheral nerve sheath tumors . Neuro-Oncology . 2018;20(Suppl . 2):i143- . PMCID: PMC6012612

Sun Y, Argani P, Tickoo S, Epstein J . Acquired cystic disease-associated renal cell carcinoma (ACKD-RCC)-like cysts . Modern Pathology . 2018;31(Suppl . 2):390-391 .

Swift L, Zhang CF, Shah R, Trippett T, Narendran A . In vitro activity and target modulation of PV-10 against relapsed and refractory pediatric leukemia . Blood . 2018;132(Suppl . 1)

Tabata K, Teplov A, Roehrl MH, Hameed M, Matsuda KM, Murray M, Brogi E, Yagi Y . The roles of micro-computed tomography (CT) in breast pathology . Modern Pathology . 2018;31(Suppl . 2):599-600 .

Tabernero J, Shitara K, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Ganea D, Yalcin Ş, Fujitani K, Beretta G, Winkler R, Makris L, Doi T, Ilson D . Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS) . Annals of Oncology . 2018;29(Suppl . 5):mdy208 .001- .

Tadros AB, Wen HY, Morrow M . Breast cancers of special histologic subtypes are biologically diverse . Annals of Surgical Oncology . 2018;25(Suppl . 1):S12- .

Taggar AS, Cohen GN, Brady PJ, Cuaron JJ, Wu A . Early clinical results for esophageal brachytherapy using a novel multi-balloon HDR applicator . Radiotherapy and Oncology . 2018;123(Suppl . 1):S675- .

Tai H, Ito T, Jungbluth A, Ladanyi M . SETD2 mutation Is a recurrent secondary alteration in synovial

sarcoma associated with loss of the H3k36me3 histone mark . Modern Pathology . 2018;31(Suppl . 2):38- .

Takahashi Y, Eguchi T, Kameda K, Lu S, Vaghjiani R, Tan KS, Jones D, Travis W, Adusumilli P . Histologic subtyping in pathologic stage I lung adenocarcinoma provides risk-based stratification for surveillance . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S354- .

Takao S, Koche R, Cifani P, Ser Z, Kentsis A . Functional profiling of patient AML stem cells reveals mechanisms of epigenetic plasticity controlling therapy resistance . Blood . 2018;132(Suppl . 1)

Takashima S, Bos J, Chandra D, Jansen SA, O’Connor M, Mertelsmann AM, Calafiore M, Egorova A, Lo YH, Shroyer NF, Lindemans CA, Hanash AM . Interferon-γ mediates direct intestinal stem cell damage in gastrointestinal graft-versus-host disease . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S64- .

Talati C, Goldberg AD, Desai P, Chan O, Famulare C, Komrokji RS, Kuykendall AT, Fernandez HF, Deutsch YE, Padron E, List AF, Lancet JE, Roboz GJ, Tallman MS, Sallman DA, Sweet KL . Genomic landscape impacts induction outcome with CPX-351 in patients with acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Talati C, Goldberg AD, Przespolewski A, Chan O, Al Ali N, Famulare C, Sallman DA, Padron E, Kuykendall A, List AF, Lancet JE, Wang ES, Tallman MS, Komrokji RS, Sweet KL . Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy . Blood . 2018;132(Suppl . 1)

Tamari R, Cho C, Hilden P, Maloy M, Borrill T, Politikos I, Papanicolaou GA, Jakubowski AA, Gyurkocza B, Shaffer BC, Papadopoulos EB, Ponce DM, Young JW, Dahi PB, Shah GL, Sauter CS, Castro-Malaspina H, Giralt SA, Perales MA . Early

269 OF 288


Meeting Abstracts

CMV reactivation adversely impacts blood counts recovery at 1 year post-transplant in recipients of CD34(+) selected graft . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S372-S373 .

Tan DSW, Lassen UN, Albert CM, Kummar S, van Tilburg C, Dubois SG, Geoerger B, Mascarenhas L, Federman N, Basu-Mallick A, Doz F, Berlin JD, Oh DY, Bielack S, McDermott R, Cruickshank S, Ku NC, Cox MC, Drilon A, Hong DS . Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach . Annals of Oncology . 2018;29(Suppl . 9):mdy430- .

Tang X, Ou Y, Saleh Z, Jeong J, Cai W, Song Y, Zhang M, Chan M, Shi C . A study on breathing pattern classification and prediction using machine learning algorithms . Medical Physics . 2018;45(6):e364-e365 .

Tanioka M, Parker JS, Henry LN, Tolaney S, Dang C, Krop IE, Harris L, Hillman D, Polley M, Berry DA, Winer EP, Carey LA, Perou CM . A prognostic model integrating clinical data and gene signatures in phase III neoadjuvant trial CALGB 40601 (Alliance) . Annals of Oncology . 2018;29(Suppl . 7):mdy373- .

Tannir NM, Fan AC, Lee RJ, Carthon BC, Iliopoulos O, Mier JW, Patel MR, Meric-Bernstam F, DeMichele A, Voss MH, Harding JJ, Srinivasan R, Shapiro G, Telli ML, Munster PN, Carvajal RD, Jenkins Y, Whiting SH, Bendell JC, Bauer TM . Phase 1 study of glutaminase (GLS) inhibitor CB-839 combined with either everolimus (E) or cabozantinib (Cabo) in patients (pts) with clear cell (cc) and papillary (pap) metastatic renal cell cancer (mRCC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Tannir NM, Naing A, Papadopoulos KP, Wong DJ, Korn WM, Aljumaily R, Autio KA, Pant S, Bauer TM, Drakaki A, Daver N, Hung A, Oft M, Leveque J . Responses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in

combination with anti-PD-1 inhibitors . Annals of Oncology . 2018;29(Suppl . 8):mdy288 .003- .

Tano Z, Kiesgen S, Chintala N, Dozier J, Messinger J, Tan KS, Adusumilli P . An ex-vivo patient-derived, immunocompetent (PDI) culture system to evaluate immunotherapeutic agents’ anti-tumor efficacy . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S376- .

Tavakkoli M, Wilkins C, Mones J V, Mauro MJ . The significance of leukocytosis in malignancies: A novel paradigm between leukocytosis, G-CSF, myeloid-derived suppressor cells and prognosis . Blood . 2018;132(Suppl . 1)

Tavitian E, Mastey D, Salcedo M, Zarski A, Chansakul A, Diab V, Mailankody S, Hassoun H, Lesokhin AM, Lendvai N, Smith EL, Hultcrantz M, Sams A, Davis M, Davis E, Puklin S, Steinberger A, Shah GL, Landgren O, Atkinson T, Lengfellner J, Korde N . Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy . Blood . 2018;132(Suppl . 1)

Tayban Y, Dhawan V, Kirnicinii G, Pastores S, Halpern N . Do-Not-Resuscitate orders in an oncologic ICU: When does no mean yes? . Critical Care Medicine . 2018;46(1 Suppl . 1):123- .

Taylor J, Coleman M, Alvarez K, Pichardo J, Sen F, Chung SS, Rampal RK, Park JH, Stein EM, Tallman MS, Abdel-Wahab O I, Klimek VM . Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents . Blood . 2018;132(Suppl . 1)

Taylor J, Donoghue M, Rampal RK, Tamari R, Tallman MS, Feldman DR, Taylor BS, Abdel-Wahab O I . Hematologic malignancies arising in patients with germ cell tumors: Secondary somatic differentiation of hematopoietic malignancies from germ cell precursors . Blood . 2018;132(Suppl . 1)

Teloken P, Miranda E, Kagacan C, Deveci S, Mulhall J . The safety and outcomes of penile implant surgery in the elderly population . Journal of Sexual Medicine . 2018;15(2 Suppl . 1):S69-S70 .

Teo MY, Al-Ahmadie H, Seier K, Ostrovnaya I, Regazzi AM, Dalbagni G, Bochner BH, Funt S, Iyer G, Bajorin DF, Rosenberg JE . Pre-operative chemotherapy (ctx) in plasmacytoid urothelial carcinoma (PUC) . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Tessier-Cloutier B, Coatham M, Soslow R, Stewart C, Kobel M, Lee CH . SWI/SNF-deficient undifferentiated endometrial carcinomas are highly aggressive and resistant to conventional chemotherapy . Modern Pathology . 2018;31(Suppl . 2):457- .

Thandra K, Ogunmuyiwa J, Yohannes-Tomicich J, Alici Y, Root J, Yang G, Zhang H, Kostelecky N, Pastores S, Halpern N, Chawla S, Voigt L . Casting a wider net: Adding a SQiD to delirium assessment . Critical Care Medicine . 2018;46(1 Suppl . 1):363- .

Thandra KC, Ogunmuyiwa J, Yang G, Tan K, Yulico H, Yesne A, Root J, Korc-Grodzicki B, Koshy A, Kostelecky N, Matsoukas K, Chawla S, Voigt LP . Can CDT scores on ICU admission predict outcomes in patients with concurrent negative CAM-ICU results? . American Journal of Respiratory and Critical Care Medicine . 2018;197

Thanh XMT, Reidy-Lagunes D, Kulke M, Wolin E, Singh S, Ferone D, Hoersch D, Houchard A, Caplin M, Baudin E . Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized, double-blind, placebo-controlled, international phase 3 SPINET study . Journal of Thoracic Oncology . 2018;13(4 Suppl .):S138-S139 .

Thompson M . Oncofertility patient advocacy: Speak up, make Change . Fertility and Sterility . 2018;110(4 Suppl .):e425- .

270 OF 288


Meeting Abstracts

Thor M . Do the current software solutions serve our needs? . Radiotherapy and Oncology . 2018;127(Suppl . 1):S238- .

Thor M, Apte A, Fontanella A, Rimner A, Deasy J . Pre-radiotherapy (RT) 18F-FDG PET as a means to predict outcomes after RT for stage III non-small cell lung cancer . Medical Physics . 2018;45(6):e188- .

Thor M, Deasy JO, Hu C, Choy H, Komaki RU, Masters G, Blumenschein GR, Forster KM, Oh JH, Kavadi VS, Narayan S, Timmerman RD, Robinson CG, Greenberger JS, Biggs D, Augspurger M, Meng J, Bradley JD . The role of heart-related dose-volume metrics on overall survival in the RTOG 0617 clinical trial . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S96- .

Thor M, Jackson A, Iyer A, Bendau E, Fontanella A, Apte A, Yorke E, Rimner A, Deasy J . Towards personalized dose-escalation in non-small cell lung cancer: Validation of published models . Radiotherapy and Oncology . 2018;127(Suppl . 1):S555-S556 .

Thor M, Hotca A, Jackson A, Yorke E, Rimner A, Deasy J . Dose to cardiac substructures predicts survival in non-small cell lung cancer chemo-radiotherapy . Radiotherapy and Oncology . 2018;127(Suppl . 1):S58-S59 .

Thorsness S, Tonorezos E, Freites-Martinez A, Lacouture M . Clinical findings, histology, and management of nonmelanoma skin cancer in cancer survivors previously treated with radiotherapy . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB78- .

Thorsteinsdottir S, Sverrisdottir IS, Gislason G, Landgren O, Turesson I, Bjorkholm M, Kristinsson SY . The impact of fractures on survival in multiple myeloma: Results from a population-based study . Blood . 2018;132(Suppl . 1)

Tierney K, Ravindranath B, Eley E, Happersett L, Zhang P, Hunt M . Comparison of an in-house

MV-kV system vs Calypso for intra-treatment monitoring during prostate SBRT . Medical Physics . 2018;45(6):e498- .

Tiriac H, Burkhart RA, Belleau P, Young MC, Ma M, Engle DD, Li E, Yu KH, Tuveson DA . Pharmacotyping patients using pancreatic cancer organoids . Cancer Research . 2018;78(10 Suppl .):74- .

Tiutan T, Stoddard MD, Wang DR, Sanchez N . Utilizing the electronic medical record to assess lesbian, gay, bisexual (LGB) patients’ disease burden and health maintenance at an academic medical center’s primary care network . Journal of General Internal Medicine . 2018;33(Suppl . 2):S838-S839 . PMCID: PMC5913041

Tixier F, Um H, Bermudez D, Iyer A, Apte A, Deasy J, Mellinghoff I, Young R, Veeraraghavan H . Complementary value of MRI-radiomics features and molecular biomarkers in glioblastoma to predict overall survival . Medical Physics . 2018;45(6):e583- .

Tolaney SM, Barry W, Guo H, Dillon D, Tan YB, Fuhrman K, Osmani W, Getz A, Baltay M, Dang C, Yardley D, Moy B, Marcom K, Krop I, Winer E . Immune profile of small HER2+ tumors in the APT trial . Cancer Research . 2018;78(4 Suppl .)

Tonsgard J, Ullrich N, Blakeley J, Rosser T, Packer R, Korf B, Fisher M, Cutter G, Plotkin S, Karajannis M, Allen J, Clapp DW, Thomas C, Campian J . Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium Study . Neuro-Oncology . 2018;20(Suppl . 2):i144- . PMCID: PMC6012612

Torremade J, Kagacan C, Narus J, Mulhall JP . The impact of androgen deprivation therapy on compliance with intracavernous injections . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S155-S156 .

Torremade J, Kagacan C, Ortega Y, Mulhall JP . Serum testosterone profiles in men on testosterone therapy after bilateral orchiectomy . Journal of Sexual Medicine . 2018;15(7 Suppl . 3):S220- .

Townsend S . Human milk glycome as a defense against pathogens . Abstracts of Papers of the American Chemical Society . 2018;256

Travis W, Gaber R, Lu S, Eguchi T, Rekhtman N, Adusumilli P . Therapeutic implications of spread

through air spaces (STAS) . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S265-S266 .

Tripathi A, Supko JG, Gray KP, Melnick Z, Taplin ME, Choudhury AD, Pomerantz M, Bellmunt J, Yu C, Sun Z, Srinivas S, Kantoff PW, Sweeney C, Harshman LC . Pharmacokinetic (PK) analysis of concurrent administration of enzalutamide (enza) and crizotinib (crizo) in patients with metastatic castration resistant prostate cancer (CRPC) . Annals of Oncology . 2018;29(Suppl . 8):mdy284 .061- .

Tripathy D, Sara T, Seidman AD, Anders CK, Ibrahim N, Rugo HS, Twelves CJ, Diéras V, Müller V, Hannah A, Tagliaferri M, Cortés J . ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician’s choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC) . Cancer Research . 2018;78(4 Suppl .)

Tripathy D, Tolaney SM, Seidman AD, Anders CK, Ibrahim NK, Rugo HS, Twelves CJ, Dieras V, Müller V, Hannah AL, Tagliaferri MA, Cortes Castan J . ATTAIN: Phase III study of etirinotecan pegol (EP) vs treatment of physician’s choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC) . Annals of Oncology . 2018;29(Suppl . 8):mdy272 .350- .

271 OF 288


Meeting Abstracts

Trippett T, Berger M, Narendran A, Lyden D, Kovalchuk O, Bodour S, Laquaglia M, Ambati S, Schultz N, Roehrl M . Characterization of the genetic landscape of low mutation burden malignancies through multi-parallel genomic and immunologic analysis . European Journal of Cancer . 2018;103(Suppl . 1):e147- .

Tsai CJ, Kim JK, McBride S, Gelblum D, Riaz N, Dutta PR, Parhar PK, Schupak KD, Higginson DS, Mueller BA, Lee N . Prospective personalized elective nodal dose de-escalation in patients with human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) undergoing definitive concurrent chemoradiation (CCRT): Acute toxicities and tolerance . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E362- .

Tsai CJ, Xie P, Woody NM, Li X, McBride SM, Caudell JJ, Ghanem A I, Liu H, Joshi NP, Geiger JL, Lamarre E, Schymick MA, Tam L, Burkey BB, Adelstein DJ, Dunlap NE, Porceddu S, Siddiqui F, Koyfman S, Lee N . Outcomes after salvage therapy in oral cavity squamous cell carcinoma (OCSCC) patients who developed locoregional failure (LRF) after definitive surgery and adjuvant (chemo) radiotherapy: A multi-institutional collaborative study . InternationalJournal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E357-E358 .

Tsai JJ, Velardi E, Shono Y, Argyropoulos K, Smith OM, Lazrak A, Liu C, Murphy GF, Fu YY, Hanash AM, Jenq RR, Dudakov JA, van den Brink MRM . Nrf2 is a critical mediator of CD4 T cell-induced acute graft-versus-host disease . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S175-S176 .

Tsamadou C, Wang T, Furst D, Lee SJ, Spellman SR, Fleischhauer K, Hsu KC, Paczesny S, Verneris MR, Neuchel C, Schrezenmeier H, Mytilineos J . The role of HLA-E, polymorphism in acute leukemia patients receiving a 10/10 HLA matched unrelated HSCT . Blood . 2018;132(Suppl . 1)

Tsurutani J, Park H, Doi T, Modi S, Takahashi S, Nakagawa K, Krop I, Waqar S, Yoh K, Li B, Taira S, Jikoh T, Singh J, Sugihara M, Janne P . Updated results of phase 1 study of DS-8201a in HER2-expressing or -mutated advanced non-small-cell lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S324- .

Turashvili G, Wu S, Serrano J, Hoang L, Soslow R, Bledea R, Vasudevaraja V, Esposito G, Zhu K, Snuderl M, Chiang S . Whole genome DNA methylation profiling distinguishes high grade endometrial carcinomas . Modern Pathology . 2018;31(Suppl . 2):458-459 .

Turashvili G, Grisham R, Chiang S, DeLair D, Park K, Soslow R, Murali R . BRAF mutations and expression of anti-BRAF-V600E (VE1) in low-grade serous tumors of the ovary . Modern Pathology . 2018;31(Suppl . 2):459- .

Turashvili G, Gomez-Hidalgo NRR, Patel P, Pike MC, Murali R, Leitao M, Soslow R . Prognostic value of clinicopathologic variables in synchronous endometrial and ovarian carcinomas: Metastases or independent primary tumors? . Modern Pathology . 2018;31(Suppl . 2):459- .

Turbitt E, Roberts MC, Wu YP, Rini C, Hay JL . Parent perspectives on healthcare decisions and health behaviors . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S664- .

Tutino RC, Buda K, Gelfarb L, Straus E, Osborn A, Saracino R, Caraline D, Stephanie N, Nelson C, Duhamel K . Comparing subject recruitment strategies: Clinic vs . letter approaches . Psycho-Oncology . 2018;27(Suppl . 3):136-137 .

Tyagi N, Italiaander M, Almujayyaz S, Yamada J, Topf J, Hunt M, Deasy J, Zakian K . A custom-designed flexible MR coil for spine radiotherapy treatment planning . Medical Physics . 2018;45(6):e537- .

Tyagi N . Clinical implementation and clinical experience with MR only workflows . Radiotherapy and Oncology . 2018;127(Suppl . 1):S349-S350 .

Uckelmann HJ, Kim SM, Antonissen NJC, Krivtsov A V, Hatton C, McGeehan GM, Levine RL, Vassiliou GS, Armstrong SA . MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development . Blood . 2018;132(Suppl . 1)

Ulrich-Merzenich G, Fu J, Chou JH, Chou TC . Quantification of drug synergism in vivo exemplified for the combination of Taxotere and T607 against colon carcinoma HCT-116 xenograft tumors in nude mice . Oncology Research and Treatment . 2018;41(Suppl . 4):264- .

Um H, Tixier F, Bermudez D, Iyer A, Apte A, Deasy J, Mellinghoff I, Young R, Veeraraghavan H . Impact of image preprocessing methods on the robustness of MRI-based radiomic classifiers for glioblastoma . Medical Physics . 2018;45(6):e384- .

Urbano S . Current concepts in iodinated contrast induced acute kidney injury . Journal of Radiology Nursing . 2018;37(2):135-136 .

Vaghjiani R, Eguchi T, Chintala N, Li X, Aly R, Emoto K, Tan KS, Jones D, Adusumilli P . Immune microenvironment and its association with adjuvant chemotherapy benefit in locoregionally advanced lung adenocarcinoma . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S371- .

Vago L, Toffalori C, Müberra A, Lange V, Lange K, Todaro S, Stempelmann K, Heinold A, Stölzel F, Waterhouse M, Claus R, Gendzekhadze K, Onozawa M, Devillier R, Tang RP, Ulman M, Lazarevic D, Stanghellini MTL, Peccatori J, Steckel NK, Horn PA, Picardi A, Manetta S, Pinana JL, Sanz J, Schaffer B, Arcese W, Sanz G, Bruno B, Pini M, Kobbe G, Hsu KC, Al Malki M, Teshima T, Kroeger N, Finke J, Nagler A, Blaise D, Mohty M, Bornhauser M, Beelen DW, Schmidt A, Ciceri F, Fleischhauer K . Exploiting

272 OF 288


Meeting Abstracts

cutting-edge technologies to analyze loss of HLA in a global multicentric cohort of post-transplantation relapses: Preliminary results from the HLALOSS collaborative study . HLA . 2018;91(5):324-325 .

Vaisey G, Long SB . Structural and functional characterization of bestrophin channel inactivation . Biophysical Journal . 2018;114(3 Suppl . 1):304a- .

Vaishampayan UN, Narayan V, Wise D, Lang JM, Lowentritt BH, Mellado B, Carles J, Saez M I, Abida W, Taplin ME, Azad A, Wang K, Barbash O, Ferron-Brady G, Fecteau D, Khaled AH, Dhar A, De Bono JS . A phase Ib open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with abiraterone or enzalutamide in metastatic castrate-resistant prostate cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Van Cutsem E, Cuyle PJ, Huijberts S, Yaeger R, Schellens JHM, Elez E, Tabernero J, Fakih M, Montagut C, Peeters M, Desai J, Yoshino T, Ciardiello F, Wasan HS, Kopetz S, Maharry K, Christy-Bittel J, Gollerkeri A, Grothey A . BEACON CRC study safety lead-in (SLI) in patients with BRAF(V600E) metastatic colorectal cancer (mCRC): Efficacy and tumor markers . Journal of Clinical Oncology . 2018;36(4 Suppl .)

Van Cutsem E, Cuyle P, Huijberts S, Schellens J, Elez E, Yaeger R, Fakih M, Montagut C, Peeters M, Desai J, Yoshino T, Ciardiello F, Wasan H, Maharry K, Christy-Bittel J, Gollerkeri A, Kopetz S, Grothey A, Tabernero J . BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib plus MEK inhibitor binimetinib plus anti-epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer . Annals of Oncology . 2018;29(Suppl . 5):mdy149 .026- .

Van de Ven C, Nuchtern JG, Matthyssens L, Jans M, Gabra H, Irtan S, Stenman J, Bjornland K, Hompes

D, Pio L, Cross KM, Avanzini S, Gomez J, Losty PD, Fuchs J, LaQuaglia MP, Von Schweinitz D, Sarnacki S . Implementation of an international standard for systematic surgery report for neuroblastoma: A SIOPEN, COG and GPOH initiative . Pediatric Blood and Cancer . 2018;65(Suppl . 2):S492- .

van den Brink M . The role of microbiome in allogenic stem cell transplant . Clinical Lymphoma, Myeloma and Leukemia . 2018;18(Suppl . 1):S133- .

Van den Broek A, Robson ME, Vos J, Bernstein JL, Offit K, Rookus MA, Chenevix-Trench G, Easton DF, Antoniou AC, Schmidt MK . The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: Analyses in the CIMBA consortium . European Journal of Cancer . 2018;92(Suppl . 3):S10- .

Van Dijk L V, Thor M, Steenbakkers RJHM, Apte A, Zhai T, Borra R, Lee N, Langendijk JA, Deasy JO, Sijtsema NM . Parotid gland fat related magnetic resonance image biomarkers improve prediction of late xerostomia . Radiotherapy and Oncology . 2018;127(Suppl . 1):S95-S96 .

van Hagen T, Sandhu S, Nghiem P, Bhatia S, Brohl AS, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbe C, Lewis KD, Linette GP, Milella M, Hennessy M, Bajars M, Hicking C, D’Angelo SP . Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy . Asia-Pacific Journal of Clinical Oncology . 2018;14(Suppl . 7):172-173 .

Van Oudenhove E, Jelinic P, Ricca J, Olvera N, Merghoub T, Levine DA, Dmitriy Z . Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade . Clinical Cancer Research . 2018;24(15 Suppl .):95- .

Vanderbilt CM, Reichel J, Zehir A, Arcila M, Dogan S, Ladanyi M, Middha S . Mining large panel hybrid capture-based clinical NGS data for novel virus

pathogen-tumor associations based on mapping of off-target reads to viral genomes . Modern Pathology . 2018;31(Suppl . 2):709- .

Vanderbilt CM, Middha S, Bowman AS, Arcila ME, Babady E, Dogan S, Ladanyi M, Hechtman JF, Zehir A . Comprehensive solid tumor microbiome profiling via analysis of unmapped reads in large panel, hybridization capture based NGS assay data . Journal of Molecular Diagnostics . 2018;20(6):938-939 .

Vargo JA, Grimm J, Mavroidis P, Moiseenko V, Jain S, Caudell JJ, Clump DA 2nd, Das SK, Marks LB, Moros EG, Vinogradskiy Y, Xue J, Yorke ED, Heron DE . Radiation dose-volume tolerance for hypofractionated head-and-neck retreatments: A report from the HyTEC Normal Tissue Complication Probability Working Group for carotid blowout syndrome . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E366-E367 .

Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos K, Jae-Hung S, Jenq RR, Hanash AM, Moore M, Kiem HP, Dudakov JA, van den Brink MRM . Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries . Biology of Blood and Marrow Transplantation . 2018;24(3 Suppl . 1):S93-S94 .

Venerito M, Kelley RK, Ryoo BY, Merle P, Park JW, Bolondi L, Chan SL, Lim HY, Baron A, Parnis F, Knox J, Cattan S, Yau T, Lougheed JC, Milwee S, El-Khoueiry AB, Cheng AL, Meyer T, Abou-Alfa GK . Outcomes in patients (pts) who had received sorafenib (S) as the only prior systemic therapy in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):282-283 .

Venerito M, Rimassa L, Cicin I, Blanc JF, Klümpen HJ, Zagonel V, Tran A, Kim S, Lin ZZ, Tam VC, Hazra S, Mangeshkar M, El-Khoueiry AB, Cheng AL, Meyer T, Kelley RK, Abou-Alfa GK . Outcomes based on age

273 OF 288


Meeting Abstracts

in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):283- .

Venet D, Rothé F, Dupont F, Maetens M, Fumagalli D, Salgado R, Bradbury I, Pusztai L, Harbeck N, Izquierdo M, de la Pena L, Ignatiadis M, de Azambuja E, Huober J, Nuciforo P, Baselga J, Piccart M, Loi S, Sotiriou C . Deregulation of A-to-I RNA editing is associated with poor prognosis in HER2+ breast cancers in the neoALTTO trial . Cancer Research . 2018;78(4 Suppl .)

Ventura A . Cancer modeling in the CRISPR age . Cancer Research . 2018;78(10 Suppl .):15- .

Verneris MR, Wang T, Spellman SR, Sees JA, Haagenson MD, Cooley S, Hsu KC, Fleischhauer K, Fleischhauer K, Lee DA, Paczesny S, Rangarajan HG, Miller JS, Lee SJ . Outcomes of pediatric patients with acute leukemia following adult unrelated donor transplant: The impact of donor KIR gene content and KIR ligand matching . Blood . 2018;132(Suppl . 1)

Verrijssen A, Bellezzo M, Habr-Gama A, Perez R, Guillem J, Bujko K, Houben R, Verhaegen F, Berbee M, Van Limbergen E . Microscopic extension of residual rectal tumor mass post-neoadjuvant chemoradiation: A meta-analysis . Radiotherapy and Oncology . 2018;127(Suppl . 1):S799- .

Virgen CA, Belum VR, Barker CA, Lacouture ME . The microbial flora of clinically infected cutaneous metastases . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S166- .

Vivier D, Rodriguez C, Adumeau P, Zeglis B . Influence of chelator conjugation method on immunoPET imaging . Abstracts of Papers of the American Chemical Society . 2018;255

Vokes N, Jimenez Alguilar E, Adeni A, Umeton R, Sholl L, Rizvi H, Hellmann M, Awad M, Van Allen E . Efficacy and genomic correlates of response to anti-

PD1/PD-L1 blockade in non-small cell lung cancers harboring targetable oncogenes . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S422- .

Vora N, Connolly K, Dusza S, Nehal K, Lee E . Comorbidity and functional status in patients 85 years of age and older with nonmelanoma skin cancer . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB81- .

Voros L, Zhang M, Song Y . Automated solid water phantom setup using light-dependent resistors (LDR) . Medical Physics . 2018;45(6):e213- .

Voso MT, Larson RA, Prior T, Marcucci G, Jones D, Krauter J, Heuser M, Lavorgna S, Nomdedeu J, Geyer SM, Klisovic R, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte TM, Jansen JH, Niederweiser D, Appelbaum FR, Medeiros BC, Tallman MS, Schlenk RF, Ganser A, Amadori S, Cheng Y, Gathmann I, Tiecke E, Thiede C, Dohner K, Dohner H, Stone RM, Bloomfield CD, Lo-Coco F . Ratify (Alliance 10603): Prognostic impact of FLT3 tyrosine kinase domain (TKD) and NPM1 mutation status in patients with newly diagnosed acute myeloid leukemia (AML) treated with midostaurin or placebo plus standard chemotherapy . Blood . 2018;132(Suppl . 1)

Vyas M, Basturk O, Jungbluth A, Askan G, Klimstra D, Shia J . Immunohistochemical (IHC) and in-situ hybridization (ISH) analysis of common hepatocellular markers in gastrointestinal adenocarcinomas with hepatoid differentiation: A pilot assessment . Modern Pathology . 2018;31(Suppl . 2):308- .

Waidmann O, Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen YH, Park JW, Blanc JF, Bolondi L, Klumpen HJ, Chan SL, Dadduzio V, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK . Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3

CELESTIAL trial . Oncology Research and Treatment . 2018;41(Suppl . 4):254- .

Waidmann O, Merle P, Rimassa L, Ryoo BY, Cicin I, Harris WP, Nemunaitis J, Olteanu S, Sarker D, Tan BR, Van Vlierberghe H, Sen S, Love C, Cheng AL, El-Khoueiry AB, Meyer T, Kelley RK, Abou-Alfa GK . Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) . Oncology Research and Treatment . 2018;41(Suppl . 4):283-284 .

Walsh S, Zabor E, Stempel M, Morrow M, Gemignani ML . Does race predict survival for women with invasive breast cancer? . Annals of Surgical Oncology . 2018;25(Suppl . 1):S42-S43 .

Walsh SM, Brennan SB, Zabor E, Rosenberger LH, Stempel M, Lebron-Zapata L, Gemignani ML . Does breast density increase the risk of re-excision for women with breast cancer having breast conservation therapy? . Cancer Research . 2018;78(4 Suppl .)

Wan J, Cheng J, Fuller J, Feldman R, Zhang Z, Kolesnick R . Intestinal radiation plays a pivotal role in CTLA-4 Ab induced an autoimmune enteritis mouse model . Radiotherapy and Oncology . 2018;127(Suppl . 1):E582-E583 .

Wang C, Tyagi N, Rimner A, Hu YC, Li G, Hunt MA, Mageras GS, Zhang P . Segmenting lung tumors on longitudinal imaging studies via patient specific self adaptive deep learning models . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E552- .

Wang C, Sidiqi B, Yorke E, McKnight D, Dick-Godfrey R, Torres D, Gelblum D, Rimner A, Wu A . Toxicity and local control in “ultra-central” lung tumors treated with SBRT or high-dose hypofractionated RT . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S357- .

274 OF 288


Meeting Abstracts

Wang C, Sidiqi BU, Yorke ED, McKnight D, Dick-Godfrey R, Torres D, Gelblum D, Rimner A, Wu AJ . Toxicity and local control in “ultra-central” lung tumors treated with stereotactic body radiation therapy (SBRT) . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S10- .

Wang C, Hu Y, Rimner A, Tyagi N, Yorke E, Mageras G, Deasy J, Zhang P . Predicting lung tumor shrinkage during radiotherapy seen in a longitudinal MR imaging study via a deep learning algorithm . Medical Physics . 2018;45(6):e582- .

Wang H, Cades J, Yochum Z, Nugent K, Rudin C, Burns T, Tran P . Modeling epithelial plasticity-induced erlotinib resistance in non-small cell lung cancer . Cancer Research . 2018;78(10 Suppl .):77-78 .

Wang Q, Zhang Y, Yue B, Zhang Y, Jiang C, Perimbeti S, Mauro MJ . Cardiovascular mortality among CML patients in the pre-TKI and TKI eras: A SEER analysis 1992-2004 . Blood . 2018;132(Suppl . 1)

Wang S, Liechty B, Hanna A, Patel S, Snuderl M, Karajannis M, Jeffrey A, Gardner S . PDL-1 expression on circulating CD68 (-) monocyte-like cells in NF2 meningioma as a biomarker for tumor progression . Neuro-Oncology . 2018;20(Suppl . 2):i102- . PMCID: PMC6012612

Wang S, Emond B, Romdhani H, Lefebvre P, Sundaram M, Mato AR . Front-line ibrutinib treatment is associated with longer time to next treatment, net total cost reduction, and lower healthcare resource utilization compared to chemoimmunotherapy in patients with chronic lymphocytic leukemia . Blood . 2018;132(Suppl . 1)

Wang T, Askan G, Zehir A, Adsay N V, Akturk G, Bhanot U, Yantiss R, Rao DS, Jarnagin WR, Klimstra D, Basturk O . Mass-forming intraductal neoplasms of the biliary tract comprise morphologically and genetically distinct entities . Modern Pathology . 2018;31(Suppl . 2):692- .

Wang T, Vakiani E, Pak LM, Simpson A, Jarnagin WR, Hechtman J, Sigel CS . Histoarchitectural pattern does not distinguish IDH1 mutant intrahepatic cholangiocarcinomas from non-IDH mutant controls . Modern Pathology . 2018;31(Suppl . 2):651- .

Wang W, Dai P, Yang N, Wang Y, Shuman S, Merghoub T, Wolchok J, Deng L . The combination of intratumoral delivery of inactivated modified vaccinia virus Ankara with systemic delivery of immune checkpoint blockade enhances antitumor immunity . Journal of Investigative Dermatology . 2018;138(5 Suppl .):S4- .

Wang W, Shim YK, Michalek JE, Barber E, Saleh LM, Choi BY, Wang CP, Ketchum N, Costello R, Marti GE, Vogt R, Landgren O, Calvo KR . Measurement of serum microRNAs in US veterans with monoclonal gammopathy of undetermined significance . Blood . 2018;132(Suppl . 1)

Wang X, Stefanski J, He Q, Chaudhari J, Hack A, Riviere I . CAR-T cell manufacturing with CliniMACS Prodigy . Molecular Therapy . 2018;26(5 Suppl . 1):287- .

Wang X, Hu CS, Tripodi J, Najfeld V, Petersen B, Rampal RK, Farnoud N, Famulare C, Mascarenhas J, Hoffman R . Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells . Blood . 2018;132(Suppl . 1)

Wang Y, Yang J, Wu W, Shah R, Danussi C, Riggins G, Kannan K, Sulman E, Chan T, Huse J . G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma . Neuro-Oncology . 2018;20(Suppl . 6):vi280- . PMCID: PMC6216117

Wang Y, Yang J, Danussi C, Riggins G, Sulman E, Chan T, Huse JT . G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma . G-Quadruplex DNA Drives Genomic Instability and Represents a Targetable Molecular Abnormality in

Atrx-Deficient Malignant Glioma . 2018;20(Suppl . 6):vi92- . PMCID: PMC6216117

Wei SC, Sharma R, Anang NA, Levine J, Zhao Y, Wang J, Pe’er D, Allison JP . Negative costimulation constrains T cell differentiation . Journal of Immunology . 2018;200(1 Suppl .)

Weinhauser I, Pereira-Martins DA, Ortiz C, Schiavinato JL, Bonaldo C, Koury LC, Wagatsuma VMD, Melo RAM, Bittencourt R, Pagnano KB, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille MD, Pasquini R, Tallman MS, Ribeiro R, Dillon R, Keating A, Ganser A, Lowenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Lucena-Araujo AR, Rego EM . Slit-Robo pathway is clinically relevant and may represent a potential target in acute promyelocytic leukemia . Blood . 2018;132(Suppl . 1)

Weissman R, Pilar N, Durham BH, Ki M, Mazor RD, Abdel-Wahab O I, Shomron N, Shpilberg O, Diamond EL, Rokah O . The role of microRNAs in the pathogenesis of Erdheim-Chester disease and their potential use as biomarkers for diagnosis and prognosis of the disease . Blood . 2018;132(Suppl . 1)

Wendlandt B, Nelson JE, Cox CE, Choudhury S, Hanson L, Danis M, Carson SS . Risk factors for post-traumatic stress disorder in family caregivers for the chronically critically ill . American Journal of Respiratory and Critical Care Medicine . 2018;197

Werneck Krauss Silva V, Al-Ahmadie H, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo S, Reuter V, Fine SW . Microscopic bladder neck invasion re-visited: Correlation with tumor topography, staging and grading . Modern Pathology . 2018;31(Suppl . 2):399- .

Wesely J, Kotini AG, Georgomanoli M, Luo H, Yuan H, Izzo F, Landau DA, Leslie C, Kharas MG, Papapetrou EP . A novel iPSC model reveals a role for RUNX1 in the maintenance of AML leukemia stem cells . Blood . 2018;132(Suppl . 1)

275 OF 288


Meeting Abstracts

Wielgos-Bonvallet M, Cybulska P, Van Oudenhove E, Jelinic P, Levine DA . Exploring the effects of PARP inhibition on CHK1 activation as a potential determinant of synergy with CHK1 inhibition . Clinical Cancer Research . 2018;24(15 Suppl .):28-29 .

Wiewiora RP, Chen S, Luo M, Chodera JD . Conformational dynamics of histone methyltransferase SET8 probed by millisecond-timescale molecular dynamics, Markov state modeling and biochemical experiments . Biophysical Journal . 2018;114(3 Suppl . 1):398a- .

Wild A, Wang Y, Wu W, Haddock SL, Chan TA . Exploitation of 2-hydroxyglutarate-mediated deficiency in homologous recombination with PARP inhibition to achieve radiosensitization in IDH-mutant tumors . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S117- .

Williams K, Carter WB, Barrio A V, Carella R, Li L . In breast recurrence in DCIS patients treated with APBI using balloon brachytherapy . Annals of Surgical Oncology . 2018;25(Suppl . 1):S106-S107 .

Williams S, Parrish JC, Zhou XK, Wang H, Dierickx A, Gucalp A, Dannenberg AJ, Iyengar NM . Obesity and adipose inflammation in men with breast cancer . Cancer Research . 2018;78(4 Suppl .)

Williamson SR, Rao P, Hes O, Epstein J, Picken M, Zhou M, Tretiakova M, Tickoo S, Chen YB, Reuter V, Fleming S, Maclean F, Gupta N, Kuroda N, Delahunt B, Mehra R, Przybycin C, Cheng L, Eble J, Grignon D, Moch H, Lopez J, Kunju LP, Tamboli P, Srigley J, Amin M, Martignoni G, Hirsch MS, Trpkov K . Challenges in pathologic staging of renal cell carcinoma: An interobserver variability study of urologic pathologists . Modern Pathology . 2018;31(Suppl . 2):399- .

Willis C, Menon J, Unni S, Au T, Ndife B, Joseph GJ, Bonifacio GJ, Stein EM, Tantravahi SK, Shami PJ, Kovacsovics T, Brixner D, Stenehjem DD . Emerging real-world midostaurin treatment patterns

and outcomes in FLT3-mutated acute myeloid leukemia at a comprehensive cancer center . Blood . 2018;132(Suppl . 1)

Willmann J, Sidiqi BU, Wang C, Wu AJ, Lovelock DM, Czmielewski C, Li H, Dick-Godfrey R, Chawla M, Lee RP, Yorke ED, Rimner A . 4DCT-based correlation of respiratory motion of lung tumors with implanted fiducials and an external surrogate . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E559-E560 .

Wirth L, Drilon A, Albert C, Farago A, El-Diery W, Ma P, Sohal D, Raez L, Baik C, Brose MS, Doebele R, Cox M, Ku N, Hong D . Larotrectinib is highly active in patients with advanced recurrent TRK fusion thyroid (TC) and salivary gland cancers (SGC) . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1318- .

Wise HC, Hu W, Gao PS, Ahmad A, McPherson VA, Dason S, Pietzak EJ, Lyer G, Al-Ahmadie H, Solit DB . Characterization of KDM6A loss in urothelial carcinoma . European Journal of Cancer . 2018;103(Suppl . 1):e95-e96 .

Wojcik J, Sajed D, Oliva E, Chiang S, Garcia BA . Epigenetic dysregulation unites ossifying fibromyxoid tumor and endometrial stromal sarcoma pathogenesis . Modern Pathology . 2018;31(Suppl . 2):40- .

Wongchenko MJ, Dent R, Kim SB, Saura C, Oliveira M, Baselga J, Kapp A V, Chan WY, Singel SM, Maslyar DJ, Gendreau S . Biomarker analysis of the LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) in metastatic triple-negative breast cancer (TNBC) . Cancer Research . 2018;78(4 Suppl .)

Woody NM, Tsai CJ, Caudell JJ, Ghanem A I, Liu H, Rybicki L, Joshi NP, Geiger JL, Lamarre E, Schymick MA, Burkey BB, Tam L, Dunlap NE, Porceddu S, Siddiqui F, Adelstein DJ, Lee N, Koyfman S . Improving prognostic classification in intermediate risk (INT) oral cavity squamous cell carcinoma

(OCSCC): A multi-institutional collaborative study . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S21- .

Wu B, Zhang P, LoSasso T . Utilizing historical performance data from trajectory logs and service reports to establish a proactive maintenance model for minimizing MLC downtime . Medical Physics . 2018;45(6):e632- .

Wu B, Zhang P, Zhang P, Mageras G, Tsai J, Mechalakos J, Hunt M . Utilizing patient anatomical changes to determine parotid mean dose changes for H&N adaptive planning decisions: A machine-learning approach . Medical Physics . 2018;45(6):e671-e672 .

Wu S, Cooper B, Bu F, Bowman C, Killian JK, Wang S, Jackson T, Gorovets D, Gorlick R, Thomas K, Karajannis M, Snuderl M . A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas . Clinical Cancer Research . 2018;24(2 Suppl .):27- .

Wu SPP, Yan SX, Tam M, Lee A, Gerber NK, Schreiber D, Schiff PB, Lymberis SC . Patterns of care and outcomes of adjuvant treatment in stage II endometrioid carcinoma . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E654-E655 .

Wu Y, Du J, Hsu A, Hristov D, Zhao W, Ma V, Chan M, Xing L . Deep learning-augmented MRI for quantitative imaging . Medical Physics . 2018;45(6):e525- .

Wu YP, Parsons BG, Aspinwall L, Hay J, Caputo H, Boucher K, Mooney R, Grossman D, Leachman S . Barriers to and facilitators of melanoma preventive behaviors predict reported sun protection in children with familial risk . Annals of Behavioral Medicine . 2018;52(Suppl . 1):S665- .

Xiao W, Goldberg AD, Famulare C, Delvin S, Patel M, McGovern E, Patel A, Schulman J, Dunbar A, Epstein-Peterson ZD, Menghrajani K, Getta B, Cai

276 OF 288


Meeting Abstracts

S, Geyer MB, Glass JL, Taylor J, Viny AD, Levine RL, Zhang Y, Tallman MS, Roshal M . Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia . Blood . 2018;132(Suppl . 1)

Xiao W, Goldberg AD, Ball B, Famulare C, Pastore F, Tallman MS, Zhang Y, Arcila ME, Papaemmanuil E, Levine RL, Roshal M . PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes . Blood . 2018;132(Suppl . 1)

Xie X, Laks D, Sun D, Poran A, Laughney A, Belenguer G, Massague J, Zhou X, Farinas I, Elemento O, Parada L . Precise investigation of cancer stem cells in a mouse glioblastoma model . Neuro-Oncology . 2018;20(Suppl . 6):vi276- . PMCID: PMC6216117

Xie XH, Alcantara S, Laks D, Shi Y, Parada LF . Lessons from modeling neural tumors in mice . Cancer Research . 2018;78(10 Suppl .):19- .

Xie Y, Cao Z, Wong WP, Guan Y, Zhang J, Walczak E, Murphy D, Ran L, Sirota I, Wang S, Shukla S, Gao D, Wongvipat J, Knott S, Chang K, Antonescu C, Hannon G, Chi P, Chen Y . COP1-ETS axis regulates ERK transcriptional output and modulates sensitivity to MAPK inhibitors . Clinical Cancer Research . 2018;24(2 Suppl .):61- .

Xing D, Kim J, Mendelsohn R, Hechtman J, Vakiani E, Klimstra D, Shia J . Pathologic patterns of anti-PD-1 induced colitis . Modern Pathology . 2018;31(Suppl . 2):312- .

Xiong W, Li X, Reyngold M, Gewanter R, Cuaron J, Yorke E, Li T . Intra-fractional tumor motion during DIBH pancreas treatment . Medical Physics . 2018;45(6):e384- .

Xu AJ, Zhang H, Hoshino A, Kim H, Bromberg J, Lyden D . Impact of radiation on tumor derived exosome production, proteomics and biodistribution . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S139-S140 .

Xu AJ, Yang J, Gao J, Kong L, Lee N, Lu JJ, Tsai CJ . Outcomes of proton and carbon ion radiation therapy for head and neck sarcomas . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E374- .

Xu AJ, Chelius M, Chau K, Yahalom J . Involved-site radiation therapy for H . pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S190- .

Xu AJ, Luo L, Leeman JE, Romesser PB, Spielsinger D, Sabol C, Waldenberg T, Brinkman T, Li X, Xie P, Riaz N, McBride S, Lee N, Tsai CJ . Efficacy and safety of three or more courses of radiation for head and neck malignancies . International Journal of Radiation Oncology, Biology, Physics . 2018;100(5):1370- .

Xu B, Mneimneh W, Torrence D, Klimstra D, Ghossein R, Katabi N . Misdiagnosed myoepithelial carcinoma of salivary gland: A challenging and potentially significant pitfall . Modern Pathology . 2018;31(Suppl . 2):491- .

Xu B, Tuttles RM, Katabi N, Aleynick N, Reznik E, Ganly I, Tallini G, Ghossein R . Outcome of non-invasive encapsulated follicular variant of papillary thyroid carcinoma (NI-EFVPTC) with oncocytic features . Modern Pathology . 2018;31(Suppl . 2):239- .

Xu B, Jungbluth A, Aleynick N, Ghossein R, Katabi N . Expression of cancer testis antigen PRAME, PD-L1, and PD-1 in salivary duct carcinoma . Modern Pathology . 2018;31(Suppl . 2):491- .

Xu C, Zhang Y, Liu D, Shen R, Razavi P, Liu S, Sun H, Offin M, Drilon A, Rudin C, Arcila M, Wu Y, Li B . Detecting HER2 alterations by next generation

sequencing (NGS) in patients with advanced NSCLC from the United States and China . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S502- .

Xu Z, Tang Y . A recurrent heterozygous RPL21 mutation responsible for hereditary hypotrichosis simplex in a Chinese family . Journal of Molecular Diagnostics . 2018;20(6):901- .

Yagi Y, Tabata K, Teplov A, Hwang S, Hameed M . Whole block imaging in bone tumor . Modern Pathology . 2018;31(Suppl . 2):40-41 .

Yagi Y, Uraoka NU, Zhang Y, Hameed M . Toward the automated scoring of fluorescence in situ hybridisation using a confocal whole slide image scanner . Virchows Archiv . 2018;473(Suppl . 1):S287-S288 .

Yagi Y, Aly R, Tabata K, Rekhtman N, Eguchi T, Montecalvo J, Manova K, Adusumilli P, Hameed M, Travis W . Three-dimensional immunofluorescence analysis of dynamic vessel co-option of spread through air spaces (STAS) in lung cancer . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S327- .

Yan D, Schaff L, Cecchi F, Benz S, Rosenblum M, Hembrough T, Lin A . Correlating MGMT protein level with temozolomide response in glioblastoma patients using mass spectrometry . Neuro-Oncology . 2018;20(Suppl . 6):vi67- . PMCID: PMC6216117

Yang DD, Mahal BA V, Muralidhar V, Martin NE, Orio PF, Mouw KW, King MT, Choueiri TK, Trinh QD, Hoffman KE, Spratt DE, Feng FY, Nguyen PL . Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer . Journal of Clinical Oncology . 2018;36(6 Suppl .)

Yang JC, Folkert MR, Crago AM, Singer S, Alektiar KM . Impact of tumor histology on local control in patients with primary soft tissue sarcoma of the extremity . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E375-E376 .

277 OF 288


Meeting Abstracts

Yang JC, Chau K, Scordo M, Sauter CS, Yahalom J . Patients with relapsed/refractory large cell lymphoma who were also refractory to salvage chemotherapy: Outcome with salvage radiation therapy followed by autologous stem cell transplant . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S125- .

Yang TT, Chong WM, Chen Z, Tsou MFB, Liao JC . 3D architectural reconstruction of mammalian centriole distal appendages using superresolution microscopy . Biophysical Journal . 2018;114(3 Suppl . 1):539a- .

Yao J, Syed M, Yu W, Maciag L, Ho C, Petrova-Drus K, Moung C, Zehir A, Roshal M, Rosado A, Ahmet D, Nafa K, Arcila M . Clinical implementation of T-cell clonality testing by next-generation sequencing: Improved detection sensitivity and reliability in initial diagnosis and minimal residual disease detection of T-cell malignancies . Journal of Molecular Diagnostics . 2018;20(6):916-917 .

Yao JC, Strosberg J, Fazio N, Pavel ME, Ruszniewski P, Bergsland E, Li D, Tafuto S, Raj N, Campana D, Hijioka S, Raderer M, Guimbaud R, Gajate P, Pusceddu S, Reising A, Degtyarev E, Mookerjee B, Aimone P, Singh S . Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx) . Annals of Oncology . 2018;29(Suppl . 8):mdy293 .001- .

Yao Z, Gao Y, Su W, Yaeger R, Na N, Zhang Y, Zhang C, Rymar A, Tao A, Torres N, McGriskin R, Zhao H, Chang Q, Qeriqi B, de Stanchina E, Barbacid M, Bollag G, Rosen N . PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling . European Journal of Cancer . 2018;103(Suppl . 1):e24- .

Yau T, Merle P, Rimassa L, Ryoo BY, Cicin I, Harris WP, Banu E, Sarker D, Tan B, van Vlierberghe H, Sen S,

Love C, Cheng AL, Meyer T, Kelley RK, Abou-Alfa GK . Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) . Annals of Oncology . 2018;29(Suppl . 9):mdy432- .

Yau T, Cheng AL, Meyer T, Ryoo BY, Park JW, Klümpen HJ, Lim HY, Kim S, Knox J, Patel M, El-Khoueiry AB, Kelley RK, Abou-Alfa GK . Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) . Annals of Oncology . 2018;29(Suppl . 8):mdy282 .087- .

Yelamos O, Manubens E, Dusza S, Marchetti MA, Barreiro A, Malvehy J, Rossi AM, Puig S, Marghoob AA, Carrera C . Impact of reflectance confocal microscopy on the physician’s diagnostic confidence and decision making of equivocal skin tumors: Outcomes after one-year follow-up . Journal of the American Academy of Dermatology . 2018;79(3 Suppl . 1):AB160- .

Yellapantula V, Hultcrantz M, Rustad EH, Landau HJ, Iacobuzio-Donahue C, Akhlaghi T, Amit I, Ledergor G, Korde N, Mailankody S, Kazandjian D, Patel A, Bolli N, Papaemmanuil E, Landgren O . Mytype: A capture based sequencing approach to detect somatic mutations, copy number changes and IGH translocations in multiple myeloma . Blood . 2018;132(Suppl . 1)

Yellapantula VD, Rustad EH, Glozdik D, Gundem G, Fan J, Medina J, Patel A, Patel M, Hultcrantz M, Peled JU, Lendvai N, Landgren O, Giralt S, Iacobuzio-Donahue C, Papaemmanuil E, Landau HJ, Lesokhin AM . Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence . Blood . 2018;132(Suppl . 1)

Yin M, Baslan T, Freeland A, Matsukawa T, Pruitt SC, Aplan PD . Mice with a unique mutator phenotype allow detection of lymphoid leukemia tumor suppressor genes . Blood . 2018;132(Suppl . 1)

Yip L, Dart RC, Spyker DA, Chapman PB . Acetaminophen immediate release pharmacokinetics in iatrogenic overdose . Clinical Toxicology . 2018;56(10):940- .

Yoshimi A, Liu Z, Wang J, Cho H, Lee SC, Ki M, Bitner LE, Chu T, Mato AR, Ruvolo PP, Fabbri G, Pasqualucci L, Rabadan R, Abdel-Wahab O I . Mutations in the RNA splicing factor SF3B1 promote transformation through MYC stabilization . Blood . 2018;132(Suppl . 1)

Yoshino T, Iwata H, Tamura K, Takahashi S, Redfern C, Modi S, Doi T, Kawakami H, Taniguchi H, Takashima A, Yamaguchi K, Fisher J, Li B, Saito K, Fujisaki Y, Sugihara M, Tsurutani J . Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer . Annals of Oncology . 2018;29(Suppl . 8):mdy281 .109- .

Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Samoilova O, Suh C, Matsumura I, Lopez-Hernandez A, Duhrsen U, Thieblemont C, Carey J, Liu G, Shreeve SM, Sun S, Vermeulen J, Staudt LM, Wilson WH . A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients with previously untreated non-germinal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL) . Blood . 2018;132(Suppl . 1)

Younge K, Berry S, Chen X, Pham H, Zhou Y, Elguindi S, Mageras G, Kessler M, Mechalakos J, Hunt M, Woch Naheedy K, Ditman M, Keranen W, Moran J . A model for collaborative software development: Integration in treatment plan checks . Medical Physics . 2018;45(6):e158- .

Yu AF, Knezevic A, Moskowitz C, Dang C, Ramanathan L, Oeffinger K, Liu J, Steingart R .

278 OF 288


Meeting Abstracts

Prospective evaluation of circulating biomarkers as predictors of cardiotoxicity in patients with HER2-positive breast cancer receiving anthracyclines and trastuzumab . Journal of the American College of Cardiology . 2018;71(11 Suppl .)

Yu K, Mantha S, Tjan C, Kaufmann E, Brenner RB, Lowery M, Ku G, Raj N, Shcherba M, Goldberg Z, Li J, Zervoudakis A, Hamilton A, Won E, Do RKG, O’Reilly EM . A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis . Annals of Oncology . 2018;29(Suppl . 8):mdy287 .002- .

Zadeh G, Lang F, Daras M, Cloughesy T, Colman H, Ong S, Ramakrishna R, Vogelbaum M, Groves M, Nassiri F, Frederick LS, Gammon K, Fulling S, Rowland KA, Mitchell E, Ewald B, Tufaro F, Peterkin J . Interim results of a phase II multicenter study of the conditionally replicative oncolytic adenovirus DNX-2401 with pembrolizumab (Keytruda) for recurrent glioblastoma: Captive study (Keynote-192) . Neuro-Oncology . 2018;20(Suppl . 6):vi6- .PMCID: PMC6216117

Zakian K, Wibmer A, Vargas HA, Iyer A, Tyagi N, Apte A, Hunt MA, Kollmeier MA, Mychalczak BR, Zelefsky MJ . Prostate cancer and benign tissue response to hypofractionated SBRT monitored by multi-modality MRI over a 2 year period . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E152- .

Zamarin D, Hamid O, Nayak A, Sahebjam S, Sznol M, Collaku A, Fox F, Marshall M, Hong D . Phase 1 study using mogamulizumab (KW-0761) to deplete regulatory T cells in combination with checkpoint inhibitors durvalumab (MEDI4736) or tremelimumab in subjects with advanced solid tumors . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Zapotocky M, Ryall S, Fukuoka K, Guerreiro Stucklin A, Bennett J, Sumerauer D, Pavelka Z, Cruz O,

Solano P, Garre ML, Hauser P, Frappaz D, Hansford J, Amayiri N, Morse H, Sabel M, Bechensteen AG, Su J, Karajannis M, Finlay J, Eisenstat D, Canete A, Toledano H, Dahiya S, Leary S, Nicolaides T, Finch E, Mueller S, Levy JM, Ellison D, Lassaletta A, Larouche V, Ramaswamy V, Dirks P, McKeown T, Bartels U, Bouffet E, Hawkins C, Tabori U, on behalf of PLGG Taskforce . Remarkable objective response and favorable survival for BRAF-V600E childhood low-grade gliomas to BRAF inhibitors compared conventional chemotherapy . Neuro-Oncology . 2018;20(Suppl . 2):i117- . PMCID: PMC6012612

Zappasodi R, Sirard C, Li Y, Budhu S, Abu-Akeel M, Liu C, Yang X, Zhong H, Newman W, Qi J, Wong P, Schaer D, Koon H, Velcheti V, Postow M, Callahan MK, Wolchok J, Merghoub T . Rational combination of GITR agonism with PD-1 blockade in cancer patients . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):114- . PMCID: PMC6220480

Zappasodi R, Budhu S, Hellmann MD, Postow MA, Senbabaoglu Y, Manne S, Gasmi B, Liu C, Zhong H, Li Y, Huang AC, Hirschhorn-Cymerman D, Panageas KS, Wherry EJ, Merghoub T, Wolchok JD . Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade . Journal of Immunology . 2018;200(1 Suppl .)

Zarepisheh M, Hong L, Zhou Y, Oh J, Mechalakos J, Hunt M, Mageras G, Deasy J . Automated IMRT treatment planning using expedited constrained hierarchical optimization (ECHO): Retrospective study and clinical implementation . Medical Physics . 2018;45(6):e626- .

Zarnegar S, Lange K, Mathias M, Nakajima-Hatano M, Offer K, Ogu U, Ortiz M, Tan KS, Kellick M, Basu E, Dingeman RS . Reppair trial: Reducing procedural pain and improving recovery of quality of life in pediatric neuroblastoma patients undergoing bone marrow procedures, a prospective, randomized, cross-over clinical trial . Pediatric Blood and Cancer . 2018;65(S1):S203- .

Zauderer M, Muller S, Lai W, Ni A, Jungbluth A, Ginsberg M, Daly R, Hellmann M, Ladanyi M, Sauter J . VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression . Journal of Thoracic Oncology . 2018;13(10 Suppl .):S758- .

Zelefsky MJ, Yamada Y, Lis E, Schoder H, Lochansingh S, Shi W, Zhigang Z, Braunstein SE, Kolesnick R, Fuks Z . Phase III multi-center, prospective randomized trial comparing high dose single fraction radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic human cancer . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S37-S38 .

Zelenetz AD, Soumerai JD, Jagadeesh D, Reddy N, Stathis A, Asch AS, Salman HS, Kenkre VP, Jhangiani H, Iasonos A, Krish P, Ghalie RG, Pagel JM . Preliminary safety and efficacy results with an intermittent schedule of the PI3kδ inhibitor ME-401 alone or in combination with rituximab for B-cell malignancies . Blood . 2018;132(Suppl . 1)

Zeng J, Brogi E, Floris G, Turashvili G, Razavi P, Baselga J, Sanford R, Ross D, Solit D, Berger MF, Weigelt B, Reis-Filho J, Wen HY . Assessing tumor infiltrating lymphocytes and genomic alterations in pre-treatment core biopsy and correlation with response to neoadjuvant chemotherapy . Modern Pathology . 2018;31(Suppl . 2):117- .

Zhang H, Huang M, Feigenberg S, Berman A, Lu W, Jain V, Xiao Y, Jin P, Mohindra P, Simone C, Bentzen S, D’Souza W . Clinical validation of four-dimensional computed tomography-based lung ventilation images using texture feature analysis and pulmonary function test . Medical Physics . 2018;45(6):e580- .

Zhang J, Wang C, Beckham T, Wu AJ, Rimner A, Li G . Feasibility of delineating gross and internal tumor volumes of lung cancer using respiratory-correlated 4DMRI in comparison with 4DCT . International

279 OF 288


Meeting Abstracts

Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):S103- .

Zhang J, Ji Z, El Asmar M, Caushi J, Anagnostou V, Chan HY, Suri P, Guo H, Marrone K, Naidoo J, Merghoub T, Chaft J, Hellmann M, Taube J, Brahmer J, Velculescu V, Zhao N, Forde P, Pardoll D, Ji H, Smith K . Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade . Journal for ImmunoTherapy of Cancer . 2018;6(Suppl . 1):115- . PMCID: PMC6220479

Zhang L, LoSasso T, Zhang P, Mageras G, Tang G . Simultaneous MLC and couch tracking: A clinical feasibility study . Medical Physics . 2018;45(6):e667- .

Zhang L, LoSasso T, Zhang P, Mageras G, Tang G . Dosimetric evaluation of MLC and couch tracking on TrueBeam for abdominal cancer treatments . Medical Physics . 2018;45(6):e683- .

Zhang M, Oh P, Brady P, Ilson DH, Janjigian Y, Ku G, Crane CH, Jackson A, Wu AJ . Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation . International Journal of Radiation Oncology, Biology, Physics . 2018;102(3 Suppl .):E46- .

Zhang P, Hu Y, Wu B, Polvorosa C, Allgood N, Fontenla S, Li X, Shi C, Mechalakos J, Mageras G, Hunt M . Adaptive planning information system . Medical Physics . 2018;45(6):e212- .

Zhang W, Khojasteh M, Hubbard A, Martin J, Wang X, Kamthamraju S, Munoz-Rodriguez JL, Jiang D, Cai Z, Li J, Anders R, Diaz L, Pestic-Dragovich L, Tang L . Characterization of PD-L1, CD8, CD3, CD68 and PanCK in tumor microenvironment of Gl tract tumors with respect to patients’ mismatch repair status and anti-PD-1 treatment outcome using 5Plex IHC and whole slide image analysis . Annals of Oncology . 2018;29(Suppl . 8)

Zhao X, Tan X, Li L, Lu W, Tan S . Tumor co-segmentation in PET/CT using cross-DenseNetfor lung cancer . Medical Physics . 2018;45(6):e491-e492 .

Zhao Z . Turbocharged CAR T cells stimulate host T cells against prostate cancer . Molecular Therapy . 2018;26(5 Suppl . 1):11- .

Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Ladanyi M, Hameed M . Comprehensive detection of known fusion genes in sarcomas and discovery of novel fusion partners by a clinical targeted RNA sequencing assay . Modern Pathology . 2018;31(Suppl . 2):41- .

Zhu G, Benayed R, Hwang S, Agaram N, Bridge J, Hameed M . Identification of COL1A1-USP6 and ANGPTL2-USP6 gene fusions in myositis ossificans-like aneurysmal bone cyst (MO-like ABC) . Journal of Molecular Diagnostics . 2018;20(6):1012- .

Zhu G, Benayed R, Ladanyi M, Katabi N, Hameed M . EWSR1-ATF1 fusion in solid tumors: Next-generation

sequencing analysis by MSK-IMPACT . Journal of

Molecular Diagnostics . 2018;20(6):1012- .

Ziv E, Boas F, Yarmohammadi H, Filtes J, Brown K, Covey A, Solomon S, Reidy D, Erinjeri J . DAXX

mutation is associated with shorter hepatic

progression free survival after hepatic artery

embolization of neuroendocrine liver metastases .

Pancreas . 2018;47(3):361- .

Zumrut H, Batool S, Argyropoulos K, Dekhang R,

Mallikaratchy P . Ligand-guided selection (LIGS): A

SELEX variant to identify specific aptamers against

cell-surface markers . Abstracts of Papers of the

American Chemical Society . 2018;256

Zwanenburg A, Abdalah MA, Apte A, Ashrafinia S,

Beukinga J, Bogowicz M, Dinh C V, Gotz M, Hatt

M, Leijenaar RTH, Lenkowicz J, Morin O, Rao AUK,

Socarras Fernandez J, Vallieres M, Van Dijk L V, Van

Griethuysen J, Van Velden FHP, Whybra P, Troost

EGC, Richter C, Lock S . Results from the Image

Biomarker Standardisation Initiative . Radiotherapy

and Oncology . 2018;127(Suppl . 1):S543-S544 .

280 OF 288

Book Sections (85)


281 OF 288


Book Sections

Baloch Z, Field AS, Katabi N, Wenig BM . The Milan system for reporting salivary gland cytopathology . In: Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DF I, Pusztaszeri M, Vielh P, editor(s) . The Milan System for Reporting Salivary Gland Cytopathology . Springer International Publishing; 2018 . p . 1-9 .

Barrio A V, Cody HS 3rd . Bilateral breast cancer . In: Bland K I, Copeland EM 3rd, Klimberg VS, Gradishar WJ, White J, Korourian S, editor(s) . The Breast: Comprehensive Management of Benign and Malignant Diseases . 5th ed . Philadelphia, PA: Elsevier Inc .; 2018 . p . 967-973 .e2 .

Basturk O, Reid MD, Adsay N V . Pathologic classification and biological behavior of pancreatic neoplasia . In:Neoptolemos JP, Urrutia R, Abbruzzese JL, Buchler MW, editor(s) . Pancreatic Cancer . 2nd ed . New York: Springer; 2018 . p . 51-87 .

Benitez V, Karajannis MA . Chemotherapy of brainstem gliomas . In: Newton HB, editor(s) . Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy . 2nd ed . London, UK: Elsevier Inc .; 2018 .p . 585-596 .

Berliner JL, Fleischut MH . Genetic mutations in cancer susceptibility genes: A family history of cancer . In: Fitzpatrick TR, editor(s) . Quality of Life Among Cancer Survivors: Challenges and Strategies for Oncology Professionals and Researchers . Cham, Switzerland: Springer; 2018 . p . 67-85 .

Boyce LM, Gibson DS, Matsoukas K . Role in evidence-based practice . In: DeRosa AP, editor(s) . A Practical Guide for Informationists: Supporting Research and Clinical Practice . Cambridge, MA: Chandos Publishing; 2018 . p . 71-81 .

Cabot JC, Pastores SM . Airway pressure release ventilation . In: Esquinas AM, Pravinkumar SE, Soubani AO, editor(s) . Mechanical Ventilation in Critically Ill Cancer Patients: Rationale and Practical Approach . Cham, Switzerland: Springer; 2018 . p . 197-203 .

Cahlon O, McCormick B . Radiotherapy and regional nodes . In: Bland K I, Copeland EM 3rd, Klimberg VS, Gradishar WJ, White J, Korourian S, editor(s) . The Breast: Comprehensive Management of Benign and Malignant Diseases . 5th ed . Philadelphia, PA: Elsevier Inc .; 2018 . p . 677-688 .e2 .

Chan MF . One-scan film dosimetry across multimodalities of delivery . In: Chan MF, editor(s) . Recent Advancements and Applications in Dosimetry . New York: Nova Science Publications, Inc .; 2018 . p . 169-188 .

Cheng JWK . Flipping the script: Key conversations to understanding the business, science, and art of fundraising and its synergies with data science . In: Liebowitz J, Paliszkiewizc J, Goluchowski J, editor(s) . Intuition, Trust, and Analytics . Boca Raton, FL: CRC Press; 2018 . p . 231-245 .

Cronin PA, Gemignani ML . Breast diseases . In: Disaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG, editor(s) . Clinical Gynecologic Oncology . 9th ed . Philadelphia, PA: Elsevier Inc .; 2018 . p . 320-352 .e6 .

Cuaron J, Wu A . Radiation therapy effects on the abdomen . In: Koontz BF, editor(s) . Radiation Therapy Treatment Effects: An Evidence-Based Guide to Managing Toxicity . New York, NY: Demos Medical Publications; 2018 . p . 101-116 .

Dean LW, Touijer KA . Evaluation and treatment for high-risk prostate cancer . In: Chang SS, Cookson MS, editor(s) . Prostate Cancer: Clinical Case Scenarios . Cham, Switzerland: Springer; 2018 . p . 135-156 .

DeSelm C, Parvathaneni U, Sine K . Head and neck reirradiation . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 187-196 .

Diamond EL . Erdheim-Chester disease . In: Abla O, Janka G, editor(s) . Histiocytic Disorders . Cham,

Switzerland: Springer International Publishing; 2018 . p . 313-338 .

Do RKG, Dick DW . PET/MRI: Safety considerations . In: Iagaru A, Hope T, Veit-Haibach P, editor(s) . PET/MRI in Oncology: Current Clinical Applications . Cham, Switzerland: Springer; 2018 . p . 115-130 .

Emanu JC, Avildsen I, Nelson CJ . Psychotherapeutic treatments for male and female sexual dysfunction disorders . In: David D, Lynn SJ, Montgomery GH, editor(s) . Evidence-Based Psychotherapy: The State of the Science and Practice . Wiley Blackwell; 2018 . p . 253-270 .

Faquin WC, Bongiovanni M, Callegari FM, Canberk S, Elsheikh TM, Kurtycz DF I, Lin O, Pusztaszeri M . Non-neoplastic . In: Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DF I, Pusztaszeri M, Vielh P, editor(s) . The Milan System for Reporting Salivary Gland Cytopathology . Cham, Switzerland: Springer International Publishing; 2018 . p . 21-41 .

Farber BA, Hammond WJ, La Quaglia MP . Hepatic tumors . In: Puri P, editor(s) . Newborn Surgery . 4th ed .Boca Raton, FL: CRC Press; 2018 . p . 935-957 .

Finan M, Pastores SM . Acute respiratory failure after hematopoietic stem cell transplantation . In: Esquinas AM, Pravinkumar SE, Soubani AO, editor(s) . Mechanical Ventilation in Critically Ill Cancer Patients: Rationale and Practical Approach . Cham, Switzerland: Springer; 2018 . p . 347-354 .

Garshick MK, Myskowski PL . Nail reactions to anticancer therapies . In: Rubin A I, Jellinek NJ, Daniel CR 3rd, Scher RK, editor(s) . Scher and Daniel’s Nails: Diagnosis, Surgery, Therapy . 4th ed . Springer; 2018 . p . 439-451 .

Gemignani ML, McCartan D . Carcinoma of the breast in pregnancy and lactation . In: Bland K I, Copeland EM 3rd, Klimberg VS, Gradishar WJ, White J, Korourian S, editor(s) . The Breast: Comprehensive

282 OF 288


Book Sections

Management of Benign and Malignant Diseases . 5th ed . Philadelphia, PA: Elsevier Inc .; 2018 . p . 993-999 .e3 .

Ghaznavi SA, Tuttle RM . Risk stratification and current management of low risk thyroid cancer . In: Mallick UK, Harmer C, Mazzaferri EL, Kendall-Taylor P, editor(s) . Practical Management of Thyroid Cancer: A Multidisciplinary Approach . 2nd ed . Cham, Switzerland: Springer; 2018 . p . 111-120 .

Gomez-Hidalgo NR, Ramirez PT . Laparoscopic surgery in endometrial carcinoma . In: Gomes-de-Silveira GG, Gomes da Silveira GP, Arenhart Pessini S, editor(s) . Minimally Invasive Gynecology: An Evidence Based Approach . Cham, Switzerland: Springer; 2018 . p . 321-332 .

Haedicke K, Kossatz S, Reiner T, Grimm J . Molecular imaging and molecular imaging technologies . In: Lewis JS, Keshari KR, editor(s) . Imaging and Metabolism . Cham, Switzerland: Springer; 2018 . p . 3-27 .

Herr H . History of transurethral resection and fulguration of bladder tumors . In: Patel SR, Nakada SY, Moran ME, editor(s) . The History of Technologic Advancements in Urology . Cham, Switzerland: Springer; 2018 . p . 59-68 .

Hou X . Ion channels . In: Cao Y, editor(s) . Advances in Membrane Proteins, Part I: Mass Processing and Transportation . Singapore: Springer; 2018 . p . 17-45 .

Hultcrantz M, Landgren O . Monoclonal gammopathy of undetermined significance . In: Wiernik PH, Dutcher JP, Gertz MA, editor(s) . Neoplastic Diseases of the Blood . 6th ed . Cham, Switzerland: Springer; 2018 . p . 525-530 .

Ibanez K, Custodio CM . Electrodiagnosis in cancer . In: Stubblefield MD, editor(s) . Cancer Rehabilitation: Principles and Practice . 2nd ed . Springer; 2018 . p . 710-726 .

Janani CS, Avila EK . Other diagnostic tools for neurological disease in cancer: EEG, EMG, and lumbar

puncture .In: Schiff D, Arrillaga I, Wen PY, editor(s) . Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment . 3rd ed . Cham, Switzerland: Springer; 2018 . p . 33-54 .

Kaleva A I, Shaha AR, Nixon IJ . Practical management of thyroid cancer: A multidisciplinary approach-medullary thyroid cancer . In: Mallick UK, Harmer C, Mazzaferri EL, Kendall-Taylor P, editor(s) . Practical Management of Thyroid Cancer: A Multidisciplinary Approach . 2nd ed . Cham, Switzerland: Springer; 2018 . p . 215-222 .

Kissane DW . Psychosocial care of families in palliative care . In: Lloyd-Williams M, editor(s) . Psychosocial Issues in Palliative Care: A Community Based Approach For Life Limiting Illness . 3rd ed . Oxford, United Kingdom: Oxford University Press; 2018 . p . 121-135 .

Kodama H, Srimathveeravalli G, Solomon SB . Irreversible electroporation of lung tumors . In: Meijerink MR, Scheffer HJ, Narayanan G, editor(s) . Irreversible Electroporation in Clinical Practice . Cham, Switzerland: Springer; 2018 . p . 239-245 .

Landau H, Giralt S . Role of hematopoietic cell transplantation for myeloma . In: Wiernik PH, Dutcher JP, Gertz MA, editor(s) . Neoplastic Diseases of the Blood . 6th ed . Cham, Switzerland: Springer; 2018 . p . 573-583 .

Leeman J, Leeman JE, Mansouri M, Singh A . Imaging of upper extremity . In: Singh A, editor(s) . Emergency Radiology: Imaging of Acute Pathologies . 2nd ed . Cham, Switzerland: Springer International Publishing; 2018 .p . 317-334 .

Leeman JE, Romesser P, Melotek J, Cahlon O, Sine K, Both S, Lee NY . Salivary gland tumors . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 153-163 .

Lewis JS, Keshari KR . Preface: Imaging and Metabolism . In: Lewis JS, Keshari KR, editor(s) . Imaging and Metabolism . Cham, Switzerland: Springer; 2018 . p . vii-viii .

Lin AL, DeAngelis LM . The prevalence and impact of neurological disease in cancer . In: Schiff D, Arrillaga I, Wen PY, editor(s) . Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment . 3rd ed . Cham, Switzerland: Springer; 2018 . p . 3-10 .

Lockney DT, Lockney NA, Schmitt A, Yamada J, Bilsky M, Laufer I . Photon irradiation for spinal chordomas and chondrosarcomas . In: Harsh GR 4th, Vaz-Guimaraes F, editor(s) . Chordomas and Chondrosarcomas of the Skull Base and Spine . 2nd ed . Academic Press, Elsevier Inc; 2018 . p . 355-362 .

Lockney NA, Han Z, Sine K, Maes D, Yamada Y . Adult intracranial tumors . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 317-327 .

Ma J, Lok BH, Sine J, Lee NY . Oral cavity tumors . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 117-130 .

Magge R, Diamond EL . Neurologic complications of gastrointestinal cancer . In: Schiff D, Arrillaga I, Wen PY, editor(s) . Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment . 3rd ed . Cham, Switzerland: Springer; 2018 . p . 471-484 .

Mah D, Moyers M, Wang KKH, Diffenderfer E, Cuaron J, Pankuch M . Physics essentials of particle therapy . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 1-16 .

283 OF 288


Book Sections

Marziliano AM, Lichtenthal WG, Prigerson HG . Diagnosis of prolonged grief disorder (PGD) . In: Lloyd-Williams M, editor(s) . Psychosocial Issues in Palliative Care: A Community Based Approach For Life Limiting Illness . Oxford University Press; 2018 . p . 210-226 .

Masterson M, Rosenfeld B, Breitbart W . Meaning-centered psychotherapy for cancer patients with advanced and terminal illness . In: Allen RS, Carpenter BD, Eichorst MK, editor(s) . Perspectives on Behavioural Interventions in Palliative and End-of-Life Care . New York, NY: Routledge/Taylor & Francis Group; 2018 . p . 70-92 .

McFarland DC, Holland J . Depression and cancer . In: Strain JJ, Blumenfield M, editor(s) . Depression as a Systemic Illness . New York, NY: Oxford University Press; 2018 . p . 97-122 .

Mehta RS, Olson A, Ponce DM, Shpall EJ . Unrelated donor cord blood transplantation for hematologic malignancies . In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz J I, Anastasi J, Salama ME, Abutalib SA, editor(s) . Hematology: Basic Principles and Practice . 7th ed . Philadelphia, PA: Elsevier, Inc .; 2018 . p . 1633-1649 .e4 .

Melsaether A, Raad R, Helbich T, Moy L, Pinker K . PET/MRI and molecular imaging in breast cancer . In: Umutlu L, Herrmann K, editor(s) . PET/MR Imaging: Current and Emerging Applications . Cham, Switzerland: Springer; 2018 . p . 83-98 .

Miloushev VZ, Blasberg RG . Brain disorders . In: Lewis JS, Keshari KR, editor(s) . Imaging and Metabolism .Cham, Switzerland: Springer; 2018 . p . 199-222 .

Miyabayashi K, Tuveson DA, Yu KH . Multiparameter modalities for the study of patients in the setting of individualized medicine . In: Neoptolemos JP, Urrutia R, Abbruzzese JL, Buchler MW, editor(s) . Pancreatic Cancer . 2nd ed . New York: Springer; 2018 . p . 1523-1549 .

Mokhtari S, Kaley TJ . Neurologic complications of head and neck cancer . In: Schiff D, Arrillaga I, Wen PY, editor(s) . Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment . 3rd ed . Cham, Switzerland: Springer; 2018 . p . 527-539 .

Molugu TR, Xu X, Leftin A, Lope-Piedrafita S, Martinez G V, Petrache H I, Brown MF . Solid-state deuterium NMR spectroscopy of membranes . In: Webb GA, editor(s) . Modern Magnetic Resonance . 2nd ed . Cham, Switzerland: Springer; 2018 . p . 581-603 .

Mulieri KM, Teusink-Cross A, Weilnau J, Spatz K, Gatwood KS . Medications commonly used in pediatric HSCT .In: Brown V I, editor(s) . Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist .Cham, Switzerland: Springer International Publishing; 2018 . p . 405-448 .

Nakajima M, Modak S . Cancer vaccines in pediatrics . In: Gray JC, Marabelle A, editor(s) . Immunotherapy for Pediatric Malignancies . Cham, Switzerland: Springer International Publishing; 2018 . p . 217-242 .

Nayak L, Grommes C . Neurologic complications of lymphoma . In: Schiff D, Arrillaga I, Wen PY, editor(s) . Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment . 3rd ed . Cham, Switzerland: Springer; 2018 . p . 571-581 .

Patel SH, Xu AJ, Sine K, Lee NY, Fox P . Oropharyngeal cancer . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 131-139 .

Pilewskie M, Cody HS 3rd . Detection and significance of axillary lymph node micrometastases . In: Bland K I, Copeland EM 3rd, Klimberg VS, Gradishar WJ, White J, Korourian S, editor(s) . The Breast: Comprehensive Management of Benign and Malignant Diseases . 5th ed . Philadelphia, PA: Elsevier Inc .; 2018 . p . 631-636 .e2 .

Plusa B, Hadjantonakis AK . Introduction . In: Current Topics in Developmental Biology . Academic Press, Elsevier Inc; 2018 . p . 1-10 .

Pusztaszeri M, Reis-Filho JS, de Lander Schmitt FC, Edelweiss M . Ancillary studies for salivary gland cytology .In: Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DF I, Pusztaszeri M, Vielh P, editor(s) . The Milan System for Reporting Salivary Gland

Cytopathology . Cham, Switzerland: Springer International Publishing; 2018 . p . 139-155 .

Reeves HM, Hong H . Transfusion medicine in obstetrics and prenatal patients . In: Maitta RW, editor(s) . Clinical Principles of Transfusion Medicine . St . Louis, MO: Elsevier; 2018 . p . 119-133 .

Roberts KE, Panjwani AA, Marziliano A, Applebaum AJ, Lichtenthal WG . End-of-life care and cancer: Psychosocial needs of patients and the bereaved . In: Hopewood P, Milroy MJ, editor(s) . Quality Cancer Care: Survivorship Before, During and After Treatment . Cham, Switzerland: Springer; 2018 . p . 243-268 .

Romesser PB, Ju N, Chen CC, Sine K, Cahlon O, Wolden SL . Pediatric tumors . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 381-396 .

Roos E, Vroomen LGPH, van Veldhuisen E, Coelen RJ, van Gulik TM, Meijerink MR . Irreversible electroporation for perihilar cholangiocarcinoma (Klatskin tumors) . In: Meijerink MR, Scheffer HJ, Narayanan G, editor(s) . Irreversible Electroporation in Clinical Practice . Cham, Switzerland: Springer; 2018 . p . 191-200 .

Rusch VW . Superior sulcus tumors . In: Kaiser LR, Thompson SK, Jamieson GG, editor(s) . Operative

284 OF 288


Thoracic Surgery . 6th ed . Boca Raton, FL: CRC Press; 2018 . p . 231-238 .

Sadelain M . Michel Sadelain . In: Canavan N, editor(s) . A Cure Within: Scientists Unleashing the Immune System to Kill Cancer . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2018 . p . 170-181 .

Samstein R, DeBlois D, Mutter RW, Cahlon O . Breast cancer . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 271-287 .

Schuler TA, Roth A, Holland J . Age-related considerations for treating body image issues in cancer patients (older adults) . In: Cororve Fingeret M, Teo I, editor(s) . Body Image Care for Cancer Patients: Principles and Practices . New York, NY: Oxford University Press; 2018 . p . 283-303 .

Sethi S, Pastores SM . Acute respiratory failure in patients with hematologic and solid malignancies: Global approach . In: Esquinas AM, Pravinkumar SE, Soubani AO, editor(s) . Mechanical Ventilation in Critically Ill Cancer Patients: Rationale and Practical Approach . Cham, Switzerland: Springer; 2018 . p . 21-31 .

Setton J, Fox P, Sine K, Riaz N, Lee NY . Tumors of the nasopharynx . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 107-116 .

Shi C, Guo B . 5D dosimetry in radiotherapy planning and delivery . In: Chan MF, editor(s) . Recent Advancements and Applications in Dosimetry . New York: Nova Science Publications, Inc .; 2018 . p . 305-329 .

Sioulas VD, Sonoda Y . Considerations for vulvar cancer . In: Delman KA, Master VA, editor(s) . Malignancies of the Groin: Surgical and Anatomic

Considerations . Cham, Switzerland: Springer International Publishing; 2018 .p . 89-108 .

Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, Liao RG, Andre F, Banks I, Barrett JC, Caldas C, Camargo AA, Fitzgerald RC, Mao M, Mattison JE, Pao W, Sellers WR, Sullivan P, Teh BT, Ward RL, ZenKlusen JC, Sawyers CL, Voest EE . Facilitating a culture of responsible and effective sharing of cancer genome data . In: Caplan AL, Redman . BK, editor(s) . Getting to Good: Research Integrity in the Biomedical Sciences . Cham, Switzerland: Springer; 2018 . p . 539-548 .

Slingerland AE, Stein-Thoeringer CK . Microbiome and diseases: Neurological disorders . In: Haller D, editor(s) . The Gut Microbiome in Health and Disease . Cham, Switzerland: Springer; 2018 . p . 295-310 .

Smith K, Chiu A, Parikh R, Yahalom J, Younes A . Hodgkin lymphoma: Clinical manifestations, staging, and therapy . In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz J I, Anastasi J, Salama ME, Abutalib SA, editor(s) . Hematology: Basic Principles and Practice . 7th ed . Philadelphia, PA: Elsevier, Inc .; 2018 . p . 1212-1229 .

Taylor J, Abdel-Wahab O . Stem cell model of hematologic diseases . In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz J I, Anastasi J, Salama ME, Abutalib SA, editor(s) . Hematology: Basic Principles and Practice . 7th ed . Philadelphia, PA: Elsevier, Inc .; 2018 . p . 111-118 .

Teo MY, O’Reilly EM . Synthetic lethality: Achilles heel in select patient subpopulations . In: Bekaii-Saab T, El-Rayes B, editor(s) . Current and Emerging Therapies in Pancreatic Cancer . Cham, Switzerland: Springer; 2018 .p . 257-270 .

Thiagarajan A, Yamada Y . Primary spine tumors . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 329-346 .

Thompson CB . Foreword for Imaging and Metabolism . In: Lewis JS, Keshari KR, editor(s) . Imaging and Metabolism . Cham, Switzerland: Springer; 2018 . p . v- .

Travis WD, Leslie KO, Beasley MB . Pulmonary vasculitis and pulmonary hemorrhage . In: Leslie KO, Wick MR, editor(s) . Practical Pulmonary Pathology: A Diagnostic Approach . 3rd ed . Philadelphia, PA: Elsevier; 2018 . p . 365-400 .

Vogel JA, Vroomen LGPH, Srimathveeravalli G . The effect of irreversible electroporation on blood vessels, bile ducts, urinary tract, intestines, and nerves . In: Meijerink MR, Scheffer HJ, Narayanan G, editor(s) . Irreversible Electroporation in Clinical Practice . Cham, Switzerland: Springer; 2018 . p . 81-94 .

Wiernik PH, Gallagher RE, Tallman MS . Acute promyelocytic leukemia . In: Wiernik PH, Dutcher JP, Gertz MA, editor(s) . Neoplastic Diseases of the Blood . 6th ed . Cham, Switzerland: Springer; 2018 . p . 409-463 .

Wolchok J . Jedd Wolchok . In: Canavan N, editor(s) . A Cure Within: Scientists Unleashing the Immune System to Kill Cancer . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2018 . p . 12-21 .

Yu H, Bates DDB, Sahani D V . Dual-energy CT in patients with an acute abdomen . In: Patlas M, Katz DS, Scaglione M, editor(s) . MDCT and MR Imaging of Acute Abdomen: New Technologies and Emerging Issues .Cham, Switzerland: Springer; 2018 . p . 23-41 .

Zambirinis CP, Allen PJ . Anatomy of the pancreas and biliary tree . In: Bekaii-Saab T, El-Rayes B, editor(s) . Current and Emerging Therapies in Pancreatic Cancer . Cham, Switzerland: Springer; 2018 . p . 23-47 .

Zeng C, Amos RA, Winey B, Beltran C, Saleh Z, Tochner Z, Kooy H, Both S . Proton treatment planing . In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Target Volume Delineation and

Book Sections

285 OF 288


Treatment Planning for Particle Therapy: A Practical Guide . Cham, Switzerland: Springer; 2018 . p . 45-105 .

Book Sections

286 OF 288

Whole Books (4)


287 OF 288


Whole Books

Recent advancements and applications in dosimetry . Chan MF, editor(s) . New York: Nova Science Publications, Inc .; 2018 . 356 p .

Target volume delineation and treatment planning for particle therapy: A practical guide . Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editor(s) . Cham, Switzerland: Springer; 2018 . 396 p .

Imaging and metabolism . Lewis JS, Keshari KR, editor(s) . Cham, Switzerland: Springer; 2018 . 331 p .

Cancer management: A multidisciplinary approach . 5th ed . Pazdur R, Coia LR, Hoskins WJ, Wagman LD, editor(s) . Melville, NY: PRR, Inc .; 2018 . 982 p .

288 OF 288


Visit Synapse to view works from 1994 to present (excluding in-press papers):

https://synapse .mskcc .org

For more information about this report, contact: Jeanine McSweeney, Associate Librarian, Scholarly Communications 212-639-5427 or mcsweenj@mskcc .org

Contact Information

https://synapse.mskcc.org

2018 Synapse Publications Report...online before print articles . Retrospective content dating back...

Documents

Transcript of 2018 Synapse Publications Report...online before print articles . Retrospective content dating back...